sample_id,temperature,variation_id,label,source_text,variation_text,delta_score_2gram,delta_entropy_2gram,delta_variance_2gram,delta_score_3gram,delta_entropy_3gram,delta_variance_3gram,delta_score_4gram,delta_entropy_4gram,delta_variance_4gram,delta_score_5gram,delta_entropy_5gram,delta_variance_5gram
0,0.3,1,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: There is evidence to suggest that loss of consciousness may be a predictor of neuropsychological deficits following a concussion, however, further research is needed to fully understand the relationship between these factors.","Question: Is loss of consciousness an indicator of neuropsychological impairments after a concussion? Answer: Evidence suggests that loss of consciousness might predict neuropsychological deficits post-concussion, but more research is necessary to clarify this relationship.",2.1317375462116791e-07,0.2591658796885761,0.012853798126951067,0.016320838183036875,0.2573458051012891,0.006842481789802304,0.016297213868575827,0.25489224962878954,0.0,2.1317375462116866e-07,0.2623642644674895,0.0
0,0.3,2,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: There is evidence to suggest that loss of consciousness may be a predictor of neuropsychological deficits following a concussion, however, further research is needed to fully understand the relationship between these factors.","Question: Can loss of consciousness forecast neuropsychological decline following a concussion? Answer: There is some evidence indicating that loss of consciousness could be a predictor of neuropsychological impairments after concussion, although additional studies are required to better understand this connection.",7.105791820705611e-08,0.07918597347650769,0.003632213294375436,0.005440279394345618,0.07865527994541788,0.0019215668371073726,0.0054324046228586,0.07796154146971057,0.0,7.105791820705622e-08,0.08004270767353416,0.0
0,0.3,3,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: There is evidence to suggest that loss of consciousness may be a predictor of neuropsychological deficits following a concussion, however, further research is needed to fully understand the relationship between these factors.","Question: Does experiencing loss of consciousness signal neuropsychological problems after a concussion? Answer: Research indicates that loss of consciousness may predict neuropsychological deficits after a concussion, yet further investigation is needed to fully comprehend the link.",1.6580180914979731e-07,0.23513277055090365,0.037460937499999986,0.012693985253473115,0.1941728480622058,0.005009756657483936,0.01267561078667008,0.19237189264745602,0.0,1.6580180914979784e-07,0.19782574332991798,0.0
0,0.3,4,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: There is evidence to suggest that loss of consciousness may be a predictor of neuropsychological deficits following a concussion, however, further research is needed to fully understand the relationship between these factors.","Question: Is loss of consciousness a predictor of neuropsychological deficits post-concussion? Answer: Current evidence suggests it may be, but more research is needed to thoroughly understand how these factors are related.",2.842316728282238e-07,0.2704582194250289,0.047500000000000014,0.021761117577382513,0.31246417912954483,0.024375,0.021729618491434448,0.356674943938732,0.0,2.8423167282822487e-07,0.36772478012531495,0.0
0,0.3,5,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: There is evidence to suggest that loss of consciousness may be a predictor of neuropsychological deficits following a concussion, however, further research is needed to fully understand the relationship between these factors.","Question: Does loss of consciousness serve as a predictor for neuropsychological impairments following concussion? Answer: There is evidence supporting this possibility, but further research is essential to fully elucidate the relationship.",2.842316728282238e-07,0.2704582194250289,0.047500000000000014,0.021761117577382513,0.31246417912954483,0.024375,0.021729618491434448,0.356674943938732,0.0,2.8423167282822487e-07,0.36772478012531495,0.0
0,0.3,6,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: There is evidence to suggest that loss of consciousness may be a predictor of neuropsychological deficits following a concussion, however, further research is needed to fully understand the relationship between these factors.","Question: Can loss of consciousness after a concussion predict neuropsychological deficits? Answer: Some evidence points to loss of consciousness as a potential predictor, though additional research is required to confirm the association.",2.605457000925385e-07,0.3271067424807397,0.016709274673008298,0.019947691112600634,0.3247724394911926,0.008918697978596915,0.019918816950481574,0.321583624127463,0.0,2.6054570009253947e-07,0.3313571359544403,0.0
0,0.3,7,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: There is evidence to suggest that loss of consciousness may be a predictor of neuropsychological deficits following a concussion, however, further research is needed to fully understand the relationship between these factors.","Question: Is there a link between loss of consciousness and neuropsychological decline after concussion? Answer: Evidence suggests a possible predictive role of loss of consciousness for neuropsychological deficits, but more studies are needed to understand the relationship.",1.42115836414112e-07,0.16515301602662324,0.00786332179930796,0.010880558788691236,0.1640203579443158,0.0041717128027681585,0.010864809245717207,0.16251892949777424,0.0,1.4211583641411244e-07,0.1670540846631643,0.0
0,0.3,8,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: There is evidence to suggest that loss of consciousness may be a predictor of neuropsychological deficits following a concussion, however, further research is needed to fully understand the relationship between these factors.","Question: Does losing consciousness indicate neuropsychological impairments after a concussion? Answer: It appears that loss of consciousness may predict such deficits, however, further research is necessary to clarify this relationship.",3.079176455639091e-07,0.30435977110071066,0.047500000000000014,0.023574544042164393,0.34755549894081383,0.024375,0.02354042003238732,0.3930425881096067,0.0,3.079176455639103e-07,0.40546510810816194,0.0
0,0.3,9,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: There is evidence to suggest that loss of consciousness may be a predictor of neuropsychological deficits following a concussion, however, further research is needed to fully understand the relationship between these factors.","Question: Is loss of consciousness associated with neuropsychological decrements following concussion? Answer: There is some evidence to suggest this association, but more research is required to fully understand the connection.",3.079176455639091e-07,0.30435977110071066,0.047500000000000014,0.023574544042164393,0.34755549894081383,0.024375,0.02354042003238732,0.3930425881096067,0.0,3.079176455639103e-07,0.40546510810816194,0.0
0,0.3,10,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: There is evidence to suggest that loss of consciousness may be a predictor of neuropsychological deficits following a concussion, however, further research is needed to fully understand the relationship between these factors.","Question: Does loss of consciousness predict cognitive deficits after a concussion? Answer: Evidence suggests it might be a predictor of neuropsychological impairments, yet further research is needed to fully grasp the relationship.",2.605457000925385e-07,0.2376683966020372,0.047500000000000014,0.019947691112600634,0.27856262745386307,0.024375,0.019918816950481574,0.321583624127463,0.0,2.6054570009253947e-07,0.3313571359544403,0.0
1,0.3,1,ai,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy is a minimally invasive procedure that involves removing the spleen through the stomach,Question: Is transgastric endoscopic splenectomy feasible? Answer: Transgastric endoscopic splenectomy is a minimally invasive technique that removes the spleen via the stomach.,4.73719454713706e-08,0.1627261447233197,0.05079439573269843,0.003626852929563759,0.16462489786031975,0.049861495844875335,0.003621603081905747,0.10008345855698142,0.0,4.7371945471370706e-08,0.10536051565782545,0.0
1,0.3,2,ai,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy is a minimally invasive procedure that involves removing the spleen through the stomach,Question: Can transgastric endoscopic splenectomy be performed? Answer: Transgastric endoscopic splenectomy is a minimally invasive surgery that extracts the spleen through the stomach.,2.36859727356853e-08,0.11020485479786402,0.046611570247933866,0.0018134264647818796,0.11253403283107888,0.047500000000000014,0.0018108015409528735,0.04879016416943127,0.0,2.3685972735685353e-08,0.05129329438755015,0.0
1,0.3,3,ai,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy is a minimally invasive procedure that involves removing the spleen through the stomach,Question: Is it possible to do a transgastric endoscopic splenectomy? Answer: Transgastric endoscopic splenectomy is a minimally invasive method for spleen removal through the stomach.,2.36859727356853e-08,0.045071017246913314,0.0018005280507428709,0.0018134264647818796,0.04445176257083405,0.0,0.0018108015409528735,0.04652001563489394,0.0,2.3685972735685353e-08,0.04879016416943127,0.0
1,0.3,4,ai,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy is a minimally invasive procedure that involves removing the spleen through the stomach,Question: Does transgastric endoscopic splenectomy work? Answer: Transgastric endoscopic splenectomy is a minimally invasive procedure that removes the spleen by accessing it through the stomach.,2.36859727356853e-08,0.01269124779974895,0.03925619834710741,0.0018134264647818796,0.015821905303944117,0.04338842975206613,0.0018108015409528735,0.04652001563489394,0.0,2.3685972735685353e-08,0.04879016416943127,0.0
1,0.3,5,ai,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy is a minimally invasive procedure that involves removing the spleen through the stomach,Question: Is transgastric endoscopic splenectomy achievable? Answer: Transgastric endoscopic splenectomy is a minimally invasive operation that entails spleen removal through the stomach.,4.73719454713706e-08,0.1627261447233197,0.05079439573269843,0.003626852929563759,0.16462489786031975,0.049861495844875335,0.003621603081905747,0.10008345855698142,0.0,4.7371945471370706e-08,0.10536051565782545,0.0
1,0.3,6,ai,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy is a minimally invasive procedure that involves removing the spleen through the stomach,Question: Can a transgastric endoscopic splenectomy be done? Answer: Transgastric endoscopic splenectomy is a minimally invasive approach to remove the spleen via the stomach.,0.0,0.060273667874777725,0.0427793707014486,0.0,0.06301338005090429,0.04535147392290251,0.0,0.0,0.0,0.0,0.0,0.0
1,0.3,7,ai,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy is a minimally invasive procedure that involves removing the spleen through the stomach,Question: Is transgastric endoscopic splenectomy a viable option? Answer: Transgastric endoscopic splenectomy is a minimally invasive procedure involving spleen removal through the stomach.,2.36859727356853e-08,0.11020485479786402,0.046611570247933866,0.0018134264647818796,0.11253403283107888,0.047500000000000014,0.0018108015409528735,0.04879016416943127,0.0,2.3685972735685353e-08,0.05129329438755015,0.0
1,0.3,8,ai,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy is a minimally invasive procedure that involves removing the spleen through the stomach,Question: Is it feasible to perform transgastric endoscopic splenectomy? Answer: Transgastric endoscopic splenectomy is a minimally invasive technique that removes the spleen through the stomach.,2.36859727356853e-08,0.045071017246913314,0.0018005280507428709,0.0018134264647818796,0.04445176257083405,0.0,0.0018108015409528735,0.04652001563489394,0.0,2.3685972735685353e-08,0.04879016416943127,0.0
1,0.3,9,ai,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy is a minimally invasive procedure that involves removing the spleen through the stomach,Question: Could transgastric endoscopic splenectomy be performed? Answer: Transgastric endoscopic splenectomy is a minimally invasive surgery that extracts the spleen through the stomach.,2.36859727356853e-08,0.11020485479786402,0.046611570247933866,0.0018134264647818796,0.11253403283107888,0.047500000000000014,0.0018108015409528735,0.04879016416943127,0.0,2.3685972735685353e-08,0.05129329438755015,0.0
1,0.3,10,ai,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy is a minimally invasive procedure that involves removing the spleen through the stomach,Question: Is transgastric endoscopic splenectomy possible? Answer: Transgastric endoscopic splenectomy is a minimally invasive procedure that entails removing the spleen via the stomach.,2.36859727356853e-08,0.11020485479786402,0.046611570247933866,0.0018134264647818796,0.11253403283107888,0.047500000000000014,0.0018108015409528735,0.04879016416943127,0.0,2.3685972735685353e-08,0.05129329438755015,0.0
2,0.3,1,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: There may be slight variations in blood pressure measurements between physicians and nurses when treating hypertensive patients, but these differences are generally considered to be minimal and not clinically significant. It is important to ensure that both physicians and nurses follow standardized protocols and use accurate measurement techniques to obtain reliable readings.","Does blood pressure vary in treated hypertensive patients based on whether a physician or a nurse takes the measurement? There might be minor differences in blood pressure readings between physicians and nurses in hypertensive patients, but these variations are usually minimal and not clinically important. Ensuring that both physicians and nurses adhere to standardized protocols and use precise measurement methods is crucial for reliable results.",2.1317375462116866e-07,0.1205975711103271,0.007848752751869949,0.01632083818303691,0.13628197667436304,0.001982752872852607,0.016297213868575813,0.13554549199622468,0.0,2.1317375462116866e-07,0.137621377876048,0.0
2,0.3,2,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: There may be slight variations in blood pressure measurements between physicians and nurses when treating hypertensive patients, but these differences are generally considered to be minimal and not clinically significant. It is important to ensure that both physicians and nurses follow standardized protocols and use accurate measurement techniques to obtain reliable readings.","In treated hypertensive patients, does blood pressure differ when measured by a physician versus a nurse? Slight discrepancies in blood pressure readings between physicians and nurses can occur, but these are typically small and lack clinical significance. It's essential that both healthcare providers follow standardized procedures and accurate techniques to ensure dependable measurements.",4.974054274493935e-07,0.28991389465569073,0.03538700034667487,0.03808195576041938,0.3255863979428453,0.013886133703630229,0.03802683236001021,0.35065687161317083,0.0,4.974054274493935e-07,0.35667494393873156,0.0
2,0.3,3,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: There may be slight variations in blood pressure measurements between physicians and nurses when treating hypertensive patients, but these differences are generally considered to be minimal and not clinically significant. It is important to ensure that both physicians and nurses follow standardized protocols and use accurate measurement techniques to obtain reliable readings.","Is there a difference in blood pressure readings for treated hypertensive patients depending on whether a physician or nurse performs the measurement? Blood pressure measurements may show slight variation between physicians and nurses, but these differences are generally minor and not clinically meaningful. Consistent use of standardized protocols and accurate measurement methods by both is important for reliable readings.",3.552895910352811e-07,0.1779567226619463,0.0373743033336999,0.027201396971728145,0.2143607628326203,0.013886133703630229,0.027162023114293013,0.2373281863061667,0.0,3.552895910352811e-07,0.2411620568168873,0.0
2,0.3,4,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: There may be slight variations in blood pressure measurements between physicians and nurses when treating hypertensive patients, but these differences are generally considered to be minimal and not clinically significant. It is important to ensure that both physicians and nurses follow standardized protocols and use accurate measurement techniques to obtain reliable readings.","For treated hypertensive patients, does blood pressure change based on whether a physician or nurse measures it? There can be small differences in blood pressure values recorded by physicians versus nurses, though these are usually minimal and not clinically relevant. It is vital that both follow standardized measurement protocols and use accurate techniques to ensure trustworthy readings.",4.026615365066519e-07,0.21390167200592547,0.03675913630201309,0.03082824990129189,0.2500788454346994,0.013886133703630229,0.030783626196198746,0.27369583047704094,0.0,4.026615365066519e-07,0.2782033284972374,0.0
2,0.3,5,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: There may be slight variations in blood pressure measurements between physicians and nurses when treating hypertensive patients, but these differences are generally considered to be minimal and not clinically significant. It is important to ensure that both physicians and nurses follow standardized protocols and use accurate measurement techniques to obtain reliable readings.","Do blood pressure readings in treated hypertensive patients differ depending on whether a nurse or physician measures it? Minor variations between measurements taken by physicians and nurses may occur, but these are typically negligible and not clinically significant. Ensuring standardized procedures and precise measurement techniques by both is key to obtaining reliable results.",4.974054274493935e-07,0.26325438771107734,0.05461037597143458,0.03808195576041938,0.3255863979428453,0.013886133703630229,0.03802683236001021,0.35065687161317083,0.0,4.974054274493935e-07,0.35667494393873156,0.0
2,0.3,6,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: There may be slight variations in blood pressure measurements between physicians and nurses when treating hypertensive patients, but these differences are generally considered to be minimal and not clinically significant. It is important to ensure that both physicians and nurses follow standardized protocols and use accurate measurement techniques to obtain reliable readings.","In patients treated for hypertension, does blood pressure vary when measured by a nurse compared to a physician? There may be slight differences in readings between nurses and physicians, but these are generally minimal and not of clinical importance. Both must adhere to standardized protocols and accurate measurement methods to get consistent results.",4.974054274493935e-07,0.26325438771107734,0.05461037597143458,0.03808195576041938,0.3255863979428453,0.013886133703630229,0.03802683236001021,0.35065687161317083,0.0,4.974054274493935e-07,0.35667494393873156,0.0
2,0.3,7,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: There may be slight variations in blood pressure measurements between physicians and nurses when treating hypertensive patients, but these differences are generally considered to be minimal and not clinically significant. It is important to ensure that both physicians and nurses follow standardized protocols and use accurate measurement techniques to obtain reliable readings.","Does the blood pressure of treated hypertensive patients differ when measured by a nurse versus a physician? Small differences might exist between nurse and physician measurements, but these are usually minor and not clinically significant. Following standardized protocols and using accurate techniques by both professionals is important for reliable blood pressure readings.",5.210914001850789e-07,0.30985471594307956,0.03501037597143459,0.039895382225201254,0.34538902523902504,0.013886133703630229,0.03983763390096308,0.37085957893068944,0.0,5.210914001850789e-07,0.3772942311414673,0.0
2,0.3,8,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: There may be slight variations in blood pressure measurements between physicians and nurses when treating hypertensive patients, but these differences are generally considered to be minimal and not clinically significant. It is important to ensure that both physicians and nurses follow standardized protocols and use accurate measurement techniques to obtain reliable readings.","Is blood pressure measurement in treated hypertensive patients influenced by whether a nurse or physician takes the reading? Slight variations can occur between measurements by nurses and physicians, but these differences are generally minimal and not clinically significant. Both should use standardized protocols and precise measurement methods to ensure accuracy.",5.684633456564497e-07,0.3226778081818784,0.05461037597143458,0.043522235154765,0.3862110197592794,0.013886133703630229,0.04345923698286881,0.41253227533125836,0.0,5.684633456564497e-07,0.41985384556026384,0.0
2,0.3,9,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: There may be slight variations in blood pressure measurements between physicians and nurses when treating hypertensive patients, but these differences are generally considered to be minimal and not clinically significant. It is important to ensure that both physicians and nurses follow standardized protocols and use accurate measurement techniques to obtain reliable readings.","In treated hypertensive patients, do blood pressure readings change depending on whether a physician or nurse measures it? There may be minor differences between physician and nurse measurements, but these are typically small and not clinically meaningful. It is important that both use standardized protocols and accurate techniques for reliable readings.",5.447773729207643e-07,0.3024751008643598,0.05461037597143458,0.041708808689983126,0.36559173255654365,0.013886133703630229,0.041648435441915946,0.3914788661334252,0.0,5.447773729207643e-07,0.3983476403393005,0.0
2,0.3,10,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: There may be slight variations in blood pressure measurements between physicians and nurses when treating hypertensive patients, but these differences are generally considered to be minimal and not clinically significant. It is important to ensure that both physicians and nurses follow standardized protocols and use accurate measurement techniques to obtain reliable readings.","Does measuring blood pressure in treated hypertensive patients by a physician versus a nurse lead to differences? Slight variations in blood pressure readings between physicians and nurses may happen, but these are generally minimal and not clinically significant. Ensuring both follow standardized procedures and use accurate measurement methods is essential for reliable results.",4.974054274493935e-07,0.28991389465569073,0.03538700034667487,0.03808195576041938,0.3255863979428453,0.013886133703630229,0.03802683236001021,0.35065687161317083,0.0,4.974054274493935e-07,0.35667494393873156,0.0
3,0.3,1,human,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: For the first time, we identify ESLD etiology as a survival prognostic factor. Renal function (measured by serum creatinine) and urinary sodium (<5 mEq/l) at diagnosis correlate with outcomes.",1.8948778188548304e-07,0.19105523676270808,0.0,0.014507411718254981,0.19574457712609394,0.0,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
3,0.3,2,human,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with,Question: Hepatorenal syndrome: are there overlooked prognostic factors? Answer: We report ESLD etiology as a novel prognostic factor for survival. Renal function indicated by serum creatinine and urinary Na (<5 mEq/l) at diagnosis are linked to prognosis.,2.3685972735685364e-07,0.24512245803298427,0.0,0.018134264647818726,0.2513144282809061,0.0,0.018108015409528673,0.2578291093020999,0.0,2.3685972735685406e-07,0.26469255422708216,0.0
3,0.3,3,human,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with,"Question: Hepatorenal syndrome: could we be missing prognostic indicators? Answer: ESLD etiology is reported for the first time as a prognostic factor for survival. Renal function, shown by serum creatinine, and urinary sodium (<5 mEq/l) at diagnosis are associated with survival.",1.4211583641411244e-07,0.13976194237515838,0.0,0.010880558788691236,0.1431008436406751,0.0,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
3,0.3,4,human,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with,Question: Hepatorenal syndrome: are some prognostic factors being overlooked? Answer: We present ESLD etiology as a new prognostic factor for survival. Renal function (serum creatinine) and urinary Na (<5 mEq/l) at diagnosis are connected to prognosis.,2.6054570009253894e-07,0.2732933349996811,0.0,0.019947691112600606,0.2803019651541576,0.0,0.019918816950481547,0.2876820724517817,0.0,2.6054570009253947e-07,0.29546421289383584,0.0
3,0.3,5,human,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with,"Question: Hepatorenal syndrome: might there be missing prognostic factors? Answer: ESLD etiology is newly reported as a prognostic factor for survival. Renal function, expressed by serum creatinine, and urinary sodium (<5 mEq/l) at diagnosis relate to survival outcomes.",2.1317375462116834e-07,0.21772348384486895,0.0,0.016320838183036854,0.22314355131420927,0.0,0.0162972138685758,0.2288415724288484,0.0,2.1317375462116866e-07,0.23483959107740038,0.0
3,0.3,6,human,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with,"Question: Hepatorenal syndrome: are additional prognostic factors unidentified? Answer: For the first time, ESLD etiology is identified as a prognostic factor for survival. Renal function (serum creatinine) and urinary Na (<5 mEq/l) at diagnosis are associated with prognosis.",2.1317375462116834e-07,0.21772348384486895,0.0,0.016320838183036854,0.22314355131420927,0.0,0.0162972138685758,0.2288415724288484,0.0,2.1317375462116866e-07,0.23483959107740038,0.0
3,0.3,7,human,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with,"Question: Hepatorenal syndrome: do we lack some prognostic factors? Answer: We report ESLD etiology as a prognostic factor for survival for the first time. Renal function, measured by serum creatinine, and urinary sodium (<5 mEq/l) at diagnosis correlate with survival.",1.6580180914979774e-07,0.1650797503594501,0.0,0.012693985253473108,0.16907633004393308,0.0,0.012675610786670066,0.17327172127403623,0.0,1.6580180914979784e-07,0.17768117723745203,0.0
3,0.3,8,human,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with,Question: Hepatorenal syndrome: are there missing prognostic elements? Answer: ESLD etiology is reported for the first time as a survival prognostic factor. Renal function (serum creatinine) and urinary Na (<5 mEq/l) at diagnosis are linked to outcomes.,2.3685972735685364e-07,0.24512245803298427,0.0,0.018134264647818726,0.2513144282809061,0.0,0.018108015409528673,0.2578291093020999,0.0,2.3685972735685406e-07,0.26469255422708216,0.0
3,0.3,9,human,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with,"Question: Hepatorenal syndrome: could some prognostic factors be missing? Answer: We identify ESLD etiology as a novel prognostic factor for survival. Renal function, indicated by serum creatinine, and urinary sodium (<5 mEq/l) at diagnosis are associated with prognosis.",2.1317375462116834e-07,0.21772348384486895,0.0,0.016320838183036854,0.22314355131420927,0.0,0.0162972138685758,0.2288415724288484,0.0,2.1317375462116866e-07,0.23483959107740038,0.0
3,0.3,10,human,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with,"Question: Hepatorenal syndrome: are we overlooking prognostic factors? Answer: For the first time, ESLD etiology is reported as a prognostic factor for survival. Renal function (serum creatinine) and urinary Na (<5 mEq/l) at diagnosis are connected to survival outcomes.",1.8948778188548304e-07,0.19105523676270808,0.0,0.014507411718254981,0.19574457712609394,0.0,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
4,0.3,1,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: There is evidence suggesting that aripiprazole, a medication used to treat schizophrenia and bipolar disorder, may be a risk factor for pathological gambling. Further","Question: Could aripiprazole be a novel risk factor for pathological gambling? Answer: Evidence indicates that aripiprazole, prescribed for schizophrenia and bipolar disorder, might increase the risk of pathological gambling. Further",9.47438909427412e-08,0.003184971378198842,0.09000000000000004,0.007253705859127518,0.04688799505452801,0.06222222222222223,0.007243206163811494,0.09343116554146613,0.0322222222222222,9.474389094274162e-08,0.14310084364067244,0.0
4,0.3,2,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: There is evidence suggesting that aripiprazole, a medication used to treat schizophrenia and bipolar disorder, may be a risk factor for pathological gambling. Further","Question: Is aripiprazole a potential new risk factor for pathological gambling? Answer: Research suggests that aripiprazole, a drug for schizophrenia and bipolar disorder, may contribute to pathological gambling risk. Further",9.47438909427412e-08,0.003184971378198842,0.09000000000000004,0.007253705859127518,0.04688799505452801,0.06222222222222223,0.007243206163811494,0.09343116554146613,0.0322222222222222,9.474389094274162e-08,0.14310084364067244,0.0
4,0.3,3,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: There is evidence suggesting that aripiprazole, a medication used to treat schizophrenia and bipolar disorder, may be a risk factor for pathological gambling. Further","Question: Aripiprazole: is it a newly identified risk factor for pathological gambling? Answer: There is data supporting that aripiprazole, used in treating schizophrenia and bipolar disorder, could be linked to pathological gambling. Further",2.36859727356853e-08,0.09525510143505445,0.09000000000000004,0.0018134264647818796,0.05489469925541446,0.06222222222222223,0.0018108015409528735,0.011929350116359316,0.0322222222222222,2.3685972735685406e-08,0.03390155167568176,0.0
4,0.3,4,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: There is evidence suggesting that aripiprazole, a medication used to treat schizophrenia and bipolar disorder, may be a risk factor for pathological gambling. Further","Question: Could aripiprazole represent a new risk factor for pathological gambling? Answer: Evidence shows that aripiprazole, a medication for schizophrenia and bipolar disorder, may pose a risk for pathological gambling. Further",7.10579182070559e-08,0.015493231739846625,0.05670630202140312,0.005440279394345639,0.011796675243259003,0.06222222222222223,0.005432404622858621,0.05706352137059145,0.0322222222222222,7.105791820705622e-08,0.10536051565782545,0.0
4,0.3,5,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: There is evidence suggesting that aripiprazole, a medication used to treat schizophrenia and bipolar disorder, may be a risk factor for pathological gambling. Further","Question: Is aripiprazole associated with an increased risk of pathological gambling? Answer: Studies suggest that aripiprazole, used in schizophrenia and bipolar disorder treatment, might be a risk factor for pathological gambling. Further",4.73719454713706e-08,0.06350640312047462,0.09000000000000004,0.003626852929563759,0.02210487643242276,0.06222222222222223,0.003621603081905747,0.021972201559322446,0.0322222222222222,4.737194547137081e-08,0.06899287148695077,0.0
4,0.3,6,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: There is evidence suggesting that aripiprazole, a medication used to treat schizophrenia and bipolar disorder, may be a risk factor for pathological gambling. Further","Question: Aripiprazole and pathological gambling: a new risk factor? Answer: There is evidence that aripiprazole, prescribed for schizophrenia and bipolar disorder, may increase the likelihood of pathological gambling. Further",1.184298636784265e-07,0.03827629118946785,0.09000000000000004,0.009067132323909398,0.08325563922540269,0.06222222222222223,0.009054007704764368,0.13117149352431312,0.0322222222222222,1.1842986367842703e-07,0.1823215567939549,0.0
4,0.3,7,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: There is evidence suggesting that aripiprazole, a medication used to treat schizophrenia and bipolar disorder, may be a risk factor for pathological gambling. Further","Question: Could aripiprazole be linked to pathological gambling as a new risk factor? Answer: Research indicates that aripiprazole, a treatment for schizophrenia and bipolar disorder, may be associated with pathological gambling risk. Further",2.36859727356853e-08,0.05193340265005686,0.05878251821019773,0.0018134264647818796,0.05489469925541446,0.06222222222222223,0.0018108015409528735,0.011929350116359316,0.0322222222222222,2.3685972735685406e-08,0.03390155167568176,0.0
4,0.3,8,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: There is evidence suggesting that aripiprazole, a medication used to treat schizophrenia and bipolar disorder, may be a risk factor for pathological gambling. Further","Question: Is aripiprazole a novel contributor to pathological gambling risk? Answer: Evidence suggests that aripiprazole, used in managing schizophrenia and bipolar disorder, might elevate the risk of pathological gambling. Further",9.47438909427412e-08,0.003184971378198842,0.09000000000000004,0.007253705859127518,0.04688799505452801,0.06222222222222223,0.007243206163811494,0.09343116554146613,0.0322222222222222,9.474389094274162e-08,0.14310084364067244,0.0
4,0.3,9,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: There is evidence suggesting that aripiprazole, a medication used to treat schizophrenia and bipolar disorder, may be a risk factor for pathological gambling. Further","Question: Aripiprazole: a potential new risk factor for pathological gambling? Answer: There is data suggesting that aripiprazole, a medication for schizophrenia and bipolar disorder, could be linked to pathological gambling. Further",7.10579182070559e-08,0.03071658029748292,0.09000000000000004,0.005440279394345639,0.011796675243259003,0.06222222222222223,0.005432404622858621,0.05706352137059145,0.0322222222222222,7.105791820705622e-08,0.10536051565782545,0.0
4,0.3,10,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: There is evidence suggesting that aripiprazole, a medication used to treat schizophrenia and bipolar disorder, may be a risk factor for pathological gambling. Further","Question: Could aripiprazole increase the risk of pathological gambling? Answer: Studies show that aripiprazole, used to treat schizophrenia and bipolar disorder, may be a risk factor for pathological gambling. Further",9.47438909427412e-08,0.003184971378198842,0.09000000000000004,0.007253705859127518,0.04688799505452801,0.06222222222222223,0.007243206163811494,0.09343116554146613,0.0322222222222222,9.474389094274162e-08,0.14310084364067244,0.0
5,0.3,1,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis within the Ultra High Risk (UHR) criteria. These levels include basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms. The higher the level of risk, the greater the likelihood of transition to psychosis.","Are there varying degrees of risk for transitioning to psychosis within the Ultra High Risk (UHR) criteria? Yes, the UHR criteria identify different risk levels such as basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms, with higher risk levels indicating a greater chance of developing psychosis.",3.789755637709665e-07,0.1206600913271405,0.14634076770882767,0.029014823436509962,0.13895441789037521,0.109375,0.028972824655245866,0.18669505620761795,0.08002462296091106,3.789755637709665e-07,0.23603296320037348,0.049048751486325794
5,0.3,2,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis within the Ultra High Risk (UHR) criteria. These levels include basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms. The higher the level of risk, the greater the likelihood of transition to psychosis.","Within the Ultra High Risk (UHR) criteria for psychosis, are there distinct risk levels for transition? Yes, the criteria categorize risk into stages including basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms, where increased risk levels correspond to a higher probability of psychosis onset.",4.263475092423373e-07,0.16573110857405204,0.14454023965808482,0.03264167636607371,0.18243952983011358,0.109375,0.0325944277371516,0.23114681877845067,0.08002462296091106,4.263475092423373e-07,0.2814953372771307,0.049048751486325794
5,0.3,3,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis within the Ultra High Risk (UHR) criteria. These levels include basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms. The higher the level of risk, the greater the likelihood of transition to psychosis.","Does the Ultra High Risk (UHR) criteria for psychosis include different risk levels for transition? Indeed, it does, encompassing basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms, with higher risk levels linked to a greater likelihood of progressing to psychosis.",5.210914001850789e-07,0.26244323610118503,0.14042866941015092,0.0398953822252012,0.27552995289612525,0.109375,0.039837633900963065,0.3264569985827763,0.08002462296091106,5.210914001850789e-07,0.3791338068410486,0.049048751486325794
5,0.3,4,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis within the Ultra High Risk (UHR) criteria. These levels include basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms. The higher the level of risk, the greater the likelihood of transition to psychosis.","Are there multiple risk levels for psychosis transition within the Ultra High Risk (UHR) criteria? Yes, these levels include basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms, and higher levels indicate an increased risk of developing psychosis.",5.92149318392135e-07,0.3416292095776927,0.1367964561157755,0.045335661619546816,0.387997290429833,0.08307843316289262,0.045270038523821665,0.4044185400524869,0.08002462296091106,5.921493183921352e-07,0.45917651451458275,0.049048751486325794
5,0.3,5,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis within the Ultra High Risk (UHR) criteria. These levels include basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms. The higher the level of risk, the greater the likelihood of transition to psychosis.","Is there a variation in risk levels for psychosis transition under the Ultra High Risk (UHR) criteria? Yes, the UHR criteria define several risk stages such as basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms, where higher stages mean a greater chance of psychosis transition.",4.026615365066519e-07,0.11344686018298944,0.16666212876742884,0.030828249901291835,0.16046062311133857,0.109375,0.030783626196198732,0.20867396292639295,0.08002462296091106,4.026615365066519e-07,0.2585058190524312,0.049048751486325794
5,0.3,6,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis within the Ultra High Risk (UHR) criteria. These levels include basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms. The higher the level of risk, the greater the likelihood of transition to psychosis.","Within the Ultra High Risk (UHR) criteria, are there different gradations of risk for psychosis transition? Yes, these gradations include basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms, with higher gradations signifying a higher risk of psychosis.",5.92149318392135e-07,0.30608320031820835,0.16230540071209,0.045335661619546816,0.35151585987404665,0.109375,0.045270038523821665,0.4044185400524869,0.08002462296091106,5.921493183921352e-07,0.45917651451458275,0.049048751486325794
5,0.3,7,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis within the Ultra High Risk (UHR) criteria. These levels include basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms. The higher the level of risk, the greater the likelihood of transition to psychosis.","Do the Ultra High Risk (UHR) criteria for psychosis specify different levels of risk for transition? Yes, they do, identifying basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms as levels, with increased risk levels linked to a higher likelihood of psychosis.",4.974054274493935e-07,0.17289872149480656,0.18792866941015093,0.038081955760419325,0.25143240131706523,0.109375,0.0380268323600102,0.3017643859924046,0.08002462296091106,4.974054274493935e-07,0.35381599885675685,0.049048751486325794
5,0.3,8,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis within the Ultra High Risk (UHR) criteria. These levels include basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms. The higher the level of risk, the greater the likelihood of transition to psychosis.","Are there distinct risk categories for psychosis transition in the Ultra High Risk (UHR) criteria? Yes, the categories include basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms, where higher categories correspond to an elevated risk of psychosis.",5.92149318392135e-07,0.30608320031820835,0.16230540071209,0.045335661619546816,0.35151585987404665,0.109375,0.045270038523821665,0.4044185400524869,0.08002462296091106,5.921493183921352e-07,0.45917651451458275,0.049048751486325794
5,0.3,9,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis within the Ultra High Risk (UHR) criteria. These levels include basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms. The higher the level of risk, the greater the likelihood of transition to psychosis.","Does the Ultra High Risk (UHR) criteria differentiate levels of risk for psychosis transition? Yes, it distinguishes levels such as basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms, with higher levels indicating a greater probability of psychosis.",5.92149318392135e-07,0.30608320031820835,0.16230540071209,0.045335661619546816,0.35151585987404665,0.109375,0.045270038523821665,0.4044185400524869,0.08002462296091106,5.921493183921352e-07,0.45917651451458275,0.049048751486325794
5,0.3,10,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis within the Ultra High Risk (UHR) criteria. These levels include basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms. The higher the level of risk, the greater the likelihood of transition to psychosis.","Within the Ultra High Risk (UHR) criteria for psychosis, are there varying risk levels for transition? Yes, these include basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms, with higher risk levels associated with an increased chance of developing psychosis.",5.447773729207643e-07,0.28815088566064073,0.1392764669117946,0.04170880868998307,0.30022256548649695,0.109375,0.04164843544191593,0.35177480656706805,0.08002462296091106,5.447773729207643e-07,0.40510929324430656,0.049048751486325794
6,0.3,1,ai,Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: There is currently no consensus on the optimal time of acid suppression for maximal healing of Los Angeles grades C and D reflux oesophagitis. Further research is needed to determine the most effective duration of acid suppression,"Question: Is there an ideal duration for acid suppression to achieve maximal healing in Los Angeles grades C and D reflux oesophagitis? Answer: At present, no consensus exists regarding the optimal acid suppression time for maximal healing of Los Angeles grades C and D reflux oesophagitis. More studies are required to identify the most effective acid suppression duration.",1.1842986367842703e-07,0.062480863353183036,0.11978920526149964,0.009067132323909363,0.09471916461937058,0.15072177768166092,0.009054007704764333,0.0432162751155718,0.08772010765090354,1.1842986367842703e-07,0.022402366025025433,0.07689350249903885
6,0.3,2,ai,Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: There is currently no consensus on the optimal time of acid suppression for maximal healing of Los Angeles grades C and D reflux oesophagitis. Further research is needed to determine the most effective duration of acid suppression,"Question: What is the best acid suppression period for maximal healing in Los Angeles grades C and D reflux oesophagitis? Answer: Currently, there is no agreed-upon optimal acid suppression time for maximal healing of Los Angeles grades C and D reflux oesophagitis. Additional research is necessary to establish the ideal duration.",2.8423167282822487e-07,0.09001200872421311,0.14247303061347266,0.02176111757738247,0.08478627569535258,0.11908440560963889,0.0217296184914344,0.10761902122088518,0.07735537190082646,2.8423167282822487e-07,0.1279045995476773,0.06872376644710716
6,0.3,3,ai,Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: There is currently no consensus on the optimal time of acid suppression for maximal healing of Los Angeles grades C and D reflux oesophagitis. Further research is needed to determine the most effective duration of acid suppression,Question: Does an optimal acid suppression time exist for maximal healing of Los Angeles grades C and D reflux oesophagitis? Answer: There is no current consensus on the best acid suppression duration for maximal healing of Los Angeles grades C and D reflux oesophagitis. Further investigation is needed to determine the most effective treatment length.,1.8948778188548325e-07,0.04591127837018494,0.12342644723914523,0.014507411718254981,0.0719728067373957,0.07644269398530767,0.014486412327622933,0.12532783901093048,0.011239669421487658,1.8948778188548325e-07,0.14801539104367345,0.001524167437190388
6,0.3,4,ai,Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: There is currently no consensus on the optimal time of acid suppression for maximal healing of Los Angeles grades C and D reflux oesophagitis. Further research is needed to determine the most effective duration of acid suppression,"Question: What is the optimal acid suppression timeframe for maximal healing in Los Angeles grades C and D reflux oesophagitis? Answer: At this time, no consensus has been reached on the ideal acid suppression period for maximal healing of Los Angeles grades C and D reflux oesophagitis. More research is required to find the most effective duration.",1.4211583641411244e-07,0.05005235354724524,0.1589784358711269,0.010880558788691236,0.04924482923736928,0.13169407856680093,0.0108648092457172,0.023000073334756177,0.08640000000000005,1.4211583641411244e-07,0.0022570942695594454,0.07585682429834678
6,0.3,5,ai,Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: There is currently no consensus on the optimal time of acid suppression for maximal healing of Los Angeles grades C and D reflux oesophagitis. Further research is needed to determine the most effective duration of acid suppression,"Question: Is there a preferred duration of acid suppression for maximal healing of Los Angeles grades C and D reflux oesophagitis? Answer: Currently, no consensus exists on the optimal acid suppression time for maximal healing of Los Angeles grades C and D reflux oesophagitis. Further studies are needed to determine the best duration.",2.3685972735685406e-07,0.09451288696009685,0.11748790271341317,0.018134264647818726,0.11967079252270407,0.07078195861678002,0.018108015409528666,0.1730795943864889,0.005804988662131583,2.3685972735685406e-07,0.19578708062162908,0.006632064590542053
6,0.3,6,ai,Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: There is currently no consensus on the optimal time of acid suppression for maximal healing of Los Angeles grades C and D reflux oesophagitis. Further research is needed to determine the most effective duration of acid suppression,Question: Can an optimal acid suppression time be identified for maximal healing of Los Angeles grades C and D reflux oesophagitis? Answer: There is no current agreement on the ideal acid suppression duration for maximal healing of Los Angeles grades C and D reflux oesophagitis. Additional research is necessary to establish the most effective timeframe.,1.8948778188548325e-07,0.04591127837018494,0.12342644723914523,0.014507411718254981,0.0719728067373957,0.07644269398530767,0.014486412327622933,0.12532783901093048,0.011239669421487658,1.8948778188548325e-07,0.14801539104367345,0.001524167437190388
6,0.3,7,ai,Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: There is currently no consensus on the optimal time of acid suppression for maximal healing of Los Angeles grades C and D reflux oesophagitis. Further research is needed to determine the most effective duration of acid suppression,"Question: What is the recommended acid suppression duration for maximal healing in Los Angeles grades C and D reflux oesophagitis? Answer: At present, no consensus exists regarding the optimal acid suppression period for maximal healing of Los Angeles grades C and D reflux oesophagitis. More studies are needed to identify the best treatment duration.",2.1317375462116866e-07,0.01761859201524274,0.1510930103579184,0.016320838183036854,0.015569566959182879,0.1257277554610376,0.0162972138685758,0.040198838810726834,0.08213671344499775,2.1317375462116866e-07,0.06071998338274742,0.07250127880264738
6,0.3,8,ai,Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: There is currently no consensus on the optimal time of acid suppression for maximal healing of Los Angeles grades C and D reflux oesophagitis. Further research is needed to determine the most effective duration of acid suppression,"Question: Is there a consensus on the optimal acid suppression time for maximal healing of Los Angeles grades C and D reflux oesophagitis? Answer: Currently, no agreement has been reached on the ideal acid suppression duration for maximal healing of Los Angeles grades C and D reflux oesophagitis. Further research is required to determine the most effective length of treatment.",7.105791820705622e-08,0.04307723961191323,0.12366834080548636,0.005440279394345618,0.03847212443074621,0.08921177952473505,0.0054324046228586,0.014811863831763805,0.023390254060807997,7.105791820705622e-08,0.03750043154853655,0.009807844706510055
6,0.3,9,ai,Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: There is currently no consensus on the optimal time of acid suppression for maximal healing of Los Angeles grades C and D reflux oesophagitis. Further research is needed to determine the most effective duration of acid suppression,Question: What duration of acid suppression leads to maximal healing in Los Angeles grades C and D reflux oesophagitis? Answer: There is presently no consensus on the optimal acid suppression timeframe for maximal healing of Los Angeles grades C and D reflux oesophagitis. Additional studies are needed to find the most effective duration.,2.3685972735685406e-07,0.014534366126256693,0.16503929134965392,0.018134264647818726,0.010941823023105535,0.14226839818315482,0.018108015409528666,0.062176045496897814,0.08060491493383747,2.3685972735685406e-07,0.08262019399959675,0.07129274112254344
6,0.3,10,ai,Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: There is currently no consensus on the optimal time of acid suppression for maximal healing of Los Angeles grades C and D reflux oesophagitis. Further research is needed to determine the most effective duration of acid suppression,"Question: Is there an optimal time frame for acid suppression to maximize healing in Los Angeles grades C and D reflux oesophagitis? Answer: At this time, no consensus exists on the best acid suppression duration for maximal healing of Los Angeles grades C and D reflux oesophagitis. Further research is necessary to determine the ideal treatment length.",1.4211583641411244e-07,0.09956286644438439,0.19135064233632954,0.010880558788691236,0.07445018125773117,0.1491493055555556,0.0108648092457172,0.02300007333475662,0.08640000000000003,1.4211583641411244e-07,0.0022570942695594454,0.07585682429834681
7,0.3,1,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further","Is it possible to predict discordance between TEOAE and AABR results in newborns? Given current screening methods, some degree of discordance between TEOAE and AABR outcomes may be unavoidable in certain types of hearing loss among seemingly healthy newborns whose mothers had prenatal care. Hence, the limitations of relying on perinatal morbidities for targeted screening in these cases deserve additional investigation.",1.1842986367842703e-07,0.04500245695569527,0.030014675859663886,0.009067132323909363,0.04373597135420315,0.03218960465994872,0.009054007704764333,0.04234784316257789,0.03443877551020409,1.1842986367842703e-07,0.06748659554926473,0.017538265306122455
7,0.3,2,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further","Can discordant results between TEOAE and AABR in newborns be anticipated? With existing screening technologies, discordance between TEOAE and AABR may be inevitable in some hearing loss categories among apparently healthy newborns whose mothers underwent prenatal care. Therefore, the potential shortcomings of using perinatal morbidities as a basis for targeted screening warrant further study.",4.737194547137081e-08,0.06510005977848854,0.02008814524741904,0.0036268529295637453,0.06538722407355735,0.01988807404770383,0.003621603081905733,0.06564852320269532,0.019599999999999992,4.737194547137081e-08,0.03922071315328246,0.0
7,0.3,3,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further","Is discordance in TEOAE and AABR test outcomes predictable in newborn infants? Considering current screening tools, discordant TEOAE and AABR results may be unavoidable for certain types of hearing loss in apparently healthy newborns whose mothers received prenatal care. This suggests that the limitations of perinatal morbidity-based targeted screening need more exploration.",9.474389094274162e-08,0.07946133321722204,0.0028384992665777056,0.0072537058591274906,0.07901481056001103,0.0014797441851465525,0.007243206163811466,0.07847161544149417,0.0,9.474389094274162e-08,0.08004270767353683,0.0
7,0.3,4,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further","Can we predict when TEOAE and AABR outcomes will be discordant in newborns? Given the screening technologies available, some discordance between TEOAE and AABR results is likely inevitable in certain hearing loss categories among apparently healthy newborns with mothers who had prenatal care. Thus, the potential limits of using perinatal morbidities for targeted screening should be further examined.",4.737194547137081e-08,0.03748687923508642,0.0012705324385313826,0.0036268529295637453,0.0372845055208213,0.0006606862828746896,0.003621603081905733,0.037041271680350096,0.0,4.737194547137081e-08,0.03774032798284743,0.0
7,0.3,5,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further","Is it feasible to predict discordance between TEOAE and AABR outcomes in newborns? Current screening methods indicate that discordance between TEOAE and AABR may be unavoidable in some hearing loss types among apparently healthy newborns whose mothers had prenatal care. Therefore, the limitations of perinatal morbidity-based targeted screening merit further research.",1.1842986367842703e-07,0.1558030246531934,0.04308323031358158,0.009067132323909363,0.15636679562165545,0.04245215722350719,0.009054007704764333,0.15685316769089175,0.04158790170132326,1.1842986367842703e-07,0.13059174157604847,0.0212665406427221
7,0.3,6,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further","Are discordant TEOAE and AABR results in newborns predictable? With the screening technologies at hand, discordance between TEOAE and AABR may be inevitable for some hearing loss categories in apparently healthy newborns whose mothers received prenatal care. Consequently, the potential limitations of targeted screening based on perinatal morbidities require additional study.",1.1842986367842703e-07,0.10035125020839786,0.003618700802974578,0.009067132323909363,0.09978335231063973,0.0018873796032593745,0.009054007704764333,0.09909090264422993,0.0,1.1842986367842703e-07,0.10109611687136999,0.0
7,0.3,7,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further","Is it possible to foresee discordance in TEOAE and AABR outcomes among newborns? Given the current screening technologies, some discordance between TEOAE and AABR results may be unavoidable in certain hearing loss cases among apparently healthy newborns whose mothers had prenatal care. Hence, the limitations of targeted screening relying on perinatal morbidities deserve further investigation.",2.3685972735685406e-08,0.019282670224506138,0.0006703937681290656,0.0018134264647818726,0.019176512593258366,0.0003490207932659514,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
7,0.3,8,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further","Can discordance in TEOAE and AABR outcomes be predicted in newborn infants? Considering available screening technologies, discordant TEOAE and AABR results may be inevitable in some hearing loss categories among apparently healthy newborns whose mothers underwent prenatal care. Therefore, the potential shortcomings of perinatal morbidity-based targeted screening should be explored further.",1.1842986367842703e-07,0.10035125020839786,0.003618700802974578,0.009067132323909363,0.09978335231063973,0.0018873796032593745,0.009054007704764333,0.09909090264422993,0.0,1.1842986367842703e-07,0.10109611687136999,0.0
7,0.3,9,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further","Is predicting discordance between TEOAE and AABR outcomes in newborns possible? Given current screening technologies, some discordance between TEOAE and AABR may be unavoidable in certain types of hearing loss among apparently healthy newborns whose mothers received prenatal care. Thus, the limitations of targeted screening based on perinatal morbidities warrant further study.",9.474389094274162e-08,0.13382581796702242,0.041551431802421296,0.0072537058591274906,0.13446658500480613,0.04124361954340325,0.007243206163811466,0.1350550587525099,0.040742417383431435,9.474389094274162e-08,0.10892384019686752,0.020823902218198284
7,0.3,10,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further","Can we anticipate discordance in TEOAE and AABR outcomes in newborns? With the screening technologies available, discordance between TEOAE and AABR may be inevitable for some hearing loss categories among apparently healthy newborns whose mothers had prenatal care. Therefore, the potential limitations of using perinatal morbidities for targeted screening merit further research.",9.474389094274162e-08,0.07946133321722204,0.0028384992665777056,0.0072537058591274906,0.07901481056001103,0.0014797441851465525,0.007243206163811466,0.07847161544149417,0.0,9.474389094274162e-08,0.08004270767353683,0.0
8,0.3,1,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","This article examines whether culture, attitudes, and faith have a role in recovery outcome measures, focusing on the cultural suitability of the RAQ in Australia and highlighting the necessity for comprehensive and inclusive recovery metrics.",4.73719454713706e-08,0.01865023714217351,0.02775510204081633,0.003626852929563759,0.058840500022933284,0.0,0.003621603081905747,0.060624621816435464,0.0,4.737194547137081e-08,0.06252035698133351,0.0
8,0.3,2,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","The paper explores the relevance of culture, attitudes, and faith in recovery outcome assessments, addressing the cultural fit of the RAQ within Australian contexts and emphasizing the importance of creating robust, inclusive recovery measures.",7.10579182070559e-08,0.048503200291855286,0.02775510204081633,0.005440279394345639,0.08961215868968697,0.0,0.005432404622858621,0.09237332013101529,0.0,7.105791820705622e-08,0.09531017980432521,0.0
8,0.3,3,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","This study considers the place of cultural factors, attitudes, and faith in recovery outcome measures, analyzing the RAQ's appropriateness in Australian settings and calling for the development of rigorous, inclusive recovery metrics.",1.184298636784265e-07,0.1110235572731888,0.02775510204081633,0.009067132323909398,0.1541506798272585,0.0,0.009054007704764368,0.15906469462968875,0.0,1.1842986367842703e-07,0.16430305129127598,0.0
8,0.3,4,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","The discussion centers on the cultural relevance of recovery outcome measures, particularly the RAQ's suitability in Australia, and stresses the need for developing thorough and inclusive recovery outcome tools.",1.894877818854824e-07,0.2623167644802704,0.007910192883737847,0.014507411718255037,0.25951119548508395,0.0,0.014486412327622988,0.2682639865946794,0.0,1.8948778188548325e-07,0.2776317365982801,0.0
8,0.3,5,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","This research addresses whether culture, attitudes, and faith should be integrated into recovery outcome measures, evaluating the RAQ's cultural appropriateness in Australia and advocating for the creation of rigorous, inclusive recovery measures.",1.184298636784265e-07,0.1110235572731888,0.02775510204081633,0.009067132323909398,0.1541506798272585,0.0,0.009054007704764368,0.15906469462968875,0.0,1.1842986367842703e-07,0.16430305129127598,0.0
8,0.3,6,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","The paper investigates the role of culture, attitudes, and faith in recovery outcome measures, focusing on the RAQ's cultural fit in Australian settings and underscoring the need for comprehensive, inclusive recovery outcome tools.",9.47438909427412e-08,0.12259655774360656,0.0034623797489859755,0.007253705859127518,0.1213608570042668,0.0,0.007243206163811494,0.125163142954007,0.0,9.474389094274162e-08,0.12921173148000697,0.0
8,0.3,7,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","This article discusses the inclusion of culture, attitudes, and faith in recovery outcome measures, assessing the RAQ's cultural relevance in Australia and identifying the need for rigorous and inclusive recovery metrics.",1.421158364141118e-07,0.1438133800961805,0.02775510204081633,0.010880558788691277,0.18805223150294026,0.0,0.010864809245717241,0.19415601444095776,0.0,1.4211583641411244e-07,0.20067069546215066,0.0
8,0.3,8,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","The study explores the potential for culture, attitudes, and faith to be part of recovery outcome measures, reviewing the RAQ's cultural appropriateness in Australian contexts and highlighting the necessity for inclusive and robust recovery measures.",4.73719454713706e-08,0.01865023714217351,0.02775510204081633,0.003626852929563759,0.058840500022933284,0.0,0.003621603081905747,0.060624621816435464,0.0,4.737194547137081e-08,0.06252035698133351,0.0
8,0.3,9,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","This paper evaluates the place of culture, attitudes, and faith in recovery outcome measures, examining the RAQ's suitability in Australian settings and emphasizing the importance of developing inclusive and rigorous recovery tools.",1.184298636784265e-07,0.1110235572731888,0.02775510204081633,0.009067132323909398,0.1541506798272585,0.0,0.009054007704764368,0.15906469462968875,0.0,1.1842986367842703e-07,0.16430305129127598,0.0
8,0.3,10,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","The discussion focuses on the cultural appropriateness of the RAQ in Australia and the broader need to develop rigorous, inclusive recovery outcome measures that consider culture, attitudes, and faith.",1.894877818854824e-07,0.21280625158313127,0.02775510204081633,0.014507411718255037,0.25951119548508395,0.0,0.014486412327622988,0.2682639865946794,0.0,1.8948778188548325e-07,0.2776317365982801,0.0
9,0.3,1,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Diffusion-weighted echo-planar MR imaging can potentially predict different histologic subtypes of primary parotid gland tumors. However, further research and studies are needed to validate its accuracy and reliability in clinical practice.","Diffusion-weighted echo-planar MR imaging may be able to predict various histologic subtypes of primary parotid gland tumors, but more research is necessary to confirm its clinical accuracy and reliability.",4.974054274493923e-07,0.3332820146913589,0.15704937537180247,0.03808195576041938,0.43095848228690636,0.10275824770146022,0.03802683236001026,0.5330598142792184,0.04246913580246913,4.974054274493935e-07,0.6097655716208945,0.0
9,0.3,2,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Diffusion-weighted echo-planar MR imaging can potentially predict different histologic subtypes of primary parotid gland tumors. However, further research and studies are needed to validate its accuracy and reliability in clinical practice.","The use of diffusion-weighted echo-planar MR imaging shows potential in identifying different histologic subtypes of primary parotid gland tumors, though additional studies are required to validate its effectiveness in practice.",4.7371945471370696e-07,0.29819069488008987,0.15704937537180247,0.0362685292956375,0.3945908381160317,0.10275824770146022,0.03621603081905739,0.49531948629637146,0.04246913580246913,4.737194547137081e-07,0.570544858467612,0.0
9,0.3,3,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Diffusion-weighted echo-planar MR imaging can potentially predict different histologic subtypes of primary parotid gland tumors. However, further research and studies are needed to validate its accuracy and reliability in clinical practice.","Predicting distinct histologic subtypes of primary parotid gland tumors might be possible with diffusion-weighted echo-planar MR imaging, yet further investigation is needed to ensure its clinical reliability.",5.447773729207629e-07,0.40738998684508054,0.15704937537180247,0.04170880868998314,0.5079195234230358,0.10275824770146022,0.04164843544191601,0.6131025219527557,0.04246913580246913,5.447773729207643e-07,0.693147180559945,0.0
9,0.3,4,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Diffusion-weighted echo-planar MR imaging can potentially predict different histologic subtypes of primary parotid gland tumors. However, further research and studies are needed to validate its accuracy and reliability in clinical practice.","Diffusion-weighted echo-planar MR imaging has the potential to differentiate histologic subtypes of primary parotid gland tumors, but more research is essential to establish its accuracy in clinical settings.",5.210914001850776e-07,0.36964965886223355,0.15704937537180247,0.03989538222520126,0.46869881026975335,0.10275824770146022,0.039837633900963135,0.5722805274325009,0.04246913580246913,5.210914001850789e-07,0.6505875661411493,0.0
9,0.3,5,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Diffusion-weighted echo-planar MR imaging can potentially predict different histologic subtypes of primary parotid gland tumors. However, further research and studies are needed to validate its accuracy and reliability in clinical practice.","It is possible that diffusion-weighted echo-planar MR imaging can predict various histologic subtypes of primary parotid gland tumors, although further studies are needed to confirm its clinical utility.",5.210914001850776e-07,0.36964965886223355,0.15704937537180247,0.03989538222520126,0.46869881026975335,0.10275824770146022,0.039837633900963135,0.5722805274325009,0.04246913580246913,5.210914001850789e-07,0.6505875661411493,0.0
9,0.3,6,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Diffusion-weighted echo-planar MR imaging can potentially predict different histologic subtypes of primary parotid gland tumors. However, further research and studies are needed to validate its accuracy and reliability in clinical practice.","The technique of diffusion-weighted echo-planar MR imaging could potentially identify different histologic subtypes of primary parotid gland tumors, but validation through additional research is required.",5.921493183921335e-07,0.4874326945186178,0.15704937537180247,0.0453356616195469,0.5913011323620863,0.10275824770146022,0.045270038523821755,0.7001138989423854,0.04246913580246913,5.921493183921352e-07,0.784118958765673,0.0
9,0.3,7,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Diffusion-weighted echo-planar MR imaging can potentially predict different histologic subtypes of primary parotid gland tumors. However, further research and studies are needed to validate its accuracy and reliability in clinical practice.","Diffusion-weighted echo-planar MR imaging might allow prediction of different histologic subtypes in primary parotid gland tumors, but more clinical studies are necessary to verify its accuracy.",5.684633456564482e-07,0.446610699998363,0.15704937537180247,0.04352223515476502,0.5487415179432906,0.10275824770146022,0.04345923698286888,0.6556621363715514,0.04246913580246913,5.684633456564497e-07,0.737598943130779,0.0
9,0.3,8,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Diffusion-weighted echo-planar MR imaging can potentially predict different histologic subtypes of primary parotid gland tumors. However, further research and studies are needed to validate its accuracy and reliability in clinical practice.","There is potential for diffusion-weighted echo-planar MR imaging to predict histologic subtypes of primary parotid gland tumors, yet its clinical accuracy and reliability need further validation.",5.684633456564482e-07,0.446610699998363,0.15704937537180247,0.04352223515476502,0.5487415179432906,0.10275824770146022,0.04345923698286888,0.6556621363715514,0.04246913580246913,5.684633456564497e-07,0.737598943130779,0.0
9,0.3,9,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Diffusion-weighted echo-planar MR imaging can potentially predict different histologic subtypes of primary parotid gland tumors. However, further research and studies are needed to validate its accuracy and reliability in clinical practice.","Using diffusion-weighted echo-planar MR imaging to predict different histologic subtypes of primary parotid gland tumors is promising, but further research must confirm its clinical effectiveness.",5.921493183921335e-07,0.4874326945186178,0.15704937537180247,0.0453356616195469,0.5913011323620863,0.10275824770146022,0.045270038523821755,0.7001138989423854,0.04246913580246913,5.921493183921352e-07,0.784118958765673,0.0
9,0.3,10,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Diffusion-weighted echo-planar MR imaging can potentially predict different histologic subtypes of primary parotid gland tumors. However, further research and studies are needed to validate its accuracy and reliability in clinical practice.","Diffusion-weighted echo-planar MR imaging could be useful in predicting histologic subtypes of primary parotid gland tumors, though additional studies are required to validate its clinical reliability.",5.684633456564482e-07,0.446610699998363,0.15704937537180247,0.04352223515476502,0.5487415179432906,0.10275824770146022,0.04345923698286888,0.6556621363715514,0.04246913580246913,5.684633456564497e-07,0.737598943130779,0.0
10,0.3,1,ai,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Studies have shown that there is a correlation between end-tidal carbon dioxide measurement and arterial carbon dioxide in extremely low birth weight infants in their first week of life.,Does end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants during their first week of life? Studies indicate a correlation between end-tidal and arterial carbon dioxide in these infants within the first week.,3.316036182995955e-07,0.04680085795817979,0.2405842670501794,0.025387970506946217,0.0968378842870079,0.14549744897959183,0.025351221573340132,0.14520514589062783,0.12643990929705212,3.316036182995957e-07,0.16672190668816533,0.1200648999459167
10,0.3,2,ai,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Studies have shown that there is a correlation between end-tidal carbon dioxide measurement and arterial carbon dioxide in extremely low birth weight infants in their first week of life.,Is there a correlation between end-tidal carbon dioxide levels and arterial carbon dioxide in extremely low birth weight infants in their first week? Research has demonstrated a link between these measurements in such infants during their initial week.,3.552895910352808e-07,0.0487588900112077,0.3762078519961404,0.02720139697172809,0.0493020281443175,0.199375,0.027162023114293,0.13486784615954983,0.15419501133786845,3.552895910352811e-07,0.19570944356141684,0.1200648999459167
10,0.3,3,ai,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Studies have shown that there is a correlation between end-tidal carbon dioxide measurement and arterial carbon dioxide in extremely low birth weight infants in their first week of life.,"In extremely low birth weight infants, does end-tidal carbon dioxide measurement align with arterial carbon dioxide in the first week of life? Evidence shows a correlation between end-tidal and arterial CO2 in this period.",4.50033481978022e-07,0.07019296603507108,0.37294058733564656,0.0344551028308556,0.16708506380070132,0.199375,0.03440522927810449,0.25622870316381663,0.15419501133786845,4.500334819780227e-07,0.32087258651542383,0.1200648999459167
10,0.3,4,ai,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Studies have shown that there is a correlation between end-tidal carbon dioxide measurement and arterial carbon dioxide in extremely low birth weight infants in their first week of life.,Does measuring end-tidal carbon dioxide reflect arterial carbon dioxide levels in extremely low birth weight infants during their first week? Studies confirm a correlation between these two measurements in that timeframe.,5.210914001850779e-07,0.1697040378427901,0.3699203268570496,0.03989538222520124,0.2655251366139546,0.199375,0.039837633900963114,0.3580113974737591,0.15419501133786845,5.210914001850789e-07,0.4262331021732493,0.1200648999459167
10,0.3,5,ai,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Studies have shown that there is a correlation between end-tidal carbon dioxide measurement and arterial carbon dioxide in extremely low birth weight infants in their first week of life.,Is end-tidal carbon dioxide measurement correlated with arterial carbon dioxide in extremely low birth weight infants in their first week? Research findings support a correlation between the two in this early life stage.,4.737194547137073e-07,0.1022774034528866,0.37199654304584423,0.03626852929563748,0.19883376211528114,0.199375,0.03621603081905737,0.28901852598680833,0.15419501133786845,4.737194547137081e-07,0.3547741381911056,0.1200648999459167
10,0.3,6,ai,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Studies have shown that there is a correlation between end-tidal carbon dioxide measurement and arterial carbon dioxide in extremely low birth weight infants in their first week of life.,"For extremely low birth weight infants, is there a correlation between end-tidal and arterial carbon dioxide measurements in the first week? Studies have found a relationship between these values in the initial week of life.",4.263475092423367e-07,0.039104446413803284,0.37382926817816264,0.03264167636607372,0.13631340513394763,0.199375,0.03259442773715162,0.2244800048492368,0.15419501133786845,4.263475092423373e-07,0.28808276369243213,0.1200648999459167
10,0.3,7,ai,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Studies have shown that there is a correlation between end-tidal carbon dioxide measurement and arterial carbon dioxide in extremely low birth weight infants in their first week of life.,Does the measurement of end-tidal carbon dioxide correspond with arterial carbon dioxide in extremely low birth weight infants during their first week? Research has shown a correlation between these parameters in that period.,4.737194547137073e-07,0.1022774034528866,0.37199654304584423,0.03626852929563748,0.19883376211528114,0.199375,0.03621603081905737,0.28901852598680833,0.15419501133786845,4.737194547137081e-07,0.3547741381911056,0.1200648999459167
10,0.3,8,ai,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Studies have shown that there is a correlation between end-tidal carbon dioxide measurement and arterial carbon dioxide in extremely low birth weight infants in their first week of life.,Is there a relationship between end-tidal carbon dioxide and arterial carbon dioxide measurements in extremely low birth weight infants within their first week? Studies indicate a positive correlation in this early phase.,4.974054274493926e-07,0.13542357592181986,0.37099180261342435,0.03808195576041936,0.23162358493827284,0.199375,0.03802683236001024,0.3229200776624901,0.15419501133786845,4.974054274493935e-07,0.3898654580023746,0.1200648999459167
10,0.3,9,ai,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Studies have shown that there is a correlation between end-tidal carbon dioxide measurement and arterial carbon dioxide in extremely low birth weight infants in their first week of life.,"In the first week of life, does end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants? Evidence suggests a correlation between these two measurements in this group.",4.737194547137073e-07,0.1022774034528866,0.37199654304584423,0.03626852929563748,0.19883376211528114,0.199375,0.03621603081905737,0.28901852598680833,0.15419501133786845,4.737194547137081e-07,0.3547741381911056,0.1200648999459167
10,0.3,10,ai,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Studies have shown that there is a correlation between end-tidal carbon dioxide measurement and arterial carbon dioxide in extremely low birth weight infants in their first week of life.,Does end-tidal carbon dioxide measurement match arterial carbon dioxide levels in extremely low birth weight infants during their first week? Research has demonstrated a correlation between these measurements in that timeframe.,5.210914001850779e-07,0.1697040378427901,0.3699203268570496,0.03989538222520124,0.2655251366139546,0.199375,0.039837633900963114,0.3580113974737591,0.15419501133786845,5.210914001850789e-07,0.4262331021732493,0.1200648999459167
11,0.3,1,human,Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be,Question: Does the coexistence of major depression and alcohol use disorder during adolescence result in worse depression outcomes? Answer: Analysis indicates that slightly elevated depression rates up to age 35 in the comorbid MD/AUD group are attributable to greater exposure to adverse childhood conditions within this group. Adolescent MD/AUD comorbidity is likely to be,1.4211583641411244e-07,0.08374901575834537,0.01694411414982164,0.010880558788691236,0.10919929196499112,0.0,0.0108648092457172,0.11122563511022499,0.0,1.4211583641411244e-07,0.11332868530700413,0.0
11,0.3,2,human,Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be,"Question: In adolescents, does having both major depression and alcohol use disorder lead to more severe depression outcomes? Answer: Findings suggest that the marginally increased depression rates by age 35 in the comorbid MD/AUD group stem from heightened exposure to adverse childhood experiences among these individuals. Adolescent MD/AUD comorbidity is likely to be",1.6580180914979784e-07,0.10279721072903847,0.01694411414982164,0.012693985253473108,0.12861737782209381,0.0,0.012675610786670066,0.13102826240640475,0.0,1.6580180914979784e-07,0.13353139262452274,0.0
11,0.3,3,human,Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be,Question: Does comorbidity of major depression and alcohol use disorder in adolescence cause poorer depression outcomes? Answer: The analyses show that the slightly higher depression rates up to age 35 in the comorbid MD/AUD group can be explained by increased exposure to adverse childhood circumstances in this group. Adolescent MD/AUD comorbidity is likely to be,1.1842986367842703e-07,0.06505688274619104,0.01694411414982164,0.009067132323909363,0.09015109699429802,0.0,0.009054007704764333,0.09180754925312229,0.0,1.1842986367842703e-07,0.09352605801082436,0.0
11,0.3,4,human,Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be,Question: Are depression outcomes worse in adolescents with both major depression and alcohol use disorder? Answer: Results suggest that the marginally elevated depression rates through age 35 in the comorbid MD/AUD group are due to greater exposure to adverse childhood environments among these individuals. Adolescent MD/AUD comorbidity is likely to be,2.1317375462116866e-07,0.14201792388232093,0.01694411414982164,0.016320838183036854,0.1686227124357922,0.0,0.0162972138685758,0.17185025692665912,0.0,2.1317375462116866e-07,0.17520408902509166,0.0
11,0.3,5,human,Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be,Question: Does the combination of major depression and alcohol use disorder in adolescence lead to poorer depression outcomes? Answer: The data indicate that the slightly higher depression rates by age 35 in the comorbid MD/AUD group are explained by increased adverse childhood experiences within this population. Adolescent MD/AUD comorbidity is likely to be,1.6580180914979784e-07,0.10279721072903847,0.01694411414982164,0.012693985253473108,0.12861737782209381,0.0,0.012675610786670066,0.13102826240640475,0.0,1.6580180914979784e-07,0.13353139262452274,0.0
11,0.3,6,human,Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be,"Question: In adolescence, does having both major depression and alcohol use disorder result in worse depression outcomes? Answer: The study results suggest that the marginally higher depression rates up to age 35 among the comorbid MD/AUD group are due to greater exposure to adverse childhood conditions. Adolescent MD/AUD comorbidity is likely to be",1.6580180914979784e-07,0.10279721072903847,0.01694411414982164,0.012693985253473108,0.12861737782209381,0.0,0.012675610786670066,0.13102826240640475,0.0,1.6580180914979784e-07,0.13353139262452274,0.0
11,0.3,7,human,Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be,Question: Does adolescent comorbidity of major depression and alcohol use disorder predict poorer depression outcomes? Answer: Findings reveal that the slightly increased depression rates through age 35 in the comorbid MD/AUD group are explained by elevated exposure to adverse childhood circumstances. Adolescent MD/AUD comorbidity is likely to be,2.8423167282822487e-07,0.20389332760040846,0.01694411414982164,0.02176111757738247,0.23180161405732447,0.0,0.0217296184914344,0.23638877806423064,0.0,2.8423167282822487e-07,0.24116205681688774,0.0
11,0.3,8,human,Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be,Question: Is depression outcome poorer in adolescents with both major depression and alcohol use disorder? Answer: The analyses suggest that the marginally higher depression rates by age 35 in the comorbid MD/AUD group result from increased exposure to adverse childhood experiences. Adolescent MD/AUD comorbidity is likely to be,2.8423167282822487e-07,0.20389332760040846,0.01694411414982164,0.02176111757738247,0.23180161405732447,0.0,0.0217296184914344,0.23638877806423064,0.0,2.8423167282822487e-07,0.24116205681688774,0.0
11,0.3,9,human,Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be,Question: Does having major depression and alcohol use disorder together in adolescence lead to worse depression outcomes? Answer: Results indicate that the slightly higher depression rates up to age 35 in the comorbid MD/AUD group are due to greater adverse childhood exposure among these individuals. Adolescent MD/AUD comorbidity is likely to be,1.8948778188548325e-07,0.12221529658614116,0.01694411414982164,0.014507411718254981,0.14842000511827358,0.0,0.014486412327622933,0.15123096972392336,0.0,1.8948778188548325e-07,0.1541506798272585,0.0
11,0.3,10,human,Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be,Question: Are depression outcomes negatively impacted by comorbid major depression and alcohol use disorder in adolescence? Answer: The findings suggest that the marginally elevated depression rates through age 35 in the comorbid MD/AUD group are explained by increased adverse childhood circumstances exposure. Adolescent MD/AUD comorbidity is likely to be,2.6054570009253947e-07,0.1828399184025753,0.01694411414982164,0.0199476911126006,0.2102954088363611,0.0,0.019918816950481533,0.21440987134545564,0.0,2.6054570009253947e-07,0.21868920096483002,0.0
12,0.3,1,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Research has shown that optimism can positively impact health and well-being, including survival rates at advanced ages. Optimistic individuals tend to have better coping strategies, healthier lifestyles, stronger immune function,","Does having an optimistic perspective lead to improved survival rates in older age? Studies indicate that optimism benefits health and longevity, with optimistic people often employing better coping mechanisms, maintaining healthier habits, and exhibiting stronger immune systems.",1.8948778188548283e-07,0.16916400543669896,0.02271498107084911,0.014507411718254981,0.20585205420414887,0.0,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
12,0.3,2,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Research has shown that optimism can positively impact health and well-being, including survival rates at advanced ages. Optimistic individuals tend to have better coping strategies, healthier lifestyles, stronger immune function,","Can optimism predict enhanced survival among the elderly? Research suggests that a positive outlook contributes to better health outcomes and increased survival, as optimistic individuals generally adopt healthier lifestyles, possess stronger immunity, and cope more effectively.",2.1317375462116813e-07,0.1973348824033958,0.02271498107084911,0.01632083818303686,0.23483959107740038,0.0,0.016297213868575813,0.24116205681688774,0.0,2.1317375462116866e-07,0.2478361639045814,0.0
12,0.3,3,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Research has shown that optimism can positively impact health and well-being, including survival rates at advanced ages. Optimistic individuals tend to have better coping strategies, healthier lifestyles, stronger immune function,","Is there a link between optimism and longer survival in advanced age? Evidence shows that optimism supports health and well-being, leading to higher survival rates, as optimistic people usually have superior coping skills, healthier behaviors, and robust immune function.",1.4211583641411222e-07,0.11509678416642277,0.02271498107084911,0.010880558788691236,0.1502822030493367,0.0,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
12,0.3,4,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Research has shown that optimism can positively impact health and well-being, including survival rates at advanced ages. Optimistic individuals tend to have better coping strategies, healthier lifestyles, stronger immune function,","Does an optimistic attitude correlate with better survival chances in later life? Studies reveal that optimism positively influences health and longevity, with optimistic individuals demonstrating better coping strategies, healthier living, and enhanced immune responses.",2.605457000925387e-07,0.2561753824263291,0.02271498107084911,0.01994769111260062,0.29546421289383584,0.0,0.01991881695048156,0.30368241379822125,0.0,2.6054570009253947e-07,0.31237468504215293,0.0
12,0.3,5,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Research has shown that optimism can positively impact health and well-being, including survival rates at advanced ages. Optimistic individuals tend to have better coping strategies, healthier lifestyles, stronger immune function,","Can a hopeful outlook improve survival at older ages? Research has found that optimism enhances health and survival rates, as optimistic individuals tend to manage stress better, lead healthier lives, and have stronger immune systems.",2.3685972735685343e-07,0.2263224192766473,0.02271498107084911,0.01813426464781874,0.26469255422708216,0.0,0.018108015409528687,0.2719337154836414,0.0,2.3685972735685406e-07,0.27958486221916123,0.0
12,0.3,6,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Research has shown that optimism can positively impact health and well-being, including survival rates at advanced ages. Optimistic individuals tend to have better coping strategies, healthier lifestyles, stronger immune function,","Is optimism a predictor of increased survival in advanced age? Findings show that optimism benefits overall health and survival, with optimistic people often exhibiting healthier lifestyles, improved coping abilities, and stronger immunity.",3.0791764556390933e-07,0.3186957394076626,0.02271498107084911,0.02357454404216438,0.36000273403140737,0.0,0.023540420032387308,0.3703737882968947,0.0,3.079176455639103e-07,0.3813675565291037,0.0
12,0.3,7,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Research has shown that optimism can positively impact health and well-being, including survival rates at advanced ages. Optimistic individuals tend to have better coping strategies, healthier lifestyles, stronger immune function,","Does maintaining optimism affect survival rates among the elderly? Research indicates that optimism supports better health and longevity, as optimistic individuals typically have better coping mechanisms, healthier habits, and stronger immune defenses.",3.0791764556390933e-07,0.3186957394076626,0.02271498107084911,0.02357454404216438,0.36000273403140737,0.0,0.023540420032387308,0.3703737882968947,0.0,3.079176455639103e-07,0.3813675565291037,0.0
12,0.3,8,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Research has shown that optimism can positively impact health and well-being, including survival rates at advanced ages. Optimistic individuals tend to have better coping strategies, healthier lifestyles, stronger immune function,","Can a positive mindset lead to better survival outcomes in old age? Studies demonstrate that optimism improves health and survival, with optimistic individuals generally having healthier lifestyles, stronger immune function, and effective coping strategies.",2.605457000925387e-07,0.2561753824263291,0.02271498107084911,0.01994769111260062,0.29546421289383584,0.0,0.01991881695048156,0.30368241379822125,0.0,2.6054570009253947e-07,0.31237468504215293,0.0
12,0.3,9,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Research has shown that optimism can positively impact health and well-being, including survival rates at advanced ages. Optimistic individuals tend to have better coping strategies, healthier lifestyles, stronger immune function,","Is there evidence that optimism enhances survival at advanced ages? Research suggests that optimism contributes to improved health and longevity, as optimistic people often adopt healthier behaviors, possess stronger immunity, and cope more effectively.",2.605457000925387e-07,0.29818430246026484,0.00755845642915089,0.01994769111260062,0.29546421289383584,0.0,0.01991881695048156,0.30368241379822125,0.0,2.6054570009253947e-07,0.31237468504215293,0.0
12,0.3,10,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Research has shown that optimism can positively impact health and well-being, including survival rates at advanced ages. Optimistic individuals tend to have better coping strategies, healthier lifestyles, stronger immune function,","Does an optimistic outlook predict greater survival in later years? Studies confirm that optimism positively impacts health and survival rates, with optimistic individuals showing better coping skills, healthier lifestyles, and stronger immune systems.",2.84231672828224e-07,0.2869470410930828,0.02271498107084911,0.0217611175773825,0.32721291120841567,0.0,0.021729618491434434,0.33647223662121295,0.0,2.8423167282822487e-07,0.3462762367178347,0.0
13,0.3,1,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk,Is the initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia a predictor of adverse maternal and neonatal outcomes? ACR independently predicts negative outcomes for both mother and newborn in suspected preeclampsia cases and may help assess risk.,1.4211583641411222e-07,0.04243666596083662,0.13296398891966765,0.010880558788691236,0.010914815685533874,0.11426592797783926,0.0108648092457172,0.0221226454348864,0.09418282548476452,1.4211583641411244e-07,0.05678783245002439,0.07271468144044323
13,0.3,2,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk,Does the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia serve as a prognostic indicator for adverse maternal and neonatal outcomes? ACR acts as an independent prognostic marker for poor outcomes in both mother and baby and could be valuable for risk assessment.,0.0,0.18904014015271198,0.13296398891966765,0.0,0.16119701873487058,0.11426592797783926,0.0,0.1320280343923712,0.09418282548476452,0.0,0.10143617276487005,0.07271468144044323
13,0.3,3,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk,Can the initial urinary albumin/creatinine ratio (ACR) in women suspected of having preeclampsia predict maternal and neonatal adverse outcomes? ACR is an independent prognostic factor for such outcomes and may assist in evaluating risk.,2.605457000925387e-07,0.0986419322990697,0.13296398891966765,0.01994769111260062,0.13426719415896526,0.11426592797783926,0.01991881695048156,0.17165437940585004,0.09418282548476452,2.6054570009253947e-07,0.21093851227728289,0.07271468144044323
13,0.3,4,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk,Is the first urinary albumin/creatinine ratio (ACR) measurement in women with suspected preeclampsia a useful prognostic tool for maternal and neonatal complications? ACR independently forecasts adverse outcomes and might be helpful for risk stratification.,2.605457000925387e-07,0.0986419322990697,0.13296398891966765,0.01994769111260062,0.13426719415896526,0.11426592797783926,0.01991881695048156,0.17165437940585004,0.09418282548476452,2.6054570009253947e-07,0.21093851227728289,0.07271468144044323
13,0.3,5,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk,Does the initial ACR in women suspected of preeclampsia predict poor maternal and neonatal outcomes? ACR is an independent prognostic factor and could be useful for informing risk.,4.0266153650665053e-07,0.29931262776122036,0.13296398891966765,0.030828249901291897,0.3419065589372092,0.11426592797783926,0.0307836261961988,0.38676575902279664,0.09418282548476452,4.026615365066519e-07,0.4340820635914926,0.07271468144044323
13,0.3,6,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk,Is the first urinary albumin/creatinine ratio (ACR) in suspected preeclampsia cases an independent predictor of adverse outcomes for mother and newborn? ACR may be valuable in risk assessment for maternal and neonatal complications.,2.84231672828224e-07,0.1294135909658234,0.13296398891966765,0.0217611175773825,0.1660158924735451,0.11426592797783926,0.021729618491434434,0.20444420222884174,0.09418282548476452,2.8423167282822487e-07,0.24484006395296465,0.07271468144044323
13,0.3,7,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk,Can the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia independently predict adverse maternal and neonatal outcomes? ACR is a prognostic factor that may help guide risk evaluation.,3.5528959103527993e-07,0.22785366377907668,0.13296398891966765,0.027201396971728138,0.26779858678348756,0.11426592797783926,0.027162023114293055,0.3098047178866672,0.09418282548476452,3.552895910352811e-07,0.3540393559179553,0.07271468144044323
13,0.3,8,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk,Is the initial urinary ACR in women suspected of preeclampsia a prognostic marker for negative maternal and neonatal outcomes? ACR independently predicts these outcomes and may be useful for risk assessment.,3.3160361829959463e-07,0.1939521121033949,0.13296398891966765,0.02538797050694626,0.23270726697221855,0.11426592797783926,0.02535122157334018,0.2734370737157925,0.09418282548476452,3.316036182995957e-07,0.31629902793510833,0.07271468144044323
13,0.3,9,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk,Does the first urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia serve as an independent prognostic factor for adverse maternal and neonatal events? ACR may help inform risk management.,3.5528959103527993e-07,0.22785366377907668,0.13296398891966765,0.027201396971728138,0.26779858678348756,0.11426592797783926,0.027162023114293055,0.3098047178866672,0.09418282548476452,3.552895910352811e-07,0.3540393559179553,0.07271468144044323
13,0.3,10,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk,Is the initial urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia an independent predictor of adverse outcomes for mother and child? ACR might be useful in assessing risk for maternal and neonatal complications.,2.605457000925387e-07,0.0986419322990697,0.13296398891966765,0.01994769111260062,0.13426719415896526,0.11426592797783926,0.01991881695048156,0.17165437940585004,0.09418282548476452,2.6054570009253947e-07,0.21093851227728289,0.07271468144044323
14,0.3,1,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening methods, such as liquid-based cytology, can effectively detect glandular cell abnormalities in Pap smears. However, further evaluation and confirmation through specialized testing, such as colposcopy and biopsy, are often required for accurate diagnosis and appropriate management.","Are glandular cell abnormalities in Pap smears detected by rapid prescreening? Rapid prescreening techniques like liquid-based cytology can identify glandular cell abnormalities in Pap smears, but accurate diagnosis and proper management usually need further specialized tests such as colposcopy and biopsy.",2.6054570009253947e-07,0.32721112997257773,0.059615078079606774,0.0199476911126006,0.3550993870769532,0.0763888888888889,0.019918816950481533,0.3271969994958135,0.05246913580246914,2.6054570009253947e-07,0.2977505134290679,0.027006172839506164
14,0.3,2,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening methods, such as liquid-based cytology, can effectively detect glandular cell abnormalities in Pap smears. However, further evaluation and confirmation through specialized testing, such as colposcopy and biopsy, are often required for accurate diagnosis and appropriate management.","Do rapid prescreening methods detect glandular cell abnormalities in Pap smears? Yes, rapid prescreening methods including liquid-based cytology can detect glandular cell abnormalities, though confirmation with additional tests like colposcopy and biopsy is often necessary for precise diagnosis and treatment.",2.8423167282822477e-07,0.3560835388828174,0.06207413577675971,0.02176111757738247,0.3473997068133321,0.05246913580246914,0.0217296184914344,0.2809023854664012,0.0,2.8423167282822487e-07,0.2876820724517808,0.0
14,0.3,3,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening methods, such as liquid-based cytology, can effectively detect glandular cell abnormalities in Pap smears. However, further evaluation and confirmation through specialized testing, such as colposcopy and biopsy, are often required for accurate diagnosis and appropriate management.","Can rapid prescreening identify glandular cell abnormalities in Pap smears? Rapid prescreening approaches, for example liquid-based cytology, are capable of detecting glandular cell abnormalities in Pap smears, but further specialized testing such as colposcopy and biopsy is typically required for definitive diagnosis and management.",1.8948778188548325e-07,0.277458051015834,0.07511557395868057,0.014507411718254981,0.2733744129390563,0.0710059171597633,0.014486412327622933,0.2458723465828987,0.04865220249835634,1.8948778188548325e-07,0.21697891582195128,0.02498356344510192
14,0.3,4,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening methods, such as liquid-based cytology, can effectively detect glandular cell abnormalities in Pap smears. However, further evaluation and confirmation through specialized testing, such as colposcopy and biopsy, are often required for accurate diagnosis and appropriate management.","Are glandular cell abnormalities found in Pap smears through rapid prescreening? Rapid prescreening methods such as liquid-based cytology can effectively detect these abnormalities, yet further evaluation with specialized procedures like colposcopy and biopsy is commonly needed for accurate diagnosis and treatment planning.",2.3685972735685406e-07,0.16388908127021784,0.039150354019158694,0.018134264647818726,0.22314355131420927,0.0,0.018108015409528666,0.22825865198098239,0.0,2.3685972735685406e-07,0.2336148511815046,0.0
14,0.3,5,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening methods, such as liquid-based cytology, can effectively detect glandular cell abnormalities in Pap smears. However, further evaluation and confirmation through specialized testing, such as colposcopy and biopsy, are often required for accurate diagnosis and appropriate management.","Is rapid prescreening effective in detecting glandular cell abnormalities in Pap smears? Techniques like liquid-based cytology used in rapid prescreening can detect glandular cell abnormalities, but confirmation through specialized tests such as colposcopy and biopsy is usually necessary for accurate diagnosis and management.",2.1317375462116866e-07,0.20580554688734187,0.00834964598084132,0.016320838183036854,0.19845093872383757,0.0,0.0162972138685758,0.20294084399669066,0.0,2.1317375462116866e-07,0.20763936477824663,0.0
14,0.3,6,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening methods, such as liquid-based cytology, can effectively detect glandular cell abnormalities in Pap smears. However, further evaluation and confirmation through specialized testing, such as colposcopy and biopsy, are often required for accurate diagnosis and appropriate management.","Do Pap smears with glandular cell abnormalities get detected by rapid prescreening? Rapid prescreening methods, including liquid-based cytology, can detect glandular cell abnormalities, but further specialized testing like colposcopy and biopsy is often required for precise diagnosis and appropriate treatment.",2.8423167282822477e-07,0.2494455111043652,0.01352708532109774,0.02176111757738247,0.27443684570175897,0.0,0.0217296184914344,0.2809023854664012,0.0,2.8423167282822487e-07,0.2876820724517808,0.0
14,0.3,7,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening methods, such as liquid-based cytology, can effectively detect glandular cell abnormalities in Pap smears. However, further evaluation and confirmation through specialized testing, such as colposcopy and biopsy, are often required for accurate diagnosis and appropriate management.","Can glandular cell abnormalities in Pap smears be detected by rapid prescreening? Yes, rapid prescreening methods such as liquid-based cytology can detect these abnormalities, although further evaluation through specialized tests like colposcopy and biopsy is generally needed for accurate diagnosis and management.",2.3685972735685406e-07,0.16388908127021784,0.039150354019158694,0.018134264647818726,0.22314355131420927,0.0,0.018108015409528666,0.22825865198098239,0.0,2.3685972735685406e-07,0.2336148511815046,0.0
14,0.3,8,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening methods, such as liquid-based cytology, can effectively detect glandular cell abnormalities in Pap smears. However, further evaluation and confirmation through specialized testing, such as colposcopy and biopsy, are often required for accurate diagnosis and appropriate management.","Are glandular cell abnormalities in Pap smears identified by rapid prescreening? Rapid prescreening techniques, for example liquid-based cytology, can detect glandular cell abnormalities, but additional specialized testing such as colposcopy and biopsy is often necessary for accurate diagnosis and treatment.",2.8423167282822477e-07,0.2494455111043652,0.01352708532109774,0.02176111757738247,0.27443684570175897,0.0,0.0217296184914344,0.2809023854664012,0.0,2.8423167282822487e-07,0.2876820724517808,0.0
14,0.3,9,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening methods, such as liquid-based cytology, can effectively detect glandular cell abnormalities in Pap smears. However, further evaluation and confirmation through specialized testing, such as colposcopy and biopsy, are often required for accurate diagnosis and appropriate management.","Does rapid prescreening detect glandular cell abnormalities in Pap smears? Rapid prescreening methods like liquid-based cytology can detect glandular cell abnormalities, but further confirmation through specialized tests such as colposcopy and biopsy is typically required for accurate diagnosis and management.",2.8423167282822477e-07,0.3205375296233335,0.0372385348697302,0.02176111757738247,0.3109182762575453,0.026296566837107373,0.0217296184914344,0.2809023854664012,0.0,2.8423167282822487e-07,0.2876820724517808,0.0
14,0.3,10,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening methods, such as liquid-based cytology, can effectively detect glandular cell abnormalities in Pap smears. However, further evaluation and confirmation through specialized testing, such as colposcopy and biopsy, are often required for accurate diagnosis and appropriate management.","Is detection of glandular cell abnormalities in Pap smears possible through rapid prescreening? Yes, rapid prescreening methods including liquid-based cytology can detect these abnormalities, but further specialized evaluation such as colposcopy and biopsy is often needed for accurate diagnosis and proper management.",2.3685972735685406e-07,0.16388908127021784,0.039150354019158694,0.018134264647818726,0.22314355131420927,0.0,0.018108015409528666,0.22825865198098239,0.0,2.3685972735685406e-07,0.2336148511815046,0.0
15,0.3,1,ai,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider service networks (PSNs) have been found to result in lower expenditures compared to Health Maintenance Organizations (HMOs) or primary care case management in Florida's Medicaid program. This is due to the increased flexibility and efficiency offered,Do provider service networks lead to reduced costs compared to HMOs or primary care case management within Florida's Medicaid program?,9.237529366917287e-07,0.8052828814737958,0.2054320987654321,0.07072363212649316,0.9094699728998084,0.16749660479855144,0.07062126009716192,1.0188515515389467,0.12244897959183676,9.237529366917306e-07,1.1087177028908815,0.08999999999999998
15,0.3,2,ai,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider service networks (PSNs) have been found to result in lower expenditures compared to Health Maintenance Organizations (HMOs) or primary care case management in Florida's Medicaid program. This is due to the increased flexibility and efficiency offered,Are expenditures lower with provider service networks than with HMOs or primary care case management in Florida's Medicaid program?,9.474389094274141e-07,0.8593501027440711,0.2054320987654321,0.07253705859127503,0.9666283867397572,0.16749660479855144,0.07243206163811479,1.0794761733553817,0.12244897959183676,9.474389094274159e-07,1.173256224028452,0.08999999999999998
15,0.3,3,ai,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider service networks (PSNs) have been found to result in lower expenditures compared to Health Maintenance Organizations (HMOs) or primary care case management in Florida's Medicaid program. This is due to the increased flexibility and efficiency offered,"In Florida's Medicaid program, do provider service networks incur less spending than HMOs or primary care case management?",9.711248821630993e-07,0.9165085165840199,0.2054320987654321,0.0743504850560569,1.0272530085561922,0.16749660479855144,0.07424286317906767,1.1440146944929523,0.12244897959183676,9.711248821631012e-07,1.2422490955154042,0.08999999999999998
15,0.3,4,ai,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider service networks (PSNs) have been found to result in lower expenditures compared to Health Maintenance Organizations (HMOs) or primary care case management in Florida's Medicaid program. This is due to the increased flexibility and efficiency offered,Does Florida's Medicaid program see decreased expenditures when using provider service networks versus HMOs or primary care case management?,9.474389094274141e-07,0.8593501027440711,0.2054320987654321,0.07253705859127503,0.9666283867397572,0.16749660479855144,0.07243206163811479,1.0794761733553817,0.12244897959183676,9.474389094274159e-07,1.173256224028452,0.08999999999999998
15,0.3,5,ai,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider service networks (PSNs) have been found to result in lower expenditures compared to Health Maintenance Organizations (HMOs) or primary care case management in Florida's Medicaid program. This is due to the increased flexibility and efficiency offered,Are provider service networks associated with lower costs compared to HMOs or primary care case management in Florida's Medicaid program?,9.237529366917287e-07,0.8052828814737958,0.2054320987654321,0.07072363212649316,0.9094699728998084,0.16749660479855144,0.07062126009716192,1.0188515515389467,0.12244897959183676,9.237529366917306e-07,1.1087177028908815,0.08999999999999998
15,0.3,6,ai,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider service networks (PSNs) have been found to result in lower expenditures compared to Health Maintenance Organizations (HMOs) or primary care case management in Florida's Medicaid program. This is due to the increased flexibility and efficiency offered,"Within Florida's Medicaid program, do provider service networks result in cost savings compared to HMOs or primary care case management?",9.237529366917287e-07,0.8052828814737958,0.2054320987654321,0.07072363212649316,0.9094699728998084,0.16749660479855144,0.07062126009716192,1.0188515515389467,0.12244897959183676,9.237529366917306e-07,1.1087177028908815,0.08999999999999998
15,0.3,7,ai,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider service networks (PSNs) have been found to result in lower expenditures compared to Health Maintenance Organizations (HMOs) or primary care case management in Florida's Medicaid program. This is due to the increased flexibility and efficiency offered,Do provider service networks reduce Medicaid expenditures in Florida more than HMOs or primary care case management?,9.948108548987847e-07,0.9771331384004549,0.2054320987654321,0.07616391152083878,1.0917915296937628,0.16749660479855144,0.07605366472002054,1.2130075659799044,0.12244897959183676,9.948108548987866e-07,1.3163570676691254,0.08999999999999998
15,0.3,8,ai,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider service networks (PSNs) have been found to result in lower expenditures compared to Health Maintenance Organizations (HMOs) or primary care case management in Florida's Medicaid program. This is due to the increased flexibility and efficiency offered,Is spending lower under provider service networks than under HMOs or primary care case management in Florida's Medicaid program?,9.474389094274141e-07,0.8593501027440711,0.2054320987654321,0.07253705859127503,0.9666283867397572,0.16749660479855144,0.07243206163811479,1.0794761733553817,0.12244897959183676,9.474389094274159e-07,1.173256224028452,0.08999999999999998
15,0.3,9,ai,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider service networks (PSNs) have been found to result in lower expenditures compared to Health Maintenance Organizations (HMOs) or primary care case management in Florida's Medicaid program. This is due to the increased flexibility and efficiency offered,Do provider service networks offer cost advantages over HMOs or primary care case management in Florida's Medicaid program?,9.711248821630993e-07,0.9165085165840199,0.2054320987654321,0.0743504850560569,1.0272530085561922,0.16749660479855144,0.07424286317906767,1.1440146944929523,0.12244897959183676,9.711248821631012e-07,1.2422490955154042,0.08999999999999998
15,0.3,10,ai,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider service networks (PSNs) have been found to result in lower expenditures compared to Health Maintenance Organizations (HMOs) or primary care case management in Florida's Medicaid program. This is due to the increased flexibility and efficiency offered,"In Florida's Medicaid program, do provider service networks produce lower expenditures relative to HMOs or primary care case management?",9.474389094274141e-07,0.8593501027440711,0.2054320987654321,0.07253705859127503,0.9666283867397572,0.16749660479855144,0.07243206163811479,1.0794761733553817,0.12244897959183676,9.474389094274159e-07,1.173256224028452,0.08999999999999998
16,0.3,1,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery can be effective in certain cases, as it helps to relieve pressure and promote healing. However, the","Question: Is lumbar drainage effective for postoperative cerebrospinal fluid fistula following spine surgery? Answer: Lumbar drainage can be beneficial in some cases of postoperative cerebrospinal fluid fistula after spine surgery by reducing pressure and aiding recovery. However, the",7.10579182070559e-08,0.08408502912065297,0.09951563692931589,0.005440279394345618,0.12730901300679065,0.13610389984481283,0.0054324046228586,0.1335235053358219,0.1462711852201247,7.105791820705622e-08,0.14024710296435083,0.1560874089490115
16,0.3,2,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery can be effective in certain cases, as it helps to relieve pressure and promote healing. However, the","Question: Does lumbar drainage work for postoperative cerebrospinal fluid fistula after spine surgery? Answer: Lumbar drainage may be effective in certain instances of postoperative cerebrospinal fluid fistula after spine surgery by alleviating pressure and supporting healing. However, the",7.10579182070559e-08,0.009150198789849462,0.049947970863683605,0.005440279394345618,0.050292659611240964,0.0820922216441208,0.0054324046228586,0.0543066847003999,0.08985696052289285,7.105791820705622e-08,0.05870037583965093,0.09749365894901149
16,0.3,3,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery can be effective in certain cases, as it helps to relieve pressure and promote healing. However, the","Question: Can lumbar drainage treat postoperative cerebrospinal fluid fistula after spine surgery? Answer: In some cases, lumbar drainage is effective for postoperative cerebrospinal fluid fistula after spine surgery as it helps decrease pressure and facilitates healing. However, the",7.10579182070559e-08,0.009150198789849462,0.04994797086368363,0.005440279394345618,0.050292659611240964,0.0820922216441208,0.0054324046228586,0.054306684700399455,0.08985696052289285,7.105791820705622e-08,0.05870037583965093,0.09749365894901149
16,0.3,4,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery can be effective in certain cases, as it helps to relieve pressure and promote healing. However, the","Question: Is lumbar drainage a successful treatment for postoperative cerebrospinal fluid fistula after spine surgery? Answer: Lumbar drainage can sometimes be effective in managing postoperative cerebrospinal fluid fistula after spine surgery by relieving pressure and encouraging healing. However, the",4.73719454713706e-08,0.04173435352970456,0.053691629812695124,0.0036268529295637453,0.08185467992884465,0.08494747876074157,0.003621603081905733,0.08577826252690546,0.09217326992371931,4.737194547137081e-08,0.09001781920218033,0.0991544429251364
16,0.3,5,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery can be effective in certain cases, as it helps to relieve pressure and promote healing. However, the","Question: How effective is lumbar drainage for postoperative cerebrospinal fluid fistula after spine surgery? Answer: Lumbar drainage may prove effective in certain postoperative cerebrospinal fluid fistula cases after spine surgery by reducing pressure and promoting tissue repair. However, the",4.73719454713706e-08,0.07821578408549135,0.07747706943620294,0.0036268529295637453,0.15678951025964993,0.13758967062371263,0.003621603081905733,0.16279461592245514,0.14706279598207653,4.737194547137081e-08,0.16923463983760234,0.1560874089490115
16,0.3,6,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery can be effective in certain cases, as it helps to relieve pressure and promote healing. However, the","Question: Does lumbar drainage help with postoperative cerebrospinal fluid fistula after spine surgery? Answer: Lumbar drainage can be helpful in some postoperative cerebrospinal fluid fistula cases following spine surgery by lowering pressure and aiding the healing process. However, the",4.73719454713706e-08,0.11469721464127769,0.1022291514389927,0.0036268529295637453,0.15678951025964993,0.13758967062371263,0.003621603081905733,0.16279461592245514,0.14706279598207653,4.737194547137081e-08,0.16923463983760234,0.1560874089490115
16,0.3,7,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery can be effective in certain cases, as it helps to relieve pressure and promote healing. However, the","Question: Is lumbar drainage beneficial for postoperative cerebrospinal fluid fistula after spine surgery? Answer: Lumbar drainage is effective in select cases of postoperative cerebrospinal fluid fistula after spine surgery as it assists in pressure relief and healing. However, the",4.73719454713706e-08,0.04173435352970456,0.053691629812695124,0.0036268529295637453,0.08185467992884465,0.08494747876074157,0.003621603081905733,0.08577826252690546,0.09217326992371931,4.737194547137081e-08,0.09001781920218033,0.0991544429251364
16,0.3,8,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery can be effective in certain cases, as it helps to relieve pressure and promote healing. However, the","Question: Can lumbar drainage effectively treat postoperative cerebrospinal fluid fistula after spine surgery? Answer: Lumbar drainage may be effective in certain postoperative cerebrospinal fluid fistula cases after spine surgery by easing pressure and supporting recovery. However, the",9.47438909427412e-08,0.014014832105275321,0.07075962539021857,0.0072537058591274906,0.09693766880022148,0.1345342556202457,0.007243206163811473,0.1033710152179319,0.1454331413654089,9.474389094274162e-08,0.11039413981466906,0.1560874089490115
16,0.3,9,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery can be effective in certain cases, as it helps to relieve pressure and promote healing. However, the","Question: What is the effectiveness of lumbar drainage for postoperative cerebrospinal fluid fistula after spine surgery? Answer: Lumbar drainage can be effective in some cases of postoperative cerebrospinal fluid fistula after spine surgery by reducing pressure and facilitating healing. However, the",0.0,0.10397207708399137,0.0607066600895117,0.0,0.14218403703793836,0.0902427318482024,0.0,0.14592572222314582,0.09645055108411735,0.0,0.14986966066160878,0.10220985792860332
16,0.3,10,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery can be effective in certain cases, as it helps to relieve pressure and promote healing. However, the","Question: Is lumbar drainage a viable option for postoperative cerebrospinal fluid fistula after spine surgery? Answer: Lumbar drainage may be a viable treatment for postoperative cerebrospinal fluid fistula after spine surgery as it helps relieve pressure and promote healing. However, the",0.0,0.03465735902799638,0.018535379812695124,0.0,0.10663802777845399,0.06603469569256373,0.0,0.10944429166735903,0.07101166964919044,0.0,0.11240224549620592,0.07563758195939214
17,0.3,1,ai,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: There is evidence to suggest that higher rates of depression in women may be partially explained by differential symptom reporting. Women tend to report more symptoms,"Are increased depression rates in women explained by differences in symptom reporting? Evidence indicates that the higher incidence of depression among women might be partly due to how symptoms are reported, with women generally reporting more symptoms.",9.47438909427412e-08,0.137240997538155,0.16712580348943987,0.0072537058591274906,0.0695164616571895,0.12543252595155707,0.007243206163811473,0.0017813434428641806,0.0783673469387755,9.474389094274162e-08,0.03947552084693973,0.05387755102040818
17,0.3,2,ai,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: There is evidence to suggest that higher rates of depression in women may be partially explained by differential symptom reporting. Women tend to report more symptoms,"Is the higher prevalence of depression in women due to variations in symptom reporting? Research suggests that women's elevated depression rates could be partially attributed to differential symptom reporting, as women often report more symptoms.",1.421158364141118e-07,0.08008258369820664,0.16712580348943987,0.01088055878869125,0.010675961634256215,0.12543252595155707,0.01086480924571722,0.062405965259299645,0.0783673469387755,1.4211583641411244e-07,0.10199587782827324,0.05387755102040818
17,0.3,3,ai,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: There is evidence to suggest that higher rates of depression in women may be partially explained by differential symptom reporting. Women tend to report more symptoms,Do differences in symptom reporting account for the greater rates of depression in women? There is evidence that the increased depression rates in women may be partly explained by their tendency to report more symptoms.,1.421158364141118e-07,0.08008258369820664,0.16712580348943987,0.01088055878869125,0.010675961634256215,0.12543252595155707,0.01086480924571722,0.062405965259299645,0.0783673469387755,1.4211583641411244e-07,0.10199587782827324,0.05387755102040818
17,0.3,4,ai,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: There is evidence to suggest that higher rates of depression in women may be partially explained by differential symptom reporting. Women tend to report more symptoms,"Can the higher depression rates in women be explained by differential symptom reporting? Studies show that women might report more symptoms, which could partially account for their higher depression rates.",2.605457000925383e-07,0.12678536476320224,0.13268702797923576,0.019947691112600648,0.15362708965701977,0.12543252595155707,0.019918816950481588,0.23230500205469662,0.0783673469387755,2.6054570009253947e-07,0.2778865442919374,0.05387755102040818
17,0.3,5,ai,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: There is evidence to suggest that higher rates of depression in women may be partially explained by differential symptom reporting. Women tend to report more symptoms,Is the disparity in depression rates between genders due to symptom reporting differences? Evidence suggests that women’s higher depression rates may be partially due to their tendency to report more symptoms.,2.36859727356853e-07,0.13750018333045944,0.10079927287719499,0.018134264647818768,0.11853576984575076,0.12543252595155707,0.018108015409528715,0.19593735788382194,0.0783673469387755,2.3685972735685406e-07,0.2401462163090904,0.05387755102040818
17,0.3,6,ai,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: There is evidence to suggest that higher rates of depression in women may be partially explained by differential symptom reporting. Women tend to report more symptoms,"Are women’s higher depression rates a result of differential symptom reporting? There is some evidence indicating that women report more symptoms, which may partly explain their increased depression prevalence.",2.842316728282236e-07,0.11407343074275111,0.16712580348943987,0.021761117577382527,0.18999473382789445,0.12543252595155707,0.02172961849143446,0.2700453300375436,0.0783673469387755,2.8423167282822487e-07,0.31710725744521984,0.05387755102040818
17,0.3,7,ai,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: There is evidence to suggest that higher rates of depression in women may be partially explained by differential symptom reporting. Women tend to report more symptoms,Does differential symptom reporting explain why depression rates are higher in women? Research points to women’s tendency to report more symptoms as a partial explanation for their elevated depression rates.,2.605457000925383e-07,0.07898211093148211,0.16712580348943987,0.019947691112600648,0.15362708965701977,0.12543252595155707,0.019918816950481588,0.23230500205469662,0.0783673469387755,2.6054570009253947e-07,0.2778865442919374,0.05387755102040818
17,0.3,8,ai,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: There is evidence to suggest that higher rates of depression in women may be partially explained by differential symptom reporting. Women tend to report more symptoms,Are elevated depression rates in women linked to differences in symptom reporting? Evidence suggests that women’s higher rates may be partially due to their increased symptom reporting.,3.316036182995942e-07,0.18818140289647278,0.16712580348943987,0.025387970506946286,0.2669557749640239,0.12543252595155707,0.02535122157334021,0.3500880377110809,0.0783673469387755,3.316036182995957e-07,0.4004888663842703,0.05387755102040818
17,0.3,9,ai,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: There is evidence to suggest that higher rates of depression in women may be partially explained by differential symptom reporting. Women tend to report more symptoms,Is the higher incidence of depression in women accounted for by how symptoms are reported? There is evidence that women’s tendency to report more symptoms may partially explain their higher depression rates.,2.131737546211677e-07,0.012290736432808647,0.16712580348943987,0.01632083818303689,0.084634218170069,0.12543252595155707,0.01629721386857584,0.16084603807255293,0.0783673469387755,2.1317375462116866e-07,0.2037785721382157,0.05387755102040818
17,0.3,10,ai,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: There is evidence to suggest that higher rates of depression in women may be partially explained by differential symptom reporting. Women tend to report more symptoms,Could differential symptom reporting be responsible for the higher depression rates in women? Studies indicate that women’s greater symptom reporting might partially account for their increased depression prevalence.,3.079176455639089e-07,0.20178531051065907,0.1301435549687298,0.023574544042164407,0.22773506181074143,0.12543252595155707,0.023540420032387335,0.30926604319082607,0.0783673469387755,3.079176455639103e-07,0.35792925196547465,0.05387755102040818
18,0.3,1,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Is there a link between crime and over-the-counter pharmacy syringe sales? Our study shows that OTC pharmacy syringe sales did not correlate with increased crime reports in Los Angeles communities from 2006 to 2008.,0.0,0.042008920033936636,0.030080360626951082,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
18,0.3,2,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Does selling syringes over the counter at pharmacies relate to crime rates? Findings indicate no association between OTC syringe sales and crime increases in Los Angeles neighborhoods between 2006 and 2008.,7.10579182070559e-08,0.011292339736452828,0.06035379812695108,0.005440279394345639,0.09844007281325329,0.0,0.005432404622858621,0.10178269430994247,0.0,7.105791820705622e-08,0.10536051565782545,0.0
18,0.3,3,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Are over-the-counter pharmacy syringe sales connected to crime? The data reveal that OTC syringe sales were not linked to a rise in reported crime in Los Angeles localities during 2006-2008.,9.47438909427412e-08,0.09299714524385472,0.02591502261674699,0.007253705859127518,0.1335313926245223,0.0,0.007243206163811494,0.13815033848081715,0.0,9.474389094274162e-08,0.14310084364067244,0.0
18,0.3,4,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Is crime connected to the sale of syringes over the counter in pharmacies? Results demonstrate no increase in crime reports associated with OTC pharmacy syringe sales in Los Angeles communities from 2006 through 2008.,0.0,0.08401784006787238,0.06035379812695108,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
18,0.3,5,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Do over-the-counter pharmacy syringe sales influence crime rates? Our findings indicate that OTC syringe sales did not lead to higher crime reports in Los Angeles areas between 2006 and 2008.,9.47438909427412e-08,0.09299714524385472,0.02591502261674699,0.007253705859127518,0.1335313926245223,0.0,0.007243206163811494,0.13815033848081715,0.0,9.474389094274162e-08,0.14310084364067244,0.0
18,0.3,6,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Is there an association between crime and OTC pharmacy syringe sales? Evidence shows no increase in reported crime linked to OTC syringe sales in Los Angeles communities during 2006-2008.,1.184298636784265e-07,0.0802852112234036,0.06035379812695108,0.009067132323909398,0.16989903679539697,0.0,0.009054007704764368,0.17589066646366414,0.0,1.1842986367842703e-07,0.1823215567939549,0.0
18,0.3,7,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Are crime rates affected by over-the-counter pharmacy syringe sales? Our research found no connection between OTC syringe sales and increased crime in Los Angeles local communities from 2006 to 2008.,9.47438909427412e-08,0.04519389141213459,0.06035379812695108,0.007253705859127518,0.1335313926245223,0.0,0.007243206163811494,0.13815033848081715,0.0,9.474389094274162e-08,0.14310084364067244,0.0
18,0.3,8,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Is selling syringes over the counter at pharmacies associated with crime? The study demonstrates that OTC syringe sales did not correspond with crime increases in Los Angeles neighborhoods during 2006-2008.,9.47438909427412e-08,0.04519389141213459,0.06035379812695108,0.007253705859127518,0.1335313926245223,0.0,0.007243206163811494,0.13815033848081715,0.0,9.474389094274162e-08,0.14310084364067244,0.0
18,0.3,9,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Does the sale of syringes over the counter at pharmacies relate to crime levels? Findings show no association between OTC pharmacy syringe sales and a rise in reported crime in Los Angeles communities from 2006 to 2008.,7.10579182070559e-08,0.17102921705750251,0.06035379812695108,0.005440279394345639,0.08961215868968697,0.0,0.005432404622858621,0.09237332013101529,0.0,7.105791820705622e-08,0.09531017980432521,0.0
18,0.3,10,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Are OTC pharmacy syringe sales linked to crime? Our results indicate that OTC syringe sales were not connected to increased crime reports in local Los Angeles communities during 2006-2008.,1.184298636784265e-07,0.12979572412054274,0.024688503202396905,0.009067132323909398,0.16989903679539697,0.0,0.009054007704764368,0.17589066646366414,0.0,1.1842986367842703e-07,0.1823215567939549,0.0
20,0.3,1,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based","Is there an initial night impact on sleep bruxism? The findings indicated no general first night effect on the severity of RMMA frequency in young, healthy individuals with SB. Clinically, a single night of sleep recording might suffice for patients with moderate to high frequency SB. Nevertheless, a second night may be needed to confirm low RMMA frequency on the first night.",2.3685972735685406e-08,0.11842726632419653,0.10305325913867522,0.0018134264647818726,0.08729666210213693,0.0507015306122449,0.0018108015409528666,0.040996060275159785,0.017236072637734686,2.3685972735685406e-08,0.01739174271186883,0.0
20,0.3,2,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based","Does the first night influence sleep bruxism? Results revealed no overall first night effect on RMMA frequency severity in young, healthy SB patients. For clinical purposes, one night of sleep recording could be adequate for those with moderate to high frequency SB. However, low RMMA frequency observed on the first night might require confirmation with a second night.",7.105791820705622e-08,0.010406662690786384,0.028290899182082302,0.005440279394345618,0.006451465833382741,0.03285029094282341,0.0054324046228586,0.02920819839808786,0.017236072637734686,7.105791820705622e-08,0.05406722127027486,0.0
20,0.3,3,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based","Is there a first night effect on sleep bruxism? The study showed no significant first night effect on RMMA frequency severity in young, healthy patients with SB. In practice, a single night’s sleep recording may be enough for patients with moderate to high SB frequency. Yet, low RMMA frequency on the first night should be verified by a second night.",2.3685972735685406e-08,0.01930457998600854,0.0023249783544075087,0.0018134264647818726,0.005591856594736377,0.01626275510204081,0.0018108015409528666,0.017811069499866328,0.0003021926683877685,2.3685972735685406e-08,0.01769957709940062,0.0
20,0.3,4,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based","Does sleep bruxism exhibit a first night effect? The results demonstrated no overall first night impact on RMMA frequency severity in young and healthy SB patients. Clinically, one night of sleep monitoring may be sufficient for moderate to high frequency SB cases. However, if RMMA frequency is low on the first night, a second night recording might be necessary.",4.737194547137081e-08,0.06564543300066328,0.10136369362559841,0.0036268529295637453,0.036003367714587675,0.0507015306122449,0.003621603081905733,0.011189692895409387,0.017236072637734686,4.737194547137081e-08,0.03571808260207909,0.0
20,0.3,5,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based","Is there an effect of the first night on sleep bruxism? Findings showed no general first night effect on the severity of RMMA frequency in young, healthy individuals with SB. For clinical use, one night of sleep recording may be adequate for patients with moderate to high SB frequency. Still, low RMMA frequency on the first night could be validated by a second night.",7.105791820705622e-08,0.07781151459235547,0.022544442976468362,0.005440279394345618,0.0977268984554529,0.034576832950326056,0.0054324046228586,0.07433248054275143,0.017236072637734686,7.105791820705622e-08,0.05129329438754926,0.0
20,0.3,6,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based","Does the initial night affect sleep bruxism? The data indicated no overall first night effect on RMMA frequency severity in young, healthy SB patients. In clinical settings, a single night of sleep recording might be enough for moderate to high frequency SB patients. However, low RMMA frequency on the first night may need confirmation by a second night.",7.105791820705622e-08,0.023094083008941002,0.08333333333333337,0.005440279394345618,0.018303790615187054,0.0507015306122449,0.0054324046228586,0.02920819839808786,0.017236072637734686,7.105791820705622e-08,0.05406722127027486,0.0
20,0.3,7,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based","Is there a first night impact on sleep bruxism? The study results showed no overall first night effect on RMMA frequency severity in young, healthy patients with SB. Clinically, one night of sleep recording could be sufficient for those with moderate to high SB frequency. Yet, low RMMA frequency on the first night might require a second night for confirmation.",2.3685972735685406e-08,0.05118496379974724,0.0493866528092719,0.0018134264647818726,0.053395110426456505,0.0507015306122449,0.0018108015409528666,0.006509884203991234,0.017236072637734686,2.3685972735685406e-08,0.01769957709940062,0.0
20,0.3,8,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based","Does the first night influence sleep bruxism severity? Findings revealed no general first night effect on RMMA frequency in young, healthy SB patients. For clinical practice, one night of sleep recording may suffice for moderate to high frequency SB patients. However, low RMMA frequency on the first night should be confirmed with a second night.",1.4211583641411244e-07,0.09606064658242808,0.003357654475244387,0.010880558788691236,0.0629124839474624,0.03184058386668277,0.0108648092457172,0.08529766504913106,0.017236072637734686,1.4211583641411244e-07,0.11122563511022499,0.0
20,0.3,9,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based","Is there a first night effect on sleep bruxism severity? The results indicated no overall first night effect on RMMA frequency in young, healthy individuals with SB. In clinical practice, one night of sleep recording might be adequate for patients with moderate to high SB frequency. Nonetheless, low RMMA frequency on the first night could be verified by a second night.",0.0,0.023104906018664995,0.016794204672992585,0.0,0.023496514595251483,0.016844959359551777,0.0,0.0,0.0,0.0,0.0,0.0
20,0.3,10,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based","Does the first night have an effect on sleep bruxism? The findings showed no significant first night effect on RMMA frequency severity in young, healthy SB patients. Clinically, one night of sleep recording may be sufficient for moderate to high frequency SB patients. However, low RMMA frequency on the first night might need to be confirmed by a second night.",2.3685972735685406e-08,0.019304579986008097,0.0023249783544075364,0.0018134264647818726,0.02949348351059644,0.03346545797451021,0.0018108015409528666,0.006509884203991234,0.017236072637734686,2.3685972735685406e-08,0.01769957709940062,0.0
21,0.3,1,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Does minimal access major surgery in newborns result in less pain? Minimal access surgery for repairing esophageal atresia or congenital diaphragmatic hernia does not lead to reduced cumulative opioid use.,7.10579182070559e-08,0.10292162785997583,0.003221293720401787,0.005440279394345639,0.10178269430994247,0.0,0.005432404622858621,0.10536051565782545,0.0,7.105791820705622e-08,0.10919929196499067,0.0
21,0.3,2,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Is pain reduced in newborns undergoing minimal access major surgery? Minimal access surgery to fix esophageal atresia or congenital diaphragmatic hernia is not linked to lower total opioid doses.,9.47438909427412e-08,0.13972020673666385,0.004447813134751871,0.007253705859127518,0.13815033848081715,0.0,0.007243206163811494,0.14310084364067244,0.0,9.474389094274162e-08,0.14842000511827314,0.0
21,0.3,3,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Does minimal access surgery cause less pain in newborns? Repairing esophageal atresia or congenital diaphragmatic hernia via minimal access surgery does not decrease overall opioid consumption.,1.658018091497971e-07,0.3144419280361208,0.04817760327636029,0.012693985253473157,0.3136956391838619,0.04158790170132326,0.012675610786670115,0.26570316573300534,0.0,1.6580180914979784e-07,0.27625337662815763,0.0
21,0.3,4,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Is there less pain with minimal access major surgery in newborns? Minimal access procedures for esophageal atresia or congenital diaphragmatic hernia repair do not correspond with reduced cumulative opioid administration.,7.10579182070559e-08,0.10292162785997583,0.003221293720401787,0.005440279394345639,0.10178269430994247,0.0,0.005432404622858621,0.10536051565782545,0.0,7.105791820705622e-08,0.10919929196499067,0.0
21,0.3,5,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Do newborns experience less pain after minimal access major surgery? Minimal access repair of esophageal atresia or congenital diaphragmatic hernia is not associated with diminished total opioid dosage.,1.184298636784265e-07,0.17792157360743266,0.005764766730907742,0.009067132323909398,0.17589066646366414,0.0,0.009054007704764368,0.1823215567939549,0.0,1.1842986367842703e-07,0.18924199963852795,0.0
21,0.3,6,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Does minimal access surgery in newborns reduce pain levels? The use of minimal access techniques for esophageal atresia or congenital diaphragmatic hernia repair does not result in lower cumulative opioid doses.,4.73719454713706e-08,0.06742663438990348,0.0020762161887946107,0.003626852929563759,0.06669137449867346,0.0,0.003621603081905747,0.06899287148695077,0.0,4.737194547137081e-08,0.07145896398214369,0.0
21,0.3,7,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Is pain relief better with minimal access major surgery in newborns? Minimal access surgery for esophageal atresia or congenital diaphragmatic hernia does not correlate with decreased opioid use overall.,9.47438909427412e-08,0.13972020673666385,0.004447813134751871,0.007253705859127518,0.13815033848081715,0.0,0.007243206163811494,0.14310084364067244,0.0,9.474389094274162e-08,0.14842000511827314,0.0
21,0.3,8,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Does undergoing minimal access major surgery cause less pain in newborns? Minimal access repair of esophageal atresia or congenital diaphragmatic hernia does not reduce the total amount of opioids administered.,7.10579182070559e-08,0.10292162785997583,0.003221293720401787,0.005440279394345639,0.10178269430994247,0.0,0.005432404622858621,0.10536051565782545,0.0,7.105791820705622e-08,0.10919929196499067,0.0
21,0.3,9,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Are pain outcomes improved with minimal access major surgery in newborns? Minimal access surgical repair of esophageal atresia or congenital diaphragmatic hernia is not linked to less cumulative opioid consumption.,7.10579182070559e-08,0.10292162785997583,0.003221293720401787,0.005440279394345639,0.10178269430994247,0.0,0.005432404622858621,0.10536051565782545,0.0,7.105791820705622e-08,0.10919929196499067,0.0
21,0.3,10,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Does minimal access major surgery in newborns lead to less pain? Minimal access repair of esophageal atresia or congenital diaphragmatic hernia is not associated with a reduction in total opioid doses.,4.73719454713706e-08,0.06742663438990348,0.0020762161887946107,0.003626852929563759,0.06669137449867346,0.0,0.003621603081905747,0.06899287148695077,0.0,4.737194547137081e-08,0.07145896398214369,0.0
22,0.3,1,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Family practice at residency teaching sites aims to closely reflect community practice. However, there may be some differences due to the emphasis on teaching and learning. Residency programs strive","Does family practice at residency teaching sites mirror community practice? Family practice at residency teaching sites seeks to closely mirror community practice, though some differences exist due to the focus on education. Residency programs endeavor",1.421158364141118e-07,0.199214956703889,0.02303862721559216,0.01088055878869125,0.19290572776097248,0.0176815744133563,0.01086480924571722,0.19237106161429018,0.014379383144458746,1.4211583641411244e-07,0.19143422370697571,0.010331723652600135
22,0.3,2,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Family practice at residency teaching sites aims to closely reflect community practice. However, there may be some differences due to the emphasis on teaching and learning. Residency programs strive","Is family practice at residency teaching sites representative of community practice? Family practice at residency teaching sites is designed to represent community practice closely, but variations may arise because of the teaching emphasis. Residency programs aim",1.184298636784265e-07,0.12362929004509526,0.006439830834294558,0.00906713232390937,0.15811053872494485,0.01433106575963719,0.009054007704764347,0.1576610666943541,0.011632653061224532,1.1842986367842703e-07,0.1568905770836877,0.00834467120181405
22,0.3,3,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Family practice at residency teaching sites aims to closely reflect community practice. However, there may be some differences due to the emphasis on teaching and learning. Residency programs strive","Do residency teaching sites' family practices reflect community practice? Family practice at residency teaching sites attempts to reflect community practice accurately, but differences may occur because of the priority on teaching. Residency programs work to",1.421158364141118e-07,0.03612150245449097,0.08673496972318342,0.01088055878869125,0.024870047625228153,0.1012244897959184,0.01086480924571722,0.062405965259299645,0.0783673469387755,1.4211583641411244e-07,0.10199587782827324,0.05387755102040818
22,0.3,4,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Family practice at residency teaching sites aims to closely reflect community practice. However, there may be some differences due to the emphasis on teaching and learning. Residency programs strive","Does family practice at residency teaching sites align with community practice? Family practice at residency teaching sites strives to align with community practice, although some differences may be present due to the educational focus. Residency programs seek",9.47438909427412e-08,0.16697359837426573,0.037786619159099505,0.0072537058591274906,0.16407159919085057,0.037664399092970466,0.007243206163811473,0.12410143412991248,0.009041602072670907,9.474389094274162e-08,0.12349336091481211,0.006476247106542904
22,0.3,5,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Family practice at residency teaching sites aims to closely reflect community practice. However, there may be some differences due to the emphasis on teaching and learning. Residency programs strive","Is the family practice at residency teaching sites similar to community practice? Family practice at residency teaching sites is intended to be similar to community practice, but there can be differences owing to the teaching and learning emphasis. Residency programs try",0.0,0.034657359027997714,0.021797083766256442,0.0,0.03554600925948437,0.024208036155638643,0.0,0.0,0.0,0.0,0.0,0.0
22,0.3,6,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Family practice at residency teaching sites aims to closely reflect community practice. However, there may be some differences due to the emphasis on teaching and learning. Residency programs strive","Does family practice at residency teaching sites correspond to community practice? Family practice at residency teaching sites corresponds closely to community practice, yet some differences exist because of the focus on teaching. Residency programs endeavor",1.421158364141118e-07,0.199214956703889,0.02303862721559216,0.01088055878869125,0.19290572776097248,0.0176815744133563,0.01086480924571722,0.19237106161429018,0.014379383144458746,1.4211583641411244e-07,0.19143422370697571,0.010331723652600135
22,0.3,7,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Family practice at residency teaching sites aims to closely reflect community practice. However, there may be some differences due to the emphasis on teaching and learning. Residency programs strive","Is family practice at residency teaching sites consistent with community practice? Family practice at residency teaching sites is consistent with community practice, though differences may arise from the emphasis on education. Residency programs aim",1.658018091497971e-07,0.27849017871702575,0.05141684240699407,0.01269398525347313,0.27225020021696533,0.0496671425771955,0.012675610786670094,0.2283121823919334,0.017295918367346966,1.6580180914979784e-07,0.22720532472592403,0.012448979591836697
22,0.3,8,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Family practice at residency teaching sites aims to closely reflect community practice. However, there may be some differences due to the emphasis on teaching and learning. Residency programs strive","Do family practice residency teaching sites reflect the nature of community practice? Family practice at residency teaching sites reflects community practice as much as possible, but some differences occur due to the teaching focus. Residency programs strive",9.47438909427412e-08,0.012940891583167247,0.06268409162400988,0.0072537058591274906,0.005637957920006098,0.07267777699315024,0.007243206163811473,0.0017813434428641806,0.0783673469387755,9.474389094274162e-08,0.03947552084693973,0.05387755102040818
22,0.3,9,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Family practice at residency teaching sites aims to closely reflect community practice. However, there may be some differences due to the emphasis on teaching and learning. Residency programs strive","Are family practices at residency teaching sites indicative of community practice? Family practice at residency teaching sites aims to be indicative of community practice, but differences may be present because of the emphasis on teaching and learning. Residency programs work to",0.0,0.034657359027997714,0.022879740131346693,0.0,0.035546009259483924,0.024835600907029506,0.0,0.07296286111157402,0.05207078010166813,0.0,0.07493483033080572,0.05387755102040818
22,0.3,10,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Family practice at residency teaching sites aims to closely reflect community practice. However, there may be some differences due to the emphasis on teaching and learning. Residency programs strive","Does family practice at residency teaching sites emulate community practice? Family practice at residency teaching sites emulates community practice closely, though some differences exist due to the focus on education. Residency programs aim",1.894877818854824e-07,0.23180789107121003,0.005562912649930474,0.014507411718255009,0.26626709636396706,0.024975784552504085,0.014486412327622968,0.26557392250886025,0.020398085159989948,1.8948778188548325e-07,0.26429375999038696,0.014709554603734486
23,0.3,1,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The duration of psychological treatment for depression is not directly related to the likelihood of returning to treatment. Factors such as the effectiveness of the treatment, the individual's personal circumstances and support system, and their willingness to continue receiving treatment play a more significant role in determining the need for future treatment.","Is the length of psychological treatment for depression connected to the chances of returning to treatment? The length of psychological treatment for depression does not directly influence the probability of returning to treatment. Instead, factors like treatment effectiveness, the person's circumstances and support network, and their readiness to continue treatment are more crucial in predicting future treatment needs.",1.8948778188548325e-07,0.1979379983578058,0.04525668647352124,0.014507411718254981,0.19541953374594634,0.04337777777777781,0.014486412327622933,0.17060893204432537,0.024779892349096472,1.8948778188548325e-07,0.17044751893701493,0.02314109957708576
23,0.3,2,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The duration of psychological treatment for depression is not directly related to the likelihood of returning to treatment. Factors such as the effectiveness of the treatment, the individual's personal circumstances and support system, and their willingness to continue receiving treatment play a more significant role in determining the need for future treatment.","Does the duration of psychological therapy for depression affect the likelihood of seeking treatment again? The duration of therapy for depression is not directly linked to the likelihood of returning for treatment. More important are factors such as how effective the treatment is, the individual's personal situation and support system, and their willingness to keep receiving treatment.",2.1317375462116866e-07,0.16960148451776114,0.014246940534329233,0.016320838183036854,0.14052255661829305,0.007858316896778433,0.0162972138685758,0.088136662631074,0.047500000000000014,2.1317375462116866e-07,0.11212329855361913,0.0322222222222222
23,0.3,3,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The duration of psychological treatment for depression is not directly related to the likelihood of returning to treatment. Factors such as the effectiveness of the treatment, the individual's personal circumstances and support system, and their willingness to continue receiving treatment play a more significant role in determining the need for future treatment.","Is there a relationship between how long psychological treatment for depression lasts and the chance of returning to treatment? The length of psychological treatment for depression is not directly associated with the probability of returning to treatment. Instead, the effectiveness of the treatment, the individual's personal circumstances and support network, and their willingness to continue treatment have a greater impact.",1.4211583641411244e-07,0.08636676563203505,0.007333855076096074,0.010880558788691236,0.08350155599084097,0.01065197428833791,0.0108648092457172,0.05839039506465671,0.02996173469387756,1.4211583641411244e-07,0.057063521370590564,0.0322222222222222
23,0.3,4,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The duration of psychological treatment for depression is not directly related to the likelihood of returning to treatment. Factors such as the effectiveness of the treatment, the individual's personal circumstances and support system, and their willingness to continue receiving treatment play a more significant role in determining the need for future treatment.","Does the time spent in psychological treatment for depression influence the likelihood of returning to treatment? The duration of psychological treatment for depression does not directly affect the chance of returning to treatment. More significant factors include treatment effectiveness, the individual's personal circumstances and support system, and their willingness to continue treatment.",3.316036182995957e-07,0.2505072157116679,0.005527847906729957,0.025387970506946217,0.24339434202872656,0.0024666767265227874,0.025351221573340132,0.2135921327402306,0.02710069444444446,3.316036182995957e-07,0.21121420119784906,0.0322222222222222
23,0.3,5,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The duration of psychological treatment for depression is not directly related to the likelihood of returning to treatment. Factors such as the effectiveness of the treatment, the individual's personal circumstances and support system, and their willingness to continue receiving treatment play a more significant role in determining the need for future treatment.","Is the duration of psychological treatment for depression related to the likelihood of returning for further treatment? The duration of psychological treatment for depression is not directly related to the likelihood of returning to treatment. Factors such as treatment effectiveness, the individual's personal situation and support system, and their willingness to continue treatment are more important.",2.3685972735685406e-07,0.31634732355300077,0.0961469405343292,0.018134264647818726,0.3143046994120522,0.09777777777777781,0.018108015409528666,0.2899242773005728,0.08151701323251415,2.3685972735685406e-07,0.2644690282473783,0.0628434183391178
23,0.3,6,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The duration of psychological treatment for depression is not directly related to the likelihood of returning to treatment. Factors such as the effectiveness of the treatment, the individual's personal circumstances and support system, and their willingness to continue receiving treatment play a more significant role in determining the need for future treatment.","Is the length of psychological treatment for depression linked to the probability of returning to treatment? The length of psychological treatment for depression is not directly linked to the probability of returning to treatment. Instead, factors like treatment effectiveness, the individual's personal circumstances and support network, and their willingness to continue treatment play a more significant role.",2.1317375462116866e-07,0.318133023209179,0.10699404797234568,0.016320838183036854,0.3169600207608245,0.11061728395061728,0.0162972138685758,0.2935136050192062,0.09616729678638947,2.1317375462116866e-07,0.26906228283134315,0.07914038529249029
23,0.3,7,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The duration of psychological treatment for depression is not directly related to the likelihood of returning to treatment. Factors such as the effectiveness of the treatment, the individual's personal circumstances and support system, and their willingness to continue receiving treatment play a more significant role in determining the need for future treatment.","Does how long psychological treatment for depression lasts impact the chance of returning to treatment? The duration of psychological treatment for depression does not directly impact the chance of returning to treatment. More influential are factors such as treatment effectiveness, the individual's personal circumstances and support system, and their willingness to continue treatment.",3.079176455639103e-07,0.308453973536972,0.05740727111284158,0.023574544042164344,0.3035075073147526,0.053333333333333344,0.023540420032387266,0.276001252656795,0.03189508506616255,3.079176455639103e-07,0.24717835730612903,0.008520195161209235
23,0.3,8,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The duration of psychological treatment for depression is not directly related to the likelihood of returning to treatment. Factors such as the effectiveness of the treatment, the individual's personal circumstances and support system, and their willingness to continue receiving treatment play a more significant role in determining the need for future treatment.","Is the time span of psychological treatment for depression connected to the likelihood of returning to treatment? The time span of psychological treatment for depression is not directly connected to the likelihood of returning to treatment. Instead, factors like treatment effectiveness, the individual's personal circumstances and support network, and their willingness to continue treatment are more decisive.",2.1317375462116866e-07,0.3428882796577475,0.11957176476364231,0.016320838183036854,0.342165372781186,0.12527777777777777,0.0162972138685758,0.3191857228177226,0.11250000000000002,2.1317375462116866e-07,0.2952187802109636,0.09679479101029195
23,0.3,9,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The duration of psychological treatment for depression is not directly related to the likelihood of returning to treatment. Factors such as the effectiveness of the treatment, the individual's personal circumstances and support system, and their willingness to continue receiving treatment play a more significant role in determining the need for future treatment.","Is there a connection between the duration of psychological treatment for depression and the chance of returning to treatment? The duration of psychological treatment for depression is not directly connected to the chance of returning to treatment. More important are factors such as treatment effectiveness, the individual's personal circumstances and support system, and their willingness to continue treatment.",1.8948778188548325e-07,0.2465799057655209,0.07614354533288067,0.014507411718254981,0.2449300466430855,0.0766666666666667,0.014486412327622933,0.22101963608504827,0.059955226988754676,1.8948778188548325e-07,0.1961196367355318,0.041377777777777784
23,0.3,10,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The duration of psychological treatment for depression is not directly related to the likelihood of returning to treatment. Factors such as the effectiveness of the treatment, the individual's personal circumstances and support system, and their willingness to continue receiving treatment play a more significant role in determining the need for future treatment.","Does the length of psychological treatment for depression determine the likelihood of returning to treatment? The length of psychological treatment for depression does not determine the likelihood of returning to treatment. Instead, factors like treatment effectiveness, the individual's personal circumstances and support network, and their willingness to continue treatment have a greater influence.",3.079176455639103e-07,0.3884324943708122,0.10495865974908233,0.023574544042164344,0.3850542344394521,0.10614512471655334,0.023540420032387266,0.3591789143239885,0.08878988642509464,3.079176455639103e-07,0.3320535222726533,0.06850091827364552
24,0.3,1,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Can a new surgical method for the temporomandibular joint enhance access and minimize complications? The VMPA offers direct access and excellent visibility to the TMJ area, resulting in favorable aesthetic and functional outcomes. It can be regarded as the preferred technique for typical TMJ surgeries.",9.474389094274162e-08,0.0029935369217577446,0.05992964702832444,0.0072537058591274906,0.05945186131181712,0.021266540642722105,0.007243206163811466,0.09097177820572666,0.0,9.474389094274162e-08,0.09309042306601167,0.0
24,0.3,2,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Is it possible for an innovative surgical approach to the temporomandibular joint to improve access and lower complication rates? The VMPA provides direct access and clear visibility to the TMJ region, achieving good cosmetic and functional results. This approach is considered the best choice for standard TMJ procedures.",2.3685972735685406e-08,0.03547987148613396,0.040175492296704425,0.0018134264647818726,0.007989419483715121,0.021266540642722105,0.0018108015409528666,0.021978906718775004,0.0,2.3685972735685406e-08,0.022472855852057716,0.0
24,0.3,3,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Does a novel surgical technique for the temporomandibular joint improve accessibility and reduce complications? The VMPA allows direct access and optimal visibility to the TMJ area, delivering positive aesthetic and functional outcomes. It is often regarded as the preferred method for common TMJ surgeries.",1.1842986367842703e-07,0.0055236348789953205,0.08264462809917356,0.009067132323909363,0.08298235872201154,0.021266540642722105,0.009054007704764333,0.11506932978478668,0.0,1.1842986367842703e-07,0.11778303565638337,0.0
24,0.3,4,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Can a new surgical approach to the temporomandibular joint enhance access and decrease complications? The VMPA grants direct access and favorable visibility to the TMJ region, producing good aesthetic and functional results. It is considered the approach of choice for routine TMJ surgeries.",1.4211583641411244e-07,0.08402087972738315,0.03514462809917354,0.010880558788691236,0.10707991030107156,0.021266540642722105,0.0108648092457172,0.13976194237515838,0.0,1.4211583641411244e-07,0.1431008436406751,0.0
24,0.3,5,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Is a novel surgical approach to the temporomandibular joint capable of improving access and minimizing complications? The VMPA provides direct access and excellent visibility to the TMJ area, yielding satisfactory aesthetic and functional outcomes. This approach is recognized as the preferred option for typical TMJ surgeries.",7.105791820705622e-08,0.010627073760686834,0.038296331722753874,0.005440279394345618,0.0364623430871176,0.021266540642722105,0.0054324046228586,0.06744128079553224,0.0,7.105791820705622e-08,0.06899287148695166,0.0
24,0.3,6,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Can an innovative surgical method for the temporomandibular joint improve access and reduce complications? The VMPA offers direct access and favorable visibility to the TMJ region, resulting in good cosmetic and functional outcomes. It is considered the approach of choice for common TMJ operations.",1.1842986367842703e-07,0.026715768867978884,0.05940199771368603,0.009067132323909363,0.08298235872201154,0.021266540642722105,0.009054007704764333,0.11506932978478668,0.0,1.1842986367842703e-07,0.11778303565638337,0.0
24,0.3,7,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Does a new surgical technique for the temporomandibular joint enhance access and lower complication risks? The VMPA provides direct access and clear visibility to the TMJ area, achieving positive aesthetic and functional results. This method is regarded as the preferred approach for standard TMJ surgeries.",9.474389094274162e-08,0.0029935369217577446,0.05992964702832444,0.0072537058591274906,0.05945186131181712,0.021266540642722105,0.007243206163811466,0.09097177820572666,0.0,9.474389094274162e-08,0.09309042306601167,0.0
24,0.3,8,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Can a novel surgical approach to the temporomandibular joint improve accessibility and reduce complications? The VMPA allows direct access and optimal visibility to the TMJ region, producing favorable aesthetic and functional outcomes. It is considered the preferred technique for common TMJ surgeries.",1.6580180914979784e-07,0.07591647169854898,0.058269628099173555,0.012693985253473108,0.13177252289144326,0.021266540642722105,0.012675610786670066,0.1650797503594501,0.0,1.6580180914979784e-07,0.16907633004393308,0.0
24,0.3,9,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Is it possible for a new surgical approach to the temporomandibular joint to enhance access and minimize complications? The VMPA grants direct access and excellent visibility to the TMJ area, yielding good cosmetic and functional results. This approach is often the method of choice for routine TMJ surgeries.",2.3685972735685406e-08,0.03547987148613396,0.040175492296704425,0.0018134264647818726,0.007989419483715121,0.021266540642722105,0.0018108015409528666,0.021978906718775004,0.0,2.3685972735685406e-08,0.022472855852057716,0.0
24,0.3,10,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Can an innovative surgical approach to the temporomandibular joint improve access and decrease complications? The VMPA provides direct access and favorable visibility to the TMJ region, delivering satisfactory aesthetic and functional outcomes. It is recognized as the preferred approach for typical TMJ surgeries.",1.4211583641411244e-07,0.08402087972738315,0.03514462809917354,0.010880558788691236,0.10707991030107156,0.021266540642722105,0.0108648092457172,0.13976194237515838,0.0,1.4211583641411244e-07,0.1431008436406751,0.0
25,0.3,1,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Do French laypersons and healthcare workers consider it acceptable to violate confidentiality to safeguard a patient's wife from a sexually transmitted infection? Most individuals in France base their opinion on situational factors when determining if a doctor should break confidentiality to protect the spouse of a patient with an STD.,4.737194547137081e-08,0.013249670855493001,0.03819444444444445,0.0036268529295637453,0.014629779924541175,0.039930555555555566,0.003621603081905733,0.013380974745060836,0.020399305555555556,4.737194547137081e-08,0.04255961441879652,0.0
25,0.3,2,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,"Are French non-professionals and medical professionals agreeable to breaching confidentiality to protect a patient's wife from an STD? In France, most people are influenced by the context when deciding whether a physician should disclose confidential information to protect the patient's spouse.",2.6054570009253947e-07,0.19605681051368595,0.03361018655489808,0.0199476911126006,0.19300958485370545,0.039930555555555566,0.019918816950481533,0.22594241672873228,0.020399305555555556,2.6054570009253947e-07,0.26028309826366547,0.0
25,0.3,3,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Is it acceptable among French laypeople and health professionals to breach confidentiality to shield a patient's wife from a sexually transmitted disease? The majority in France consider situational factors when deciding if a doctor should breach confidentiality for the spouse's protection.,2.6054570009253947e-07,0.19605681051368595,0.03361018655489808,0.0199476911126006,0.19300958485370545,0.039930555555555566,0.019918816950481533,0.22594241672873228,0.020399305555555556,2.6054570009253947e-07,0.26028309826366547,0.0
25,0.3,4,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Do French health professionals and laypeople find it acceptable to break confidentiality to protect a patient's wife from a sexually transmitted disease? Most French people are influenced by the circumstances when deciding if a physician should breach confidentiality to protect the patient's spouse.,2.1317375462116866e-07,0.1786233045124419,0.011093749999999986,0.016320838183036854,0.1768112218673319,0.015555555555555566,0.0162972138685758,0.17464912234118257,0.020399305555555556,2.1317375462116866e-07,0.20763936477824663,0.0
25,0.3,5,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,"Do French laypeople and medical professionals accept breaching confidentiality to protect a patient's wife from an STD? In France, most people take situational factors into account when deciding if confidentiality should be breached to protect the spouse.",3.5528959103528067e-07,0.3052681438412903,0.03083864795918367,0.02720139697172809,0.30122316949393646,0.039930555555555566,0.027162023114293006,0.3371680518389568,0.020399305555555556,3.552895910352811e-07,0.3746934494414109,0.0
25,0.3,6,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Is breaching confidentiality to protect a patient's wife from a sexually transmitted disease considered acceptable by French health professionals and laypeople? Most individuals in France rely on situational factors when deciding if a physician should disclose confidential information to protect the spouse.,2.3685972735685406e-07,0.17051889648360774,0.03421875,0.018134264647818726,0.16769177686941372,0.039930555555555566,0.018108015409528666,0.1999669303254743,0.020399305555555556,2.3685972735685406e-07,0.2336148511815046,0.0
25,0.3,7,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Do French laypersons and healthcare providers find it acceptable to violate confidentiality to protect a patient's wife from an STD? Most people in France are influenced by the situation when deciding if a doctor should breach confidentiality to protect the spouse.,2.6054570009253947e-07,0.23071416954168367,0.008732254155124665,0.0199476911126006,0.22855559411318938,0.014307286857494612,0.019918816950481533,0.22594241672873228,0.020399305555555556,2.6054570009253947e-07,0.26028309826366547,0.0
25,0.3,8,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Are French health professionals and laypeople comfortable with breaching confidentiality to protect a patient's wife from a sexually transmitted infection? Most French people consider situational factors when deciding if a physician should break confidentiality to protect the spouse.,3.3160361829959537e-07,0.31429582328620587,0.004716198979591822,0.025387970506946217,0.31156046922501446,0.012175453514739237,0.025351221573340132,0.3081805149657053,0.020399305555555556,3.316036182995957e-07,0.34484048629172914,0.0
25,0.3,9,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Is it acceptable to breach confidentiality to protect a patient's wife from an STD according to French laypeople and health professionals? Most people in France are influenced by the context when deciding if a doctor should breach confidentiality for the spouse's protection.,2.3685972735685406e-07,0.17051889648360774,0.03421875,0.018134264647818726,0.16769177686941372,0.039930555555555566,0.018108015409528666,0.1999669303254743,0.020399305555555556,2.3685972735685406e-07,0.2336148511815046,0.0
25,0.3,10,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Do French laypeople and healthcare professionals find it permissible to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Most individuals in France are guided by situational factors when deciding if a physician should disclose confidential information to protect the spouse.,1.8948778188548325e-07,0.12131819365303764,0.035351119614512476,0.014507411718254981,0.118901612699982,0.039930555555555566,0.014486412327622933,0.14995650975081087,0.020399305555555556,1.8948778188548325e-07,0.1823215567939549,0.0
26,0.3,1,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The ACE gene I/D polymorphism is a potential candidate gene for insulin resistance due to its involvement in the renin-angiotensin-aldosterone system, which plays a role in glucose metabolism. However, further research is needed to","The insertion allele of the ACE gene I/D polymorphism is considered a possible candidate gene for insulin resistance because it is part of the renin-angiotensin-aldosterone system, which influences glucose metabolism. Nonetheless, additional studies are required to confirm this.",3.0791764556390996e-07,0.17221718461493518,0.0907624222018161,0.023574544042164344,0.19513447303248466,0.08098765432098766,0.023540420032387266,0.2580906843718158,0.04158790170132326,3.079176455639103e-07,0.323787077093896,0.0
26,0.3,2,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The ACE gene I/D polymorphism is a potential candidate gene for insulin resistance due to its involvement in the renin-angiotensin-aldosterone system, which plays a role in glucose metabolism. However, further research is needed to","The ACE gene I/D polymorphism's insertion allele may be a candidate gene for insulin resistance, given its role in the renin-angiotensin-aldosterone system that affects glucose metabolism. Further investigation is necessary to validate this hypothesis.",4.0266153650665116e-07,0.24916012062727821,0.11776859504132227,0.030828249901291856,0.3129175086888685,0.08098765432098766,0.03078362619619876,0.3794515413760826,0.04158790170132326,4.026615365066519e-07,0.44895022004790297,0.0
26,0.3,3,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The ACE gene I/D polymorphism is a potential candidate gene for insulin resistance due to its involvement in the renin-angiotensin-aldosterone system, which plays a role in glucose metabolism. However, further research is needed to","Due to its involvement in the renin-angiotensin-aldosterone system, which impacts glucose metabolism, the insertion allele of the ACE gene I/D polymorphism is a potential candidate gene for insulin resistance. More research is needed to establish this link.",3.3160361829959526e-07,0.16214874363764809,0.11776859504132227,0.025387970506946217,0.2233053499991815,0.08098765432098766,0.02535122157334014,0.2870782212450673,0.04158790170132326,3.316036182995957e-07,0.35364004024357776,0.0
26,0.3,4,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The ACE gene I/D polymorphism is a potential candidate gene for insulin resistance due to its involvement in the renin-angiotensin-aldosterone system, which plays a role in glucose metabolism. However, further research is needed to","The insertion allele of the ACE gene I/D polymorphism is a potential candidate for insulin resistance because it participates in the renin-angiotensin-aldosterone system, influencing glucose metabolism. However, more research is essential to confirm this association.",3.7897556377096586e-07,0.21930715747759644,0.11776859504132227,0.029014823436509976,0.2821458500221148,0.08098765432098766,0.028972824655245887,0.3477028430615028,0.04158790170132326,3.789755637709665e-07,0.41616039722491127,0.0
26,0.3,5,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The ACE gene I/D polymorphism is a potential candidate gene for insulin resistance due to its involvement in the renin-angiotensin-aldosterone system, which plays a role in glucose metabolism. However, further research is needed to","As part of the renin-angiotensin-aldosterone system that regulates glucose metabolism, the insertion allele of the ACE gene I/D polymorphism is considered a candidate gene for insulin resistance, though further studies are required.",4.5003348197802176e-07,0.35639965054796274,0.08554637281910007,0.034455102830855615,0.37745602982644,0.08098765432098766,0.03440522927810451,0.4461429158747561,0.04158790170132326,4.500334819780227e-07,0.5179430915348537,0.0
26,0.3,6,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The ACE gene I/D polymorphism is a potential candidate gene for insulin resistance due to its involvement in the renin-angiotensin-aldosterone system, which plays a role in glucose metabolism. However, further research is needed to","The ACE gene I/D polymorphism's insertion allele is a likely candidate gene for insulin resistance due to its role in the renin-angiotensin-aldosterone system, which is involved in glucose metabolism. Additional research is needed to verify this.",3.5528959103528056e-07,0.19031962060434493,0.11776859504132227,0.027201396971728097,0.252292886872433,0.08098765432098766,0.027162023114293013,0.3169311843947491,0.04158790170132326,3.552895910352811e-07,0.38441169891033145,0.0
26,0.3,7,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The ACE gene I/D polymorphism is a potential candidate gene for insulin resistance due to its involvement in the renin-angiotensin-aldosterone system, which plays a role in glucose metabolism. However, further research is needed to","Because it is involved in the renin-angiotensin-aldosterone system affecting glucose metabolism, the insertion allele of the ACE gene I/D polymorphism is a candidate gene for insulin resistance, but further research is necessary.",4.5003348197802176e-07,0.31168047760861173,0.11776859504132227,0.034455102830855615,0.37745602982644,0.08098765432098766,0.03440522927810451,0.4461429158747561,0.04158790170132326,4.500334819780227e-07,0.5179430915348537,0.0
26,0.3,8,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The ACE gene I/D polymorphism is a potential candidate gene for insulin resistance due to its involvement in the renin-angiotensin-aldosterone system, which plays a role in glucose metabolism. However, further research is needed to","The insertion allele of the ACE gene I/D polymorphism might be a candidate gene for insulin resistance, as it plays a role in the renin-angiotensin-aldosterone system that influences glucose metabolism. More studies are needed to confirm this.",3.3160361829959526e-07,0.16214874363764809,0.11776859504132227,0.025387970506946217,0.2233053499991815,0.08098765432098766,0.02535122157334014,0.2870782212450673,0.04158790170132326,3.316036182995957e-07,0.35364004024357776,0.0
26,0.3,9,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The ACE gene I/D polymorphism is a potential candidate gene for insulin resistance due to its involvement in the renin-angiotensin-aldosterone system, which plays a role in glucose metabolism. However, further research is needed to","Given its role in the renin-angiotensin-aldosterone system, which affects glucose metabolism, the insertion allele of the ACE gene I/D polymorphism is a potential candidate gene for insulin resistance, although further research is required.",4.2634750924233646e-07,0.2799317792940319,0.11776859504132227,0.032641676366073735,0.3446662070034483,0.08098765432098766,0.032594427737151634,0.4122413641990743,0.04158790170132326,4.263475092423373e-07,0.48285177172358473,0.0
26,0.3,10,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The ACE gene I/D polymorphism is a potential candidate gene for insulin resistance due to its involvement in the renin-angiotensin-aldosterone system, which plays a role in glucose metabolism. However, further research is needed to","The ACE gene I/D polymorphism insertion allele is potentially linked to insulin resistance because it is part of the renin-angiotensin-aldosterone system involved in glucose metabolism, but additional research is necessary.",4.974054274493924e-07,0.3783718521072852,0.11776859504132227,0.038081955760419374,0.44644890131339077,0.08098765432098766,0.038026832360010254,0.5176018798568998,0.04158790170132326,4.974054274493935e-07,0.5920510636885754,0.0
27,0.3,1,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: There is evidence suggesting that androgens, such as testosterone, may play a role in sexual desire in women. However, the relationship between androgens and sexual desire in women is complex and influenced by various factors including hormone levels, individual differences, and psychological factors. Further","Is there a link between androgens and sexual desire in women? Evidence indicates that androgens like testosterone might influence sexual desire in women. Nonetheless, the connection between androgens and female sexual desire is intricate and affected by multiple factors such as hormone levels, personal differences, and psychological aspects. Further research is needed.",1.1842986367842703e-07,0.04772280856425537,0.06372246441109522,0.009067132323909363,0.015221591533411516,0.09006944444444444,0.009054007704764333,0.020147395058098372,0.05536332179930796,1.1842986367842703e-07,0.04677790788498859,0.037677816224529016
27,0.3,2,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: There is evidence suggesting that androgens, such as testosterone, may play a role in sexual desire in women. However, the relationship between androgens and sexual desire in women is complex and influenced by various factors including hormone levels, individual differences, and psychological factors. Further","Does a correlation exist between androgens and sexual desire in women? Research suggests that androgens, including testosterone, could have a role in women's sexual desire. Yet, this relationship is complex and shaped by various factors like hormone concentrations, individual variability, and psychological influences. Additional study is required.",2.3685972735685406e-07,0.004736065400191336,0.2040816326530612,0.018134264647818726,0.06513033274644187,0.13,0.018108015409528666,0.12777805925046337,0.05536332179930796,2.3685972735685406e-07,0.15677880309931735,0.037677816224529016
27,0.3,3,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: There is evidence suggesting that androgens, such as testosterone, may play a role in sexual desire in women. However, the relationship between androgens and sexual desire in women is complex and influenced by various factors including hormone levels, individual differences, and psychological factors. Further","Are androgens related to sexual desire in women? There is evidence that androgens such as testosterone may contribute to sexual desire in women. However, the association is complicated and depends on factors like hormone levels, individual differences, and psychological components. More investigation is necessary.",3.079176455639103e-07,0.16889555743664664,0.1347066326530612,0.023574544042164344,0.20013722142957757,0.08249999999999999,0.023540420032387266,0.2322076840527072,0.03098832179930796,3.079176455639103e-07,0.2290994646789435,0.037677816224529016
27,0.3,4,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: There is evidence suggesting that androgens, such as testosterone, may play a role in sexual desire in women. However, the relationship between androgens and sexual desire in women is complex and influenced by various factors including hormone levels, individual differences, and psychological factors. Further","Is there an association between androgens and sexual desire in women? Studies show that androgens, particularly testosterone, might affect sexual desire in women. The relationship is complex and influenced by hormone levels, individual variability, and psychological factors. Further exploration is warranted.",3.789755637709665e-07,0.2138127258313438,0.15422013680818586,0.029014823436509962,0.2437771856466009,0.10437673130193906,0.028972824655245866,0.27438153344233873,0.05536332179930796,3.789755637709665e-07,0.30706100614865406,0.037677816224529016
27,0.3,5,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: There is evidence suggesting that androgens, such as testosterone, may play a role in sexual desire in women. However, the relationship between androgens and sexual desire in women is complex and influenced by various factors including hormone levels, individual differences, and psychological factors. Further","Do androgens influence sexual desire in women? Evidence points to androgens like testosterone playing a role in female sexual desire. The relationship, however, is multifaceted and impacted by hormone levels, personal differences, and psychological factors. More research is needed to clarify this.",3.552895910352811e-07,0.11980539518497801,0.2040816326530612,0.02720139697172809,0.18291336840282524,0.13,0.027162023114293,0.24840604703908076,0.05536332179930796,3.552895910352811e-07,0.2803927590664932,0.037677816224529016
27,0.3,6,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: There is evidence suggesting that androgens, such as testosterone, may play a role in sexual desire in women. However, the relationship between androgens and sexual desire in women is complex and influenced by various factors including hormone levels, individual differences, and psychological factors. Further","Can androgens affect sexual desire in women? There is some evidence that androgens such as testosterone may be involved in sexual desire among women. The link is complex and influenced by hormone levels, individual differences, and psychological factors. Further studies are essential.",3.552895910352811e-07,0.15361745277326788,0.1797066326530612,0.02720139697172809,0.18291336840282524,0.13,0.027162023114293,0.24840604703908076,0.05536332179930796,3.552895910352811e-07,0.2803927590664932,0.037677816224529016
27,0.3,7,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: There is evidence suggesting that androgens, such as testosterone, may play a role in sexual desire in women. However, the relationship between androgens and sexual desire in women is complex and influenced by various factors including hormone levels, individual differences, and psychological factors. Further","Is sexual desire in women correlated with androgens? Evidence suggests that androgens, including testosterone, may influence sexual desire in women. This relationship is complex and affected by hormone levels, individual differences, and psychological factors. Additional research is necessary.",4.500334819780224e-07,0.297394379575866,0.15020408163265303,0.03445510283085558,0.326782060758426,0.10224489795918368,0.034405229278104466,0.35661963167931177,0.05536332179930796,4.500334819780227e-07,0.39161839417671773,0.037677816224529016
27,0.3,8,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: There is evidence suggesting that androgens, such as testosterone, may play a role in sexual desire in women. However, the relationship between androgens and sexual desire in women is complex and influenced by various factors including hormone levels, individual differences, and psychological factors. Further","Are androgens connected to sexual desire in women? Research indicates that androgens like testosterone could play a role in women's sexual desire. The relationship is complex and influenced by hormone levels, individual variability, and psychological factors. Further investigation is needed.",4.026615365066518e-07,0.16981581575964144,0.2040816326530612,0.030828249901291835,0.23420666279037494,0.13,0.030783626196198732,0.3010497805244996,0.05536332179930796,4.026615365066519e-07,0.3344599803367694,0.037677816224529016
27,0.3,9,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: There is evidence suggesting that androgens, such as testosterone, may play a role in sexual desire in women. However, the relationship between androgens and sexual desire in women is complex and influenced by various factors including hormone levels, individual differences, and psychological factors. Further","Is there a connection between androgens and sexual desire in women? Evidence supports that androgens such as testosterone may contribute to sexual desire in women. The relationship is complex and shaped by hormone levels, individual differences, and psychological factors. More research is required.",3.316036182995957e-07,0.16172186080210205,0.1565816326530612,0.025387970506946217,0.1920328134007434,0.105625,0.025351221573340132,0.22308823905478903,0.05536332179930796,3.316036182995957e-07,0.2544172726632352,0.037677816224529016
27,0.3,10,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: There is evidence suggesting that androgens, such as testosterone, may play a role in sexual desire in women. However, the relationship between androgens and sexual desire in women is complex and influenced by various factors including hormone levels, individual differences, and psychological factors. Further","Does sexual desire in women relate to androgens? There is evidence that androgens, including testosterone, might impact sexual desire in women. The relationship is complex and influenced by hormone levels, individual differences, and psychological factors. Further research is warranted.",4.263475092423371e-07,0.26875416327447255,0.15161249685059205,0.03264167636607371,0.2983423250379382,0.10299382716049384,0.0325944277371516,0.3284487547126149,0.05536332179930796,4.263475092423373e-07,0.3626308573034662,0.037677816224529016
28,0.3,1,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are relevant and applicable to practitioners and athletes as they provide up-to-date research, information, and guidelines on various aspects of sports medicine, including injury prevention, diagnosis, treatment, and","Are sports medicine journals useful and pertinent to both practitioners and athletes? Yes, they are, as these journals offer current research, information, and guidelines on many facets of sports medicine, such as injury prevention, diagnosis, and treatment.",1.8948778188548283e-07,0.019876134716013016,0.15339663988312632,0.014507411718254981,0.04465503546927829,0.11426592797783926,0.01448641232762294,0.11228806787292722,0.0710059171597633,1.8948778188548325e-07,0.14944039006124799,0.04865220249835634
28,0.3,2,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are relevant and applicable to practitioners and athletes as they provide up-to-date research, information, and guidelines on various aspects of sports medicine, including injury prevention, diagnosis, treatment, and","Do sports medicine journals hold relevance and applicability for practitioners and athletes? Indeed, they do, since they provide the latest research, data, and protocols covering various areas of sports medicine including injury prevention, diagnosis, and treatment.",2.1317375462116813e-07,0.04790315256839506,0.12484992708035816,0.01632083818303686,0.0736425723425298,0.11426592797783926,0.016297213868575813,0.142141031022609,0.0710059171597633,2.1317375462116866e-07,0.18021204872800167,0.04865220249835634
28,0.3,3,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are relevant and applicable to practitioners and athletes as they provide up-to-date research, information, and guidelines on various aspects of sports medicine, including injury prevention, diagnosis, treatment, and","Are sports medicine journals important and applicable to practitioners and athletes? Yes, because they deliver up-to-date studies, information, and recommendations on different aspects of sports medicine like injury prevention, diagnosis, and treatment.",3.0791764556390933e-07,0.17437477219430164,0.12117441766090412,0.02357454404216438,0.1988057152965368,0.11426592797783926,0.023540420032387308,0.271352762502616,0.0710059171597633,3.079176455639103e-07,0.31374344135252397,0.04865220249835634
28,0.3,4,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are relevant and applicable to practitioners and athletes as they provide up-to-date research, information, and guidelines on various aspects of sports medicine, including injury prevention, diagnosis, treatment, and","Can practitioners and athletes find sports medicine journals relevant and useful? Absolutely, as these journals supply current research, insights, and guidelines on multiple topics in sports medicine, including injury prevention, diagnosis, and treatment.",2.84231672828224e-07,0.0979069009403708,0.15339663988312632,0.0217611175773825,0.1660158924735451,0.11426592797783926,0.021729618491434434,0.2374512108269342,0.0710059171597633,2.8423167282822487e-07,0.27865212154125496,0.04865220249835634
28,0.3,5,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are relevant and applicable to practitioners and athletes as they provide up-to-date research, information, and guidelines on various aspects of sports medicine, including injury prevention, diagnosis, treatment, and","Are sports medicine journals pertinent and practical for practitioners and athletes? Yes, they are, offering the latest research findings, information, and guidelines on various sports medicine topics such as injury prevention, diagnosis, and treatment.",2.605457000925387e-07,0.10914416230755286,0.12312320238312632,0.01994769111260062,0.13426719415896526,0.11426592797783926,0.01991881695048156,0.2046613880039425,0.0710059171597633,2.6054570009253947e-07,0.2447505698655732,0.04865220249835634
28,0.3,6,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are relevant and applicable to practitioners and athletes as they provide up-to-date research, information, and guidelines on various aspects of sports medicine, including injury prevention, diagnosis, treatment, and","Do sports medicine journals apply to and benefit practitioners and athletes? Yes, they do, by providing updated research, information, and protocols on many aspects of sports medicine including injury prevention, diagnosis, and treatment.",2.84231672828224e-07,0.1412285997253684,0.12217915809332403,0.0217611175773825,0.1660158924735451,0.11426592797783926,0.021729618491434434,0.2374512108269342,0.0710059171597633,2.8423167282822487e-07,0.27865212154125496,0.04865220249835634
28,0.3,7,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are relevant and applicable to practitioners and athletes as they provide up-to-date research, information, and guidelines on various aspects of sports medicine, including injury prevention, diagnosis, treatment, and","Are sports medicine journals relevant and beneficial to both practitioners and athletes? Certainly, as they provide current research, information, and guidance on several aspects of sports medicine like injury prevention, diagnosis, and treatment.",2.84231672828224e-07,0.1412285997253684,0.12217915809332403,0.0217611175773825,0.1660158924735451,0.11426592797783926,0.021729618491434434,0.2374512108269342,0.0710059171597633,2.8423167282822487e-07,0.27865212154125496,0.04865220249835634
28,0.3,8,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are relevant and applicable to practitioners and athletes as they provide up-to-date research, information, and guidelines on various aspects of sports medicine, including injury prevention, diagnosis, treatment, and","Is the content of sports medicine journals applicable and relevant to practitioners and athletes? Yes, because they offer the most recent research, data, and guidelines on various elements of sports medicine including injury prevention, diagnosis, and treatment.",1.8948778188548283e-07,0.05714021867953667,0.09803331808381835,0.014507411718254981,0.08426344578698952,0.0857192151750711,0.01448641232762294,0.11228806787292722,0.0710059171597633,1.8948778188548325e-07,0.14944039006124799,0.04865220249835634
28,0.3,9,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are relevant and applicable to practitioners and athletes as they provide up-to-date research, information, and guidelines on various aspects of sports medicine, including injury prevention, diagnosis, treatment, and","Are sports medicine journals useful and applicable to practitioners and athletes? Yes, since they deliver updated research, information, and guidelines covering different facets of sports medicine such as injury prevention, diagnosis, and treatment.",2.84231672828224e-07,0.1412285997253684,0.12217915809332403,0.0217611175773825,0.1660158924735451,0.11426592797783926,0.021729618491434434,0.2374512108269342,0.0710059171597633,2.8423167282822487e-07,0.27865212154125496,0.04865220249835634
28,0.3,10,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are relevant and applicable to practitioners and athletes as they provide up-to-date research, information, and guidelines on various aspects of sports medicine, including injury prevention, diagnosis, treatment, and","Do sports medicine journals hold significance and applicability for practitioners and athletes? Yes, as they provide up-to-date research, information, and protocols on various aspects of sports medicine including injury prevention, diagnosis, and treatment.",2.84231672828224e-07,0.1412285997253684,0.12217915809332403,0.0217611175773825,0.1660158924735451,0.11426592797783926,0.021729618491434434,0.2374512108269342,0.0710059171597633,2.8423167282822487e-07,0.27865212154125496,0.04865220249835634
29,0.3,1,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: The number of needles used in acupuncture treatment for neck pain may vary depending on the individual's condition and the practitioner's approach. While research on the specific impact of needle quantity is limited, the","Question: Does the quantity of needles influence acupuncture treatment for neck pain? Answer: The number of needles applied in acupuncture for neck pain can differ based on the patient's condition and the practitioner's method. Although studies on the exact effect of needle count are scarce, the",2.3685972735685406e-08,0.03628563889351,0.040752588959438646,0.0018134264647818726,0.03914022686438168,0.04434829637641968,0.0018108015409528666,0.008517171800753065,0.02271498107084911,2.3685972735685406e-08,0.023530497410194418,0.0
29,0.3,2,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: The number of needles used in acupuncture treatment for neck pain may vary depending on the individual's condition and the practitioner's approach. While research on the specific impact of needle quantity is limited, the","Question: In acupuncture for neck pain, is the number of needles important? Answer: The amount of needles used in acupuncture therapy for neck pain varies according to the individual's situation and the practitioner's technique. Research focusing on the precise role of needle quantity is limited, but the",0.0,0.060273667874777725,0.042179173654971786,0.0,0.061613082716439393,0.04434829637641968,0.0,0.03150669002545259,0.02271498107084911,0.0,0.0,0.0
29,0.3,3,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: The number of needles used in acupuncture treatment for neck pain may vary depending on the individual's condition and the practitioner's approach. While research on the specific impact of needle quantity is limited, the","Question: When treating neck pain with acupuncture, does the needle count matter? Answer: The needle count in acupuncture treatment for neck pain depends on the patient's specific condition and the practitioner's style. There is limited research on how the number of needles affects outcomes, however, the",2.3685972735685406e-08,0.03628563889351,0.040752588959438646,0.0018134264647818726,0.007633536838929089,0.021633315305570573,0.0018108015409528666,0.008517171800753065,0.02271498107084911,2.3685972735685406e-08,0.023530497410194418,0.0
29,0.3,4,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: The number of needles used in acupuncture treatment for neck pain may vary depending on the individual's condition and the practitioner's approach. While research on the specific impact of needle quantity is limited, the","Question: Does the number of needles affect acupuncture treatment for neck pain? Answer: The number of needles utilized in acupuncture for neck pain treatment varies with the individual's condition and the practitioner's approach. Although there is limited research on the impact of needle quantity, the",4.737194547137081e-08,0.01979435298569765,0.017079119571683538,0.0036268529295637453,0.048328098854266255,0.0020526554379765236,0.003621603081905733,0.04802033420753293,0.0010803788339694455,4.737194547137081e-08,0.047628048989254435,0.0
29,0.3,5,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: The number of needles used in acupuncture treatment for neck pain may vary depending on the individual's condition and the practitioner's approach. While research on the specific impact of needle quantity is limited, the","Question: Is the number of needles significant in acupuncture for neck pain? Answer: The quantity of needles used during acupuncture for neck pain treatment may change depending on the patient's condition and the practitioner's method. Research on the direct influence of needle number is limited, but the",0.0,0.03013683393738864,0.020911319118168778,0.0,0.030806541358219697,0.02213755257476679,0.0,0.03150669002545259,0.02271498107084911,0.0,0.0,0.0
29,0.3,6,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: The number of needles used in acupuncture treatment for neck pain may vary depending on the individual's condition and the practitioner's approach. While research on the specific impact of needle quantity is limited, the","Question: How does the number of needles influence acupuncture treatment for neck pain? Answer: The number of needles employed in acupuncture for neck pain varies based on the individual's condition and the practitioner's approach. While there is limited research on the specific effects of needle quantity, the",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
29,0.3,7,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: The number of needles used in acupuncture treatment for neck pain may vary depending on the individual's condition and the practitioner's approach. While research on the specific impact of needle quantity is limited, the","Question: Does needle quantity play a role in acupuncture treatment for neck pain? Answer: The number of needles used in acupuncture for neck pain treatment can vary depending on the patient's condition and the practitioner's technique. Research on the exact impact of needle quantity is limited, yet the",2.3685972735685406e-08,0.05420787608919353,0.022709189879958278,0.0018134264647818726,0.0835919894352144,0.04434829637641968,0.0018108015409528666,0.053979545877510304,0.02271498107084911,2.3685972735685406e-08,0.022989518224699523,0.0
29,0.3,8,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: The number of needles used in acupuncture treatment for neck pain may vary depending on the individual's condition and the practitioner's approach. While research on the specific impact of needle quantity is limited, the","Question: In acupuncture therapy for neck pain, does the number of needles used matter? Answer: The number of needles applied during acupuncture for neck pain may differ according to the individual's condition and the practitioner's approach. Although research on the specific effect of needle count is limited, the",2.3685972735685406e-08,0.05420787608919353,0.022709189879958278,0.0018134264647818726,0.023318321560436672,0.0009598666243535586,0.0018108015409528666,0.023173004519290608,0.0005042372691962185,2.3685972735685406e-08,0.022989518224699523,0.0
29,0.3,9,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: The number of needles used in acupuncture treatment for neck pain may vary depending on the individual's condition and the practitioner's approach. While research on the specific impact of needle quantity is limited, the","Question: Is the amount of needles used important in acupuncture for neck pain? Answer: The amount of needles used in acupuncture treatment for neck pain depends on the patient's condition and the practitioner's style. Research on the precise impact of needle quantity is limited, but the",2.3685972735685406e-08,0.08694052653936968,0.043197888738565754,0.0018134264647818726,0.0553798432119752,0.02346847935231325,0.0018108015409528666,0.055961635693195344,0.023685970743547096,2.3685972735685406e-08,0.056537506008286,0.023795359904818555
29,0.3,10,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: The number of needles used in acupuncture treatment for neck pain may vary depending on the individual's condition and the practitioner's approach. While research on the specific impact of needle quantity is limited, the","Question: Does the number of needles affect the effectiveness of acupuncture for neck pain? Answer: The number of needles utilized in acupuncture for neck pain treatment varies with the individual's condition and the practitioner's method. While research on the specific influence of needle count is limited, the",0.0,0.0,0.0,0.0,0.030806541358219697,0.021978234235825206,0.0,0.0,0.0,0.0,0.0,0.0
30,0.3,1,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to","Question: Are we following guidelines when preparing high-fall-risk patients for discharge after rehabilitation? Answer: Evidence suggests that systematic falls risk assessments are rarely conducted during rehabilitation for those at high risk. When risks are found, strategies are usually applied. However, failures occur...",1.8948778188548325e-07,0.06508134478428707,0.08098765432098766,0.014507411718254981,0.09567815922396194,0.06222222222222222,0.014486412327622933,0.1275947061710565,0.04246913580246913,1.8948778188548325e-07,0.16091840282531944,0.021728395061728398
30,0.3,2,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to","Question: Do we adhere to guidelines in preparing patients at high risk of falls for discharge post-rehabilitation? Answer: There is minimal evidence that systematic falls risk assessments are performed during rehabilitation for high-risk individuals. When risks are identified, strategies tend to be implemented. Nevertheless, failures to...",9.474389094274162e-08,0.02800907828172461,0.08098765432098766,0.0072537058591274906,0.00036797941963628844,0.06222222222222222,0.007243206163811466,0.029956236607138642,0.04246913580246913,9.474389094274162e-08,0.06083494426833802,0.021728395061728398
30,0.3,3,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to","Question: Are guidelines met in preparing patients with high fall risk for discharge after rehabilitation? Answer: Little evidence shows that systematic falls risk assessments are done during rehabilitation for high-risk patients. When risks are detected, strategies are generally put in place. However, failures to...",1.4211583641411244e-07,0.01745329579503263,0.08098765432098766,0.010880558788691236,0.04688799505453023,0.06222222222222222,0.0108648092457172,0.07758428559639308,0.04246913580246913,1.4211583641411244e-07,0.10962510843776974,0.021728395061728398
30,0.3,4,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to","Question: Preparing high-fall-risk patients for discharge after rehabilitation: Are guidelines followed? Answer: Evidence indicates that systematic falls risk assessments are seldom conducted during rehabilitation for those at high risk. When a risk is identified, a strategy is usually implemented. However, failures to...",1.8948778188548325e-07,0.06508134478428707,0.08098765432098766,0.014507411718254981,0.09567815922396194,0.06222222222222222,0.014486412327622933,0.1275947061710565,0.04246913580246913,1.8948778188548325e-07,0.16091840282531944,0.021728395061728398
30,0.3,5,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to","Question: Do we meet guidelines when discharging patients at high risk of falls after rehabilitation? Answer: There is scant evidence that systematic falls risk assessments occur during rehabilitation for high-risk patients. When risks are recognized, strategies are typically applied. However, failures to...",1.8948778188548325e-07,0.06508134478428707,0.08098765432098766,0.014507411718254981,0.09567815922396194,0.06222222222222222,0.014486412327622933,0.1275947061710565,0.04246913580246913,1.8948778188548325e-07,0.16091840282531944,0.021728395061728398
30,0.3,6,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to","Question: Are patients at high risk of falls properly prepared for discharge after rehabilitation according to guidelines? Answer: Little evidence supports that systematic falls risk assessments are performed during rehabilitation for high-risk patients. When risks are identified, strategies are generally implemented. However, failures to...",1.4211583641411244e-07,0.01745329579503263,0.08098765432098766,0.010880558788691236,0.04688799505453023,0.06222222222222222,0.0108648092457172,0.07758428559639308,0.04246913580246913,1.4211583641411244e-07,0.10962510843776974,0.021728395061728398
30,0.3,7,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to","Question: Is the preparation of high-fall-risk patients for discharge after rehabilitation guideline-compliant? Answer: Evidence is limited that systematic falls risk assessments are conducted during rehabilitation for those at high risk. When risks are found, strategies are usually applied. However, failures to...",2.1317375462116866e-07,0.08977395737465876,0.08098765432098766,0.016320838183036854,0.12099596720825367,0.06222222222222222,0.0162972138685758,0.15357019257431448,0.04246913580246913,2.1317375462116866e-07,0.1875866499074803,0.021728395061728398
30,0.3,8,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to","Question: Do we comply with guidelines in preparing patients at high risk of falls for discharge following rehabilitation? Answer: There is little evidence that systematic falls risk assessments are carried out during rehabilitation for high-risk individuals. When risks are detected, strategies tend to be implemented. However, failures to...",4.737194547137081e-08,0.07149419022146297,0.08098765432098766,0.0036268529295637453,0.04408378315119643,0.06222222222222222,0.003621603081905733,0.015506137469618597,0.04246913580246913,4.737194547137081e-08,0.01431492863344408,0.021728395061728398
30,0.3,9,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to","Question: Preparing patients at high risk of falls for discharge after rehabilitation: Are guidelines being met? Answer: Evidence shows that systematic falls risk assessments are rarely conducted during rehabilitation for high-risk patients. When a risk is identified, a strategy is typically implemented. However, failures to...",1.1842986367842703e-07,0.005536222429666893,0.08098765432098766,0.009067132323909363,0.023357497644335812,0.06222222222222222,0.009054007704764333,0.05348673401733306,0.04246913580246913,1.1842986367842703e-07,0.08493249584739804,0.021728395061728398
30,0.3,10,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to","Question: Are guidelines followed when preparing high-fall-risk patients for discharge post-rehabilitation? Answer: There is minimal evidence that systematic falls risk assessments occur during rehabilitation for those at high risk. When risks are recognized, strategies are generally put in place. However, failures to...",1.8948778188548325e-07,0.06508134478428707,0.08098765432098766,0.014507411718254981,0.09567815922396194,0.06222222222222222,0.014486412327622933,0.1275947061710565,0.04246913580246913,1.8948778188548325e-07,0.16091840282531944,0.021728395061728398
31,0.3,1,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for phase I clinical trials. This is","Question: Are symptoms important when selecting patients for phase I clinical trials? Answer: Yes, symptoms are important when selecting patients for phase I clinical trials.",4.73719454713706e-08,0.1111454657755857,0.009527552262554029,0.003626852929563759,0.11231296951894443,0.012307220427685561,0.003621603081905747,0.11326695201084025,0.01370663957288959,4.737194547137081e-08,0.1139331754913564,0.013725809698166364
31,0.3,2,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for phase I clinical trials. This is","Question: Should symptoms be taken into account when choosing patients for phase I clinical trials? Answer: Yes, symptoms should be taken into account when choosing patients for phase I clinical trials.",9.47438909427412e-08,0.05423582049196085,0.01731301939058169,0.007253705859127518,0.05090136730156347,0.03143351800554017,0.007243206163811494,0.046877901883457085,0.046094182825484775,9.474389094274162e-08,0.04202767239506011,0.06129501385041558
31,0.3,3,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for phase I clinical trials. This is","Question: Do symptoms play a role in patient selection for phase I clinical trials? Answer: Yes, symptoms play a role in patient selection for phase I clinical trials.",2.36859727356853e-08,0.10246893076289787,0.009527552262554029,0.0018134264647818796,0.10793976518098347,0.03306846610242603,0.0018108015409528735,0.11398087580479999,0.055229130922370556,2.3685972735685406e-08,0.1206815694087271,0.07600954672238783
31,0.3,4,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for phase I clinical trials. This is","Question: Is it necessary to consider symptoms when enrolling patients in phase I clinical trials? Answer: Yes, it is necessary to consider symptoms when enrolling patients in phase I clinical trials.",9.47438909427412e-08,0.05423582049196085,0.01731301939058169,0.007253705859127518,0.05090136730156347,0.03143351800554017,0.007243206163811494,0.046877901883457085,0.046094182825484775,9.474389094274162e-08,0.04202767239506011,0.06129501385041558
31,0.3,5,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for phase I clinical trials. This is","Question: Are symptoms a factor in deciding patient eligibility for phase I clinical trials? Answer: Yes, symptoms are a factor in deciding patient eligibility for phase I clinical trials.",4.73719454713706e-08,0.001746453304056761,0.016620498614958484,0.003626852929563759,0.001082196971361249,0.02770083102493079,0.003621603081905747,0.004379064317738823,0.03878116343490304,4.737194547137081e-08,0.008234366230611467,0.049861495844875287
31,0.3,6,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for phase I clinical trials. This is","Question: Do symptoms influence the selection of patients for phase I clinical trials? Answer: Yes, symptoms influence the selection of patients for phase I clinical trials.",2.36859727356853e-08,0.16505358593185626,0.013406769390581691,0.0018134264647818796,0.1702094682247779,0.0339335180055402,0.0018108015409528735,0.1756639643089315,0.05218793282548473,2.3685972735685406e-08,0.1814373713771471,0.06817001385041549
31,0.3,7,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for phase I clinical trials. This is","Question: Should symptoms be evaluated when considering patients for phase I clinical trials? Answer: Yes, symptoms should be evaluated when considering patients for phase I clinical trials.",0.0,0.053319013889226774,0.014226599637495285,0.0,0.05545177444479599,0.02158783899319447,0.0,0.057762265046662264,0.02831640504770694,0.0,0.060273667874777725,0.03441229780103275
31,0.3,8,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for phase I clinical trials. This is","Question: Is symptom assessment important in the consideration of patients for phase I clinical trials? Answer: Yes, symptom assessment is important in the consideration of patients for phase I clinical trials.",9.47438909427412e-08,0.05423582049196085,0.01731301939058169,0.007253705859127518,0.0987046211332836,0.01976118240463315,0.007243206163811494,0.09638841478059623,0.028316405047706827,9.474389094274162e-08,0.09337190799209338,0.037876646503476746
31,0.3,9,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for phase I clinical trials. This is","Question: Are symptoms relevant when assessing patients for phase I clinical trials? Answer: Yes, symptoms are relevant when assessing patients for phase I clinical trials.",4.73719454713706e-08,0.1111454657755857,0.009527552262554029,0.003626852929563759,0.11231296951894443,0.012307220427685561,0.003621603081905747,0.11326695201084025,0.01370663957288959,4.737194547137081e-08,0.1139331754913564,0.013725809698166364
31,0.3,10,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for phase I clinical trials. This is","Question: Do symptoms matter in the process of selecting patients for phase I clinical trials? Answer: Yes, symptoms matter in the process of selecting patients for phase I clinical trials.",7.10579182070559e-08,0.04340340295934686,0.004967340378236013,0.005440279394345639,0.049065796995612754,0.030847098252453797,0.005432404622858621,0.05550375948360298,0.05609418282548473,7.105791820705622e-08,0.06285511752236816,0.08070859409732908
32,0.3,1,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this","Does airway surgery reduce serum lipid levels in patients with obstructive sleep apnea? Surgery might enhance blood lipid profiles in OSA patients, particularly those with preoperative dyslipidemia, possibly offering significant metabolic and cardiovascular advantages. Further prospective research is needed to confirm this.",7.105791820705622e-08,0.05540919288785506,0.09,0.005440279394345618,0.007841854085677724,0.046400951814396206,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
32,0.3,2,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this","Can airway surgery decrease serum lipid levels in obstructive sleep apnea sufferers? Surgical intervention may improve lipid levels in OSA patients, especially in those with dyslipidemia before surgery, potentially providing important metabolic and cardiovascular benefits. Prospective studies should investigate this further.",9.474389094274162e-08,0.03859813775851073,0.04013850415512466,0.0072537058591274906,0.06870567132945338,0.020777683116335252,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
32,0.3,3,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this","Is there a reduction in serum lipid levels following airway surgery in obstructive sleep apnea patients? Surgery could lead to better blood lipid levels in OSA patients, notably in those with preoperative dyslipidemia, which might result in substantial metabolic and cardiovascular improvements. This warrants prospective study.",2.3685972735685406e-08,0.11769307459564704,0.06778925619834711,0.0018134264647818726,0.08746832571864793,0.046400951814396206,0.0018108015409528666,0.023530497410194418,0.0,2.3685972735685406e-08,0.024097551579060017,0.0
32,0.3,4,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this","Does performing airway surgery lower serum lipid concentrations in patients with obstructive sleep apnea? Airway surgery may improve lipid profiles in OSA patients, particularly those with preoperative dyslipidemia, potentially offering major metabolic and cardiovascular benefits. Prospective studies are recommended to explore this.",7.105791820705622e-08,0.021597135299565196,0.06562499999999999,0.005440279394345618,0.007841854085677724,0.046400951814396206,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
32,0.3,5,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this","Can surgery on the airway reduce serum lipid levels in obstructive sleep apnea patients? Surgery may positively affect blood lipid levels in OSA patients, especially those with dyslipidemia before the operation, potentially yielding significant metabolic and cardiovascular benefits. This should be examined in prospective studies.",0.0,0.06301338005090429,0.0446485260770975,0.0,0.032239403746974205,0.023158321428908682,0.0,0.0,0.0,0.0,0.0,0.0
32,0.3,6,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this","Does airway surgery have an effect on serum lipid levels in obstructive sleep apnea patients? It may improve lipid levels in patients with OSA, particularly those with preoperative dyslipidemia, potentially providing important metabolic and cardiovascular advantages. Prospective studies should be conducted to assess this.",2.3685972735685406e-08,0.03855843438316109,0.04359904818560379,0.0018134264647818726,0.007941301485662411,0.02260559190957765,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
32,0.3,7,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this","Is airway surgery effective in lowering serum lipid levels among obstructive sleep apnea patients? Surgery might improve blood lipid profiles in OSA patients, especially those with preoperative dyslipidemia, potentially resulting in major metabolic and cardiovascular benefits. This needs to be studied prospectively.",7.105791820705622e-08,0.05540919288785506,0.09,0.005440279394345618,0.007841854085677724,0.046400951814396206,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
32,0.3,8,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this","Does airway surgery contribute to lowering serum lipid levels in obstructive sleep apnea patients? Surgical treatment may enhance lipid levels in OSA patients, particularly those with preoperative dyslipidemia, potentially offering significant metabolic and cardiovascular benefits. Prospective studies should further evaluate this.",9.474389094274162e-08,0.03859813775851073,0.04013850415512466,0.0072537058591274906,0.06870567132945338,0.020777683116335252,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
32,0.3,9,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this","Can airway surgery improve serum lipid levels in patients with obstructive sleep apnea? Surgery may lead to better blood lipid levels in OSA patients, especially those with preoperative dyslipidemia, potentially providing major metabolic and cardiovascular advantages. This should be investigated in prospective studies.",4.737194547137081e-08,0.01349272727073103,0.04249999999999998,0.0036268529295637453,0.016961299083595893,0.022025951814396205,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
32,0.3,10,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this","Is there an impact of airway surgery on serum lipid levels in obstructive sleep apnea patients? Surgery may improve lipid profiles in OSA patients, particularly those with preoperative dyslipidemia, potentially yielding important metabolic and cardiovascular benefits. Prospective studies are necessary to explore this.",4.737194547137081e-08,0.07950674446691508,0.09,0.0036268529295637453,0.016850758504693975,0.046400951814396206,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
33,0.3,1,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Is computerized tomography a suitable alternative to bone scintigraphy for identifying bone metastases in breast cancer? Answer: Our results indicate that routine bone scintigraphy is unnecessary for patients with metastatic breast cancer if CT scans of the thorax, abdomen, and pelvis are conducted.",1.8948778188548272e-07,0.17361265045717467,0.023242630385487524,0.014507411718254988,0.21130909366720596,0.0,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
33,0.3,2,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Can CT scans replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our study suggests that routine bone scintigraphy is not needed for patients with metastatic breast cancer when CT imaging of the thorax, abdomen, and pelvis is performed.",1.421158364141119e-07,0.12441194762660457,0.024375,0.010880558788691243,0.16251892949777424,0.0,0.010864809245717214,0.1670540846631643,0.0,1.4211583641411244e-07,0.17185025692666,0.0
33,0.3,3,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Is bone scintigraphy required if computerized tomography is used to detect bone metastases in breast cancer patients? Answer: Findings imply that routine bone scintigraphy is unnecessary if CT of the thorax, abdomen, and pelvis is done in metastatic breast cancer cases.",1.421158364141119e-07,0.0905998900383147,0.04865220249835634,0.010880558788691243,0.16251892949777424,0.0,0.010864809245717214,0.1670540846631643,0.0,1.4211583641411244e-07,0.17185025692666,0.0
33,0.3,4,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Can computerized tomography substitute bone scintigraphy for detecting bone metastases in breast cancer? Answer: Our data suggest that routine bone scintigraphy is not required for metastatic breast cancer patients if CT scans of the thorax, abdomen, and pelvis are utilized.",1.184298636784265e-07,0.09887403359652636,0.02498356344510192,0.00906713232390937,0.13720112151348252,0.0,0.009054007704764347,0.14107859825990632,0.0,1.1842986367842703e-07,0.14518200984449914,0.0
33,0.3,5,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Does computerized tomography eliminate the need for bone scintigraphy in identifying bone metastases from breast cancer? Answer: Our findings show that routine bone scintigraphy is unnecessary when CT imaging of the thorax, abdomen, and pelvis is performed in metastatic breast cancer patients.",1.6580180914979731e-07,0.14931454819586287,0.023795359904818555,0.012693985253473115,0.18721154208814594,0.0,0.01267561078667008,0.19237189264745602,0.0,1.6580180914979784e-07,0.19782574332991798,0.0
33,0.3,6,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Can CT imaging replace bone scintigraphy in the detection of bone metastases from breast cancer? Answer: The evidence suggests that routine bone scintigraphy is not needed for patients with metastatic breast cancer if CT scans of the thorax, abdomen, and pelvis are carried out.",2.1317375462116813e-07,0.1973348824033958,0.02271498107084911,0.01632083818303686,0.23483959107740038,0.0,0.016297213868575813,0.24116205681688774,0.0,2.1317375462116866e-07,0.2478361639045814,0.0
33,0.3,7,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Is bone scintigraphy essential if computerized tomography is used for detecting bone metastases in breast cancer? Answer: Our findings indicate that routine bone scintigraphy is not required for metastatic breast cancer patients undergoing CT of the thorax, abdomen, and pelvis.",1.184298636784265e-07,0.09887403359652636,0.02498356344510192,0.00906713232390937,0.13720112151348252,0.0,0.009054007704764347,0.14107859825990632,0.0,1.1842986367842703e-07,0.14518200984449914,0.0
33,0.3,8,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Can computerized tomography be used instead of bone scintigraphy to detect bone metastases in breast cancer? Answer: Our results suggest that routine bone scintigraphy is unnecessary if CT scans covering the thorax, abdomen, and pelvis are performed in patients with metastatic breast cancer.",1.8948778188548272e-07,0.17361265045717467,0.023242630385487524,0.014507411718254988,0.21130909366720596,0.0,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
33,0.3,9,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Is routine bone scintigraphy necessary when computerized tomography is performed to detect bone metastases from breast cancer? Answer: Our findings suggest it is not required if CT imaging of the thorax, abdomen, and pelvis is done in metastatic breast cancer patients.",1.421158364141119e-07,0.15822400521489444,0.0,0.010880558788691243,0.16251892949777424,0.0,0.010864809245717214,0.1670540846631643,0.0,1.4211583641411244e-07,0.17185025692666,0.0
33,0.3,10,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Can CT scans serve as a replacement for bone scintigraphy in detecting bone metastases in breast cancer patients? Answer: Our data suggest that routine bone scintigraphy is not necessary if CT of the thorax, abdomen, and pelvis is conducted in patients with metastatic breast cancer.",2.3685972735685353e-07,0.2205078869226864,0.02221074380165289,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
34,0.3,1,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry as it is often associated with mental health conditions such as depression, anxiety, and post-traumatic stress disorder. Treating pain alongside psychiatric symptoms is crucial for comprehensive patient care and improving","Is pain considered a clinically significant issue in general adult psychiatry? Yes, pain is a clinically significant concern in general adult psychiatry because it frequently coexists with mental health disorders like depression, anxiety, and PTSD. Addressing pain in conjunction with psychiatric symptoms is essential for thorough patient care and better outcomes.",4.737194547137081e-08,0.009832779624805887,0.034026465028355435,0.0036268529295637453,0.039322433949785296,0.05613848998896933,0.003621603081905733,0.07008155436933672,0.07939508506616257,4.737194547137081e-08,0.04320246856595489,0.060964083175803374
34,0.3,2,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry as it is often associated with mental health conditions such as depression, anxiety, and post-traumatic stress disorder. Treating pain alongside psychiatric symptoms is crucial for comprehensive patient care and improving","Does pain represent a clinically important problem in general adult psychiatry? Indeed, pain is a clinically important problem in general adult psychiatry as it commonly occurs alongside mental health conditions such as depression, anxiety, and post-traumatic stress disorder. Managing pain together with psychiatric symptoms is vital for comprehensive treatment and patient improvement.",2.3685972735685406e-08,0.022554498438822623,0.0021340054610375775,0.0018134264647818726,0.02252085153366945,0.0018845247263646892,0.0018108015409528666,0.022466045049959416,0.0015925692548250936,2.3685972735685406e-08,0.022387519806204903,0.0012581390464188463
34,0.3,3,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry as it is often associated with mental health conditions such as depression, anxiety, and post-traumatic stress disorder. Treating pain alongside psychiatric symptoms is crucial for comprehensive patient care and improving","Is pain a relevant clinical issue in the field of general adult psychiatry? Yes, pain is a relevant clinical issue in general adult psychiatry, often linked with mental illnesses including depression, anxiety, and PTSD. Effective treatment of pain alongside psychiatric symptoms is key to holistic patient care and enhanced recovery.",7.105791820705622e-08,0.04092498708066161,0.012698409598650276,0.005440279394345618,0.011356807511927691,0.034658685150178545,0.0054324046228586,0.009963104237853404,0.036925949263693435,7.105791820705622e-08,0.008440570592397112,0.039235688114074976
34,0.3,4,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry as it is often associated with mental health conditions such as depression, anxiety, and post-traumatic stress disorder. Treating pain alongside psychiatric symptoms is crucial for comprehensive patient care and improving","Is pain recognized as a clinically relevant problem in general adult psychiatry? Yes, pain is recognized as a clinically relevant problem in general adult psychiatry because it is frequently associated with mental health disorders like depression, anxiety, and post-traumatic stress disorder. Treating pain in parallel with psychiatric symptoms is critical for complete patient care and better health outcomes.",1.1842986367842703e-07,0.057196961289939896,0.023188195844674034,0.009067132323909363,0.05615047474533741,0.02556807221943601,0.009054007704764333,0.05498161657174627,0.028060141922592097,1.1842986367842703e-07,0.05367832442758891,0.030664404954142535
34,0.3,5,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry as it is often associated with mental health conditions such as depression, anxiety, and post-traumatic stress disorder. Treating pain alongside psychiatric symptoms is crucial for comprehensive patient care and improving","Is pain a clinically pertinent problem within general adult psychiatry? Yes, pain is a clinically pertinent issue in general adult psychiatry, often connected with conditions such as depression, anxiety, and PTSD. Addressing pain alongside psychiatric symptoms is essential for comprehensive care and improved patient prognosis.",1.8948778188548325e-07,0.10161711307184351,0.04560477436578507,0.014507411718254981,0.06695370890323771,0.07363827698691325,0.014486412327622933,0.06344983825518646,0.07939508506616257,1.8948778188548325e-07,0.09337306643979515,0.060964083175803374
34,0.3,6,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry as it is often associated with mental health conditions such as depression, anxiety, and post-traumatic stress disorder. Treating pain alongside psychiatric symptoms is crucial for comprehensive patient care and improving","Is pain an important clinical concern in general adult psychiatry? Yes, pain is an important clinical concern in general adult psychiatry since it is often linked to mental health conditions including depression, anxiety, and post-traumatic stress disorder. Managing pain together with psychiatric symptoms is crucial for thorough patient care and better outcomes.",2.3685972735685406e-08,0.022554498438822623,0.0021340054610375775,0.0018134264647818726,0.02252085153366945,0.0018845247263646892,0.0018108015409528666,0.022466045049959416,0.0015925692548250936,2.3685972735685406e-08,0.022387519806204903,0.0012581390464188463
34,0.3,7,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry as it is often associated with mental health conditions such as depression, anxiety, and post-traumatic stress disorder. Treating pain alongside psychiatric symptoms is crucial for comprehensive patient care and improving","Is pain a significant clinical problem in general adult psychiatry? Yes, pain is a significant clinical problem in general adult psychiatry as it frequently co-occurs with mental health issues like depression, anxiety, and PTSD. Treating pain alongside psychiatric symptoms is vital for comprehensive patient management and improvement.",1.4211583641411244e-07,0.1434662840489871,0.014078449905482002,0.010880558788691236,0.14328463787060475,0.012494092627599235,0.0108648092457172,0.14295658272210154,0.010604914933837431,1.4211583641411244e-07,0.14246322869146377,0.008410916824196618
34,0.3,8,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry as it is often associated with mental health conditions such as depression, anxiety, and post-traumatic stress disorder. Treating pain alongside psychiatric symptoms is crucial for comprehensive patient care and improving","Is pain a clinically meaningful issue in general adult psychiatry? Yes, pain is a clinically meaningful issue in general adult psychiatry because it is commonly associated with mental health disorders such as depression, anxiety, and post-traumatic stress disorder. Addressing pain in conjunction with psychiatric symptoms is important for holistic patient care and enhanced recovery.",2.3685972735685406e-08,0.022066252360648964,0.002058942579805517,0.0018134264647818726,0.022031763008536043,0.00181526681106077,0.0018108015409528666,0.02197720668617098,0.0015317985111602817,2.3685972735685406e-08,0.021900210616849325,0.001208537680103941
34,0.3,9,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry as it is often associated with mental health conditions such as depression, anxiety, and post-traumatic stress disorder. Treating pain alongside psychiatric symptoms is crucial for comprehensive patient care and improving","Is pain a clinically relevant challenge in general adult psychiatry? Yes, pain is a clinically relevant challenge in general adult psychiatry as it often accompanies mental health conditions like depression, anxiety, and PTSD. Effective treatment of pain alongside psychiatric symptoms is essential for comprehensive patient care and improved outcomes.",9.474389094274162e-08,0.09337246114584374,0.009027429497318759,0.0072537058591274906,0.0932449426631603,0.007994376074311263,0.007243206163811466,0.09302539579901525,0.006772715387352191,9.474389094274162e-08,0.09270226744844257,0.005362447436441514
34,0.3,10,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry as it is often associated with mental health conditions such as depression, anxiety, and post-traumatic stress disorder. Treating pain alongside psychiatric symptoms is crucial for comprehensive patient care and improving","Is pain considered a clinically important problem in general adult psychiatry? Yes, pain is considered a clinically important problem in general adult psychiatry since it is frequently linked with mental health disorders such as depression, anxiety, and post-traumatic stress disorder. Treating pain together with psychiatric symptoms is crucial for comprehensive care and better patient health.",4.737194547137081e-08,0.017992545060911525,0.013332637320601928,0.0036268529295637453,0.01743850842457162,0.014481700142311718,0.003621603081905733,0.0168267273198075,0.01567055549517743,4.737194547137081e-08,0.01615153008062231,0.01689920337919891
35,0.3,1,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Do preoperative statins lower the incidence of atrial fibrillation following coronary artery bypass grafting? Answer: Our research suggests that administering statins before surgery appears to decrease the occurrence of AF after CABG.,1.421158364141118e-07,0.20763936477824396,0.0,0.010880558788691277,0.2151113796169466,0.0,0.010864809245717241,0.2231435513142097,0.0,1.4211583641411244e-07,0.23180161405732358,0.0
35,0.3,2,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Can preoperative statin use prevent atrial fibrillation post-coronary artery bypass grafting? Answer: Findings from our study indicate that pre-surgical statin treatment may reduce AF development after CABG.,2.36859727356853e-08,0.03774032798284699,0.0,0.0018134264647818796,0.03922071315328246,0.0,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
35,0.3,3,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Is there a reduction in atrial fibrillation after CABG with preoperative statins? Answer: Our study showed that statin therapy prior to surgery seems to lessen AF incidence following CABG.,7.10579182070559e-08,0.10919929196499067,0.0,0.005440279394345639,0.11332868530700413,0.0,0.005432404622858621,0.11778303565638426,0.0,7.105791820705622e-08,0.1226023220923329,0.0
35,0.3,4,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,"Question: Do statins given before coronary artery bypass grafting reduce the risk of atrial fibrillation? Answer: According to our study, preoperative statin use appears to diminish AF occurrence after CABG.",7.10579182070559e-08,0.10919929196499067,0.0,0.005440279394345639,0.11332868530700413,0.0,0.005432404622858621,0.11778303565638426,0.0,7.105791820705622e-08,0.1226023220923329,0.0
35,0.3,5,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Does preoperative statin therapy decrease atrial fibrillation after coronary artery bypass surgery? Answer: Our findings indicate that statins administered before CABG seem to lower the chance of developing AF.,7.10579182070559e-08,0.10919929196499067,0.0,0.005440279394345639,0.11332868530700413,0.0,0.005432404622858621,0.11778303565638426,0.0,7.105791820705622e-08,0.1226023220923329,0.0
35,0.3,6,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Are atrial fibrillation rates reduced after CABG when patients receive statins preoperatively? Answer: Our study suggests that preoperative statin treatment reduces the likelihood of AF post-CABG.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
35,0.3,7,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Does taking statins before coronary artery bypass grafting help prevent atrial fibrillation? Answer: Our research indicates that preoperative statin therapy may reduce AF development after CABG.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
35,0.3,8,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Can preoperative statin administration reduce atrial fibrillation following CABG? Answer: The study results show that statins given before surgery seem to decrease AF occurrence after CABG.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
35,0.3,9,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Do pre-surgery statins impact atrial fibrillation rates after coronary artery bypass grafting? Answer: Our study suggests that preoperative statin therapy reduces AF incidence post-CABG.,4.73719454713706e-08,0.08004270767353727,0.0,0.003626852929563759,0.08338160893905044,0.0,0.003621603081905747,0.08701137698962969,0.0,4.737194547137081e-08,0.090971778205728,0.0
35,0.3,10,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Is atrial fibrillation less common after CABG in patients treated with statins before surgery? Answer: Our findings reveal that preoperative statin use appears to lower AF development after CABG.,7.10579182070559e-08,0.10919929196499067,0.0,0.005440279394345639,0.11332868530700413,0.0,0.005432404622858621,0.11778303565638426,0.0,7.105791820705622e-08,0.1226023220923329,0.0
36,0.3,1,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals pertinent and useful for practitioners and athletes? There is a lack of research focusing on diagnostic and treatment methods in sports medicine literature. The evidence supporting sports medicine needs to grow both in quantity and quality.,1.1842986367842692e-07,0.13023124206019032,0.012215745806479397,0.009067132323909363,0.12361395596717584,0.0,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
36,0.3,2,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Do sports medicine journals hold relevance and practical value for practitioners and athletes? Few studies explore diagnostic and therapeutic interventions within sports medicine publications. The body of evidence in sports medicine should expand in both volume and quality.,1.6580180914979753e-07,0.18744301000992758,0.018049886621315223,0.012693985253473108,0.17768117723745203,0.0,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
36,0.3,3,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals applicable and meaningful to practitioners and athletes? The sports medicine literature shows a scarcity of studies on diagnostic and treatment interventions. Increasing the amount and quality of evidence in sports medicine is essential.,1.8948778188548283e-07,0.2173163361995467,0.02121632966912254,0.014507411718254981,0.20585205420414887,0.0,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
36,0.3,4,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals significant and beneficial for practitioners and athletes? There is an insufficiency of research on diagnostic and treatment approaches in sports medicine literature. The evidence base for sports medicine requires enhancement in both size and quality.,1.4211583641411222e-07,0.15843063997897167,0.015054169816074561,0.010880558788691236,0.1502822030493367,0.0,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
36,0.3,5,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Do sports medicine journals provide relevant and applicable information for practitioners and athletes? Studies addressing diagnostic and treatment interventions are limited in sports medicine literature. The evidence supporting sports medicine must be augmented in volume and quality.,1.8948778188548283e-07,0.2173163361995467,0.02121632966912254,0.014507411718254981,0.20585205420414887,0.0,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
36,0.3,6,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals relevant and practical for practitioners and athletes? The literature in sports medicine lacks sufficient studies on diagnostic and treatment interventions. It is necessary to increase the quantity and quality of evidence in sports medicine.,1.6580180914979753e-07,0.17330116828656106,0.03909297052154192,0.012693985253473108,0.17768117723745203,0.0,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
36,0.3,7,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals useful and applicable to practitioners and athletes? There is a shortage of research concerning diagnostic and treatment interventions in sports medicine literature. The evidence base in sports medicine needs to be expanded in both volume and quality.,9.474389094274162e-08,0.13745807716414937,0.03559047188390818,0.0072537058591274906,0.1331844788234018,0.02562326869806095,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
36,0.3,8,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals important and relevant to practitioners and athletes? The sports medicine literature has few studies addressing diagnostic and treatment interventions. The evidence supporting sports medicine should continue to grow in both quantity and quality.,1.8948778188548283e-07,0.2173163361995467,0.02121632966912254,0.014507411718254981,0.20585205420414887,0.0,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
36,0.3,9,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals meaningful and applicable for practitioners and athletes? A dearth of studies on diagnostic and treatment interventions exists in sports medicine literature. The evidence base in sports medicine must increase in both volume and quality.,1.6580180914979753e-07,0.22491042517533,0.04630283485943398,0.012693985253473108,0.21618935393522687,0.02775510204081633,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
36,0.3,10,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals relevant and beneficial to practitioners and athletes? There is a lack of sufficient studies on diagnostic and treatment interventions within sports medicine literature. The evidence base for sports medicine needs ongoing growth in both quantity and quality.,9.474389094274162e-08,0.10280071813615255,0.00952255325029372,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
37,0.3,1,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
37,0.3,2,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Question: Does robotically assisted laparoscopic radical prostatectomy cause less tissue damage compared to retropubic radical prostatectomy? Answer: This study demonstrated for the first time that RALP results in reduced tissue trauma relative to RRP.,1.184298636784265e-07,0.16430305129127598,0.0,0.009067132323909398,0.16989903679539697,0.0,0.009054007704764368,0.17589066646366414,0.0,1.1842986367842703e-07,0.1823215567939549,0.0
37,0.3,3,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Question: Is robotically assisted laparoscopic radical prostatectomy a less invasive procedure than retropubic radical prostatectomy? Answer: This study revealed for the first time that RALP leads to less tissue trauma than RRP.,7.10579182070559e-08,0.10178269430994247,0.0,0.005440279394345639,0.10536051565782545,0.0,0.005432404622858621,0.10919929196499067,0.0,7.105791820705622e-08,0.11332868530700413,0.0
37,0.3,4,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Question: Does robotically assisted laparoscopic radical prostatectomy minimize invasiveness compared to retropubic radical prostatectomy? Answer: This study found for the first time that RALP causes lower tissue trauma than RRP.,2.36859727356853e-08,0.035091319811269006,0.0,0.0018134264647818796,0.03636764417087468,0.0,0.0018108015409528735,0.03774032798284699,0.0,2.3685972735685406e-08,0.03922071315328246,0.0
37,0.3,5,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Question: Is the invasiveness of robotically assisted laparoscopic radical prostatectomy less than that of retropubic radical prostatectomy? Answer: This study showed for the first time that RALP results in decreased tissue trauma compared to RRP.,1.421158364141118e-07,0.19415601444095776,0.0,0.010880558788691277,0.20067069546215066,0.0,0.010864809245717241,0.20763936477824396,0.0,1.4211583641411244e-07,0.2151113796169466,0.0
37,0.3,6,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Question: Is robotically assisted laparoscopic radical prostatectomy associated with less tissue trauma than retropubic radical prostatectomy? Answer: This study demonstrated for the first time that RALP induces less tissue trauma than RRP.,7.10579182070559e-08,0.032374824508111466,0.09566326530612247,0.005440279394345639,0.012940891583166358,0.06632653061224487,0.005432404622858621,0.06139603813327055,0.03443877551020409,7.105791820705622e-08,0.11332868530700413,0.0
37,0.3,7,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Question: Does robotically assisted laparoscopic radical prostatectomy cause less invasive tissue damage than retropubic radical prostatectomy? Answer: This study revealed for the first time that RALP produces lower tissue trauma than RRP.,7.10579182070559e-08,0.10178269430994247,0.0,0.005440279394345639,0.10536051565782545,0.0,0.005432404622858621,0.10919929196499067,0.0,7.105791820705622e-08,0.11332868530700413,0.0
37,0.3,8,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Question: Is robotically assisted laparoscopic radical prostatectomy a less damaging procedure than retropubic radical prostatectomy? Answer: This study found for the first time that RALP causes less tissue trauma than RRP.,4.73719454713706e-08,0.06899287148695077,0.0,0.003626852929563759,0.07145896398214369,0.0,0.003621603081905747,0.07410797215372167,0.0,4.737194547137081e-08,0.07696104113612945,0.0
37,0.3,9,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Question: Is robotically assisted laparoscopic radical prostatectomy less harmful to tissues than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP results in reduced tissue trauma compared to RRP.,9.47438909427412e-08,0.1335313926245223,0.0,0.007253705859127518,0.13815033848081715,0.0,0.007243206163811494,0.14310084364067244,0.0,9.474389094274162e-08,0.14842000511827314,0.0
37,0.3,10,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Question: Does robotically assisted laparoscopic radical prostatectomy result in less tissue injury than retropubic radical prostatectomy? Answer: This study demonstrated for the first time that RALP induces lower tissue trauma than RRP.,7.10579182070559e-08,0.10178269430994247,0.0,0.005440279394345639,0.10536051565782545,0.0,0.005432404622858621,0.10919929196499067,0.0,7.105791820705622e-08,0.11332868530700413,0.0
38,0.3,1,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Question: Is there an optimal duration of acid suppression for maximal healing in a model of Los Angeles grades C and D reflux oesophagitis? Answer: After 4 weeks of acid-suppressive treatment for LA grade C or D oesophagitis, healing seems to plateau, with further improvements unlikely despite longer periods of intragastric pH>4.",2.6054570009253947e-07,0.1953087523207664,0.0,0.0199476911126006,0.19885085874516495,0.0,0.019918816950481533,0.20252426411147262,0.0,2.6054570009253947e-07,0.20633643299782767,0.0
38,0.3,2,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Question: What is the best time frame for acid suppression to maximize healing in Los Angeles grades C and D reflux oesophagitis? Answer: Healing of LA grade C or D oesophagitis after 4 weeks of acid suppression reaches a threshold, beyond which additional hours with intragastric pH>4 do not significantly enhance recovery.",2.6054570009253947e-07,0.2224909946956659,0.019599999999999992,0.0199476911126006,0.19885085874516495,0.0,0.019918816950481533,0.20252426411147262,0.0,2.6054570009253947e-07,0.20633643299782767,0.0
38,0.3,3,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Question: Does an optimal acid suppression duration exist for maximal healing in Los Angeles grades C and D reflux oesophagitis? Answer: After 4 weeks of acid-suppressive therapy in LA grade C or D oesophagitis, healing plateaus, and further increases in intragastric pH>4 duration do not yield significant improvements.",3.552895910352811e-07,0.2769867833350337,0.0,0.02720139697172809,0.28223246768421584,0.0,0.027162023114293,0.2876820724517799,0.0,3.552895910352811e-07,0.2933478099874569,0.0
38,0.3,4,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Question: In Los Angeles grades C and D reflux oesophagitis, is there a best time for acid suppression to achieve maximal healing? Answer: Successful healing after 4 weeks of acid suppression for LA grade C or D oesophagitis reaches a limit, with no notable gains despite longer intragastric pH>4 periods.",3.079176455639103e-07,0.26360580858997285,0.020399305555555556,0.023574544042164344,0.23967285326541932,0.0,0.023540420032387266,0.24419696051204154,0.0,3.079176455639103e-07,0.2488960474166242,0.0
38,0.3,5,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Question: What is the optimal acid suppression period for maximal healing in a model of Los Angeles grades C and D reflux oesophagitis? Answer: After 4 weeks of acid-suppressive therapy for LA grade C or D oesophagitis, healing attains a threshold beyond which additional intragastric pH>4 hours do not improve outcomes.",2.8423167282822487e-07,0.21511137961694615,0.0,0.02176111757738247,0.21905356606268356,0.0,0.0217296184914344,0.22314355131420838,0.0,2.8423167282822487e-07,0.22738984219566083,0.0
38,0.3,6,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Question: Is there a maximum effective duration of acid suppression for healing Los Angeles grades C and D reflux oesophagitis? Answer: Healing after 4 weeks of acid suppression in LA grade C or D oesophagitis appears to plateau, with no further benefit from increased intragastric pH>4 time.",3.789755637709665e-07,0.35876665643077477,0.043388429752066124,0.029014823436509962,0.33501791576121054,0.02221074380165289,0.028972824655245866,0.3101549283038376,0.0,3.789755637709665e-07,0.31633732821215643,0.0
38,0.3,7,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Question: How long should acid suppression be applied for optimal healing in Los Angeles grades C and D reflux oesophagitis? Answer: Four weeks of acid-suppressive therapy for LA grade C or D oesophagitis results in a healing plateau, beyond which additional intragastric pH>4 hours do not enhance healing.",3.552895910352811e-07,0.2769867833350337,0.0,0.02720139697172809,0.28223246768421584,0.0,0.027162023114293,0.2876820724517799,0.0,3.552895910352811e-07,0.2933478099874569,0.0
38,0.3,8,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Question: What is the ideal duration of acid suppression for maximal healing in Los Angeles grades C and D reflux oesophagitis? Answer: After 4 weeks of acid suppression, healing in LA grade C or D oesophagitis reaches a threshold, with no significant improvement despite longer intragastric pH>4 exposure.",3.552895910352811e-07,0.33597803274439064,0.04246913580246913,0.02720139697172809,0.28223246768421584,0.0,0.027162023114293,0.2876820724517799,0.0,3.552895910352811e-07,0.2933478099874569,0.0
38,0.3,9,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Question: Can maximal healing be achieved by extending acid suppression time in Los Angeles grades C and D reflux oesophagitis? Answer: Healing plateaus after 4 weeks of acid-suppressive therapy in LA grade C or D oesophagitis, and increasing intragastric pH>4 duration does not yield further benefits.",4.026615365066519e-07,0.32047189527477205,0.0,0.030828249901291835,0.32668423025504856,0.0,0.030783626196198732,0.33314444652853714,0.0,4.026615365066519e-07,0.33986782562235085,0.0
38,0.3,10,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Question: Is there an optimal acid suppression time frame for maximal healing in Los Angeles grades C and D reflux oesophagitis? Answer: Successful healing after 4 weeks of acid suppression in LA grade C or D oesophagitis appears to reach a limit, beyond which longer intragastric pH>4 periods do not improve healing.",2.6054570009253947e-07,0.2224909946956659,0.019599999999999992,0.0199476911126006,0.19885085874516495,0.0,0.019918816950481533,0.20252426411147262,0.0,2.6054570009253947e-07,0.20633643299782767,0.0
39,0.3,1,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Is there a connection between viral infections and benign paroxysmal positional vertigo? BPPV is linked to positive viral serology, especially in spring and autumn. Viral infections may trigger BPPV episodes by causing vestibulopathy or lead to secondary BPPV through viral neurolabyrinthitis.",2.6054570009253947e-07,0.2776035376383854,0.02498356344510192,0.0199476911126006,0.248461359298501,0.0,0.019918816950481533,0.25423413838424036,0.0,2.6054570009253947e-07,0.26028309826366547,0.0
39,0.3,2,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Do viral infections contribute to benign paroxysmal positional vertigo? BPPV shows an association with positive viral serology, mainly during spring and autumn months. Viral infections might cause BPPV attacks by inducing vestibulopathy or secondary BPPV via neurolabyrinthitis related to the virus.",2.6054570009253947e-07,0.2776035376383854,0.02498356344510192,0.0199476911126006,0.248461359298501,0.0,0.019918816950481533,0.25423413838424036,0.0,2.6054570009253947e-07,0.26028309826366547,0.0
39,0.3,3,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Can viral infections play a role in benign paroxysmal positional vertigo? BPPV is connected with positive viral serology, particularly in spring and autumn. Viral infections may promote BPPV attacks by developing vestibulopathy or cause secondary BPPV through viral neurolabyrinthitis.",3.0791764556391007e-07,0.3307209035537251,0.026296566837107373,0.023574544042164344,0.30110509278391984,0.0,0.023540420032387266,0.30830135965451655,0.0,3.079176455639103e-07,0.31585294941847764,0.0
39,0.3,4,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Are viral infections involved in benign paroxysmal positional vertigo? BPPV is associated with positive viral serology, especially in the spring and autumn seasons. Viral infections might trigger BPPV episodes by causing vestibulopathy or lead to secondary BPPV due to viral neurolabyrinthitis.",2.6054570009253947e-07,0.2776035376383854,0.02498356344510192,0.0199476911126006,0.248461359298501,0.0,0.019918816950481533,0.25423413838424036,0.0,2.6054570009253947e-07,0.26028309826366547,0.0
39,0.3,5,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Do viral infections have an impact on benign paroxysmal positional vertigo? BPPV correlates with positive viral serology, mainly in spring and autumn. Viral infections could provoke BPPV attacks by inducing vestibulopathy or cause secondary BPPV through viral neurolabyrinthitis.",3.3160361829959537e-07,0.358375135245502,0.027006172839506164,0.025387970506946217,0.32850406697203516,0.0,0.025351221573340132,0.3364722366212134,0.0,3.316036182995957e-07,0.34484048629172914,0.0
39,0.3,6,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Is there a role for viral infections in benign paroxysmal positional vertigo? BPPV is linked to positive viral serology, particularly during spring and autumn. Viral infections might initiate BPPV attacks by causing vestibulopathy or induce secondary BPPV via viral neurolabyrinthitis.",2.8423167282822477e-07,0.3038099958541647,0.025623268698060954,0.02176111757738247,0.27443684570175897,0.0,0.0217296184914344,0.2809023854664012,0.0,2.8423167282822487e-07,0.2876820724517808,0.0
39,0.3,7,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Can viral infections influence benign paroxysmal positional vertigo? BPPV is associated with positive viral serology, especially in spring and autumn months. Viral infections may promote BPPV attacks by developing vestibulopathy or cause secondary BPPV through viral neurolabyrinthitis.",3.5528959103528067e-07,0.38681487096598977,0.02775510204081633,0.02720139697172809,0.356674943938732,0.0,0.027162023114293006,0.3654597734944649,0.0,3.552895910352811e-07,0.3746934494414109,0.0
39,0.3,8,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Are viral infections a factor in benign paroxysmal positional vertigo? BPPV shows a connection with positive viral serology, mainly during spring and autumn. Viral infections might trigger BPPV episodes by inducing vestibulopathy or lead to secondary BPPV via viral neurolabyrinthitis.",2.8423167282822477e-07,0.3038099958541647,0.025623268698060954,0.02176111757738247,0.27443684570175897,0.0,0.0217296184914344,0.2809023854664012,0.0,2.8423167282822487e-07,0.2876820724517808,0.0
39,0.3,9,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Do viral infections contribute to the development of benign paroxysmal positional vertigo? BPPV is related to positive viral serology, particularly in spring and autumn. Viral infections may cause BPPV attacks by causing vestibulopathy or induce secondary BPPV through viral neurolabyrinthitis.",2.8423167282822477e-07,0.3038099958541647,0.025623268698060954,0.02176111757738247,0.27443684570175897,0.0,0.0217296184914344,0.2809023854664012,0.0,2.8423167282822487e-07,0.2876820724517808,0.0
39,0.3,10,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Is benign paroxysmal positional vertigo associated with viral infections? BPPV correlates with positive viral serology, especially in spring and autumn. Viral infections might promote BPPV attacks by inducing vestibulopathy or cause secondary BPPV via viral neurolabyrinthitis.",3.7897556377096597e-07,0.37647757123491177,0.0,0.02901482343650997,0.3856624808119835,0.0,0.02897282465524588,0.3953127366441467,0.0,3.789755637709665e-07,0.4054651081081646,0.0
40,0.3,1,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Does aerobic fitness affect microvascular function in healthy adults who are at risk of Type 2 diabetes? In this at-risk group with skin microvascular dysfunction, maximal oxygen uptake was not lower than in healthy controls. However, within the at-risk group, those with greater aerobic fitness showed improved microvascular and endothelial responsiveness.",1.1842986367842703e-07,0.10035125020839786,0.003618700802974578,0.009067132323909363,0.0971637484536485,0.0,0.009054007704764333,0.09909090264422993,0.0,1.1842986367842703e-07,0.10109611687136999,0.0
40,0.3,2,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Is there an impact of aerobic fitness on microvascular function in healthy adults at risk for Type 2 diabetes? Among this at-risk population with skin microvascular dysfunction, maximal oxygen uptake was comparable to healthy controls. Yet, individuals with higher aerobic fitness in the at-risk group exhibited enhanced microvascular and endothelial function.",1.1842986367842703e-07,0.07262536298600031,0.016320184615138254,0.009067132323909363,0.0971637484536485,0.0,0.009054007704764333,0.09909090264422993,0.0,1.1842986367842703e-07,0.10109611687136999,0.0
40,0.3,3,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Does aerobic fitness influence microvascular function in healthy adults predisposed to Type 2 diabetes? In the at-risk group with skin microvascular dysfunction, maximal oxygen uptake was not diminished relative to healthy controls. Nevertheless, within this group, higher aerobic fitness correlated with better microvascular and endothelial responsiveness.",2.3685972735685406e-07,0.1810665327796479,0.014101110950928097,0.018134264647818726,0.2047944126460135,0.0,0.018108015409528666,0.2090917978585587,0.0,2.3685972735685406e-07,0.21357410029806,0.0
40,0.3,4,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","How does aerobic fitness affect microvascular function in healthy adults at risk of developing Type 2 diabetes? The at-risk group with skin microvascular dysfunction did not show reduced maximal oxygen uptake compared to healthy controls. Still, those with higher aerobic fitness in this group had superior microvascular and endothelial responsiveness.",1.4211583641411244e-07,0.09339390473662901,0.015912549197025432,0.010880558788691236,0.11778303565638426,0.0,0.0108648092457172,0.12014431184206309,0.0,1.4211583641411244e-07,0.12260232209233335,0.0
40,0.3,5,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Is microvascular function in healthy adults at risk for Type 2 diabetes influenced by aerobic fitness? Maximal oxygen uptake in the at-risk group with skin microvascular dysfunction was not lower than in healthy controls. However, within this group, individuals with greater aerobic fitness demonstrated enhanced microvascular and endothelial responsiveness.",1.6580180914979784e-07,0.11460260280718737,0.015487952534382704,0.012693985253473108,0.13883644485421742,0.0,0.012675610786670066,0.14165051706302645,0.0,1.6580180914979784e-07,0.14458122881110835,0.0
40,0.3,6,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Does aerobic fitness impact microvascular function among healthy adults at risk of Type 2 diabetes? In the at-risk group exhibiting skin microvascular dysfunction, maximal oxygen uptake was similar to that of healthy controls. Yet, higher aerobic fitness within this group was associated with improved microvascular and endothelial responsiveness.",1.8948778188548325e-07,0.13627050418636832,0.015045314109858886,0.014507411718254981,0.16034265007518078,0.0,0.014486412327622933,0.16362942378180145,0.0,1.8948778188548325e-07,0.16705408466316607,0.0
40,0.3,7,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Can aerobic fitness influence microvascular function in healthy adults at risk for Type 2 diabetes? Maximal oxygen uptake was not reduced in the at-risk group with skin microvascular dysfunction compared to healthy controls. However, those with higher aerobic fitness in this group showed better microvascular and endothelial responsiveness.",1.8948778188548325e-07,0.13627050418636832,0.015045314109858886,0.014507411718254981,0.16034265007518078,0.0,0.014486412327622933,0.16362942378180145,0.0,1.8948778188548325e-07,0.16705408466316607,0.0
40,0.3,8,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Is there a relationship between aerobic fitness and microvascular function in healthy adults at risk of Type 2 diabetes? The at-risk group with skin microvascular dysfunction did not have reduced maximal oxygen uptake compared to healthy controls. Nonetheless, individuals with higher aerobic fitness within this group had improved microvascular and endothelial function.",9.474389094274162e-08,0.052279090842322073,0.016711854752580996,0.0072537058591274906,0.07696104113612989,0.0,0.007243206163811466,0.07847161544149417,0.0,9.474389094274162e-08,0.08004270767353683,0.0
40,0.3,9,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Does aerobic fitness have an effect on microvascular function in healthy adults at risk for Type 2 diabetes? Maximal oxygen uptake was not decreased in the at-risk group with skin microvascular dysfunction relative to healthy controls. However, higher aerobic fitness in this group was linked to better microvascular and endothelial responsiveness.",1.1842986367842703e-07,0.07262536298600031,0.016320184615138254,0.009067132323909363,0.0971637484536485,0.0,0.009054007704764333,0.09909090264422993,0.0,1.1842986367842703e-07,0.10109611687136999,0.0
40,0.3,10,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","How does aerobic fitness relate to microvascular function in healthy adults at risk of developing Type 2 diabetes? In the at-risk group with skin microvascular dysfunction, maximal oxygen uptake was not lower than in healthy controls. Still, those with greater aerobic fitness within this group exhibited enhanced microvascular and endothelial responsiveness.",1.1842986367842703e-07,0.10035125020839786,0.003618700802974578,0.009067132323909363,0.0971637484536485,0.0,0.009054007704764333,0.09909090264422993,0.0,1.1842986367842703e-07,0.10109611687136999,0.0
41,0.3,1,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates",Our findings indicate that the ultra high risk (UHR) criteria for psychosis predict transition risk over six months in the sequence: Trait alone < APS < BLIPS.,9.00066963956044e-07,0.8791256959456923,0.015621063240110858,0.06891020566171123,0.9242589015233351,0.0,0.06881045855620901,0.9490805546971464,0.0,9.000669639560454e-07,0.9753796482441608,0.0
41,0.3,2,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates","Data suggest that among UHR criteria, the likelihood of transitioning to psychosis within six months increases from Trait alone to APS, and is highest for BLIPS.",9.237529366917293e-07,0.9183464090989748,0.015621063240110858,0.0707236321264931,0.9650808960435899,0.0,0.07062126009716188,0.991640169115942,0.0,9.237529366917308e-07,1.0198314108149948,0.0
41,0.3,3,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates","According to our data, the UHR intake criteria forecast psychosis transition risk over six months, ranked as Trait alone less than APS, which is less than BLIPS.",9.00066963956044e-07,0.9324447098349191,0.022778936759889144,0.06891020566171123,0.9242589015233351,0.0,0.06881045855620901,0.9490805546971464,0.0,9.000669639560454e-07,0.9753796482441608,0.0
41,0.3,4,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates","The evidence shows that UHR criteria predict six-month psychosis transition risk in ascending order: Trait alone, then APS, and highest for BLIPS.",1.0184968276344706e-06,1.0926997962437532,0.015621063240110858,0.07797733798562062,1.1474024528375448,0.0,0.07786446626097338,1.1826954058786514,0.0,1.0184968276344723e-06,1.2205021062771455,0.0
41,0.3,5,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates",Our data imply that the risk of psychosis transition over six months for UHR criteria follows the pattern Trait alone < APS < BLIPS.,9.711248821630997e-07,1.0017280180380252,0.015621063240110858,0.07435048505605688,1.0520922730332196,0.0,0.07424286317906763,1.08261194732167,0.0,9.711248821631017e-07,1.11514159061932,0.0
41,0.3,6,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates","The UHR intake criteria appear to predict psychosis transition within six months, with risk levels increasing from Trait alone to APS and peaking at BLIPS.",9.474389094274146e-07,0.9591684036192296,0.015621063240110858,0.07253705859127499,1.0076405104623856,0.0,0.07243206163811475,1.036091931686776,0.0,9.474389094274162e-07,1.0663514264498888,0.0
41,0.3,7,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates","Findings suggest that among UHR criteria, BLIPS patients have the greatest short-term risk of psychosis transition, followed by APS, then Trait alone.",1.0184968276344706e-06,1.0926997962437532,0.015621063240110858,0.07797733798562062,1.1474024528375448,0.0,0.07786446626097338,1.1826954058786514,0.0,1.0184968276344723e-06,1.2205021062771455,0.0
41,0.3,8,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates","The data support that UHR criteria predict psychosis transition over six months, with BLIPS patients at highest risk, consistent with the early versus late prodrome model.",9.237529366917293e-07,0.9183464090989748,0.015621063240110858,0.0707236321264931,0.9650808960435899,0.0,0.07062126009716188,0.991640169115942,0.0,9.237529366917308e-07,1.0198314108149948,0.0
41,0.3,9,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates","Our results show that the risk of transitioning to psychosis over six months is lowest for Trait alone, higher for APS, and highest for BLIPS in UHR criteria.",8.763809912203587e-07,0.8413853679628454,0.015621063240110858,0.06709677919692936,0.8850381883700527,0.0,0.06699965701525613,0.9082585601768915,0.0,8.7638099122036e-07,0.9328200338253652,0.0
41,0.3,10,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates",The fact that BLIPS patients have the highest short-term transition risk aligns with the early versus late prodrome model and supports the UHR criteria's predictive order: Trait alone < APS < BLIPS.,7.816371002776174e-07,0.7032350294820282,0.015621063240110858,0.05984307333780183,0.7419373447293802,0.0,0.05975645085144464,0.7598385550586184,0.0,7.816371002776184e-07,0.7786693539981062,0.0
42,0.3,1,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: The preoperative platelet count in esophageal squamous cell carcinoma may be a prognostic factor, indicating the likelihood of disease progression and overall survival. However, further research is needed to fully understand the relationship between platelet count","Is the preoperative platelet count a prognostic factor in esophageal squamous cell carcinoma? It might be, as it could reflect the chances of disease progression and overall survival, though more studies are required to clarify this link.",3.3160361829959526e-07,0.09623200631756168,0.20181405895691615,0.025387970506946217,0.19501362834367342,0.10072314049586772,0.02535122157334014,0.22931595619840506,0.08264462809917356,3.316036182995957e-07,0.2651531661295423,0.06353305785123965
42,0.3,2,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: The preoperative platelet count in esophageal squamous cell carcinoma may be a prognostic factor, indicating the likelihood of disease progression and overall survival. However, further research is needed to fully understand the relationship between platelet count","Can preoperative platelet count predict outcomes in esophageal squamous cell carcinoma? It potentially serves as a prognostic indicator for disease progression and survival, but additional research is necessary to confirm this association.",4.5003348197802176e-07,0.24576374028852532,0.20181405895691615,0.034455102830855615,0.3491643081709319,0.10072314049586772,0.03440522927810451,0.3883806508280938,0.08264462809917356,4.500334819780227e-07,0.4294562174208183,0.06353305785123965
42,0.3,3,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: The preoperative platelet count in esophageal squamous cell carcinoma may be a prognostic factor, indicating the likelihood of disease progression and overall survival. However, further research is needed to fully understand the relationship between platelet count","Does the preoperative platelet count have prognostic value in esophageal squamous cell carcinoma? It may indicate the risk of disease advancement and patient survival, yet further investigation is needed to fully understand this connection.",4.0266153650665116e-07,0.1832433833071918,0.20181405895691615,0.030828249901291856,0.2846257870333604,0.10072314049586772,0.03078362619619876,0.32168927632942035,0.08264462809917356,4.026615365066519e-07,0.36046334593386753,0.06353305785123965
42,0.3,4,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: The preoperative platelet count in esophageal squamous cell carcinoma may be a prognostic factor, indicating the likelihood of disease progression and overall survival. However, further research is needed to fully understand the relationship between platelet count","Is the platelet count before surgery a prognostic marker in esophageal squamous cell carcinoma? It could be related to the likelihood of disease progression and overall survival, although more research is essential to establish this relationship.",3.5528959103528056e-07,0.12440288328425853,0.20181405895691615,0.027201396971728097,0.22400116521692492,0.10072314049586772,0.027162023114293013,0.25916891934808683,0.08264462809917356,3.552895910352811e-07,0.295924824796296,0.06353305785123965
42,0.3,5,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: The preoperative platelet count in esophageal squamous cell carcinoma may be a prognostic factor, indicating the likelihood of disease progression and overall survival. However, further research is needed to fully understand the relationship between platelet count","Could the preoperative platelet count serve as a prognostic factor in esophageal squamous cell carcinoma? It might reflect disease progression risk and survival chances, but further studies are required to elucidate this association.",4.2634750924233646e-07,0.2140150419739455,0.20181405895691615,0.032641676366073735,0.3163744853479402,0.10072314049586772,0.032594427737151634,0.35447909915241205,0.08264462809917356,4.263475092423373e-07,0.3943648976095493,0.06353305785123965
42,0.3,6,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: The preoperative platelet count in esophageal squamous cell carcinoma may be a prognostic factor, indicating the likelihood of disease progression and overall survival. However, further research is needed to fully understand the relationship between platelet count","Is there prognostic significance to the preoperative platelet count in esophageal squamous cell carcinoma? It may predict disease progression and survival outcomes, though more research is needed to verify this link.",4.7371945471370706e-07,0.278553563111517,0.20181405895691615,0.036268529295637494,0.3830658598466137,0.10072314049586772,0.03621603081905738,0.4234719706393628,0.08264462809917356,4.737194547137081e-07,0.465823861591693,0.06353305785123965
42,0.3,7,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: The preoperative platelet count in esophageal squamous cell carcinoma may be a prognostic factor, indicating the likelihood of disease progression and overall survival. However, further research is needed to fully understand the relationship between platelet count","Does preoperative platelet count influence prognosis in esophageal squamous cell carcinoma? It possibly indicates the likelihood of disease progression and overall survival, but additional research is necessary to fully comprehend this relationship.",4.5003348197802176e-07,0.24576374028852532,0.20181405895691615,0.034455102830855615,0.3491643081709319,0.10072314049586772,0.03440522927810451,0.3883806508280938,0.08264462809917356,4.500334819780227e-07,0.4294562174208183,0.06353305785123965
42,0.3,8,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: The preoperative platelet count in esophageal squamous cell carcinoma may be a prognostic factor, indicating the likelihood of disease progression and overall survival. However, further research is needed to fully understand the relationship between platelet count","Is the preoperative platelet count an indicator of prognosis in esophageal squamous cell carcinoma? It might be associated with disease progression and survival, yet further studies are required to understand this connection.",4.5003348197802176e-07,0.24576374028852532,0.20181405895691615,0.034455102830855615,0.3491643081709319,0.10072314049586772,0.03440522927810451,0.3883806508280938,0.08264462809917356,4.500334819780227e-07,0.4294562174208183,0.06353305785123965
42,0.3,9,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: The preoperative platelet count in esophageal squamous cell carcinoma may be a prognostic factor, indicating the likelihood of disease progression and overall survival. However, further research is needed to fully understand the relationship between platelet count","Can the platelet count before surgery predict prognosis in esophageal squamous cell carcinoma? It may serve as a marker for disease progression and survival, but more research is needed to confirm this correlation.",4.2634750924233646e-07,0.2140150419739455,0.20181405895691615,0.032641676366073735,0.3163744853479402,0.10072314049586772,0.032594427737151634,0.35447909915241205,0.08264462809917356,4.263475092423373e-07,0.3943648976095493,0.06353305785123965
42,0.3,10,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: The preoperative platelet count in esophageal squamous cell carcinoma may be a prognostic factor, indicating the likelihood of disease progression and overall survival. However, further research is needed to fully understand the relationship between platelet count","Is preoperative platelet count a prognostic factor in esophageal squamous cell carcinoma? It potentially signals the risk of disease progression and overall survival, although further research is essential to fully grasp this relationship.",4.2634750924233646e-07,0.2140150419739455,0.20181405895691615,0.032641676366073735,0.3163744853479402,0.10072314049586772,0.032594427737151634,0.35447909915241205,0.08264462809917356,4.263475092423373e-07,0.3943648976095493,0.06353305785123965
43,0.3,1,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation,Do residents' leadership abilities correlate with assessments of their technical skills? Research on general surgery residents found that intraoperative leadership skills significantly correlated with their perceptions of skill decline and task difficulty during bowel repair. Assessing residents' directional instructions could offer an additional personalized intraoperative evaluation metric. Further study is needed.,4.737194547137081e-08,0.06970312704358506,0.020823902218198284,0.0036268529295637453,0.04167269640056892,0.0,0.003621603081905733,0.04255961441879652,0.0,4.737194547137081e-08,0.04348511193973836,0.0
43,0.3,2,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation,Is there a relationship between residents' leadership skills and their technical skill ratings? Studies on general surgery research residents revealed that intraoperative leadership abilities significantly correlated with their views on skill decay and task difficulty in bowel repair. Evaluating residents' directional guidance might provide another individualized intraoperative assessment tool. Further investigation is warranted.,9.474389094274162e-08,0.10892384019686752,0.020823902218198284,0.0072537058591274906,0.0816780310142673,0.0,0.007243206163811466,0.08338160893905089,0.0,9.474389094274162e-08,0.08515780834030728,0.0
43,0.3,3,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation,Are residents' leadership skills linked to their technical skill ratings? Research involving general surgery residents showed significant correlations between intraoperative leadership skills and perceptions of skill deterioration and task difficulty during bowel repair. Assessing residents' directional instructions may serve as an additional personalized intraoperative evaluation measure. More research is required.,2.3685972735685406e-08,0.021208698070558363,0.0004245966626427282,0.0018134264647818726,0.02105340919783316,0.0,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
43,0.3,4,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation,"Does a resident's leadership ability relate to their technical skill evaluations? In general surgery research, residents' intraoperative leadership skills were significantly correlated with their perceptions of skill decay and task difficulty in bowel repair. Evaluating directional instructions from residents could add a personalized intraoperative assessment metric. Further evaluation is necessary.",2.3685972735685406e-08,0.04950041972606645,0.020823902218198284,0.0018134264647818726,0.02105340919783316,0.0,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
43,0.3,5,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation,How do residents' leadership skills correspond with ratings of their technical skills? Research on general surgery residents indicated that intraoperative leadership skills significantly correlated with perceptions of skill decline and task difficulty during bowel repair. Assessing residents' directional instructions might provide an individualized intraoperative assessment metric. Additional research is needed.,2.3685972735685406e-08,0.021208698070558363,0.0004245966626427282,0.0018134264647818726,0.02105340919783316,0.0,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
43,0.3,6,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation,Is there a connection between residents' leadership skills and their technical skill ratings? Studies with general surgery research residents found significant correlations between intraoperative leadership skills and perceptions of skill decay and task difficulty during bowel repair. Evaluating residents' directional instructions could offer an extra personalized intraoperative assessment metric. Further study is advised.,9.474389094274162e-08,0.05560482630764074,0.017576097781801726,0.0072537058591274906,0.05449578863936777,0.019599999999999992,0.007243206163811466,0.08338160893905089,0.0,9.474389094274162e-08,0.08515780834030728,0.0
43,0.3,7,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation,Do leadership skills of residents relate to their technical skill ratings? Research on general surgery residents demonstrated significant correlations between intraoperative leadership abilities and perceptions of skill decay and task difficulty in bowel repair. Assessing directional instructions may provide an additional individualized intraoperative evaluation metric. Further evaluation is recommended.,0.0,0.028881132523330688,0.020823902218198284,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
43,0.3,8,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation,Are the leadership skills of residents associated with ratings of their technical skills? General surgery research residents' intraoperative leadership skills showed significant correlations with their perceptions of skill decay and task difficulty during bowel repair. Evaluating residents' directional instructions could serve as an additional personalized intraoperative assessment metric. More research is needed.,7.105791820705622e-08,0.0623235119648653,0.0012239022181982917,0.005440279394345618,0.06187540371808753,0.0,0.0054324046228586,0.06317890162153228,0.0,7.105791820705622e-08,0.06453852113757153,0.0
43,0.3,9,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation,Does leadership ability in residents correlate with technical skill ratings? Research on general surgery residents found significant correlations between intraoperative leadership skills and perceptions of skill decay and task difficulty during bowel repair. Assessing residents' directional instructions might provide an additional individualized intraoperative assessment metric. Further evaluation is necessary.,0.0,0.028881132523330688,0.020823902218198284,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
43,0.3,10,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation,How do residents' leadership skills relate to their technical skill assessments? Studies with general surgery research residents revealed significant correlations between intraoperative leadership skills and perceptions of skill decay and task difficulty during bowel repair. Evaluating residents' directional instructions may offer an additional personalized intraoperative assessment metric. Further research is warranted.,4.737194547137081e-08,0.04197723982118706,0.0008322320807555503,0.0036268529295637453,0.04167269640056892,0.0,0.003621603081905733,0.04255961441879652,0.0,4.737194547137081e-08,0.04348511193973836,0.0
44,0.3,1,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Does the polymorphism of the angiotensin-converting enzyme-1 (ACE-1) gene contribute to chronic kidney disease in patients with hypertension? It is concluded that the ACE-DD genotype might be a risk factor for causing and progressing chronic kidney failure in hypertensive individuals.,2.36859727356853e-08,0.06339233825534718,0.026845867104408186,0.0018134264647818726,0.026668247082160867,0.0,0.0018108015409528666,0.02739897418811532,0.0,2.3685972735685406e-08,0.028170876966696845,0.0
44,0.3,2,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Is the ACE-1 gene polymorphism associated with chronic kidney disease in hypertensive patients? The conclusion is that the ACE-DD genotype may increase the risk of developing chronic kidney failure among those with hypertension.,1.421158364141118e-07,0.14220909460008446,0.021251654012666835,0.010880558788691264,0.17693070815907896,0.0,0.010864809245717234,0.18232155679395534,0.0,1.4211583641411244e-07,0.18805223150294026,0.0
44,0.3,3,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Does the angiotensin-converting enzyme-1 gene polymorphism cause chronic kidney disease in patients suffering from hypertension? Findings suggest that the ACE-DD genotype could be a risk factor for the onset and progression of chronic kidney failure in hypertensive patients.,2.36859727356853e-08,0.008827198864009844,0.025462962962962975,0.0018134264647818726,0.02739897418811532,0.0,0.0018108015409528666,0.028170876966696845,0.0,2.3685972735685406e-08,0.028987536873251507,0.0
44,0.3,4,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Is there a link between ACE-1 gene polymorphism and chronic kidney disease in hypertensive patients? It is concluded that the ACE-DD genotype may play a role as a risk factor in the development of chronic kidney failure among hypertensive individuals.,2.36859727356853e-08,0.06339233825534718,0.026845867104408186,0.0018134264647818726,0.026668247082160867,0.0,0.0018108015409528666,0.02739897418811532,0.0,2.3685972735685406e-08,0.028170876966696845,0.0
44,0.3,5,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Does polymorphism in the ACE-1 gene lead to chronic kidney disease in patients with high blood pressure? The conclusion indicates that the ACE-DD genotype might be a contributing risk factor for chronic kidney failure in hypertensive patients.,4.73719454713706e-08,0.019612536856477902,0.02471403376165281,0.0036268529295637453,0.055569851154812167,0.0,0.00362160308190574,0.05715841383994835,0.0,4.737194547137081e-08,0.058840500022933284,0.0
44,0.3,6,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Is chronic kidney disease among hypertensive patients influenced by ACE-1 gene polymorphism? It is concluded that the ACE-DD genotype may be a significant risk factor for the causation and progression of chronic kidney failure in these patients.,4.73719454713706e-08,0.019612536856477902,0.02471403376165281,0.0036268529295637453,0.055569851154812167,0.0,0.00362160308190574,0.05715841383994835,0.0,4.737194547137081e-08,0.058840500022933284,0.0
44,0.3,7,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Does the presence of ACE-1 gene polymorphism cause chronic kidney disease in hypertensive individuals? The conclusion drawn is that the ACE-DD genotype could be a risk factor for chronic kidney failure development in hypertensive patients.,9.47438909427412e-08,0.11980950112335131,0.00612461419753086,0.007253705859127504,0.11441035117774545,0.0,0.007243206163811487,0.11778303565638382,0.0,9.474389094274162e-08,0.1213608570042668,0.0
44,0.3,8,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Is the ACE-1 gene polymorphism responsible for chronic kidney disease in patients with hypertension? It is concluded that the ACE-DD genotype may increase susceptibility to chronic kidney failure among hypertensive patients.,1.894877818854824e-07,0.20963572898998795,0.019175437823872224,0.014507411718255023,0.24362208265775243,0.0,0.014486412327622981,0.2513144282809061,0.0,1.8948778188548325e-07,0.25951119548508395,0.0
44,0.3,9,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Does the angiotensin-converting enzyme-1 gene polymorphism contribute to chronic kidney disease in hypertensive patients? The conclusion is that the ACE-DD genotype might be a risk factor for the onset and progression of chronic kidney failure in these patients.,2.36859727356853e-08,0.008827198864009844,0.025462962962962975,0.0018134264647818726,0.02739897418811532,0.0,0.0018108015409528666,0.028170876966696845,0.0,2.3685972735685406e-08,0.028987536873251507,0.0
44,0.3,10,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Is there an association between ACE-1 gene polymorphism and chronic kidney disease in hypertensive patients? It is concluded that the ACE-DD genotype may be a risk factor for causing and developing chronic kidney failure among hypertensive individuals.,4.73719454713706e-08,0.019612536856477902,0.02471403376165281,0.0036268529295637453,0.055569851154812167,0.0,0.00362160308190574,0.05715841383994835,0.0,4.737194547137081e-08,0.058840500022933284,0.0
45,0.3,1,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness","Are laboratories accurately reporting serum quantitative hCG results? Multiple factors lead to incorrect hCG result reporting, such as (a) the complex nature of the hCG molecule and confusion over the terminology of its different forms; (b) a lack of awareness among laboratory staff.",0.0,0.03300700859809158,0.023795359904818555,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
45,0.3,2,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness","Do laboratories report serum quantitative hCG results correctly? Errors in hCG reporting arise from several causes, including (a) the complexity of the hCG molecule and confusion regarding the names of its various forms; (b) insufficient knowledge among laboratory personnel.",9.474389094274141e-08,0.06707644995888984,0.023795359904818555,0.0072537058591274906,0.10265415406008227,0.0,0.007243206163811466,0.10536051565782589,0.0,9.474389094274162e-08,0.10821358464023101,0.0
45,0.3,3,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness","Is the reporting of serum quantitative hCG results by laboratories accurate? Many factors cause errors in hCG result reporting, including (a) the complicated structure of the hCG molecule and confusion about the nomenclature of its different forms; (b) laboratory staff's lack of understanding.",0.0,0.03300700859809158,0.023795359904818555,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
45,0.3,4,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness","Are serum quantitative hCG results being reported correctly by laboratories? Several factors contribute to erroneous hCG reporting, such as (a) the complex hCG molecule and confusion over the terminology of its various forms; (b) laboratory personnel not being fully aware.",7.105791820705611e-08,0.041100963555631864,0.023795359904818555,0.005440279394345618,0.0759859069779214,0.0,0.0054324046228586,0.07796154146971057,0.0,7.105791820705622e-08,0.08004270767353416,0.0
45,0.3,5,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness",Do laboratories provide correct serum quantitative hCG results? Errors often stem from (a) the complexity of the hCG molecule and confusion about the nomenclature of its forms; (b) laboratory staff's lack of awareness.,2.3685972735685321e-07,0.23892670688554984,0.023795359904818555,0.018134264647818754,0.27958486221916123,0.0,0.0181080154095287,0.28768207245178123,0.0,2.3685972735685406e-07,0.29626581614317127,0.0
45,0.3,6,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness",Are serum quantitative hCG results accurately reported by laboratories? The incorrect reporting of hCG results is influenced by (a) the complexity of the hCG molecule and confusion about its various forms' nomenclature; (b) laboratory personnel's limited awareness.,1.42115836414112e-07,0.15965184792694087,0.003959742135997774,0.010880558788691236,0.15822400521489444,0.0,0.010864809245717207,0.16251892949777424,0.0,1.4211583641411244e-07,0.1670540846631643,0.0
45,0.3,7,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness","Is the reporting of serum quantitative hCG results by labs correct? Many factors cause errors, including (a) the complexity of the hCG molecule and confusion over the names of its different forms; (b) lack of awareness among lab personnel.",9.474389094274141e-08,0.06707644995888984,0.023795359904818555,0.0072537058591274906,0.10265415406008227,0.0,0.007243206163811466,0.10536051565782589,0.0,9.474389094274162e-08,0.10821358464023101,0.0
45,0.3,8,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness",Are laboratories correctly reporting serum quantitative hCG results? Errors in reporting hCG results are due to (a) the complex nature of the hCG molecule and confusion about the nomenclature of its various forms; (b) laboratory staff's lack of awareness.,9.474389094274141e-08,0.06707644995888984,0.023795359904818555,0.0072537058591274906,0.10265415406008227,0.0,0.007243206163811466,0.10536051565782589,0.0,9.474389094274162e-08,0.10821358464023101,0.0
45,0.3,9,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness","Do labs report serum quantitative hCG results accurately? Several factors contribute to errors, including (a) the complexity of the hCG molecule and confusion regarding the nomenclature of its forms; (b) laboratory personnel's lack of knowledge.",1.8948778188548261e-07,0.17830208506911438,0.023795359904818555,0.014507411718254995,0.21706450523782772,0.0,0.014486412327622954,0.2231435513142097,0.0,1.8948778188548325e-07,0.2295744416444978,0.0
45,0.3,10,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness","Are serum quantitative hCG results reported correctly by laboratories? Many factors lead to erroneous reporting, such as (a) the complexity of the hCG molecule and confusion about the nomenclature of its various forms; (b) laboratory personnel's lack of awareness.",9.474389094274141e-08,0.06707644995888984,0.023795359904818555,0.0072537058591274906,0.10265415406008227,0.0,0.007243206163811466,0.10536051565782589,0.0,9.474389094274162e-08,0.10821358464023101,0.0
46,0.3,1,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Yes, the fibronectin-aggrecan complex is present in cervical disk disease. It is a key component of the extracellular matrix in the intervertebral discs and is involved in the degeneration and breakdown of the disc structure.","Is the fibronectin-aggrecan complex found in cervical disk disease? Yes, it is present and plays a crucial role in the extracellular matrix of intervertebral discs, contributing to disc degeneration and breakdown.",3.5528959103528003e-07,0.18981931860062584,0.1502770083102493,0.02720139697172813,0.3223737338554318,0.06781677572873293,0.027162023114293048,0.39675620177138393,0.023242630385487524,3.552895910352811e-07,0.4418327522790384,0.0
46,0.3,2,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Yes, the fibronectin-aggrecan complex is present in cervical disk disease. It is a key component of the extracellular matrix in the intervertebral discs and is involved in the degeneration and breakdown of the disc structure.","Does cervical disk disease involve the fibronectin-aggrecan complex? Yes, this complex is a significant part of the extracellular matrix in intervertebral discs and is implicated in the degeneration and structural breakdown of the disc.",2.8423167282822413e-07,0.13651805883023638,0.12000357081024929,0.021761117577382492,0.2239336610421785,0.06781677572873293,0.021729618491434427,0.29497350746144146,0.023242630385487524,2.8423167282822487e-07,0.33647223662121295,0.0
46,0.3,3,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Yes, the fibronectin-aggrecan complex is present in cervical disk disease. It is a key component of the extracellular matrix in the intervertebral discs and is involved in the degeneration and breakdown of the disc structure.","Is the fibronectin-aggrecan complex associated with cervical disk disease? Indeed, it is present and serves as a vital component of the extracellular matrix in intervertebral discs, participating in disc degeneration and deterioration.",3.3160361829959473e-07,0.15702949577763414,0.1502770083102493,0.02538797050694625,0.28847218217975,0.06781677572873293,0.025351221573340174,0.3616648819601149,0.023242630385487524,3.316036182995957e-07,0.4054651081081637,0.0
46,0.3,4,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Yes, the fibronectin-aggrecan complex is present in cervical disk disease. It is a key component of the extracellular matrix in the intervertebral discs and is involved in the degeneration and breakdown of the disc structure.","Is the fibronectin-aggrecan complex detected in cervical disk disease? Yes, it is a key element of the extracellular matrix within intervertebral discs and plays a role in the degeneration and breakdown of the disc.",2.8423167282822413e-07,0.13651805883023638,0.12000357081024929,0.021761117577382492,0.2239336610421785,0.06781677572873293,0.021729618491434427,0.29497350746144146,0.023242630385487524,2.8423167282822487e-07,0.33647223662121295,0.0
46,0.3,5,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Yes, the fibronectin-aggrecan complex is present in cervical disk disease. It is a key component of the extracellular matrix in the intervertebral discs and is involved in the degeneration and breakdown of the disc structure.","Does the fibronectin-aggrecan complex exist in cervical disk disease? Yes, it is an essential part of the extracellular matrix in the intervertebral discs and is involved in the degeneration and structural breakdown of the disc.",2.6054570009253883e-07,0.14620290277131875,0.09168325831024929,0.019947691112600613,0.1931620023754248,0.06781677572873293,0.019918816950481553,0.26322480914686164,0.023242630385487524,2.6054570009253947e-07,0.30368241379822125,0.0
46,0.3,6,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Yes, the fibronectin-aggrecan complex is present in cervical disk disease. It is a key component of the extracellular matrix in the intervertebral discs and is involved in the degeneration and breakdown of the disc structure.","Is the fibronectin-aggrecan complex present in cases of cervical disk disease? Yes, it is found within the extracellular matrix of intervertebral discs and contributes to the degeneration and breakdown of the disc structure.",3.0791764556390943e-07,0.12528079746305432,0.1502770083102493,0.023574544042164372,0.2556823593567583,0.06781677572873293,0.0235404200323873,0.32776333028443316,0.023242630385487524,3.079176455639103e-07,0.3703737882968947,0.0
46,0.3,7,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Yes, the fibronectin-aggrecan complex is present in cervical disk disease. It is a key component of the extracellular matrix in the intervertebral discs and is involved in the degeneration and breakdown of the disc structure.","Is the fibronectin-aggrecan complex a component of cervical disk disease? Yes, it is present in the extracellular matrix of intervertebral discs and plays a role in disc degeneration and breakdown.",3.7897556377096533e-07,0.2237208702763076,0.1502770083102493,0.02901482343651001,0.3574650536667008,0.06781677572873293,0.02897282465524592,0.4331238459422586,0.023242630385487524,3.789755637709665e-07,0.4795730802618854,0.0
46,0.3,8,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Yes, the fibronectin-aggrecan complex is present in cervical disk disease. It is a key component of the extracellular matrix in the intervertebral discs and is involved in the degeneration and breakdown of the disc structure.","Is the fibronectin-aggrecan complex involved in cervical disk disease? Yes, it is a critical part of the extracellular matrix in intervertebral discs and is linked to the degeneration and breakdown of the disc.",3.0791764556390943e-07,0.1686024962480519,0.11905952652044699,0.023574544042164372,0.2556823593567583,0.06781677572873293,0.0235404200323873,0.32776333028443316,0.023242630385487524,3.079176455639103e-07,0.3703737882968947,0.0
46,0.3,9,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Yes, the fibronectin-aggrecan complex is present in cervical disk disease. It is a key component of the extracellular matrix in the intervertebral discs and is involved in the degeneration and breakdown of the disc structure.","Is the fibronectin-aggrecan complex part of cervical disk disease pathology? Yes, it is present in the extracellular matrix of intervertebral discs and contributes to disc degeneration and structural breakdown.",4.0266153650665063e-07,0.2588121900875766,0.1502770083102493,0.03082824990129189,0.39383269783757546,0.06781677572873293,0.030783626196198795,0.4708641739251056,0.023242630385487524,4.026615365066519e-07,0.5187937934151678,0.0
46,0.3,10,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Yes, the fibronectin-aggrecan complex is present in cervical disk disease. It is a key component of the extracellular matrix in the intervertebral discs and is involved in the degeneration and breakdown of the disc structure.","Is the fibronectin-aggrecan complex found in the extracellular matrix during cervical disk disease? Yes, it is a key component involved in the degeneration and breakdown of intervertebral disc structure.",4.0266153650665063e-07,0.30832270298471576,0.11461171338569512,0.03082824990129189,0.39383269783757546,0.06781677572873293,0.030783626196198795,0.4708641739251056,0.023242630385487524,4.026615365066519e-07,0.5187937934151678,0.0
47,0.3,1,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: The residency selection criteria may provide some indication of a candidate's potential performance in an orthopaedic surgery residency, but it may not be a definitive predictor. Other factors such as work ethic, dedication, and clinical skills developed during residency can also greatly impact performance.","Does the criteria for selecting residents predict how well they will perform in orthopaedic surgery residency? The selection criteria might offer some insight into a candidate's potential performance in orthopaedic surgery residency, but they are not a conclusive predictor. Performance is also influenced by factors like work ethic, dedication, and clinical skills gained during residency.",2.3685972735685406e-08,0.03112803381621765,0.03529764382838643,0.0018134264647818726,0.019176512593258366,0.0003490207932659514,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
47,0.3,2,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: The residency selection criteria may provide some indication of a candidate's potential performance in an orthopaedic surgery residency, but it may not be a definitive predictor. Other factors such as work ethic, dedication, and clinical skills developed during residency can also greatly impact performance.","Can residency selection criteria forecast success in orthopaedic surgery residency? While these criteria may hint at a candidate's potential success, they do not definitively predict performance. Other elements such as commitment, work ethic, and clinical skills developed throughout residency play a significant role.",3.079176455639103e-07,0.16884215886765608,0.07227989234909649,0.023574544042164344,0.2497398620614506,0.01851192595229618,0.023540420032387266,0.2814124594381848,0.0,3.079176455639103e-07,0.28768207245178345,0.0
47,0.3,3,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: The residency selection criteria may provide some indication of a candidate's potential performance in an orthopaedic surgery residency, but it may not be a definitive predictor. Other factors such as work ethic, dedication, and clinical skills developed during residency can also greatly impact performance.","Are residency selection criteria reliable indicators of performance in orthopaedic surgery residency? They may suggest a candidate's potential, but are not absolute predictors. Performance is also shaped by work ethic, dedication, and clinical skills acquired during the residency period.",4.026615365066517e-07,0.2689256174246375,0.07227989234909649,0.030828249901291835,0.35239401612153287,0.01851192595229618,0.030783626196198732,0.3867729750960107,0.0,4.026615365066519e-07,0.39589565709201446,0.0
47,0.3,4,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: The residency selection criteria may provide some indication of a candidate's potential performance in an orthopaedic surgery residency, but it may not be a definitive predictor. Other factors such as work ethic, dedication, and clinical skills developed during residency can also greatly impact performance.","Do the criteria used to select residents predict their performance in orthopaedic surgery residency? These criteria might give some indication of potential performance but are not definitive predictors. Factors like work ethic, dedication, and clinical skills developed during residency also significantly affect outcomes.",3.079176455639103e-07,0.16884215886765608,0.07227989234909649,0.023574544042164344,0.2497398620614506,0.01851192595229618,0.023540420032387266,0.2814124594381848,0.0,3.079176455639103e-07,0.28768207245178345,0.0
47,0.3,5,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: The residency selection criteria may provide some indication of a candidate's potential performance in an orthopaedic surgery residency, but it may not be a definitive predictor. Other factors such as work ethic, dedication, and clinical skills developed during residency can also greatly impact performance.","Is it possible to predict orthopaedic surgery residency performance based on selection criteria? The criteria may provide some clues about a candidate's potential, but they are not definitive predictors. Performance is also heavily influenced by work ethic, dedication, and clinical skills gained during residency.",2.8423167282822487e-07,0.14531166145746166,0.07227989234909649,0.02176111757738247,0.22564231048239058,0.01851192595229618,0.0217296184914344,0.2567198468478131,0.0,2.8423167282822487e-07,0.2623642644674917,0.0
47,0.3,6,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: The residency selection criteria may provide some indication of a candidate's potential performance in an orthopaedic surgery residency, but it may not be a definitive predictor. Other factors such as work ethic, dedication, and clinical skills developed during residency can also greatly impact performance.","Does the selection criteria for residency predict how well a candidate will perform in orthopaedic surgery residency? They may offer some indication but are not conclusive predictors. Other factors such as dedication, work ethic, and clinical skills developed during residency also impact performance.",3.079176455639103e-07,0.16884215886765608,0.07227989234909649,0.023574544042164344,0.2497398620614506,0.01851192595229618,0.023540420032387266,0.2814124594381848,0.0,3.079176455639103e-07,0.28768207245178345,0.0
47,0.3,7,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: The residency selection criteria may provide some indication of a candidate's potential performance in an orthopaedic surgery residency, but it may not be a definitive predictor. Other factors such as work ethic, dedication, and clinical skills developed during residency can also greatly impact performance.","Can the criteria for selecting residents predict their performance in orthopaedic surgery residency? These criteria might indicate potential but are not definitive predictors. Work ethic, dedication, and clinical skills developed during residency also play a crucial role.",4.500334819780223e-07,0.3229928386949137,0.07227989234909649,0.03445510283085558,0.40796386727634504,0.01851192595229618,0.03440522927810447,0.44393138893595907,0.0,4.500334819780227e-07,0.45473615711494775,0.0
47,0.3,8,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: The residency selection criteria may provide some indication of a candidate's potential performance in an orthopaedic surgery residency, but it may not be a definitive predictor. Other factors such as work ethic, dedication, and clinical skills developed during residency can also greatly impact performance.","Are the residency selection criteria a good predictor of performance in orthopaedic surgery residency? They may provide some insight but are not absolute predictors. Performance is also influenced by factors like work ethic, dedication, and clinical skills acquired during residency.",3.789755637709664e-07,0.24295013102137952,0.07227989234909649,0.029014823436509962,0.325725769039372,0.01851192595229618,0.028972824655245866,0.3593740009078954,0.0,3.789755637709665e-07,0.3677247801253176,0.0
47,0.3,9,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: The residency selection criteria may provide some indication of a candidate's potential performance in an orthopaedic surgery residency, but it may not be a definitive predictor. Other factors such as work ethic, dedication, and clinical skills developed during residency can also greatly impact performance.","Do residency selection criteria serve as predictors for performance in orthopaedic surgery residency? They might suggest potential but do not definitively predict performance. Other factors such as work ethic, dedication, and clinical skills developed during residency greatly impact outcomes.",4.026615365066517e-07,0.2689256174246375,0.07227989234909649,0.030828249901291835,0.35239401612153287,0.01851192595229618,0.030783626196198732,0.3867729750960107,0.0,4.026615365066519e-07,0.39589565709201446,0.0
47,0.3,10,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: The residency selection criteria may provide some indication of a candidate's potential performance in an orthopaedic surgery residency, but it may not be a definitive predictor. Other factors such as work ethic, dedication, and clinical skills developed during residency can also greatly impact performance.","Is performance in orthopaedic surgery residency predicted by residency selection criteria? While these criteria may indicate potential, they are not definitive predictors. Work ethic, dedication, and clinical skills gained during residency also significantly influence performance.",4.974054274493929e-07,0.38015125253486204,0.07227989234909649,0.03808195576041934,0.4668043672992783,0.01851192595229618,0.03802683236001022,0.5045560107523945,0.0,4.974054274493935e-07,0.5172565140962813,0.0
48,0.3,1,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs,Amblyopia: Is the visual loss permanent? Older adults with amblyopia who later lose vision in their previously normal eye may regain visual function in the amblyopic eye over time. This improvement in vision happens gradually.,2.1317375462116802e-07,0.13812137983647732,0.06937499999999999,0.016320838183036868,0.24116205681688774,0.0,0.01629721386857582,0.2478361639045814,0.0,2.1317375462116866e-07,0.25489224962878954,0.0
48,0.3,2,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs,"Question: Is visual loss due to amblyopia permanent? In older individuals with a history of amblyopia, if the previously unaffected eye loses vision, the amblyopic eye can recover visual function after some time. This visual recovery takes place progressively.",1.1842986367842682e-07,0.02689574472625278,0.06937499999999999,0.009067132323909363,0.1267517056391423,0.0,0.009054007704764333,0.1300531282481976,0.0,1.1842986367842703e-07,0.13353139262452274,0.0
48,0.3,3,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs,Amblyopia: Does visual loss last forever? Older people who have amblyopia and then suffer vision loss in their previously normal eye might experience a restoration of vision in the amblyopic eye over a period. This recovery of sight occurs gradually.,9.474389094274152e-08,0.0009202583229948047,0.06937499999999999,0.0072537058591274906,0.10008345855698142,0.0,0.007243206163811466,0.10265415406008227,0.0,9.474389094274162e-08,0.10536051565782589,0.0
48,0.3,4,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs,"Question: Is visual impairment from amblyopia permanent? In elderly patients with amblyopia, when the normal eye develops vision loss, the amblyopic eye may regain visual ability over time. This visual function recovery unfolds gradually.",2.3685972735685332e-07,0.1679743429861591,0.06937499999999999,0.018134264647818747,0.2719337154836414,0.0,0.018108015409528694,0.27958486221916123,0.0,2.3685972735685406e-07,0.28768207245178123,0.0
48,0.3,5,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs,Amblyopia: Is the vision loss irreversible? Older individuals with amblyopia who develop vision loss in their previously normal eye can see improvement in the amblyopic eye's function over time. This recovery happens progressively.,2.605457000925386e-07,0.24206770043791037,0.03815751821019769,0.019947691112600627,0.30368241379822125,0.0,0.019918816950481567,0.31237468504215293,0.0,2.6054570009253947e-07,0.321583624127463,0.0
48,0.3,6,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs,"Question: Is visual loss caused by amblyopia permanent? In older adults with a history of amblyopia, vision loss in the formerly normal eye can lead to recovery of visual function in the amblyopic eye over time. This restoration of vision occurs gradually.",4.737194547137081e-08,0.015278104663378755,0.04499999999999999,0.0036268529295637453,0.048790164169431716,0.0,0.003621603081905733,0.05001042057466343,0.0,4.737194547137081e-08,0.051293294387549704,0.0
48,0.3,7,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs,Amblyopia: Is the loss of vision permanent? Older patients with amblyopia who experience vision loss in their previously normal eye may regain visual function in the amblyopic eye over a period. This improvement in vision develops over time.,1.4211583641411212e-07,0.05356399180841365,0.06937499999999999,0.010880558788691236,0.1541506798272576,0.0,0.0108648092457172,0.15822400521489444,0.0,1.4211583641411244e-07,0.16251892949777424,0.0
48,0.3,8,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs,"Question: Does amblyopia cause permanent visual loss? In older people with amblyopia, if the previously normal eye loses vision, the amblyopic eye can recover its visual function over time. This recovery occurs gradually.",2.605457000925386e-07,0.19874600165291278,0.06937499999999999,0.019947691112600627,0.30368241379822125,0.0,0.019918816950481567,0.31237468504215293,0.0,2.6054570009253947e-07,0.321583624127463,0.0
48,0.3,9,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs,Amblyopia: Is vision loss permanent? Older individuals with amblyopia who lose vision in their previously normal eye can experience a recovery of visual function in the amblyopic eye over time. This visual improvement happens progressively.,2.1317375462116802e-07,0.13812137983647732,0.06937499999999999,0.016320838183036868,0.24116205681688774,0.0,0.01629721386857582,0.2478361639045814,0.0,2.1317375462116866e-07,0.25489224962878954,0.0
48,0.3,10,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs,Question: Is the visual loss from amblyopia permanent? Older adults with amblyopia who develop vision loss in their previously normal eye may regain visual function in the amblyopic eye over a period of time. This recovery in vision takes place gradually.,7.105791820705622e-08,0.024397549661296924,0.06937499999999999,0.005440279394345618,0.07410797215372344,0.0,0.0054324046228586,0.0759859069779214,0.0,7.105791820705622e-08,0.07796154146971057,0.0
49,0.3,1,ai,Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: Studies suggest that high flow nasal cannulae (HFNC) are generally quieter than bubble continuous,Are high flow nasal cannulae louder than bubble CPAP for preterm infants? Research indicates that high flow nasal cannulae (HFNC) tend to be quieter than bubble continuous positive airway pressure.,4.73719454713706e-08,0.08562289104339493,0.009267296786389406,0.003626852929563759,0.08172497413789648,0.005382971729125552,0.003621603081905747,0.08106857998389128,0.0029483070348455126,4.737194547137081e-08,0.08004270767353727,0.0
49,0.3,2,ai,Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: Studies suggest that high flow nasal cannulae (HFNC) are generally quieter than bubble continuous,Do high flow nasal cannulae produce more noise than bubble CPAP in preterm infants? Studies show that high flow nasal cannulae (HFNC) are usually less noisy than bubble continuous positive airway pressure.,9.47438909427412e-08,0.1646505891115435,0.017467022437966856,0.007253705859127518,0.1573192473444669,0.010062358276644007,0.007243206163811494,0.1560685257313481,0.005491780045351467,9.474389094274162e-08,0.15415067982725894,0.0
49,0.3,3,ai,Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: Studies suggest that high flow nasal cannulae (HFNC) are generally quieter than bubble continuous,Is the noise level of high flow nasal cannulae higher than bubble CPAP for preterm infants? Evidence suggests that high flow nasal cannulae (HFNC) are typically quieter than bubble continuous positive airway pressure.,1.184298636784265e-07,0.2019891840435415,0.02121831719455264,0.009067132323909398,0.1930903483634152,0.012179614215880569,0.009054007704764368,0.19156351920142045,0.0066368575769586435,1.1842986367842703e-07,0.18924199963852795,0.0
49,0.3,4,ai,Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: Studies suggest that high flow nasal cannulae (HFNC) are generally quieter than bubble continuous,Are high flow nasal cannulae noisier compared to bubble CPAP in preterm infants? Research findings indicate that high flow nasal cannulae (HFNC) are generally less noisy than bubble continuous positive airway pressure.,9.47438909427412e-08,0.20936976205089497,0.0480040314802669,0.007253705859127518,0.1573192473444669,0.010062358276644007,0.007243206163811494,0.1560685257313481,0.005491780045351467,9.474389094274162e-08,0.15415067982725894,0.0
49,0.3,5,ai,Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: Studies suggest that high flow nasal cannulae (HFNC) are generally quieter than bubble continuous,Do high flow nasal cannulae generate more noise than bubble CPAP for preterm infants? Studies suggest that high flow nasal cannulae (HFNC) are commonly quieter than bubble continuous positive airway pressure.,7.10579182070559e-08,0.12589820989663858,0.013489781993489935,0.005440279394345639,0.12023081208000397,0.007801783264746218,0.005432404622858621,0.11926994685466008,0.004265260631001383,7.105791820705622e-08,0.11778303565638426,0.0
49,0.3,6,ai,Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: Studies suggest that high flow nasal cannulae (HFNC) are generally quieter than bubble continuous,Is the sound produced by high flow nasal cannulae louder than bubble CPAP in preterm infants? Research suggests that high flow nasal cannulae (HFNC) are usually quieter than bubble continuous positive airway pressure.,1.184298636784265e-07,0.2019891840435415,0.02121831719455264,0.009067132323909398,0.1930903483634152,0.012179614215880569,0.009054007704764368,0.19156351920142045,0.0066368575769586435,1.1842986367842703e-07,0.18924199963852795,0.0
49,0.3,7,ai,Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: Studies suggest that high flow nasal cannulae (HFNC) are generally quieter than bubble continuous,Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Studies indicate that high flow nasal cannulae (HFNC) tend to be quieter than bubble continuous positive airway pressure.,4.73719454713706e-08,0.08562289104339493,0.009267296786389406,0.003626852929563759,0.08172497413789648,0.005382971729125552,0.003621603081905747,0.08106857998389128,0.0029483070348455126,4.737194547137081e-08,0.08004270767353727,0.0
49,0.3,8,ai,Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: Studies suggest that high flow nasal cannulae (HFNC) are generally quieter than bubble continuous,Do high flow nasal cannulae make more noise than bubble CPAP in preterm infants? Evidence shows that high flow nasal cannulae (HFNC) are generally quieter than bubble continuous positive airway pressure.,7.10579182070559e-08,0.12589820989663858,0.013489781993489935,0.005440279394345639,0.12023081208000397,0.007801783264746218,0.005432404622858621,0.11926994685466008,0.004265260631001383,7.105791820705622e-08,0.11778303565638426,0.0
49,0.3,9,ai,Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: Studies suggest that high flow nasal cannulae (HFNC) are generally quieter than bubble continuous,Is the noise from high flow nasal cannulae greater than bubble CPAP for preterm infants? Research suggests that high flow nasal cannulae (HFNC) are typically less noisy than bubble continuous positive airway pressure.,1.184298636784265e-07,0.2019891840435415,0.02121831719455264,0.009067132323909398,0.1930903483634152,0.012179614215880569,0.009054007704764368,0.19156351920142045,0.0066368575769586435,1.1842986367842703e-07,0.18924199963852795,0.0
49,0.3,10,ai,Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: Studies suggest that high flow nasal cannulae (HFNC) are generally quieter than bubble continuous,Are high flow nasal cannulae louder than bubble CPAP in preterm infants? Studies indicate that high flow nasal cannulae (HFNC) are generally quieter than bubble continuous positive airway pressure.,2.36859727356853e-08,0.04370253497044985,0.004778407897500503,0.0018134264647818796,0.04168988456723399,0.0027888888888888963,0.0018108015409528735,0.041353473708850785,0.001530555555555549,2.3685972735685406e-08,0.04082199452025481,0.0
50,0.3,1,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible combined approach in acute overt-obscure gastrointestinal bleeding.","Question: Is emergency double-balloon enteroscopy with real-time capsule endoscopy viewing a viable method for acute overt-obscure gastrointestinal bleeding? Answer: Yes, this combined approach is feasible for such cases.",3.316036182995943e-07,0.08944566312437141,0.24408284023668642,0.02538797050694628,0.01976275127150995,0.2496570644718793,0.025351221573340202,0.05367971940711769,0.23852040816326525,3.316036182995957e-07,0.1311994543763615,0.21403091557669443
50,0.3,2,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible combined approach in acute overt-obscure gastrointestinal bleeding.","Question: Can emergency double-balloon enteroscopy paired with real-time capsule endoscopy viewing be effectively used in acute overt-obscure gastrointestinal bleeding? Answer: Yes, it is a feasible combined approach.",3.552895910352796e-07,0.05170533514152442,0.24408284023668642,0.02720139697172816,0.019457961881772512,0.2496570644718793,0.027162023114293075,0.0945017139273725,0.23852040816326525,3.552895910352811e-07,0.17375906879515712,0.21403091557669443
50,0.3,3,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible combined approach in acute overt-obscure gastrointestinal bleeding.","Question: Is it practical to use emergency double-balloon enteroscopy along with real-time capsule endoscopy for acute overt-obscure gastrointestinal bleeding? Answer: Yes, this combined method is feasible.",3.789755637709649e-07,0.012484621988241962,0.24408284023668642,0.02901482343651004,0.060279956402027324,0.2496570644718793,0.02897282465524595,0.13706132834616813,0.23852040816326525,3.789755637709665e-07,0.21821083136599118,0.21403091557669443
50,0.3,4,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible combined approach in acute overt-obscure gastrointestinal bleeding.","Question: Does emergency double-balloon enteroscopy combined with real-time capsule endoscopy viewing work as a feasible approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, it does.",4.026615365066502e-07,0.02833737253201285,0.24408284023668642,0.030828249901291918,0.10283957082082296,0.2496570644718793,0.030783626196198823,0.18151309091700218,0.23852040816326525,4.026615365066519e-07,0.2647308470008851,0.21403091557669443
50,0.3,5,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible combined approach in acute overt-obscure gastrointestinal bleeding.","Question: Can emergency double-balloon enteroscopy together with real-time capsule endoscopy viewing be considered a feasible approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, it is feasible.",3.789755637709649e-07,0.012484621988241962,0.24408284023668642,0.02901482343651004,0.060279956402027324,0.2496570644718793,0.02897282465524595,0.13706132834616813,0.23852040816326525,3.789755637709665e-07,0.21821083136599118,0.21403091557669443
50,0.3,6,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible combined approach in acute overt-obscure gastrointestinal bleeding.","Question: Is the combination of emergency double-balloon enteroscopy and real-time capsule endoscopy viewing a practical approach for acute overt-obscure gastrointestinal bleeding? Answer: Yes, it is feasible.",3.789755637709649e-07,0.012484621988241962,0.24408284023668642,0.02901482343651004,0.060279956402027324,0.2496570644718793,0.02897282465524595,0.13706132834616813,0.23852040816326525,3.789755637709665e-07,0.21821083136599118,0.21403091557669443
50,0.3,7,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible combined approach in acute overt-obscure gastrointestinal bleeding.","Question: Is emergency double-balloon enteroscopy combined with real-time capsule endoscopy a workable approach in cases of acute overt-obscure gastrointestinal bleeding? Answer: Yes, it is feasible.",4.026615365066502e-07,0.02833737253201285,0.24408284023668642,0.030828249901291918,0.10283957082082296,0.2496570644718793,0.030783626196198823,0.18151309091700218,0.23852040816326525,4.026615365066519e-07,0.2647308470008851,0.21403091557669443
50,0.3,8,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible combined approach in acute overt-obscure gastrointestinal bleeding.","Question: Can emergency double-balloon enteroscopy with real-time capsule endoscopy viewing be feasibly applied in acute overt-obscure gastrointestinal bleeding? Answer: Yes, it can.",4.737194547137061e-07,0.16186876515653648,0.24408284023668642,0.03626852929563756,0.24260151319598222,0.2496570644718793,0.03621603081905744,0.32811656510887754,0.23852040816326525,4.7371945471370796e-07,0.41888152682814184,0.21403091557669443
50,0.3,9,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible combined approach in acute overt-obscure gastrointestinal bleeding.","Question: Is it feasible to use emergency double-balloon enteroscopy along with real-time capsule endoscopy viewing in acute overt-obscure gastrointestinal bleeding? Answer: Yes, it is.",4.263475092423355e-07,0.07089698695080848,0.24408284023668642,0.0326416763660738,0.147291333391657,0.2496570644718793,0.032594427737151696,0.22803310655189613,0.23852040816326525,4.2634750924233726e-07,0.3135210111703164,0.21403091557669443
50,0.3,10,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible combined approach in acute overt-obscure gastrointestinal bleeding.","Question: Does combining emergency double-balloon enteroscopy with real-time capsule endoscopy viewing provide a feasible approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, it does.",4.263475092423355e-07,0.07089698695080848,0.24408284023668642,0.0326416763660738,0.147291333391657,0.2496570644718793,0.032594427737151696,0.22803310655189613,0.23852040816326525,4.2634750924233726e-07,0.3135210111703164,0.21403091557669443
51,0.3,1,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Does misclassifying gestational age account for the birthweight differences between Australian Aborigines and whites? It is improbable that gestational age misclassification explains the observed differences in average birthweights between Aborigines and whites. These findings may aid in understanding other comparisons between populations.,7.105791820705622e-08,0.043721612314176816,0.01916457323037659,0.005440279394345618,0.04008125783265193,0.023242630385487524,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
51,0.3,2,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Is gestational age misclassification responsible for the birthweight disparities seen in Australian Aborigines versus whites? Gestational age misclassification is unlikely to be the cause of the reported differences in average birthweights between Aborigines and whites. The results could assist in interpreting other population-based comparisons.,2.3685972735685406e-08,0.0070517443577089445,0.021415823914336725,0.0018134264647818726,0.024298102261311794,0.0005527295193310314,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
51,0.3,3,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Can the difference in birthweights between Australian Aborigines and whites be attributed to gestational age misclassification? Gestational age misclassification does not likely explain the reported variation in average birthweights for Aborigines and whites. These findings might be useful for interpreting other comparisons across populations.,2.3685972735685406e-08,0.0070517443577089445,0.021415823914336725,0.0018134264647818726,0.008708906336779787,0.023242630385487524,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
51,0.3,4,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Does the misclassification of gestational age explain why Australian Aborigines and whites have different birthweights? It is unlikely that gestational age misclassification accounts for the reported differences in average birthweights between Aborigines and whites. The results may help interpret other between-population comparisons.,7.105791820705622e-08,0.043721612314176816,0.01916457323037659,0.005440279394345618,0.04008125783265193,0.023242630385487524,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
51,0.3,5,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Is the difference in birthweights between Australian Aborigines and whites due to gestational age misclassification? Gestational age misclassification is an improbable explanation for the observed divergence in average birthweights between Aborigines and whites. These findings might aid in understanding other population comparisons.,7.105791820705622e-08,0.07753366990246668,0.004897905711710296,0.005440279394345618,0.04008125783265193,0.023242630385487524,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
51,0.3,6,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Could gestational age misclassification explain the birthweight differences between Australian Aborigines and whites? It is unlikely that misclassification of gestational age accounts for the reported differences in average birthweights between Aborigines and whites. The results may assist in interpreting other between-population comparisons.,7.105791820705622e-08,0.043721612314176816,0.01916457323037659,0.005440279394345618,0.04008125783265193,0.023242630385487524,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
51,0.3,7,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Does gestational age misclassification account for the birthweight differences between Australian Aborigines and whites? Gestational age misclassification is an unlikely reason for the reported differences in average birthweights between Aborigines and whites. These results might help with the interpretation of other population comparisons.,4.737194547137081e-08,0.08402797995090827,0.026366049756031573,0.0036268529295637453,0.0492007028305701,0.0011323696145124768,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
51,0.3,8,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Is gestational age misclassification the cause of birthweight differences between Australian Aborigines and whites? It is improbable that gestational age misclassification explains the reported divergence in average birthweights for Aborigines and whites. The findings may be useful in interpreting other between-population comparisons.,7.105791820705622e-08,0.07753366990246668,0.004897905711710296,0.005440279394345618,0.07473861686064831,0.0017409330596143968,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
51,0.3,9,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Can the difference in birthweights between Australian Aborigines and whites be explained by gestational age misclassification? Gestational age misclassification is unlikely to explain the reported differences in average birthweights between Aborigines and whites. These results could help interpret other between-population comparisons.,9.474389094274162e-08,0.1047621868119597,0.0066901636430713035,0.0072537058591274906,0.06539906581694366,0.023242630385487524,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
51,0.3,10,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Is gestational age misclassification responsible for the difference in birthweights between Australian Aborigines and whites? Gestational age misclassification is an unlikely explanation for the reported divergence in average birthweights for Aborigines and whites. The findings might assist in interpreting other population comparisons.,7.105791820705622e-08,0.11134572749075655,0.028603969340660812,0.005440279394345618,0.07473861686064831,0.0017409330596143968,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
52,0.3,1,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is challenging but not impossible. It requires a comprehensive approach that includes proper hygiene practices, staff education, use of appropriate protocols, and continuous monitoring and improvement. While sustaining zero infections may be difficult, implementing effective","Is it possible to maintain a zero rate of central line-associated bloodstream infections? Achieving zero infections is difficult but achievable through comprehensive hygiene, staff training, protocol adherence, and ongoing monitoring and improvement. Although sustaining zero infections is challenging, effective implementation makes it feasible.",2.3685972735685406e-07,0.146290582771178,0.04756564056133998,0.018134264647818726,0.14333665410870733,0.05348828655500228,0.018108015409528666,0.13996588964701617,0.05975554549569943,2.3685972735685406e-07,0.17167520866996666,0.040742417383431435
52,0.3,2,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is challenging but not impossible. It requires a comprehensive approach that includes proper hygiene practices, staff education, use of appropriate protocols, and continuous monitoring and improvement. While sustaining zero infections may be difficult, implementing effective","Can a zero central line-associated bloodstream infection rate be sustained? While challenging, reaching zero infections is attainable with thorough hygiene practices, staff education, strict protocols, and continuous oversight and enhancement. Maintaining zero infections requires persistent effort but is possible.",3.316036182995955e-07,0.21684145468776173,0.06876907372423262,0.025387970506946217,0.21217875058049973,0.07786328655500228,0.025351221573340132,0.24532640530484207,0.05975554549569943,3.316036182995957e-07,0.27988879331019767,0.040742417383431435
52,0.3,3,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is challenging but not impossible. It requires a comprehensive approach that includes proper hygiene practices, staff education, use of appropriate protocols, and continuous monitoring and improvement. While sustaining zero infections may be difficult, implementing effective","Is sustaining a zero rate of central line-associated bloodstream infections feasible? Achieving zero infections demands a multifaceted approach involving proper hygiene, education, protocol use, and constant monitoring and improvement. Though difficult, sustaining zero infections can be accomplished with effective strategies.",3.079176455639102e-07,0.18993054698820133,0.06944237186327903,0.023574544042164344,0.18551050349833886,0.07786328655500228,0.023540420032387266,0.21792743111672674,0.05975554549569943,3.079176455639103e-07,0.2517179163435008,0.040742417383431435
52,0.3,4,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is challenging but not impossible. It requires a comprehensive approach that includes proper hygiene practices, staff education, use of appropriate protocols, and continuous monitoring and improvement. While sustaining zero infections may be difficult, implementing effective","Is it sustainable to have zero central line-associated bloodstream infections? Achieving this goal is tough but not impossible, requiring comprehensive hygiene, staff training, protocol adherence, and ongoing monitoring and improvement. Sustaining zero infections is challenging but achievable with the right measures.",2.8423167282822487e-07,0.12906672974442568,0.09506564056134,0.02176111757738247,0.1595350170950809,0.07786328655500228,0.0217296184914344,0.19125918403456588,0.05975554549569943,2.8423167282822487e-07,0.2243189421553855,0.040742417383431435
52,0.3,5,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is challenging but not impossible. It requires a comprehensive approach that includes proper hygiene practices, staff education, use of appropriate protocols, and continuous monitoring and improvement. While sustaining zero infections may be difficult, implementing effective","Can zero central line-associated bloodstream infection rates be maintained? Achieving zero infections is challenging but possible through proper hygiene, educating staff, following protocols, and continuous monitoring and improvement. While sustaining zero infections is hard, effective implementation can make it sustainable.",3.079176455639102e-07,0.2254765562476857,0.043933427266964545,0.023574544042164344,0.2219919340541252,0.05156671971789491,0.023540420032387266,0.21792743111672674,0.05975554549569943,3.079176455639103e-07,0.2517179163435008,0.040742417383431435
52,0.3,6,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is challenging but not impossible. It requires a comprehensive approach that includes proper hygiene practices, staff education, use of appropriate protocols, and continuous monitoring and improvement. While sustaining zero infections may be difficult, implementing effective","Is maintaining a zero central line-associated bloodstream infection rate achievable? It is challenging but feasible by employing thorough hygiene practices, educating staff, adhering to protocols, and continuous monitoring and improvement. Sustaining zero infections requires dedication but is attainable.",3.552895910352808e-07,0.20702827121413625,0.09506564056134,0.02720139697172809,0.23957772476861505,0.07786328655500228,0.027162023114293,0.2734972822715389,0.05975554549569943,3.552895910352811e-07,0.3088763301834492,0.040742417383431435
52,0.3,7,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is challenging but not impossible. It requires a comprehensive approach that includes proper hygiene practices, staff education, use of appropriate protocols, and continuous monitoring and improvement. While sustaining zero infections may be difficult, implementing effective","Is a zero rate of central line-associated bloodstream infections sustainable? Achieving zero infections is difficult but not impossible, requiring comprehensive hygiene, staff education, protocol use, and ongoing monitoring and improvement. Maintaining zero infections is challenging but can be done with effective measures.",2.6054570009253947e-07,0.17199823233063372,0.046413438062983654,0.0199476911126006,0.16887456813878554,0.05287972310990036,0.019918816950481533,0.1652836976313079,0.05975554549569943,2.6054570009253947e-07,0.19765069507322464,0.040742417383431435
52,0.3,8,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is challenging but not impossible. It requires a comprehensive approach that includes proper hygiene practices, staff education, use of appropriate protocols, and continuous monitoring and improvement. While sustaining zero infections may be difficult, implementing effective","Is it possible to sustain zero central line-associated bloodstream infections? While difficult, achieving zero infections is possible through proper hygiene, staff education, protocol adherence, and continuous monitoring and improvement. Sustaining zero infections demands effort but can be achieved.",3.552895910352808e-07,0.24449568637953867,0.06805946772183383,0.02720139697172809,0.23957772476861505,0.07786328655500228,0.027162023114293,0.2734972822715389,0.05975554549569943,3.552895910352811e-07,0.3088763301834492,0.040742417383431435
52,0.3,9,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is challenging but not impossible. It requires a comprehensive approach that includes proper hygiene practices, staff education, use of appropriate protocols, and continuous monitoring and improvement. While sustaining zero infections may be difficult, implementing effective","Can zero central line-associated bloodstream infection rates be sustained? Achieving zero infections is challenging but achievable with comprehensive hygiene, staff training, protocol adherence, and ongoing monitoring and improvement. Maintaining zero infections is difficult but feasible.",4.263475092423367e-07,0.3731323863668998,0.036471890561339995,0.03264167636607372,0.36859802179218093,0.047589849055002284,0.03259442773715162,0.3631094409612259,0.05975554549569943,4.263475092423373e-07,0.40124965031446447,0.040742417383431435
52,0.3,10,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is challenging but not impossible. It requires a comprehensive approach that includes proper hygiene practices, staff education, use of appropriate protocols, and continuous monitoring and improvement. While sustaining zero infections may be difficult, implementing effective","Is sustaining a zero central line-associated bloodstream infection rate possible? Achieving zero infections requires a comprehensive approach including hygiene, staff education, protocol use, and continuous monitoring and improvement. Although challenging, sustaining zero infections is attainable with effective implementation.",3.552895910352808e-07,0.24449568637953867,0.06805946772183383,0.02720139697172809,0.23957772476861505,0.07786328655500228,0.027162023114293,0.2734972822715389,0.05975554549569943,3.552895910352811e-07,0.3088763301834492,0.040742417383431435
53,0.3,1,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known,"Question: How is gender dimorphism characterized following injury and hemorrhagic shock: do hormonal differences play a role? Answer: The female gender independently offers protection against multiple organ failure and nosocomial infections, a benefit observed in both premenopausal and postmenopausal women compared to men of the same age. This finding contrasts with earlier experimental research and established knowledge.",4.737194547137081e-08,0.036367644170874236,0.0,0.0036268529295637453,0.037041271680350096,0.0,0.003621603081905733,0.03774032798284743,0.0,4.737194547137081e-08,0.038466280827795796,0.0
53,0.3,2,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known,"Question: What defines gender dimorphism after injury and hemorrhagic shock, and are hormones the cause? Answer: Female gender independently reduces the risk of multiple organ failure and hospital-acquired infections in both premenopausal and postmenopausal women relative to age-matched men, opposing prior experimental findings and accepted understanding.",2.1317375462116866e-07,0.18232155679395579,0.0,0.016320838183036854,0.18610227963385917,0.0,0.0162972138685758,0.1900436028878656,0.0,2.1317375462116866e-07,0.19415601444095731,0.0
53,0.3,3,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known,"Question: How is gender dimorphism characterized post-injury and hemorrhagic shock, and are hormonal differences the reason? Answer: Female gender independently protects against multiple organ failure and nosocomial infection rates in both premenopausal and postmenopausal women compared to men of similar age, which contradicts previous experimental studies and known data.",1.4211583641411244e-07,0.11778303565638426,0.0,0.010880558788691236,0.12014431184206309,0.0,0.0108648092457172,0.12260232209233335,0.0,1.4211583641411244e-07,0.12516314295400566,0.0
53,0.3,4,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known,"Question: What is the characterization of gender dimorphism after injury and hemorrhagic shock, and do hormones account for it? Answer: The protective effect of being female against multiple organ failure and nosocomial infections remains significant in both premenopausal and postmenopausal women when compared with men of the same age, contrary to earlier experimental studies and established knowledge.",4.737194547137081e-08,0.036367644170874236,0.0,0.0036268529295637453,0.037041271680350096,0.0,0.003621603081905733,0.03774032798284743,0.0,4.737194547137081e-08,0.038466280827795796,0.0
53,0.3,5,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known,"Question: How does gender dimorphism manifest after injury and hemorrhagic shock, and are hormonal differences responsible? Answer: Female gender independently confers protection against multiple organ failure and nosocomial infections in both premenopausal and postmenopausal women compared to similarly aged men, which is contrary to previous experimental research and known facts.",1.1842986367842703e-07,0.0971637484536485,0.0,0.009067132323909363,0.09909090264422993,0.0,0.009054007704764333,0.10109611687136999,0.0,1.1842986367842703e-07,0.10318423623523065,0.0
53,0.3,6,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known,"Question: What characterizes gender dimorphism following injury and hemorrhagic shock, and are hormones the cause? Answer: The female gender has an independent protective effect on multiple organ failure and nosocomial infection rates in both premenopausal and postmenopausal women relative to men of similar age, opposing prior experimental studies and accepted knowledge.",9.474389094274162e-08,0.07696104113612989,0.0,0.0072537058591274906,0.07847161544149417,0.0,0.007243206163811466,0.08004270767353683,0.0,9.474389094274162e-08,0.0816780310142673,0.0
53,0.3,7,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known,"Question: How is gender dimorphism defined after injury and hemorrhagic shock, and do hormonal differences explain it? Answer: Female gender independently protects against multiple organ failure and nosocomial infections in both premenopausal and postmenopausal women compared to age-matched men, which contradicts previous experimental findings and established understanding.",1.8948778188548325e-07,0.16034265007518078,0.0,0.014507411718254981,0.16362942378180145,0.0,0.014486412327622933,0.16705408466316607,0.0,1.8948778188548325e-07,0.1706255170307629,0.0
53,0.3,8,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known,"Question: What is the nature of gender dimorphism after injury and hemorrhagic shock, and are hormones responsible? Answer: The protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men, contrary to earlier experimental studies and known data.",2.3685972735685406e-08,0.018692133012154333,0.0,0.0018134264647818726,0.0190481949706931,0.0,0.0018108015409528666,0.019418085857102696,0.0,2.3685972735685406e-08,0.019802627296179764,0.0
53,0.3,9,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known,"Question: How does gender dimorphism present after injury and hemorrhagic shock, and are hormonal differences the cause? Answer: Female gender independently reduces the incidence of multiple organ failure and nosocomial infections in both premenopausal and postmenopausal women compared to men of the same age, which is contrary to previous experimental research and accepted knowledge.",2.3685972735685406e-08,0.018692133012154333,0.0,0.0018134264647818726,0.0190481949706931,0.0,0.0018108015409528666,0.019418085857102696,0.0,2.3685972735685406e-08,0.019802627296179764,0.0
53,0.3,10,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known,"Question: What defines gender dimorphism after injury and hemorrhagic shock, and are hormones to blame? Answer: The female gender shows an independent protective effect against multiple organ failure and nosocomial infection rates in both premenopausal and postmenopausal women compared to similarly aged men, opposing prior experimental studies and established facts.",1.1842986367842703e-07,0.0971637484536485,0.0,0.009067132323909363,0.09909090264422993,0.0,0.009054007704764333,0.10109611687136999,0.0,1.1842986367842703e-07,0.10318423623523065,0.0
54,0.3,1,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: There is no definitive answer as caloric needs vary based on factors such as age, height, weight, activity level, and overall metabolism. However, research","Question: Do African American women need fewer calories to maintain their weight? Answer: There is no clear answer since caloric requirements depend on factors like age, height, weight, activity level, and metabolism. However, research",4.73719454713706e-08,0.058840500022933284,0.0,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
54,0.3,2,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: There is no definitive answer as caloric needs vary based on factors such as age, height, weight, activity level, and overall metabolism. However, research","Question: Is it true that African American women require fewer calories to sustain their weight? Answer: No definitive conclusion exists because calorie needs vary with age, height, weight, activity, and metabolism. Nonetheless, studies",7.10579182070559e-08,0.08961215868968697,0.0,0.005440279394345639,0.09237332013101529,0.0,0.005432404622858621,0.09531017980432521,0.0,7.105791820705622e-08,0.09844007281325329,0.0
54,0.3,3,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: There is no definitive answer as caloric needs vary based on factors such as age, height, weight, activity level, and overall metabolism. However, research","Question: Do African American women have lower calorie needs for weight maintenance? Answer: Caloric needs differ based on age, height, weight, activity, and metabolism, so no definitive answer is available. However, research shows",7.10579182070559e-08,0.08961215868968697,0.0,0.005440279394345639,0.09237332013101529,0.0,0.005432404622858621,0.09531017980432521,0.0,7.105791820705622e-08,0.09844007281325329,0.0
54,0.3,4,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: There is no definitive answer as caloric needs vary based on factors such as age, height, weight, activity level, and overall metabolism. However, research","Question: Are fewer calories necessary for African American women to maintain weight? Answer: There is no absolute answer as calorie requirements vary by age, height, weight, activity level, and metabolism. Still, research indicates",7.10579182070559e-08,0.08961215868968697,0.0,0.005440279394345639,0.09237332013101529,0.0,0.005432404622858621,0.09531017980432521,0.0,7.105791820705622e-08,0.09844007281325329,0.0
54,0.3,5,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: There is no definitive answer as caloric needs vary based on factors such as age, height, weight, activity level, and overall metabolism. However, research","Question: Do African American women require less calorie intake to keep their weight stable? Answer: Caloric needs vary depending on age, height, weight, activity, and metabolism, so no definitive answer exists. However, research suggests",4.73719454713706e-08,0.058840500022933284,0.0,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
54,0.3,6,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: There is no definitive answer as caloric needs vary based on factors such as age, height, weight, activity level, and overall metabolism. However, research","Question: Is the caloric requirement lower for African American women to maintain weight? Answer: There is no definitive answer because calorie needs depend on factors such as age, height, weight, activity level, and metabolism. Research, however,",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
54,0.3,7,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: There is no definitive answer as caloric needs vary based on factors such as age, height, weight, activity level, and overall metabolism. However, research","Question: Do African American women need fewer calories to maintain their current weight? Answer: Caloric needs vary with age, height, weight, activity, and metabolism, so no definitive conclusion can be drawn. Nevertheless, research",7.10579182070559e-08,0.08961215868968697,0.0,0.005440279394345639,0.09237332013101529,0.0,0.005432404622858621,0.09531017980432521,0.0,7.105791820705622e-08,0.09844007281325329,0.0
54,0.3,8,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: There is no definitive answer as caloric needs vary based on factors such as age, height, weight, activity level, and overall metabolism. However, research","Question: Are fewer calories needed by African American women to sustain weight? Answer: No definitive answer exists since caloric requirements depend on age, height, weight, activity level, and metabolism. Research, however,",1.184298636784265e-07,0.1541506798272585,0.0,0.009067132323909398,0.15906469462968875,0.0,0.009054007704764368,0.16430305129127598,0.0,1.1842986367842703e-07,0.16989903679539697,0.0
54,0.3,9,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: There is no definitive answer as caloric needs vary based on factors such as age, height, weight, activity level, and overall metabolism. However, research","Question: Is it necessary for African American women to consume fewer calories to maintain weight? Answer: Caloric needs differ based on age, height, weight, activity, and metabolism, so no clear answer is available. However, research",2.36859727356853e-08,0.028987536873251507,0.0,0.0018134264647818796,0.029852963149681777,0.0,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
54,0.3,10,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: There is no definitive answer as caloric needs vary based on factors such as age, height, weight, activity level, and overall metabolism. However, research","Question: Do African American women require a reduced calorie intake to maintain weight? Answer: There is no definitive answer as calorie needs vary depending on age, height, weight, activity level, and metabolism. Nonetheless, research",4.73719454713706e-08,0.058840500022933284,0.0,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
55,0.3,1,ai,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: There is evidence to suggest that increased neutrophil migratory activity after major trauma could contribute to the development of acute respiratory distress syndrome (ARDS).,Increased neutrophil migration following severe trauma may play a role in causing acute respiratory distress syndrome (ARDS).,6.158352911278182e-07,0.7010248272588457,0.1799307958477509,0.047149088084328813,0.8026495200723578,0.14204081632653065,0.04708084006477467,0.9111926883866897,0.09876543209876547,6.158352911278201e-07,1.027520270149139,0.05113221329437545
55,0.3,2,ai,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: There is evidence to suggest that increased neutrophil migratory activity after major trauma could contribute to the development of acute respiratory distress syndrome (ARDS).,There is evidence indicating that heightened neutrophil migratory activity after major trauma might be involved in the onset of acute respiratory distress syndrome (ARDS).,4.500334819780209e-07,0.3381193335694772,0.1799307958477509,0.03445510283085567,0.4196572678162527,0.14204081632653065,0.03440522927810456,0.5057275802785264,0.09876543209876547,4.5003348197802266e-07,0.5967373540566858,0.05113221329437545
55,0.3,3,ai,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: There is evidence to suggest that increased neutrophil migratory activity after major trauma could contribute to the development of acute respiratory distress syndrome (ARDS).,Elevated neutrophil migration post-major trauma could be a contributing factor to the development of acute respiratory distress syndrome (ARDS).,5.684633456564476e-07,0.5832417916024619,0.1799307958477509,0.04352223515476507,0.6774863771183521,0.14204081632653065,0.04345923698286892,0.7776612957621669,0.09876543209876547,5.684633456564494e-07,0.8844194265084657,0.05113221329437545
55,0.3,4,ai,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: There is evidence to suggest that increased neutrophil migratory activity after major trauma could contribute to the development of acute respiratory distress syndrome (ARDS).,The increased movement of neutrophils after significant trauma is suggested to contribute to acute respiratory distress syndrome (ARDS).,5.921493183921329e-07,0.6404002054424107,0.1799307958477509,0.04533566161954694,0.7381109989347872,0.14204081632653065,0.045270038523821804,0.8421998168997376,0.09876543209876547,5.921493183921347e-07,0.9534122979954178,0.05113221329437545
55,0.3,5,ai,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: There is evidence to suggest that increased neutrophil migratory activity after major trauma could contribute to the development of acute respiratory distress syndrome (ARDS).,Data suggests that enhanced neutrophil migratory activity following major trauma may lead to acute respiratory distress syndrome (ARDS).,5.921493183921329e-07,0.6404002054424107,0.1799307958477509,0.04533566161954694,0.7381109989347872,0.14204081632653065,0.045270038523821804,0.8421998168997376,0.09876543209876547,5.921493183921347e-07,0.9534122979954178,0.05113221329437545
55,0.3,6,ai,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: There is evidence to suggest that increased neutrophil migratory activity after major trauma could contribute to the development of acute respiratory distress syndrome (ARDS).,Heightened neutrophil migration after severe trauma appears to be a factor in the etiology of acute respiratory distress syndrome (ARDS).,5.447773729207622e-07,0.5291745703321866,0.1799307958477509,0.04170880868998319,0.6203279632784033,0.14204081632653065,0.04164843544191606,0.7170366739457319,0.09876543209876547,5.447773729207641e-07,0.8198809053708951,0.05113221329437545
55,0.3,7,ai,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: There is evidence to suggest that increased neutrophil migratory activity after major trauma could contribute to the development of acute respiratory distress syndrome (ARDS).,There is evidence supporting that increased neutrophil migratory activity post-major trauma could cause acute respiratory distress syndrome (ARDS).,5.921493183921329e-07,0.6404002054424107,0.1799307958477509,0.04533566161954694,0.7381109989347872,0.14204081632653065,0.045270038523821804,0.8421998168997376,0.09876543209876547,5.921493183921347e-07,0.9534122979954178,0.05113221329437545
55,0.3,8,ai,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: There is evidence to suggest that increased neutrophil migratory activity after major trauma could contribute to the development of acute respiratory distress syndrome (ARDS).,Increased neutrophil migration after major trauma is believed to play a role in the development of acute respiratory distress syndrome (ARDS).,5.210914001850768e-07,0.4778812759446365,0.1799307958477509,0.03989538222520131,0.566260742008128,0.14204081632653065,0.03983763390096318,0.6598782601057831,0.09876543209876547,5.210914001850787e-07,0.7592562835544601,0.05113221329437545
55,0.3,9,ai,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: There is evidence to suggest that increased neutrophil migratory activity after major trauma could contribute to the development of acute respiratory distress syndrome (ARDS).,The role of increased neutrophil migratory activity after major trauma is implicated in the pathogenesis of acute respiratory distress syndrome (ARDS).,5.210914001850768e-07,0.4778812759446365,0.1799307958477509,0.03989538222520131,0.566260742008128,0.14204081632653065,0.03983763390096318,0.6598782601057831,0.09876543209876547,5.210914001850787e-07,0.7592562835544601,0.05113221329437545
55,0.3,10,ai,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: There is evidence to suggest that increased neutrophil migratory activity after major trauma could contribute to the development of acute respiratory distress syndrome (ARDS).,"Following major trauma, elevated neutrophil migratory activity may contribute to the emergence of acute respiratory distress syndrome (ARDS).",5.921493183921329e-07,0.6404002054424107,0.1799307958477509,0.04533566161954694,0.7381109989347872,0.14204081632653065,0.045270038523821804,0.8421998168997376,0.09876543209876547,5.921493183921347e-07,0.9534122979954178,0.05113221329437545
56,0.3,1,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is decompressive surgery beneficial for spinal cord sarcoidosis with compressive cervical myelopathy? The effectiveness of decompression in such cases was unclear. Early diagnosis of sarcoidosis in other organs and steroid treatment are necessary.,2.131737546211678e-07,0.11258793355142194,0.09642074506939374,0.01632083818303688,0.18557753157279544,0.049861495844875335,0.016297213868575834,0.22681825520800558,0.025623268698060954,2.1317375462116866e-07,0.2702903297399133,0.0
56,0.3,2,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Does decompressive surgery help in spinal cord sarcoidosis with compressive cervical myelopathy? The impact of decompression was not apparent. Early detection of sarcoidosis in different organs and steroid therapy is required.,2.605457000925384e-07,0.17712645468899346,0.09642074506939374,0.01994769111260064,0.2522689060714689,0.049861495844875335,0.01991881695048158,0.29581112669495635,0.025623268698060954,2.6054570009253947e-07,0.341749293722057,0.0
56,0.3,3,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is decompressive surgery effective for spinal cord sarcoidosis accompanied by compressive cervical myelopathy? The benefits of decompression were not evident. Early diagnosis of sarcoidosis from other organs and steroid treatment should be administered.,2.131737546211678e-07,0.11258793355142194,0.09642074506939374,0.01632083818303688,0.18557753157279544,0.049861495844875335,0.016297213868575834,0.22681825520800558,0.025623268698060954,2.1317375462116866e-07,0.2702903297399133,0.0
56,0.3,4,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Can decompressive surgery improve outcomes in spinal cord sarcoidosis with compressive cervical myelopathy? The effect of decompression was not clear. Early identification of sarcoidosis in other organs and steroid therapy are needed.,2.368597273568531e-07,0.14433663186600176,0.09642074506939374,0.01813426464781876,0.21836735439578714,0.049861495844875335,0.018108015409528708,0.26071980688368734,0.025623268698060954,2.3685972735685406e-07,0.3053816495511823,0.0
56,0.3,5,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is decompressive surgery a useful treatment for spinal cord sarcoidosis with compressive cervical myelopathy? The effect of decompression was not obvious. Early diagnosis of sarcoidosis in other organs and steroid therapy is necessary.,2.131737546211678e-07,0.11258793355142194,0.09642074506939374,0.01632083818303688,0.18557753157279544,0.049861495844875335,0.016297213868575834,0.22681825520800558,0.025623268698060954,2.1317375462116866e-07,0.2702903297399133,0.0
56,0.3,6,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Does decompressive surgery show efficacy in spinal cord sarcoidosis with compressive cervical myelopathy? The benefit of decompression was not demonstrated. Early detection of sarcoidosis in other organs and steroid treatment should be considered.,2.131737546211678e-07,0.11258793355142194,0.09642074506939374,0.01632083818303688,0.18557753157279544,0.049861495844875335,0.016297213868575834,0.22681825520800558,0.025623268698060954,2.1317375462116866e-07,0.2702903297399133,0.0
56,0.3,7,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is decompressive surgery effective in cases of spinal cord sarcoidosis with compressive cervical myelopathy? The impact of decompression was not evident. Early diagnosis of sarcoidosis in other organs and steroid therapy is essential.,2.131737546211678e-07,0.11258793355142194,0.09642074506939374,0.01632083818303688,0.18557753157279544,0.049861495844875335,0.016297213868575834,0.22681825520800558,0.025623268698060954,2.1317375462116866e-07,0.2702903297399133,0.0
56,0.3,8,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is decompressive surgery beneficial for patients with spinal cord sarcoidosis and compressive cervical myelopathy? The effect of decompression was unclear. Early diagnosis of sarcoidosis from other organs and steroid therapy is necessary.,2.368597273568531e-07,0.14433663186600176,0.09642074506939374,0.01813426464781876,0.21836735439578714,0.049861495844875335,0.018108015409528708,0.26071980688368734,0.025623268698060954,2.3685972735685406e-07,0.3053816495511823,0.0
56,0.3,9,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Does decompressive surgery provide benefit in spinal cord sarcoidosis with compressive cervical myelopathy? The effectiveness of decompression was not apparent. Early diagnosis of sarcoidosis in other organs and steroid treatment is required.,2.368597273568531e-07,0.14433663186600176,0.09642074506939374,0.01813426464781876,0.21836735439578714,0.049861495844875335,0.018108015409528708,0.26071980688368734,0.025623268698060954,2.3685972735685406e-07,0.3053816495511823,0.0
56,0.3,10,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is decompressive surgery effective for spinal cord sarcoidosis with compressive cervical myelopathy? The effect of decompression was not evident. Early diagnosis of sarcoidosis in other organs and steroid therapy should be pursued.,2.368597273568531e-07,0.14433663186600176,0.09642074506939374,0.01813426464781876,0.21836735439578714,0.049861495844875335,0.018108015409528708,0.26071980688368734,0.025623268698060954,2.3685972735685406e-07,0.3053816495511823,0.0
57,0.3,1,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Is advanced age a contraindication for laparoscopic surgery for GERD? Answer: Laparoscopic antireflux surgery remains a safe and effective option for treating GERD in elderly patients, showing low morbidity and mortality rates and symptom improvement similar to younger individuals.",7.105791820705611e-08,0.07410797215372344,0.0,0.005440279394345618,0.0759859069779214,0.0,0.0054324046228586,0.07796154146971057,0.0,7.105791820705622e-08,0.08004270767353416,0.0
57,0.3,2,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Does advanced age contraindicate laparoscopic surgery for GERD? Answer: Laparoscopic antireflux surgery is safe and effective for GERD treatment in elderly patients, with low morbidity and mortality and symptom relief comparable to younger patients.",1.8948778188548261e-07,0.21130909366720596,0.0,0.014507411718254995,0.21706450523782772,0.0,0.014486412327622954,0.2231435513142097,0.0,1.8948778188548325e-07,0.2295744416444978,0.0
57,0.3,3,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Is elderly age a contraindication for GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe, effective treatment for GERD in elderly patients, associated with low morbidity and mortality and symptom improvement on par with younger patients.",1.1842986367842671e-07,0.1642191208045447,0.027006172839506164,0.009067132323909363,0.1300531282481976,0.0,0.009054007704764333,0.13353139262452274,0.0,1.1842986367842703e-07,0.13720112151348252,0.0
57,0.3,4,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Does advanced age prevent the use of laparoscopic surgery for GERD? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD in elderly patients, with low morbidity and mortality rates and symptom improvement similar to that seen in younger patients.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
57,0.3,5,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Is laparoscopic surgery for GERD contraindicated in elderly patients? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in older patients, showing low morbidity and mortality and significant symptom improvement comparable to younger individuals.",9.474389094274141e-08,0.13656488911276776,0.026296566837107373,0.0072537058591274906,0.10265415406008227,0.0,0.007243206163811466,0.10536051565782589,0.0,9.474389094274162e-08,0.10821358464023101,0.0
57,0.3,6,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Is advanced age a limiting factor for GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is safe and effective for GERD in elderly patients, with low morbidity and mortality and symptom relief comparable to younger patients.",1.6580180914979731e-07,0.22192996711166568,0.02854671280276816,0.012693985253473115,0.18721154208814594,0.0,0.01267561078667008,0.19237189264745602,0.0,1.6580180914979784e-07,0.19782574332991798,0.0
57,0.3,7,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Does advanced age contraindicate laparoscopic antireflux surgery for GERD? Answer: Laparoscopic antireflux surgery is a safe, effective treatment for GERD in elderly patients, with low morbidity and mortality rates and symptom improvement similar to younger patients.",1.42115836414112e-07,0.2311670332228073,0.055363321799307974,0.010880558788691236,0.19783241553260567,0.02854671280276816,0.010864809245717207,0.16251892949777424,0.0,1.4211583641411244e-07,0.1670540846631643,0.0
57,0.3,8,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Is elderly age a contraindication for laparoscopic antireflux surgery in GERD? Answer: Laparoscopic antireflux surgery is safe and effective for GERD treatment in elderly patients, resulting in low morbidity and mortality and symptom improvement comparable to younger patients.",9.474389094274141e-08,0.17304631966855455,0.05246913580246914,0.0072537058591274906,0.1401215692254847,0.027006172839506164,0.007243206163811466,0.10536051565782589,0.0,9.474389094274162e-08,0.10821358464023101,0.0
57,0.3,9,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Is advanced age a contraindication for laparoscopic antireflux surgery in GERD patients? Answer: Laparoscopic antireflux surgery is safe and effective even in elderly GERD patients, with low morbidity and mortality rates and symptom improvement similar to younger patients.",9.474389094274141e-08,0.17304631966855455,0.05246913580246914,0.0072537058591274906,0.1401215692254847,0.027006172839506164,0.007243206163811466,0.10536051565782589,0.0,9.474389094274162e-08,0.10821358464023101,0.0
57,0.3,10,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Is advanced age a contraindication to performing laparoscopic surgery for GERD? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD in elderly patients, with low morbidity and mortality and symptom improvement comparable to younger patients.",9.474389094274141e-08,0.10008345855698142,0.0,0.0072537058591274906,0.10265415406008227,0.0,0.007243206163811466,0.10536051565782589,0.0,9.474389094274162e-08,0.10821358464023101,0.0
58,0.3,1,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: The acceptability of breaching confidentiality to protect a patient's wife from a sexually transmitted disease may vary among French lay people and health professionals. It is important,Question: Is it acceptable for French lay people and health professionals to breach confidentiality in order to protect a patient's wife from a sexually transmitted infection? Answer: The acceptability of breaching confidentiality to safeguard a patient's wife from a sexually transmitted infection may differ among French lay people and health professionals. It is important,4.737194547137081e-08,0.13027045790528824,0.04659440080660504,0.0036268529295637453,0.1309294170427524,0.0537380257659979,0.003621603081905733,0.13153737526387088,0.05881944444444444,4.737194547137081e-08,0.13208637329398076,0.06218730636750788
58,0.3,2,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: The acceptability of breaching confidentiality to protect a patient's wife from a sexually transmitted disease may vary among French lay people and health professionals. It is important,Question: Do French lay people and healthcare professionals consider it acceptable to violate confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: The degree to which breaching confidentiality to protect a patient's wife from a sexually transmitted disease is acceptable may vary among French lay people and healthcare professionals. It is important,7.105791820705622e-08,0.07679003333293322,0.008531476943713395,0.005440279394345618,0.07553219639452546,0.009187698748138406,0.0054324046228586,0.07411335286885334,0.008880137912385067,7.105791820705622e-08,0.07251685285545273,0.00780139969813326
58,0.3,3,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: The acceptability of breaching confidentiality to protect a patient's wife from a sexually transmitted disease may vary among French lay people and health professionals. It is important,Question: Are French lay people and health professionals comfortable with breaching confidentiality to protect a patient's wife from sexually transmitted infections? Answer: The acceptability of breaking confidentiality to protect a patient's wife from sexually transmitted infections may differ between French lay people and health professionals. It is important,9.474389094274162e-08,0.08225637659671081,0.00023687037141723044,0.0072537058591274906,0.07976518886656425,0.001881072393893013,0.007243206163811466,0.07698464430649388,0.004908235938641314,9.474389094274162e-08,0.07388358947902374,0.008618402514002838
58,0.3,4,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: The acceptability of breaching confidentiality to protect a patient's wife from a sexually transmitted disease may vary among French lay people and health professionals. It is important,Question: Do French lay people and medical professionals find it acceptable to breach confidentiality to protect a patient's wife from sexually transmitted diseases? Answer: The acceptability of breaching confidentiality to protect a patient's wife from sexually transmitted diseases may vary among French lay people and medical professionals. It is important,4.737194547137081e-08,0.026136843606095805,0.00593119510166748,0.0036268529295637453,0.024648560307188205,0.008592539169995,0.003621603081905733,0.023012199138424894,0.011324375410913912,4.737194547137081e-08,0.021212690379812216,0.01408239143367046
58,0.3,5,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: The acceptability of breaching confidentiality to protect a patient's wife from a sexually transmitted disease may vary among French lay people and health professionals. It is important,Question: Is it considered acceptable by French lay people and health professionals to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: The acceptability of breaching confidentiality to protect a patient's wife from a sexually transmitted disease may differ among French lay people and health professionals. It is important,2.3685972735685406e-08,0.026213646450828687,0.0028470298553401607,0.0018134264647818726,0.025782720618658495,0.0031233563445102475,0.0018108015409528666,0.025295217215510313,0.0030484086853063697,2.3685972735685406e-08,0.024745163277497095,0.0026935025447815675
58,0.3,6,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: The acceptability of breaching confidentiality to protect a patient's wife from a sexually transmitted disease may vary among French lay people and health professionals. It is important,Question: Do French lay people and health workers find breaching confidentiality acceptable to protect a patient's wife from sexually transmitted diseases? Answer: The acceptability of breaching confidentiality to protect a patient's wife from sexually transmitted diseases may vary among French lay people and health workers. It is important,9.474389094274162e-08,0.08225637659671081,0.00023687037141723044,0.0072537058591274906,0.04962835492917517,0.01842238848475866,0.007243206163811466,0.04617810294827418,0.024097991689750714,9.474389094274162e-08,0.042376899453570704,0.02981381812663561
58,0.3,7,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: The acceptability of breaching confidentiality to protect a patient's wife from a sexually transmitted disease may vary among French lay people and health professionals. It is important,Question: Are French lay people and health professionals agreeable to breaching confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: The acceptability of breaching confidentiality to protect a patient's wife from a sexually transmitted disease may differ among French lay people and health professionals. It is important,4.737194547137081e-08,0.08272028691711197,0.014930747922437704,0.0036268529295637453,0.08241082535385047,0.019723865877711938,0.003621603081905733,0.08200344854778185,0.02284925127830531,4.737194547137081e-08,0.08148635825459083,0.024622594715913992
58,0.3,8,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: The acceptability of breaching confidentiality to protect a patient's wife from a sexually transmitted disease may vary among French lay people and health professionals. It is important,Question: Do French lay people and healthcare providers find it acceptable to breach confidentiality to protect a patient's wife from sexually transmitted diseases? Answer: The acceptability of breaching confidentiality to protect a patient's wife from sexually transmitted diseases may vary among French lay people and healthcare providers. It is important,4.737194547137081e-08,0.026136843606095805,0.00593119510166748,0.0036268529295637453,0.024648560307188205,0.008592539169995,0.003621603081905733,0.023012199138424894,0.011324375410913912,4.737194547137081e-08,0.021212690379812216,0.01408239143367046
58,0.3,9,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: The acceptability of breaching confidentiality to protect a patient's wife from a sexually transmitted disease may vary among French lay people and health professionals. It is important,Question: Is breaching confidentiality to protect a patient's wife from a sexually transmitted disease acceptable to French lay people and health professionals? Answer: The acceptability of breaching confidentiality to protect a patient's wife from a sexually transmitted disease may vary among French lay people and health professionals. It is important,4.737194547137081e-08,0.11101200857261961,0.021470540309980884,0.0036268529295637453,0.11129195787718205,0.030971031410591765,0.003621603081905733,0.11149907325246033,0.03781635802469133,4.737194547137081e-08,0.11162319219197947,0.04249357642608115
58,0.3,10,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: The acceptability of breaching confidentiality to protect a patient's wife from a sexually transmitted disease may vary among French lay people and health professionals. It is important,Question: Do French lay people and health professionals approve of breaching confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: The acceptability of breaching confidentiality to protect a patient's wife from a sexually transmitted disease may differ among French lay people and health professionals. It is important,4.737194547137081e-08,0.11101200857261961,0.021470540309980884,0.0036268529295637453,0.1112919578771816,0.030971031410591765,0.003621603081905733,0.11149907325246033,0.03781635802469133,4.737194547137081e-08,0.11162319219197947,0.04249357642608115
59,0.3,1,human,Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but,"Question: Can diffusion-weighted echo-planar MR imaging predict different histologic subtypes of primary parotid gland tumors? Answer: epiDWI shows promise in distinguishing pleomorphic adenoma and myoepithelial adenomas from other studied types. However, there is overlap among benign and malignant lesions as well.",2.1317375462116866e-07,0.20294084399669066,0.0,0.016320838183036854,0.20763936477824663,0.0,0.0162972138685758,0.21256144198367144,0.0,2.1317375462116866e-07,0.21772348384486895,0.0
59,0.3,2,human,Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but,"Question: Is it possible to use diffusion-weighted echo-planar MR imaging to predict various histologic subtypes of primary parotid gland tumors? Answer: epiDWI can potentially differentiate pleomorphic adenoma and myoepithelial adenomas from other entities examined, though overlaps exist within benign and malignant groups.",1.8948778188548325e-07,0.17824823140631896,0.0,0.014507411718254981,0.1823215567939549,0.0,0.014486412327622933,0.18658595558041347,0.0,1.8948778188548325e-07,0.19105523676270808,0.0
59,0.3,3,human,Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but,"Question: Can diffusion-weighted echo-planar MR imaging help predict different histologic subtypes in primary parotid gland tumors? Answer: epiDWI may differentiate pleomorphic adenoma and myoepithelial adenomas from other types studied, but overlaps occur among benign and malignant lesions.",3.0791764556390986e-07,0.30830135965451655,0.0,0.023574544042164344,0.31585294941847764,0.0,0.023540420032387273,0.323787077093896,0.0,3.079176455639103e-07,0.3321338350226144,0.0
59,0.3,4,human,Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but,"Question: Does diffusion-weighted echo-planar MR imaging allow prediction of distinct histologic subtypes of primary parotid gland tumors? Answer: epiDWI has the capability to distinguish pleomorphic adenoma and myoepithelial adenomas from other examined entities, despite overlaps within benign and malignant lesions.",2.3685972735685396e-07,0.22825865198098239,0.0,0.018134264647818726,0.2336148511815046,0.0,0.018108015409528666,0.2392296890658323,0.0,2.3685972735685406e-07,0.24512245803298427,0.0
59,0.3,5,human,Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but,"Question: Is predicting different histologic subtypes of primary parotid gland tumors possible with diffusion-weighted echo-planar MR imaging? Answer: epiDWI can differentiate pleomorphic adenoma and myoepithelial adenomas from other studied lesions, although overlaps are present among benign and malignant groups.",2.6054570009253926e-07,0.25423413838424036,0.0,0.0199476911126006,0.26028309826366547,0.0,0.019918816950481533,0.26662866325394763,0.0,2.6054570009253947e-07,0.2732933349996811,0.0
59,0.3,6,human,Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but,"Question: Can diffusion-weighted echo-planar MR imaging predict various histologic subtypes of primary parotid gland tumors? Answer: epiDWI potentially distinguishes pleomorphic adenoma and myoepithelial adenomas from other entities, but overlaps exist within benign and malignant lesions.",3.5528959103528046e-07,0.3654597734944649,0.0,0.027201396971728103,0.3746934494414109,0.0,0.02716202311429302,0.38441169891033145,0.0,3.552895910352811e-07,0.3946541920039479,0.0
59,0.3,7,human,Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but,"Question: Is diffusion-weighted echo-planar MR imaging effective in predicting different histologic subtypes of primary parotid gland tumors? Answer: epiDWI shows potential to differentiate pleomorphic adenoma and myoepithelial adenomas from other examined types, despite some overlap among benign and malignant lesions.",2.3685972735685396e-07,0.22825865198098239,0.0,0.018134264647818726,0.2336148511815046,0.0,0.018108015409528666,0.2392296890658323,0.0,2.3685972735685406e-07,0.24512245803298427,0.0
59,0.3,8,human,Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but,"Question: Can diffusion-weighted echo-planar MR imaging be used to predict histologic subtypes of primary parotid gland tumors? Answer: epiDWI might differentiate pleomorphic adenoma and myoepithelial adenomas from other entities studied, although there is overlap within benign and malignant lesions.",2.6054570009253926e-07,0.25423413838424036,0.0,0.0199476911126006,0.26028309826366547,0.0,0.019918816950481533,0.26662866325394763,0.0,2.6054570009253947e-07,0.2732933349996811,0.0
59,0.3,9,human,Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but,"Question: Does diffusion-weighted echo-planar MR imaging enable prediction of different histologic subtypes in primary parotid gland tumors? Answer: epiDWI has potential to separate pleomorphic adenoma and myoepithelial adenomas from other examined lesions, but overlaps occur among benign and malignant groups.",2.3685972735685396e-07,0.22825865198098239,0.0,0.018134264647818726,0.2336148511815046,0.0,0.018108015409528666,0.2392296890658323,0.0,2.3685972735685406e-07,0.24512245803298427,0.0
59,0.3,10,human,Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but,"Question: Is it feasible to predict various histologic subtypes of primary parotid gland tumors using diffusion-weighted echo-planar MR imaging? Answer: epiDWI can potentially distinguish pleomorphic adenoma and myoepithelial adenomas from other entities studied, though overlaps exist within benign and malignant lesions.",2.1317375462116866e-07,0.20294084399669066,0.0,0.016320838183036854,0.20763936477824663,0.0,0.0162972138685758,0.21256144198367144,0.0,2.1317375462116866e-07,0.21772348384486895,0.0
60,0.3,1,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Correlated results from homebrew assays for BCRABL transcript detection by quantitative real-time PCR are possible if the assay is properly designed, validated, and executed following established protocols and guidelines. However, it is recommended to use commercially available kits that have undergone rigorous testing for accurate and reliable results.","Is it possible to obtain correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR? Correlated results can be achieved with homebrew assays if they are carefully designed, validated, and performed according to established protocols and guidelines. Nonetheless, using commercially available kits that have been rigorously tested is recommended for accuracy and reliability.",2.1317375462116866e-07,0.02867380702793776,0.08613712483925579,0.016320838183036854,0.044127317833616786,0.07877526753864449,0.0162972138685758,0.06740412561426679,0.06420927467300831,2.1317375462116866e-07,0.09145173438926513,0.049048751486325794
60,0.3,2,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Correlated results from homebrew assays for BCRABL transcript detection by quantitative real-time PCR are possible if the assay is properly designed, validated, and executed following established protocols and guidelines. However, it is recommended to use commercially available kits that have undergone rigorous testing for accurate and reliable results.","Can homebrew assays yield correlated results in BCRABL transcript detection by quantitative real-time PCR? Yes, provided the assay is well-designed, validated, and executed following standard protocols and guidelines. However, it is advisable to use commercially available kits that have undergone thorough testing for dependable results.",4.737194547137081e-07,0.20140665430142368,0.12244897959183677,0.03626852929563745,0.2719112487043298,0.07877526753864449,0.03621603081905733,0.3000264208830199,0.06420927467300831,4.737194547137081e-07,0.32912338626638515,0.049048751486325794
60,0.3,3,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Correlated results from homebrew assays for BCRABL transcript detection by quantitative real-time PCR are possible if the assay is properly designed, validated, and executed following established protocols and guidelines. However, it is recommended to use commercially available kits that have undergone rigorous testing for accurate and reliable results.","Are correlated results achievable from homebrew assays for BCRABL transcript detection via quantitative real-time PCR? Such results are possible if the assay is properly designed, validated, and conducted according to established protocols and guidelines. Still, it is recommended to rely on commercially available kits that have been extensively tested for accuracy and reliability.",2.8423167282822487e-07,0.03435256963825761,0.12244897959183677,0.02176111757738247,0.10128573167356691,0.07877526753864449,0.0217296184914344,0.12567303373824235,0.06420927467300831,2.8423167282822487e-07,0.1508751548600662,0.049048751486325794
60,0.3,4,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Correlated results from homebrew assays for BCRABL transcript detection by quantitative real-time PCR are possible if the assay is properly designed, validated, and executed following established protocols and guidelines. However, it is recommended to use commercially available kits that have undergone rigorous testing for accurate and reliable results.","Is it feasible to get correlated results from homebrew assays in quantitative real-time PCR detection of BCRABL transcripts? Correlated outcomes can be attained if the assay is correctly designed, validated, and implemented following established protocols and guidelines. However, using commercially available kits with rigorous testing is recommended for reliable and accurate results.",3.079176455639103e-07,0.05377065549536031,0.12244897959183677,0.023574544042164344,0.12108835896974668,0.07877526753864449,0.023540420032387266,0.14587574105576095,0.06420927467300831,3.079176455639103e-07,0.17149444206280196,0.049048751486325794
60,0.3,5,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Correlated results from homebrew assays for BCRABL transcript detection by quantitative real-time PCR are possible if the assay is properly designed, validated, and executed following established protocols and guidelines. However, it is recommended to use commercially available kits that have undergone rigorous testing for accurate and reliable results.","Can quantitative real-time PCR homebrew assays for BCRABL transcript detection produce correlated results? Yes, if the assay is designed, validated, and executed properly in line with established protocols and guidelines. Nevertheless, commercially available kits that have been thoroughly tested are recommended for precise and reliable outcomes.",4.500334819780227e-07,0.17893379844936597,0.12244897959183677,0.03445510283085558,0.2489217304796303,0.07877526753864449,0.034405229278104466,0.2764959234728255,0.06420927467300831,4.500334819780227e-07,0.30502583468732514,0.049048751486325794
60,0.3,6,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Correlated results from homebrew assays for BCRABL transcript detection by quantitative real-time PCR are possible if the assay is properly designed, validated, and executed following established protocols and guidelines. However, it is recommended to use commercially available kits that have undergone rigorous testing for accurate and reliable results.","Are homebrew assays capable of providing correlated results in BCRABL transcript detection by quantitative real-time PCR? Correlated results are achievable when the assay is properly designed, validated, and performed according to established protocols and guidelines. However, it is advisable to use commercially available kits that have undergone stringent testing for trustworthy results.",3.079176455639103e-07,0.08095289787025983,0.10284897959183678,0.023574544042164344,0.12108835896974668,0.07877526753864449,0.023540420032387266,0.14587574105576095,0.06420927467300831,3.079176455639103e-07,0.17149444206280196,0.049048751486325794
60,0.3,7,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Correlated results from homebrew assays for BCRABL transcript detection by quantitative real-time PCR are possible if the assay is properly designed, validated, and executed following established protocols and guidelines. However, it is recommended to use commercially available kits that have undergone rigorous testing for accurate and reliable results.","Is it possible to achieve correlated results from homebrew assays detecting BCRABL transcripts by quantitative real-time PCR? Yes, if the assay is well-designed, validated, and executed following established protocols and guidelines. Still, it is recommended to use commercially available kits that have been rigorously tested for accuracy and reliability.",3.789755637709665e-07,0.11439527731179444,0.12244897959183677,0.029014823436509962,0.1829637626878342,0.07877526753864449,0.028972824655245866,0.20905464267729323,0.06420927467300831,3.789755637709665e-07,0.23603296320037348,0.049048751486325794
60,0.3,8,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Correlated results from homebrew assays for BCRABL transcript detection by quantitative real-time PCR are possible if the assay is properly designed, validated, and executed following established protocols and guidelines. However, it is recommended to use commercially available kits that have undergone rigorous testing for accurate and reliable results.","Can homebrew assays for BCRABL transcript detection via quantitative real-time PCR yield correlated results? Correlated results can be obtained if the assay is properly designed, validated, and carried out according to established protocols and guidelines. However, using commercially available kits that have undergone thorough testing is recommended for dependable results.",3.552895910352811e-07,0.09377599010905868,0.12244897959183677,0.02720139697172809,0.16191035349000105,0.07877526753864449,0.027162023114293,0.18754843745632988,0.06420927467300831,3.552895910352811e-07,0.21405405648159848,0.049048751486325794
60,0.3,9,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Correlated results from homebrew assays for BCRABL transcript detection by quantitative real-time PCR are possible if the assay is properly designed, validated, and executed following established protocols and guidelines. However, it is recommended to use commercially available kits that have undergone rigorous testing for accurate and reliable results.","Are correlated results from homebrew assays for BCRABL transcript detection by quantitative real-time PCR possible? They are, provided the assay is designed, validated, and performed correctly following established protocols and guidelines. Nevertheless, it is advisable to use commercially available kits that have been rigorously tested for accurate and reliable results.",3.552895910352811e-07,0.09377599010905868,0.12244897959183677,0.02720139697172809,0.16191035349000105,0.07877526753864449,0.027162023114293,0.18754843745632988,0.06420927467300831,3.552895910352811e-07,0.21405405648159848,0.049048751486325794
60,0.3,10,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Correlated results from homebrew assays for BCRABL transcript detection by quantitative real-time PCR are possible if the assay is properly designed, validated, and executed following established protocols and guidelines. However, it is recommended to use commercially available kits that have undergone rigorous testing for accurate and reliable results.","Is it possible to get correlated results from homebrew assays in the detection of BCRABL transcripts by quantitative real-time PCR? Yes, if the assay is properly designed, validated, and executed according to established protocols and guidelines. However, the use of commercially available kits that have undergone extensive testing is recommended for reliable and accurate results.",2.3685972735685406e-07,0.0033877583445898196,0.12244897959183677,0.018134264647818726,0.06281945084577112,0.07877526753864449,0.018108015409528666,0.08645232058495989,0.06420927467300831,2.3685972735685406e-07,0.11086982024636782,0.049048751486325794
61,0.3,1,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be","Is imaging necessary to diagnose appendicitis in children? Clinical evaluation remains the primary method for diagnosis. However, for girls over 10 years old, selective imaging is recommended to prevent unnecessary appendectomies. In uncertain cases, the preferred imaging modality should be used.",9.474389094274162e-08,0.032296799753420924,0.045351473922902494,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
61,0.3,2,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be","Do we require imaging to diagnose appendicitis in pediatric patients? Diagnosis mainly relies on clinical assessment. Still, in girls older than 10, targeted imaging is advised to avoid needless surgeries. The imaging technique of choice should be applied in ambiguous situations.",9.474389094274162e-08,0.032296799753420924,0.045351473922902494,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
61,0.3,3,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be","Is imaging needed for diagnosing appendicitis in children? The diagnosis depends primarily on clinical examination. Yet, for girls above 10 years, selective imaging is suggested to reduce unnecessary appendectomies. The preferred imaging method should be utilized in doubtful cases.",1.4211583641411222e-07,0.08359009414097063,0.045351473922902494,0.010880558788691236,0.1502822030493367,0.0,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
61,0.3,4,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be","Should imaging be used to diagnose appendicitis in children? Clinical assessment is essential for diagnosis. Nevertheless, in girls older than 10 years, selective imaging should be employed to prevent unnecessary appendectomies. The imaging of choice should be used in equivocal cases.",9.474389094274162e-08,0.10161151780941502,0.004510021921972848,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
61,0.3,5,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be","Do children with suspected appendicitis require imaging for diagnosis? Clinical evaluation is fundamental. However, in girls over 10 years, selective imaging is recommended to avoid unnecessary appendectomies. The chosen imaging modality should be applied in uncertain cases.",1.8948778188548283e-07,0.13765731541124682,0.045351473922902494,0.014507411718254981,0.20585205420414887,0.0,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
61,0.3,6,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be","Is imaging essential to diagnose appendicitis in children? Diagnosis is primarily clinical. However, for girls older than 10, selective imaging should be considered to prevent unnecessary appendectomies. The imaging technique of choice should be used when the diagnosis is unclear.",1.1842986367842692e-07,0.12870662625668094,0.005780739371472957,0.009067132323909363,0.12361395596717584,0.0,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
61,0.3,7,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be","Do we need to use imaging to diagnose appendicitis in children? Clinical assessment is the cornerstone of diagnosis. Yet, in girls older than 10 years, selective imaging is advised to avoid unnecessary appendectomies. The preferred imaging method should be used in equivocal cases.",4.737194547137081e-08,0.01649336441601079,0.045351473922902494,0.0036268529295637453,0.047628048989254435,0.0,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
61,0.3,8,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be","Is imaging required to diagnose appendicitis in pediatric patients? The diagnosis relies mainly on clinical assessment. Still, selective imaging is recommended for girls over 10 to prevent unnecessary appendectomies. The imaging of choice should be used in uncertain cases.",1.4211583641411222e-07,0.08359009414097063,0.045351473922902494,0.010880558788691236,0.1502822030493367,0.0,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
61,0.3,9,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be","Should imaging be performed to diagnose appendicitis in children? Clinical evaluation is key. However, in girls older than 10 years, selective imaging should be implemented to avoid unnecessary appendectomies. The preferred imaging modality should be used in ambiguous cases.",1.4211583641411222e-07,0.12007152469675697,0.01905490708579512,0.010880558788691236,0.1502822030493367,0.0,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
61,0.3,10,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be","Is imaging necessary for diagnosing appendicitis in children? Clinical assessment is the primary diagnostic tool. Nevertheless, in girls above 10 years, selective imaging is advised to prevent unnecessary appendectomies. The imaging technique of choice should be utilized in equivocal cases.",1.1842986367842692e-07,0.05761460773771265,0.045351473922902494,0.009067132323909363,0.12361395596717584,0.0,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
62,0.3,1,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is","Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: Using MEP and SSEP monitoring, it is safe to sacrifice up to 15 intercostal and lumbar arteries without reimplantation during TAA/A repair, leading to low rates of immediate and delayed paraplegia. This suggests routine surgical reimplantation of segmental vessels may not be necessary.",2.3685972735685406e-08,0.00640208123595265,0.01694411414982164,0.0018134264647818726,0.01739174271186883,0.0,0.0018108015409528666,0.01769957709940062,0.0,2.3685972735685406e-08,0.018018505502678472,0.0
62,0.3,2,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is","Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: Monitoring MEP and SSEP shows that sacrificing as many as 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe and results in acceptably low paraplegia rates, indicating that routine reimplantation might be unnecessary.",1.4211583641411244e-07,0.10919929196499112,0.0,0.010880558788691236,0.11122563511022499,0.0,0.0108648092457172,0.11332868530700413,0.0,1.4211583641411244e-07,0.11551288712184427,0.0
62,0.3,3,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is","Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With MEP and SSEP monitoring, sacrificing up to 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe and yields low immediate and delayed paraplegia rates, suggesting routine reimplantation of segmental arteries may be redundant.",1.1842986367842703e-07,0.11630759437391891,0.018860946745562133,0.009067132323909363,0.09180754925312229,0.0,0.009054007704764333,0.09352605801082436,0.0,1.1842986367842703e-07,0.09531017980432566,0.0
62,0.3,4,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is","Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: The use of MEP and SSEP monitoring allows safe sacrifice of as many as 15 intercostal and lumbar arteries without reimplantation during TAA/A repair, with low rates of paraplegia, implying routine segmental vessel reimplantation may not be needed.",9.474389094274162e-08,0.07145896398214369,0.0,0.0072537058591274906,0.07275935428242919,0.0,0.007243206163811466,0.07410797215372167,0.0,9.474389094274162e-08,0.07550755250814589,0.0
62,0.3,5,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is","Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: Monitoring with MEP and SSEP confirms that sacrificing up to 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe and results in low paraplegia rates, suggesting routine reimplantation of these vessels may be unnecessary.",1.1842986367842703e-07,0.11630759437391891,0.018860946745562133,0.009067132323909363,0.09180754925312229,0.0,0.009054007704764333,0.09352605801082436,0.0,1.1842986367842703e-07,0.09531017980432566,0.0
62,0.3,6,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is","Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: The experience with MEP and SSEP monitoring shows that sacrificing as many as 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe, with low immediate and delayed paraplegia rates, indicating routine reimplantation may be superfluous.",9.474389094274162e-08,0.07145896398214369,0.0,0.0072537058591274906,0.07275935428242919,0.0,0.007243206163811466,0.07410797215372167,0.0,9.474389094274162e-08,0.07550755250814589,0.0
62,0.3,7,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is","Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: Using MEP and SSEP monitoring, it is safe to sacrifice up to 15 intercostal and lumbar arteries without reimplantation during TAA/A repair, resulting in low rates of paraplegia, which suggests routine segmental vessel reimplantation might be unnecessary.",1.1842986367842703e-07,0.09015109699429802,0.0,0.009067132323909363,0.09180754925312229,0.0,0.009054007704764333,0.09352605801082436,0.0,1.1842986367842703e-07,0.09531017980432566,0.0
62,0.3,8,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is","Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With MEP and SSEP monitoring, sacrificing as many as 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe and leads to acceptably low paraplegia rates, implying that routine reimplantation of segmental arteries may be unnecessary.",9.474389094274162e-08,0.09713108178066054,0.01851192595229618,0.0072537058591274906,0.07275935428242919,0.0,0.007243206163811466,0.07410797215372167,0.0,9.474389094274162e-08,0.07550755250814589,0.0
62,0.3,9,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is","Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: The data from MEP and SSEP monitoring indicate that sacrificing up to 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe and results in low rates of paraplegia, suggesting routine reimplantation may not be required.",9.474389094274162e-08,0.07145896398214369,0.0,0.0072537058591274906,0.07275935428242919,0.0,0.007243206163811466,0.07410797215372167,0.0,9.474389094274162e-08,0.07550755250814589,0.0
62,0.3,10,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is","Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: Experience with MEP and SSEP monitoring demonstrates that sacrificing as many as 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe, with acceptably low immediate and delayed paraplegia rates, indicating routine reimplantation of segmental vessels might be unnecessary.",2.3685972735685406e-08,0.04171269641572639,0.017538265306122455,0.0018134264647818726,0.01769957709940062,0.0,0.0018108015409528666,0.018018505502678472,0.0,2.3685972735685406e-08,0.018349138668195764,0.0
63,0.3,1,ai,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: There is no direct relation between cervical cord plaques and discopathy in patients with,Is there a connection between cervical cord plaques and discopathy in multiple sclerosis patients? There is no direct link between cervical cord plaques and discopathy in these patients.,7.10579182070559e-08,0.002462379095944378,0.040816326530612235,0.005440279394345639,0.006631669242640026,0.054421768707483,0.005432404622858621,0.011437807193785066,0.0680272108843536,7.105791820705622e-08,0.016995582785828578,0.08163265306122455
63,0.3,2,ai,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: There is no direct relation between cervical cord plaques and discopathy in patients with,Are cervical cord plaques related to discopathy in patients with multiple sclerosis? No direct relationship exists between cervical cord plaques and discopathy in such patients.,1.421158364141118e-07,0.019457961881772956,0.12244897959183679,0.010880558788691277,0.09035074872166104,0.1924392346470268,0.010864809245717241,0.10541153346308363,0.2222222222222221,1.4211583641411244e-07,0.05675098530128997,0.20408163265306126
63,0.3,3,ai,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: There is no direct relation between cervical cord plaques and discopathy in patients with,Does cervical cord plaque presence correlate with discopathy in multiple sclerosis patients? There is no direct association between cervical cord plaques and discopathy in these individuals.,1.184298636784265e-07,0.12266320265242081,0.1655028741175109,0.009067132323909398,0.19318403101523485,0.23582766439909295,0.009054007704764368,0.14986329603391768,0.2222222222222221,1.1842986367842703e-07,0.10327100093618391,0.20408163265306126
63,0.3,4,ai,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: There is no direct relation between cervical cord plaques and discopathy in patients with,Is there an association between cervical cord plaques and discopathy among multiple sclerosis patients? No direct relation is found between cervical cord plaques and discopathy in these patients.,7.10579182070559e-08,0.05380661469297765,0.06927812447292964,0.005440279394345639,0.0599506831318668,0.0870673338205806,0.005432404622858621,0.06688958163858016,0.10445362718089983,7.105791820705622e-08,0.07475784783249084,0.12143700455388771
63,0.3,5,ai,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: There is no direct relation between cervical cord plaques and discopathy in patients with,Are cervical cord plaques and discopathy connected in patients with multiple sclerosis? There is no direct connection between cervical cord plaques and discopathy in these cases.,1.184298636784265e-07,0.011759653762829725,0.09070294784580499,0.009067132323909398,0.01989723587524983,0.11337868480725624,0.009054007704764368,0.029315960284361786,0.13605442176870736,1.1842986367842703e-07,0.04025762088527962,0.15873015873015875
63,0.3,6,ai,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: There is no direct relation between cervical cord plaques and discopathy in patients with,Is there any link between cervical cord plaques and discopathy in multiple sclerosis patients? No direct link exists between cervical cord plaques and discopathy in these patients.,9.47438909427412e-08,0.04712661864006362,0.03489795918367353,0.007253705859127518,0.0432528466884885,0.048327664399092946,0.007243206163811494,0.03862614973393397,0.06222222222222207,9.474389094274162e-08,0.03309824011731566,0.07658163265306125
63,0.3,7,ai,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: There is no direct relation between cervical cord plaques and discopathy in patients with,Do cervical cord plaques relate to discopathy in patients suffering from multiple sclerosis? There is no direct relationship between cervical cord plaques and discopathy in these patients.,9.47438909427412e-08,0.1128304230276167,0.13147640908915553,0.007253705859127518,0.17855425109069456,0.1958971088435374,0.007243206163811494,0.1924229104527133,0.2222222222222221,9.474389094274162e-08,0.14772276350701796,0.20408163265306126
63,0.3,8,ai,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: There is no direct relation between cervical cord plaques and discopathy in patients with,Is there a relationship between cervical cord plaques and discopathy in multiple sclerosis patients? No direct relation has been observed between cervical cord plaques and discopathy in these patients.,4.73719454713706e-08,0.04983235946618336,0.0465508517456569,0.003626852929563759,0.054245888686454524,0.06020782968834909,0.003621603081905747,0.059189562569345266,0.07346189164370975,4.737194547137081e-08,0.06474904911168045,0.08631303761173899
63,0.3,9,ai,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: There is no direct relation between cervical cord plaques and discopathy in patients with,Are cervical cord plaques associated with discopathy in patients with multiple sclerosis? There is no direct association between cervical cord plaques and discopathy in these patients.,1.184298636784265e-07,0.06721142820762482,0.1271293641423512,0.009067132323909398,0.13542176596857436,0.19423976269776969,0.009054007704764368,0.14986329603391768,0.2222222222222221,1.1842986367842703e-07,0.10327100093618391,0.20408163265306126
63,0.3,10,ai,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: There is no direct relation between cervical cord plaques and discopathy in patients with,Is there any correlation between cervical cord plaques and discopathy in patients with multiple sclerosis? No direct correlation exists between cervical cord plaques and discopathy in these patients.,7.10579182070559e-08,0.002462379095944378,0.040816326530612235,0.005440279394345639,0.006631669242640026,0.054421768707483,0.005432404622858621,0.011437807193785066,0.0680272108843536,7.105791820705622e-08,0.016995582785828578,0.08163265306122455
64,0.3,1,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Yes, the 30-day and 1-year mortality rates in emergency general surgery laparotomies are a cause for concern and indicate the need for improvement in the field.","Question: Are the 30-day and 1-year mortality rates in emergency general surgery laparotomies a concern and in need of improvement? Answer: Yes, these mortality rates are worrisome and highlight the necessity for advancements in this area.",2.1317375462116813e-07,0.016396462542942913,0.14429279337007134,0.01632083818303686,0.105881976089504,0.09204470742932283,0.016297213868575813,0.1751480396207037,0.047500000000000014,2.1317375462116866e-07,0.2478361639045814,0.0
64,0.3,2,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Yes, the 30-day and 1-year mortality rates in emergency general surgery laparotomies are a cause for concern and indicate the need for improvement in the field.","Question: Is there a concern regarding 30-day and 1-year mortality following emergency general surgery laparotomies, and is improvement needed? Answer: Yes, the mortality rates at both 30 days and 1 year post-surgery are concerning and suggest that improvements are required.",1.1842986367842692e-07,0.13142553241499932,0.1728395061728395,0.009067132323909363,0.005343659020720537,0.09204470742932283,0.009054007704764333,0.06073768844295824,0.047500000000000014,1.1842986367842703e-07,0.1300531282481976,0.0
64,0.3,3,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Yes, the 30-day and 1-year mortality rates in emergency general surgery laparotomies are a cause for concern and indicate the need for improvement in the field.","Question: Do 30-day and 1-year mortality rates in emergency general surgery laparotomies represent an issue that needs addressing? Answer: Yes, these mortality statistics are alarming and point to a need for better outcomes in this surgical field.",1.8948778188548283e-07,0.05138282474146516,0.1728395061728395,0.014507411718254981,0.0768944392162525,0.09204470742932283,0.01448641232762294,0.1452950764710219,0.047500000000000014,1.8948778188548325e-07,0.21706450523782772,0.0
64,0.3,4,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Yes, the 30-day and 1-year mortality rates in emergency general surgery laparotomies are a cause for concern and indicate the need for improvement in the field.","Question: Are the mortality rates at 30 days and 1 year after emergency general surgery laparotomies a matter of concern and in need of enhancement? Answer: Yes, the rates are troubling and indicate that improvements are necessary.",1.8948778188548283e-07,0.05138282474146516,0.1728395061728395,0.014507411718254981,0.0768944392162525,0.09204470742932283,0.01448641232762294,0.1452950764710219,0.047500000000000014,1.8948778188548325e-07,0.21706450523782772,0.0
64,0.3,5,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Yes, the 30-day and 1-year mortality rates in emergency general surgery laparotomies are a cause for concern and indicate the need for improvement in the field.","Question: Is there a significant concern about 30-day and 1-year mortality in emergency general surgery laparotomies that demands improvement? Answer: Yes, the mortality figures at these time points are concerning and call for efforts to improve.",2.1317375462116813e-07,0.023211947774768316,0.1728395061728395,0.01632083818303686,0.105881976089504,0.09204470742932283,0.016297213868575813,0.1751480396207037,0.047500000000000014,2.1317375462116866e-07,0.2478361639045814,0.0
64,0.3,6,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Yes, the 30-day and 1-year mortality rates in emergency general surgery laparotomies are a cause for concern and indicate the need for improvement in the field.","Question: Do emergency general surgery laparotomies have concerning 30-day and 1-year mortality rates that require improvement? Answer: Yes, these mortality rates are a cause for concern and show the need for better practices.",2.84231672828224e-07,0.10972190969991624,0.1416220243830372,0.0217611175773825,0.1982552962205193,0.09204470742932283,0.021729618491434434,0.2704582194250289,0.047500000000000014,2.8423167282822487e-07,0.3462762367178347,0.0
64,0.3,7,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Yes, the 30-day and 1-year mortality rates in emergency general surgery laparotomies are a cause for concern and indicate the need for improvement in the field.","Question: Are the 30-day and 1-year mortality outcomes in emergency general surgery laparotomies problematic and in need of improvement? Answer: Yes, these outcomes are concerning and highlight the necessity for progress in this area.",2.605457000925387e-07,0.03562855224816497,0.1728395061728395,0.01994769111260062,0.16650659790593947,0.09204470742932283,0.01991881695048156,0.2376683966020372,0.047500000000000014,2.6054570009253947e-07,0.31237468504215293,0.0
64,0.3,8,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Yes, the 30-day and 1-year mortality rates in emergency general surgery laparotomies are a cause for concern and indicate the need for improvement in the field.","Question: Is the mortality within 30 days and 1 year after emergency general surgery laparotomies an area that needs attention and improvement? Answer: Yes, these mortality rates are worrying and suggest improvements are needed.",2.605457000925387e-07,0.03562855224816497,0.1728395061728395,0.01994769111260062,0.16650659790593947,0.09204470742932283,0.01991881695048156,0.2376683966020372,0.047500000000000014,2.6054570009253947e-07,0.31237468504215293,0.0
64,0.3,9,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Yes, the 30-day and 1-year mortality rates in emergency general surgery laparotomies are a cause for concern and indicate the need for improvement in the field.","Question: Are the 30-day and 1-year mortality rates following emergency general surgery laparotomies an issue that requires improvement? Answer: Yes, these rates are concerning and indicate a need for enhancement in care.",3.0791764556390933e-07,0.09814890922949848,0.1728395061728395,0.02357454404216438,0.231045119043511,0.09204470742932283,0.023540420032387308,0.30435977110071066,0.047500000000000014,3.079176455639103e-07,0.3813675565291037,0.0
64,0.3,10,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Yes, the 30-day and 1-year mortality rates in emergency general surgery laparotomies are a cause for concern and indicate the need for improvement in the field.","Question: Is there a need to improve the 30-day and 1-year mortality rates in emergency general surgery laparotomies due to concern? Answer: Yes, the mortality rates at these intervals are troubling and necessitate improvement.",2.605457000925387e-07,0.07763747228210072,0.1425660686728395,0.01994769111260062,0.16650659790593947,0.09204470742932283,0.01991881695048156,0.2376683966020372,0.047500000000000014,2.6054570009253947e-07,0.31237468504215293,0.0
65,0.3,1,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients.","Is emergency double-balloon enteroscopy combined with real-time capsule endoscopy a viable method for acute overt-obscure gastrointestinal bleeding? Emergency DBE is practical, safe, and effective for acute OGIB, potentially preventing major surgery by diagnosing and treating most cases successfully.",9.474389094274131e-08,0.10630951163719482,0.0026311728395061636,0.0072537058591274906,0.10536051565782589,0.0,0.007243206163811466,0.10821358464023101,0.0,9.474389094274162e-08,0.11122563511022454,0.0
65,0.3,2,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients.","Can emergency double-balloon enteroscopy with live capsule endoscopy viewing be an effective approach in acute overt-obscure gastrointestinal bleeding? Emergency DBE proves to be feasible, safe, and effective in acute OGIB, often avoiding the need for major surgery through accurate diagnosis and treatment.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
65,0.3,3,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients.","Does combining emergency double-balloon enteroscopy with real-time capsule endoscopy offer a feasible solution for acute overt-obscure gastrointestinal bleeding? Emergency DBE is a safe and effective procedure in acute OGIB that can diagnose and treat most patients, possibly eliminating the need for major surgery.",2.3685972735685406e-08,0.057909609167349885,0.024375,0.0018134264647818726,0.0246926125903717,0.0,0.0018108015409528666,0.02531780798429173,0.0,2.3685972735685406e-08,0.025975486403257975,0.0
65,0.3,4,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients.","Is the use of emergency double-balloon enteroscopy alongside real-time capsule endoscopy a practical approach for acute overt-obscure gastrointestinal bleeding? Emergency DBE is both safe and effective in acute OGIB, frequently avoiding major surgical interventions by diagnosing and treating patients successfully.",4.7371945471370706e-08,0.01619836298637356,0.024375,0.0036268529295637453,0.051293294387549704,0.0,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
65,0.3,5,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients.",Can emergency double-balloon enteroscopy with simultaneous real-time capsule endoscopy viewing be a feasible method in acute overt-obscure gastrointestinal bleeding? Emergency DBE is a safe and effective technique in acute OGIB that may prevent major surgery by diagnosing and treating the majority of patients.,2.3685972735685406e-08,0.024902600569258304,0.0005796400951814454,0.0018134264647818726,0.0246926125903717,0.0,0.0018108015409528666,0.02531780798429173,0.0,2.3685972735685406e-08,0.025975486403257975,0.0
65,0.3,6,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients.","Is emergency double-balloon enteroscopy combined with real-time capsule endoscopy viewing a viable approach for acute overt-obscure gastrointestinal bleeding? Emergency DBE is feasible, safe, and effective in acute OGIB, often avoiding major surgery through successful diagnosis and treatment.",1.1842986367842661e-07,0.09624107065990772,0.024375,0.009067132323909363,0.13353139262452274,0.0,0.00905400770476434,0.13720112151348252,0.0,1.1842986367842703e-07,0.14107859825990632,0.0
65,0.3,7,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients.","Does emergency double-balloon enteroscopy with real-time capsule endoscopy provide a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Emergency DBE is practical, safe, and effective in acute OGIB and may help avoid major surgery by diagnosing and treating most patients.",4.7371945471370706e-08,0.051744372245857484,0.001248268698060953,0.0036268529295637453,0.051293294387549704,0.0,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
65,0.3,8,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients.","Is emergency double-balloon enteroscopy paired with real-time capsule endoscopy a feasible and effective approach in acute overt-obscure gastrointestinal bleeding? Emergency DBE is safe, feasible, and effective in acute OGIB, potentially preventing major surgery by diagnosing and treating most cases.",7.1057918207056e-08,0.11513671050120466,0.02809413580246914,0.005440279394345618,0.07796154146971057,0.0,0.0054324046228586,0.08004270767353416,0.0,7.105791820705622e-08,0.08223809823697303,0.0
65,0.3,9,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients.","Can emergency double-balloon enteroscopy integrated with real-time capsule endoscopy viewing be an effective combined approach for acute overt-obscure gastrointestinal bleeding? Emergency DBE is feasible, safe, and effective in acute OGIB, often avoiding the need for major surgery by diagnosing and treating most patients.",2.3685972735685406e-08,0.057909609167349885,0.024375,0.0018134264647818726,0.0246926125903717,0.0,0.0018108015409528666,0.02531780798429173,0.0,2.3685972735685406e-08,0.025975486403257975,0.0
65,0.3,10,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients.","Is emergency double-balloon enteroscopy along with real-time capsule endoscopy a feasible and safe approach in acute overt-obscure gastrointestinal bleeding? Emergency DBE is effective, safe, and feasible in acute OGIB and may prevent major surgery by successfully diagnosing and treating most patients.",2.3685972735685406e-08,0.025537914030078213,0.0006085634451019201,0.0018134264647818726,0.02531780798429173,0.0,0.0018108015409528666,0.025975486403257975,0.0,2.3685972735685406e-08,0.026668247082160867,0.0
66,0.3,1,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke,",Does sex affect the response to intravenous thrombolysis in ischemic stroke? Data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register indicate that intravenous thrombolysis might alter the survival and recovery benefits typically seen in men during the natural progression of ischemic stroke.,4.737194547137081e-08,0.04582161865889667,0.0009865860091207122,0.0036268529295637453,0.04546237407675724,0.0,0.003621603081905733,0.04652001563489394,0.0,4.737194547137081e-08,0.047628048989254435,0.0
66,0.3,2,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke,",Is the response to intravenous thrombolysis in ischemic stroke influenced by sex? Evidence from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggests that intravenous thrombolysis could change the survival and recovery advantage usually observed in men with ischemic stroke.,1.1842986367842703e-07,0.1187445534356879,0.002646604938271603,0.009067132323909363,0.11778303565638337,0.0,0.009054007704764333,0.12062798778861739,0.0,1.1842986367842703e-07,0.12361395596717584,0.0
66,0.3,3,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke,","Does gender impact the effectiveness of intravenous thrombolysis in ischemic stroke? According to data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register, intravenous thrombolysis may modify the expected survival and recovery benefits for men in ischemic stroke's natural course.",1.1842986367842703e-07,0.15255661102397777,0.026923807436627943,0.009067132323909363,0.11778303565638337,0.0,0.009054007704764333,0.12062798778861739,0.0,1.1842986367842703e-07,0.12361395596717584,0.0
66,0.3,4,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke,",Is intravenous thrombolysis response in ischemic stroke affected by sex? Findings from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis might influence the survival and recovery advantage typically seen in men during ischemic stroke.,1.6580180914979774e-07,0.1704889256815454,0.003894873636332556,0.012693985253473108,0.16907633004393308,0.0,0.012675610786670066,0.17327172127403623,0.0,1.6580180914979784e-07,0.17768117723745203,0.0
66,0.3,5,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke,",Does sex play a role in the response to intravenous thrombolysis for ischemic stroke? Data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register imply that intravenous thrombolysis may alter the survival and recovery benefits usually expected for men in ischemic stroke.,7.105791820705622e-08,0.06954385060511781,0.0015142353237591263,0.005440279394345618,0.06899287148695166,0.0,0.0054324046228586,0.07061756721395396,0.0,7.105791820705622e-08,0.07232066157962613,0.0
66,0.3,6,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke,",Is there a sex difference in response to intravenous thrombolysis in ischemic stroke? The Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register data suggest that intravenous thrombolysis could modify the survival and recovery advantage commonly observed in men during ischemic stroke.,1.1842986367842703e-07,0.1187445534356879,0.002646604938271603,0.009067132323909363,0.11778303565638337,0.0,0.009054007704764333,0.12062798778861739,0.0,1.1842986367842703e-07,0.12361395596717584,0.0
66,0.3,7,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke,",Does intravenous thrombolysis response in ischemic stroke vary by sex? Data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register indicate that intravenous thrombolysis may change the survival and recovery benefits typically expected for men.,2.3685972735685364e-07,0.25349380079337047,0.006026706979087932,0.018134264647818726,0.2513144282809061,0.0,0.018108015409528673,0.2578291093020999,0.0,2.3685972735685406e-07,0.26469255422708216,0.0
66,0.3,8,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke,","Is the effect of intravenous thrombolysis on ischemic stroke influenced by sex? According to the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register, intravenous thrombolysis might modify the survival and recovery advantage usually seen in men.",2.3685972735685364e-07,0.25349380079337047,0.006026706979087932,0.018134264647818726,0.2513144282809061,0.0,0.018108015409528673,0.2578291093020999,0.0,2.3685972735685406e-07,0.26469255422708216,0.0
66,0.3,9,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke,",Does sex influence outcomes after intravenous thrombolysis in ischemic stroke? Data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may alter the survival and recovery benefits men typically experience in ischemic stroke.,1.8948778188548304e-07,0.23388126393689257,0.030740740740740742,0.014507411718254981,0.19574457712609394,0.0,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
66,0.3,10,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke,",Is the response to intravenous thrombolysis in ischemic stroke sex-dependent? Evidence from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggests that intravenous thrombolysis may modify the survival and recovery advantage expected for men in the natural course of ischemic stroke.,9.474389094274162e-08,0.0938419528664296,0.0020669648430901577,0.0072537058591274906,0.09309042306601167,0.0,0.007243206163811466,0.09531017980432566,0.0,9.474389094274162e-08,0.09763846956391786,0.0
67,0.3,1,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers do not release gamma-aminobutyric acid (GABA). Mossy fibers are a type of nerve fiber found in the cerebellum that release the neurotransmitter glutamate. GABA is primarily released by inhibitory neurons in the brain.","Do mossy fibers secrete GABA? No, mossy fibers do not secrete gamma-aminobutyric acid (GABA). Instead, they are cerebellar nerve fibers that release glutamate as their neurotransmitter. GABA is mainly released by inhibitory neurons in the brain.",1.6580180914979731e-07,0.11045065218013583,0.09374125563904646,0.012693985253473115,0.18721154208814594,0.0,0.01267561078667008,0.19237189264745602,0.0,1.6580180914979784e-07,0.19782574332991798,0.0
67,0.3,2,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers do not release gamma-aminobutyric acid (GABA). Mossy fibers are a type of nerve fiber found in the cerebellum that release the neurotransmitter glutamate. GABA is primarily released by inhibitory neurons in the brain.","Are GABA neurotransmitters released by mossy fibers? No, mossy fibers do not release gamma-aminobutyric acid (GABA). These fibers, located in the cerebellum, release glutamate. GABA is predominantly released by inhibitory neurons in the brain.",2.1317375462116791e-07,0.21370058195323027,0.06193417031486354,0.016320838183036875,0.2478361639045814,0.0,0.016297213868575827,0.25489224962878954,0.0,2.1317375462116866e-07,0.2623642644674895,0.0
67,0.3,3,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers do not release gamma-aminobutyric acid (GABA). Mossy fibers are a type of nerve fiber found in the cerebellum that release the neurotransmitter glutamate. GABA is primarily released by inhibitory neurons in the brain.","Is GABA released by mossy fibers? No, mossy fibers do not release gamma-aminobutyric acid (GABA). They are nerve fibers in the cerebellum that release glutamate, while GABA is mainly released by inhibitory neurons in the brain.",1.6580180914979731e-07,0.15005906249784662,0.06535500241793951,0.012693985253473115,0.18721154208814594,0.0,0.01267561078667008,0.19237189264745602,0.0,1.6580180914979784e-07,0.19782574332991798,0.0
67,0.3,4,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers do not release gamma-aminobutyric acid (GABA). Mossy fibers are a type of nerve fiber found in the cerebellum that release the neurotransmitter glutamate. GABA is primarily released by inhibitory neurons in the brain.","Do mossy fibers emit GABA? No, mossy fibers do not emit gamma-aminobutyric acid (GABA). They are cerebellar nerve fibers that release glutamate, whereas GABA is primarily released by inhibitory neurons in the brain.",2.3685972735685321e-07,0.20377609933710916,0.09107048665201231,0.018134264647818754,0.27958486221916123,0.0,0.0181080154095287,0.28768207245178123,0.0,2.3685972735685406e-07,0.29626581614317127,0.0
67,0.3,5,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers do not release gamma-aminobutyric acid (GABA). Mossy fibers are a type of nerve fiber found in the cerebellum that release the neurotransmitter glutamate. GABA is primarily released by inhibitory neurons in the brain.","Are mossy fibers responsible for releasing GABA? No, mossy fibers do not release gamma-aminobutyric acid (GABA). They release glutamate in the cerebellum, while GABA is released mainly by inhibitory neurons in the brain.",2.3685972735685321e-07,0.24709779812210586,0.0600657462195924,0.018134264647818754,0.27958486221916123,0.0,0.0181080154095287,0.28768207245178123,0.0,2.3685972735685406e-07,0.29626581614317127,0.0
67,0.3,6,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers do not release gamma-aminobutyric acid (GABA). Mossy fibers are a type of nerve fiber found in the cerebellum that release the neurotransmitter glutamate. GABA is primarily released by inhibitory neurons in the brain.","Do mossy fibers discharge GABA? No, mossy fibers do not discharge gamma-aminobutyric acid (GABA). Instead, they release glutamate in the cerebellum. GABA is chiefly released by inhibitory neurons in the brain.",2.842316728282238e-07,0.3174125457643422,0.055961437829569735,0.021761117577382513,0.3462762367178347,0.0,0.021729618491434448,0.356674943938732,0.0,2.8423167282822487e-07,0.36772478012531495,0.0
67,0.3,7,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers do not release gamma-aminobutyric acid (GABA). Mossy fibers are a type of nerve fiber found in the cerebellum that release the neurotransmitter glutamate. GABA is primarily released by inhibitory neurons in the brain.","Is GABA a neurotransmitter released by mossy fibers? No, mossy fibers do not release gamma-aminobutyric acid (GABA). They are cerebellar fibers that release glutamate, with GABA being released mainly by inhibitory neurons in the brain.",1.8948778188548261e-07,0.09982977873567611,0.12228796844181462,0.014507411718254995,0.21706450523782772,0.0,0.014486412327622954,0.2231435513142097,0.0,1.8948778188548325e-07,0.2295744416444978,0.0
67,0.3,8,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers do not release gamma-aminobutyric acid (GABA). Mossy fibers are a type of nerve fiber found in the cerebellum that release the neurotransmitter glutamate. GABA is primarily released by inhibitory neurons in the brain.","Do mossy fibers produce GABA? No, mossy fibers do not produce gamma-aminobutyric acid (GABA). They release glutamate in the cerebellum, while GABA is primarily released by inhibitory neurons in the brain.",2.842316728282238e-07,0.3174125457643422,0.05596143782956975,0.021761117577382513,0.3462762367178347,0.0,0.021729618491434448,0.356674943938732,0.0,2.8423167282822487e-07,0.36772478012531495,0.0
67,0.3,9,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers do not release gamma-aminobutyric acid (GABA). Mossy fibers are a type of nerve fiber found in the cerebellum that release the neurotransmitter glutamate. GABA is primarily released by inhibitory neurons in the brain.","Are mossy fibers the source of GABA release? No, mossy fibers are not the source of gamma-aminobutyric acid (GABA) release. They release glutamate in the cerebellum, whereas GABA is mostly released by inhibitory neurons in the brain.",1.42115836414112e-07,0.19670407168682758,0.012912968441814623,0.010880558788691236,0.19783241553260567,0.02854671280276816,0.010864809245717207,0.16251892949777424,0.0,1.4211583641411244e-07,0.1670540846631643,0.0
67,0.3,10,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers do not release gamma-aminobutyric acid (GABA). Mossy fibers are a type of nerve fiber found in the cerebellum that release the neurotransmitter glutamate. GABA is primarily released by inhibitory neurons in the brain.","Do mossy fibers release the neurotransmitter GABA? No, mossy fibers do not release gamma-aminobutyric acid (GABA). They are cerebellar nerve fibers that release glutamate, with GABA being mainly released by inhibitory neurons in the brain.",1.8948778188548261e-07,0.14060314229802584,0.09290321178433068,0.014507411718254995,0.21706450523782772,0.0,0.014486412327622954,0.2231435513142097,0.0,1.8948778188548325e-07,0.2295744416444978,0.0
68,0.3,1,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Assessing living arrangements is essential for understanding and clarifying gender disparities in mortality risks related to marital status. The effects of living alone versus living with a partner appear to",0.0,0.032239403746974205,0.023242630385487524,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
68,0.3,2,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Examining living arrangements plays a key role in identifying and explaining gender-related differences in mortality risks associated with marital status. The influence of living alone compared to living with a partner seems to",7.105791820705622e-08,0.09968068454250645,0.023242630385487524,0.005440279394345618,0.06899287148695166,0.0,0.0054324046228586,0.07061756721395396,0.0,7.105791820705622e-08,0.07232066157962613,0.0
68,0.3,3,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Analyzing living arrangements is vital for detecting and interpreting gender differences in mortality risks linked to marital status. The impact of living alone and cohabiting with a partner appears to",0.0,0.032239403746974205,0.023242630385487524,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
68,0.3,4,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Understanding living arrangements is important for recognizing and explaining gender variations in mortality risks by marital status. The effect of living alone versus living with a partner seems to",2.3685972735685406e-08,0.008708906336779787,0.023242630385487524,0.0018134264647818726,0.024097551579060017,0.0,0.0018108015409528666,0.0246926125903717,0.0,2.3685972735685406e-08,0.02531780798429173,0.0
68,0.3,5,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluating living arrangements is critical for identifying and elucidating gender disparities in mortality risks related to marital status. The consequences of living alone and living with a partner seem to",0.0,0.032239403746974205,0.023242630385487524,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
68,0.3,6,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Assessing living arrangements is fundamental for uncovering and explaining gender differences in mortality risks by marital status. The influence of living alone and living with a partner appears to",2.3685972735685406e-08,0.008708906336779787,0.023242630385487524,0.0018134264647818726,0.024097551579060017,0.0,0.0018108015409528666,0.0246926125903717,0.0,2.3685972735685406e-08,0.02531780798429173,0.0
68,0.3,7,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Investigating living arrangements is crucial for detecting and clarifying gender differences in mortality risks associated with marital status. The impact of living alone compared to living with a partner seems to",2.3685972735685406e-08,0.05522892197167373,0.023242630385487524,0.0018134264647818726,0.023530497410194418,0.0,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
68,0.3,8,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Considering living arrangements is essential for identifying and explaining gender disparities in mortality risks linked to marital status. The effect of living alone and living with a partner appears to",0.0,0.032239403746974205,0.023242630385487524,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
68,0.3,9,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Reviewing living arrangements is important for recognizing and interpreting gender differences in mortality risks by marital status. The consequences of living alone versus living with a partner seem to",2.3685972735685406e-08,0.008708906336779787,0.023242630385487524,0.0018134264647818726,0.024097551579060017,0.0,0.0018108015409528666,0.0246926125903717,0.0,2.3685972735685406e-08,0.02531780798429173,0.0
68,0.3,10,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Exploring living arrangements is vital for understanding and explaining gender variations in mortality risks related to marital status. The impact of living alone and living with a partner appears to",0.0,0.032239403746974205,0.023242630385487524,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
69,0.3,1,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Preventing osteoporosis may not be the sole solution to eliminating aromatase inhibitor-related musculoskeletal symptoms. While maintaining bone health is important, addressing other factors such as inflammation, hormonal imbalances, and individual patient characteristics may also play a significant role in managing these symptoms effectively.","Is preventing osteoporosis the main strategy to eliminate musculoskeletal symptoms caused by aromatase inhibitors? Preventing osteoporosis alone might not fully resolve these symptoms. Although bone health is crucial, factors like inflammation, hormonal changes, and individual patient differences are also important in managing these symptoms.",3.316036182995957e-07,0.2490461448195047,0.023374769082720202,0.025387970506946217,0.2629268160032119,0.017851239669421492,0.025351221573340132,0.2937611185281632,0.0,3.316036182995957e-07,0.30010459245033916,0.0
69,0.3,2,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Preventing osteoporosis may not be the sole solution to eliminating aromatase inhibitor-related musculoskeletal symptoms. While maintaining bone health is important, addressing other factors such as inflammation, hormonal imbalances, and individual patient characteristics may also play a significant role in managing these symptoms effectively.","Are aromatase inhibitor-related musculoskeletal symptoms best addressed by preventing osteoporosis? While bone preservation is vital, solely focusing on osteoporosis prevention may not eliminate these symptoms. Other elements such as inflammation, hormonal imbalances, and patient-specific factors contribute to effective symptom management.",4.263475092423372e-07,0.28220580688947416,0.06977572089711641,0.03264167636607371,0.3630102745601933,0.017851239669421492,0.0325944277371516,0.3964152725882455,0.0,4.263475092423373e-07,0.40546510810816505,0.0
69,0.3,3,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Preventing osteoporosis may not be the sole solution to eliminating aromatase inhibitor-related musculoskeletal symptoms. While maintaining bone health is important, addressing other factors such as inflammation, hormonal imbalances, and individual patient characteristics may also play a significant role in managing these symptoms effectively.","Does preventing osteoporosis hold the key to stopping musculoskeletal symptoms linked to aromatase inhibitors? Preventing osteoporosis may not be enough to eradicate these symptoms. Besides bone health, inflammation, hormonal fluctuations, and unique patient characteristics must be considered for effective treatment.",4.263475092423372e-07,0.3177518161489581,0.044152452199055454,0.03264167636607371,0.3630102745601933,0.017851239669421492,0.0325944277371516,0.3964152725882455,0.0,4.263475092423373e-07,0.40546510810816505,0.0
69,0.3,4,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Preventing osteoporosis may not be the sole solution to eliminating aromatase inhibitor-related musculoskeletal symptoms. While maintaining bone health is important, addressing other factors such as inflammation, hormonal imbalances, and individual patient characteristics may also play a significant role in managing these symptoms effectively.","Is osteoporosis prevention the key to overcoming musculoskeletal symptoms from aromatase inhibitors? Maintaining bone health is important, but it may not be the only factor. Inflammation, hormonal imbalances, and individual patient traits also significantly influence symptom management.",4.974054274493931e-07,0.36224851456300833,0.06977572089711641,0.038081955760419325,0.44524837279716634,0.017851239669421492,0.038026832360010206,0.48097266061630917,0.0,4.974054274493935e-07,0.4924764850977952,0.0
69,0.3,5,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Preventing osteoporosis may not be the sole solution to eliminating aromatase inhibitor-related musculoskeletal symptoms. While maintaining bone health is important, addressing other factors such as inflammation, hormonal imbalances, and individual patient characteristics may also play a significant role in managing these symptoms effectively.","Can stopping osteoporosis prevent musculoskeletal symptoms caused by aromatase inhibitors? Preventing osteoporosis alone might not be sufficient to eliminate these symptoms. Addressing inflammation, hormonal imbalances, and patient-specific factors is also crucial for effective management.",5.68463345656449e-07,0.44925989155263846,0.06977572089711641,0.043522235154764964,0.5348605314868533,0.017851239669421492,0.043459236982868826,0.5733459807473245,0.0,5.684633456564497e-07,0.5877866649021204,0.0
69,0.3,6,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Preventing osteoporosis may not be the sole solution to eliminating aromatase inhibitor-related musculoskeletal symptoms. While maintaining bone health is important, addressing other factors such as inflammation, hormonal imbalances, and individual patient characteristics may also play a significant role in managing these symptoms effectively.","Is the prevention of osteoporosis the solution to aromatase inhibitor-related musculoskeletal symptoms? While important, osteoporosis prevention may not fully address these symptoms. Other factors like inflammation, hormonal changes, and individual patient differences play a key role.",5.210914001850784e-07,0.3904193915297052,0.06977572089711641,0.039895382225201205,0.47423590967041784,0.017851239669421492,0.03983763390096308,0.5108256237659909,0.0,5.210914001850789e-07,0.5232481437645489,0.0
69,0.3,7,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Preventing osteoporosis may not be the sole solution to eliminating aromatase inhibitor-related musculoskeletal symptoms. While maintaining bone health is important, addressing other factors such as inflammation, hormonal imbalances, and individual patient characteristics may also play a significant role in managing these symptoms effectively.","Does preventing osteoporosis effectively eliminate musculoskeletal symptoms related to aromatase inhibitors? Osteoporosis prevention is important but might not be the sole answer. Managing inflammation, hormonal imbalances, and patient-specific characteristics is also essential.",6.158352911278196e-07,0.511780248533972,0.06977572089711641,0.04714908808432872,0.5993990526244248,0.017851239669421492,0.04708084006477457,0.6400373552459979,0.0,6.158352911278206e-07,0.6567795363890712,0.0
69,0.3,8,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Preventing osteoporosis may not be the sole solution to eliminating aromatase inhibitor-related musculoskeletal symptoms. While maintaining bone health is important, addressing other factors such as inflammation, hormonal imbalances, and individual patient characteristics may also play a significant role in managing these symptoms effectively.","Is the key to eliminating aromatase inhibitor-related musculoskeletal symptoms found in osteoporosis prevention? Preventing osteoporosis is important but may not completely resolve these symptoms. Other contributors such as inflammation, hormonal shifts, and individual patient factors are also important.",4.737194547137078e-07,0.334849540374893,0.06977572089711641,0.03626852929563745,0.4170774958304695,0.017851239669421492,0.03621603081905733,0.45198512374305766,0.0,4.737194547137081e-07,0.4626235219481134,0.0
69,0.3,9,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Preventing osteoporosis may not be the sole solution to eliminating aromatase inhibitor-related musculoskeletal symptoms. While maintaining bone health is important, addressing other factors such as inflammation, hormonal imbalances, and individual patient characteristics may also play a significant role in managing these symptoms effectively.","Is osteoporosis prevention enough to stop musculoskeletal symptoms caused by aromatase inhibitors? Maintaining bone health is critical but may not fully eliminate symptoms. Addressing inflammation, hormonal imbalances, and patient-specific factors is necessary.",6.158352911278196e-07,0.511780248533972,0.06977572089711641,0.04714908808432872,0.5993990526244248,0.017851239669421492,0.04708084006477457,0.6400373552459979,0.0,6.158352911278206e-07,0.6567795363890712,0.0
69,0.3,10,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Preventing osteoporosis may not be the sole solution to eliminating aromatase inhibitor-related musculoskeletal symptoms. While maintaining bone health is important, addressing other factors such as inflammation, hormonal imbalances, and individual patient characteristics may also play a significant role in managing these symptoms effectively.","Does preventing osteoporosis guarantee the elimination of musculoskeletal symptoms from aromatase inhibitors? While bone health maintenance is vital, it may not be sufficient alone. Other factors including inflammation, hormonal imbalances, and individual patient characteristics must be addressed.",4.974054274493931e-07,0.36224851456300833,0.06977572089711641,0.038081955760419325,0.44524837279716634,0.017851239669421492,0.038026832360010206,0.48097266061630917,0.0,4.974054274493935e-07,0.4924764850977952,0.0
70,0.3,1,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Is colorectal cancer in young patients a unique clinical entity? Colorectal cancer in young individuals might represent a distinct clinical entity. Additional studies are required to confirm our observations and determine the best treatment strategy for this group.,4.73719454713706e-08,0.05840795120317477,0.004060938100730452,0.0036268529295637453,0.09460214411003953,0.0290667549622006,0.003621603081905733,0.0951782614725234,0.02854671280276816,4.737194547137081e-08,0.05715841383994835,0.0
70,0.3,2,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Does colorectal cancer in young patients represent a separate clinical entity? Colorectal cancer among younger patients could be a distinct clinical entity. More research is necessary to verify our results and establish the ideal management for this population.,4.73719454713706e-08,0.0165268791276314,0.04938271604938273,0.0036268529295637453,0.017585790714489846,0.026296566837107373,0.003621603081905733,0.055569851154812167,0.0,4.737194547137081e-08,0.05715841383994835,0.0
70,0.3,3,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Is colorectal cancer in young people a different clinical entity? Colorectal cancer in young patients may be considered a distinct clinical entity. Further investigation is essential to validate these findings and identify the optimal approach for this demographic.,4.73719454713706e-08,0.05840795120317477,0.004060938100730452,0.0036268529295637453,0.09460214411003953,0.0290667549622006,0.003621603081905733,0.0951782614725234,0.02854671280276816,4.737194547137081e-08,0.05715841383994835,0.0
70,0.3,4,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Could colorectal cancer in young patients be a distinct clinical entity? Colorectal cancer in younger individuals might constitute a unique clinical entity. Additional research is needed to confirm our findings and define the best treatment approach for this group.,2.36859727356853e-08,0.0076996802636215556,0.023919753086419755,0.0018134264647818726,0.027654231691776943,0.000709606002398791,0.0018108015409528666,0.02739897418811532,0.0,2.3685972735685406e-08,0.028170876966696845,0.0
70,0.3,5,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Is colorectal cancer in young patients a separate clinical entity? Colorectal cancer among young patients may represent a distinct clinical entity. Further studies are required to validate our findings and determine the optimal management in this population.,7.10579182070559e-08,0.05042103329063119,0.02102556708958092,0.005440279394345618,0.04575666768118669,0.026296566837107373,0.005432404622858607,0.08455738802806367,0.0,7.105791820705622e-08,0.08701137698963013,0.0
70,0.3,6,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Is colorectal cancer in young individuals a distinct clinical entity? Colorectal cancer in young patients might be a unique clinical entity. More research is needed to confirm our findings and establish the best approach for this group.,7.10579182070559e-08,0.08892920998840603,0.006255739210284647,0.005440279394345618,0.1249734883166087,0.03063639918676773,0.005432404622858607,0.1253307515904134,0.029384756657483937,7.105791820705622e-08,0.08701137698963013,0.0
70,0.3,7,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Is colorectal cancer in young patients a distinct clinical condition? Colorectal cancer among young patients may constitute a unique clinical entity. Further research is necessary to validate our findings and define the optimal treatment strategy for this population.,4.73719454713706e-08,0.020940536037771906,0.022511337868480717,0.0036268529295637453,0.017585790714489846,0.026296566837107373,0.003621603081905733,0.055569851154812167,0.0,4.737194547137081e-08,0.05715841383994835,0.0
70,0.3,8,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Is colorectal cancer in young patients a unique clinical entity? Colorectal cancer in young individuals could represent a distinct clinical entity. Additional studies are needed to confirm our observations and determine the best management approach for this group.,4.73719454713706e-08,0.05840795120317477,0.004060938100730452,0.0036268529295637453,0.09460214411003953,0.0290667549622006,0.003621603081905733,0.0951782614725234,0.02854671280276816,4.737194547137081e-08,0.05715841383994835,0.0
70,0.3,9,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Is colorectal cancer in young patients a distinct clinical syndrome? Colorectal cancer among young patients may be a distinct clinical entity. Further research is essential to validate our findings and identify the optimal approach for this population.,7.10579182070559e-08,0.12743738668618088,0.032986111111111105,0.005440279394345618,0.08536507799889792,0.002250145965660786,0.005432404622858607,0.08455738802806367,0.0,7.105791820705622e-08,0.08701137698963013,0.0
70,0.3,10,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Is colorectal cancer in young patients a different clinical entity? Colorectal cancer in young patients might constitute a distinct clinical entity. More investigation is required to confirm our findings and establish the best treatment strategy for this group.,4.73719454713706e-08,0.09587536636857719,0.030130853994490336,0.0036268529295637453,0.13311032080781438,0.056348061262066165,0.003621603081905733,0.13478667179023418,0.056932966023875105,4.737194547137081e-08,0.09793177740229808,0.029384756657483937
71,0.3,1,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Does septoplasty alter the size of compensatory hypertrophy in the middle turbinate? Answer: The current study indicates that septoplasty does not impact compensatory hypertrophy of the middle turbinate, even after one year.",4.73719454713706e-08,0.015825434862968724,0.053333333333333365,0.003626852929563759,0.06350640312047462,0.09000000000000004,0.003621603081905747,0.02210487643242276,0.06222222222222223,4.737194547137081e-08,0.021972201559322446,0.0322222222222222
71,0.3,2,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Is the dimension of compensatory hypertrophy of the middle turbinate changed by septoplasty? Answer: Findings from this study suggest that septoplasty does not affect the compensatory hypertrophy of the middle turbinate, even after a year.",2.36859727356853e-08,0.03364734985180551,0.0031726211122673764,0.0018134264647818796,0.03355963256444161,0.0025910509885536254,0.0018108015409528735,0.03339721616887559,0.0018684240952711456,2.3685972735685406e-08,0.033146172468933255,0.0010047404324198955
71,0.3,3,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Does septoplasty modify the compensatory hypertrophy dimensions of the middle turbinate? Answer: According to the present study, septoplasty does not influence compensatory hypertrophy of the middle turbinate, even after one year.",7.10579182070559e-08,0.06343738469967075,0.01989229024943312,0.005440279394345639,0.015493231739846625,0.05670630202140312,0.005432404622858621,0.011796675243259003,0.06222222222222223,7.105791820705622e-08,0.05706352137059145,0.0322222222222222
71,0.3,4,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Can septoplasty alter the size of the middle turbinate's compensatory hypertrophy? Answer: The study's results suggest that compensatory hypertrophy of the middle turbinate remains unchanged by septoplasty, even after one year.",7.10579182070559e-08,0.018718211760319292,0.05134628088254728,0.005440279394345639,0.015493231739846625,0.05670630202140312,0.005432404622858621,0.011796675243259003,0.06222222222222223,7.105791820705622e-08,0.05706352137059145,0.0322222222222222
71,0.3,5,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Does septoplasty impact the dimensions of compensatory hypertrophy in the middle turbinate? Answer: The findings from this study show that septoplasty does not affect the compensatory hypertrophy of the middle turbinate, even after a year.",2.36859727356853e-08,0.11286417048722797,0.05862258953168049,0.0018134264647818796,0.1558797232514899,0.09000000000000004,0.0018108015409528735,0.11741505623674797,0.06222222222222223,2.3685972735685406e-08,0.07646787125393084,0.0322222222222222
71,0.3,6,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Is compensatory hypertrophy of the middle turbinate affected by septoplasty in terms of size? Answer: The present study suggests that septoplasty does not change the compensatory hypertrophy of the middle turbinate, even after one year.",2.36859727356853e-08,0.03364734985180551,0.0031726211122673764,0.0018134264647818796,0.03355963256444161,0.0025910509885536254,0.0018108015409528735,0.03339721616887559,0.0018684240952711456,2.3685972735685406e-08,0.033146172468933255,0.0010047404324198955
71,0.3,7,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Does septoplasty influence the size of compensatory hypertrophy of the middle turbinate? Answer: This study's findings indicate that compensatory hypertrophy of the middle turbinate is not altered by septoplasty, even after one year.",2.36859727356853e-08,0.03479518903602763,0.0033505086537191087,0.0018134264647818796,0.03470999491993654,0.002746730083234214,0.0018108015409528735,0.034543646623288016,0.001987052450786085,2.3685972735685406e-08,0.03428046192097023,0.0010714757563747151
71,0.3,8,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Does septoplasty cause changes in the compensatory hypertrophy dimensions of the middle turbinate? Answer: The current study suggests no effect of septoplasty on compensatory hypertrophy of the middle turbinate, even after one year.",2.36859727356853e-08,0.007213730997908563,0.025555555555555554,0.0018134264647818796,0.05193340265005686,0.05878251821019773,0.0018108015409528735,0.05489469925541446,0.06222222222222223,2.3685972735685406e-08,0.011929350116359316,0.0322222222222222
71,0.3,9,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Is the compensatory hypertrophy of the middle turbinate dimensionally changed by septoplasty? Answer: According to the study, septoplasty does not affect the size of compensatory hypertrophy of the middle turbinate, even after one year.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
71,0.3,10,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Does septoplasty result in changes to the size of compensatory hypertrophy of the middle turbinate? Answer: The study findings suggest that compensatory hypertrophy of the middle turbinate remains unaffected by septoplasty, even after one year.",2.36859727356853e-08,0.03364734985180551,0.0031726211122673764,0.0018134264647818796,0.03355963256444161,0.0025910509885536254,0.0018108015409528735,0.03339721616887559,0.0018684240952711456,2.3685972735685406e-08,0.033146172468933255,0.0010047404324198955
72,0.3,1,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics can influence the uptake of an IT innovation in primary care. Factors such as the size of the practice, the presence of IT infrastructure, and the attitudes and beliefs of healthcare professionals can all impact the adoption and implementation of new technology.","Question: Do the attributes of general practices affect the adoption of IT innovations in primary care? Answer: Yes, characteristics of general practices can affect how IT innovations are adopted in primary care. Elements like practice size, existing IT infrastructure, and healthcare professionals' attitudes and beliefs play a role in technology adoption and implementation.",2.3685972735685406e-07,0.14837117542406242,0.01927437641723359,0.018134264647818726,0.13805206262126735,0.0294487514863258,0.018108015409528666,0.182321556793954,0.0,2.3685972735685406e-07,0.1857171457950919,0.0
72,0.3,2,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics can influence the uptake of an IT innovation in primary care. Factors such as the size of the practice, the presence of IT infrastructure, and the attitudes and beliefs of healthcare professionals can all impact the adoption and implementation of new technology.","Question: Can general practice features influence the uptake of IT innovations in primary care? Answer: Yes, the features of general practices can influence the adoption of IT innovations in primary care. Factors including the size of the practice, available IT infrastructure, and the perspectives of healthcare providers impact the implementation of new technology.",2.3685972735685406e-07,0.17503068236867492,0.0005976247447824767,0.018134264647818726,0.19241654737106728,0.009544998513674206,0.018108015409528666,0.23777333123874955,0.039930555555555566,2.3685972735685406e-07,0.2140088674506,0.020399305555555556
72,0.3,3,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics can influence the uptake of an IT innovation in primary care. Factors such as the size of the practice, the presence of IT infrastructure, and the attitudes and beliefs of healthcare professionals can all impact the adoption and implementation of new technology.","Question: Are general practice traits a factor in the adoption of IT innovations in primary care? Answer: Yes, traits of general practices can affect the uptake of IT innovations in primary care. Variables such as practice size, IT infrastructure presence, and healthcare professionals' beliefs and attitudes influence technology adoption.",3.316036182995957e-07,0.23730038541246978,0.013018637206948902,0.025387970506946217,0.28103472537467056,0.014484306364913858,0.025351221573340132,0.3259768336077826,0.043388429752066124,3.316036182995957e-07,0.3016814954936189,0.02221074380165289
72,0.3,4,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics can influence the uptake of an IT innovation in primary care. Factors such as the size of the practice, the presence of IT infrastructure, and the attitudes and beliefs of healthcare professionals can all impact the adoption and implementation of new technology.","Question: Does the nature of general practices affect the uptake of IT innovations in primary care? Answer: Yes, the nature of general practices can influence the adoption of IT innovations. Aspects like practice size, IT infrastructure availability, and healthcare workers' attitudes and beliefs impact the implementation process.",3.789755637709665e-07,0.3150196394248863,0.011415854265561062,0.029014823436509962,0.32845258727503257,0.017277779125919095,0.028972824655245866,0.37316830835474235,0.045351473922902494,3.789755637709665e-07,0.34857673195913064,0.023242630385487524
72,0.3,5,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics can influence the uptake of an IT innovation in primary care. Factors such as the size of the practice, the presence of IT infrastructure, and the attitudes and beliefs of healthcare professionals can all impact the adoption and implementation of new technology.","Question: Do characteristics of general practices impact the adoption of IT innovations in primary care? Answer: Yes, characteristics such as practice size, IT infrastructure, and healthcare professionals' attitudes and beliefs can influence the uptake and implementation of IT innovations in primary care.",4.974054274493935e-07,0.41465302987588837,0.000757479763271271,0.038081955760419325,0.4577880759407478,0.02545818788547844,0.0380268323600102,0.5018749346114233,0.05113221329437545,4.974054274493935e-07,0.4764327147351186,0.026296566837107373
72,0.3,6,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics can influence the uptake of an IT innovation in primary care. Factors such as the size of the practice, the presence of IT infrastructure, and the attitudes and beliefs of healthcare professionals can all impact the adoption and implementation of new technology.","Question: Can the features of general practices affect the adoption of IT innovations in primary care? Answer: Yes, features including the size of the practice, the presence of IT infrastructure, and the attitudes and beliefs of healthcare professionals can affect the uptake of new technology in primary care.",3.552895910352811e-07,0.2313161386310143,0.03213020745488282,0.02720139697172809,0.21405405648159848,0.049048751486325794,0.027162023114293,0.2876820724517799,0.0,3.552895910352811e-07,0.2933478099874569,0.0
72,0.3,7,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics can influence the uptake of an IT innovation in primary care. Factors such as the size of the practice, the presence of IT infrastructure, and the attitudes and beliefs of healthcare professionals can all impact the adoption and implementation of new technology.","Question: Are the characteristics of general practices influential in the uptake of IT innovations in primary care? Answer: Yes, general practice characteristics like size, IT infrastructure, and healthcare professionals' attitudes and beliefs can influence the adoption and implementation of IT innovations.",5.210914001850789e-07,0.338754771141097,0.07067970186102054,0.0398953822252012,0.3791338068410486,0.049048751486325794,0.039837633900963065,0.456758402495713,0.0,5.210914001850789e-07,0.46661953126149314,0.0
72,0.3,8,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics can influence the uptake of an IT innovation in primary care. Factors such as the size of the practice, the presence of IT infrastructure, and the attitudes and beliefs of healthcare professionals can all impact the adoption and implementation of new technology.","Question: Does the size and IT infrastructure of general practices influence the adoption of IT innovations in primary care? Answer: Yes, factors such as practice size, IT infrastructure, and healthcare professionals' beliefs and attitudes can impact the uptake of IT innovations in primary care.",4.500334819780227e-07,0.36073436552137084,0.0036185578767996412,0.03445510283085558,0.4040468604816039,0.021957165673437508,0.034405229278104466,0.4483966106943713,0.04865220249835634,4.500334819780227e-07,0.42331534881977895,0.02498356344510192
72,0.3,9,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics can influence the uptake of an IT innovation in primary care. Factors such as the size of the practice, the presence of IT infrastructure, and the attitudes and beliefs of healthcare professionals can all impact the adoption and implementation of new technology.","Question: Do general practice characteristics play a role in the adoption of IT innovations in primary care? Answer: Yes, characteristics including practice size, IT infrastructure, and healthcare professionals' attitudes and beliefs contribute to the uptake and implementation of IT innovations.",5.447773729207642e-07,0.36496122935687625,0.07003999660806151,0.04170880868998307,0.40510929324430656,0.049048751486325794,0.04164843544191593,0.48342664957787385,0.0,5.447773729207643e-07,0.49401850544960846,0.0
72,0.3,10,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics can influence the uptake of an IT innovation in primary care. Factors such as the size of the practice, the presence of IT infrastructure, and the attitudes and beliefs of healthcare professionals can all impact the adoption and implementation of new technology.","Question: Is the uptake of IT innovations in primary care influenced by general practice characteristics? Answer: Yes, general practice characteristics like size, IT infrastructure, and healthcare professionals' attitudes and beliefs influence the adoption and implementation of IT innovations in primary care.",5.210914001850789e-07,0.47738420725308606,0.02678571428571426,0.0398953822252012,0.4857718346195008,0.0273401374025631,0.039837633900963065,0.5297212636072861,0.05246913580246914,5.210914001850789e-07,0.5040869464268956,0.027006172839506164
73,0.3,1,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: The fragility of the esophageal mucosa may be a significant endoscopic sign of primary eosinophilic esophagitis, indicating potential damage and inflammation in the esophagus. However, further diagnostic tests and evaluations are necessary to confirm the diagnosis.","The fragility of the esophageal mucosa could serve as an important endoscopic indicator of primary eosinophilic esophagitis, reflecting possible esophageal damage and inflammation, though additional diagnostic procedures are required for confirmation.",4.7371945471370706e-07,0.3167444132092059,0.13628988642509465,0.036268529295637494,0.3830658598466137,0.10072314049586774,0.03621603081905738,0.45235310316269395,0.06222222222222221,4.737194547137081e-07,0.5248151110010499,0.0212665406427221
73,0.3,2,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: The fragility of the esophageal mucosa may be a significant endoscopic sign of primary eosinophilic esophagitis, indicating potential damage and inflammation in the esophagus. However, further diagnostic tests and evaluations are necessary to confirm the diagnosis.","Fragility in the esophageal mucosa might be a key endoscopic sign pointing to primary eosinophilic esophagitis, suggesting underlying damage and inflammation, but further tests are needed to verify the diagnosis.",4.974054274493924e-07,0.35064596488488764,0.13628988642509465,0.038081955760419374,0.4181571796578827,0.10072314049586774,0.038026832360010254,0.48872074733356863,0.06222222222222221,4.974054274493935e-07,0.5625554389838969,0.0212665406427221
73,0.3,3,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: The fragility of the esophageal mucosa may be a significant endoscopic sign of primary eosinophilic esophagitis, indicating potential damage and inflammation in the esophagus. However, further diagnostic tests and evaluations are necessary to confirm the diagnosis.","Esophageal mucosal fragility may represent a notable endoscopic marker of primary eosinophilic esophagitis, indicating potential esophageal injury and inflammation; however, confirmation demands more diagnostic evaluation.",6.158352911278189e-07,0.5398879645234156,0.13628988642509465,0.04714908808432877,0.6148674739039373,0.10072314049586774,0.04708084006477462,0.6935151599795826,0.06222222222222221,6.158352911278206e-07,0.7761295392819578,0.0212665406427221
73,0.3,4,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: The fragility of the esophageal mucosa may be a significant endoscopic sign of primary eosinophilic esophagitis, indicating potential damage and inflammation in the esophagus. However, further diagnostic tests and evaluations are necessary to confirm the diagnosis.","The presence of fragile esophageal mucosa might be a distinctive endoscopic feature of primary eosinophilic esophagitis, signifying possible inflammation and damage, yet further diagnostic assessments are essential to establish the diagnosis.",4.7371945471370706e-07,0.3167444132092059,0.13628988642509465,0.036268529295637494,0.3830658598466137,0.10072314049586774,0.03621603081905738,0.45235310316269395,0.06222222222222221,4.737194547137081e-07,0.5248151110010499,0.0212665406427221
73,0.3,5,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: The fragility of the esophageal mucosa may be a significant endoscopic sign of primary eosinophilic esophagitis, indicating potential damage and inflammation in the esophagus. However, further diagnostic tests and evaluations are necessary to confirm the diagnosis.","Fragile esophageal mucosa can be an important endoscopic sign of primary eosinophilic esophagitis, highlighting possible esophageal inflammation and injury, but additional diagnostic testing is necessary to confirm this.",5.44777372920763e-07,0.4221049288670313,0.13628988642509465,0.04170880868998313,0.49226515181160435,0.10072314049586774,0.041648435441916,0.5656817884696981,0.06222222222222221,5.447773729207643e-07,0.6425981466574342,0.0212665406427221
73,0.3,6,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: The fragility of the esophageal mucosa may be a significant endoscopic sign of primary eosinophilic esophagitis, indicating potential damage and inflammation in the esophagus. However, further diagnostic tests and evaluations are necessary to confirm the diagnosis.","Fragility observed in the esophageal mucosa may act as a pathognomonic endoscopic sign of primary eosinophilic esophagitis, indicating inflammation and damage, although further diagnostic workup is required for confirmation.",5.210914001850777e-07,0.38573728469615665,0.13628988642509465,0.039895382225201254,0.45452482382875736,0.10072314049586774,0.03983763390096313,0.5264610753164156,0.06222222222222221,5.210914001850789e-07,0.6017761521371794,0.0212665406427221
73,0.3,7,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: The fragility of the esophageal mucosa may be a significant endoscopic sign of primary eosinophilic esophagitis, indicating potential damage and inflammation in the esophagus. However, further diagnostic tests and evaluations are necessary to confirm the diagnosis.","The fragility of the esophageal lining might indicate primary eosinophilic esophagitis as a significant endoscopic sign, reflecting esophageal damage and inflammation, but further diagnostic evaluation is needed to confirm.",5.210914001850777e-07,0.38573728469615665,0.13628988642509465,0.039895382225201254,0.45452482382875736,0.10072314049586774,0.03983763390096313,0.5264610753164156,0.06222222222222221,5.210914001850789e-07,0.6017761521371794,0.0212665406427221
73,0.3,8,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: The fragility of the esophageal mucosa may be a significant endoscopic sign of primary eosinophilic esophagitis, indicating potential damage and inflammation in the esophagus. However, further diagnostic tests and evaluations are necessary to confirm the diagnosis.","Esophageal mucosal fragility could be a diagnostic endoscopic sign characteristic of primary eosinophilic esophagitis, suggesting inflammation and injury, though confirmation requires additional tests.",6.632072365991895e-07,0.6268993415130453,0.13628988642509465,0.05077594101389253,0.7058392521096652,0.10072314049586774,0.05070244314668037,0.7888253397839078,0.06222222222222221,6.632072365991913e-07,0.8762129978389392,0.0212665406427221
73,0.3,9,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: The fragility of the esophageal mucosa may be a significant endoscopic sign of primary eosinophilic esophagitis, indicating potential damage and inflammation in the esophagus. However, further diagnostic tests and evaluations are necessary to confirm the diagnosis.","Fragile mucosa in the esophagus may be a hallmark endoscopic sign of primary eosinophilic esophagitis, indicating possible damage and inflammation, but further diagnostic procedures are necessary to confirm the condition.",4.974054274493924e-07,0.35064596488488764,0.13628988642509465,0.038081955760419374,0.4181571796578827,0.10072314049586774,0.038026832360010254,0.48872074733356863,0.06222222222222221,4.974054274493935e-07,0.5625554389838969,0.0212665406427221
73,0.3,10,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: The fragility of the esophageal mucosa may be a significant endoscopic sign of primary eosinophilic esophagitis, indicating potential damage and inflammation in the esophagus. However, further diagnostic tests and evaluations are necessary to confirm the diagnosis.","The fragility of the esophageal mucosa might serve as a pathognomonic endoscopic indicator of primary eosinophilic esophagitis, pointing to inflammation and damage, yet further diagnostic confirmation is essential.",5.44777372920763e-07,0.4221049288670313,0.13628988642509465,0.04170880868998313,0.49226515181160435,0.10072314049586774,0.041648435441916,0.5656817884696981,0.06222222222222221,5.447773729207643e-07,0.6425981466574342,0.0212665406427221
74,0.3,1,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Is spinal cord untethering required before scoliosis surgery in patients with myelomeningocele? The study indicates that untethering might not be needed for MM patients undergoing scoliosis correction if they show no clinical signs of tethered cord, despite radiographic evidence of tethering.",2.3685972735685406e-07,0.22314355131420927,0.0,0.018134264647818726,0.22825865198098239,0.0,0.018108015409528666,0.2336148511815046,0.0,2.3685972735685406e-07,0.2392296890658323,0.0
74,0.3,2,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","For patients with myelomeningocele, is untethering the spinal cord necessary before scoliosis correction? Findings suggest that untethering may be unnecessary in MM patients having scoliosis surgery who lack clinical symptoms of tethered cord, even if imaging shows tethering.",3.0791764556390996e-07,0.30110509278391984,0.0,0.023574544042164344,0.30830135965451655,0.0,0.023540420032387266,0.31585294941847764,0.0,3.079176455639103e-07,0.323787077093896,0.0
74,0.3,3,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Does a patient with myelomeningocele need spinal cord untethering prior to scoliosis correction? The research suggests that untethering might not be required for MM patients undergoing scoliosis correction without clinical tethered cord symptoms, despite radiographic tethering.",3.5528959103528056e-07,0.356674943938732,0.0,0.027201396971728097,0.3654597734944649,0.0,0.027162023114293013,0.3746934494414109,0.0,3.552895910352811e-07,0.38441169891033145,0.0
74,0.3,4,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Is untethering the spinal cord essential before scoliosis correction in myelomeningocele patients? Study results imply that untethering may be unnecessary for MM patients having scoliosis surgery if they do not exhibit clinical signs of tethered cord, even when tethering is seen on imaging.",1.8948778188548325e-07,0.17435338714477755,0.0,0.014507411718254981,0.17824823140631896,0.0,0.014486412327622933,0.1823215567939549,0.0,1.8948778188548325e-07,0.18658595558041347,0.0
74,0.3,5,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Should patients with myelomeningocele undergo spinal cord untethering before scoliosis surgery? The study suggests that for MM patients without clinical symptoms of tethered cord, untethering might not be needed despite radiographic evidence of tethering.",4.0266153650665116e-07,0.4155154439616653,0.0,0.030828249901291856,0.42608439531090037,0.0,0.03078362619619876,0.43721380642274443,0.0,4.026615365066519e-07,0.44895022004790297,0.0
74,0.3,6,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","In patients with myelomeningocele, is spinal cord untethering needed before scoliosis correction? According to the study, untethering may be unnecessary in those undergoing scoliosis surgery who lack clinical tethered cord symptoms, even if tethering is visible on radiographs.",3.0791764556390996e-07,0.30110509278391984,0.0,0.023574544042164344,0.30830135965451655,0.0,0.023540420032387266,0.31585294941847764,0.0,3.079176455639103e-07,0.323787077093896,0.0
74,0.3,7,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Is it necessary to perform spinal cord untethering prior to scoliosis correction in myelomeningocele patients? The study findings indicate untethering might not be required for MM patients without clinical signs of tethered cord, despite radiographic tethering.",3.5528959103528056e-07,0.356674943938732,0.0,0.027201396971728097,0.3654597734944649,0.0,0.027162023114293013,0.3746934494414109,0.0,3.552895910352811e-07,0.38441169891033145,0.0
74,0.3,8,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Do patients with myelomeningocele require untethering of the spinal cord before scoliosis correction? Research suggests that untethering may be unnecessary in MM patients undergoing scoliosis correction who do not have clinical symptoms of tethered cord, even if imaging shows tethering.",2.6054570009253936e-07,0.248461359298501,0.0,0.0199476911126006,0.25423413838424036,0.0,0.019918816950481533,0.26028309826366547,0.0,2.6054570009253947e-07,0.26662866325394763,0.0
74,0.3,9,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","For myelomeningocele patients, is untethering necessary before scoliosis surgery? The study indicates that spinal cord untethering may not be needed in MM patients without clinical tethered cord symptoms undergoing scoliosis correction, despite radiographic evidence of tethering.",3.5528959103528056e-07,0.356674943938732,0.0,0.027201396971728097,0.3654597734944649,0.0,0.027162023114293013,0.3746934494414109,0.0,3.552895910352811e-07,0.38441169891033145,0.0
74,0.3,10,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Is spinal cord untethering a prerequisite for scoliosis correction in patients with myelomeningocele? Study results suggest that untethering may be unnecessary in MM patients who lack clinical signs of tethered cord, even when tethering is demonstrated radiographically.",3.3160361829959526e-07,0.32850406697203516,0.0,0.025387970506946217,0.3364722366212134,0.0,0.02535122157334014,0.34484048629172914,0.0,3.316036182995957e-07,0.35364004024357776,0.0
75,0.3,1,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge refers to a mixture of thickened bile, cholesterol crystals, and other substances that can accumulate in the bile ducts. While it shares similarities with bile","Question: What is the clinical importance of bile duct sludge, and how does it differ from bile duct stones? Answer: Bile duct sludge is a combination of thickened bile, cholesterol crystals, and various substances that build up in the bile ducts. Although it resembles bile duct stones in some ways...",1.4211583641411244e-07,0.09410066477187762,0.09621742616522508,0.010880558788691236,0.13353139262452318,0.0,0.0108648092457172,0.13657553500575004,0.0,1.4211583641411244e-07,0.13976194237515838,0.0
75,0.3,2,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge refers to a mixture of thickened bile, cholesterol crystals, and other substances that can accumulate in the bile ducts. While it shares similarities with bile","Question: How clinically significant is bile duct sludge compared to bile duct stones? Answer: Bile duct sludge consists of thickened bile, cholesterol crystals, and other materials that accumulate within the bile ducts. It has similarities to bile duct stones but is distinct in certain aspects...",2.3685972735685406e-08,0.08940325295116658,0.17043328753391424,0.0018134264647818726,0.04094831008375399,0.046400951814396206,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
75,0.3,3,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge refers to a mixture of thickened bile, cholesterol crystals, and other substances that can accumulate in the bile ducts. While it shares similarities with bile","Question: Can you explain the clinical relevance of bile duct sludge and how it differs from bile duct stones? Answer: Bile duct sludge is made up of thickened bile, cholesterol crystals, and other components that collect in the bile ducts. It shares some characteristics with bile duct stones but is not the same...",2.1317375462116866e-07,0.1333934371416441,0.10620744926961473,0.016320838183036854,0.1669737720660578,0.019599999999999992,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
75,0.3,4,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge refers to a mixture of thickened bile, cholesterol crystals, and other substances that can accumulate in the bile ducts. While it shares similarities with bile","Question: What distinguishes bile duct sludge from bile duct stones in terms of clinical significance? Answer: Bile duct sludge is a mixture of thickened bile, cholesterol crystals, and other substances found in the bile ducts. While it is similar to bile duct stones, there are important differences...",7.105791820705622e-08,0.006595519914566861,0.13384350369138337,0.005440279394345618,0.03818633012873196,0.02221074380165289,0.0054324046228586,0.07061756721395396,0.0,7.105791820705622e-08,0.07232066157962613,0.0
75,0.3,5,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge refers to a mixture of thickened bile, cholesterol crystals, and other substances that can accumulate in the bile ducts. While it shares similarities with bile","Question: Discuss the clinical significance of bile duct sludge and its difference from bile duct stones. Answer: Bile duct sludge comprises thickened bile, cholesterol crystals, and other materials that accumulate in the bile ducts. It has similarities to bile duct stones but differs in composition and implications...",7.105791820705622e-08,0.006595519914566861,0.13384350369138331,0.005440279394345618,0.03818633012873196,0.02221074380165289,0.0054324046228586,0.07061756721395396,0.0,7.105791820705622e-08,0.07232066157962613,0.0
75,0.3,6,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge refers to a mixture of thickened bile, cholesterol crystals, and other substances that can accumulate in the bile ducts. While it shares similarities with bile","Question: How does the clinical importance of bile duct sludge compare to that of bile duct stones? Answer: Bile duct sludge is a blend of thickened bile, cholesterol crystals, and other substances that gather in the bile ducts. It shares features with bile duct stones but is distinct in several ways...",1.6580180914979784e-07,0.061114935377041046,0.1369173258128244,0.012693985253473108,0.09756723651624322,0.040742417383431435,0.012675610786670066,0.1576289442035832,0.0,1.6580180914979784e-07,0.16126814759612174,0.0
75,0.3,7,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge refers to a mixture of thickened bile, cholesterol crystals, and other substances that can accumulate in the bile ducts. While it shares similarities with bile","Question: What is the clinical role of bile duct sludge, and how is it different from bile duct stones? Answer: Bile duct sludge consists of thickened bile, cholesterol crystals, and other elements that accumulate in the bile ducts. Although it resembles bile duct stones, it has unique characteristics...",9.474389094274162e-08,0.04761235617462667,0.10471525459560177,0.0072537058591274906,0.09097177820572666,0.0,0.007243206163811466,0.09309042306601167,0.0,9.474389094274162e-08,0.09531017980432566,0.0
75,0.3,8,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge refers to a mixture of thickened bile, cholesterol crystals, and other substances that can accumulate in the bile ducts. While it shares similarities with bile","Question: Explain the clinical significance of bile duct sludge versus bile duct stones. Answer: Bile duct sludge is composed of thickened bile, cholesterol crystals, and other substances that collect in the bile ducts. It shares some similarities with bile duct stones but is different in key aspects...",7.105791820705622e-08,0.006595519914566861,0.13384350369138331,0.005440279394345618,0.03818633012873196,0.02221074380165289,0.0054324046228586,0.07061756721395396,0.0,7.105791820705622e-08,0.07232066157962613,0.0
75,0.3,9,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge refers to a mixture of thickened bile, cholesterol crystals, and other substances that can accumulate in the bile ducts. While it shares similarities with bile","Question: What clinical differences exist between bile duct sludge and bile duct stones? Answer: Bile duct sludge is a mixture of thickened bile, cholesterol crystals, and other materials that accumulate in the bile ducts. While it is similar to bile duct stones, it has distinct clinical features...",7.105791820705622e-08,0.006595519914566861,0.13384350369138331,0.005440279394345618,0.03818633012873196,0.02221074380165289,0.0054324046228586,0.07061756721395396,0.0,7.105791820705622e-08,0.07232066157962613,0.0
75,0.3,10,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge refers to a mixture of thickened bile, cholesterol crystals, and other substances that can accumulate in the bile ducts. While it shares similarities with bile","Question: Describe the clinical significance of bile duct sludge and how it differs from bile duct stones. Answer: Bile duct sludge includes thickened bile, cholesterol crystals, and other substances that build up in the bile ducts. It shares similarities with bile duct stones but also has important differences...",9.474389094274162e-08,0.01811673146994819,0.1287233737933813,0.0072537058591274906,0.06083494426833802,0.021728395061728398,0.007243206163811466,0.09309042306601167,0.0,9.474389094274162e-08,0.09531017980432566,0.0
76,0.3,1,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not","Do quantitative real-time PCR assays for BCRABL transcript detection yield comparable results across different homebrew methods? The findings indicate that despite methodological differences, results can be correlated if the same positive control cell line and quality control gene are employed, highlighting the need for assay standardization between labs.",4.026615365066519e-07,0.2654137828646186,0.031217481789802295,0.030828249901291835,0.2924886575037129,0.01586888657648284,0.030783626196198732,0.32047189527477205,0.0,4.026615365066519e-07,0.32668423025504856,0.0
76,0.3,2,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not","Can homebrew quantitative real-time PCR assays for BCRABL transcript detection produce correlated results? The data suggest that comparable outcomes are achievable between labs using different methods, provided they use the same positive control cell line and quality control gene, emphasizing the importance of assay standardization.",4.737194547137081e-07,0.33137175065641467,0.031217481789802295,0.03626852929563745,0.35992993829924513,0.01586888657648284,0.03621603081905733,0.3894647667617237,0.0,4.737194547137081e-07,0.3973017974690025,0.0
76,0.3,3,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not","Are correlated results achievable from homebrew quantitative real-time PCR assays for BCRABL transcript detection? Results imply that despite methodological variations, consistent detection is possible if labs use identical positive control cell lines and quality control genes, underscoring the necessity for assay standardization.",5.447773729207643e-07,0.4019893178703686,0.031217481789802295,0.04170880868998307,0.43225059987887127,0.01586888657648284,0.04164843544191593,0.46357273891544715,0.0,5.447773729207643e-07,0.4732877044469239,0.0
76,0.3,4,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not","Is it possible to obtain correlated results from homebrew quantitative real-time PCR assays for BCRABL transcript detection? The evidence suggests comparability between labs with different methods when the same positive control cell line and quality control gene are used, stressing the importance of standardizing assays.",4.737194547137081e-07,0.33137175065641467,0.031217481789802295,0.03626852929563745,0.35992993829924513,0.01586888657648284,0.03621603081905733,0.3894647667617237,0.0,4.737194547137081e-07,0.3973017974690025,0.0
76,0.3,5,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not","Do quantitative real-time PCR assays for BCRABL transcript detection from homebrew protocols yield consistent results? Findings indicate that results can be comparable across labs despite methodological differences if the same positive control cell line and quality control gene are utilized, making assay standardization essential.",4.974054274493935e-07,0.3543612688811142,0.031217481789802295,0.038081955760419325,0.38346043570943955,0.01586888657648284,0.0380268323600102,0.4135623183407837,0.0,4.974054274493935e-07,0.4219944100593742,0.0
76,0.3,6,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not","Can BCRABL transcript detection by quantitative real-time PCR from homebrew assays produce correlated results? The study suggests that comparable results are possible between labs using different methods if the same positive control cell line and quality control gene are applied, highlighting the need for assay standardization.",4.500334819780227e-07,0.30889889480435695,0.031217481789802295,0.03445510283085558,0.3369404200745456,0.01586888657648284,0.034405229278104466,0.3659342693515293,0.0,4.500334819780227e-07,0.3732042458899425,0.0
76,0.3,7,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not","Are results from homebrew quantitative real-time PCR assays for BCRABL detection correlated? Evidence shows that despite methodological differences, comparable results can be achieved if the same positive control cell line and quality control gene are used, pointing to the need for assay standardization.",5.210914001850789e-07,0.3778917662913086,0.031217481789802295,0.0398953822252012,0.40755798728849957,0.01586888657648284,0.039837633900963065,0.4382549309311554,0.0,5.210914001850789e-07,0.44731221804366594,0.0
76,0.3,8,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not","Is correlated detection of BCRABL transcripts by quantitative real-time PCR feasible with homebrew assays? The results indicate that labs can achieve comparable outcomes despite methodological differences by using the same positive control cell line and quality control gene, emphasizing assay standardization.",5.684633456564497e-07,0.4266819304607403,0.031217481789802295,0.04352223515476494,0.457568407863163,0.01586888657648284,0.0434592369828688,0.4895482253187051,0.0,5.684633456564497e-07,0.4999559515290848,0.0
76,0.3,9,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not","Can homebrew quantitative real-time PCR assays for BCRABL transcript detection yield comparable results? The findings suggest that despite significant methodological differences, results can be correlated if the same positive control cell line and quality control gene are employed, underscoring the importance of assay standardization.",4.974054274493935e-07,0.3543612688811142,0.031217481789802295,0.038081955760419325,0.38346043570943955,0.01586888657648284,0.0380268323600102,0.4135623183407837,0.0,4.974054274493935e-07,0.4219944100593742,0.0
76,0.3,10,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not","Are comparable results possible from homebrew quantitative real-time PCR assays for BCRABL transcript detection? The data indicate that despite methodological variations, consistent results can be obtained if the same positive control cell line and quality control gene are used, stressing the imperative of assay standardization.",4.737194547137081e-07,0.33137175065641467,0.031217481789802295,0.03626852929563745,0.35992993829924513,0.01586888657648284,0.03621603081905733,0.3894647667617237,0.0,4.737194547137081e-07,0.3973017974690025,0.0
77,0.3,1,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as","Does the fibronectin-aggrecan complex exist in cervical disk disease? Biochemical studies of damaged cervical intervertebral disks show inflammatory markers like MCP, fragments of structural matrix proteins such as FAC, and a link to pH levels. Further analysis of FAC is ongoing.",1.1842986367842703e-07,0.08697649429816368,0.02221074380165289,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
77,0.3,2,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as","Is the fibronectin-aggrecan complex found in cervical disk disease? Injured cervical intervertebral disks exhibit inflammatory markers including MCP, structural matrix protein fragments like FAC, and a relationship with pH, according to biochemical analysis. Additional evaluation of FAC continues.",1.8948778188548293e-07,0.16493803576787425,0.02221074380165289,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
77,0.3,3,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as","Is the fibronectin-aggrecan complex detectable in cervical disk disease? Biochemical examination of injured cervical intervertebral disks identifies inflammatory markers such as MCP, fragments of structural matrix proteins like FAC, and an association with pH. Further study of FAC is underway.",1.4211583641411233e-07,0.1122943022824554,0.02221074380165289,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
77,0.3,4,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as","Does cervical disk disease involve the fibronectin-aggrecan complex? Analysis of injured cervical intervertebral disks biochemically reveals inflammatory markers such as MCP, structural matrix protein fragments like FAC, and a correlation with pH. FAC is being further evaluated.",2.1317375462116823e-07,0.19233700995598957,0.02221074380165289,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
77,0.3,5,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as","Is the fibronectin-aggrecan complex present in cases of cervical disk disease? Biochemical analysis of damaged cervical intervertebral disks uncovers inflammatory markers like MCP, fragments of structural matrix proteins such as FAC, and a pH correlation. Further assessment of FAC is in progress.",9.474389094274162e-08,0.06228388170779198,0.02221074380165289,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
77,0.3,6,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as","Is the fibronectin-aggrecan complex associated with cervical disk disease? Biochemical studies of injured cervical intervertebral disks show inflammatory markers including MCP, fragments of structural matrix proteins like FAC, and a pH relationship. FAC is subject to further evaluation.",1.8948778188548293e-07,0.16493803576787425,0.02221074380165289,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
77,0.3,7,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as","Can the fibronectin-aggrecan complex be found in cervical disk disease? Biochemical analysis of damaged cervical intervertebral disks reveals inflammatory markers such as MCP, fragments of structural matrix proteins like FAC, and a correlation with pH. Further investigation of FAC is ongoing.",1.1842986367842703e-07,0.08697649429816368,0.02221074380165289,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
77,0.3,8,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as","Is the fibronectin-aggrecan complex involved in cervical disk disease? Injured cervical intervertebral disks display inflammatory markers including MCP, fragments of structural matrix proteins such as FAC, and a link to pH, as shown by biochemical analysis. Further evaluation of FAC continues.",1.1842986367842703e-07,0.08697649429816368,0.02221074380165289,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
77,0.3,9,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as","Is the fibronectin-aggrecan complex present in cervical disk disease? Biochemical examination of injured cervical intervertebral disks reveals inflammatory markers like MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. FAC is being further studied.",1.6580180914979763e-07,0.13826978868571338,0.02221074380165289,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
77,0.3,10,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as","Does the fibronectin-aggrecan complex appear in cervical disk disease? Biochemical analysis of injured cervical intervertebral disks identifies inflammatory markers such as MCP, fragments of structural matrix proteins like FAC, and an association with pH. Further evaluation of FAC is ongoing.",1.4211583641411233e-07,0.1122943022824554,0.02221074380165289,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
78,0.3,1,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,"Question: Could Alveolar Macrophage Phagocytic Dysfunction in Children with Protracted Bacterial Bronchitis be a Precursor to Bronchiectasis? Answer: A diminished alveolar macrophage phagocytic response to apoptotic cells or NTHi might lead to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. However, it is still unclear if this process contributes to the development of bronchiectasis from PBB.",4.737194547137081e-08,0.03748687923508642,0.0012705324385313826,0.0036268529295637453,0.0372845055208213,0.0006606862828746896,0.003621603081905733,0.037041271680350096,0.0,4.737194547137081e-08,0.03774032798284743,0.0
78,0.3,2,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children with Protracted Bacterial Bronchitis an Early Indicator of Bronchiectasis? Answer: A weakened alveolar macrophage phagocytic response to apoptotic cells or NTHi may play a role in neutrophilic inflammation and NTHi colonization seen in both PBB and bronchiectasis. The role of this mechanism in the progression from PBB to bronchiectasis remains uncertain.,7.105791820705622e-08,0.05571727552295114,0.001873079242376896,0.005440279394345618,0.05541838536493415,0.0009736606461737268,0.0054324046228586,0.05505977718302857,0.0,7.105791820705622e-08,0.056089466651043196,0.0
78,0.3,3,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Question: Does Alveolar Macrophage Phagocytic Dysfunction in Children with Protracted Bacterial Bronchitis Signal the Onset of Bronchiectasis? Answer: Reduced alveolar macrophage phagocytic activity against apoptotic cells or NTHi could contribute to neutrophilic inflammation and NTHi colonization in PBB and bronchiectasis. Whether this dysfunction drives the transition from PBB to bronchiectasis is not yet known.,4.737194547137081e-08,0.03894356239886809,0.0013659614719480281,0.0036268529295637453,0.03872771712894396,0.0007114496724635287,0.003621603081905733,0.038466280827795796,0.0,4.737194547137081e-08,0.03922071315328246,0.0
78,0.3,4,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children with Protracted Bacterial Bronchitis a Potential Precursor to Bronchiectasis? Answer: A compromised alveolar macrophage phagocytic response to apoptotic cells or NTHi may facilitate neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. The involvement of this mechanism in PBB progressing to bronchiectasis remains to be determined.,2.3685972735685406e-08,0.019282670224506138,0.0006703937681290656,0.0018134264647818726,0.019176512593258366,0.0003490207932659514,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
78,0.3,5,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Question: Could Dysfunction of Alveolar Macrophage Phagocytosis in Children with Protracted Bacterial Bronchitis Lead to Bronchiectasis? Answer: A decreased phagocytic response by alveolar macrophages to apoptotic cells or NTHi might contribute to neutrophilic inflammation and NTHi colonization in PBB and bronchiectasis. It is still unknown if this contributes to the progression from PBB to bronchiectasis.,2.3685972735685406e-08,0.03206156537252758,0.03631185475258099,0.0018134264647818726,0.006979984786362525,0.01851192595229618,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
78,0.3,6,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children with Protracted Bacterial Bronchitis a Marker for Bronchiectasis Development? Answer: Impaired alveolar macrophage phagocytic activity towards apoptotic cells or NTHi may promote neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism is involved in the evolution of PBB into bronchiectasis remains unclear.,4.737194547137081e-08,0.03894356239886809,0.0013659614719480281,0.0036268529295637453,0.03872771712894396,0.0007114496724635287,0.003621603081905733,0.038466280827795796,0.0,4.737194547137081e-08,0.03922071315328246,0.0
78,0.3,7,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Question: Does Alveolar Macrophage Phagocytic Dysfunction in Children with Protracted Bacterial Bronchitis Precede Bronchiectasis? Answer: A reduced phagocytic host response by alveolar macrophages to apoptotic cells or NTHi could contribute to neutrophilic inflammation and NTHi colonization in PBB and bronchiectasis. The role of this dysfunction in the progression from PBB to bronchiectasis is still unknown.,2.3685972735685406e-08,0.00638944757401072,0.017799928800284807,0.0018134264647818726,0.006979984786362525,0.01851192595229618,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
78,0.3,8,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children with Protracted Bacterial Bronchitis Linked to Bronchiectasis Onset? Answer: A diminished alveolar macrophage phagocytic response to apoptotic cells or NTHi may be a factor in neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism contributes to PBB advancing to bronchiectasis remains to be established.,0.0,0.025205352020361893,0.01805205057286282,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
78,0.3,9,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Question: Could Alveolar Macrophage Phagocytic Dysfunction in Children with Protracted Bacterial Bronchitis Trigger Bronchiectasis? Answer: A lowered phagocytic activity of alveolar macrophages against apoptotic cells or NTHi might lead to neutrophilic inflammation and NTHi colonization in PBB and bronchiectasis. It is not yet known if this mechanism causes PBB to progress to bronchiectasis.,7.105791820705622e-08,0.005678762610319854,0.03631185475258099,0.005440279394345618,0.03148629604143327,0.01851192595229618,0.0054324046228586,0.05826890812397556,0.0,7.105791820705622e-08,0.05942342047080107,0.0
78,0.3,10,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children with Protracted Bacterial Bronchitis an Early Step Toward Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism plays a role in the progression from PBB to bronchiectasis remains unknown.,2.3685972735685406e-08,0.018918696646262223,0.0006465598280268187,0.0018134264647818726,0.01881590444635073,0.0003363429618983803,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
79,0.3,1,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Yes, biochemical markers of bone turnover are representative of bone histomorphometry in 370 postmenopausal women, as indicated by the results of the study.","Are biochemical markers of bone turnover indicative of bone histomorphometry in 370 postmenopausal women? Yes, the study's findings confirm that biochemical markers of bone turnover accurately represent bone histomorphometry in these women.",1.658018091497971e-07,0.09573497152676147,0.1737182784636488,0.012693985253473143,0.0948204578081695,0.06958467307868202,0.012675610786670108,0.08078055594642919,0.09141289437585737,1.6580180914979784e-07,0.11422042294050394,0.07671763951873403
79,0.3,2,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Yes, biochemical markers of bone turnover are representative of bone histomorphometry in 370 postmenopausal women, as indicated by the results of the study.","Do biochemical markers of bone turnover reflect bone histomorphometry in 370 postmenopausal women? Yes, according to the study, these markers are representative of bone histomorphometry in the group.",2.605457000925383e-07,0.05800483384371713,0.35427383401920437,0.01994769111260066,0.10640106718875009,0.16136218787158144,0.019918816950481602,0.13359405340126207,0.16000000000000003,2.6054570009253947e-07,0.21886058987062373,0.11238293444328822
79,0.3,3,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Yes, biochemical markers of bone turnover are representative of bone histomorphometry in 370 postmenopausal women, as indicated by the results of the study.","Is there a correlation between biochemical markers of bone turnover and bone histomorphometry in 370 postmenopausal women? Yes, the study shows that biochemical markers effectively represent bone histomorphometry in these women.",1.894877818854824e-07,0.0627589524932195,0.3648834019204389,0.014507411718255023,0.008313984833747234,0.16532341236137738,0.014486412327622981,0.02026536809425794,0.16000000000000003,1.8948778188548325e-07,0.10107755421423947,0.11238293444328822
79,0.3,4,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Yes, biochemical markers of bone turnover are representative of bone histomorphometry in 370 postmenopausal women, as indicated by the results of the study.","Can biochemical markers of bone turnover serve as indicators of bone histomorphometry in 370 postmenopausal women? Yes, the study results demonstrate that these markers are representative of bone histomorphometry.",2.36859727356853e-07,0.01468705761810174,0.3157198399363642,0.018134264647818782,0.015341725316676325,0.19976218787158145,0.01810801540952873,0.09437334024797961,0.16000000000000003,2.3685972735685406e-07,0.17803859535036892,0.11238293444328822
79,0.3,5,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Yes, biochemical markers of bone turnover are representative of bone histomorphometry in 370 postmenopausal women, as indicated by the results of the study.","Are biochemical markers of bone turnover reliable indicators of bone histomorphometry in 370 postmenopausal women? Yes, the study confirms that these markers correspond well with bone histomorphometry in the sample.",2.131737546211677e-07,0.02407707543436599,0.3615778281020446,0.016320838183036902,0.028484594042940792,0.16409689294702728,0.016297213868575855,0.05663301226513262,0.16000000000000003,2.1317375462116866e-07,0.13881788219708646,0.11238293444328822
79,0.3,6,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Yes, biochemical markers of bone turnover are representative of bone histomorphometry in 370 postmenopausal women, as indicated by the results of the study.","Do biochemical markers of bone turnover accurately represent bone histomorphometry in 370 postmenopausal women? Yes, the study's evidence supports that these markers are representative of bone histomorphometry.",2.842316728282236e-07,0.004968531075308924,0.4252488340192044,0.02176111757738254,0.09230276645280577,0.19976218787158145,0.021729618491434476,0.17441604792151688,0.16000000000000003,2.8423167282822487e-07,0.26142020428941937,0.11238293444328822
79,0.3,7,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Yes, biochemical markers of bone turnover are representative of bone histomorphometry in 370 postmenopausal women, as indicated by the results of the study.","Is bone histomorphometry in 370 postmenopausal women reflected by biochemical markers of bone turnover? Yes, the study indicates that biochemical markers are representative of bone histomorphometry in this population.",2.36859727356853e-07,0.06564653447029922,0.3247599451303155,0.018134264647818782,0.0666859609137096,0.1627799393508714,0.01810801540952873,0.09437334024797961,0.16000000000000003,2.3685972735685406e-07,0.17803859535036892,0.11238293444328822
79,0.3,8,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Yes, biochemical markers of bone turnover are representative of bone histomorphometry in 370 postmenopausal women, as indicated by the results of the study.","Are biochemical markers of bone turnover valid proxies for bone histomorphometry in 370 postmenopausal women? Yes, the study findings affirm that these markers represent bone histomorphometry.",3.079176455639089e-07,0.019066831811253238,0.46364883401920437,0.02357454404216442,0.13312476097306059,0.19976218787158145,0.02354042003238735,0.21697566234031251,0.16000000000000003,3.079176455639103e-07,0.3058719668602534,0.11238293444328822
79,0.3,9,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Yes, biochemical markers of bone turnover are representative of bone histomorphometry in 370 postmenopausal women, as indicated by the results of the study.","Do biochemical markers of bone turnover correspond to bone histomorphometry in 370 postmenopausal women? Yes, the study results show that these markers are representative of bone histomorphometry.",2.842316728282236e-07,0.004968531075308924,0.4252488340192044,0.02176111757738254,0.09230276645280577,0.19976218787158145,0.021729618491434476,0.17441604792151688,0.16000000000000003,2.8423167282822487e-07,0.26142020428941937,0.11238293444328822
79,0.3,10,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Yes, biochemical markers of bone turnover are representative of bone histomorphometry in 370 postmenopausal women, as indicated by the results of the study.","Is there evidence that biochemical markers of bone turnover represent bone histomorphometry in 370 postmenopausal women? Yes, the study confirms that biochemical markers of bone turnover are representative of bone histomorphometry.",1.894877818854824e-07,0.09331208841092131,0.19281550068587106,0.014507411718255023,0.13509577666141315,0.06536218787158149,0.014486412327622981,0.16879690678567538,0.054400000000000004,1.8948778188548325e-07,0.20376602540830602,0.03878293444328823
80,0.3,1,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, opioid dependence and methadone maintenance treatment (MMT) should be documented in the medical record as they are important factors in a patient's medical history and ongoing treatment plan.","Are opioid dependence and methadone maintenance treatment (MMT) recorded in the medical record? Yes, both opioid dependence and MMT must be documented in the medical record since they are crucial elements of a patient's medical history and treatment plan.",1.1842986367842682e-07,0.020614955532444856,0.09083044982698962,0.009067132323909363,0.029362524216700603,0.10612244897959186,0.009054007704764333,0.03900715969325175,0.11959876543209881,1.1842986367842703e-07,0.029559315540531816,0.07450693937180423
80,0.3,2,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, opioid dependence and methadone maintenance treatment (MMT) should be documented in the medical record as they are important factors in a patient's medical history and ongoing treatment plan.","Is opioid dependence and methadone maintenance treatment (MMT) noted in the medical record? Yes, documenting opioid dependence and MMT in the medical record is essential because they play a significant role in the patient's medical history and ongoing care.",1.1842986367842682e-07,0.029636163017145556,0.005472307218139266,0.009067132323909363,0.029362524216700603,0.10612244897959186,0.009054007704764333,0.03900715969325175,0.11959876543209881,1.1842986367842703e-07,0.029559315540531816,0.07450693937180423
80,0.3,3,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, opioid dependence and methadone maintenance treatment (MMT) should be documented in the medical record as they are important factors in a patient's medical history and ongoing treatment plan.","Do medical records include opioid dependence and methadone maintenance treatment (MMT)? Yes, opioid dependence and MMT should be recorded in the medical record as they are key components of a patient's medical history and treatment strategy.",1.8948778188548272e-07,0.005085758883196956,0.13770371217681696,0.014507411718254988,0.021033397042907076,0.1306152433425161,0.014486412327622947,0.04800421729637838,0.11959876543209881,1.8948778188548325e-07,0.11917147423021879,0.07450693937180423
80,0.3,4,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, opioid dependence and methadone maintenance treatment (MMT) should be documented in the medical record as they are important factors in a patient's medical history and ongoing treatment plan.","Are opioid dependence and methadone maintenance treatment (MMT) included in the medical record? Yes, these conditions must be documented in the medical record since they are important for understanding the patient's medical history and treatment plan.",1.8948778188548272e-07,0.005085758883196956,0.13770371217681696,0.014507411718254988,0.021033397042907076,0.1306152433425161,0.014486412327622947,0.04800421729637838,0.11959876543209881,1.8948778188548325e-07,0.11917147423021879,0.07450693937180423
80,0.3,5,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, opioid dependence and methadone maintenance treatment (MMT) should be documented in the medical record as they are important factors in a patient's medical history and ongoing treatment plan.","Is there documentation of opioid dependence and methadone maintenance treatment (MMT) in the medical record? Yes, it is necessary to document opioid dependence and MMT in the medical record because they are vital to the patient's medical history and ongoing treatment.",7.105791820705622e-08,0.07920453603115307,0.0958712461019266,0.005440279394345618,0.08584906951395688,0.10886778670562458,0.0054324046228586,0.09307438096352794,0.11959876543209881,7.105791820705622e-08,0.02601053561428035,0.07450693937180423
80,0.3,6,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, opioid dependence and methadone maintenance treatment (MMT) should be documented in the medical record as they are important factors in a patient's medical history and ongoing treatment plan.","Are opioid dependence and methadone maintenance treatment (MMT) captured in the medical record? Yes, these should be documented as they are significant factors in the patient's medical history and treatment plan.",3.079176455639092e-07,0.11605791234596907,0.16134298022209514,0.023574544042164386,0.1393247281102461,0.16000000000000003,0.023540420032387314,0.21230726858765436,0.11959876543209881,3.079176455639103e-07,0.28907051102561576,0.07450693937180423
80,0.3,7,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, opioid dependence and methadone maintenance treatment (MMT) should be documented in the medical record as they are important factors in a patient's medical history and ongoing treatment plan.","Are opioid dependence and methadone maintenance treatment (MMT) recorded in the patient's medical record? Yes, it is important to document opioid dependence and MMT in the medical record as they are critical to the patient's medical history and treatment approach.",9.474389094274152e-08,0.01478611786142947,0.06920415224913498,0.0072537058591274906,0.058002740518094065,0.10753086419753088,0.007243206163811466,0.06640613388136707,0.11959876543209881,9.474389094274162e-08,0.0013884385738349714,0.07450693937180423
80,0.3,8,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, opioid dependence and methadone maintenance treatment (MMT) should be documented in the medical record as they are important factors in a patient's medical history and ongoing treatment plan.","Is opioid dependence along with methadone maintenance treatment (MMT) documented in the medical record? Yes, both should be included in the medical record because they are important aspects of the patient's medical history and ongoing treatment.",1.8948778188548272e-07,0.005085758883196956,0.13770371217681696,0.014507411718254988,0.021033397042907076,0.1306152433425161,0.014486412327622947,0.04800421729637838,0.11959876543209881,1.8948778188548325e-07,0.11917147423021879,0.07450693937180423
80,0.3,9,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, opioid dependence and methadone maintenance treatment (MMT) should be documented in the medical record as they are important factors in a patient's medical history and ongoing treatment plan.","Are opioid dependence and methadone maintenance treatment (MMT) documented within the medical record? Yes, documenting these is essential as they constitute important parts of a patient's medical history and treatment plan.",3.079176455639092e-07,0.06984810030863953,0.19463667820069205,0.023574544042164386,0.1393247281102461,0.16000000000000003,0.023540420032387314,0.21230726858765436,0.11959876543209881,3.079176455639103e-07,0.28907051102561576,0.07450693937180423
80,0.3,10,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, opioid dependence and methadone maintenance treatment (MMT) should be documented in the medical record as they are important factors in a patient's medical history and ongoing treatment plan.","Does the medical record document opioid dependence and methadone maintenance treatment (MMT)? Yes, these conditions should be recorded since they are important factors in the patient's medical history and treatment plan.",3.079176455639092e-07,0.06984810030863953,0.19463667820069205,0.023574544042164386,0.1393247281102461,0.16000000000000003,0.023540420032387314,0.21230726858765436,0.11959876543209881,3.079176455639103e-07,0.28907051102561576,0.07450693937180423
81,0.3,1,ai,Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The applicability of current prediction equations for estimating basal metabolic rate in Chinese individuals needs further investigation to ensure accuracy.,Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: Further research is required to confirm whether existing prediction equations accurately estimate basal metabolic rate in Chinese people.,4.73719454713706e-08,0.0300445991446745,0.020238297459292856,0.003626852929563759,0.025931942758227855,0.025790725326991726,0.003621603081905747,0.06742663438990348,0.0020762161887946107,4.737194547137081e-08,0.06669137449867346,0.0
81,0.3,2,ai,Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The applicability of current prediction equations for estimating basal metabolic rate in Chinese individuals needs further investigation to ensure accuracy.,Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: It is necessary to examine the suitability of current prediction formulas for estimating basal metabolic rate in Chinese individuals to guarantee precision.,4.73719454713706e-08,0.10699252486059718,0.033312277051129574,0.003626852929563759,0.1056504394893194,0.033067033976124934,0.003621603081905747,0.06317295703908332,0.0018327251323183684,4.737194547137081e-08,0.06252035698133351,0.0
81,0.3,3,ai,Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The applicability of current prediction equations for estimating basal metabolic rate in Chinese individuals needs further investigation to ensure accuracy.,Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The current equations used to predict basal metabolic rate in Chinese populations need additional validation to ascertain their accuracy.,2.36859727356853e-08,0.0059781745263221,0.023781212841854873,0.0018134264647818796,0.00861170386506016,0.02777777777777781,0.0018108015409528735,0.033146172468933255,0.0010047404324198955,2.3685972735685406e-08,0.0327898228229917,0.0
81,0.3,4,ai,Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The applicability of current prediction equations for estimating basal metabolic rate in Chinese individuals needs further investigation to ensure accuracy.,Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: More studies are needed to determine if the existing basal metabolic rate prediction equations are valid for Chinese individuals.,2.36859727356853e-08,0.04798709456025829,0.052687277051129536,0.0018134264647818796,0.05193340265005686,0.05878251821019773,0.0018108015409528735,0.01157300047041776,0.031217481789802305,2.3685972735685406e-08,0.0327898228229917,0.0
81,0.3,5,ai,Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The applicability of current prediction equations for estimating basal metabolic rate in Chinese individuals needs further investigation to ensure accuracy.,Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The accuracy of current basal metabolic rate prediction models for Chinese people requires further assessment.,1.184298636784265e-07,0.050804384481380804,0.07410017142698691,0.009067132323909398,0.087786804086607,0.05433470507544586,0.009054007704764368,0.1265773380103994,0.031217481789802305,1.1842986367842703e-07,0.17589066646366414,0.0
81,0.3,6,ai,Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The applicability of current prediction equations for estimating basal metabolic rate in Chinese individuals needs further investigation to ensure accuracy.,Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: Additional investigation is essential to verify the applicability of current basal metabolic rate prediction equations for the Chinese population.,2.36859727356853e-08,0.04798709456025829,0.052687277051129536,0.0018134264647818796,0.05193340265005686,0.05878251821019773,0.0018108015409528735,0.01157300047041776,0.031217481789802305,2.3685972735685406e-08,0.0327898228229917,0.0
81,0.3,7,ai,Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The applicability of current prediction equations for estimating basal metabolic rate in Chinese individuals needs further investigation to ensure accuracy.,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To ensure precise estimation, the relevance of current basal metabolic rate prediction equations for Chinese individuals must be further evaluated.",0.0,0.0815467271246999,0.05527832803968315,0.0,0.08401784006787238,0.05972656250000004,0.0,0.043321698784997587,0.031217481789802305,0.0,0.0,0.0
81,0.3,8,ai,Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The applicability of current prediction equations for estimating basal metabolic rate in Chinese individuals needs further investigation to ensure accuracy.,Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: Current prediction equations for basal metabolic rate may not be fully applicable to Chinese individuals without further validation.,4.73719454713706e-08,0.0300445991446745,0.020238297459292856,0.003626852929563759,0.025931942758227855,0.025790725326991726,0.003621603081905747,0.02121682235257394,0.031217481789802305,4.737194547137081e-08,0.06669137449867346,0.0
81,0.3,9,ai,Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The applicability of current prediction equations for estimating basal metabolic rate in Chinese individuals needs further investigation to ensure accuracy.,Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The use of existing basal metabolic rate prediction equations for Chinese people should be re-examined to confirm their accuracy.,2.36859727356853e-08,0.04798709456025829,0.052687277051129536,0.0018134264647818796,0.05193340265005686,0.05878251821019773,0.0018108015409528735,0.01157300047041776,0.031217481789802305,2.3685972735685406e-08,0.0327898228229917,0.0
81,0.3,10,ai,Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The applicability of current prediction equations for estimating basal metabolic rate in Chinese individuals needs further investigation to ensure accuracy.,Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: It is important to conduct further studies to verify if current basal metabolic rate prediction equations apply accurately to Chinese individuals.,2.36859727356853e-08,0.11402912373186647,0.057726339551129574,0.0018134264647818796,0.11510635968914018,0.0606152433425161,0.0018108015409528735,0.07409335745175127,0.031217481789802305,2.3685972735685406e-08,0.031748698314579826,0.0
82,0.3,1,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Does the lipid-lowering agent bezafibrate, a peroxisome proliferator-activated receptor ligand, prevent colon cancer in coronary artery disease patients? Our findings from coronary artery disease patients support the idea that bezafibrate may help prevent colon cancer.",2.1317375462116802e-07,0.2604414705235256,0.01803394901144642,0.016320838183036868,0.21715695965463944,0.017226562500000014,0.01629721386857582,0.21402410631629154,0.024375,2.1317375462116866e-07,0.25489224962878954,0.0
82,0.3,2,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Is bezafibrate, a peroxisome proliferator-activated receptor ligand used to lower lipids, effective in preventing colon cancer in patients with coronary artery disease? Data from these patients suggest a potential preventive role of bezafibrate against colon cancer.",1.8948778188548272e-07,0.10913384296322581,0.06937499999999999,0.014507411718254988,0.1452950764710219,0.047500000000000014,0.014486412327622947,0.18325244764953785,0.024375,1.8948778188548325e-07,0.2231435513142097,0.0
82,0.3,3,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Can the lipid-lowering drug bezafibrate, which targets peroxisome proliferator-activated receptors, prevent colon cancer in individuals with coronary artery disease? Our patient data supports the hypothesis that bezafibrate might reduce colon cancer risk.",2.842316728282239e-07,0.2752138729068436,0.03715277777777779,0.021761117577382506,0.2704582194250289,0.047500000000000014,0.02172961849143444,0.31246417912954483,0.024375,2.8423167282822487e-07,0.356674943938732,0.0
82,0.3,4,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Does bezafibrate, a ligand for peroxisome proliferator-activated receptors used to lower lipids, have a preventive effect on colon cancer in coronary artery disease patients? Evidence from these patients backs the possibility of such an effect.",2.1317375462116802e-07,0.13812137983647732,0.06937499999999999,0.016320838183036868,0.1751480396207037,0.047500000000000014,0.01629721386857582,0.21402410631629154,0.024375,2.1317375462116866e-07,0.25489224962878954,0.0
82,0.3,5,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.",Is there a preventive effect of the lipid-lowering peroxisome proliferator-activated receptor ligand bezafibrate on colon cancer among patients with coronary artery disease? Our data from these patients support this potential benefit.,3.079176455639092e-07,0.2632845227904843,0.06937499999999999,0.023574544042164386,0.30435977110071066,0.047500000000000014,0.023540420032387314,0.34755549894081383,0.024375,3.079176455639103e-07,0.3930425881096067,0.0
82,0.3,6,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Does the use of bezafibrate, a peroxisome proliferator-activated receptor ligand that lowers lipids, prevent colon cancer in patients suffering from coronary artery disease? Findings from our coronary artery disease cohort support this preventive hypothesis.",2.3685972735685332e-07,0.20998326302009485,0.03910156249999999,0.018134264647818747,0.20591969828745738,0.047500000000000014,0.018108015409528694,0.24577280463087137,0.024375,2.3685972735685406e-07,0.28768207245178123,0.0
82,0.3,7,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Can bezafibrate, a lipid-lowering peroxisome proliferator-activated receptor ligand, reduce the incidence of colon cancer in patients with coronary artery disease? Our data from such patients endorse the idea of a preventive effect.",2.842316728282239e-07,0.2304946999674926,0.06937499999999999,0.021761117577382506,0.2704582194250289,0.047500000000000014,0.02172961849143444,0.31246417912954483,0.024375,2.8423167282822487e-07,0.356674943938732,0.0
82,0.3,8,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Is the lipid-lowering drug bezafibrate, which acts as a peroxisome proliferator-activated receptor ligand, effective in preventing colon cancer in coronary artery disease patients? Patient data supports the hypothesis of its preventive potential.",2.842316728282239e-07,0.2304946999674926,0.06937499999999999,0.021761117577382506,0.2704582194250289,0.047500000000000014,0.02172961849143444,0.31246417912954483,0.024375,2.8423167282822487e-07,0.356674943938732,0.0
82,0.3,9,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Does bezafibrate, a peroxisome proliferator-activated receptor ligand used for lipid lowering, prevent colon cancer in patients with coronary artery disease? Our data from these patients support the hypothesis of a possible preventive effect.",2.605457000925386e-07,0.19874600165291278,0.06937499999999999,0.019947691112600627,0.2376683966020372,0.047500000000000014,0.019918816950481567,0.27856262745386307,0.024375,2.6054570009253947e-07,0.321583624127463,0.0
82,0.3,10,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.",Does the lipid-lowering ligand bezafibrate for peroxisome proliferator-activated receptors prevent colon cancer in coronary artery disease patients? Data from these patients supports the hypothesis of bezafibrate's preventive role against colon cancer.,3.079176455639092e-07,0.2632845227904843,0.06937499999999999,0.023574544042164386,0.30435977110071066,0.047500000000000014,0.023540420032387314,0.34755549894081383,0.024375,3.079176455639103e-07,0.3930425881096067,0.0
83,0.3,1,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Question: Are UK radiologists content with the training and support provided for suspected child abuse cases? Answer: The survey reveals considerable dissatisfaction among consultant radiologists regarding the current service, highlights a small number of paediatric radiologists handling this work, and indicates a 27% potential increase in radiology child abuse specialists if training is enhanced.",7.105791820705622e-08,0.056461018114079664,0.001009707076140641,0.005440279394345618,0.056089466651043196,0.0,0.0054324046228586,0.05715841383995013,0.0,7.105791820705622e-08,0.05826890812397556,0.0
83,0.3,2,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Question: Do UK radiologists feel adequately trained and supported in cases of suspected child abuse? Answer: Survey results indicate notable dissatisfaction among consultant radiologists with existing services, a limited number of paediatric radiologists involved, and a possible 27% rise in child abuse radiology experts if training improves.",2.3685972735685406e-07,0.17195503779748522,0.017851239669421492,0.018134264647818726,0.20067069546215155,0.0,0.018108015409528666,0.2047944126460135,0.0,2.3685972735685406e-07,0.2090917978585587,0.0
83,0.3,3,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Question: Are radiologists in the UK satisfied with the training and support they receive for suspected child abuse? Answer: The survey points to significant dissatisfaction among consultant radiologists about the current service, a low count of paediatric radiologists engaged in this area, and a potential 27% increase in specialists if training is improved.",9.474389094274162e-08,0.04935271570515187,0.017851239669421492,0.0072537058591274906,0.07550755250814589,0.0,0.007243206163811466,0.07696104113612989,0.0,9.474389094274162e-08,0.07847161544149417,0.0
83,0.3,4,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Question: How satisfied are UK radiologists with the training and support for suspected child abuse cases? Answer: Findings show considerable dissatisfaction among consultant radiologists with the current setup, few paediatric radiologists working in this field, and a potential 27% growth in child abuse radiology experts with better training.",2.1317375462116866e-07,0.2389357066905573,0.04568181818181816,0.016320838183036854,0.20882862268076519,0.021728395061728398,0.0162972138685758,0.18232155679395579,0.0,2.1317375462116866e-07,0.18610227963385917,0.0
83,0.3,5,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Question: Are UK consultant radiologists happy with the training and support available for suspected child abuse? Answer: The survey demonstrates marked dissatisfaction among consultants, a small number of paediatric radiologists involved, and suggests that improved training could boost child abuse radiology experts by 27%.",3.079176455639103e-07,0.23939631859301747,0.017851239669421492,0.023574544042164344,0.2696635669491032,0.0,0.023540420032387266,0.27541197985996746,0.0,3.079176455639103e-07,0.2814124594381848,0.0
83,0.3,6,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Question: Is the training and support for suspected child abuse adequate for UK radiologists? Answer: Survey data reveals significant dissatisfaction among consultant radiologists, a low number of paediatric radiologists participating, and a potential 27% increase in experts if training is enhanced.",3.789755637709665e-07,0.3117169801726436,0.017851239669421492,0.029014823436509962,0.34377153910282665,0.0,0.028972824655245866,0.35139788683788886,0.0,3.789755637709665e-07,0.3593740009078954,0.0
83,0.3,7,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Question: Do UK radiologists feel supported and well-trained in suspected child abuse cases? Answer: The survey highlights considerable dissatisfaction among consultants, a limited number of paediatric radiologists engaged, and a 27% potential increase in specialists with improved training.",4.500334819780224e-07,0.38967852164235417,0.017851239669421492,0.03445510283085558,0.4238142467763608,0.0,0.034405229278104466,0.4336359850748619,0.0,4.500334819780227e-07,0.44393138893595907,0.0
83,0.3,8,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Question: Are UK radiologists satisfied with their training and support regarding suspected child abuse? Answer: The survey uncovers significant dissatisfaction among consultant radiologists, few paediatric radiologists involved, and a potential 27% growth in child abuse radiology experts if training improves.",4.026615365066518e-07,0.3370347881569353,0.017851239669421492,0.030828249901291835,0.3697470255060846,0.0,0.030783626196198732,0.37806613392004973,0.0,4.026615365066519e-07,0.3867729750960107,0.0
83,0.3,9,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Question: How do UK radiologists rate the training and support for suspected child abuse? Answer: The survey shows notable dissatisfaction among consultant radiologists, a low number of paediatric radiologists working in this area, and a possible 27% increase in experts if training is enhanced.",3.079176455639103e-07,0.23939631859301747,0.017851239669421492,0.023574544042164344,0.2696635669491032,0.0,0.023540420032387266,0.27541197985996746,0.0,3.079176455639103e-07,0.2814124594381848,0.0
83,0.3,10,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Question: Are UK radiologists content with the current training and support for suspected child abuse? Answer: Survey findings reveal significant dissatisfaction among consultant radiologists, a small number of paediatric radiologists involved, and a potential 27% rise in child abuse radiology specialists with better training.",3.079176455639103e-07,0.23939631859301747,0.017851239669421492,0.023574544042164344,0.2696635669491032,0.0,0.023540420032387266,0.27541197985996746,0.0,3.079176455639103e-07,0.2814124594381848,0.0
84,0.3,1,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high","Does the selection criteria for residency predict performance in orthopaedic surgery residency? Our study found that USMLE Step 2 scores, the number of honors received during medical school clerkships, and AOA membership showed the strongest correlations with resident performance. The purpose of analyzing this data was to give residency programs a clearer idea of which criteria might be considered ""high"".",9.474389094274162e-08,0.07020425867324764,0.0,0.0072537058591274906,0.07145896398214369,0.0,0.007243206163811466,0.07275935428242919,0.0,9.474389094274162e-08,0.07410797215372167,0.0
84,0.3,2,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high","Can residency selection criteria forecast performance in orthopaedic surgery residency? We discovered that USMLE Step 2 results, the count of honors in medical school clerkships, and AOA membership had the most significant correlations with how residents performed. Our aim in reviewing these data was to help residency programs understand which criteria could be deemed ""high.""",2.3685972735685406e-08,0.018349138668195764,0.0,0.0018134264647818726,0.018692133012154333,0.0,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
84,0.3,3,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high","Is it possible for residency selection criteria to predict performance in orthopaedic surgery residency? Our findings indicated that USMLE Step 2 scores, the number of honors earned in medical school clerkships, and AOA membership were most strongly linked to resident performance. We analyzed this data to assist residency programs in identifying which criteria might be considered ""high.""",2.3685972735685406e-08,0.018018505502678472,0.0,0.0018134264647818726,0.018349138668195764,0.0,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
84,0.3,4,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high","Do the criteria used for residency selection predict performance in orthopaedic surgery residency? We found that USMLE Step 2 scores, the number of honors in medical school clerkships, and AOA membership correlated most strongly with resident performance. Our goal in analyzing these data was to provide residency programs with insight into which criteria may be ""high.""",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
84,0.3,5,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high","Can performance in orthopaedic surgery residency be predicted by residency selection criteria? Our research showed that USMLE Step 2 scores, honors in medical school clerkships, and AOA membership had the strongest correlation with resident performance. We aimed to analyze these data to inform residency programs about which criteria might be considered ""high.""",9.474389094274162e-08,0.07550755250814589,0.0,0.0072537058591274906,0.07696104113612989,0.0,0.007243206163811466,0.07847161544149417,0.0,9.474389094274162e-08,0.08004270767353683,0.0
84,0.3,6,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high","Does the selection process for residency predict how well residents perform in orthopaedic surgery? We identified that USMLE Step 2 scores, the number of honors in medical school clerkships, and AOA membership had the strongest associations with resident performance. Our intent in analyzing these data was to help residency programs recognize which criteria may be ""high.""",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
84,0.3,7,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high","Are residency selection criteria predictive of performance in orthopaedic surgery residency? Our study revealed that USMLE Step 2 scores, honors in medical school clerkships, and AOA membership were the strongest predictors of resident performance. The purpose of this analysis was to guide residency programs on which criteria might be considered ""high.""",1.1842986367842703e-07,0.09531017980432566,0.0,0.009067132323909363,0.0971637484536485,0.0,0.009054007704764333,0.09909090264422993,0.0,1.1842986367842703e-07,0.10109611687136999,0.0
84,0.3,8,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high","Do the criteria for selecting residents predict their performance in orthopaedic surgery residency? We found that USMLE Step 2 scores, the number of honors in medical school clerkships, and AOA membership had the strongest correlations with resident performance. Our goal was to analyze these data to help residency programs understand which criteria may be ""high.""",2.3685972735685406e-08,0.018349138668195764,0.0,0.0018134264647818726,0.018692133012154333,0.0,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
84,0.3,9,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high","Is resident performance in orthopaedic surgery residency predicted by selection criteria? Our findings showed that USMLE Step 2 scores, honors in medical school clerkships, and AOA membership were most strongly correlated with resident performance. We analyzed these data to provide residency programs with a sense of which criteria might be ""high.""",1.1842986367842703e-07,0.09531017980432566,0.0,0.009067132323909363,0.0971637484536485,0.0,0.009054007704764333,0.09909090264422993,0.0,1.1842986367842703e-07,0.10109611687136999,0.0
84,0.3,10,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high","Can the criteria used for residency selection predict performance in orthopaedic surgery residency? We discovered that USMLE Step 2 scores, the number of honors in medical school clerkships, and AOA membership had the strongest correlations with resident performance. Our goal was to analyze these data to inform residency programs about which criteria may be ""high.""",2.3685972735685406e-08,0.018349138668195764,0.0,0.0018134264647818726,0.018692133012154333,0.0,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
85,0.3,1,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Is external palliative radiotherapy an effective treatment for gallbladder carcinoma? External radiotherapy appears to be a safe and effective palliative option for managing gallbladder carcinoma, though more research is needed to clarify its role in palliative or adjuvant therapy.",1.4211583641411222e-07,0.08359009414097063,0.045351473922902494,0.010880558788691236,0.1180427993023625,0.023242630385487524,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
85,0.3,2,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Does external palliative radiotherapy work well for gallbladder carcinoma? External radiotherapy seems to be a safe and effective palliative treatment for gallbladder carcinoma, but additional studies are required to define its role in palliative or adjuvant care.",1.8948778188548283e-07,0.17616549210902166,0.017596371882086164,0.014507411718254981,0.17361265045717467,0.023242630385487524,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
85,0.3,3,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Is external radiotherapy effective as palliative treatment for gallbladder carcinoma? External radiotherapy is considered a safe and effective palliative approach for gallbladder carcinoma, yet further research is necessary to establish its role in palliative or adjuvant treatment.",1.8948778188548283e-07,0.2146736688067965,0.01001184787640548,0.014507411718254981,0.17361265045717467,0.023242630385487524,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
85,0.3,4,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Can external palliative radiotherapy effectively manage gallbladder carcinoma? External radiotherapy appears safe and effective for palliative management of gallbladder carcinoma, but more studies are needed to determine its role in palliative or adjuvant therapy.",2.605457000925387e-07,0.22466869240087695,0.045351473922902494,0.01994769111260062,0.26322480914686164,0.023242630385487524,0.01991881695048156,0.30368241379822125,0.0,2.6054570009253947e-07,0.31237468504215293,0.0
85,0.3,5,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Is external radiotherapy a safe and effective palliative treatment for gallbladder carcinoma? External radiotherapy seems to be a safe and effective method for palliative management of gallbladder carcinoma; however, further investigation is required to understand its role in palliative or adjuvant treatment.",7.105791820705622e-08,0.1428524175162087,0.05106927114649125,0.005440279394345618,0.10939597588864602,0.02661886545938781,0.0054324046228586,0.10965398141320737,0.025623268698060954,7.105791820705622e-08,0.0759859069779214,0.0
85,0.3,6,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","How effective is external palliative radiotherapy for gallbladder carcinoma? External radiotherapy is regarded as a safe and effective palliative treatment for gallbladder carcinoma, though additional studies are necessary to clarify its role in palliative or adjuvant therapy.",1.8948778188548283e-07,0.17616549210902166,0.017596371882086164,0.014507411718254981,0.17361265045717467,0.023242630385487524,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
85,0.3,7,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Is external radiotherapy beneficial as palliative care for gallbladder carcinoma? External radiotherapy appears to be a safe and effective palliative treatment for gallbladder carcinoma, but more research is needed to determine its role in palliative or adjuvant treatment.",1.6580180914979753e-07,0.18519317155393722,0.008526077097505684,0.012693985253473108,0.14544177349047782,0.023242630385487524,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
85,0.3,8,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Does external radiotherapy provide effective palliative treatment for gallbladder carcinoma? External radiotherapy seems to be a safe and effective method for palliative management of gallbladder carcinoma; however, further studies are required to define its role in palliative or adjuvant therapy.",1.1842986367842692e-07,0.09316061699719658,0.01972820522484154,0.009067132323909363,0.09137455222020163,0.023242630385487524,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
85,0.3,9,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Is external palliative radiotherapy a viable option for gallbladder carcinoma? External radiotherapy is considered a safe and effective palliative treatment for gallbladder carcinoma, yet more research is needed to establish its role in palliative or adjuvant care.",1.8948778188548283e-07,0.17616549210902166,0.017596371882086164,0.014507411718254981,0.17361265045717467,0.023242630385487524,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
85,0.3,10,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","What is the effectiveness of external palliative radiotherapy in gallbladder carcinoma? External radiotherapy appears to be a safe and effective palliative management method for gallbladder carcinoma, although further studies are necessary to determine its role in palliative or adjuvant treatment.",1.1842986367842692e-07,0.05761460773771265,0.045351473922902494,0.009067132323909363,0.09137455222020163,0.023242630385487524,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
86,0.3,1,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Is central venous pressure a reliable predictor of fluid responsiveness? Answer: Evidence does not support the common use of central venous pressure to direct fluid therapy. This method of fluid resuscitation should be discontinued.,2.36859727356853e-08,0.07209080692487779,0.030475982987571308,0.0018134264647818796,0.031088519621267796,0.0008886808425160632,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
86,0.3,2,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Can central venous pressure indicate fluid responsiveness? Answer: There is no data backing the routine use of central venous pressure for guiding fluid therapy. This practice in fluid resuscitation ought to be stopped.,4.73719454713706e-08,0.06364151945538365,0.003420832103075977,0.003626852929563759,0.06317295703908332,0.0018327251323183684,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
86,0.3,3,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Does measuring central venous pressure help predict fluid responsiveness? Answer: Current evidence does not justify the widespread use of central venous pressure to manage fluid therapy. This strategy for fluid resuscitation should be abandoned.,2.36859727356853e-08,0.031317443362529396,0.0016607839761248952,0.0018134264647818796,0.031088519621267796,0.0008886808425160632,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
86,0.3,4,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Is central venous pressure an effective tool to predict fluid responsiveness? Answer: No data supports the common practice of using central venous pressure to guide fluid therapy. This approach should be discontinued.,7.10579182070559e-08,0.09703873562425924,0.005289256198347123,0.005440279394345639,0.09631912950801658,0.002837465564738264,0.005432404622858621,0.09531017980432521,0.0,7.105791820705622e-08,0.09844007281325329,0.0
86,0.3,5,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Does central venous pressure serve as a predictor for fluid responsiveness? Answer: There is a lack of evidence supporting the use of central venous pressure to guide fluid therapy. This method should be abandoned in fluid resuscitation.,4.73719454713706e-08,0.059851841459428456,0.003055415003466927,0.003626852929563752,0.05942360070452324,0.001629654616667607,0.003621603081905747,0.058840500022933284,0.0,4.737194547137081e-08,0.060624621816435464,0.0
86,0.3,6,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Can central venous pressure be used to predict fluid responsiveness? Answer: The widespread practice of using central venous pressure to guide fluid therapy is not supported by data. This approach should be stopped.,4.73719454713706e-08,0.06364151945538365,0.003420832103075977,0.003626852929563759,0.06317295703908332,0.0018327251323183684,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
86,0.3,7,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Is central venous pressure a valid predictor of fluid responsiveness? Answer: Data does not support the routine use of central venous pressure for fluid therapy guidance. This practice should be abandoned.,9.47438909427412e-08,0.13158238224754726,0.007276308649133208,0.007253705859127518,0.1305995914289868,0.003908941321112979,0.007243206163811494,0.12921173148000697,0.0,9.474389094274162e-08,0.1335313926245223,0.0
86,0.3,8,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Does central venous pressure reliably predict fluid responsiveness? Answer: There is no evidence to endorse the common use of central venous pressure to guide fluid therapy. This method should be discontinued.,9.47438909427412e-08,0.13158238224754726,0.007276308649133208,0.007253705859127518,0.1305995914289868,0.003908941321112979,0.007243206163811494,0.12921173148000697,0.0,9.474389094274162e-08,0.1335313926245223,0.0
86,0.3,9,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Can central venous pressure predict fluid responsiveness? Answer: No data supports the widespread use of central venous pressure in guiding fluid therapy. This approach should be abandoned.,1.894877818854824e-07,0.2829828460437285,0.01666703397612488,0.014507411718255037,0.28080963692155647,0.009015243342516074,0.014486412327622988,0.2776317365982801,0.0,1.8948778188548325e-07,0.28768207245178123,0.0
86,0.3,10,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,"Question: Is the use of central venous pressure effective in predicting fluid responsiveness? Answer: Evidence does not support using central venous pressure to guide fluid therapy, and this practice should be stopped.",9.47438909427412e-08,0.13158238224754726,0.007276308649133208,0.007253705859127518,0.1305995914289868,0.003908941321112979,0.007243206163811494,0.12921173148000697,0.0,9.474389094274162e-08,0.1335313926245223,0.0
87,0.3,1,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia,Is (18)F-FDG an effective surrogate tracer for assessing tumor hypoxia? This research demonstrated that FDG does not serve well as a surrogate tracer for tumor hypoxia in either normal or low oxygen environments. Only targeted hypoxia...,4.73719454713706e-08,0.02163259942144702,0.026659528523875105,0.003626852929563759,0.019851258254085735,0.029384756657483937,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
87,0.3,2,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia,Can (18)F-FDG be used as a surrogate tracer to evaluate tumor hypoxia? The study found that FDG is not an appropriate surrogate tracer for tumor hypoxia under both ambient and hypoxic conditions. Only specific hypoxia...,2.36859727356853e-08,0.031088519621267796,0.0008886808425160632,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
87,0.3,3,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia,Does (18)F-FDG act as a surrogate tracer for measuring tumor hypoxia? Findings indicate that FDG is ineffective as a surrogate tracer for tumor hypoxia in both normal and hypoxic states. Only particular hypoxia...,2.36859727356853e-08,0.16204953377280518,0.09217554209183673,0.0018134264647818796,0.16590621713263376,0.09566326530612247,0.0018108015409528735,0.1252094468976508,0.06632653061224487,2.3685972735685406e-08,0.08170480550740189,0.03443877551020409
87,0.3,4,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia,Is (18)F-FDG suitable as a surrogate tracer for tumor hypoxia measurement? The study revealed that FDG is not a reliable surrogate tracer for tumor hypoxia under ambient or hypoxic conditions. Only certain hypoxia...,2.36859727356853e-08,0.16204953377280518,0.09217554209183673,0.0018134264647818796,0.16590621713263376,0.09566326530612247,0.0018108015409528735,0.1252094468976508,0.06632653061224487,2.3685972735685406e-08,0.08170480550740189,0.03443877551020409
87,0.3,5,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia,Can (18)F-FDG serve as a surrogate tracer to detect tumor hypoxia? Research shows FDG is not a good surrogate tracer for tumor hypoxia in either normal or hypoxic conditions. Only specific hypoxia...,4.73719454713706e-08,0.06523060988674878,0.0019487847222222007,0.003626852929563759,0.06453852113757153,0.0,0.003621603081905747,0.06669137449867346,0.0,4.737194547137081e-08,0.06899287148695077,0.0
87,0.3,6,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia,Is (18)F-FDG a valid surrogate tracer for tumor hypoxia evaluation? This study concluded that FDG is not effective as a surrogate tracer for tumor hypoxia under both ambient and hypoxic conditions. Only specific hypoxia...,0.0,0.12602676010180858,0.0886326267092747,0.0,0.12996509635499054,0.09274673008323425,0.0,0.08943834587870247,0.06420927467300831,0.0,0.046209812037329545,0.033293697978596916
87,0.3,7,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia,Does (18)F-FDG function as a surrogate tracer to measure tumor hypoxia? The study demonstrated that FDG is not suitable as a surrogate tracer for tumor hypoxia in either ambient or hypoxic environments. Only specific hypoxia...,2.36859727356853e-08,0.050458207503430774,0.05713551151144641,0.0018134264647818796,0.0532461814011187,0.06035379812695108,0.0018108015409528735,0.01157300047041776,0.031217481789802305,2.3685972735685406e-08,0.0327898228229917,0.0
87,0.3,8,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia,Is (18)F-FDG an appropriate surrogate tracer for tumor hypoxia? The research indicated that FDG is not a good surrogate tracer for tumor hypoxia under normal or hypoxic conditions. Only specific hypoxia...,7.10579182070559e-08,0.19193069588237854,0.06849199459876545,0.005440279394345639,0.19404658047669354,0.06858710562414266,0.005432404622858621,0.15129320720708161,0.035665294924554176,7.105791820705622e-08,0.10536051565782545,0.0
87,0.3,9,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia,Can (18)F-FDG be considered a surrogate tracer for tumor hypoxia? The findings showed that FDG is not effective as a surrogate tracer for tumor hypoxia in ambient or hypoxic conditions. Only specific hypoxia...,2.36859727356853e-08,0.16204953377280518,0.09217554209183673,0.0018134264647818796,0.16590621713263376,0.09566326530612247,0.0018108015409528735,0.1252094468976508,0.06632653061224487,2.3685972735685406e-08,0.08170480550740189,0.03443877551020409
87,0.3,10,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia,Is (18)F-FDG useful as a surrogate tracer for measuring tumor hypoxia? The study showed that FDG does not perform well as a surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia...,4.73719454713706e-08,0.05758422121397544,0.08210949694328822,0.003626852929563759,0.061695468870612835,0.08740894901144641,0.003621603081905747,0.02149748308653887,0.06035379812695108,4.737194547137081e-08,0.02121682235257394,0.031217481789802305
89,0.3,1,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Does glomerular hyperfiltration during pregnancy harm the kidneys of women with multiple pregnancies? Our study indicates that pregnancy-induced glomerular hyperfiltration does not negatively impact the kidneys in women with higher parity. Pregnancy might offer protective effects against the harmful consequences of glomerular hyperfiltration on the kidneys.,1.4211583641411244e-07,0.09692359066558609,0.021267763897151196,0.010880558788691236,0.044655709842690516,0.05975554549569943,0.0108648092457172,0.0740367391060488,0.040742417383431435,1.4211583641411244e-07,0.1046502601011925,0.020823902218198284
89,0.3,2,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.","Is kidney damage caused by glomerular hyperfiltration in pregnant women with several childbirths? According to our research, glomerular hyperfiltration from pregnancy does not adversely affect the kidneys in women with more parities. Pregnancy may provide protective mechanisms for the kidneys against the detrimental effects of glomerular hyperfiltration.",1.1842986367842703e-07,0.030501283797998102,0.050655609638843815,0.009067132323909363,0.0221828539906328,0.05975554549569943,0.009054007704764333,0.051047220881349276,0.040742417383431435,1.1842986367842703e-07,0.08111976269099808,0.020823902218198284
89,0.3,3,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Does glomerular hyperfiltration in pregnancy lead to kidney damage in women who have had multiple births? Our findings suggest that the increased glomerular filtration during pregnancy does not harm the kidneys of women with higher parity. Pregnancy might protect the kidneys from the negative impact of glomerular hyperfiltration.,9.474389094274162e-08,0.05191979853045359,0.09428901491283345,0.0072537058591274906,0.00020394727185779615,0.05975554549569943,0.007243206163811466,0.02857436502929156,0.040742417383431435,9.474389094274162e-08,0.05813024446629855,0.020823902218198284
89,0.3,4,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Can glomerular hyperfiltration during pregnancy damage the kidneys in women with multiple pregnancies? Our study proposes that pregnancy-related glomerular hyperfiltration does not cause kidney damage in women with more parities. Pregnancy may have protective roles against the harmful effects of glomerular hyperfiltration on the kidney.,1.6580180914979784e-07,0.1224613079258492,0.02444444444444442,0.012693985253473108,0.09988463181436424,0.03651291511021191,0.012675610786670066,0.09756723651624322,0.040742417383431435,1.6580180914979784e-07,0.1287478116802525,0.020823902218198284
89,0.3,5,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Does pregnancy-induced glomerular hyperfiltration cause kidney injury in women with several parities? Our research suggests that glomerular hyperfiltration from pregnancy does not adversely affect kidney function in women with multiple childbirths. Pregnancy might confer protective mechanisms to the kidneys against glomerular hyperfiltration's adverse effects.,1.8948778188548325e-07,0.1042502740222866,0.04618055555555557,0.014507411718254981,0.12418273407567604,0.03596018559088088,0.014486412327622933,0.12166478809530323,0.040742417383431435,1.8948778188548325e-07,0.1534404242706242,0.020823902218198284
89,0.3,6,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Is there kidney damage from glomerular hyperfiltration during pregnancy in women with many parities? Our study suggests that pregnancy-related glomerular hyperfiltration does not harm the kidneys in women with higher parity. Pregnancy may have protective effects shielding the kidneys from glomerular hyperfiltration damage.,2.1317375462116866e-07,0.2415629009173652,0.07888888888888886,0.016320838183036854,0.1828973922332242,0.011103342997343092,0.0162972138685758,0.14635740068567493,0.040742417383431435,2.1317375462116866e-07,0.17875823225491594,0.020823902218198284
89,0.3,7,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Does glomerular hyperfiltration during pregnancy harm the kidneys of women with multiple births? Our research indicates that pregnancy-induced glomerular hyperfiltration does not negatively affect kidney health in women with more parities. Pregnancy may provide protective mechanisms against the adverse effects of glomerular hyperfiltration on kidneys.,1.6580180914979784e-07,0.09095461790039705,0.001041707978055334,0.012693985253473108,0.06764522806739004,0.05975554549569943,0.012675610786670066,0.09756723651624322,0.040742417383431435,1.6580180914979784e-07,0.1287478116802525,0.020823902218198284
89,0.3,8,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Does glomerular hyperfiltration in pregnancy cause kidney damage in women with increased parity? Our study suggests that the hyperfiltration associated with pregnancy does not have harmful effects on the kidneys of women with multiple pregnancies. Pregnancy might offer protective benefits to the kidneys against glomerular hyperfiltration damage.,1.1842986367842703e-07,0.030501283797998102,0.050655609638843815,0.009067132323909363,0.0221828539906328,0.05975554549569943,0.009054007704764333,0.051047220881349276,0.040742417383431435,1.1842986367842703e-07,0.08111976269099808,0.020823902218198284
89,0.3,9,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Is kidney damage linked to glomerular hyperfiltration during pregnancy in women with many parities? Our findings indicate that pregnancy-induced glomerular hyperfiltration does not adversely impact kidney function in women with higher parity. Pregnancy may have protective mechanisms that guard the kidneys from the negative effects of glomerular hyperfiltration.,9.474389094274162e-08,0.007071450878903374,0.05202249770431591,0.0072537058591274906,0.030340781209246437,0.038027150433971035,0.007243206163811466,0.02857436502929156,0.040742417383431435,9.474389094274162e-08,0.05813024446629855,0.020823902218198284
89,0.3,10,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Does glomerular hyperfiltration from pregnancy damage the kidneys in women with multiple childbirths? Our study suggests that pregnancy-related glomerular hyperfiltration does not cause kidney harm in women with more parities. Pregnancy might provide protective effects to the kidneys against the adverse consequences of glomerular hyperfiltration.,1.6580180914979784e-07,0.11056930465847348,0.025555555555555567,0.012693985253473108,0.09988463181436424,0.03651291511021191,0.012675610786670066,0.09756723651624322,0.040742417383431435,1.6580180914979784e-07,0.1287478116802525,0.020823902218198284
90,0.3,1,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: The reliability of stroke patients' reports of home blood pressure readings may vary. It is important for healthcare professionals to assess the accuracy and consistency of these readings through validation methods, such as comparing them to in-clinic measurements or using automated home blood pressure monitoring devices.",Are the home blood pressure readings reported by stroke patients dependable? The dependability of these reports can differ. Healthcare providers should verify the accuracy and consistency of these readings by comparing them with clinic measurements or using automated home monitoring devices.,4.026615365066519e-07,0.15158100542215225,0.21069351988823143,0.030828249901291835,0.1791595326125801,0.16326530612244897,0.030783626196198732,0.24372026540427605,0.08999999999999998,4.026615365066519e-07,0.27537766272598274,0.07359999999999998
90,0.3,2,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: The reliability of stroke patients' reports of home blood pressure readings may vary. It is important for healthcare professionals to assess the accuracy and consistency of these readings through validation methods, such as comparing them to in-clinic measurements or using automated home blood pressure monitoring devices.","Can stroke patients' self-reported home blood pressure readings be trusted? The trustworthiness of these reports may vary, so healthcare professionals need to validate them by cross-checking with in-clinic readings or employing automated home blood pressure monitors.",5.210914001850784e-07,0.3296718596541006,0.17874411730945824,0.039895382225201205,0.35713401768841235,0.13388054946496503,0.03983763390096308,0.38479886366418237,0.08999999999999998,5.210914001850789e-07,0.4205596725704819,0.07359999999999998
90,0.3,3,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: The reliability of stroke patients' reports of home blood pressure readings may vary. It is important for healthcare professionals to assess the accuracy and consistency of these readings through validation methods, such as comparing them to in-clinic measurements or using automated home blood pressure monitoring devices.","Do stroke patients provide reliable home blood pressure readings? The reliability can fluctuate, making it essential for healthcare workers to confirm accuracy through validation techniques like comparing with clinical measurements or using automated devices at home.",5.210914001850784e-07,0.2504550390186786,0.23567708333333334,0.039895382225201205,0.3163606541260626,0.16326530612244897,0.03983763390096308,0.38479886366418237,0.08999999999999998,5.210914001850789e-07,0.4205596725704819,0.07359999999999998
90,0.3,4,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: The reliability of stroke patients' reports of home blood pressure readings may vary. It is important for healthcare professionals to assess the accuracy and consistency of these readings through validation methods, such as comparing them to in-clinic measurements or using automated home blood pressure monitoring devices.","Is the information stroke patients give about their home blood pressure readings reliable? The reliability may differ, and it is crucial for healthcare professionals to assess these readings by validating them against in-clinic measurements or automated home monitoring tools.",4.500334819780225e-07,0.16821694078170557,0.23567708333333334,0.03445510283085558,0.23180326609799895,0.16326530612244897,0.034405229278104466,0.29778748667455224,0.08999999999999998,4.500334819780227e-07,0.3309475138807949,0.07359999999999998
90,0.3,5,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: The reliability of stroke patients' reports of home blood pressure readings may vary. It is important for healthcare professionals to assess the accuracy and consistency of these readings through validation methods, such as comparing them to in-clinic measurements or using automated home blood pressure monitoring devices.","Are reports of home blood pressure readings from stroke patients accurate? Their accuracy can vary, so healthcare providers should evaluate the consistency and correctness by comparing with clinic readings or using automated home devices.",5.68463345656449e-07,0.3092955390416119,0.23567708333333334,0.043522235154764964,0.3769852759424981,0.16326530612244897,0.043459236982868826,0.4473192206455159,0.08999999999999998,5.684633456564497e-07,0.4850981937080534,0.07359999999999998
90,0.3,6,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: The reliability of stroke patients' reports of home blood pressure readings may vary. It is important for healthcare professionals to assess the accuracy and consistency of these readings through validation methods, such as comparing them to in-clinic measurements or using automated home blood pressure monitoring devices.","How reliable are stroke patients' reports of their home blood pressure readings? Reliability may vary, requiring healthcare professionals to validate these readings by comparing them with clinical measurements or using automated home blood pressure monitors.",5.447773729207637e-07,0.36098930301663,0.17708333333333334,0.041708808689983085,0.38822253730968015,0.13299186862244897,0.04164843544191595,0.41557052233093605,0.08999999999999998,5.447773729207643e-07,0.4523083708850617,0.07359999999999998
90,0.3,7,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: The reliability of stroke patients' reports of home blood pressure readings may vary. It is important for healthcare professionals to assess the accuracy and consistency of these readings through validation methods, such as comparing them to in-clinic measurements or using automated home blood pressure monitoring devices.","Can the home blood pressure readings reported by stroke patients be considered reliable? The reliability might differ, thus healthcare professionals must assess their accuracy through validation methods such as comparing with in-clinic measurements or automated home devices.",4.974054274493931e-07,0.22228416205198176,0.23567708333333334,0.038081955760419325,0.2873731172528111,0.16326530612244897,0.038026832360010206,0.3549459005145006,0.08999999999999998,4.974054274493935e-07,0.3897880139037282,0.07359999999999998
90,0.3,8,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: The reliability of stroke patients' reports of home blood pressure readings may vary. It is important for healthcare professionals to assess the accuracy and consistency of these readings through validation methods, such as comparing them to in-clinic measurements or using automated home blood pressure monitoring devices.","Are stroke patients' self-reports of home blood pressure readings consistent and accurate? Consistency and accuracy may vary, so it is important for healthcare providers to verify these readings by comparing them to clinic measurements or using automated home monitoring devices.",4.263475092423372e-07,0.1422414543784476,0.23567708333333334,0.03264167636607371,0.20513501901583808,0.16326530612244897,0.0325944277371516,0.2703885124864369,0.08999999999999998,4.263475092423373e-07,0.30277663691409806,0.07359999999999998
90,0.3,9,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: The reliability of stroke patients' reports of home blood pressure readings may vary. It is important for healthcare professionals to assess the accuracy and consistency of these readings through validation methods, such as comparing them to in-clinic measurements or using automated home blood pressure monitoring devices.","Is it dependable to rely on stroke patients' reports of home blood pressure readings? Dependability can vary, and healthcare professionals should validate these readings by cross-referencing with clinical measurements or automated home blood pressure monitoring devices.",5.210914001850784e-07,0.3296718596541006,0.17874411730945824,0.039895382225201205,0.35713401768841235,0.13388054946496503,0.03983763390096308,0.38479886366418237,0.08999999999999998,5.210914001850789e-07,0.4205596725704819,0.07359999999999998
90,0.3,10,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: The reliability of stroke patients' reports of home blood pressure readings may vary. It is important for healthcare professionals to assess the accuracy and consistency of these readings through validation methods, such as comparing them to in-clinic measurements or using automated home blood pressure monitoring devices.","Do stroke patients reliably report their home blood pressure readings? The reliability can be inconsistent, making it necessary for healthcare providers to confirm accuracy through validation against in-clinic measurements or automated home monitoring systems.",5.68463345656449e-07,0.3092955390416119,0.23567708333333334,0.043522235154764964,0.3769852759424981,0.16326530612244897,0.043459236982868826,0.4473192206455159,0.08999999999999998,5.684633456564497e-07,0.4850981937080534,0.07359999999999998
91,0.3,1,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Are elevated carotid artery pulsatility and resistance indexes early indicators of vascular issues in young obese males? Our findings indicate that reduced vessel compliance and heightened vascular resistance characterize young, obese, normotensive individuals, independent of other cardiovascular risk factors. Alterations in arterial wall properties may...",1.8948778188548325e-07,0.16705408466316607,0.0,0.014507411718254981,0.1706255170307629,0.0,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
91,0.3,2,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Do increased carotid artery pulsatility and resistance indexes serve as early markers of vascular abnormalities in young obese men? The results show that young, obese, normotensive subjects exhibit decreased vessel compliance and increased vascular resistance, beyond traditional cardiovascular risk factors. Changes in arterial wall properties might...",1.6580180914979784e-07,0.14458122881110835,0.0,0.012693985253473108,0.14763599880606337,0.0,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
91,0.3,3,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Is there a link between higher carotid artery pulsatility and resistance indexes and early vascular abnormalities in young obese males? Our study suggests that young, obese, normotensive individuals have impaired vessel compliance and elevated vascular resistance, separate from cardiovascular risk factors. Modifications in arterial wall characteristics may...",1.4211583641411244e-07,0.12260232209233335,0.0,0.010880558788691236,0.12516314295400566,0.0,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
91,0.3,4,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Are increased pulsatility and resistance indexes in the carotid artery early signs of vascular dysfunction in young obese males? Findings reveal that young, obese, normotensive subjects display reduced vessel compliance and increased vascular resistance, independent of cardiovascular risk factors. Arterial wall property changes could...",2.1317375462116866e-07,0.1900436028878656,0.0,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
91,0.3,5,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Can elevated carotid artery pulsatility and resistance indexes indicate early vascular abnormalities in young obese males? The data imply that young, obese, normotensive individuals have diminished vessel compliance and higher vascular resistance, regardless of cardiovascular risk factors. Altered arterial wall properties may...",2.6054570009253947e-07,0.23767165187712003,0.0,0.0199476911126006,0.24294617861038903,0.0,0.019918816950481533,0.248461359298501,0.0,2.6054570009253947e-07,0.25423413838424036,0.0
91,0.3,6,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Do young obese males show early vascular abnormalities through increased carotid artery pulsatility and resistance indexes? Our results suggest that depressed vessel compliance and raised vascular resistance are present in young, obese, normotensive subjects, independent of cardiovascular risk factors. Changes in arterial wall properties may...",1.8948778188548325e-07,0.16705408466316607,0.0,0.014507411718254981,0.1706255170307629,0.0,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
91,0.3,7,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Are higher carotid artery pulsatility and resistance indexes early indicators of vascular problems in young obese males? The findings suggest that young, obese, normotensive individuals have decreased vessel compliance and increased vascular resistance, beyond cardiovascular risk factors. Alterations in arterial wall properties might...",2.3685972735685406e-07,0.21357410029806,0.0,0.018134264647818726,0.21825356602001733,0.0,0.018108015409528666,0.22314355131420927,0.0,2.3685972735685406e-07,0.22825865198098239,0.0
91,0.3,8,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Is increased carotid artery pulsatility and resistance indexes a sign of early vascular abnormalities in young obese males? Our study indicates that young, obese, normotensive subjects exhibit reduced vessel compliance and elevated vascular resistance, independent of cardiovascular risk factors. Changes in arterial wall properties may...",1.8948778188548325e-07,0.16705408466316607,0.0,0.014507411718254981,0.1706255170307629,0.0,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
91,0.3,9,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Could increased carotid artery pulsatility and resistance indexes be early markers of vascular abnormalities in young obese males? Results suggest that young, obese, normotensive individuals have impaired vessel compliance and increased vascular resistance, apart from cardiovascular risk factors. Alterations in arterial wall properties may...",2.1317375462116866e-07,0.1900436028878656,0.0,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
91,0.3,10,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Are elevated carotid artery pulsatility and resistance indexes associated with early vascular abnormalities in young obese males? Our findings indicate that depressed vessel compliance and increased vascular resistance characterize young, obese, normotensive subjects independently of cardiovascular risk factors. Changes in arterial wall properties might...",2.1317375462116866e-07,0.1900436028878656,0.0,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
92,0.3,1,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Question: Does having an optimistic outlook predict better survival rates in advanced age? Answer: Optimism seems to be a strong predictor of survival in the oldest-old women. It might also predict survival in men, though the sample size is limited.",1.1842986367842692e-07,0.0013594530791580794,0.0861453046089739,0.009067132323909363,0.02689574472625278,0.06937499999999999,0.009054007704764333,0.0937446970410507,0.023795359904818555,1.1842986367842703e-07,0.1300531282481976,0.0
92,0.3,2,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Question: Is an optimistic perspective linked to improved survival in very old age? Answer: An optimistic attitude appears to significantly predict survival among the oldest-old women and may also be important for men, but the male sample is small.",1.4211583641411222e-07,0.025551454620402314,0.08547200646992748,0.010880558788691236,0.05356399180841365,0.06937499999999999,0.0108648092457172,0.12114367122916603,0.023795359904818555,1.4211583641411244e-07,0.15822400521489444,0.0
92,0.3,3,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Question: Can optimism forecast better survival outcomes in advanced age? Answer: Among the oldest-old women, optimism is a notable predictor of survival. It could also be relevant for men, though the sample size is small.",2.3685972735685343e-07,0.10029565917484051,0.11176857330703485,0.01813426464781874,0.1679743429861591,0.06937499999999999,0.018108015409528687,0.23892670688554984,0.023795359904818555,2.3685972735685406e-07,0.27958486221916123,0.0
92,0.3,4,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Question: Does optimism influence survival chances at advanced ages? Answer: Optimistic outlooks are significant predictors of survival in the oldest-old women and potentially for men, but the male sample size is limited.",3.0791764556390933e-07,0.1926689793058558,0.11176857330703485,0.02357454404216438,0.2632845227904843,0.06937499999999999,0.023540420032387308,0.33736677969880313,0.023795359904818555,3.079176455639103e-07,0.3813675565291037,0.0
92,0.3,5,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Question: Is a positive outlook associated with higher survival rates in the oldest-old? Answer: Optimism is a significant survival predictor for oldest-old women and may be for men as well, though the men's sample is small.",2.1317375462116813e-07,0.11091653261930023,0.08322186050426669,0.01632083818303686,0.13812137983647732,0.06937499999999999,0.016297213868575813,0.20815504821879616,0.023795359904818555,2.1317375462116866e-07,0.2478361639045814,0.0
92,0.3,6,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Question: Does having an optimistic view improve survival at very old ages? Answer: Optimism appears to be a key predictor of survival among oldest-old women and possibly men, but the male sample is small.",2.605457000925387e-07,0.1301486223245223,0.11176857330703485,0.01994769111260062,0.19874600165291278,0.06937499999999999,0.01991881695048156,0.27067540520012967,0.023795359904818555,2.6054570009253947e-07,0.31237468504215293,0.0
92,0.3,7,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Question: Can an optimistic mindset predict longevity in advanced age? Answer: Among the oldest-old women, optimism significantly predicts survival and may also do so for men, though the sample size for men is small.",2.605457000925387e-07,0.1301486223245223,0.11176857330703485,0.01994769111260062,0.19874600165291278,0.06937499999999999,0.01991881695048156,0.27067540520012967,0.023795359904818555,2.6054570009253947e-07,0.31237468504215293,0.0
92,0.3,8,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Question: Is optimism a predictor of better survival in the oldest-old population? Answer: An optimistic outlook is a significant survival predictor for oldest-old women and might be for men, but the male sample size is limited.",2.1317375462116813e-07,0.071308122301589,0.11176857330703485,0.01632083818303686,0.13812137983647732,0.06937499999999999,0.016297213868575813,0.20815504821879616,0.023795359904818555,2.1317375462116866e-07,0.2478361639045814,0.0
92,0.3,9,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Question: Does an optimistic attitude correlate with improved survival at advanced ages? Answer: Optimism is a significant factor predicting survival among oldest-old women and possibly men, though the male sample is small.",3.0791764556390933e-07,0.1926689793058558,0.11176857330703485,0.02357454404216438,0.2632845227904843,0.06937499999999999,0.023540420032387308,0.33736677969880313,0.023795359904818555,3.079176455639103e-07,0.3813675565291037,0.0
92,0.3,10,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Question: Can optimism forecast better survival chances in very old age? Answer: Optimism appears to be a significant predictor of survival for oldest-old women and may also be for men, but the sample size for men is small.",1.6580180914979753e-07,0.01573827114677684,0.11176857330703485,0.012693985253473108,0.08096296599652897,0.06937499999999999,0.012675610786670066,0.14931454819586287,0.023795359904818555,1.6580180914979784e-07,0.18721154208814594,0.0
93,0.3,1,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone in Hirschsprung's disease typically correlates with the level of aganglionosis observed on the specimen.",Does the radiographic transition zone correspond to the extent of aganglionosis in Hirschsprung's disease specimens?,5.447773729207622e-07,0.6346538465403451,0.21811224489795913,0.04170880868998321,0.8260286975056998,0.13527575442247655,0.041648435441916085,0.9516161807482795,0.0849609375,5.447773729207638e-07,1.0876918882554416,0.029384756657483937
93,0.3,2,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone in Hirschsprung's disease typically correlates with the level of aganglionosis observed on the specimen.",Is there a correlation between the radiographic transition zone and the level of aganglionosis in Hirschsprung's disease?,4.974054274493916e-07,0.5011224539158223,0.21811224489795913,0.03808195576041945,0.6829278538650265,0.13527575442247655,0.03802683236001034,0.7974655009210219,0.0849609375,4.974054274493931e-07,0.9206378035922751,0.029384756657483937
93,0.3,3,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone in Hirschsprung's disease typically correlates with the level of aganglionosis observed on the specimen.","In Hirschsprung's disease, does the radiographic transition zone match the aganglionosis level seen in the specimen?",5.210914001850769e-07,0.565660975053393,0.21811224489795913,0.03989538222520133,0.7519207253519786,0.13527575442247655,0.03983763390096322,0.8715734730747431,0.0849609375,5.210914001850785e-07,1.0006805112658115,0.029384756657483937
93,0.3,4,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone in Hirschsprung's disease typically correlates with the level of aganglionosis observed on the specimen.",Does the location of the radiographic transition zone align with the aganglionosis level on the Hirschsprung's disease specimen?,4.737194547137062e-07,0.4404978320993873,0.21811224489795913,0.03626852929563758,0.6183893327274559,0.13527575442247655,0.03621603081905747,0.7284726294340698,0.0849609375,4.7371945471370775e-07,0.8465298314385539,0.029384756657483937
93,0.3,5,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone in Hirschsprung's disease typically correlates with the level of aganglionosis observed on the specimen.",Is the radiographic transition zone indicative of the aganglionosis extent in Hirschsprung's disease specimens?,5.684633456564476e-07,0.7087618186940663,0.21811224489795913,0.04352223515476508,0.9060714051792362,0.13527575442247655,0.043459236982868965,1.0386275577379096,0.0849609375,5.684633456564491e-07,1.1830020680597668,0.029384756657483937
93,0.3,6,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone in Hirschsprung's disease typically correlates with the level of aganglionosis observed on the specimen.","For Hirschsprung's disease, does the radiographic transition zone reflect the level of aganglionosis found in the specimen?",4.974054274493916e-07,0.5011224539158223,0.21811224489795913,0.03808195576041945,0.6829278538650265,0.13527575442247655,0.03802683236001034,0.7974655009210219,0.0849609375,4.974054274493931e-07,0.9206378035922751,0.029384756657483937
93,0.3,7,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone in Hirschsprung's disease typically correlates with the level of aganglionosis observed on the specimen.",Does the radiographic transition zone in Hirschsprung's disease correspond to the specimen's aganglionosis level?,5.684633456564476e-07,0.7087618186940663,0.21811224489795913,0.04352223515476508,0.9060714051792362,0.13527575442247655,0.043459236982868965,1.0386275577379096,0.0849609375,5.684633456564491e-07,1.1830020680597668,0.029384756657483937
93,0.3,8,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone in Hirschsprung's disease typically correlates with the level of aganglionosis observed on the specimen.","In Hirschsprung's disease, is the radiographic transition zone consistent with the level of aganglionosis on the specimen?",4.974054274493916e-07,0.5011224539158223,0.21811224489795913,0.03808195576041945,0.6829278538650265,0.13527575442247655,0.03802683236001034,0.7974655009210219,0.0849609375,4.974054274493931e-07,0.9206378035922751,0.029384756657483937
93,0.3,9,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone in Hirschsprung's disease typically correlates with the level of aganglionosis observed on the specimen.",Does the radiographic transition zone typically indicate the aganglionosis level in Hirschsprung's disease specimens?,5.684633456564476e-07,0.7087618186940663,0.21811224489795913,0.04352223515476508,0.9060714051792362,0.13527575442247655,0.043459236982868965,1.0386275577379096,0.0849609375,5.684633456564491e-07,1.1830020680597668,0.029384756657483937
93,0.3,10,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone in Hirschsprung's disease typically correlates with the level of aganglionosis observed on the specimen.",Is there a typical correlation between the radiographic transition zone and aganglionosis level in Hirschsprung's disease?,5.210914001850769e-07,0.565660975053393,0.21811224489795913,0.03989538222520133,0.7519207253519786,0.13527575442247655,0.03983763390096322,0.8715734730747431,0.0849609375,5.210914001850785e-07,1.0006805112658115,0.029384756657483937
94,0.3,1,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Can D-dimer serve as a novel diagnostic marker for acute appendicitis? Answer: Elevated D-dimer levels should not be used as a diagnostic criterion for acute appendicitis.,2.36859727356853e-08,0.09303412016426726,0.039406640368178834,0.0018134264647818796,0.03922071315328246,0.0,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
94,0.3,2,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Is D-dimer a potential new diagnostic tool for acute appendicitis? Answer: High D-dimer levels are not reliable for diagnosing acute appendicitis.,1.421158364141118e-07,0.19997019268387461,0.03698224852071005,0.010880558788691277,0.26236426446749217,0.0,0.010864809245717241,0.27443684570175986,0.0,1.4211583641411228e-07,0.28768207245178035,0.0
94,0.3,3,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Could D-dimer be introduced as a diagnostic parameter for acute appendicitis? Answer: Increased D-dimer should not be considered diagnostic for acute appendicitis.,1.184298636784265e-07,0.21646355709988496,0.00836922540219246,0.009067132323909398,0.2135741002980609,0.0,0.009054007704764368,0.2231435513142097,0.0,1.1842986367842692e-07,0.23361485118150505,0.0
94,0.3,4,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Can D-dimer levels be used as a new diagnostic indicator for acute appendicitis? Answer: Raised D-dimer levels are not appropriate for diagnosing acute appendicitis.,7.10579182070559e-08,0.12420106510601148,0.004605653180613213,0.005440279394345639,0.1226023220923329,0.0,0.005432404622858621,0.1278333715098845,0.0,7.105791820705622e-08,0.13353139262452363,0.0
94,0.3,5,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Is it possible for D-dimer to become a diagnostic marker for acute appendicitis? Answer: Elevated D-dimer should not be regarded as a diagnostic parameter in acute appendicitis.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
94,0.3,6,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Can D-dimer act as a new diagnostic parameter in acute appendicitis? Answer: Increased D-dimer levels should not be considered diagnostic for acute appendicitis.,9.47438909427412e-08,0.10899841447814662,0.03698224852071005,0.007253705859127518,0.16705408466316696,0.0,0.007243206163811494,0.17435338714477844,0.0,9.474389094274157e-08,0.1823215567939549,0.0
94,0.3,7,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Could D-dimer be a novel diagnostic parameter for acute appendicitis? Answer: High levels of D-dimer are not suitable for diagnosing acute appendicitis.,1.184298636784265e-07,0.15345017704898067,0.03698224852071005,0.009067132323909398,0.2135741002980609,0.0,0.009054007704764368,0.2231435513142097,0.0,1.1842986367842692e-07,0.23361485118150505,0.0
94,0.3,8,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Is D-dimer a viable new diagnostic marker for acute appendicitis? Answer: Elevated D-dimer levels should not be used to diagnose acute appendicitis.,1.184298636784265e-07,0.15345017704898067,0.03698224852071005,0.009067132323909398,0.2135741002980609,0.0,0.009054007704764368,0.2231435513142097,0.0,1.1842986367842692e-07,0.23361485118150505,0.0
94,0.3,9,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Can D-dimer be utilized as a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer should not be considered a diagnostic marker for acute appendicitis.,4.73719454713706e-08,0.08106857998389128,0.0029483070348455126,0.003626852929563759,0.08004270767353727,0.0,0.003621603081905747,0.08338160893905044,0.0,4.737194547137081e-08,0.08701137698962969,0.0
94,0.3,10,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Could D-dimer serve as a new diagnostic tool for acute appendicitis? Answer: Raised D-dimer levels are not a valid diagnostic parameter for acute appendicitis.,7.10579182070559e-08,0.12420106510601148,0.004605653180613213,0.005440279394345639,0.1226023220923329,0.0,0.005432404622858621,0.1278333715098845,0.0,7.105791820705622e-08,0.13353139262452363,0.0
95,0.3,1,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-β1 expression.","Is the formation of endometrial polyps linked to higher levels of vascular endothelial growth factor and transforming growth factor-beta1 expression? The study found elevated TGF-β1 and VEGF expression in polyps relative to nearby normal endometrial tissue, indicating these cytokines may contribute to polyp development. Moreover, a significant correlation was observed between steroid receptor expression and the expression of VEGF and TGF-β1.",7.105791820705622e-08,0.06123319782420733,0.07877526753864447,0.005440279394345618,0.02723735466969668,0.016124697661918846,0.0054324046228586,0.05043085362689137,0.0,7.105791820705622e-08,0.05129329438754926,0.0
95,0.3,2,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-β1 expression.","Does the development of endometrial polyps correlate with increased expression of VEGF and TGF-β1? Results showed that TGF-β1 and VEGF were more highly expressed in polyps than in adjacent normal endometrial tissue, suggesting these cytokines could be involved in polyp formation. Additionally, there was a notable association between steroid receptor levels and VEGF and TGF-β1 expression.",1.8948778188548325e-07,0.07618888320614436,0.042463412786063484,0.014507411718254981,0.11579075201114009,0.016124697661918846,0.014486412327622933,0.1405819506211894,0.0,1.8948778188548325e-07,0.14310084364067155,0.0
95,0.3,3,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-β1 expression.","Is there an association between endometrial polyp formation and elevated expression of vascular endothelial growth factor and transforming growth factor-beta1? Findings revealed increased TGF-β1 and VEGF expression in polyps compared to normal endometrial tissue nearby, implying these cytokines might influence polyp formation. Furthermore, steroid receptor expression was significantly correlated with VEGF and TGF-β1 levels.",2.3685972735685406e-07,0.06281945084577112,0.07877526753864447,0.018134264647818726,0.15353107999398752,0.016124697661918846,0.018108015409528666,0.17904823144898518,0.0,2.3685972735685406e-07,0.182321556793954,0.0
95,0.3,4,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-β1 expression.","Are vascular endothelial growth factor and transforming growth factor-beta1 expressions increased in endometrial polyps? The data indicated higher TGF-β1 and VEGF expression in polyps versus adjacent normal endometrium, suggesting a potential role of these cytokines in polyp formation. There was also a significant link between steroid receptor expression and VEGF and TGF-β1 expression.",2.6054570009253947e-07,0.1085271527610776,0.05955189191388476,0.0199476911126006,0.17294916585109021,0.016124697661918846,0.019918816950481533,0.19885085874516495,0.0,2.6054570009253947e-07,0.20252426411147262,0.0
95,0.3,5,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-β1 expression.","Is increased expression of VEGF and TGF-β1 associated with the formation of endometrial polyps? The study demonstrated elevated levels of TGF-β1 and VEGF in polyps compared to surrounding normal endometrial tissue, suggesting these cytokines may be involved in polyp development. Additionally, steroid receptor expression showed a significant correlation with VEGF and TGF-β1 expression.",2.6054570009253947e-07,0.135186659705691,0.04037526753864446,0.0199476911126006,0.20013140822598974,0.003475302338081146,0.019918816950481533,0.19885085874516495,0.0,2.6054570009253947e-07,0.20252426411147262,0.0
95,0.3,6,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-β1 expression.","Does endometrial polyp formation involve heightened expression of vascular endothelial growth factor and transforming growth factor-beta1? Elevated expression of TGF-β1 and VEGF was observed in polyps relative to adjacent normal tissue, indicating these cytokines might play a role in polyp formation. A significant correlation was also found between steroid receptor expression and VEGF and TGF-β1 levels.",1.8948778188548325e-07,0.07618888320614436,0.042463412786063484,0.014507411718254981,0.11579075201114009,0.016124697661918846,0.014486412327622933,0.1405819506211894,0.0,1.8948778188548325e-07,0.14310084364067155,0.0
95,0.3,7,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-β1 expression.","Is there a relationship between endometrial polyp formation and increased VEGF and TGF-β1 expression? The findings showed that TGF-β1 and VEGF expression was higher in polyps than in adjacent normal endometrial tissue, suggesting these cytokines could contribute to polyp formation. Furthermore, steroid receptor expression was significantly correlated with VEGF and TGF-β1 expression.",2.8423167282822487e-07,0.18283245879826593,0.020181517538644472,0.02176111757738247,0.22047768036966797,0.0038669724755238874,0.0217296184914344,0.21905356606268356,0.0,2.8423167282822487e-07,0.22314355131420838,0.0
95,0.3,8,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-β1 expression.","Are vascular endothelial growth factor and transforming growth factor-beta1 expressions elevated in endometrial polyps compared to normal tissue? The results indicated increased TGF-β1 and VEGF levels in polyps, implying these cytokines may be involved in polyp formation. Additionally, there was a significant correlation between steroid receptor expression and VEGF and TGF-β1 expression.",2.8423167282822487e-07,0.12846797404846644,0.05917526753864448,0.02176111757738247,0.19275179314726998,0.016124697661918846,0.0217296184914344,0.21905356606268356,0.0,2.8423167282822487e-07,0.22314355131420838,0.0
95,0.3,9,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-β1 expression.","Is the expression of VEGF and TGF-β1 increased in endometrial polyps, suggesting a role in their formation? The study found higher levels of these cytokines in polyps compared to adjacent normal endometrium, indicating their possible involvement in polyp development. Steroid receptor expression was also significantly correlated with VEGF and TGF-β1 expression.",3.079176455639103e-07,0.17654013341454222,0.038844711983088906,0.023574544042164344,0.24124622212029667,0.0042746078936367095,0.023540420032387266,0.23967285326541932,0.0,3.079176455639103e-07,0.24419696051204154,0.0
95,0.3,10,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-β1 expression.","Does the formation of endometrial polyps coincide with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Elevated TGF-β1 and VEGF expression was detected in polyps relative to normal endometrial tissue, suggesting these cytokines may contribute to polyp formation. A significant association was also observed between steroid receptor expression and VEGF and TGF-β1 levels.",1.8948778188548325e-07,0.050983531185782915,0.06059968454824667,0.014507411718254981,0.11579075201114009,0.016124697661918846,0.014486412327622933,0.1405819506211894,0.0,1.8948778188548325e-07,0.14310084364067155,0.0
96,0.3,1,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: A sternal fracture in growing children is a rare type of fracture that is often overlooked. It can be challenging to diagnose due to the cartilaginous nature of the sternum in children. However, early identification and proper","Question: Is sternal fracture in growing children a rare and frequently missed injury? Answer: Sternal fractures in growing children are uncommon and often go unnoticed. Diagnosing them is difficult because the sternum is cartilaginous in children. Nevertheless, early detection and appropriate management are important.",1.6580180914979784e-07,0.07667226111654246,0.05236448028436925,0.012693985253473108,0.10228252345882671,0.03716872327098482,0.012675610786670066,0.09986667915692138,0.04158790170132326,1.6580180914979784e-07,0.13177252289144326,0.0212665406427221
96,0.3,2,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: A sternal fracture in growing children is a rare type of fracture that is often overlooked. It can be challenging to diagnose due to the cartilaginous nature of the sternum in children. However, early identification and proper",Question: Are sternal fractures in growing children rare and commonly overlooked? Answer: Sternal fractures in children who are still growing are rare and frequently missed. The cartilaginous composition of the sternum in children makes diagnosis challenging. Early recognition and correct treatment are crucial.,1.8948778188548325e-07,0.16775198542515968,0.004582606614000936,0.014507411718254981,0.12718512402808502,0.03658908317580337,0.014486412327622933,0.12455929174729308,0.04158790170132326,1.8948778188548325e-07,0.15709033087573498,0.0212665406427221
96,0.3,3,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: A sternal fracture in growing children is a rare type of fracture that is often overlooked. It can be challenging to diagnose due to the cartilaginous nature of the sternum in children. However, early identification and proper","Question: Is a sternal fracture in growing children a rare and often ignored injury? Answer: In growing children, sternal fractures are rare and tend to be overlooked. The cartilaginous nature of the pediatric sternum complicates diagnosis. However, timely identification and suitable care are essential.",1.6580180914979784e-07,0.07667226111654246,0.05236448028436925,0.012693985253473108,0.06927551486073513,0.060964083175803374,0.012675610786670066,0.09986667915692138,0.04158790170132326,1.6580180914979784e-07,0.13177252289144326,0.0212665406427221
96,0.3,4,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: A sternal fracture in growing children is a rare type of fracture that is often overlooked. It can be challenging to diagnose due to the cartilaginous nature of the sternum in children. However, early identification and proper","Question: Are sternal fractures in children rare and often unnoticed? Answer: Sternal fractures in growing children are infrequent and commonly overlooked due to the cartilage in their sternum. Diagnosing these fractures can be difficult, but early detection and proper management are vital.",2.1317375462116866e-07,0.12744561778842822,0.050113229600409114,0.016320838183036854,0.15272303805816323,0.03598051973070145,0.0162972138685758,0.1498770997315848,0.04158790170132326,2.1317375462116866e-07,0.18306581727899296,0.0212665406427221
96,0.3,5,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: A sternal fracture in growing children is a rare type of fracture that is often overlooked. It can be challenging to diagnose due to the cartilaginous nature of the sternum in children. However, early identification and proper",Question: Is the sternal fracture in growing children a rare and frequently missed diagnosis? Answer: Sternal fractures in children who are still developing are rare and often missed because the sternum is largely cartilage. Early diagnosis and treatment are important for better outcomes.,1.8948778188548325e-07,0.06873095963088005,0.0749700721939469,0.014507411718254981,0.09337306643979515,0.060964083175803374,0.014486412327622933,0.12455929174729308,0.04158790170132326,1.8948778188548325e-07,0.15709033087573498,0.0212665406427221
96,0.3,6,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: A sternal fracture in growing children is a rare type of fracture that is often overlooked. It can be challenging to diagnose due to the cartilaginous nature of the sternum in children. However, early identification and proper","Question: Are sternal fractures rare and often overlooked in growing children? Answer: In growing children, sternal fractures are uncommon and frequently overlooked. The cartilaginous sternum makes diagnosis challenging, but early identification and appropriate intervention are necessary.",3.5528959103528056e-07,0.29726232846216494,0.04183246607489035,0.027201396971728097,0.2805846085279411,0.060964083175803374,0.027162023114293013,0.3169311843947491,0.04158790170132326,3.552895910352811e-07,0.35491607420565296,0.0212665406427221
96,0.3,7,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: A sternal fracture in growing children is a rare type of fracture that is often overlooked. It can be challenging to diagnose due to the cartilaginous nature of the sternum in children. However, early identification and proper","Question: Is sternal fracture a rare and often ignored injury in growing children? Answer: Sternal fractures in children are rare and often go unnoticed due to the cartilage in their sternum. Diagnosing these fractures is difficult, yet early recognition and proper care are important.",1.6580180914979784e-07,0.07667226111654246,0.05236448028436925,0.012693985253473108,0.10228252345882671,0.03716872327098482,0.012675610786670066,0.09986667915692138,0.04158790170132326,1.6580180914979784e-07,0.13177252289144326,0.0212665406427221
96,0.3,8,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: A sternal fracture in growing children is a rare type of fracture that is often overlooked. It can be challenging to diagnose due to the cartilaginous nature of the sternum in children. However, early identification and proper",Question: Are sternal fractures in growing children uncommon and often missed? Answer: Sternal fractures in children who are still growing are uncommon and often missed because the sternum is cartilaginous. Early detection and correct management are essential.,3.3160361829959526e-07,0.34390733765114545,0.010609567901234546,0.025387970506946217,0.3308138922901116,0.004031117151928269,0.02535122157334014,0.2870782212450673,0.04158790170132326,3.316036182995957e-07,0.3241444155388993,0.0212665406427221
96,0.3,9,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: A sternal fracture in growing children is a rare type of fracture that is often overlooked. It can be challenging to diagnose due to the cartilaginous nature of the sternum in children. However, early identification and proper","Question: Is a sternal fracture in growing children a rare and often undiagnosed injury? Answer: Sternal fractures in growing children are rare and often undiagnosed due to the cartilaginous nature of the sternum. However, early detection and appropriate treatment are critical.",2.3685972735685406e-07,0.25780091034220565,0.023683547493071277,0.018134264647818726,0.2500215147929108,0.015424805713085521,0.018108015409528666,0.21233401669062912,0.015291334864215887,2.3685972735685406e-07,0.20973406436115383,0.0212665406427221
96,0.3,10,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: A sternal fracture in growing children is a rare type of fracture that is often overlooked. It can be challenging to diagnose due to the cartilaginous nature of the sternum in children. However, early identification and proper",Question: Are sternal fractures in growing children rare and frequently overlooked? Answer: Sternal fractures in children during growth are rare and frequently overlooked because the sternum is mostly cartilage. Early diagnosis and proper management are key.,3.5528959103528056e-07,0.3764791490975874,0.013617502344522761,0.027201396971728097,0.362131335652641,0.002370333175803374,0.027162023114293013,0.3169311843947491,0.04158790170132326,3.552895910352811e-07,0.35491607420565296,0.0212665406427221
97,0.3,1,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Do African American women need fewer calories to keep their weight stable? Answer: The findings do not back the idea that African American women are more prone to obesity due to needing fewer calories for weight maintenance.,4.73719454713706e-08,0.10160124692944805,0.03193310745366887,0.003626852929563752,0.1409703278292218,0.05965384697063009,0.003621603081905747,0.14285834009080567,0.06035379812695108,4.737194547137081e-08,0.10394632060143305,0.031217481789802305
97,0.3,2,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Is it true that African American women require fewer calories to maintain their weight? Answer: The data does not support the notion that African American women have a higher obesity risk because they need fewer calories to maintain their weight.,1.184298636784265e-07,0.04936352069938632,0.05474286904615165,0.00906713232390937,0.08179116590311031,0.03802357694011063,0.009054007704764347,0.11565214666041834,0.018013548811824424,1.1842986367842703e-07,0.1510362934640943,0.004211308950296141
97,0.3,3,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Do African American women have lower calorie needs to sustain their weight? Answer: These results do not confirm that African American women are at increased risk of obesity because of lower calorie requirements for weight maintenance.,2.36859727356853e-08,0.07107998814421679,0.029738306344114673,0.0018134264647818796,0.11169921724258858,0.058862236208678254,0.0018108015409528735,0.11387080321755416,0.06035379812695108,2.3685972735685406e-08,0.07409335745175127,0.031217481789802305
97,0.3,4,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Are fewer calories necessary for African American women to maintain their weight? Answer: The evidence does not uphold the belief that African American women face greater obesity risk due to needing fewer calories to maintain weight.,2.36859727356853e-08,0.032571811446441945,0.0030079344432882155,0.0018134264647818796,0.11169921724258858,0.058862236208678254,0.0018108015409528735,0.11387080321755416,0.06035379812695108,2.3685972735685406e-08,0.07409335745175127,0.031217481789802305
97,0.3,5,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Do African American women require less caloric intake to keep their weight steady? Answer: The results do not support the perspective that African American women are more susceptible to obesity because they need fewer calories to maintain weight.,7.10579182070559e-08,0.16770887839624438,0.059913798640819076,0.005440279394345625,0.16941006354970956,0.060402776171940245,0.005432404622858614,0.17102921705750251,0.06035379812695108,7.105791820705622e-08,0.13293385747468456,0.031217481789802305
97,0.3,6,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Is a reduced calorie intake needed for African American women to maintain weight? Answer: These findings do not endorse the view that African American women are at higher risk of obesity because of lower calorie needs for weight maintenance.,9.47438909427412e-08,0.1955552073921072,0.061250721148912765,0.0072537058591274975,0.1970642952414865,0.061112382174339036,0.00724320616381148,0.19842819124561784,0.06035379812695108,9.474389094274162e-08,0.1611047344413814,0.031217481789802305
97,0.3,7,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Do African American women need fewer calories to preserve their weight? Answer: The data does not support the claim that African American women are more likely to become obese due to requiring fewer calories to maintain their weight.,7.10579182070559e-08,0.09474601728467036,0.008576706069585785,0.005440279394345625,0.13194264838430625,0.033531397991038235,0.005432404622858614,0.17102921705750251,0.06035379812695108,7.105791820705622e-08,0.13293385747468456,0.031217481789802305
97,0.3,8,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Are African American women at risk of obesity because they require fewer calories to maintain weight? Answer: The results do not support this hypothesis that African American women need fewer calories and thus have a higher obesity risk.,7.10579182070559e-08,0.13122744784045715,0.03401558750451271,0.005440279394345625,0.16941006354970956,0.060402776171940245,0.005432404622858614,0.17102921705750251,0.06035379812695108,7.105791820705622e-08,0.13293385747468456,0.031217481789802305
97,0.3,9,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Do African American women have a lower calorie requirement to maintain their weight? Answer: These results do not back the idea that African American women are at greater obesity risk because of needing fewer calories to maintain weight.,7.10579182070559e-08,0.13122744784045715,0.034015587504512695,0.005440279394345625,0.16941006354970956,0.060402776171940245,0.005432404622858614,0.17102921705750251,0.06035379812695108,7.105791820705622e-08,0.13293385747468456,0.031217481789802305
97,0.3,10,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Is it accurate that African American women require fewer calories to sustain their weight? Answer: The findings do not support the belief that African American women are at increased risk for obesity due to lower calorie requirements for weight maintenance.,1.184298636784265e-07,0.1879929568113763,0.03787599507148398,0.00906713232390937,0.18842919368156252,0.03627673571707096,0.009054007704764347,0.18861500777199236,0.03405723128984371,1.1842986367842703e-07,0.18850370862949672,0.031217481789802305
98,0.3,1,ai,Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: There is limited research available specifically on the satisfaction of UK radiologists with training and support in suspected child abuse. Further studies are needed to gather comprehensive data and feedback from radiologists regarding their experiences and satisfaction levels in this area.,Question: Do UK radiologists feel content with the training and support provided for suspected child abuse? Answer: Research specifically addressing UK radiologists' satisfaction with training and support in suspected child abuse is scarce. More studies are necessary to collect detailed data and feedback on their experiences and satisfaction.,2.1317375462116866e-07,0.13991468089627945,0.024894470022655005,0.016320838183036854,0.15841791864004184,0.01458345969085259,0.0162972138685758,0.18232155679395579,0.0,2.1317375462116866e-07,0.18610227963385917,0.0
98,0.3,2,ai,Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: There is limited research available specifically on the satisfaction of UK radiologists with training and support in suspected child abuse. Further studies are needed to gather comprehensive data and feedback from radiologists regarding their experiences and satisfaction levels in this area.,Question: Are radiologists in the UK happy with the training and support they get for suspected child abuse cases? Answer: There is a lack of focused research on how satisfied UK radiologists are with their training and support in suspected child abuse. Additional research is required to obtain thorough insights and feedback from radiologists about their satisfaction.,0.0,0.0495105128971387,0.035027741473040254,0.0,0.02520535202036145,0.018136271762183187,0.0,0.0,0.0,0.0,0.0,0.0
98,0.3,3,ai,Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: There is limited research available specifically on the satisfaction of UK radiologists with training and support in suspected child abuse. Further studies are needed to gather comprehensive data and feedback from radiologists regarding their experiences and satisfaction levels in this area.,Question: How satisfied are UK radiologists with the training and support related to suspected child abuse? Answer: Limited research exists on UK radiologists' satisfaction with training and support in suspected child abuse. Further investigation is needed to gather comprehensive feedback and data from radiologists.,3.079176455639103e-07,0.23709350403966267,0.019052527873894665,0.023574544042164344,0.25225987150647144,0.012516494847762433,0.023540420032387266,0.27541197985996746,0.0,3.079176455639103e-07,0.2814124594381848,0.0
98,0.3,4,ai,Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: There is limited research available specifically on the satisfaction of UK radiologists with training and support in suspected child abuse. Further studies are needed to gather comprehensive data and feedback from radiologists regarding their experiences and satisfaction levels in this area.,Question: Do UK radiologists express satisfaction with the training and support they receive for suspected child abuse? Answer: There is minimal research specifically exploring UK radiologists' satisfaction with training and support in suspected child abuse. More studies are needed to comprehensively assess their experiences and satisfaction.,2.6054570009253947e-07,0.21813908415486116,0.0003846962260659892,0.0199476911126006,0.2042395372989385,0.013596873681731878,0.019918816950481533,0.22778393087071303,0.0,2.6054570009253947e-07,0.2326222952687531,0.0
98,0.3,5,ai,Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: There is limited research available specifically on the satisfaction of UK radiologists with training and support in suspected child abuse. Further studies are needed to gather comprehensive data and feedback from radiologists regarding their experiences and satisfaction levels in this area.,Question: Are UK radiologists content with the training and support provided for suspected child abuse cases? Answer: Specific research on UK radiologists' satisfaction with training and support in suspected child abuse is limited. Additional studies are essential to collect detailed feedback and data.,3.316036182995957e-07,0.29593382460130524,0.005755297610869847,0.025387970506946217,0.3109745296640196,0.012340347745775353,0.025351221573340132,0.30010459245033916,0.0,3.316036182995957e-07,0.30673026742247655,0.0
98,0.3,6,ai,Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: There is limited research available specifically on the satisfaction of UK radiologists with training and support in suspected child abuse. Further studies are needed to gather comprehensive data and feedback from radiologists regarding their experiences and satisfaction levels in this area.,Question: What is the level of satisfaction among UK radiologists regarding training and support in suspected child abuse? Answer: Research focusing on UK radiologists' satisfaction with training and support in suspected child abuse is limited. More comprehensive studies are required to gather their feedback and experiences.,2.6054570009253947e-07,0.24894562551308086,0.020947472126105343,0.0199476911126006,0.29875960737529494,0.05368814524741901,0.019918816950481533,0.3245021421116361,0.06937499999999999,2.6054570009253947e-07,0.29863631246493716,0.047500000000000014
98,0.3,7,ai,Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: There is limited research available specifically on the satisfaction of UK radiologists with training and support in suspected child abuse. Further studies are needed to gather comprehensive data and feedback from radiologists regarding their experiences and satisfaction levels in this area.,Question: Is the training and support for suspected child abuse satisfactory to UK radiologists? Answer: There is a shortage of research specifically on UK radiologists' satisfaction with training and support in suspected child abuse. Further studies are necessary to obtain detailed data and feedback.,3.079176455639103e-07,0.23709350403966267,0.019052527873894665,0.023574544042164344,0.25225987150647144,0.012516494847762433,0.023540420032387266,0.27541197985996746,0.0,3.079176455639103e-07,0.2814124594381848,0.0
98,0.3,8,ai,Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: There is limited research available specifically on the satisfaction of UK radiologists with training and support in suspected child abuse. Further studies are needed to gather comprehensive data and feedback from radiologists regarding their experiences and satisfaction levels in this area.,Question: Are UK radiologists pleased with the training and support they receive for suspected child abuse? Answer: Limited research is available on UK radiologists' satisfaction with training and support in suspected child abuse. More research is needed to gather comprehensive feedback and data.,3.316036182995957e-07,0.29593382460130524,0.005755297610869861,0.025387970506946217,0.27716247207572975,0.011936854752580987,0.025351221573340132,0.30010459245033916,0.0,3.316036182995957e-07,0.30673026742247655,0.0
98,0.3,9,ai,Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: There is limited research available specifically on the satisfaction of UK radiologists with training and support in suspected child abuse. Further studies are needed to gather comprehensive data and feedback from radiologists regarding their experiences and satisfaction levels in this area.,Question: How do UK radiologists rate their training and support in suspected child abuse cases? Answer: There is little research specifically examining UK radiologists' satisfaction with training and support in suspected child abuse. Additional studies are needed to collect thorough data and feedback.,3.316036182995957e-07,0.3289408331993977,0.028446102513249222,0.025387970506946217,0.37859864484059935,0.060108890316812755,0.025351221573340132,0.4040766695343301,0.07450693937180423,3.316036182995957e-07,0.37782228594144485,0.05113221329437545
98,0.3,10,ai,Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: There is limited research available specifically on the satisfaction of UK radiologists with training and support in suspected child abuse. Further studies are needed to gather comprehensive data and feedback from radiologists regarding their experiences and satisfaction levels in this area.,Question: Do UK radiologists feel adequately supported and trained for suspected child abuse cases? Answer: Research specifically on UK radiologists' satisfaction with training and support in suspected child abuse is limited. Further studies are required to gather detailed feedback and experiences.,3.789755637709665e-07,0.28201067243435984,0.03856603202901932,0.029014823436509962,0.32890684432158723,0.010688586054520034,0.028972824655245866,0.35139788683788886,0.0,3.789755637709665e-07,0.3593740009078954,0.0
99,0.3,1,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Does discharging patients earlier from Winnipeg hospitals negatively impact the quality of care? Answer: Enhancing hospital efficiency by reducing length of stay does not seem to lead to higher readmission rates or more physician visits within 30 days post-discharge. Further research is necessary to determine optimal lengths of stay and anticipated readmission rates.,9.474389094274162e-08,0.07459489795819252,0.0013226814394396817,0.0072537058591274906,0.07410797215372167,0.0,0.007243206163811466,0.07550755250814589,0.0,9.474389094274162e-08,0.07696104113612989,0.0
99,0.3,2,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Is early discharge from Winnipeg hospitals detrimental to care quality? Answer: Shortening hospital stays to improve efficiency does not appear to increase readmission rates or physician visits within 30 days after discharge. Additional studies are needed to establish ideal lengths of stay and expected readmission rates.,2.6054570009253947e-07,0.19008891764159808,0.01753826530612245,0.0199476911126006,0.21868920096483002,0.0,0.019918816950481533,0.22314355131420927,0.0,2.6054570009253947e-07,0.22778393087071303,0.0
99,0.3,3,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Does earlier patient discharge from Winnipeg hospitals compromise care quality? Answer: Improving hospital efficiency by decreasing length of stay does not seem to cause higher readmission or physician visit rates within 30 days post-discharge. Research is required to find optimal stay durations and expected readmission rates.,2.6054570009253947e-07,0.19008891764159808,0.01753826530612245,0.0199476911126006,0.21868920096483002,0.0,0.019918816950481533,0.22314355131420927,0.0,2.6054570009253947e-07,0.22778393087071303,0.0
99,0.3,4,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Does discharging patients sooner from Winnipeg hospitals affect care quality negatively? Answer: Reducing length of stay to boost hospital efficiency does not appear to raise readmission or physician visit rates within 30 days after discharge. Further investigation is needed to identify optimal stay lengths and expected readmission rates.,2.1317375462116866e-07,0.14752930322280156,0.01753826530612245,0.016320838183036854,0.17520408902509166,0.0,0.0162972138685758,0.17869178874337655,0.0,2.1317375462116866e-07,0.18232155679395579,0.0
99,0.3,5,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Is the quality of care impacted by earlier discharge from Winnipeg hospitals? Answer: Making hospitals more efficient by shortening stays does not seem to increase readmission or physician visits within 30 days of discharge. Research is needed to determine the best lengths of stay and expected readmission rates.,2.1317375462116866e-07,0.14752930322280156,0.01753826530612245,0.016320838183036854,0.17520408902509166,0.0,0.0162972138685758,0.17869178874337655,0.0,2.1317375462116866e-07,0.18232155679395579,0.0
99,0.3,6,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Does early discharge from Winnipeg hospitals adversely affect care quality? Answer: Increasing hospital efficiency through shorter stays does not appear to result in more readmissions or physician visits within 30 days post-discharge. Further research is necessary to identify optimal lengths of stay and expected readmission rates.,2.6054570009253947e-07,0.19008891764159808,0.01753826530612245,0.0199476911126006,0.21868920096483002,0.0,0.019918816950481533,0.22314355131420927,0.0,2.6054570009253947e-07,0.22778393087071303,0.0
99,0.3,7,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Does discharging patients earlier in Winnipeg hospitals lower the quality of care? Answer: Improving efficiency by reducing hospital stay length does not seem to increase readmission rates or physician visits within 30 days after discharge. Research is needed to find the best lengths of stay and expected readmission rates.,1.8948778188548325e-07,0.1269100160200658,0.01753826530612245,0.014507411718254981,0.1541506798272585,0.0,0.014486412327622933,0.15718558352241319,0.0,1.8948778188548325e-07,0.16034265007518078,0.0
99,0.3,8,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Does earlier discharge from Winnipeg hospitals lead to poorer quality of care? Answer: Shortening hospital stays to improve efficiency does not appear to cause higher rates of readmission or physician visits within 30 days post-discharge. Additional research is required to determine optimal stay lengths and expected readmission rates.,2.1317375462116866e-07,0.14752930322280156,0.01753826530612245,0.016320838183036854,0.17520408902509166,0.0,0.0162972138685758,0.17869178874337655,0.0,2.1317375462116866e-07,0.18232155679395579,0.0
99,0.3,9,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Does releasing patients sooner from Winnipeg hospitals negatively influence care quality? Answer: Enhancing hospital efficiency by decreasing length of stay does not seem to increase readmission or physician visit rates within 30 days after discharge. Further studies are needed to establish optimal lengths of stay and expected readmission rates.,1.8948778188548325e-07,0.15520173767557388,0.002861040249433105,0.014507411718254981,0.1541506798272585,0.0,0.014486412327622933,0.15718558352241319,0.0,1.8948778188548325e-07,0.16034265007518078,0.0
99,0.3,10,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Does earlier patient discharge from Winnipeg hospitals harm the quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to lead to increased readmission or physician visits within 30 days post-discharge. Research is necessary to identify optimal stay durations and expected readmission rates.,2.1317375462116866e-07,0.14752930322280156,0.01753826530612245,0.016320838183036854,0.17520408902509166,0.0,0.0162972138685758,0.17869178874337655,0.0,2.1317375462116866e-07,0.18232155679395579,0.0
100,0.3,1,ai,"Question: Is there a first night effect on sleep bruxism? Answer: There is evidence to suggest that there may be a first night effect on sleep bruxism, where individuals may experience increased tooth grinding and clenching during the first night in a new environment or when using a sleep monitoring device. However, more research is needed to fully understand this phenomenon.","Is there a first night effect on sleep bruxism? Evidence indicates that a first night effect might exist, with individuals showing increased tooth grinding and clenching during their first night in a new setting or when using a sleep monitoring device. Nonetheless, further studies are required to fully comprehend this phenomenon.",2.3685972735685406e-07,0.15633983005077257,0.012929123200074694,0.018134264647818726,0.14831453072509948,0.026695599145494193,0.018108015409528666,0.14641825141427756,0.030746345715686026,2.3685972735685406e-07,0.14426175871677627,0.035041322314049606
100,0.3,2,ai,"Question: Is there a first night effect on sleep bruxism? Answer: There is evidence to suggest that there may be a first night effect on sleep bruxism, where individuals may experience increased tooth grinding and clenching during the first night in a new environment or when using a sleep monitoring device. However, more research is needed to fully understand this phenomenon.","Does sleep bruxism exhibit a first night effect? Research suggests that people may experience heightened tooth grinding and clenching on the first night in unfamiliar environments or when monitored by sleep devices, but more investigation is necessary to understand this fully.",4.737194547137081e-07,0.2927722286280958,0.11081890569070058,0.03626852929563745,0.31998973939506614,0.06743801652892563,0.03621603081905733,0.35115197007245147,0.05157024793388431,4.737194547137081e-07,0.3834914477826086,0.035041322314049606
100,0.3,3,ai,"Question: Is there a first night effect on sleep bruxism? Answer: There is evidence to suggest that there may be a first night effect on sleep bruxism, where individuals may experience increased tooth grinding and clenching during the first night in a new environment or when using a sleep monitoring device. However, more research is needed to fully understand this phenomenon.","Is there an impact of the first night on sleep bruxism? Some evidence points to increased tooth grinding and clenching during the initial night in a new environment or with sleep monitoring equipment, although additional research is needed to clarify this effect.",4.500334819780227e-07,0.23342225700972774,0.1358024691358025,0.03445510283085558,0.2946719314107744,0.06743801652892563,0.034405229278104466,0.3251764836691935,0.05157024793388431,4.500334819780227e-07,0.3568232007004477,0.035041322314049606
100,0.3,4,ai,"Question: Is there a first night effect on sleep bruxism? Answer: There is evidence to suggest that there may be a first night effect on sleep bruxism, where individuals may experience increased tooth grinding and clenching during the first night in a new environment or when using a sleep monitoring device. However, more research is needed to fully understand this phenomenon.","Can sleep bruxism be influenced by the first night effect? Studies suggest that individuals might grind and clench their teeth more on the first night in a novel setting or when using sleep monitoring tools, but more research is essential to grasp the full scope.",3.789755637709665e-07,0.22581806984667852,0.0904509952129,0.029014823436509962,0.2545906735781225,0.044195386143438105,0.028972824655245866,0.25106851151547005,0.05157024793388431,3.789755637709665e-07,0.2808372937225263,0.035041322314049606
100,0.3,5,ai,"Question: Is there a first night effect on sleep bruxism? Answer: There is evidence to suggest that there may be a first night effect on sleep bruxism, where individuals may experience increased tooth grinding and clenching during the first night in a new environment or when using a sleep monitoring device. However, more research is needed to fully understand this phenomenon.","Is sleep bruxism affected by the first night effect? There is some evidence that tooth grinding and clenching increase during the first night in a new environment or when a sleep monitoring device is used, yet further research is required to understand this phenomenon completely.",3.789755637709665e-07,0.22581806984667852,0.0904509952129,0.029014823436509962,0.2545906735781225,0.044195386143438105,0.028972824655245866,0.25106851151547005,0.05157024793388431,3.789755637709665e-07,0.2808372937225263,0.035041322314049606
100,0.3,6,ai,"Question: Is there a first night effect on sleep bruxism? Answer: There is evidence to suggest that there may be a first night effect on sleep bruxism, where individuals may experience increased tooth grinding and clenching during the first night in a new environment or when using a sleep monitoring device. However, more research is needed to fully understand this phenomenon.","Does the first night effect influence sleep bruxism? Evidence hints that people may experience more tooth grinding and clenching on the first night in unfamiliar surroundings or with sleep monitoring devices, but more studies are needed for full understanding.",5.210914001850787e-07,0.3823710250992223,0.08333333333333334,0.0398953822252012,0.4101008880458874,0.04043184368941946,0.039837633900963065,0.40521919134272766,0.05157024793388431,5.210914001850789e-07,0.43906129893742074,0.035041322314049606
100,0.3,7,ai,"Question: Is there a first night effect on sleep bruxism? Answer: There is evidence to suggest that there may be a first night effect on sleep bruxism, where individuals may experience increased tooth grinding and clenching during the first night in a new environment or when using a sleep monitoring device. However, more research is needed to fully understand this phenomenon.","Is there a first night effect associated with sleep bruxism? Research indicates increased tooth grinding and clenching during the first night in new environments or when using sleep monitoring devices, though more research is necessary to fully understand this.",5.210914001850787e-07,0.3458895945434355,0.10950590229869511,0.0398953822252012,0.372633472880485,0.06743801652892563,0.039837633900963065,0.40521919134272766,0.05157024793388431,5.210914001850789e-07,0.43906129893742074,0.035041322314049606
100,0.3,8,ai,"Question: Is there a first night effect on sleep bruxism? Answer: There is evidence to suggest that there may be a first night effect on sleep bruxism, where individuals may experience increased tooth grinding and clenching during the first night in a new environment or when using a sleep monitoring device. However, more research is needed to fully understand this phenomenon.","Is sleep bruxism subject to a first night effect? Some data suggest that tooth grinding and clenching may be elevated during the first night in a new environment or when sleep is monitored, but further research is needed to confirm this.",4.737194547137081e-07,0.2927722286280958,0.11081890569070058,0.03626852929563745,0.31998973939506614,0.06743801652892563,0.03621603081905733,0.35115197007245147,0.05157024793388431,4.737194547137081e-07,0.3834914477826086,0.035041322314049606
100,0.3,9,ai,"Question: Is there a first night effect on sleep bruxism? Answer: There is evidence to suggest that there may be a first night effect on sleep bruxism, where individuals may experience increased tooth grinding and clenching during the first night in a new environment or when using a sleep monitoring device. However, more research is needed to fully understand this phenomenon.","Does sleep bruxism show a first night effect? Evidence suggests that individuals might experience increased tooth grinding and clenching on their first night in a new environment or with sleep monitoring devices, but more research is required to fully understand this phenomenon.",4.500334819780227e-07,0.2672343145980176,0.11142746913580248,0.03445510283085558,0.2946719314107744,0.06743801652892563,0.034405229278104466,0.3251764836691935,0.05157024793388431,4.500334819780227e-07,0.3568232007004477,0.035041322314049606
100,0.3,10,ai,"Question: Is there a first night effect on sleep bruxism? Answer: There is evidence to suggest that there may be a first night effect on sleep bruxism, where individuals may experience increased tooth grinding and clenching during the first night in a new environment or when using a sleep monitoring device. However, more research is needed to fully understand this phenomenon.","Is there a first night effect on sleep bruxism? Findings suggest that tooth grinding and clenching may increase during the first night in a novel environment or when using a sleep monitoring device, however, more research is needed to fully grasp this effect.",4.263475092423373e-07,0.2423317140287593,0.11200710923098393,0.03264167636607371,0.2699793188204027,0.06743801652892563,0.0325944277371516,0.29985867568490177,0.05157024793388431,4.263475092423373e-07,0.33084771429718973,0.035041322314049606
101,0.3,1,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity an independent risk factor for negative perinatal outcomes? Grandmultiparous women experienced higher maternal and neonatal complications, including neonatal death, even after adjusting for confounding variables, indicating the necessity for more vigilant monitoring compared to regular multiparous women during labor and delivery.",2.3685972735685406e-08,0.057909609167349885,0.024375,0.0018134264647818726,0.0246926125903717,0.0,0.0018108015409528666,0.02531780798429173,0.0,2.3685972735685406e-08,0.025975486403257975,0.0
101,0.3,2,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Does grandmultiparity independently increase the risk of adverse perinatal outcomes? Women with grandmultiparity showed elevated maternal and neonatal morbidity and mortality rates despite controlling for confounders, implying they require closer surveillance than typical multiparous patients during childbirth.",1.1842986367842661e-07,0.09624107065990772,0.024375,0.009067132323909363,0.13353139262452274,0.0,0.00905400770476434,0.13720112151348252,0.0,1.1842986367842703e-07,0.14107859825990632,0.0
101,0.3,3,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity a standalone risk factor for poor perinatal outcomes? Even after accounting for confounders, grandmultiparous women had greater maternal and neonatal health issues and higher neonatal mortality, suggesting the need for enhanced observation during labor and delivery compared to other multiparous women.",2.3685972735685406e-08,0.057909609167349885,0.024375,0.0018134264647818726,0.0246926125903717,0.0,0.0018108015409528666,0.02531780798429173,0.0,2.3685972735685406e-08,0.025975486403257975,0.0
101,0.3,4,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Can grandmultiparity be considered an independent risk factor for unfavorable perinatal outcomes? Grandmultiparous women demonstrated increased maternal and neonatal morbidity and neonatal mortality after controlling for confounders, highlighting the importance of closer monitoring than standard multiparous patients during labor and delivery.",2.3685972735685406e-08,0.025537914030078213,0.0006085634451019166,0.0018134264647818726,0.02531780798429173,0.0,0.0018108015409528666,0.025975486403257975,0.0,2.3685972735685406e-08,0.026668247082160867,0.0
101,0.3,5,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity independently associated with adverse perinatal outcomes? After adjusting for confounding factors, grandmultiparous women still showed increased maternal and neonatal complications and neonatal death, indicating a need for more intensive observation during labor and delivery than usual multiparous patients.",4.7371945471370706e-08,0.051744372245857484,0.0012482686980609496,0.0036268529295637453,0.051293294387549704,0.0,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
101,0.3,6,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Does being grandmultiparous independently raise the risk of adverse perinatal outcomes? Even when confounders are controlled, grandmultiparous women have higher rates of maternal and neonatal morbidity and neonatal mortality, suggesting they should be monitored more closely than regular multiparous women during labor and delivery.",4.737194547137081e-08,0.0492007028305701,0.0011323696145124768,0.0036268529295637453,0.048790164169431716,0.0,0.003621603081905733,0.05001042057466343,0.0,4.737194547137081e-08,0.051293294387549704,0.0
101,0.3,7,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity an independent predictor of negative perinatal outcomes? Grandmultiparous women had increased maternal and neonatal health problems and neonatal mortality despite controlling for confounders, which suggests the need for closer observation than typical multiparous patients during labor and delivery.",4.7371945471370706e-08,0.051744372245857484,0.001248268698060953,0.0036268529295637453,0.051293294387549704,0.0,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
101,0.3,8,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity a distinct risk factor for adverse perinatal outcomes? After adjusting for confounders, grandmultiparous women exhibited higher maternal and neonatal morbidity and neonatal mortality, indicating the necessity for more careful monitoring than regular multiparous women during labor and delivery.",4.7371945471370706e-08,0.051744372245857484,0.0012482686980609496,0.0036268529295637453,0.051293294387549704,0.0,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
101,0.3,9,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity independently linked to poor perinatal outcomes? Grandmultiparous women showed increased maternal and neonatal morbidity and neonatal mortality even after controlling for confounders, pointing to the need for closer observation compared to other multiparous patients during labor and delivery.",4.7371945471370706e-08,0.051744372245857484,0.001248268698060953,0.0036268529295637453,0.051293294387549704,0.0,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
101,0.3,10,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Does grandmultiparity independently contribute to adverse perinatal outcomes? Despite controlling for confounding factors, grandmultiparous women had elevated maternal and neonatal morbidity and neonatal mortality, suggesting a requirement for more vigilant monitoring than typical multiparous women during labor and delivery.",7.1057918207056e-08,0.07865527994541788,0.0019215668371073726,0.005440279394345618,0.07796154146971057,0.0,0.0054324046228586,0.08004270767353416,0.0,7.105791820705622e-08,0.08223809823697303,0.0
102,0.3,1,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers","Are doctors adequately addressing the needs of family caregivers for the frail elderly? Several hypotheses for this dissatisfaction are discussed. Physicians might lack interest in assisting caregivers; even if they are open to counseling caregivers, they may receive insufficient compensation for the typical counseling sessions caregivers require; and they may also be acting as professional caregivers to family caregivers.",0.0,0.023901626915860064,0.017202702872469406,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102,0.3,2,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers","Do physicians fulfill the needs of family caregivers of frail elderly patients? Possible reasons for this dissatisfaction are outlined. Doctors may be uninterested in supporting caregivers; even if willing to counsel caregivers, they might be poorly paid for the usual counseling sessions caregivers need; and they may serve as professional caregivers to family caregivers.",1.1842986367842703e-07,0.06624947007843796,0.017236072637734686,0.009067132323909363,0.09180754925312229,0.0,0.009054007704764333,0.09352605801082436,0.0,1.1842986367842703e-07,0.09531017980432566,0.0
102,0.3,3,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers","Are medical professionals meeting the expectations of family caregivers for the frail elderly? Hypotheses explaining this dissatisfaction are proposed. Physicians might not be interested in aiding caregivers; even if they are willing to provide counseling, they could be inadequately compensated for the typical sessions caregivers require; and they might act as professional caregivers to family caregivers.",7.105791820705622e-08,0.05441355041844975,0.000939510352663115,0.005440279394345618,0.05406722127027486,0.0,0.0054324046228586,0.05505977718302857,0.0,7.105791820705622e-08,0.056089466651043196,0.0
102,0.3,4,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers","Are physicians adequately supporting family caregivers of the frail elderly? Theories for this dissatisfaction are presented. Doctors may be uninterested in helping caregivers; even if they are open to counseling, they might receive low remuneration for the usual counseling sessions caregivers need; and they may function as professional caregivers to family caregivers.",1.6580180914979784e-07,0.10471575090623375,0.017236072637734686,0.012693985253473108,0.13102826240640475,0.0,0.012675610786670066,0.13353139262452274,0.0,1.6580180914979784e-07,0.13613217432458002,0.0
102,0.3,5,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers","Are doctors meeting the needs of family caregivers of frail elderly individuals? Possible explanations for this dissatisfaction are given. Physicians may lack interest in assisting caregivers; even if they are receptive to counseling, they might be poorly compensated for the typical sessions caregivers require; and they may serve as professional caregivers to family caregivers.",1.1842986367842703e-07,0.06624947007843796,0.017236072637734686,0.009067132323909363,0.09180754925312229,0.0,0.009054007704764333,0.09352605801082436,0.0,1.1842986367842703e-07,0.09531017980432566,0.0
102,0.3,6,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers","Do physicians adequately address the needs of family caregivers of the frail elderly? Hypotheses for this dissatisfaction are offered. Doctors may be uninterested in helping caregivers; even if willing to counsel caregivers, they could be underpaid for the usual counseling sessions caregivers need; and they may act as professional caregivers to family caregivers.",1.4211583641411244e-07,0.08529766504913106,0.017236072637734686,0.010880558788691236,0.11122563511022499,0.0,0.0108648092457172,0.11332868530700413,0.0,1.4211583641411244e-07,0.11551288712184427,0.0
102,0.3,7,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers","Are physicians fulfilling the needs of family caregivers of frail elderly patients? Possible reasons for this dissatisfaction are suggested. Physicians may be uninterested in assisting caregivers; even if they provide counseling, they might be poorly remunerated for the typical sessions caregivers require; and they may serve as professional caregivers to family caregivers.",1.6580180914979784e-07,0.10471575090623375,0.017236072637734686,0.012693985253473108,0.13102826240640475,0.0,0.012675610786670066,0.13353139262452274,0.0,1.6580180914979784e-07,0.13613217432458002,0.0
102,0.3,8,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers","Are medical doctors meeting the needs of family caregivers of the frail elderly? Hypotheses explaining this dissatisfaction are presented. Physicians may lack interest in helping caregivers; even if they are receptive to counseling, they might receive inadequate compensation for the usual counseling sessions caregivers need; and they may act as professional caregivers to family caregivers.",9.474389094274162e-08,0.04755733706628362,0.017236072637734686,0.0072537058591274906,0.07275935428242919,0.0,0.007243206163811466,0.07410797215372167,0.0,9.474389094274162e-08,0.07550755250814589,0.0
102,0.3,9,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers","Are physicians adequately responding to the needs of family caregivers of frail elderly individuals? Possible hypotheses for this dissatisfaction are discussed. Doctors may be uninterested in assisting caregivers; even if they are open to counseling, they might be poorly paid for the typical sessions caregivers require; and they may function as professional caregivers to family caregivers.",7.105791820705622e-08,0.02920819839808786,0.017236072637734686,0.005440279394345618,0.05406722127027486,0.0,0.0054324046228586,0.05505977718302857,0.0,7.105791820705622e-08,0.056089466651043196,0.0
102,0.3,10,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers","Are doctors meeting the needs of family caregivers for frail elderly patients? Theories for this dissatisfaction are presented. Physicians may be uninterested in helping caregivers; even if they are willing to counsel caregivers, they could be undercompensated for the usual counseling sessions caregivers need; and they may serve as professional caregivers to family caregivers.",1.1842986367842703e-07,0.06624947007843796,0.017236072637734686,0.009067132323909363,0.09180754925312229,0.0,0.009054007704764333,0.09352605801082436,0.0,1.1842986367842703e-07,0.09531017980432566,0.0
103,0.3,1,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: There is limited evidence suggesting that airway surgery may lower serum lipid levels in obstructive sleep apnea patients, but further research is needed to establish a clear connection between the two.","Question: Does airway surgery reduce serum lipid levels in patients with obstructive sleep apnea? Answer: Limited evidence indicates that airway surgery might decrease serum lipid levels in obstructive sleep apnea patients, though more research is required to confirm this link.",1.1842986367842692e-07,0.04630451388242118,0.04740698022128245,0.009067132323909363,0.0031403945969037395,0.08339645952258565,0.009054007704764333,0.0008159221859189714,0.08986745754763771,1.1842986367842703e-07,0.0051951021049618795,0.09642074506939374
103,0.3,2,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: There is limited evidence suggesting that airway surgery may lower serum lipid levels in obstructive sleep apnea patients, but further research is needed to establish a clear connection between the two.","Question: Can airway surgery lower serum lipid levels in obstructive sleep apnea sufferers? Answer: Some limited data suggest airway surgery could reduce serum lipid levels in obstructive sleep apnea patients, but additional studies are necessary to verify this relationship.",1.4211583641411222e-07,0.14991996787876483,0.0019783918500533293,0.010880558788691236,0.1441828563945049,0.004029657825054794,0.0108648092457172,0.1431483436278933,0.007498630387143879,1.4211583641411244e-07,0.14180100581486865,0.011459807569393743
103,0.3,3,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: There is limited evidence suggesting that airway surgery may lower serum lipid levels in obstructive sleep apnea patients, but further research is needed to establish a clear connection between the two.","Question: Is there an effect of airway surgery on serum lipid levels in obstructive sleep apnea patients? Answer: Evidence is limited but suggests airway surgery may lower serum lipid levels in these patients; however, further investigation is needed to establish a definitive connection.",4.737194547137081e-08,0.07350547017635156,0.07865668068807499,0.0036268529295637453,0.07818425831601106,0.08721339282669846,0.003621603081905733,0.08158751979303558,0.09189006694204196,4.737194547137081e-08,0.08523780977849604,0.09642074506939374
103,0.3,4,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: There is limited evidence suggesting that airway surgery may lower serum lipid levels in obstructive sleep apnea patients, but further research is needed to establish a clear connection between the two.","Question: Does performing airway surgery impact serum lipid levels in obstructive sleep apnea patients? Answer: There is scarce evidence that airway surgery might reduce serum lipid levels in patients with obstructive sleep apnea, yet more research is essential to confirm this association.",7.105791820705622e-08,0.012375665048213413,0.053240740740740686,0.005440279394345618,0.051801042846225,0.08600409948017945,0.0054324046228586,0.05538106157725631,0.09125036168908293,7.105791820705622e-08,0.05926232337523807,0.09642074506939374
103,0.3,5,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: There is limited evidence suggesting that airway surgery may lower serum lipid levels in obstructive sleep apnea patients, but further research is needed to establish a clear connection between the two.","Question: Could airway surgery lead to lower serum lipid levels in obstructive sleep apnea patients? Answer: Limited findings imply that airway surgery may help reduce serum lipid levels in such patients, but further research is required to establish a clear link.",9.474389094274162e-08,0.018113904287302862,0.07407407407407403,0.0072537058591274906,0.024705934398959073,0.08473338203067934,0.007243206163811466,0.028470153877695914,0.0905770635500365,9.474389094274162e-08,0.0325940762930772,0.09642074506939374
103,0.3,6,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: There is limited evidence suggesting that airway surgery may lower serum lipid levels in obstructive sleep apnea patients, but further research is needed to establish a clear connection between the two.","Question: Is airway surgery effective in lowering serum lipid levels among obstructive sleep apnea patients? Answer: Current limited evidence suggests a potential reduction in serum lipid levels post-airway surgery in these patients, though more studies are needed to confirm this effect.",9.474389094274162e-08,0.08742862234329696,0.12297801032796415,0.0072537058591274906,0.06025194365844344,0.11024232662699385,0.007243206163811466,0.06495158443348226,0.11687363038714388,9.474389094274162e-08,0.0325940762930772,0.09642074506939374
103,0.3,7,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: There is limited evidence suggesting that airway surgery may lower serum lipid levels in obstructive sleep apnea patients, but further research is needed to establish a clear connection between the two.","Question: Does airway surgery have an impact on serum lipid levels in patients with obstructive sleep apnea? Answer: There is limited evidence pointing to a possible decrease in serum lipid levels following airway surgery in obstructive sleep apnea patients, but additional research is necessary to validate this.",4.737194547137081e-08,0.17595794702489398,0.08667170571932474,0.0036268529295637453,0.20809225520038277,0.1136548515234019,0.003621603081905733,0.21155505862535762,0.11687363038714388,4.737194547137081e-08,0.1828762793424139,0.09642074506939374
103,0.3,8,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: There is limited evidence suggesting that airway surgery may lower serum lipid levels in obstructive sleep apnea patients, but further research is needed to establish a clear connection between the two.","Question: Can airway surgery influence serum lipid levels in obstructive sleep apnea patients? Answer: Some limited evidence suggests airway surgery may lower serum lipid levels in these patients, but further research is required to establish a definitive connection.",1.6580180914979753e-07,0.07108786173203052,0.06631976328946027,0.012693985253473108,0.061261108151156485,0.08050227352574682,0.012675610786670066,0.056894924121202006,0.08832691758437572,1.6580180914979784e-07,0.05196331173498647,0.09642074506939374
103,0.3,9,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: There is limited evidence suggesting that airway surgery may lower serum lipid levels in obstructive sleep apnea patients, but further research is needed to establish a clear connection between the two.","Question: Is there a reduction in serum lipid levels after airway surgery in obstructive sleep apnea patients? Answer: Limited evidence suggests airway surgery might reduce serum lipid levels in obstructive sleep apnea patients, though more research is needed to confirm this relationship.",7.105791820705622e-08,0.0214363925400769,0.030798689846308847,0.005440279394345618,0.017143683818228173,0.06135865595325056,0.0054324046228586,0.05538106157725631,0.09125036168908293,7.105791820705622e-08,0.05926232337523807,0.09642074506939374
103,0.3,10,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: There is limited evidence suggesting that airway surgery may lower serum lipid levels in obstructive sleep apnea patients, but further research is needed to establish a clear connection between the two.","Question: Does airway surgery contribute to lowering serum lipid levels in obstructive sleep apnea patients? Answer: There is limited evidence indicating that airway surgery could lower serum lipid levels in these patients, but further studies are necessary to establish a clear connection.",7.105791820705622e-08,0.04618772263650328,0.07641876110344575,0.005440279394345618,0.051801042846225,0.08600409948017945,0.0054324046228586,0.05538106157725631,0.09125036168908293,7.105791820705622e-08,0.05926232337523807,0.09642074506939374
104,0.3,1,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: The use of audit to identify maternal mortality in different settings is not just a difference between the rich and the poor. While socioeconomic factors can influence access to healthcare and overall maternal health outcomes, audit processes can help identify and address systemic issues in both resource-rich and resource-poor settings.","Is the use of audit to identify maternal mortality in various settings merely a distinction between wealthy and impoverished areas? The use of audit to identify maternal mortality across different settings goes beyond just the divide between the rich and the poor. Although socioeconomic factors affect healthcare access and maternal health outcomes, audit processes can uncover and tackle systemic problems in both affluent and under-resourced environments.",1.8948778188548325e-07,0.03847992928095012,0.09578461716382866,0.014507411718255037,0.021809104873051766,0.09036860879904872,0.014486412327622947,0.004734759658528986,0.08324713981556413,1.8948778188548325e-07,0.01275715129441668,0.07467961421588064
104,0.3,2,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: The use of audit to identify maternal mortality in different settings is not just a difference between the rich and the poor. While socioeconomic factors can influence access to healthcare and overall maternal health outcomes, audit processes can help identify and address systemic issues in both resource-rich and resource-poor settings.","Does auditing maternal mortality in diverse settings simply reflect the gap between rich and poor? Auditing maternal mortality is not solely about the disparity between rich and poor settings. While socioeconomic status impacts healthcare availability and maternal health, audits serve to detect and resolve systemic issues in both well-resourced and low-resource areas.",5.210914001850789e-07,0.1635174385001279,0.12404499291560399,0.039895382225201254,0.15053765114828055,0.1431847833267274,0.03983763390096308,0.1365563066287363,0.16202240735420861,5.210914001850789e-07,0.1792521795529134,0.13888888888888895
104,0.3,3,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: The use of audit to identify maternal mortality in different settings is not just a difference between the rich and the poor. While socioeconomic factors can influence access to healthcare and overall maternal health outcomes, audit processes can help identify and address systemic issues in both resource-rich and resource-poor settings.","Is the identification of maternal mortality through audits in different settings only a matter of economic disparity? The identification of maternal mortality via audits in various settings is more complex than just economic differences. Socioeconomic conditions influence healthcare access and maternal outcomes, but audits help pinpoint and address systemic challenges in both wealthy and poor regions.",4.263475092423373e-07,0.10530767659419071,0.11190827947060629,0.03264167636607376,0.09514118896290524,0.127752017082975,0.03259442773715161,0.11039768594648347,0.1243445911296796,4.263475092423373e-07,0.12586897882398995,0.11966551326412925
104,0.3,4,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: The use of audit to identify maternal mortality in different settings is not just a difference between the rich and the poor. While socioeconomic factors can influence access to healthcare and overall maternal health outcomes, audit processes can help identify and address systemic issues in both resource-rich and resource-poor settings.","Is auditing maternal mortality in different environments just a reflection of wealth differences? Auditing maternal mortality is not merely a question of rich versus poor. Socioeconomic factors do influence healthcare access and maternal health, yet audit procedures can reveal and fix systemic issues in both resource-rich and resource-limited settings.",5.921493183921352e-07,0.17317535586362398,0.160320377769283,0.04533566161954687,0.18645690512625102,0.1618487982395609,0.04527003852382168,0.19973520825026858,0.16202240735420861,5.921493183921352e-07,0.24379070069048492,0.13888888888888895
104,0.3,5,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: The use of audit to identify maternal mortality in different settings is not just a difference between the rich and the poor. While socioeconomic factors can influence access to healthcare and overall maternal health outcomes, audit processes can help identify and address systemic issues in both resource-rich and resource-poor settings.","Is the use of audits to detect maternal mortality across settings simply a contrast between affluent and impoverished areas? The use of audits to detect maternal mortality transcends the simple rich-poor divide. Although socioeconomic factors affect healthcare access and maternal outcomes, audits can identify and address systemic problems in both high-resource and low-resource settings.",4.737194547137081e-07,0.19941766983007625,0.07289126623809211,0.03626852929563751,0.21582220521788198,0.06969378878776498,0.036216030819057346,0.23246218388953732,0.06514149998180785,4.737194547137081e-07,0.2493337339222501,0.059493803822726385
104,0.3,6,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: The use of audit to identify maternal mortality in different settings is not just a difference between the rich and the poor. While socioeconomic factors can influence access to healthcare and overall maternal health outcomes, audit processes can help identify and address systemic issues in both resource-rich and resource-poor settings.","Is maternal mortality audit usage in various settings only about the difference between rich and poor? Using audits to identify maternal mortality is not just about economic disparities. Socioeconomic factors influence healthcare and maternal health, but audit processes help uncover systemic issues in both wealthy and resource-poor settings.",6.158352911278206e-07,0.1659621247194738,0.18064173882788417,0.047149088084328744,0.1784674856425359,0.18311533888228299,0.047080840064774546,0.22171411496904359,0.16202240735420861,6.158352911278206e-07,0.26626355654254263,0.13888888888888895
104,0.3,7,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: The use of audit to identify maternal mortality in different settings is not just a difference between the rich and the poor. While socioeconomic factors can influence access to healthcare and overall maternal health outcomes, audit processes can help identify and address systemic issues in both resource-rich and resource-poor settings.","Is the role of audits in identifying maternal mortality across different settings just a matter of economic inequality? The role of audits in identifying maternal mortality is not confined to economic inequality between rich and poor. While socioeconomic factors impact healthcare access and maternal health, audits can highlight and address systemic problems in all settings.",4.500334819780227e-07,0.17733487975019324,0.07515409205548634,0.034455102830855636,0.19375595285723302,0.0717527313675705,0.03440522927810448,0.21043042088100128,0.06695676679286862,4.500334819780227e-07,0.22735652723607913,0.06102560233388667
104,0.3,8,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: The use of audit to identify maternal mortality in different settings is not just a difference between the rich and the poor. While socioeconomic factors can influence access to healthcare and overall maternal health outcomes, audit processes can help identify and address systemic issues in both resource-rich and resource-poor settings.","Is auditing maternal mortality in different contexts merely a distinction between the wealthy and the poor? Auditing maternal mortality is more than just a wealthy-poor distinction. Socioeconomic factors do affect healthcare access and maternal health outcomes, but audits help identify and resolve systemic issues in both affluent and disadvantaged areas.",5.684633456564497e-07,0.15137724692524213,0.16116586208717484,0.043522235154765,0.16478900374707006,0.1622914366640847,0.04345923698286881,0.17822900302930522,0.16202240735420861,5.684633456564497e-07,0.22181179397170991,0.13888888888888895
104,0.3,9,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: The use of audit to identify maternal mortality in different settings is not just a difference between the rich and the poor. While socioeconomic factors can influence access to healthcare and overall maternal health outcomes, audit processes can help identify and address systemic issues in both resource-rich and resource-poor settings.","Is the application of audits to identify maternal mortality in diverse settings simply a difference between economic classes? The application of audits to identify maternal mortality goes beyond economic class differences. Socioeconomic factors influence healthcare access and maternal health, but audits can reveal and address systemic challenges in both rich and poor settings.",4.974054274493935e-07,0.22198693175571815,0.07055025477924828,0.03808195576041938,0.2383767036567046,0.06755978332672741,0.03802683236001021,0.25498303542320677,0.06325697525544316,4.974054274493935e-07,0.2717997789722095,0.05790123456790129
104,0.3,10,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: The use of audit to identify maternal mortality in different settings is not just a difference between the rich and the poor. While socioeconomic factors can influence access to healthcare and overall maternal health outcomes, audit processes can help identify and address systemic issues in both resource-rich and resource-poor settings.","Is the use of audits for maternal mortality identification in various settings just about the divide between rich and poor? The use of audits for maternal mortality identification is not solely about the rich-poor divide. Although socioeconomic factors affect healthcare access and maternal outcomes, audits help detect and tackle systemic issues in both resource-rich and resource-poor environments.",4.026615365066519e-07,0.1593044625782598,0.0630193905817174,0.03082824990129189,0.15100780902132982,0.07566011189352832,0.030783626196198746,0.1677531471676712,0.0703939192242627,4.026615365066519e-07,0.1847872664271657,0.06392012587347871
105,0.3,1,ai,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The characterization of gender dimorphism after injury and hemorrhagic shock suggests that hormonal differences may be responsible. Further research is needed to fully understand the role of hormones in these conditions and their impact on outcomes and treatment strategies.,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The characterization of gender dimorphism following injury and hemorrhagic shock indicates that hormonal differences could be a contributing factor. Additional studies are required to comprehensively understand the influence of hormones on these conditions and their effects on outcomes and treatment approaches.,4.737194547137081e-08,0.0922961865176406,0.03832665954122526,0.0036268529295637453,0.11646190917847044,0.05679318002501245,0.003621603081905733,0.1177188488166876,0.057476051645147866,4.737194547137081e-08,0.09283076557759529,0.039150354019158694
105,0.3,2,ai,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The characterization of gender dimorphism after injury and hemorrhagic shock suggests that hormonal differences may be responsible. Further research is needed to fully understand the role of hormones in these conditions and their impact on outcomes and treatment strategies.,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: Gender dimorphism observed after injury and hemorrhagic shock appears to be linked to hormonal differences. More research is necessary to clarify the role hormones play in these conditions and how they affect treatment and recovery.,9.474389094274162e-08,0.00815976543610697,0.04735910234895736,0.0072537058591274906,0.03042906923402766,0.034226345631978815,0.007243206163811466,0.028945319363027355,0.03665214942694958,9.474389094274162e-08,0.027313546264467803,0.039150354019158694
105,0.3,3,ai,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The characterization of gender dimorphism after injury and hemorrhagic shock suggests that hormonal differences may be responsible. Further research is needed to fully understand the role of hormones in these conditions and their impact on outcomes and treatment strategies.,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The observed gender dimorphism post-injury and hemorrhagic shock suggests that hormones may be responsible. Further investigation is essential to fully elucidate the hormonal impact on these conditions and their therapeutic implications.,1.8948778188548325e-07,0.0409114933603445,0.0833657576630538,0.014507411718254981,0.05900343426331922,0.07496876301541025,0.014486412327622933,0.08707556382932591,0.057476051645147866,1.8948778188548325e-07,0.1162610322809634,0.039150354019158694
105,0.3,4,ai,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The characterization of gender dimorphism after injury and hemorrhagic shock suggests that hormonal differences may be responsible. Further research is needed to fully understand the role of hormones in these conditions and their impact on outcomes and treatment strategies.,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: Hormonal differences seem to underlie the gender dimorphism seen after injury and hemorrhagic shock. Continued research is needed to better understand the hormonal contributions to these conditions and their influence on clinical outcomes and treatment.,9.474389094274162e-08,0.06361153988090251,0.008985592373797632,0.0072537058591274906,0.058720790889535746,0.014004679839606876,0.007243206163811466,0.028945319363027355,0.03665214942694958,9.474389094274162e-08,0.027313546264467803,0.039150354019158694
105,0.3,5,ai,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The characterization of gender dimorphism after injury and hemorrhagic shock suggests that hormonal differences may be responsible. Further research is needed to fully understand the role of hormones in these conditions and their impact on outcomes and treatment strategies.,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The gender differences following injury and hemorrhagic shock are likely influenced by hormonal variations. More detailed studies are required to determine the exact role of hormones in these scenarios and their impact on patient management.,9.474389094274162e-08,0.019566121786291024,0.0669986419194205,0.0072537058591274906,0.0021373475785200213,0.0545694574598547,0.007243206163811466,6.418683969666716e-05,0.057476051645147866,9.474389094274162e-08,0.027313546264467803,0.039150354019158694
105,0.3,6,ai,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The characterization of gender dimorphism after injury and hemorrhagic shock suggests that hormonal differences may be responsible. Further research is needed to fully understand the role of hormones in these conditions and their impact on outcomes and treatment strategies.,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: Hormonal disparities may explain the gender dimorphism observed after injury and hemorrhagic shock. Further research is crucial to fully comprehend how hormones affect these conditions and guide treatment strategies.,2.3685972735685406e-07,0.18262303818365888,0.014985614108085077,0.018134264647818726,0.20118401958099952,0.005593763015410258,0.018108015409528666,0.16660258806231143,0.03368069174032931,2.3685972735685406e-07,0.16388908127021784,0.039150354019158694
105,0.3,7,ai,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The characterization of gender dimorphism after injury and hemorrhagic shock suggests that hormonal differences may be responsible. Further research is needed to fully understand the role of hormones in these conditions and their impact on outcomes and treatment strategies.,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The gender-specific differences after injury and hemorrhagic shock suggest a hormonal basis. Additional research is necessary to understand the hormonal mechanisms involved and their effects on outcomes and therapies.,2.3685972735685406e-07,0.11960965813275637,0.058937411686387,0.018134264647818726,0.16894461583402487,0.028567811201014044,0.018108015409528666,0.16660258806231143,0.03368069174032931,2.3685972735685406e-07,0.16388908127021784,0.039150354019158694
105,0.3,8,ai,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The characterization of gender dimorphism after injury and hemorrhagic shock suggests that hormonal differences may be responsible. Further research is needed to fully understand the role of hormones in these conditions and their impact on outcomes and treatment strategies.,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: Hormones might be responsible for the gender dimorphism seen after injury and hemorrhagic shock. More research is needed to explore the hormonal role and its implications for treatment and recovery.,2.1317375462116866e-07,0.15664943899544026,0.01737918741511993,0.016320838183036854,0.1759963601917338,0.007151987286677319,0.0162972138685758,0.14230448580099964,0.03423342125966034,2.1317375462116866e-07,0.13979152969115782,0.039150354019158694
105,0.3,9,ai,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The characterization of gender dimorphism after injury and hemorrhagic shock suggests that hormonal differences may be responsible. Further research is needed to fully understand the role of hormones in these conditions and their impact on outcomes and treatment strategies.,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The gender dimorphism following injury and hemorrhagic shock is potentially due to hormonal differences. Further studies are required to clarify the hormonal influence on these conditions and their clinical significance.,2.1317375462116866e-07,0.12584289763722056,0.03871135576729126,0.016320838183036854,0.14448967016628167,0.029617289092507756,0.0162972138685758,0.11006508205402543,0.057476051645147866,2.1317375462116866e-07,0.13979152969115782,0.039150354019158694
105,0.3,10,ai,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The characterization of gender dimorphism after injury and hemorrhagic shock suggests that hormonal differences may be responsible. Further research is needed to fully understand the role of hormones in these conditions and their impact on outcomes and treatment strategies.,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: Hormonal differences are likely a factor in the gender dimorphism observed after injury and hemorrhagic shock. Continued research is essential to fully understand their role in these conditions and how they affect treatment outcomes.,1.1842986367842703e-07,0.08720925379708255,0.006689287469203234,0.009067132323909363,0.08110831069574065,0.01274654079318803,0.009054007704764333,0.05061322074220831,0.03620951100242577,1.1842986367842703e-07,0.04881975148543116,0.039150354019158694
106,0.3,1,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as,What is the impact of MPH programs on strengthening health systems in low- and middle-income countries? The answer shows significant effects at multiple levels; graduates were seen as making substantial contributions to their workplaces and frequently influencing national policies. Much of this impact aligns with the goals of public health education. The qualitative study provided deeper insights into the graduates' influence.,1.6580180914979784e-07,0.11034805716886531,0.0,0.012693985253473108,0.11211729812070548,0.0,0.012675610786670066,0.1139442593492177,0.0,1.6580180914979784e-07,0.11583181552512123,0.0
106,0.3,2,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as,How do MPH programs contribute to health system strengthening in low- and middle-income countries? The findings indicate considerable impact across various levels; graduates are recognized for their significant workplace contributions and often hold sway at the national level. This impact largely corresponds with the objectives of public health education. The qualitative research offered a more detailed understanding of graduates' effects.,1.8948778188548325e-07,0.12715517548524602,0.0,0.014507411718254981,0.1292117314800052,0.0,0.014486412327622933,0.13133600206108653,0.0,1.8948778188548325e-07,0.13353139262452185,0.0
106,0.3,3,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as,What is the role of MPH programs in enhancing health systems in low- and middle-income countries? There was notable impact at several levels; graduates were regarded as capable of making meaningful contributions to their workplaces and frequently had national-level influence. Much of the described impact aligns with public health educational goals. The qualitative study revealed deeper insights into the graduates' impact.,1.6580180914979784e-07,0.11034805716886531,0.0,0.012693985253473108,0.11211729812070548,0.0,0.012675610786670066,0.1139442593492177,0.0,1.6580180914979784e-07,0.11583181552512123,0.0
106,0.3,4,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as,How do MPH programs affect health system strengthening in low- and middle-income countries? The impact was substantial at many levels; graduates were perceived as significantly contributing to their workplaces and often exerting influence nationally. Much of the impact described aligns with the aims of public health education. The qualitative study provided a deeper understanding of graduates' impact.,2.6054570009253947e-07,0.204096185104385,0.017851239669421492,0.0199476911126006,0.18232155679395312,0.0,0.019918816950481533,0.1854032233313614,0.0,2.6054570009253947e-07,0.18859116980755042,0.0
106,0.3,5,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as,What impact do MPH programs have on health system strengthening in low- and middle-income countries? There was considerable influence at multiple levels; graduates were seen as able to contribute significantly to their workplaces and often influenced national policies. Much of the impact aligns with the goals of public health education. The qualitative study gave more in-depth insights into graduates' impact.,1.8948778188548325e-07,0.12715517548524602,0.0,0.014507411718254981,0.1292117314800052,0.0,0.014486412327622933,0.13133600206108653,0.0,1.8948778188548325e-07,0.13353139262452185,0.0
106,0.3,6,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as,How significant is the impact of MPH programs on health system strengthening in low- and middle-income countries? The impact was evident at various levels; graduates were viewed as making important contributions to their workplaces and often had national-level influence. Much of the impact described aligns with public health educational aims. The qualitative study revealed a deeper understanding of graduates' impact.,1.8948778188548325e-07,0.18301681728192953,0.06894429055093874,0.014507411718254981,0.1292117314800052,0.0,0.014486412327622933,0.13133600206108653,0.0,1.8948778188548325e-07,0.13353139262452185,0.0
106,0.3,7,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as,What contributions do MPH programs make to health system strengthening in low- and middle-income countries? The impact was notable across many levels; graduates were perceived as contributing significantly to their workplaces and often had influence at the national level. Much of the impact aligns with public health education objectives. The qualitative study provided a more detailed understanding of graduates' impact.,1.8948778188548325e-07,0.1506516900804984,0.01694411414982164,0.014507411718254981,0.1292117314800052,0.0,0.014486412327622933,0.13133600206108653,0.0,1.8948778188548325e-07,0.13353139262452185,0.0
106,0.3,8,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as,How do MPH programs influence health system strengthening in low- and middle-income countries? There was considerable impact at multiple levels; graduates were seen as able to contribute meaningfully to their workplaces and often influenced national policies. Much of the described impact aligns with public health educational goals. The qualitative study revealed deeper insights into graduates' impact.,2.8423167282822487e-07,0.19735943415849366,0.0,0.02176111757738247,0.20067069546214888,0.0,0.0217296184914344,0.20409535634351572,0.0,2.8423167282822487e-07,0.20763936477824352,0.0
106,0.3,9,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as,What is the effect of MPH programs on health system strengthening in low- and middle-income countries? The impact was substantial at many levels; graduates were regarded as making significant contributions to their workplaces and often had national influence. Much of the impact aligns with the aims of public health education. The qualitative study provided a deeper understanding of graduates' impact.,1.8948778188548325e-07,0.1506516900804984,0.01694411414982164,0.014507411718254981,0.1292117314800052,0.0,0.014486412327622933,0.13133600206108653,0.0,1.8948778188548325e-07,0.13353139262452185,0.0
106,0.3,10,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as,How do MPH programs contribute to strengthening health systems in low- and middle-income countries? There was notable impact at various levels; graduates were perceived as significantly contributing to their workplaces and often influencing national policies. Much of the impact described aligns with public health educational objectives. The qualitative study offered a more in-depth understanding of graduates' impact.,2.6054570009253947e-07,0.1793409286558152,0.0,0.0199476911126006,0.18232155679395312,0.0,0.019918816950481533,0.1854032233313614,0.0,2.6054570009253947e-07,0.18859116980755042,0.0
107,0.3,1,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless","Can neoadjuvant chemotherapy alter the extent of lymphadenectomy in cervical cancer? The occurrence and location of lymph node metastases remain unchanged by NACT, with clinical non-responders exhibiting more affected lymph nodes. Therefore, a thorough and systemic lymphadenectomy is recommended for patients undergoing NACT followed by surgery.",9.474389094274162e-08,0.0568660866847992,0.020399305555555556,0.0072537058591274906,0.08701137698962924,0.0,0.007243206163811466,0.0889474860164956,0.0,9.474389094274162e-08,0.09097177820572666,0.0
107,0.3,2,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless","Is it possible to change the scope of lymphadenectomy through neoadjuvant chemotherapy in cervical cancer? Neoadjuvant chemotherapy does not affect the frequency or distribution of lymph node metastases, and patients who do not respond clinically have more involved lymph nodes. Hence, an extensive systemic lymphadenectomy should be performed in patients treated with NACT plus surgery.",1.1842986367842703e-07,0.09978335231063973,0.0018873796032593745,0.009067132323909363,0.09909090264422993,0.0,0.009054007704764333,0.10109611687136999,0.0,1.1842986367842703e-07,0.10318423623523065,0.0
107,0.3,3,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless","Does neoadjuvant chemotherapy influence the extent of lymphadenectomy in cervical cancer? The rate and anatomical distribution of lymph node metastases are not altered by NACT, and clinical non-responders have a higher number of involved lymph nodes. Consequently, patients receiving NACT and surgery should undergo a comprehensive systemic lymphadenectomy.",4.737194547137081e-08,0.013380974745060836,0.020399305555555556,0.0036268529295637453,0.04255961441879652,0.0,0.003621603081905733,0.04348511193973836,0.0,4.737194547137081e-08,0.04445176257083272,0.0
107,0.3,4,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless","Can the degree of lymphadenectomy be adjusted by neoadjuvant chemotherapy in cervical cancer? The frequency and location of lymph node metastases are unaffected by NACT, with clinical non-responders showing increased lymph node involvement. Therefore, a systemic and extensive lymphadenectomy is advised for patients treated with NACT plus surgery.",4.737194547137081e-08,0.04287659944973932,0.0008672350871665492,0.0036268529295637453,0.04255961441879652,0.0,0.003621603081905733,0.04348511193973836,0.0,4.737194547137081e-08,0.04445176257083272,0.0
107,0.3,5,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless","Is the extent of lymphadenectomy modifiable by neoadjuvant chemotherapy in cervical cancer? NACT does not change the frequency or topographic distribution of lymph node metastases, and clinical non-responders present with more involved lymph nodes. Thus, a broad and systemic lymphadenectomy should be performed in patients treated with NACT and surgery.",0.0,0.028291721655508084,0.020399305555555556,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
107,0.3,6,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless","Could neoadjuvant chemotherapy impact the extent of lymphadenectomy in cervical cancer? The frequency and anatomical distribution of lymph node metastases remain consistent despite NACT, and clinical non-responders have more involved lymph nodes. As a result, a systemic and extensive lymphadenectomy is necessary for patients treated with NACT plus surgery.",2.3685972735685406e-08,0.007672434452772325,0.020399305555555556,0.0018134264647818726,0.02105340919783316,0.0,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
107,0.3,7,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless","Might the extent of lymphadenectomy be influenced by neoadjuvant chemotherapy in cervical cancer? The occurrence and distribution of lymph node metastases are not modified by NACT, and clinical non-responders show greater lymph node involvement. Therefore, patients treated with NACT and surgery should undergo a systemic and extensive lymphadenectomy.",4.737194547137081e-08,0.04287659944973932,0.0008672350871665492,0.0036268529295637453,0.04255961441879652,0.0,0.003621603081905733,0.04348511193973836,0.0,4.737194547137081e-08,0.04445176257083272,0.0
107,0.3,8,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless","Is it feasible to modify the extent of lymphadenectomy through neoadjuvant chemotherapy in cervical cancer? NACT does not alter the frequency or distribution of lymph node metastases, and clinical non-responders have more involved lymph nodes. Hence, a comprehensive systemic lymphadenectomy is recommended for patients receiving NACT plus surgery.",4.737194547137081e-08,0.013380974745060836,0.020399305555555556,0.0036268529295637453,0.04255961441879652,0.0,0.003621603081905733,0.04348511193973836,0.0,4.737194547137081e-08,0.04445176257083272,0.0
107,0.3,9,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless","Can neoadjuvant chemotherapy change the extent of lymphadenectomy in cervical cancer? The frequency and topographic distribution of lymph node metastases are not affected by NACT, and clinical non-responders exhibit more involved lymph nodes. Therefore, a systemic and extensive lymphadenectomy should be conducted in patients treated with NACT and surgery.",2.3685972735685406e-08,0.007672434452772325,0.020399305555555556,0.0018134264647818726,0.02105340919783316,0.0,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
107,0.3,10,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless","Does neoadjuvant chemotherapy modify the extent of lymphadenectomy in cervical cancer? The frequency and anatomical distribution of lymph node metastases remain unchanged by NACT, with clinical non-responders showing increased lymph node involvement. Thus, a systemic and extensive lymphadenectomy is warranted for patients treated with NACT plus surgery.",7.105791820705622e-08,0.06502401390341284,0.0013290895061728418,0.005440279394345618,0.06453852113757153,0.0,0.0054324046228586,0.06595796779179608,0.0,7.105791820705622e-08,0.06744128079553224,0.0
108,0.3,1,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: There is ongoing debate on whether physicians are adequately addressing the needs of family caregivers of the frail elderly. While some argue that healthcare providers are not doing enough to support caregivers, others believe that efforts are being made to improve caregiver education and resources.","Question: Are physicians adequately supporting family caregivers of the frail elderly? Answer: There is continuous discussion about whether doctors sufficiently meet the needs of family caregivers for frail elderly patients. Some feel healthcare professionals fall short in providing support, while others think progress is being made in caregiver education and resource availability.",1.6580180914979784e-07,0.011511768214027995,0.0988159938485198,0.012693985253473108,0.01489745981674151,0.10380622837370242,0.012675610786670066,0.009755110381675092,0.08842752787389466,1.6580180914979784e-07,0.035310766243132896,0.07227989234909649
108,0.3,2,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: There is ongoing debate on whether physicians are adequately addressing the needs of family caregivers of the frail elderly. While some argue that healthcare providers are not doing enough to support caregivers, others believe that efforts are being made to improve caregiver education and resources.","Question: Do physicians fulfill the needs of family caregivers of frail elderly individuals? Answer: The adequacy of physicians in addressing family caregivers' needs for the frail elderly remains debated. Some argue healthcare providers lack sufficient support efforts, whereas others see improvements in caregiver training and resource provision.",2.8423167282822487e-07,0.09462705958369177,0.0966875987867914,0.02176111757738247,0.09046305584108438,0.10380622837370242,0.0217296184914344,0.11738577457404009,0.08842752787389466,2.8423167282822487e-07,0.14531166145746166,0.07227989234909649
108,0.3,3,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: There is ongoing debate on whether physicians are adequately addressing the needs of family caregivers of the frail elderly. While some argue that healthcare providers are not doing enough to support caregivers, others believe that efforts are being made to improve caregiver education and resources.","Question: Are family caregivers of the frail elderly receiving proper support from physicians? Answer: Debate persists on whether physicians effectively meet the needs of family caregivers for frail elderly patients. While some claim healthcare providers do not offer enough assistance, others believe there are ongoing enhancements in caregiver education and resources.",1.8948778188548325e-07,0.03656039115204779,0.07848543829296423,0.014507411718254981,0.005305247500777099,0.10380622837370242,0.014486412327622933,0.03037439758441085,0.08842752787389466,1.8948778188548325e-07,0.05636417544096606,0.07227989234909649
108,0.3,4,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: There is ongoing debate on whether physicians are adequately addressing the needs of family caregivers of the frail elderly. While some argue that healthcare providers are not doing enough to support caregivers, others believe that efforts are being made to improve caregiver education and resources.","Question: Are doctors meeting the requirements of family caregivers for frail elderly patients? Answer: There is an ongoing discussion about the extent to which physicians address the needs of family caregivers of frail elderly individuals. Some suggest healthcare professionals are not providing adequate support, while others note efforts to improve caregiver education and resources.",1.1842986367842703e-07,0.0013092007221384705,0.06201599384851977,0.009067132323909363,0.027458666025410583,0.0845828527489427,0.009054007704764333,0.03025022423202328,0.08842752787389466,1.1842986367842703e-07,0.0055112282771214716,0.07227989234909649
108,0.3,5,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: There is ongoing debate on whether physicians are adequately addressing the needs of family caregivers of the frail elderly. While some argue that healthcare providers are not doing enough to support caregivers, others believe that efforts are being made to improve caregiver education and resources.","Question: Are physicians addressing the needs of family caregivers of the frail elderly adequately? Answer: Opinions vary on whether physicians sufficiently support family caregivers of frail elderly patients. Some argue that healthcare providers fall short, but others believe that initiatives to enhance caregiver education and resources are underway.",2.6054570009253947e-07,0.13147089453937522,0.05488293599728014,0.0199476911126006,0.09862098305969802,0.08207783331197402,0.019918816950481533,0.09491291872198238,0.08842752787389466,2.6054570009253947e-07,0.12232214323276214,0.07227989234909649
108,0.3,6,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: There is ongoing debate on whether physicians are adequately addressing the needs of family caregivers of the frail elderly. While some argue that healthcare providers are not doing enough to support caregivers, others believe that efforts are being made to improve caregiver education and resources.","Question: Do physicians provide enough support to family caregivers of the frail elderly? Answer: There is debate over whether doctors meet the needs of family caregivers for frail elderly individuals. Some feel healthcare providers are not doing enough, while others see progress in caregiver education and resource availability.",2.6054570009253947e-07,0.07247964513001826,0.0971494532057977,0.0199476911126006,0.06848414912230938,0.10380622837370242,0.019918816950481533,0.09491291872198238,0.08842752787389466,2.6054570009253947e-07,0.12232214323276214,0.07227989234909649
108,0.3,7,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: There is ongoing debate on whether physicians are adequately addressing the needs of family caregivers of the frail elderly. While some argue that healthcare providers are not doing enough to support caregivers, others believe that efforts are being made to improve caregiver education and resources.","Question: Are family caregivers of frail elderly patients getting adequate attention from physicians? Answer: The question of whether physicians adequately address the needs of family caregivers for the frail elderly remains controversial. Some believe healthcare professionals lack sufficient support efforts, while others think improvements are being made in caregiver education and resources.",1.6580180914979784e-07,0.015670474160871972,0.0792656398293611,0.012693985253473108,0.01489745981674151,0.10380622837370242,0.012675610786670066,0.009755110381675092,0.08842752787389466,1.6580180914979784e-07,0.035310766243132896,0.07227989234909649
108,0.3,8,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: There is ongoing debate on whether physicians are adequately addressing the needs of family caregivers of the frail elderly. While some argue that healthcare providers are not doing enough to support caregivers, others believe that efforts are being made to improve caregiver education and resources.","Question: Are physicians fulfilling the needs of family caregivers caring for the frail elderly? Answer: There is ongoing debate about whether doctors adequately support family caregivers of frail elderly patients. Some argue that healthcare providers do not offer enough assistance, whereas others believe efforts to enhance caregiver education and resources are in progress.",1.4211583641411244e-07,0.03145258950141683,0.09919261822376008,0.010880558788691236,0.034700087112921274,0.10380622837370242,0.0108648092457172,0.010447596935843517,0.08842752787389466,1.4211583641411244e-07,0.014691479040397137,0.07227989234909649
108,0.3,9,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: There is ongoing debate on whether physicians are adequately addressing the needs of family caregivers of the frail elderly. While some argue that healthcare providers are not doing enough to support caregivers, others believe that efforts are being made to improve caregiver education and resources.","Question: Are physicians meeting the support needs of family caregivers of frail elderly individuals? Answer: The adequacy of physician support for family caregivers of the frail elderly is debated. Some feel healthcare providers are insufficiently supportive, while others see ongoing improvements in caregiver education and resources.",3.079176455639103e-07,0.17888875643973723,0.052089463236274905,0.023574544042164344,0.1444426017185947,0.0810912473028533,0.023540420032387266,0.14037529279873961,0.08842752787389466,3.079176455639103e-07,0.16884215886765608,0.07227989234909649
108,0.3,10,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: There is ongoing debate on whether physicians are adequately addressing the needs of family caregivers of the frail elderly. While some argue that healthcare providers are not doing enough to support caregivers, others believe that efforts are being made to improve caregiver education and resources.","Question: Are doctors adequately addressing the needs of family caregivers for frail elderly patients? Answer: There is continued discussion about whether physicians provide enough support to family caregivers of the frail elderly. Some claim healthcare professionals do not do enough, while others believe that caregiver education and resource efforts are improving.",1.8948778188548325e-07,0.00883450392965024,0.09842432371107707,0.014507411718254981,0.005305247500777099,0.10380622837370242,0.014486412327622933,0.03037439758441085,0.08842752787389466,1.8948778188548325e-07,0.05636417544096606,0.07227989234909649
109,0.3,1,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising,Is neck pain linked to poorer health-related quality of life six months afterward? We discovered that neck pain was negatively correlated with physical health-related quality of life but not with mental health. Our findings indicate that neck pain could contribute to future declines in physical HRQoL in the population.,2.3685972735685406e-08,0.03401895088950102,0.039186469612182334,0.0018134264647818726,0.03684383495568344,0.041804662789511254,0.0018108015409528666,0.008157927218613636,0.021728395061728398,2.3685972735685406e-08,0.022472855852057716,0.0
109,0.3,2,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising,"Does neck pain predict worse health-related quality of life six months later? Our study found that neck pain adversely affects physical HRQoL, though it does not impact mental HRQoL. This suggests neck pain may lead to poorer physical health outcomes over time.",1.4211583641411244e-07,0.08784636198249851,0.030947303818294344,0.010880558788691236,0.10962510843776974,0.021728395061728398,0.0108648092457172,0.1431008436406751,0.0,1.4211583641411244e-07,0.14660347419187536,0.0
109,0.3,3,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising,Is there an association between neck pain and reduced health-related quality of life after six months? The results showed neck pain was negatively linked to physical HRQoL but had no significant effect on mental HRQoL. This implies neck pain might be a factor in future physical health decline.,0.0,0.05899124940935696,0.04396797735178842,0.0,0.03013683393738864,0.021728395061728398,0.0,0.0,0.0,0.0,0.0,0.0
109,0.3,4,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising,"Can neck pain be associated with diminished health-related quality of life six months later? We observed that neck pain negatively influenced physical HRQoL but not mental HRQoL, indicating it may contribute to future physical health deterioration.",2.8423167282822434e-07,0.20529251249060865,0.10233484479593385,0.02176111757738248,0.272144037935544,0.021728395061728398,0.021729618491434413,0.3101549283038394,0.0,2.8423167282822487e-07,0.31845373111853537,0.0
109,0.3,5,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising,"Does experiencing neck pain relate to worse health-related quality of life half a year later? Our analysis revealed a negative association between neck pain and physical HRQoL, whereas mental HRQoL remained unaffected. This points to neck pain as a potential cause of future physical health issues.",4.737194547137081e-08,0.012389506863468291,0.040021633315305574,0.0036268529295637453,0.01431492863344408,0.021728395061728398,0.003621603081905733,0.04546237407675724,0.0,4.737194547137081e-08,0.04652001563489394,0.0
109,0.3,6,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising,"Is neck pain connected to poorer health-related quality of life six months down the line? Findings indicated neck pain was linked to lower physical HRQoL but did not affect mental HRQoL, suggesting it may be a factor in future physical health decline.",1.4211583641411244e-07,0.04127215454629285,0.106506557598702,0.010880558788691236,0.10962510843776974,0.021728395061728398,0.0108648092457172,0.1431008436406751,0.0,1.4211583641411244e-07,0.14660347419187536,0.0
109,0.3,7,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising,"Is there a relationship between neck pain and health-related quality of life six months later? We found neck pain was negatively associated with physical HRQoL but not mental HRQoL, implying it could contribute to future physical health problems.",2.3685972735685374e-07,0.14758166618348767,0.10387538475919585,0.018134264647818726,0.21498562409559563,0.021728395061728398,0.018108015409528666,0.2513144282809061,0.0,2.3685972735685406e-07,0.2578291093020999,0.0
109,0.3,8,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising,"Does neck pain impact health-related quality of life six months later? Our study showed a negative correlation between neck pain and physical HRQoL, with no effect on mental HRQoL, suggesting neck pain may lead to poorer physical health outcomes.",2.1317375462116844e-07,0.17017855304130158,0.022856866240677357,0.016320838183036854,0.1875866499074803,0.021728395061728398,0.0162972138685758,0.22314355131420927,0.0,2.1317375462116866e-07,0.2288415724288484,0.0
109,0.3,9,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising,"Is neck pain a predictor of worse health-related quality of life after six months? The analysis indicated that neck pain negatively affects physical HRQoL but not mental HRQoL, suggesting it may contribute to future physical health decline.",2.6054570009253904e-07,0.17602140190397542,0.10312645555788569,0.0199476911126006,0.24315650106229247,0.021728395061728398,0.01991881695048154,0.2803019651541576,0.0,2.6054570009253947e-07,0.2876820724517817,0.0
109,0.3,10,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising,"Can neck pain influence health-related quality of life six months later? We found neck pain was associated with worse physical HRQoL but had no impact on mental HRQoL, indicating it might be a factor in future physical health deterioration.",2.1317375462116844e-07,0.11992743449171073,0.10458499076159464,0.016320838183036854,0.1875866499074803,0.021728395061728398,0.0162972138685758,0.22314355131420927,0.0,2.1317375462116866e-07,0.2288415724288484,0.0
110,0.3,1,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,"Question: What is the clinical importance of bile duct sludge, and how does it compare to bile duct stones? Answer: The results suggest that the clinical relevance of symptomatic bile duct sludge (BDS) is comparable to that of common bile duct (CBD) stones. Bile duct sludge appears to represent an initial phase of choledocholithiasis.",2.3685972735685406e-07,0.17831061799311287,0.19978424952567517,0.018134264647818726,0.2529286105496307,0.028276624375240304,0.018108015409528666,0.2520656236083072,0.024375,2.3685972735685406e-07,0.22314355131420927,0.0
110,0.3,2,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: How does the clinical significance of bile duct sludge differ from bile duct stones? Answer: Findings show that symptomatic bile duct sludge has a clinical significance similar to that of CBD stones. Bile duct sludge likely represents an early stage of choledocholithiasis.,2.3685972735685406e-08,0.09367226651632743,0.19421360418590353,0.0018134264647818726,0.0384697994073715,0.052434253780407655,0.0018108015409528666,0.009119444997918169,0.024375,2.3685972735685406e-08,0.02531780798429173,0.0
110,0.3,3,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: Is the clinical impact of bile duct sludge distinct from that of bile duct stones? Answer: The evidence indicates that symptomatic bile duct sludge shares similar clinical significance with CBD stones. Bile duct sludge may be an early form of choledocholithiasis.,4.737194547137081e-08,0.12370902173743303,0.2037147379727515,0.0036268529295637453,0.09982942765135228,0.08106099342585826,0.003621603081905733,0.01619836298637356,0.024375,4.737194547137081e-08,0.051293294387549704,0.0
110,0.3,4,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: What is the difference in clinical significance between bile duct sludge and bile duct stones? Answer: The data reveal that symptomatic bile duct sludge has clinical significance akin to CBD stones. Bile duct sludge seems to be an initial stage in the development of choledocholithiasis.,4.737194547137081e-08,0.008445571741115376,0.16840821299589673,0.0036268529295637453,0.0376286495127971,0.04547052154195008,0.003621603081905733,0.0814401065775443,0.024375,4.737194547137081e-08,0.048790164169431716,0.0
110,0.3,5,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: Does bile duct sludge have a different clinical significance compared to bile duct stones? Answer: The findings demonstrate that symptomatic bile duct sludge is clinically similar to CBD stones. Bile duct sludge appears to be an early phase of choledocholithiasis.,7.105791820705622e-08,0.11998043912395584,0.18412290123805772,0.005440279394345618,0.09260259254739323,0.05768626734842948,0.0054324046228586,0.042173849389631535,0.024375,7.105791820705622e-08,0.07796154146971057,0.0
110,0.3,6,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,"Question: How significant is bile duct sludge clinically, and is it different from bile duct stones? Answer: The clinical significance of symptomatic bile duct sludge is comparable to that of CBD stones, with bile duct sludge representing an early stage of choledocholithiasis.",4.737194547137081e-08,0.08989696414914272,0.1749234807291132,0.0036268529295637453,0.06517206862335545,0.0549930747922438,0.003621603081905733,0.01619836298637356,0.024375,4.737194547137081e-08,0.051293294387549704,0.0
110,0.3,7,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: Can the clinical significance of bile duct sludge be distinguished from that of bile duct stones? Answer: Research indicates that symptomatic bile duct sludge has a clinical significance similar to CBD stones and may represent an early stage of choledocholithiasis.,7.105791820705622e-08,0.08532308009595813,0.012694329809486177,0.005440279394345618,0.07918597347650769,0.003632213294375436,0.0054324046228586,0.042173849389631535,0.024375,7.105791820705622e-08,0.07796154146971057,0.0
110,0.3,8,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,"Question: What does the clinical significance of bile duct sludge imply compared to bile duct stones? Answer: The clinical importance of symptomatic bile duct sludge is similar to that of CBD stones, suggesting that bile duct sludge is an early stage of choledocholithiasis.",2.3685972735685406e-08,0.1266792751144199,0.22167392164622082,0.0018134264647818726,0.07228185699566136,0.07784626038781156,0.0018108015409528666,0.025537914030078213,0.0006085634451019166,2.3685972735685406e-08,0.02531780798429173,0.0
110,0.3,9,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: Is there a difference in clinical significance between bile duct sludge and stones? Answer: The findings suggest that symptomatic bile duct sludge shares clinical significance with CBD stones and likely represents an early stage of choledocholithiasis.,1.6580180914979742e-07,0.1198401271130094,0.08425287882603415,0.012693985253473108,0.15591594991548163,0.018953287197231855,0.012675610786670073,0.15339948449985608,0.024375,1.6580180914979784e-07,0.19237189264745602,0.0
110,0.3,10,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,"Question: How does the clinical relevance of bile duct sludge compare to bile duct stones? Answer: The clinical significance of symptomatic bile duct sludge is similar to that of CBD stones, with bile duct sludge being an early stage of choledocholithiasis.",7.105791820705622e-08,0.1546377981519531,0.21372533044503436,0.005440279394345618,0.09260259254739323,0.05768626734842948,0.0054324046228586,0.042173849389631535,0.024375,7.105791820705622e-08,0.07796154146971057,0.0
111,0.3,1,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: There is limited evidence to suggest that a prior benign prostate biopsy may not be a strong predictor of outcome for patients undergoing radical perineal prostatectomy.,"Question: Does a previous benign prostate biopsy forecast the results for patients treated with radical perineal prostatectomy? Answer: Evidence is limited, indicating that a prior benign prostate biopsy might not strongly predict outcomes for those undergoing radical perineal prostatectomy.",7.1057918207056e-08,0.017442146884457888,0.06367346938775514,0.005440279394345618,0.011456879551122068,0.04750076653229807,0.0054324046228586,0.04449669841405024,0.025623268698060954,7.105791820705622e-08,0.08223809823697303,0.0
111,0.3,2,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: There is limited evidence to suggest that a prior benign prostate biopsy may not be a strong predictor of outcome for patients undergoing radical perineal prostatectomy.,Question: Can a prior benign prostate biopsy predict outcomes in patients receiving radical perineal prostatectomy? Answer: Limited evidence suggests that having a previous benign prostate biopsy is not a strong predictor of outcomes for patients treated with radical perineal prostatectomy.,4.7371945471370706e-08,0.04622389717662356,0.06565192743764175,0.0036268529295637453,0.016197352140654875,0.04821037253469686,0.003621603081905733,0.017097724225934918,0.025623268698060954,4.737194547137081e-08,0.05406722127027619,0.0
111,0.3,3,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: There is limited evidence to suggest that a prior benign prostate biopsy may not be a strong predictor of outcome for patients undergoing radical perineal prostatectomy.,Question: Is the outcome of radical perineal prostatectomy influenced by a prior benign prostate biopsy? Answer: There is scarce evidence indicating that a prior benign prostate biopsy may not be a reliable predictor of patient outcomes after radical perineal prostatectomy.,4.7371945471370706e-08,0.010677887917140083,0.04081632653061225,0.0036268529295637453,0.020284078415131912,0.022037803569335095,0.003621603081905733,0.054565139391337336,0.0013829041414452105,4.737194547137081e-08,0.05406722127027619,0.0
111,0.3,4,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: There is limited evidence to suggest that a prior benign prostate biopsy may not be a strong predictor of outcome for patients undergoing radical perineal prostatectomy.,Question: Does a history of benign prostate biopsy affect the prognosis for patients undergoing radical perineal prostatectomy? Answer: Current limited evidence suggests that prior benign prostate biopsy does not strongly predict the outcome for these patients.,1.421158364141119e-07,0.0345684803205768,0.08510785030265555,0.010880558788691243,0.09932021597613305,0.045122182714320294,0.010864809245717214,0.13150807540368037,0.025623268698060954,1.4211583641411244e-07,0.17185025692666,0.0
111,0.3,5,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: There is limited evidence to suggest that a prior benign prostate biopsy may not be a strong predictor of outcome for patients undergoing radical perineal prostatectomy.,Question: Does prior benign prostate biopsy serve as a predictor for outcomes in radical perineal prostatectomy patients? Answer: Evidence is limited and suggests that a prior benign prostate biopsy may not be a significant predictor of outcomes for patients treated with radical perineal prostatectomy.,4.737194547137081e-08,0.12154277953109771,0.04999610889720782,0.0036268529295637453,0.08674822405723859,0.02700693937180422,0.003621603081905733,0.051744372245857484,0.001248268698060953,4.737194547137081e-08,0.051293294387549704,0.0
111,0.3,6,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: There is limited evidence to suggest that a prior benign prostate biopsy may not be a strong predictor of outcome for patients undergoing radical perineal prostatectomy.,Question: Can prior benign prostate biopsy status predict the results of radical perineal prostatectomy? Answer: There is limited evidence indicating that a previous benign prostate biopsy might not be a strong indicator of patient outcomes following radical perineal prostatectomy.,7.1057918207056e-08,0.017442146884457888,0.06367346938775513,0.005440279394345618,0.011456879551122068,0.04750076653229807,0.0054324046228586,0.04449669841405024,0.025623268698060954,7.105791820705622e-08,0.08223809823697303,0.0
111,0.3,7,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: There is limited evidence to suggest that a prior benign prostate biopsy may not be a strong predictor of outcome for patients undergoing radical perineal prostatectomy.,Question: Does having a prior benign prostate biopsy predict the outcome for patients undergoing radical perineal prostatectomy? Answer: Limited evidence suggests that prior benign prostate biopsy may not be a strong predictor of outcomes in these patients.,1.1842986367842661e-07,0.04270531281178247,0.05939618822735711,0.009067132323909363,0.10877613617595383,0.01757397334792913,0.00905400770476434,0.14242847581634832,0.003761487959422983,1.1842986367842703e-07,0.14107859825990632,0.0
111,0.3,8,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: There is limited evidence to suggest that a prior benign prostate biopsy may not be a strong predictor of outcome for patients undergoing radical perineal prostatectomy.,Question: Is prior benign prostate biopsy a reliable predictor of outcomes in patients treated with radical perineal prostatectomy? Answer: Evidence is limited but suggests that prior benign prostate biopsy may not reliably predict patient outcomes after radical perineal prostatectomy.,7.1057918207056e-08,0.0190392836713289,0.03823458795282822,0.005440279394345618,0.048924294716525374,0.020629388351396057,0.0054324046228586,0.08300487511182508,0.002131833342755376,7.105791820705622e-08,0.08223809823697303,0.0
111,0.3,9,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: There is limited evidence to suggest that a prior benign prostate biopsy may not be a strong predictor of outcome for patients undergoing radical perineal prostatectomy.,Question: Does a previous benign prostate biopsy influence the outcome for patients treated with radical perineal prostatectomy? Answer: There is limited evidence to suggest it may not be a strong predictor of outcomes for these patients.,1.421158364141119e-07,0.044648340314845214,0.14204081632653065,0.010880558788691243,0.058546852413783323,0.07450693937180423,0.010864809245717214,0.13150807540368037,0.025623268698060954,1.4211583641411244e-07,0.17185025692666,0.0
111,0.3,10,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: There is limited evidence to suggest that a prior benign prostate biopsy may not be a strong predictor of outcome for patients undergoing radical perineal prostatectomy.,Question: Does prior benign prostate biopsy status predict outcomes in patients undergoing radical perineal prostatectomy? Answer: Limited evidence suggests that a prior benign prostate biopsy is unlikely to be a strong predictor of patient outcomes after radical perineal prostatectomy.,7.1057918207056e-08,0.0190392836713289,0.03823458795282822,0.005440279394345618,0.048924294716525374,0.020629388351396057,0.0054324046228586,0.08300487511182508,0.002131833342755376,7.105791820705622e-08,0.08223809823697303,0.0
112,0.3,1,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,Advanced epithelial ovarian carcinoma in Thai women: is it still advisable to perform second-look laparotomy? The second-look laparotomy does not improve overall or disease-free survival. Tumor grade remains the sole independent prognostic factor for patient survival.,1.421158364141119e-07,0.15822400521489444,0.0,0.010880558788691243,0.16251892949777424,0.0,0.010864809245717214,0.1670540846631643,0.0,1.4211583641411244e-07,0.17185025692666,0.0
112,0.3,2,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,"In Thai women with advanced epithelial ovarian carcinoma, should second-look laparotomy still be recommended? Second-look laparotomy shows no benefit on overall or disease-free survival. Tumor grade is the only independent predictor of survival.",2.131737546211678e-07,0.291157862689579,0.031217481789802305,0.01632083818303688,0.25489224962878954,0.0,0.016297213868575834,0.2623642644674895,0.0,2.1317375462116866e-07,0.2702903297399133,0.0
112,0.3,3,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,"For advanced epithelial ovarian carcinoma in Thai women, is continuing second-look laparotomy justified? The procedure does not enhance overall or disease-free survival rates. Tumor grade is the only independent prognostic indicator for survival.",2.131737546211678e-07,0.2478361639045814,0.0,0.01632083818303688,0.25489224962878954,0.0,0.016297213868575834,0.2623642644674895,0.0,2.1317375462116866e-07,0.2702903297399133,0.0
112,0.3,4,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,Should second-look laparotomy be continued in Thai women with advanced epithelial ovarian carcinoma? This surgery does not positively affect overall or disease-free survival. The only independent prognostic factor for survival is tumor grade.,2.131737546211678e-07,0.2478361639045814,0.0,0.01632083818303688,0.25489224962878954,0.0,0.016297213868575834,0.2623642644674895,0.0,2.1317375462116866e-07,0.2702903297399133,0.0
112,0.3,5,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,"In cases of advanced epithelial ovarian carcinoma among Thai women, is second-look laparotomy still warranted? It does not improve overall or disease-free survival outcomes. Tumor grade stands as the sole independent prognostic variable for survival.",1.658018091497972e-07,0.18721154208814594,0.0,0.012693985253473122,0.19237189264745602,0.0,0.012675610786670087,0.19782574332991798,0.0,1.6580180914979784e-07,0.20359895524123983,0.0
112,0.3,6,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,Is it appropriate to keep offering second-look laparotomy to Thai women with advanced epithelial ovarian carcinoma? The procedure does not favorably impact overall or disease-free survival. Tumor grade is the only independent survival predictor.,1.894877818854825e-07,0.21706450523782772,0.0,0.014507411718255002,0.2231435513142097,0.0,0.01448641232762296,0.2295744416444978,0.0,1.8948778188548325e-07,0.23638877806423153,0.0
112,0.3,7,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,"For Thai women with advanced epithelial ovarian carcinoma, should second-look laparotomy remain a treatment option? The surgery fails to improve overall and disease-free survival. Tumor grade is the only independent prognostic factor affecting survival.",1.894877818854825e-07,0.21706450523782772,0.0,0.014507411718255002,0.2231435513142097,0.0,0.01448641232762296,0.2295744416444978,0.0,1.8948778188548325e-07,0.23638877806423153,0.0
112,0.3,8,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,Should second-look laparotomy continue to be offered to Thai women with advanced epithelial ovarian carcinoma? It has no beneficial effect on overall or disease-free survival. Tumor grade is the only independent variable predicting survival.,1.894877818854825e-07,0.21706450523782772,0.0,0.014507411718255002,0.2231435513142097,0.0,0.01448641232762296,0.2295744416444978,0.0,1.8948778188548325e-07,0.23638877806423153,0.0
112,0.3,9,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,"In Thai women suffering from advanced epithelial ovarian carcinoma, is second-look laparotomy still beneficial? The procedure does not enhance overall or disease-free survival. Tumor grade is the only independent prognostic factor for survival.",2.131737546211678e-07,0.2478361639045814,0.0,0.01632083818303688,0.25489224962878954,0.0,0.016297213868575834,0.2623642644674895,0.0,2.1317375462116866e-07,0.2702903297399133,0.0
112,0.3,10,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,"Regarding advanced epithelial ovarian carcinoma in Thai women, should second-look laparotomy still be performed? The operation does not improve overall or disease-free survival. Tumor grade is the only independent prognostic factor influencing survival.",2.131737546211678e-07,0.2478361639045814,0.0,0.01632083818303688,0.25489224962878954,0.0,0.016297213868575834,0.2623642644674895,0.0,2.1317375462116866e-07,0.2702903297399133,0.0
113,0.3,1,ai,Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone may not reliably exclude aspiration following acute stroke. Additional tests such as swallow evaluations or imaging studies may be necessary to accurately diagnose aspiration in stroke patients.,Question: Is bedside assessment sufficient to rule out aspiration after an acute stroke? Answer: Bedside assessment by itself might not reliably rule out aspiration after an acute stroke. Further evaluations like swallow tests or imaging may be needed to properly diagnose aspiration in stroke patients.,9.474389094274162e-08,0.07955683479159914,0.010515009327830893,0.0072537058591274906,0.0753188823544737,0.015655818540433936,0.007243206163811466,0.07402529387427581,0.01853678135729416,9.474389094274162e-08,0.07249745404890495,0.021646029658850176
113,0.3,2,ai,Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone may not reliably exclude aspiration following acute stroke. Additional tests such as swallow evaluations or imaging studies may be necessary to accurately diagnose aspiration in stroke patients.,Question: Can aspiration be reliably excluded after an acute stroke using only bedside assessment? Answer: Bedside assessment alone may not be enough to reliably exclude aspiration following an acute stroke. Additional diagnostic tests such as swallowing assessments or imaging studies are often required for accurate diagnosis.,1.1842986367842703e-07,0.26026328943814914,0.10023823579018384,0.009067132323909363,0.2272660155670696,0.0763888888888889,0.009054007704764333,0.19657681707874897,0.05246913580246914,1.1842986367842703e-07,0.1642191208045447,0.027006172839506164
113,0.3,3,ai,Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone may not reliably exclude aspiration following acute stroke. Additional tests such as swallow evaluations or imaging studies may be necessary to accurately diagnose aspiration in stroke patients.,Question: Does bedside assessment reliably exclude aspiration after an acute stroke? Answer: Bedside assessment alone may not reliably exclude aspiration post-acute stroke. Supplementary tests like swallow evaluations or imaging are often necessary for an accurate diagnosis.,1.184298636784265e-07,0.07906982843767052,0.03748804209183673,0.00906713232390937,0.07133645729738003,0.047004132231404955,0.009054007704764347,0.06811573714833319,0.05246913580246914,1.1842986367842703e-07,0.10771459467909672,0.027006172839506164
113,0.3,4,ai,Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone may not reliably exclude aspiration following acute stroke. Additional tests such as swallow evaluations or imaging studies may be necessary to accurately diagnose aspiration in stroke patients.,Question: Can aspiration be ruled out with just bedside assessment after an acute stroke? Answer: Bedside assessment by itself may not reliably rule out aspiration following an acute stroke. Additional tests such as swallowing evaluations or imaging studies may be needed to confirm aspiration.,7.105791820705622e-08,0.18112864922566319,0.07604802777744052,0.005440279394345618,0.18074599993217566,0.0763888888888889,0.0054324046228586,0.14894876808949453,0.05246913580246914,7.105791820705622e-08,0.11542895663511299,0.027006172839506164
113,0.3,5,ai,Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone may not reliably exclude aspiration following acute stroke. Additional tests such as swallow evaluations or imaging studies may be necessary to accurately diagnose aspiration in stroke patients.,Question: Is bedside assessment alone reliable for excluding aspiration after an acute stroke? Answer: Bedside assessment alone might not be reliable enough to exclude aspiration after an acute stroke. Additional diagnostic methods like swallow tests or imaging studies may be required for accurate detection.,7.105791820705622e-08,0.08441043798474102,0.008183051613997475,0.005440279394345618,0.08172497413789692,0.0053829717291255935,0.0054324046228586,0.11513671050120466,0.02809413580246914,7.105791820705622e-08,0.11542895663511299,0.027006172839506164
113,0.3,6,ai,Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone may not reliably exclude aspiration following acute stroke. Additional tests such as swallow evaluations or imaging studies may be necessary to accurately diagnose aspiration in stroke patients.,Question: Can bedside assessment definitively exclude aspiration following an acute stroke? Answer: Bedside assessment alone may not definitively exclude aspiration after an acute stroke. Further testing such as swallowing evaluations or imaging may be necessary for accurate diagnosis.,7.10579182070559e-08,0.054544406991336114,0.0159292367084575,0.005440279394345618,0.011912856592856791,0.04863378684807257,0.0054324046228586,0.009275237125399904,0.05246913580246914,7.105791820705622e-08,0.047089972862661256,0.027006172839506164
113,0.3,7,ai,Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone may not reliably exclude aspiration following acute stroke. Additional tests such as swallow evaluations or imaging studies may be necessary to accurately diagnose aspiration in stroke patients.,Question: Is it possible to exclude aspiration after acute stroke using only bedside assessment? Answer: Using only bedside assessment may not reliably exclude aspiration following an acute stroke. Additional evaluations like swallow studies or imaging are often needed for accurate diagnosis.,0.0,0.06931471805599454,0.0479420402200325,0.0,0.07109201851896829,0.05076562019082794,0.0,0.07296286111157313,0.05246913580246914,0.0,0.03746741516540242,0.027006172839506164
113,0.3,8,ai,Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone may not reliably exclude aspiration following acute stroke. Additional tests such as swallow evaluations or imaging studies may be necessary to accurately diagnose aspiration in stroke patients.,Question: Can aspiration be excluded reliably after an acute stroke by bedside assessment alone? Answer: Bedside assessment alone may not reliably exclude aspiration post-acute stroke. Additional tests such as swallowing evaluations or imaging studies might be necessary for accurate diagnosis.,2.36859727356853e-08,0.11242297789620981,0.09682571089377578,0.0018134264647818726,0.08066254137519424,0.0763888888888889,0.0018108015409528666,0.04629461402941226,0.05246913580246914,2.3685972735685406e-08,0.010068440977287096,0.027006172839506164
113,0.3,9,ai,Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone may not reliably exclude aspiration following acute stroke. Additional tests such as swallow evaluations or imaging studies may be necessary to accurately diagnose aspiration in stroke patients.,Question: Does bedside assessment alone suffice to exclude aspiration after an acute stroke? Answer: Bedside assessment alone may not suffice to reliably exclude aspiration following an acute stroke. Additional diagnostic procedures like swallow tests or imaging may be required for accurate diagnosis.,2.3685972735685406e-08,0.02891911978890782,0.002850214159737921,0.0018134264647818726,0.09729847673474756,0.051405325443786974,0.0018108015409528666,0.0989383475148311,0.05246913580246914,2.3685972735685406e-08,0.06413566224756329,0.027006172839506164
113,0.3,10,ai,Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone may not reliably exclude aspiration following acute stroke. Additional tests such as swallow evaluations or imaging studies may be necessary to accurately diagnose aspiration in stroke patients.,Question: Is bedside assessment a reliable method to exclude aspiration after an acute stroke? Answer: Bedside assessment by itself may not be a reliable method to exclude aspiration after an acute stroke. Additional tests such as swallow evaluations or imaging studies may be necessary for accurate diagnosis.,1.4211583641411244e-07,0.04181723207864341,0.06162698826791488,0.010880558788691236,0.03409308191158855,0.0738881194213604,0.0108648092457172,0.030526195150736513,0.08049485311719848,1.4211583641411244e-07,0.026552599479868544,0.08725975513833309
114,0.3,1,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by the Catholic bishops did have an impact on the polio vaccination coverage in Kenya in 2015.","Did the Catholic bishops' boycott call influence polio vaccination rates in Kenya in 2015? Yes, it did affect the coverage.",5.210914001850768e-07,0.3295763388900981,0.24872448979591835,0.039895382225201316,0.4172767469098022,0.23543400713436385,0.03983763390096319,0.5104342187380695,0.20999999999999996,5.210914001850787e-07,0.6096274235960992,0.1748178980228928
114,0.3,2,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by the Catholic bishops did have an impact on the polio vaccination coverage in Kenya in 2015.","Was the polio vaccination coverage in Kenya in 2015 impacted by the Catholic bishops' boycott call? Yes, it was.",5.447773729207622e-07,0.3836435601603734,0.24872448979591835,0.041708808689983196,0.474435160749751,0.23543400713436385,0.04164843544191606,0.5710588405545045,0.20999999999999996,5.44777372920764e-07,0.6741659447336699,0.1748178980228928
114,0.3,3,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by the Catholic bishops did have an impact on the polio vaccination coverage in Kenya in 2015.","Did the boycott urged by Catholic bishops affect Kenya's polio vaccination coverage in 2015? Yes, it had an impact.",5.447773729207622e-07,0.3836435601603734,0.24872448979591835,0.041708808689983196,0.474435160749751,0.23543400713436385,0.04164843544191606,0.5710588405545045,0.20999999999999996,5.44777372920764e-07,0.6741659447336699,0.1748178980228928
114,0.3,4,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by the Catholic bishops did have an impact on the polio vaccination coverage in Kenya in 2015.","In 2015, did the Catholic bishops' call for a boycott influence polio vaccination coverage in Kenya? Yes, it did.",5.447773729207622e-07,0.3836435601603734,0.24872448979591835,0.041708808689983196,0.474435160749751,0.23543400713436385,0.04164843544191606,0.5710588405545045,0.20999999999999996,5.44777372920764e-07,0.6741659447336699,0.1748178980228928
114,0.3,5,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by the Catholic bishops did have an impact on the polio vaccination coverage in Kenya in 2015.","Was there an effect on polio vaccination coverage in Kenya in 2015 due to the Catholic bishops' boycott call? Yes, there was.",4.737194547137061e-07,0.22949288033311666,0.24872448979591835,0.03626852929563756,0.31191623125197676,0.23543400713436385,0.03621603081905744,0.3992085836278454,0.20999999999999996,4.7371945471370796e-07,0.4918443879397154,0.1748178980228928
114,0.3,6,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by the Catholic bishops did have an impact on the polio vaccination coverage in Kenya in 2015.","Did the Catholic bishops' boycott call in 2015 impact polio vaccination coverage in Kenya? Yes, it did have an effect.",5.210914001850768e-07,0.3295763388900981,0.24872448979591835,0.039895382225201316,0.4172767469098022,0.23543400713436385,0.03983763390096319,0.5104342187380695,0.20999999999999996,5.210914001850787e-07,0.6096274235960992,0.1748178980228928
114,0.3,7,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by the Catholic bishops did have an impact on the polio vaccination coverage in Kenya in 2015.","Did the 2015 boycott call by Catholic bishops affect polio vaccination coverage in Kenya? Yes, it influenced the coverage.",5.447773729207622e-07,0.3836435601603734,0.24872448979591835,0.041708808689983196,0.474435160749751,0.23543400713436385,0.04164843544191606,0.5710588405545045,0.20999999999999996,5.44777372920764e-07,0.6741659447336699,0.1748178980228928
114,0.3,8,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by the Catholic bishops did have an impact on the polio vaccination coverage in Kenya in 2015.","Did the call for boycott by Catholic bishops influence polio vaccination coverage in Kenya in 2015? Yes, it did.",5.447773729207622e-07,0.3836435601603734,0.24872448979591835,0.041708808689983196,0.474435160749751,0.23543400713436385,0.04164843544191606,0.5710588405545045,0.20999999999999996,5.44777372920764e-07,0.6741659447336699,0.1748178980228928
114,0.3,9,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by the Catholic bishops did have an impact on the polio vaccination coverage in Kenya in 2015.","In 2015, did the Catholic bishops' boycott call impact polio vaccination coverage in Kenya? Yes, it did have an impact.",5.210914001850768e-07,0.3295763388900981,0.24872448979591835,0.039895382225201316,0.4172767469098022,0.23543400713436385,0.03983763390096319,0.5104342187380695,0.20999999999999996,5.210914001850787e-07,0.6096274235960992,0.1748178980228928
114,0.3,10,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by the Catholic bishops did have an impact on the polio vaccination coverage in Kenya in 2015.","Was polio vaccination coverage in Kenya in 2015 affected by the Catholic bishops' boycott call? Yes, it was impacted.",5.447773729207622e-07,0.3836435601603734,0.24872448979591835,0.041708808689983196,0.474435160749751,0.23543400713436385,0.04164843544191606,0.5710588405545045,0.20999999999999996,5.44777372920764e-07,0.6741659447336699,0.1748178980228928
115,0.3,1,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,Question: Is transgastric endoscopic splenectomy achievable? Answer: Performing transgastric endoscopic splenectomy in a pig model seems technically possible. Further long-term survival studies are scheduled.,0.0,0.060273667874777725,0.0427793707014486,0.0,0.06301338005090429,0.04535147392290251,0.0,0.0,0.0,0.0,0.0,0.0
115,0.3,2,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,Question: Can transgastric endoscopic splenectomy be done? Answer: Transgastric endoscopic splenectomy in a porcine model is technically feasible. Additional experiments focusing on long-term survival are planned.,4.73719454713706e-08,0.03275172792423664,0.03600665531409646,0.003626852929563759,0.029249111942969197,0.04158790170132326,0.003621603081905747,0.090971778205728,0.0,4.737194547137076e-08,0.09531017980432521,0.0
115,0.3,3,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,"Question: Is it feasible to perform transgastric endoscopic splenectomy? Answer: In a porcine model, transgastric endoscopic splenectomy appears to be technically achievable. More long-term survival trials are intended.",9.47438909427412e-08,0.1692720823529248,0.006406181231356084,0.007253705859127518,0.16705408466316696,0.0,0.007243206163811494,0.17435338714477844,0.0,9.474389094274157e-08,0.1823215567939549,0.0
115,0.3,4,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,Question: Does transgastric endoscopic splenectomy work? Answer: The procedure is technically feasible in a pig model. Further long-term survival research is planned.,4.73719454713706e-08,0.030698110330949824,0.04338842975206613,0.003626852929563759,0.09531017980432521,0.0,0.003621603081905747,0.10008345855698142,0.0,4.7371945471370706e-08,0.10536051565782545,0.0
115,0.3,5,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,Question: Is transgastric endoscopic splenectomy possible? Answer: It seems technically feasible in a porcine model. Additional long-term survival experiments will be conducted.,4.73719454713706e-08,0.030698110330949824,0.04338842975206613,0.003626852929563759,0.09531017980432521,0.0,0.003621603081905747,0.10008345855698142,0.0,4.7371945471370706e-08,0.10536051565782545,0.0
115,0.3,6,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,Question: Can transgastric endoscopic splenectomy be performed? Answer: Technical feasibility has been demonstrated in a pig model. Long-term survival studies are planned next.,2.36859727356853e-08,0.015821905303944117,0.04338842975206613,0.0018134264647818796,0.04652001563489394,0.0,0.0018108015409528735,0.04879016416943127,0.0,2.3685972735685353e-08,0.05129329438755015,0.0
115,0.3,7,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,Question: Is transgastric endoscopic splenectomy technically possible? Answer: The technique appears feasible in a porcine model. Further long-term survival experiments are planned.,4.73719454713706e-08,0.030698110330949824,0.04338842975206613,0.003626852929563759,0.09531017980432521,0.0,0.003621603081905747,0.10008345855698142,0.0,4.7371945471370706e-08,0.10536051565782545,0.0
115,0.3,8,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,"Question: Is it possible to do transgastric endoscopic splenectomy? Answer: In a pig model, the procedure is technically feasible. Additional long-term survival experiments are planned.",2.36859727356853e-08,0.1028332822935738,0.04338842975206613,0.0018134264647818796,0.04445176257083405,0.0,0.0018108015409528735,0.04652001563489394,0.0,2.3685972735685353e-08,0.04879016416943127,0.0
115,0.3,9,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,"Question: Can transgastric endoscopic splenectomy be technically achieved? Answer: It appears feasible in a porcine model, with more long-term survival studies planned.",4.73719454713706e-08,0.030698110330949824,0.04338842975206613,0.003626852929563759,0.09531017980432521,0.0,0.003621603081905747,0.10008345855698142,0.0,4.7371945471370706e-08,0.10536051565782545,0.0
115,0.3,10,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,"Question: Is transgastric endoscopic splenectomy achievable in practice? Answer: The procedure is technically feasible in a pig model, and further long-term survival experiments are planned.",2.36859727356853e-08,0.1028332822935738,0.04338842975206613,0.0018134264647818796,0.04445176257083405,0.0,0.0018108015409528735,0.04652001563489394,0.0,2.3685972735685353e-08,0.04879016416943127,0.0
116,0.3,1,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: Does fondaparinux have a role in perioperative bridging? Answer: The use of fondaparinux in perioperative bridging therapy remains unproven, with significant limitations preventing its routine application.",2.36859727356853e-07,0.30172506092830487,0.016963321799307964,0.018134264647818796,0.29686382630350217,0.02854671280276816,0.018108015409528735,0.3483066942682167,0.0,2.3685972735685406e-07,0.36101334553733055,0.0
116,0.3,2,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: Is fondaparinux used for perioperative bridging? Answer: Fondaparinux's role in perioperative bridge therapy is not well established, and there are notable restrictions on its routine use.",2.36859727356853e-07,0.2484060470390781,0.055363321799307974,0.018134264647818796,0.29686382630350217,0.02854671280276816,0.018108015409528735,0.3483066942682167,0.0,2.3685972735685406e-07,0.36101334553733055,0.0
116,0.3,3,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: Can fondaparinux be used in perioperative bridging? Answer: The role of fondaparinux in perioperative bridging has yet to be defined, and important limitations hinder its regular use.",2.131737546211677e-07,0.2620099546532644,0.018381073278597927,0.016320838183036916,0.2576431131502197,0.02854671280276816,0.016297213868575862,0.3074846997479619,0.0,2.1317375462116866e-07,0.3184537311185349,0.0
116,0.3,4,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.",Question: Is fondaparinux indicated for perioperative bridging? Answer: Fondaparinux has not been established as a standard agent for perioperative bridging due to several important limitations.,2.842316728282236e-07,0.38621101975927585,0.013775420097984714,0.021761117577382555,0.3802454352425526,0.02854671280276816,0.021729618491434483,0.4353180712578464,0.0,2.8423167282822487e-07,0.45198512374305855,0.0
116,0.3,5,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: What is the role of fondaparinux in perioperative bridging? Answer: Fondaparinux's role in perioperative bridging therapy is unclear, with significant constraints limiting its routine use.",2.605457000925383e-07,0.34307853463715565,0.015432766243752415,0.019947691112600675,0.337685820823757,0.02854671280276816,0.01991881695048161,0.39086630868701233,0.0,2.6054570009253947e-07,0.4054651081081646,0.0
116,0.3,6,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: Does fondaparinux serve a purpose in perioperative bridging? Answer: The role of fondaparinux in perioperative bridging therapy is not established, and there are key limitations to its routine use.",1.658018091497971e-07,0.18701000890580755,0.020924546289103882,0.012693985253473157,0.18353514099649804,0.02854671280276816,0.012675610786670115,0.23052365861183244,0.0,1.6580180914979784e-07,0.23841102344499765,0.0
116,0.3,7,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.",Question: Is fondaparinux recommended for perioperative bridging? Answer: Fondaparinux has not been proven effective for perioperative bridging and has important limitations for routine use.,3.079176455639089e-07,0.43128203700618917,0.011974892047241843,0.023574544042164434,0.42469719781338666,0.02854671280276816,0.023540420032387356,0.4818380868927403,0.0,3.0791764556391023e-07,0.5007752879124898,0.0
116,0.3,8,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: How is fondaparinux used in perioperative bridging? Answer: The use of fondaparinux in perioperative bridging is not established, with several important limitations restricting its routine application.",2.36859727356853e-07,0.30172506092830487,0.016963321799307964,0.018134264647818796,0.29686382630350217,0.02854671280276816,0.018108015409528735,0.3483066942682167,0.0,2.3685972735685406e-07,0.36101334553733055,0.0
116,0.3,9,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: Is there an established role for fondaparinux in perioperative bridging? Answer: Fondaparinux's role in perioperative bridging therapy has not been confirmed, and there are significant limitations to its routine use.",1.421158364141118e-07,0.1515150154357352,0.022069623820711058,0.010880558788691277,0.14844382118522903,0.02854671280276816,0.010864809245717241,0.19415601444095776,0.0,1.4211583641411244e-07,0.20067069546215066,0.0
116,0.3,10,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.",Question: Can fondaparinux be routinely used for perioperative bridging? Answer: The role of fondaparinux in perioperative bridging is not established and its routine use is limited by important factors.,1.894877818854824e-07,0.17429807488535642,0.055363321799307974,0.014507411718255037,0.21990278516737272,0.02854671280276816,0.014486412327622988,0.2682639865946794,0.0,1.8948778188548325e-07,0.2776317365982801,0.0
117,0.3,1,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Episodic migraineurs may exhibit selective attention towards headache-related visual stimuli, as their brains may prioritize processing of such stimuli due to their relevance to their condition. This attentional bias can contribute to the perception and experience of migraines.",Do individuals with episodic migraines focus specifically on headache-related visual cues?,9.000669639560428e-07,1.4819725203438527,0.06222222222222221,0.06891020566171131,1.6529230243738384,0.0,0.06881045855620911,1.7491998548092589,0.0,9.000669639560447e-07,1.8607523407150057,0.0
117,0.3,2,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Episodic migraineurs may exhibit selective attention towards headache-related visual stimuli, as their brains may prioritize processing of such stimuli due to their relevance to their condition. This attentional bias can contribute to the perception and experience of migraines.",Do people suffering from episodic migraines show selective attention to visual stimuli associated with headaches?,8.053230730133015e-07,1.1455002837226398,0.06222222222222221,0.06165649980258381,1.2851982442485208,0.0,0.06156725239239762,1.3437347467010938,0.0,8.053230730133033e-07,1.408767216971949,0.0
117,0.3,3,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Episodic migraineurs may exhibit selective attention towards headache-related visual stimuli, as their brains may prioritize processing of such stimuli due to their relevance to their condition. This attentional bias can contribute to the perception and experience of migraines.",Are episodic migraine sufferers more likely to attend to headache-related visual information?,8.763809912203575e-07,1.3866623405395275,0.06222222222222221,0.06709677919692944,1.5475625087160125,0.0,0.06699965701525624,1.631416819152875,0.0,8.763809912203594e-07,1.7272209480904839,0.0
117,0.3,4,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Episodic migraineurs may exhibit selective attention towards headache-related visual stimuli, as their brains may prioritize processing of such stimuli due to their relevance to their condition. This attentional bias can contribute to the perception and experience of migraines.",Do those with episodic migraines preferentially process visual stimuli linked to headaches?,8.763809912203575e-07,1.3866623405395275,0.06222222222222221,0.06709677919692944,1.5475625087160125,0.0,0.06699965701525624,1.631416819152875,0.0,8.763809912203594e-07,1.7272209480904839,0.0
117,0.3,5,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Episodic migraineurs may exhibit selective attention towards headache-related visual stimuli, as their brains may prioritize processing of such stimuli due to their relevance to their condition. This attentional bias can contribute to the perception and experience of migraines.",Is there selective attention to headache-related visuals among episodic migraineurs?,9.237529366917282e-07,1.5873330360016786,0.06222222222222221,0.07072363212649319,1.7707060600302222,0.0,0.07062126009716199,1.8827312474337807,0.0,9.2375293669173e-07,2.0149030205422647,0.0
117,0.3,6,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Episodic migraineurs may exhibit selective attention towards headache-related visual stimuli, as their brains may prioritize processing of such stimuli due to their relevance to their condition. This attentional bias can contribute to the perception and experience of migraines.",Do episodic migraine patients exhibit a bias towards attending to headache-related visual stimuli?,8.526950184846721e-07,1.2996509635498974,0.06222222222222221,0.06528335273214755,1.4522523289116873,0.0,0.06518885547430336,1.5260563034950492,0.0,8.52695018484674e-07,1.6094379124341,0.0
117,0.3,7,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Episodic migraineurs may exhibit selective attention towards headache-related visual stimuli, as their brains may prioritize processing of such stimuli due to their relevance to their condition. This attentional bias can contribute to the perception and experience of migraines.",Are visual stimuli related to headaches more likely to capture the attention of episodic migraine sufferers?,7.816371002776161e-07,1.0765074122356877,0.06222222222222221,0.05984307333780193,1.2110902720947996,0.0,0.05975645085144475,1.2636920390275574,0.0,7.81637100277618e-07,1.3217558399823188,0.0
117,0.3,8,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Episodic migraineurs may exhibit selective attention towards headache-related visual stimuli, as their brains may prioritize processing of such stimuli due to their relevance to their condition. This attentional bias can contribute to the perception and experience of migraines.",Do episodic migraineurs demonstrate focused attention on headache-associated visual cues?,9.237529366917282e-07,1.5873330360016786,0.06222222222222221,0.07072363212649319,1.7707060600302222,0.0,0.07062126009716199,1.8827312474337807,0.0,9.2375293669173e-07,2.0149030205422647,0.0
117,0.3,9,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Episodic migraineurs may exhibit selective attention towards headache-related visual stimuli, as their brains may prioritize processing of such stimuli due to their relevance to their condition. This attentional bias can contribute to the perception and experience of migraines.",Is there a tendency for episodic migraine sufferers to selectively attend to headache-related visual inputs?,8.053230730133015e-07,1.1455002837226398,0.06222222222222221,0.06165649980258381,1.2851982442485208,0.0,0.06156725239239762,1.3437347467010938,0.0,8.053230730133033e-07,1.408767216971949,0.0
117,0.3,10,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Episodic migraineurs may exhibit selective attention towards headache-related visual stimuli, as their brains may prioritize processing of such stimuli due to their relevance to their condition. This attentional bias can contribute to the perception and experience of migraines.",Do individuals with episodic migraines prioritize processing of headache-related visual stimuli?,9.000669639560428e-07,1.4819725203438527,0.06222222222222221,0.06891020566171131,1.6529230243738384,0.0,0.06881045855620911,1.7491998548092589,0.0,9.000669639560447e-07,1.8607523407150057,0.0
118,0.3,1,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Experience allows the surgeon to develop skills, knowledge, and expertise, which are crucial for successfully performing the procedure and minimizing complications.","Is a surgeon's prior experience a factor in their capability to perform transurethral resection of the prostate? Yes, previous experience impacts a surgeon's ability to carry out transurethral resection of the prostate. Experience helps the surgeon gain essential skills, knowledge, and expertise needed for successful procedures and reducing complications.",1.6580180914979784e-07,0.05080751982643594,0.11854520424263276,0.012693985253473108,0.05889348372159109,0.13315069890827463,0.012675610786670066,0.03746462803654982,0.12444444444444445,1.6580180914979784e-07,0.01537581285657108,0.113421550094518
118,0.3,2,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Experience allows the surgeon to develop skills, knowledge, and expertise, which are crucial for successfully performing the procedure and minimizing complications.","Does a surgeon's past experience affect their proficiency in performing transurethral resection of the prostate? Indeed, the surgeon's prior experience influences their proficiency in this procedure. Experience equips the surgeon with the necessary skills, knowledge, and expertise to perform the surgery effectively and lower the risk of complications.",1.8948778188548325e-07,0.0862873913125699,0.15872069653933718,0.014507411718254981,0.06624169397259605,0.15389143964901536,0.014486412327622933,0.045622555255163455,0.14617283950617285,1.8948778188548325e-07,0.007097042995486635,0.113421550094518
118,0.3,3,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Experience allows the surgeon to develop skills, knowledge, and expertise, which are crucial for successfully performing the procedure and minimizing complications.","Is the skill to perform transurethral resection of the prostate dependent on the surgeon's earlier experience? Yes, the surgeon's earlier experience plays a significant role in their ability to perform the procedure. Experience enables the development of skills, knowledge, and expertise essential for successful surgery and minimizing complications.",1.8948778188548325e-07,0.056791766607891425,0.13765677449056668,0.014507411718254981,0.06624169397259605,0.15389143964901536,0.014486412327622933,0.045622555255163455,0.14617283950617285,1.8948778188548325e-07,0.007097042995486635,0.113421550094518
118,0.3,4,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Experience allows the surgeon to develop skills, knowledge, and expertise, which are crucial for successfully performing the procedure and minimizing complications.","Does previous experience impact a surgeon's ability to perform transurethral resection of the prostate? Yes, a surgeon's previous experience affects their ability to perform this procedure. It allows the surgeon to build the skills, knowledge, and expertise required for successful outcomes and fewer complications.",2.8423167282822487e-07,0.07262646028246511,0.10914512491248349,0.02176111757738247,0.02760025889383355,0.1518244748059252,0.0217296184914344,0.04746786781084822,0.14617283950617285,2.8423167282822487e-07,0.10240722279981229,0.113421550094518
118,0.3,5,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Experience allows the surgeon to develop skills, knowledge, and expertise, which are crucial for successfully performing the procedure and minimizing complications.","Is the capability to carry out transurethral resection of the prostate influenced by the surgeon's experience? Yes, the surgeon's experience influences their capability to perform the procedure. Experience helps in acquiring the skills, knowledge, and expertise necessary for success and complication reduction.",3.316036182995957e-07,0.05892100946040291,0.15253762984344998,0.025387970506946217,0.043383414465173686,0.17561983471074377,0.025351221573340132,0.09747828838551165,0.14617283950617285,3.316036182995957e-07,0.153700517187362,0.113421550094518
118,0.3,6,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Experience allows the surgeon to develop skills, knowledge, and expertise, which are crucial for successfully performing the procedure and minimizing complications.","Does the surgeon’s prior experience influence their ability to perform transurethral resection of the prostate? Yes, prior experience does influence the surgeon’s ability. Experience fosters the skills, knowledge, and expertise crucial for effectively performing the surgery and minimizing risks.",4.026615365066517e-07,0.1402456623733177,0.14872069653933717,0.030828249901291835,0.12134495593488426,0.17561983471074377,0.030783626196198732,0.1775209960590458,0.14617283950617285,4.026615365066519e-07,0.23593861542433503,0.113421550094518
118,0.3,7,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Experience allows the surgeon to develop skills, knowledge, and expertise, which are crucial for successfully performing the procedure and minimizing complications.","Is the ability to execute transurethral resection of the prostate affected by the surgeon’s previous experience? Yes, previous experience affects the surgeon’s ability to perform the procedure. It provides the skills, knowledge, and expertise vital for successful surgery and reducing complications.",3.552895910352811e-07,0.08530422493018897,0.15132833649693098,0.02720139697172809,0.06870122244946542,0.17561983471074377,0.027162023114293,0.12345377478876962,0.14617283950617285,3.552895910352811e-07,0.18036876426952286,0.113421550094518
118,0.3,8,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Experience allows the surgeon to develop skills, knowledge, and expertise, which are crucial for successfully performing the procedure and minimizing complications.","Does the surgeon's experience impact their skill in performing transurethral resection of the prostate? Yes, the surgeon’s experience impacts their skill level. Experience helps develop the necessary skills, knowledge, and expertise to perform the procedure successfully and avoid complications.",4.026615365066517e-07,0.10376423181753092,0.17489326550469894,0.030828249901291835,0.12134495593488426,0.17561983471074377,0.030783626196198732,0.1775209960590458,0.14617283950617285,4.026615365066519e-07,0.23593861542433503,0.113421550094518
118,0.3,9,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Experience allows the surgeon to develop skills, knowledge, and expertise, which are crucial for successfully performing the procedure and minimizing complications.","Is a surgeon’s ability to perform transurethral resection of the prostate shaped by their prior experience? Yes, a surgeon’s prior experience shapes their ability to perform the procedure. Experience cultivates the skills, knowledge, and expertise needed for successful outcomes and complication prevention.",3.316036182995957e-07,0.09273306704869322,0.12847515090136308,0.025387970506946217,0.07804077349317007,0.15063627126564186,0.025351221573340132,0.09747828838551165,0.14617283950617285,3.316036182995957e-07,0.153700517187362,0.113421550094518
118,0.3,10,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Experience allows the surgeon to develop skills, knowledge, and expertise, which are crucial for successfully performing the procedure and minimizing complications.","Is the proficiency in performing transurethral resection of the prostate influenced by the surgeon’s previous experience? Yes, proficiency is influenced by prior experience. Experience allows the surgeon to gain the skills, knowledge, and expertise essential for success and minimizing complications.",3.789755637709664e-07,0.07685332411797052,0.17556656364374537,0.029014823436509962,0.09467670885272339,0.17561983471074377,0.028972824655245866,0.1501220218709305,0.14617283950617285,3.789755637709665e-07,0.20776773845763818,0.113421550094518
119,0.3,1,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: The association between marital status, living arrangement, and mortality may vary depending on gender. Further research is needed to determine the specific differences and factors that contribute to these variations.","Question: Marital status, living arrangement, and mortality: does the relationship differ by gender? Answer: The link between marital status, living arrangement, and mortality might differ based on gender. More studies are required to identify the exact differences and contributing factors.",9.474389094274152e-08,0.14310429536093094,0.03184948979591841,0.0072537058591274906,0.1765207416262502,0.05457198703395695,0.007243206163811466,0.177588984390888,0.05387755102040818,9.474389094274162e-08,0.14386869235560074,0.02775510204081633
119,0.3,2,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: The association between marital status, living arrangement, and mortality may vary depending on gender. Further research is needed to determine the specific differences and factors that contribute to these variations.","Question: Does gender influence the association between marital status, living arrangement, and mortality? Answer: The connection between marital status, living arrangement, and mortality could vary with gender. Additional research is necessary to clarify the specific differences and underlying factors.",1.1842986367842682e-07,0.20930289750518627,0.05918331037649219,0.009067132323909363,0.2436143577026617,0.08272438297856068,0.009054007704764333,0.24557765834152212,0.08264462809917354,1.1842986367842703e-07,0.21274821325994475,0.056932966023875105
119,0.3,3,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: The association between marital status, living arrangement, and mortality may vary depending on gender. Further research is needed to determine the specific differences and factors that contribute to these variations.","Question: How does gender affect the association between marital status, living arrangement, and mortality? Answer: Gender may influence the association between marital status, living arrangement, and mortality. Further investigation is needed to understand the particular differences and contributing elements.",1.1842986367842682e-07,0.28226575861675895,0.10544289802289286,0.009067132323909363,0.3185491880334652,0.13229204904419295,0.009054007704764333,0.3225940117370709,0.13527575442247655,1.1842986367842703e-07,0.2919650338953672,0.11238293444328822
119,0.3,4,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: The association between marital status, living arrangement, and mortality may vary depending on gender. Further research is needed to determine the specific differences and factors that contribute to these variations.","Question: Is the association between marital status, living arrangement, and mortality different for men and women? Answer: The relationship between marital status, living arrangement, and mortality may change depending on gender. More research is needed to pinpoint the specific variations and factors involved.",2.3685972735685406e-08,0.1248543377578275,0.06951388888888888,0.0018134264647818726,0.16015083092241778,0.09580340552728026,0.0018108015409528666,0.1633220487023599,0.09876543209876545,2.3685972735685406e-08,0.13195583576274394,0.0763888888888889
119,0.3,5,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: The association between marital status, living arrangement, and mortality may vary depending on gender. Further research is needed to determine the specific differences and factors that contribute to these variations.","Question: Does the link between marital status, living arrangement, and mortality vary by gender? Answer: The association of marital status and living arrangement with mortality might differ according to gender. Further studies are required to determine the exact differences and contributing factors.",4.737194547137081e-08,0.04909016225166862,0.06937499999999999,0.0036268529295637453,0.015783155571340135,0.023795359904818555,0.003621603081905733,0.05001042057466343,0.0,4.737194547137081e-08,0.051293294387549704,0.0
119,0.3,6,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: The association between marital status, living arrangement, and mortality may vary depending on gender. Further research is needed to determine the specific differences and factors that contribute to these variations.","Question: Are there gender differences in the association between marital status, living arrangement, and mortality? Answer: The association between marital status, living arrangement, and mortality may vary by gender. Additional research is needed to identify the specific differences and factors that contribute to these variations.",2.3685972735685406e-08,0.10083910071254198,0.08402163988312633,0.0018134264647818726,0.13689891647355923,0.11207023542023624,0.0018108015409528666,0.14093749141140366,0.11687363038714388,2.3685972735685406e-08,0.11055561776278777,0.09642074506939374
119,0.3,7,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: The association between marital status, living arrangement, and mortality may vary depending on gender. Further research is needed to determine the specific differences and factors that contribute to these variations.","Question: Question: Marital status, living arrangement, and mortality: is the association gender-dependent? Answer: The relationship between marital status, living arrangement, and mortality could depend on gender. More research is necessary to explore the specific differences and contributing factors.",1.4211583641411212e-07,0.20343365247002465,0.03714474288337924,0.010880558788691236,0.23666820132249056,0.05884926819435499,0.0108648092457172,0.23744082585031645,0.056932966023875105,1.4211583641411244e-07,0.20329229306012397,0.029384756657483937
119,0.3,8,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: The association between marital status, living arrangement, and mortality may vary depending on gender. Further research is needed to determine the specific differences and factors that contribute to these variations.","Question: Does gender modify the association between marital status, living arrangement, and mortality? Answer: The association between marital status, living arrangement, and mortality might be influenced by gender. Further research is needed to clarify the particular differences and factors involved.",9.474389094274152e-08,0.24974232313938316,0.10152343750000001,0.0072537058591274906,0.2859650332936101,0.12854839009518143,0.007243206163811466,0.2899912298870957,0.1318359375,9.474389094274162e-08,0.25939322244892526,0.109375
119,0.3,9,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: The association between marital status, living arrangement, and mortality may vary depending on gender. Further research is needed to determine the specific differences and factors that contribute to these variations.","Question: Question: Is the association between marital status, living arrangement, and mortality influenced by gender? Answer: The link between marital status, living arrangement, and mortality may be affected by gender. Additional studies are required to understand the specific differences and contributing factors.",4.737194547137081e-08,0.15378218327807103,0.07266581632653066,0.0036268529295637453,0.1890699507113256,0.09865361968701818,0.003621603081905733,0.19219445761259957,0.1012244897959184,4.737194547137081e-08,0.16073758605491006,0.0783673469387755
119,0.3,10,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: The association between marital status, living arrangement, and mortality may vary depending on gender. Further research is needed to determine the specific differences and factors that contribute to these variations.","Question: Question: Marital status, living arrangement, and mortality: are there gender-based differences in the association? Answer: The association between marital status, living arrangement, and mortality may vary based on gender. More research is needed to determine the exact differences and contributing factors.",4.737194547137081e-08,0.08615806810149085,0.02704574506939375,0.0036268529295637453,0.11975523265533106,0.05071157946698568,0.003621603081905733,0.12110243909363172,0.05113221329437545,4.737194547137081e-08,0.08777472494333605,0.026296566837107373
120,0.3,1,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life","Question: Does living in an urban setting affect the risk of non-communicable diseases in Thailand depending on timing? Answer: Urban living correlated with higher behavioral and physiological risk factors, but these did not necessarily lead to increased biological risk factors. The biological risks likely stem from a complex interplay of long-term exposure and early life influences.",1.8948778188548325e-07,0.06978752396287824,0.0475,0.014507411718254981,0.13815033848081626,0.0,0.014486412327622933,0.1405819506211894,0.0,1.8948778188548325e-07,0.14310084364067155,0.0
120,0.3,2,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life","Question: In Thailand, does the timing of urban living impact non-communicable disease risk? Answer: Urbanicity was linked to rises in behavioral and physiological risks, yet these may not directly cause biological risk increases. Biological factors probably result from a complex mix of prolonged exposure and early life conditions.",3.789755637709665e-07,0.22697310748529143,0.0475,0.029014823436509962,0.29849298855599704,0.0,0.028972824655245866,0.30421137440299084,0.0,3.789755637709665e-07,0.3101549283038376,0.0
120,0.3,3,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life","Question: How does living in an urban environment relate to non-communicable disease risks in Thailand, and does timing play a role? Answer: Urban living was associated with increased behavioral and physiological risk factors, but these associations might not directly increase biological risks. Biological risk factors likely arise from a complex interaction of long-term exposure and early life.",1.6580180914979784e-07,0.05176901846019977,0.0475,0.012693985253473108,0.1198011998126205,0.0,0.012675610786670066,0.12188981760903506,0.0,1.6580180914979784e-07,0.12405264866997845,0.0
120,0.3,4,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life","Question: Does the timing of urban residence affect non-communicable disease risk in Thailand? Answer: Urbanicity corresponded with elevated behavioral and physiological risk factors; however, these may not directly cause biological risk increases. The biological risks are probably due to a complex interaction between cumulative exposure and early life factors.",3.552895910352811e-07,0.20591969828745826,0.0475,0.02720139697172809,0.2769867833350337,0.0,0.027162023114293,0.28223246768421584,0.0,3.552895910352811e-07,0.2876820724517799,0.0
120,0.3,5,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life","Question: Is there a timing effect of urban living on non-communicable disease risk in Thailand? Answer: Urban living was linked to increased behavioral and physiological risk factors, though these may not directly translate into biological risk increases. Biological risks likely result from a complex interaction of long-term exposure and early life.",3.079176455639103e-07,0.1928235909896019,0.027508329862557267,0.023574544042164344,0.23531408693446476,0.0,0.023540420032387266,0.23967285326541932,0.0,3.079176455639103e-07,0.24419696051204154,0.0
120,0.3,6,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life","Question: Does living in urban areas influence non-communicable disease risk in Thailand depending on timing? Answer: Urbanicity was associated with higher behavioral and physiological risk factors, but these associations might not directly increase biological risk factors. Biological risks probably arise from a complex interplay between cumulative exposure and early life.",3.316036182995957e-07,0.1853004110847225,0.0475,0.025387970506946217,0.2559333741372005,0.0,0.025351221573340132,0.2607262624632525,0.0,3.316036182995957e-07,0.2657031657330049,0.0
120,0.3,7,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life","Question: What is the impact of urban living timing on non-communicable disease risk in Thailand? Answer: Urban living correlated with increased behavioral and physiological risk factors, yet these may not directly lead to biological risk increases. Biological risk factors likely result from a complex interaction of long-term exposure and early life.",3.079176455639103e-07,0.22054947821199944,0.007569444444444441,0.023574544042164344,0.23531408693446476,0.0,0.023540420032387266,0.23967285326541932,0.0,3.079176455639103e-07,0.24419696051204154,0.0
120,0.3,8,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life","Question: Does the timing of urban exposure affect non-communicable disease risk in Thailand? Answer: Urbanicity was linked to rises in behavioral and physiological risk factors; however, these may not directly cause biological risk increases. Biological risks are probably due to a complex interaction between prolonged exposure and early life factors.",3.316036182995957e-07,0.1853004110847225,0.0475,0.025387970506946217,0.2559333741372005,0.0,0.025351221573340132,0.2607262624632525,0.0,3.316036182995957e-07,0.2657031657330049,0.0
120,0.3,9,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life","Question: How does the timing of living in urban environments relate to non-communicable disease risk in Thailand? Answer: Urban living was associated with increased behavioral and physiological risk factors, but these may not directly translate to biological risk increases. Biological risk factors likely result from a complex interaction of long-term exposure and early life influences.",2.1317375462116866e-07,0.11380878042959086,0.028988074047703816,0.016320838183036854,0.1568424714929706,0.0,0.0162972138685758,0.1596301455918825,0.0,2.1317375462116866e-07,0.16251892949777424,0.0
120,0.3,10,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life","Question: Does timing matter for non-communicable disease risk associated with urban living in Thailand? Answer: Urbanicity corresponded with elevated behavioral and physiological risk factors, though these may not directly increase biological risk factors. Biological risks probably arise from a complex interplay of cumulative exposure and early life.",4.026615365066519e-07,0.24847931270625478,0.0475,0.030828249901291835,0.32047189527477205,0.0,0.030783626196198732,0.32668423025504856,0.0,4.026615365066519e-07,0.33314444652853714,0.0
121,0.3,1,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Sex does not appear to influence the response to intravenous thrombolysis in ischemic stroke, according to a study. Both males and females showed similar rates of recanalization and functional outcome after receiving this treatment.","Does gender affect the effectiveness of intravenous thrombolysis in ischemic stroke? Research indicates that gender does not impact the response to intravenous thrombolysis in ischemic stroke, with both men and women exhibiting comparable recanalization rates and functional outcomes following treatment.",1.6580180914979774e-07,0.06075994057617917,0.0708826429980276,0.012693985253473108,0.05719994300618714,0.07770837899043032,0.012675610786670066,0.0532056863121797,0.08476240046752868,1.6580180914979784e-07,0.04872356224955565,0.09204470742932283
121,0.3,2,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Sex does not appear to influence the response to intravenous thrombolysis in ischemic stroke, according to a study. Both males and females showed similar rates of recanalization and functional outcome after receiving this treatment.","Is the response to intravenous thrombolysis in ischemic stroke influenced by sex? Studies suggest that sex does not affect the response to intravenous thrombolysis in ischemic stroke, as males and females have similar recanalization and functional recovery rates after treatment.",1.6580180914979774e-07,0.1673979683546314,0.0014887986915958773,0.012693985253473108,0.1666442346735475,0.0016192044164072827,0.012675610786670066,0.1656079318083883,0.0052488304236556205,1.6580180914979784e-07,0.16424809234288018,0.009400079330149289
121,0.3,3,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Sex does not appear to influence the response to intravenous thrombolysis in ischemic stroke, according to a study. Both males and females showed similar rates of recanalization and functional outcome after receiving this treatment.",Does intravenous thrombolysis response in ischemic stroke vary by sex? Evidence shows that sex does not influence the response to intravenous thrombolysis in ischemic stroke; both sexes demonstrate equivalent recanalization and functional outcomes.,3.3160361829959484e-07,0.23859105369763922,0.08504930966469426,0.025387970506946245,0.18783603713585384,0.13017751479289946,0.025351221573340167,0.22545880212884795,0.11176857330703485,3.316036182995957e-07,0.26494667071919276,0.09204470742932283
121,0.3,4,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Sex does not appear to influence the response to intravenous thrombolysis in ischemic stroke, according to a study. Both males and females showed similar rates of recanalization and functional outcome after receiving this treatment.","Is there a difference in response to intravenous thrombolysis for ischemic stroke between males and females? Findings reveal that sex does not alter the response to intravenous thrombolysis in ischemic stroke, with similar recanalization and functional results in both sexes.",1.6580180914979774e-07,0.06075994057617917,0.0708826429980276,0.012693985253473108,0.05719994300618714,0.07770837899043032,0.012675610786670066,0.0532056863121797,0.08476240046752868,1.6580180914979784e-07,0.04872356224955565,0.09204470742932283
121,0.3,5,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Sex does not appear to influence the response to intravenous thrombolysis in ischemic stroke, according to a study. Both males and females showed similar rates of recanalization and functional outcome after receiving this treatment.","Does sex play a role in how patients respond to intravenous thrombolysis in ischemic stroke? According to research, sex does not seem to affect the response to intravenous thrombolysis in ischemic stroke, as men and women have comparable outcomes and recanalization rates.",1.1842986367842703e-07,0.039359722576223,0.05085078681752275,0.009067132323909363,0.036915864591055225,0.05567057542109523,0.009054007704764333,0.03418655618032673,0.0606363600126594,1.1842986367842703e-07,0.031137771535065806,0.06574814059221545
121,0.3,6,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Sex does not appear to influence the response to intravenous thrombolysis in ischemic stroke, according to a study. Both males and females showed similar rates of recanalization and functional outcome after receiving this treatment.","Does the patient's sex impact the effectiveness of intravenous thrombolysis in ischemic stroke? Studies indicate that sex does not influence the response to intravenous thrombolysis in ischemic stroke, with both genders showing similar functional outcomes and recanalization rates.",2.1317375462116834e-07,0.11916789177935438,0.06682170489729715,0.016320838183036854,0.11532065656043988,0.07481419299359149,0.0162972138685758,0.11091653261930068,0.08322186050426669,2.1317375462116866e-07,0.105881976089504,0.09204470742932283
121,0.3,7,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Sex does not appear to influence the response to intravenous thrombolysis in ischemic stroke, according to a study. Both males and females showed similar rates of recanalization and functional outcome after receiving this treatment.","Is the outcome of intravenous thrombolysis in ischemic stroke dependent on sex? Research suggests that sex does not affect the response to intravenous thrombolysis in ischemic stroke, with males and females achieving similar recanalization and functional recovery.",2.3685972735685364e-07,0.14968915056458565,0.06462690378774295,0.018134264647818726,0.14569200076700906,0.07324454876902436,0.018108015409528673,0.14106902273719069,0.08238381664955091,2.3685972735685406e-07,0.13573493923918578,0.09204470742932283
121,0.3,8,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Sex does not appear to influence the response to intravenous thrombolysis in ischemic stroke, according to a study. Both males and females showed similar rates of recanalization and functional outcome after receiving this treatment.","Does sex affect the therapeutic response to intravenous thrombolysis in ischemic stroke? Evidence points to no significant influence of sex on the response to intravenous thrombolysis in ischemic stroke, as both men and women have comparable rates of recanalization and functional outcomes.",1.1842986367842703e-07,0.07317178016451287,0.027672766454817685,0.009067132323909363,0.0715732236190525,0.031412082694133994,0.009054007704764333,0.06973256543981066,0.03537968441814596,1.1842986367842703e-07,0.06761920209085259,0.03957557162685369
121,0.3,9,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Sex does not appear to influence the response to intravenous thrombolysis in ischemic stroke, according to a study. Both males and females showed similar rates of recanalization and functional outcome after receiving this treatment.","Is there a sex-based difference in response to intravenous thrombolysis for ischemic stroke? Studies show that sex does not impact the response to intravenous thrombolysis in ischemic stroke, with similar recanalization and functional outcomes observed in both sexes.",2.1317375462116834e-07,0.11916789177935438,0.06682170489729715,0.016320838183036854,0.11532065656043988,0.07481419299359149,0.0162972138685758,0.11091653261930068,0.08322186050426669,2.1317375462116866e-07,0.105881976089504,0.09204470742932283
121,0.3,10,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Sex does not appear to influence the response to intravenous thrombolysis in ischemic stroke, according to a study. Both males and females showed similar rates of recanalization and functional outcome after receiving this treatment.","Does the effectiveness of intravenous thrombolysis in ischemic stroke differ by sex? Research demonstrates that sex does not influence the response to intravenous thrombolysis in ischemic stroke, with males and females exhibiting similar rates of recanalization and functional recovery.",1.8948778188548304e-07,0.08954169086834529,0.06890418494814099,0.014507411718254981,0.0858401593075806,0.07629996377249129,0.014486412327622933,0.08164542203266745,0.08401347126621853,1.8948778188548325e-07,0.0768944392162525,0.09204470742932283
122,0.3,1,ai,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Withdrawal-induced anxiety in alcoholism may be associated with a beta-endorphin deficiency. Beta-endorphins are natural peptides that play a role in regulating mood and,Is withdrawal-induced anxiety in alcoholism linked to a deficiency in beta-endorphins?,5.447773729207624e-07,1.0678957083706266,0.09000000000000004,0.041708808689983196,1.1818679278935127,0.06222222222222223,0.041648435441916085,1.30982648986596,0.0322222222222222,5.447773729207636e-07,1.4552872326068411,0.0
122,0.3,2,ai,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Withdrawal-induced anxiety in alcoholism may be associated with a beta-endorphin deficiency. Beta-endorphins are natural peptides that play a role in regulating mood and,Could beta-endorphin deficiency be the cause of withdrawal-induced anxiety in alcoholism?,5.447773729207624e-07,1.0678957083706266,0.09000000000000004,0.041708808689983196,1.1818679278935127,0.06222222222222223,0.041648435441916085,1.30982648986596,0.0322222222222222,5.447773729207636e-07,1.4552872326068411,0.0
122,0.3,3,ai,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Withdrawal-induced anxiety in alcoholism may be associated with a beta-endorphin deficiency. Beta-endorphins are natural peptides that play a role in regulating mood and,Does withdrawal anxiety in alcoholism stem from a lack of beta-endorphins?,5.447773729207624e-07,1.0678957083706266,0.09000000000000004,0.041708808689983196,1.1818679278935127,0.06222222222222223,0.041648435441916085,1.30982648986596,0.0322222222222222,5.447773729207636e-07,1.4552872326068411,0.0
122,0.3,4,ai,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Withdrawal-induced anxiety in alcoholism may be associated with a beta-endorphin deficiency. Beta-endorphins are natural peptides that play a role in regulating mood and,Is the anxiety experienced during alcohol withdrawal related to beta-endorphin deficiency?,5.447773729207624e-07,1.0678957083706266,0.09000000000000004,0.041708808689983196,1.1818679278935127,0.06222222222222223,0.041648435441916085,1.30982648986596,0.0322222222222222,5.447773729207636e-07,1.4552872326068411,0.0
122,0.3,5,ai,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Withdrawal-induced anxiety in alcoholism may be associated with a beta-endorphin deficiency. Beta-endorphins are natural peptides that play a role in regulating mood and,Might withdrawal-induced anxiety in alcoholism be due to insufficient beta-endorphins?,5.684633456564478e-07,1.1732562240284525,0.09000000000000004,0.043522235154765075,1.2996509635498965,0.06222222222222223,0.043459236982868965,1.4433578824904818,0.0322222222222222,5.684633456564489e-07,1.6094379124341,0.0
122,0.3,6,ai,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Withdrawal-induced anxiety in alcoholism may be associated with a beta-endorphin deficiency. Beta-endorphins are natural peptides that play a role in regulating mood and,Is there a connection between beta-endorphin deficiency and anxiety during alcohol withdrawal?,5.210914001850771e-07,0.9725855285663014,0.09000000000000004,0.03989538222520132,1.0765074122356868,0.06222222222222223,0.03983763390096322,1.1920434542095761,0.0322222222222222,5.210914001850783e-07,1.3217558399823193,0.0
122,0.3,7,ai,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Withdrawal-induced anxiety in alcoholism may be associated with a beta-endorphin deficiency. Beta-endorphins are natural peptides that play a role in regulating mood and,Can withdrawal anxiety in alcoholism be attributed to a beta-endorphin shortfall?,5.447773729207624e-07,1.0678957083706266,0.09000000000000004,0.041708808689983196,1.1818679278935127,0.06222222222222223,0.041648435441916085,1.30982648986596,0.0322222222222222,5.447773729207636e-07,1.4552872326068411,0.0
122,0.3,8,ai,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Withdrawal-induced anxiety in alcoholism may be associated with a beta-endorphin deficiency. Beta-endorphins are natural peptides that play a role in regulating mood and,Is beta-endorphin deficiency responsible for anxiety symptoms during alcohol withdrawal?,5.684633456564478e-07,1.1732562240284525,0.09000000000000004,0.043522235154765075,1.2996509635498965,0.06222222222222223,0.043459236982868965,1.4433578824904818,0.0322222222222222,5.684633456564489e-07,1.6094379124341,0.0
122,0.3,9,ai,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Withdrawal-induced anxiety in alcoholism may be associated with a beta-endorphin deficiency. Beta-endorphins are natural peptides that play a role in regulating mood and,Does a lack of beta-endorphins contribute to withdrawal-induced anxiety in alcoholism?,5.447773729207624e-07,1.0678957083706266,0.09000000000000004,0.041708808689983196,1.1818679278935127,0.06222222222222223,0.041648435441916085,1.30982648986596,0.0322222222222222,5.447773729207636e-07,1.4552872326068411,0.0
122,0.3,10,ai,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Withdrawal-induced anxiety in alcoholism may be associated with a beta-endorphin deficiency. Beta-endorphins are natural peptides that play a role in regulating mood and,Is withdrawal anxiety in alcoholism potentially caused by a deficiency in beta-endorphins?,5.210914001850771e-07,0.9725855285663014,0.09000000000000004,0.03989538222520132,1.0765074122356868,0.06222222222222223,0.03983763390096322,1.1920434542095761,0.0322222222222222,5.210914001850783e-07,1.3217558399823193,0.0
123,0.3,1,ai,Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: It is unclear whether patients at high risk of falls are adequately prepared for discharge home after rehabilitation. Further evaluation is needed to determine if current practices align with established guidelines.,Question: Are patients at high risk of falls properly prepared for discharge home following rehabilitation according to guidelines? Answer: It remains uncertain if these patients receive adequate preparation for discharge. Additional assessment is required to verify compliance with current guidelines.,2.3685972735685396e-07,0.0019248787369186005,0.15704937537180244,0.018134264647818726,0.06032805604151825,0.12244897959183676,0.018108015409528666,0.12124719024711839,0.08436992969172526,2.3685972735685406e-07,0.18484879015820654,0.043388429752066124
123,0.3,2,ai,Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: It is unclear whether patients at high risk of falls are adequately prepared for discharge home after rehabilitation. Further evaluation is needed to determine if current practices align with established guidelines.,Question: Do we follow guidelines when preparing high fall-risk patients for discharge after rehabilitation? Answer: It is unclear if patients at high risk of falling are sufficiently prepared for discharge home post-rehabilitation. More evaluation is necessary to confirm adherence to guidelines.,2.1317375462116866e-07,0.011264429780623253,0.13206581192670053,0.016320838183036854,0.03435256963826028,0.12244897959183676,0.0162972138685758,0.09457894316495752,0.08436992969172526,2.1317375462116866e-07,0.15744981597009122,0.043388429752066124
123,0.3,3,ai,Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: It is unclear whether patients at high risk of falls are adequately prepared for discharge home after rehabilitation. Further evaluation is needed to determine if current practices align with established guidelines.,Question: Are discharge preparations for patients at high risk of falls after rehabilitation meeting established guidelines? Answer: There is uncertainty about whether these patients are adequately prepared for discharge. Further investigation is needed to assess guideline compliance.,3.0791764556390986e-07,0.08196758641045276,0.15704937537180244,0.023574544042164344,0.14256615427849129,0.12244897959183676,0.023540420032387273,0.20580457827518206,0.08436992969172526,3.079176455639103e-07,0.2718601671478367,0.043388429752066124
123,0.3,4,ai,Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: It is unclear whether patients at high risk of falls are adequately prepared for discharge home after rehabilitation. Further evaluation is needed to determine if current practices align with established guidelines.,Question: Preparing patients with a high risk of falls for discharge home after rehabilitation: Are guidelines being met? Answer: It is not clear if the preparation for discharge of high fall-risk patients aligns with guidelines. Additional evaluation is needed.,2.6054570009253926e-07,0.06438179569596292,0.13075280853469506,0.0199476911126006,0.08699630312367912,0.12244897959183676,0.019918816950481533,0.1486461644352337,0.08436992969172526,2.6054570009253947e-07,0.2130196671249034,0.043388429752066124
123,0.3,5,ai,Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: It is unclear whether patients at high risk of falls are adequately prepared for discharge home after rehabilitation. Further evaluation is needed to determine if current practices align with established guidelines.,Question: Do current practices meet guidelines in preparing high fall-risk patients for discharge after rehabilitation? Answer: It is uncertain whether these patients are adequately prepared for discharge home. Further review is required to determine guideline adherence.,3.3160361829959516e-07,0.14974687369486084,0.12850266256903428,0.025387970506946224,0.1715536911517428,0.12244897959183676,0.025351221573340146,0.23565754142486384,0.08436992969172526,3.316036182995957e-07,0.30263182581459036,0.043388429752066124
123,0.3,6,ai,Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: It is unclear whether patients at high risk of falls are adequately prepared for discharge home after rehabilitation. Further evaluation is needed to determine if current practices align with established guidelines.,Question: Are patients at high risk of falls adequately prepared for discharge home following rehabilitation as per guidelines? Answer: It remains unclear if current discharge preparations meet established standards. More evaluation is necessary.,4.0266153650665106e-07,0.19975062206683658,0.15704937537180244,0.030828249901291863,0.2639270112827581,0.12244897959183676,0.030783626196198767,0.33096772122918905,0.08436992969172526,4.026615365066519e-07,0.40107189862784365,0.043388429752066124
123,0.3,7,ai,Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: It is unclear whether patients at high risk of falls are adequately prepared for discharge home after rehabilitation. Further evaluation is needed to determine if current practices align with established guidelines.,Question: Is the preparation of high fall-risk patients for discharge home after rehabilitation consistent with guidelines? Answer: There is a lack of clarity on whether these patients are properly prepared. Further assessment is needed to confirm compliance.,3.0791764556390986e-07,0.08196758641045276,0.15704937537180244,0.023574544042164344,0.14256615427849129,0.12244897959183676,0.023540420032387273,0.20580457827518206,0.08436992969172526,3.079176455639103e-07,0.2718601671478367,0.043388429752066124
123,0.3,8,ai,Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: It is unclear whether patients at high risk of falls are adequately prepared for discharge home after rehabilitation. Further evaluation is needed to determine if current practices align with established guidelines.,Question: Are the guidelines being followed when preparing patients at high risk of falls for discharge after rehabilitation? Answer: It is uncertain if discharge preparations are adequate. Additional evaluation is required to ensure alignment with guidelines.,3.3160361829959516e-07,0.11013846337714961,0.15704937537180244,0.025387970506946224,0.1715536911517428,0.12244897959183676,0.025351221573340146,0.23565754142486384,0.08436992969172526,3.316036182995957e-07,0.30263182581459036,0.043388429752066124
123,0.3,9,ai,Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: It is unclear whether patients at high risk of falls are adequately prepared for discharge home after rehabilitation. Further evaluation is needed to determine if current practices align with established guidelines.,Question: Do we adequately prepare patients at high risk of falls for discharge home after rehabilitation in line with guidelines? Answer: It is unclear if current practices meet the necessary standards. Further investigation is needed.,3.5528959103528046e-07,0.13912600025040112,0.15704937537180244,0.027201396971728103,0.20140665430142457,0.12244897959183676,0.02716202311429302,0.2664292000916175,0.08436992969172526,3.552895910352811e-07,0.3343805241291702,0.043388429752066124
123,0.3,10,ai,Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: It is unclear whether patients at high risk of falls are adequately prepared for discharge home after rehabilitation. Further evaluation is needed to determine if current practices align with established guidelines.,Question: Is the discharge preparation for patients at high risk of falls after rehabilitation meeting the recommended guidelines? Answer: It remains uncertain whether these patients are sufficiently prepared. More evaluation is needed to verify guideline adherence.,3.3160361829959516e-07,0.11013846337714961,0.15704937537180244,0.025387970506946224,0.1715536911517428,0.12244897959183676,0.025351221573340146,0.23565754142486384,0.08436992969172526,3.316036182995957e-07,0.30263182581459036,0.043388429752066124
124,0.3,1,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Is lumbar drainage an effective method for managing postoperative cerebrospinal fluid fistula following spine surgery? Lumbar drainage appears to be both effective and safe for preventing CSF fistulas in patients with large dural tears or those who are debilitated or irradiated, as well as for treating existing CSF leaks.",1.8948778188548325e-07,0.1880977832986206,0.004159661226903637,0.014507411718254981,0.18658595558041347,0.0,0.014486412327622933,0.19105523676270808,0.0,1.8948778188548325e-07,0.19574457712609394,0.0
124,0.3,2,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Does lumbar drainage effectively treat postoperative cerebrospinal fluid fistulas after spine surgery? Evidence suggests lumbar drainage is a safe and effective approach for preventing CSF fistulas in cases involving significant dural tears and compromised patients, and for resolving CSF leaks.",2.36859727356853e-08,0.02620645821577927,0.000639705252959033,0.0018134264647818726,0.025975486403257975,0.0,0.0018108015409528666,0.026668247082160867,0.0,2.3685972735685406e-08,0.02739897418811532,0.0
124,0.3,3,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Is lumbar drainage a reliable treatment for cerebrospinal fluid fistulas occurring after spine surgery? Lumbar drainage seems to provide a safe and effective means to prevent CSF fistulas in patients with large dural tears or those who are debilitated or irradiated, and to treat CSF leaks.",1.1842986367842703e-07,0.12163385332616006,0.0027728196434490295,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
124,0.3,4,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,Can lumbar drainage effectively prevent and treat postoperative cerebrospinal fluid fistulas following spine surgery? It appears to be a safe and effective method for both preventing CSF fistulas in patients with large dural tears or compromised health and for managing CSF leaks.,2.3685972735685406e-08,0.05934997161836808,0.02498356344510192,0.0018134264647818726,0.02531780798429173,0.0,0.0018108015409528666,0.025975486403257975,0.0,2.3685972735685406e-08,0.026668247082160867,0.0
124,0.3,5,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Is lumbar drainage effective and safe for postoperative cerebrospinal fluid fistulas after spine surgery? Lumbar drainage is considered effective and safe for preventing CSF fistulas in cases with large dural tears and debilitated or irradiated patients, as well as for treating CSF leaks.",4.737194547137081e-08,0.04858051119494311,0.06919926203966259,0.0036268529295637453,0.017613694601916308,0.04865220249835634,0.003621603081905733,0.016635935359553322,0.02498356344510192,4.737194547137081e-08,0.05264373348541884,0.0
124,0.3,6,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Does lumbar drainage provide an effective and safe solution for postoperative CSF fistulas after spine surgery? It seems to be effective and safe in preventing CSF fistulas in patients with large dural tears or those who are debilitated or irradiated, and in treating CSF leaks.",9.474389094274162e-08,0.03544746875596516,0.04283321228363101,0.0072537058591274906,0.06539906581694366,0.023242630385487524,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
124,0.3,7,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,Is lumbar drainage a beneficial and safe intervention for postoperative cerebrospinal fluid fistulas following spine surgery? Lumbar drainage appears to be effective and safe for both preventing CSF fistulas in patients with large dural tears or compromised conditions and treating CSF leaks.,2.3685972735685406e-08,0.008274143558211655,0.02366863905325442,0.0018134264647818726,0.02531780798429173,0.0,0.0018108015409528666,0.025975486403257975,0.0,2.3685972735685406e-08,0.026668247082160867,0.0
124,0.3,8,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Is lumbar drainage a practical and safe approach for managing postoperative cerebrospinal fluid fistulas after spine surgery? It seems effective and safe in preventing CSF fistulas in cases of large dural tears and debilitated or irradiated patients, as well as in treating CSF leaks.",7.105791820705622e-08,0.07473861686064831,0.0017409330596143968,0.005440279394345618,0.07410797215372344,0.0,0.0054324046228586,0.0759859069779214,0.0,7.105791820705622e-08,0.07796154146971057,0.0
124,0.3,9,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,Is lumbar drainage an effective and safe technique for postoperative cerebrospinal fluid fistulas after spine surgery? Lumbar drainage appears to be effective and safe in preventing CSF fistulas in patients with significant dural tears or compromised health and in treating CSF leaks.,2.3685972735685406e-08,0.04208620114650197,0.047731117995341306,0.0018134264647818726,0.009339551043704652,0.02498356344510192,0.0018108015409528666,0.025975486403257975,0.0,2.3685972735685406e-08,0.026668247082160867,0.0
124,0.3,10,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Is lumbar drainage effective and safe in handling postoperative cerebrospinal fluid fistulas after spine surgery? It seems to be a safe and effective method for preventing CSF fistulas in cases with large dural tears and debilitated or irradiated patients, and for treating CSF leaks.",7.105791820705622e-08,0.10697802060762251,0.02498356344510192,0.005440279394345618,0.07410797215372344,0.0,0.0054324046228586,0.0759859069779214,0.0,7.105791820705622e-08,0.07796154146971057,0.0
125,0.3,1,ai,Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not have a significant influence on the incidence of ventriculoperitoneal shunt infection.,Does using a neuroendoscope simultaneously affect the rate of ventriculoperitoneal shunt infections? The simultaneous use of a neuroendoscope does not significantly impact the incidence of ventriculoperitoneal shunt infections.,1.658018091497971e-07,0.01759609334178469,0.121025,0.012693985253473157,0.0023324029033284788,0.15834556213017748,0.012675610786670115,0.03025158400654293,0.1508916323731139,1.6580180914979784e-07,0.12177585531914747,0.09566326530612247
125,0.3,2,ai,Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not have a significant influence on the incidence of ventriculoperitoneal shunt infection.,Is the incidence of ventriculoperitoneal shunt infection influenced by the concurrent use of a neuroendoscope? Concurrent use of a neuroendoscope does not significantly alter the incidence of ventriculoperitoneal shunt infection.,1.184298636784265e-07,0.12672719939058386,0.013457851239669388,0.009067132323909398,0.11779317553941793,0.026613236988400513,0.009054007704764368,0.1073232496615133,0.0415166323731139,1.1842986367842703e-07,0.09505216153483698,0.05726326530612246
125,0.3,3,ai,Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not have a significant influence on the incidence of ventriculoperitoneal shunt infection.,Does simultaneous neuroendoscope use affect ventriculoperitoneal shunt infection rates? Using a neuroendoscope simultaneously does not significantly affect the occurrence of ventriculoperitoneal shunt infections.,2.842316728282236e-07,0.1313711792476031,0.18504852607709749,0.021761117577382555,0.15792268350550565,0.1967455621301775,0.021729618491434483,0.25339513532075264,0.1508916323731139,2.8423167282822477e-07,0.3553907065006525,0.09566326530612247
125,0.3,4,ai,Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not have a significant influence on the incidence of ventriculoperitoneal shunt infection.,Does the use of a neuroendoscope at the same time influence ventriculoperitoneal shunt infection incidence? The use of a neuroendoscope simultaneously shows no significant effect on ventriculoperitoneal shunt infection rates.,1.184298636784265e-07,0.07892394555886328,0.037583364839319566,0.009067132323909398,0.06828266264227967,0.0578566732412886,0.009054007704764368,0.055979014064480026,0.07729163237311391,1.1842986367842703e-07,0.09505216153483698,0.05726326530612246
125,0.3,5,ai,Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not have a significant influence on the incidence of ventriculoperitoneal shunt infection.,Is there an effect on ventriculoperitoneal shunt infection incidence when a neuroendoscope is used simultaneously? The simultaneous use of a neuroendoscope does not significantly influence ventriculoperitoneal shunt infection incidence.,1.421158364141118e-07,0.024272718928772363,0.12479999999999997,0.010880558788691277,0.04204750917836897,0.15976331360946744,0.010864809245717241,0.00896912914673953,0.1508916323731139,1.4211583641411244e-07,0.08095386079889266,0.09566326530612247
125,0.3,6,ai,Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not have a significant influence on the incidence of ventriculoperitoneal shunt infection.,Does the simultaneous application of a neuroendoscope impact the frequency of ventriculoperitoneal shunt infections? The simultaneous application of a neuroendoscope does not have a significant impact on ventriculoperitoneal shunt infection frequency.,9.47438909427412e-08,0.035461743116837585,0.042899999999999994,0.007253705859127518,0.02636230656933458,0.06234556213017753,0.007243206163811494,0.06545443739095536,0.04529163237311386,9.474389094274162e-08,0.10668129085682976,0.022063265306122487
125,0.3,7,ai,Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not have a significant influence on the incidence of ventriculoperitoneal shunt infection.,Does using a neuroendoscope at the same time affect the likelihood of ventriculoperitoneal shunt infection? Using a neuroendoscope simultaneously does not significantly affect the likelihood of ventriculoperitoneal shunt infection.,1.421158364141118e-07,0.17376933265978245,0.008177777777777895,0.010880558788691277,0.1633294332097628,0.021125727419433638,0.010864809245717241,0.15098791252093946,0.037470082278595954,1.4211583641411244e-07,0.19185740968848464,0.01626818023995988
125,0.3,8,ai,Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not have a significant influence on the incidence of ventriculoperitoneal shunt infection.,Is the rate of ventriculoperitoneal shunt infection affected by simultaneous neuroendoscope use? The rate of ventriculoperitoneal shunt infection is not significantly affected by simultaneous neuroendoscope use.,2.131737546211677e-07,0.38413862324517867,0.018734948096885834,0.016320838183036916,0.37096488116095383,0.025476660092044717,0.016297213868575862,0.3547278644447047,0.015313353776470612,2.1317375462116866e-07,0.3348139924105853,0.005663265306122475
125,0.3,9,ai,Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not have a significant influence on the incidence of ventriculoperitoneal shunt infection.,Does the concurrent use of a neuroendoscope influence ventriculoperitoneal shunt infection rates? Concurrent neuroendoscope use does not significantly influence the rates of ventriculoperitoneal shunt infection.,2.36859727356853e-07,0.039108687253729624,0.18881209829867673,0.018134264647818796,0.06695090529977765,0.1967455621301775,0.018108015409528735,0.15808495551642743,0.1508916323731139,2.3685972735685406e-07,0.2553072479436711,0.09566326530612247
125,0.3,10,ai,Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not have a significant influence on the incidence of ventriculoperitoneal shunt infection.,Does simultaneous neuroendoscope utilization have an effect on ventriculoperitoneal shunt infection incidence? Simultaneous neuroendoscope utilization does not significantly affect ventriculoperitoneal shunt infection incidence.,2.842316728282236e-07,0.32041131940031464,0.0575604938271605,0.021761117577382555,0.2899507178978755,0.10256273664541293,0.021729618491434483,0.25339513532075264,0.1508916323731139,2.8423167282822477e-07,0.3553907065006525,0.09566326530612247
127,0.3,1,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Does preoperative anemia negatively impact the results of colon and rectal surgeries? This extensive multicenter database study indicates that severe, moderate, and even mild preoperative anemia independently increase the risk of complications and prolong hospital stays following colon surgery.",1.4211583641411222e-07,0.15157821472220911,0.0035815857662582634,0.010880558788691236,0.1502822030493367,0.0,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
127,0.3,2,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Is there an adverse effect of preoperative anemia on outcomes of colon and rectal surgery? Analysis of a large multicenter database shows that severe, moderate, and mild preoperative anemia serve as independent risk factors for postoperative complications and extended hospitalization after colon surgery.",4.737194547137081e-08,0.04802033420753293,0.0010803788339694455,0.0036268529295637453,0.047628048989254435,0.0,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
127,0.3,3,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Does having anemia before surgery worsen outcomes in colon and rectal procedures? Findings from a large multicenter database reveal that severe, moderate, and mild preoperative anemia independently contribute to higher complication rates and longer hospital stays post colon surgery.",1.4211583641411222e-07,0.11509678416642277,0.02271498107084911,0.010880558788691236,0.1502822030493367,0.0,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
127,0.3,4,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Does preoperative anemia have a detrimental effect on the outcomes of colon and rectal surgeries? This large multicenter database analysis demonstrates that severe, moderate, and even mild anemia before surgery independently raise the risk of complications and lengthen hospital stays after colon surgery.",4.737194547137081e-08,0.015013325609441353,0.02271498107084911,0.0036268529295637453,0.047628048989254435,0.0,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
127,0.3,5,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Is preoperative anemia linked to poorer outcomes in colon and rectal surgery? Data from a large multicenter database suggest that severe, moderate, and mild anemia prior to surgery are independent risk factors for complications and extended hospitalization following colon surgery.",1.1842986367842692e-07,0.0891212977631648,0.02271498107084911,0.009067132323909363,0.12361395596717584,0.0,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
127,0.3,6,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Does anemia before surgery adversely influence the results of colon and rectal surgery? According to a large multicenter database analysis, severe, moderate, and mild preoperative anemia independently increase the likelihood of complications and longer hospital stays after colon surgery.",1.4211583641411222e-07,0.11509678416642277,0.02271498107084911,0.010880558788691236,0.1502822030493367,0.0,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
127,0.3,7,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Does the presence of preoperative anemia negatively affect colon and rectal surgery outcomes? This analysis of a large multicenter database indicates that severe, moderate, and mild anemia before surgery independently elevate the risk of postoperative complications and prolonged hospital stays after colon surgery.",4.737194547137081e-08,0.015013325609441353,0.02271498107084911,0.0036268529295637453,0.047628048989254435,0.0,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
127,0.3,8,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Is preoperative anemia an independent risk factor for complications and longer hospital stays after colon surgery? The findings from a large multicenter database analysis suggest that severe, moderate, and mild anemia before surgery adversely impact colon and rectal surgery outcomes.",1.1842986367842692e-07,0.0891212977631648,0.02271498107084911,0.009067132323909363,0.12361395596717584,0.0,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
127,0.3,9,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Does preoperative anemia contribute to worse outcomes in colon and rectal surgery? Evidence from a large multicenter database analysis shows that severe, moderate, and mild anemia before surgery independently increase complication risks and hospital stay duration after colon surgery.",1.4211583641411222e-07,0.11509678416642277,0.02271498107084911,0.010880558788691236,0.1502822030493367,0.0,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
127,0.3,10,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Does preoperative anemia affect the outcomes of colon and rectal surgery negatively? This large multicenter database study suggests that severe, moderate, and mild anemia before surgery independently pose a risk for complications and longer hospitalization following colon surgery.",1.6580180914979753e-07,0.14176503124858364,0.02271498107084911,0.012693985253473108,0.17768117723745203,0.0,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
128,0.3,1,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: The first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia is not a prognostic factor for maternal and neonatal adverse outcome.,Is the initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia a predictor of negative maternal and neonatal outcomes? The first urinary albumin/creatinine ratio (ACR) in these women does not predict adverse maternal or neonatal outcomes.,1.8948778188548283e-07,0.1809103281794342,0.12382115912208497,0.014507411718254981,0.15891377104733095,0.1637635522959184,0.01448641232762294,0.1362352909832989,0.18873086355529137,1.8948778188548325e-07,0.11285920819942596,0.20194878472222216
128,0.3,2,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: The first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia is not a prognostic factor for maternal and neonatal adverse outcome.,Does the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia serve as a prognostic indicator for poor maternal and neonatal outcomes? It is not a prognostic factor for adverse maternal or neonatal results.,2.3685972735685343e-07,0.2370112575682355,0.20381140246460103,0.01813426464781874,0.2188985019775309,0.2487244897959184,0.018108015409528687,0.15715739629156333,0.24732461355529137,2.3685972735685406e-07,0.0923477712520282,0.23222222222222216
128,0.3,3,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: The first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia is not a prognostic factor for maternal and neonatal adverse outcome.,Can the initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia forecast maternal and neonatal complications? The first ACR measurement is not predictive of negative outcomes for mother or newborn.,3.3160361829959463e-07,0.15262147817657823,0.23319615912208497,0.02538797050694626,0.08968677049752394,0.2487244897959184,0.02535122157334018,0.02362600366704104,0.24732461355529137,3.316036182995957e-07,0.04580256722878895,0.23222222222222216
128,0.3,4,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: The first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia is not a prognostic factor for maternal and neonatal adverse outcome.,Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia useful for predicting adverse maternal and neonatal outcomes? It does not serve as a prognostic factor for such outcomes.,3.3160361829959463e-07,0.15262147817657823,0.23319615912208497,0.02538797050694626,0.08968677049752394,0.2487244897959184,0.02535122157334018,0.02362600366704104,0.24732461355529137,3.316036182995957e-07,0.04580256722878895,0.23222222222222216
128,0.3,5,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: The first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia is not a prognostic factor for maternal and neonatal adverse outcome.,Does the initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia predict poor outcomes for mother and baby? The first ACR is not a prognostic marker for maternal or neonatal adverse events.,2.84231672828224e-07,0.21715999931414975,0.23319615912208497,0.0217611175773825,0.1563781449961974,0.2487244897959184,0.021729618491434434,0.09261887515399181,0.24732461355529137,2.8423167282822487e-07,0.025656396753354738,0.23222222222222216
128,0.3,6,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: The first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia is not a prognostic factor for maternal and neonatal adverse outcome.,Is the first urinary albumin/creatinine ratio (ACR) measurement in women with suspected preeclampsia a reliable predictor of maternal and neonatal adverse outcomes? It is not considered a prognostic factor for these outcomes.,3.0791764556390933e-07,0.18541130099956993,0.23319615912208497,0.02357454404216438,0.1235883221732057,0.2487244897959184,0.023540420032387308,0.058717323478310046,0.24732461355529137,3.079176455639103e-07,0.009434923057914268,0.23222222222222216
128,0.3,7,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: The first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia is not a prognostic factor for maternal and neonatal adverse outcome.,Can the initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia indicate the risk of adverse maternal and neonatal outcomes? The first ACR does not predict such risks.,3.7897556377096523e-07,0.08362860668962746,0.23319615912208497,0.029014823436510018,0.01822780651538025,0.2487244897959184,0.028972824655245928,0.05048196848668063,0.24732461355529137,3.789755637709665e-07,0.1227636083649184,0.23222222222222216
128,0.3,8,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: The first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia is not a prognostic factor for maternal and neonatal adverse outcome.,Is the first urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia a useful prognostic tool for maternal and neonatal adverse outcomes? It is not a reliable prognostic factor.,3.7897556377096523e-07,0.08362860668962746,0.23319615912208497,0.029014823436510018,0.01822780651538025,0.2487244897959184,0.028972824655245928,0.05048196848668063,0.24732461355529137,3.789755637709665e-07,0.1227636083649184,0.23222222222222216
128,0.3,9,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: The first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia is not a prognostic factor for maternal and neonatal adverse outcome.,Does the initial urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia forecast negative maternal and neonatal outcomes? The first ACR measurement is not prognostic for these outcomes.,4.0266153650665053e-07,0.04726096251875278,0.23319615912208497,0.030828249901291897,0.019512521467466737,0.2487244897959184,0.0307836261961988,0.08970268163996309,0.24732461355529137,4.026615365066519e-07,0.1635856028851732,0.23222222222222216
128,0.3,10,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: The first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia is not a prognostic factor for maternal and neonatal adverse outcome.,Is the first urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia an indicator for predicting maternal and neonatal adverse outcomes? It is not a prognostic indicator for such outcomes.,3.5528959103527993e-07,0.07091667266917634,0.1987573836118809,0.027201396971728138,0.05459545068625493,0.2487244897959184,0.027162023114293055,0.01274164050383364,0.24732461355529137,3.552895910352811e-07,0.08354289521163594,0.23222222222222216
129,0.3,1,ai,Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT imaging has been found to provide additional and valuable information for preoperative staging of patients with liver metastases of colorectal carcinoma when compared to multidetector CT alone.,Question: Does PET/CT offer any additional benefits over multidetector CT in the preoperative staging of patients with liver metastases from colorectal carcinoma? Answer: PET/CT imaging has been shown to deliver extra and valuable insights for preoperative staging of liver metastases in colorectal carcinoma patients compared to multidetector CT alone.,2.3685972735685406e-08,0.1709895014466154,0.09810329433849953,0.0018134264647818726,0.20296841807800803,0.1260049912441944,0.0018108015409528666,0.20681815486809407,0.13017751479289946,2.3685972735685406e-08,0.1800063059793171,0.11176857330703485
129,0.3,2,ai,Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT imaging has been found to provide additional and valuable information for preoperative staging of patients with liver metastases of colorectal carcinoma when compared to multidetector CT alone.,"Question: In preoperative staging of liver metastases from colorectal carcinoma, does PET/CT add value beyond multidetector CT? Answer: PET/CT imaging provides supplementary and important information for preoperative staging of colorectal carcinoma liver metastases compared to using multidetector CT alone.",2.1317375462116844e-07,0.05654511130892548,0.10238057549889759,0.016320838183036854,0.04423306144854822,0.12026535904741033,0.0162972138685758,0.0383043031648902,0.13017751479289946,2.1317375462116866e-07,0.071308122301589,0.11176857330703485
129,0.3,3,ai,Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT imaging has been found to provide additional and valuable information for preoperative staging of patients with liver metastases of colorectal carcinoma when compared to multidetector CT alone.,"Question: For patients with liver metastases of colorectal carcinoma, does PET/CT enhance preoperative staging beyond what multidetector CT offers? Answer: PET/CT imaging has been demonstrated to add valuable and additional information for preoperative staging when compared to multidetector CT alone.",1.8948778188548314e-07,0.007782648242724566,0.12961570914329765,0.014507411718254981,0.01990260079901507,0.1472715318869165,0.014486412327622933,0.010905328976774875,0.13017751479289946,1.8948778188548325e-07,0.04313724533489216,0.11176857330703485
129,0.3,4,ai,Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT imaging has been found to provide additional and valuable information for preoperative staging of patients with liver metastases of colorectal carcinoma when compared to multidetector CT alone.,Question: Is PET/CT imaging beneficial for preoperative staging of colorectal carcinoma liver metastases over multidetector CT? Answer: PET/CT provides extra and crucial information that improves preoperative staging of liver metastases from colorectal carcinoma compared to multidetector CT alone.,2.3685972735685374e-07,0.12363872738533699,0.07422817955429387,0.018134264647818726,0.07267279716903596,0.11951642984610017,0.018108015409528666,0.06647518013158704,0.13017751479289946,2.3685972735685406e-07,0.10029565917484051,0.11176857330703485
129,0.3,5,ai,Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT imaging has been found to provide additional and valuable information for preoperative staging of patients with liver metastases of colorectal carcinoma when compared to multidetector CT alone.,Question: Does PET/CT contribute additional information in the preoperative staging of liver metastases in colorectal carcinoma patients beyond multidetector CT? Answer: PET/CT imaging offers valuable supplementary data for preoperative staging of colorectal carcinoma liver metastases compared to multidetector CT alone.,1.8948778188548314e-07,0.06330937027624328,0.0795234326417547,0.014507411718254981,0.016578829756771274,0.12097496504980912,0.014486412327622933,0.010905328976774875,0.13017751479289946,1.8948778188548325e-07,0.04313724533489216,0.11176857330703485
129,0.3,6,ai,Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT imaging has been found to provide additional and valuable information for preoperative staging of patients with liver metastases of colorectal carcinoma when compared to multidetector CT alone.,"Question: When staging liver metastases of colorectal carcinoma preoperatively, does PET/CT add value to multidetector CT? Answer: PET/CT has been found to provide additional and important information for preoperative staging beyond what multidetector CT alone can offer.",2.6054570009253904e-07,0.001168040911841306,0.1807479224376731,0.0199476911126006,0.062335497437957965,0.1472715318869165,0.01991881695048154,0.09546271700483855,0.13017751479289946,2.6054570009253947e-07,0.1301486223245223,0.11176857330703485
129,0.3,7,ai,Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT imaging has been found to provide additional and valuable information for preoperative staging of patients with liver metastases of colorectal carcinoma when compared to multidetector CT alone.,"Question: In the context of preoperative staging for colorectal carcinoma liver metastases, does PET/CT add information beyond multidetector CT? Answer: PET/CT imaging supplies additional and valuable insights that enhance preoperative staging compared to multidetector CT alone.",2.8423167282822434e-07,0.06894732819624938,0.15220120963490494,0.02176111757738248,0.09132303431120947,0.1472715318869165,0.021729618491434413,0.12531568015452033,0.13017751479289946,2.8423167282822487e-07,0.16092028099127598,0.11176857330703485
129,0.3,8,ai,Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT imaging has been found to provide additional and valuable information for preoperative staging of patients with liver metastases of colorectal carcinoma when compared to multidetector CT alone.,Question: Does the use of PET/CT improve preoperative staging accuracy for liver metastases of colorectal carcinoma compared to multidetector CT? Answer: PET/CT imaging provides extra and significant information that benefits preoperative staging over multidetector CT alone.,2.8423167282822434e-07,0.06894732819624938,0.15220120963490494,0.02176111757738248,0.09132303431120947,0.1472715318869165,0.021729618491434413,0.12531568015452033,0.13017751479289946,2.8423167282822487e-07,0.16092028099127598,0.11176857330703485
129,0.3,9,ai,Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT imaging has been found to provide additional and valuable information for preoperative staging of patients with liver metastases of colorectal carcinoma when compared to multidetector CT alone.,"Question: For preoperative staging of liver metastases from colorectal carcinoma, is PET/CT superior to multidetector CT in providing additional information? Answer: PET/CT has been shown to add valuable and supplementary information beyond multidetector CT alone for preoperative staging.",2.3685972735685374e-07,0.04870389705453171,0.12687037141726493,0.018134264647818726,0.03416462047126112,0.1472715318869165,0.018108015409528666,0.06647518013158704,0.13017751479289946,2.3685972735685406e-07,0.10029565917484051,0.11176857330703485
129,0.3,10,ai,Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT imaging has been found to provide additional and valuable information for preoperative staging of patients with liver metastases of colorectal carcinoma when compared to multidetector CT alone.,Question: Does PET/CT imaging add meaningful information to multidetector CT in the preoperative staging of colorectal carcinoma liver metastases? Answer: PET/CT offers additional and important data that enhances preoperative staging compared to multidetector CT alone.,3.0791764556390964e-07,0.18064654543883796,0.09333897342622668,0.023574544042164358,0.163184917494827,0.1169980943869165,0.023540420032387287,0.156087338821274,0.13017751479289946,3.079176455639103e-07,0.1926689793058558,0.11176857330703485
130,0.3,1,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","Question: What is the long-term importance of postictal psychotic episodes II? Do they predict interictal psychotic episodes? Answer: A history of PIPE might increase the risk of developing IPE. However, the lack of significance in multivariate analysis suggests it is not an independent predictor.",4.737194547137081e-08,0.04546237407675724,0.0,0.0036268529295637453,0.04652001563489394,0.0,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
130,0.3,2,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","Question: How significant are postictal psychotic episodes II in the long term? Can they forecast interictal psychotic episodes? Answer: Having a history of PIPE could be a risk factor for IPE, but multivariate analysis shows it is not an independent predictor.",1.1842986367842703e-07,0.11778303565638337,0.0,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
130,0.3,3,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","Question: What is the long-term relevance of postictal psychotic episodes II? Are they indicative of future interictal psychotic episodes? Answer: A history of PIPE may raise the risk of IPE, yet multivariate analysis reveals it is not an independent predictor.",1.4211583641411233e-07,0.1431008436406751,0.0,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
130,0.3,4,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","Question: Long-term impact of postictal psychotic episodes II: do they predict interictal psychotic episodes? Answer: While a history of PIPE could be a risk factor for IPE, multivariate analysis indicates it is not an independent predictor.",2.3685972735685353e-07,0.2513144282809061,0.0,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
130,0.3,5,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","Question: What is the long-term significance of postictal psychotic episodes II? Are they predictive of interictal psychotic episodes? Answer: Although a history of PIPE may increase risk for IPE, multivariate analysis shows it is not an independent predictor.",1.8948778188548293e-07,0.19574457712609394,0.0,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
130,0.3,6,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","Question: Do postictal psychotic episodes II have long-term significance in predicting interictal psychotic episodes? Answer: A history of PIPE might be linked to IPE risk, but multivariate analysis suggests it is not an independent predictor.",2.6054570009253883e-07,0.2803019651541576,0.0,0.019947691112600613,0.2876820724517817,0.0,0.019918816950481553,0.29546421289383584,0.0,2.6054570009253947e-07,0.30368241379822125,0.0
130,0.3,7,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","Question: Assessing the long-term significance of postictal psychotic episodes II: are they predictive of interictal psychotic episodes? Answer: A history of PIPE may pose a risk for IPE, yet multivariate analysis indicates it is not an independent predictor.",1.8948778188548293e-07,0.19574457712609394,0.0,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
130,0.3,8,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","Question: What is the predictive value of postictal psychotic episodes II for interictal psychotic episodes in the long term? Answer: History of PIPE might be a risk factor for IPE, but multivariate analysis shows it is not an independent predictor.",1.4211583641411233e-07,0.17864685290015903,0.025623268698060954,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
130,0.3,9,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","Question: Long-term significance of postictal psychotic episodes II: are they a predictor of interictal psychotic episodes? Answer: A history of PIPE could increase IPE risk, but multivariate analysis reveals it is not an independent predictor.",2.6054570009253883e-07,0.2803019651541576,0.0,0.019947691112600613,0.2876820724517817,0.0,0.019918816950481553,0.29546421289383584,0.0,2.6054570009253947e-07,0.30368241379822125,0.0
130,0.3,10,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","Question: Can postictal psychotic episodes II predict interictal psychotic episodes in the long term? Answer: While a history of PIPE may be a risk factor for IPE, multivariate analysis demonstrates it is not an independent predictor.",2.3685972735685353e-07,0.29092283859861734,0.02854671280276816,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
131,0.3,1,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Does a previous benign prostate biopsy forecast results for patients undergoing radical perineal prostatectomy? A prior benign prostate biopsy might independently correlate with better surgical and biochemical outcomes post-prostatectomy. Further research is required to validate these findings.,1.1842986367842661e-07,0.10563330887887723,0.017351359641135253,0.009067132323909363,0.10382508488623987,0.021314783042107176,0.00905400770476434,0.10165511225399859,0.025623268698060954,1.1842986367842703e-07,0.14107859825990632,0.0
131,0.3,2,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Can a history of benign prostate biopsy predict outcomes in patients treated with radical perineal prostatectomy? Having a prior benign prostate biopsy may be independently linked to improved surgical and biochemical results after prostatectomy. More studies are necessary to confirm this.,2.3685972735685406e-08,0.007428842118504253,0.02285318559556789,0.0018134264647818726,0.008450900812218443,0.02423822714681438,0.0018108015409528666,0.00957052285622595,0.025623268698060954,2.3685972735685406e-08,0.026668247082160867,0.0
131,0.3,3,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Is prior benign prostate biopsy a predictor of outcomes for patients receiving radical perineal prostatectomy? A previous benign prostate biopsy could be independently associated with more favorable surgical and biochemical outcomes following prostatectomy. Additional research is needed to verify these results.,2.3685972735685406e-08,0.007428842118504253,0.02285318559556789,0.0018134264647818726,0.008450900812218443,0.02423822714681438,0.0018108015409528666,0.00957052285622595,0.025623268698060954,2.3685972735685406e-08,0.026668247082160867,0.0
131,0.3,4,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Does a benign prostate biopsy before treatment influence outcomes for patients undergoing radical perineal prostatectomy? Prior benign prostate biopsy may independently relate to better surgical and biochemical outcomes after prostatectomy. Further studies are essential to confirm these observations.,9.474389094274131e-08,0.07615281162601795,0.01883713042003505,0.0072537058591274906,0.07455397429960664,0.022106393804059005,0.007243206163811466,0.07266757538074708,0.025623268698060954,9.474389094274162e-08,0.11122563511022454,0.0
131,0.3,5,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Can prior benign prostate biopsy serve as a predictor for outcomes in patients treated with radical perineal prostatectomy? A history of benign prostate biopsy might independently predict more favorable surgical and biochemical outcomes post-prostatectomy. Additional investigation is required to substantiate these findings.,0.0,0.03381205758829031,0.024062478942086886,0.0,0.034657359027997714,0.024877932399773414,0.0,0.035546009259483924,0.025623268698060954,0.0,0.0,0.0
131,0.3,6,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Is a previous benign prostate biopsy indicative of outcomes for patients treated with radical perineal prostatectomy? Prior benign prostate biopsy may be independently associated with improved surgical and biochemical outcomes after prostatectomy. More research is needed to confirm these findings.,4.7371945471370706e-08,0.019666266328761672,0.021582468146067776,0.0036268529295637453,0.01846000688734195,0.02356492900776796,0.003621603081905733,0.017097724225934918,0.025623268698060954,4.737194547137081e-08,0.05406722127027619,0.0
131,0.3,7,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Does having a prior benign prostate biopsy predict the outcome for patients undergoing radical perineal prostatectomy? A prior benign prostate biopsy could independently be linked to better surgical and biochemical outcomes following prostatectomy. Further studies are needed to confirm this association.,2.3685972735685406e-08,0.06188587593748984,0.026050750658322228,0.0018134264647818726,0.06264111770674985,0.02652739304401356,0.0018108015409528666,0.06339233825534718,0.026845867104408186,2.3685972735685406e-08,0.06413566224756329,0.027006172839506164
131,0.3,8,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Can a prior benign prostate biopsy independently predict outcomes in patients treated with radical perineal prostatectomy? Such a biopsy may be related to more favorable surgical and biochemical results after prostatectomy. Additional studies are necessary to confirm these findings.,7.1057918207056e-08,0.025450265786948645,0.07271468144044323,0.005440279394345618,0.008646823413716476,0.049861495844875335,0.0054324046228586,0.04449669841405024,0.025623268698060954,7.105791820705622e-08,0.08223809823697303,0.0
131,0.3,9,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Is the outcome for patients treated with radical perineal prostatectomy influenced by prior benign prostate biopsy? Prior benign prostate biopsy may independently correlate with improved surgical and biochemical outcomes post-prostatectomy. Further research is required to validate these findings.,9.474389094274131e-08,0.07615281162601795,0.01883713042003505,0.0072537058591274906,0.07455397429960664,0.022106393804059005,0.007243206163811466,0.07266757538074708,0.025623268698060954,9.474389094274162e-08,0.11122563511022454,0.0
131,0.3,10,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Does prior benign prostate biopsy have predictive value for outcomes in patients undergoing radical perineal prostatectomy? A previous benign prostate biopsy might independently be associated with better surgical and biochemical outcomes after prostatectomy. More studies are needed to confirm these results.,2.3685972735685406e-08,0.007428842118504253,0.02285318559556789,0.0018134264647818726,0.008450900812218443,0.02423822714681438,0.0018108015409528666,0.00957052285622595,0.025623268698060954,2.3685972735685406e-08,0.026668247082160867,0.0
132,0.3,1,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The extent of lymphadenectomy in cervical cancer could potentially be modified by neoadjuvant chemotherapy. However, further research is needed to determine the optimal approach and to evaluate the benefits and potential risks of this modification.","Question: Is it possible to alter the extent of lymphadenectomy in cervical cancer through neoadjuvant chemotherapy? Answer: Neoadjuvant chemotherapy may potentially change the extent of lymphadenectomy in cervical cancer, but additional studies are required to identify the best method and assess the advantages and possible risks of such changes.",2.3685972735685406e-08,0.03301710176916517,0.036130641187428675,0.0018134264647818726,0.023511377923222998,0.0017253015925516868,0.0018108015409528666,0.05292545762377321,0.022430810114242618,2.3685972735685406e-08,0.0835919894352144,0.04434829637641968
132,0.3,2,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The extent of lymphadenectomy in cervical cancer could potentially be modified by neoadjuvant chemotherapy. However, further research is needed to determine the optimal approach and to evaluate the benefits and potential risks of this modification.","Question: Can neoadjuvant chemotherapy influence the scope of lymphadenectomy in cervical cancer? Answer: The scope of lymphadenectomy in cervical cancer might be adjusted by neoadjuvant chemotherapy, though more research is necessary to find the optimal strategy and to weigh the benefits against potential risks.",1.4211583641411244e-07,0.09377514956337896,0.024622960911049638,0.010880558788691236,0.1500348969235703,0.011538197385590934,0.0108648092457172,0.17902045836126268,0.030245545637974096,1.4211583641411244e-07,0.20907666043115247,0.049861495844875335
132,0.3,3,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The extent of lymphadenectomy in cervical cancer could potentially be modified by neoadjuvant chemotherapy. However, further research is needed to determine the optimal approach and to evaluate the benefits and potential risks of this modification.","Question: Does neoadjuvant chemotherapy have the potential to modify lymphadenectomy extent in cervical cancer? Answer: Neoadjuvant chemotherapy could possibly modify the extent of lymphadenectomy in cervical cancer, but further investigation is essential to determine the best approach and evaluate its benefits and risks.",1.6580180914979784e-07,0.022122645434886845,0.09138888888888888,0.012693985253473108,0.042104414110259114,0.08264462809917357,0.012675610786670066,0.10227689818676478,0.04246913580246913,1.6580180914979784e-07,0.1650797503594501,0.0
132,0.3,4,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The extent of lymphadenectomy in cervical cancer could potentially be modified by neoadjuvant chemotherapy. However, further research is needed to determine the optimal approach and to evaluate the benefits and potential risks of this modification.","Question: Could neoadjuvant chemotherapy lead to changes in the extent of lymphadenectomy for cervical cancer? Answer: It is possible that neoadjuvant chemotherapy alters the extent of lymphadenectomy in cervical cancer, yet more research is needed to establish the optimal approach and to assess the potential benefits and risks.",4.737194547137081e-08,0.0383868563692733,0.05451895919716364,0.0036268529295637453,0.012691247799749839,0.039256198347107446,0.003621603081905733,0.0153004038886011,0.02025839200081624,4.737194547137081e-08,0.04445176257083272,0.0
132,0.3,5,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The extent of lymphadenectomy in cervical cancer could potentially be modified by neoadjuvant chemotherapy. However, further research is needed to determine the optimal approach and to evaluate the benefits and potential risks of this modification.","Question: Is the extent of lymphadenectomy in cervical cancer subject to modification by neoadjuvant chemotherapy? Answer: The extent of lymphadenectomy in cervical cancer might be modified by neoadjuvant chemotherapy, but further studies are required to determine the best approach and to evaluate the benefits and potential risks.",7.105791820705622e-08,0.07609468759469928,0.0083826429980276,0.005440279394345618,0.10304669783534592,0.02673037190082643,0.0054324046228586,0.13299347848424814,0.047530864197530866,7.105791820705622e-08,0.1641594920364553,0.06937499999999999
132,0.3,6,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The extent of lymphadenectomy in cervical cancer could potentially be modified by neoadjuvant chemotherapy. However, further research is needed to determine the optimal approach and to evaluate the benefits and potential risks of this modification.","Question: Can the extent of lymphadenectomy be adjusted by neoadjuvant chemotherapy in cases of cervical cancer? Answer: Neoadjuvant chemotherapy may adjust the extent of lymphadenectomy in cervical cancer, but additional research is necessary to identify the optimal approach and assess the benefits and risks involved.",1.1842986367842703e-07,0.035615372705617876,0.0488888888888889,0.009067132323909363,0.05895517261495309,0.036243676284777364,0.009054007704764333,0.08649374261542464,0.018673775897650575,1.1842986367842703e-07,0.11506932978478668,0.0
132,0.3,7,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The extent of lymphadenectomy in cervical cancer could potentially be modified by neoadjuvant chemotherapy. However, further research is needed to determine the optimal approach and to evaluate the benefits and potential risks of this modification.","Question: Might neoadjuvant chemotherapy alter the extent of lymphadenectomy in cervical cancer treatment? Answer: The extent of lymphadenectomy in cervical cancer could be altered by neoadjuvant chemotherapy; however, further research is needed to determine the optimal method and evaluate potential benefits and risks.",1.6580180914979784e-07,0.15415067982725894,2.7755575615628914e-17,0.012693985253473108,0.21116470205170845,0.03695413733292524,0.012675610786670066,0.24090633429875297,0.05629629629629634,1.6580180914979784e-07,0.2717177781379023,0.0763888888888889
132,0.3,8,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The extent of lymphadenectomy in cervical cancer could potentially be modified by neoadjuvant chemotherapy. However, further research is needed to determine the optimal approach and to evaluate the benefits and potential risks of this modification.","Question: Is it feasible to modify the extent of lymphadenectomy in cervical cancer through neoadjuvant chemotherapy? Answer: Modifying the extent of lymphadenectomy in cervical cancer via neoadjuvant chemotherapy is possible, but more research is required to find the best approach and to assess the benefits and risks.",7.105791820705622e-08,0.04595785365730931,0.011388888888888893,0.005440279394345618,0.10304669783534592,0.02673037190082643,0.0054324046228586,0.13299347848424814,0.047530864197530866,7.105791820705622e-08,0.1641594920364553,0.06937499999999999
132,0.3,9,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The extent of lymphadenectomy in cervical cancer could potentially be modified by neoadjuvant chemotherapy. However, further research is needed to determine the optimal approach and to evaluate the benefits and potential risks of this modification.","Question: Could the application of neoadjuvant chemotherapy change the extent of lymphadenectomy in cervical cancer? Answer: The application of neoadjuvant chemotherapy might change the extent of lymphadenectomy in cervical cancer, though further studies are needed to establish the optimal approach and evaluate its benefits and risks.",9.474389094274162e-08,0.195181170333949,0.06519274376417236,0.0072537058591274906,0.22354036709992187,0.09019487807366593,0.007243206163811466,0.22339265908898343,0.09339645952258566,9.474389094274162e-08,0.22299981259809787,0.0941828254847645
132,0.3,10,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The extent of lymphadenectomy in cervical cancer could potentially be modified by neoadjuvant chemotherapy. However, further research is needed to determine the optimal approach and to evaluate the benefits and potential risks of this modification.","Question: Does neoadjuvant chemotherapy have the capacity to modify lymphadenectomy extent in cervical cancer? Answer: Neoadjuvant chemotherapy has the potential to modify the extent of lymphadenectomy in cervical cancer; however, additional research is necessary to determine the best approach and assess the associated benefits and risks.",9.474389094274162e-08,0.02046461917358977,0.072562358276644,0.0072537058591274906,0.028513153103694844,0.08264462809917357,0.007243206163811466,0.029956236607138642,0.04246913580246913,9.474389094274162e-08,0.09097177820572666,0.0
133,0.3,1,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: Do environmental factors play a role in primary systemic vasculitis? Answer: For the first time, a strong link between farming and PSV has been found. The findings also confirm earlier reported connections with silica, solvents, and allergies.",7.10579182070559e-08,0.08455738802806367,0.0,0.005440279394345632,0.08701137698963013,0.0,0.005432404622858621,0.08961215868968697,0.0,7.105791820705622e-08,0.09237332013101529,0.0
133,0.3,2,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: Are environmental influences significant in primary systemic vasculitis? Answer: A notable correlation between farming and PSV has been discovered for the first time. The results also reinforce previously known associations with silica, solvents, and allergic reactions.",4.73719454713706e-08,0.05715841383994835,0.0,0.003626852929563759,0.058840500022933284,0.0,0.003621603081905747,0.060624621816435464,0.0,4.737194547137081e-08,0.06252035698133351,0.0
133,0.3,3,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: Is there an importance of environmental factors in primary systemic vasculitis? Answer: A significant relationship between farming and PSV has been identified for the first time. The data also supports earlier reported links with silica, solvents, and allergies.",9.47438909427412e-08,0.11122563511022454,0.0,0.007253705859127504,0.11441035117774545,0.0,0.007243206163811487,0.11778303565638382,0.0,9.474389094274162e-08,0.1213608570042668,0.0
133,0.3,4,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: Do environmental factors matter in primary systemic vasculitis? Answer: A strong association between farming and PSV has been recognized for the first time. The results further back previously reported connections with silica, solvents, and allergy.",2.36859727356853e-08,0.028987536873251507,0.0,0.0018134264647818796,0.029852963149681777,0.0,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
133,0.3,5,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: Are environmental factors relevant to primary systemic vasculitis? Answer: For the first time, a significant association between farming and PSV has been established. The findings also uphold earlier reported associations with silica, solvents, and allergic conditions.",4.73719454713706e-08,0.05715841383994835,0.0,0.003626852929563759,0.058840500022933284,0.0,0.003621603081905747,0.060624621816435464,0.0,4.737194547137081e-08,0.06252035698133351,0.0
133,0.3,6,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: Is there a role of environmental factors in primary systemic vasculitis? Answer: A significant link between farming and PSV has been identified for the first time. The results also support previously documented associations with silica, solvents, and allergy.",9.47438909427412e-08,0.11122563511022454,0.0,0.007253705859127504,0.11441035117774545,0.0,0.007243206163811487,0.11778303565638382,0.0,9.474389094274162e-08,0.1213608570042668,0.0
133,0.3,7,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: How important are environmental factors in primary systemic vasculitis? Answer: A significant connection between farming and PSV has been found for the first time. The findings also confirm earlier reported links with silica, solvents, and allergies.",4.73719454713706e-08,0.05715841383994835,0.0,0.003626852929563759,0.058840500022933284,0.0,0.003621603081905747,0.060624621816435464,0.0,4.737194547137081e-08,0.06252035698133351,0.0
133,0.3,8,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: Are environmental factors significant in primary systemic vasculitis? Answer: For the first time, a strong association between farming and PSV has been discovered. The results also reinforce previously known connections with silica, solvents, and allergy.",2.36859727356853e-08,0.028987536873251507,0.0,0.0018134264647818796,0.029852963149681777,0.0,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
133,0.3,9,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: Do environmental factors have an impact on primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. The data also supports previously reported links with silica, solvents, and allergies.",7.10579182070559e-08,0.08455738802806367,0.0,0.005440279394345632,0.08701137698963013,0.0,0.005432404622858621,0.08961215868968697,0.0,7.105791820705622e-08,0.09237332013101529,0.0
133,0.3,10,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Question: Is there an influence of environmental factors on primary systemic vasculitis? Answer: A notable association between farming and PSV has been found for the first time. The results also uphold earlier reported connections with silica, solvents, and allergy.",9.47438909427412e-08,0.11122563511022454,0.0,0.007253705859127504,0.11441035117774545,0.0,0.007243206163811487,0.11778303565638382,0.0,9.474389094274162e-08,0.1213608570042668,0.0
134,0.3,1,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: There is limited research on the direct impact of the Supplemental Security Income program on reducing disability in the elderly. However, providing financial support through the program can alleviate economic challenges and potentially improve access to healthcare and resources, which may indirectly contribute to better health outcomes for older individuals.","Does the Supplemental Security Income program decrease disability among the elderly? Research directly linking the program to reduced disability in older adults is limited. Nevertheless, the financial aid it provides can ease economic hardships and improve access to healthcare and resources, potentially leading to better health outcomes for seniors.",3.789755637709665e-07,0.15771697609679114,0.09274673008323427,0.029014823436509962,0.20496843508656282,0.06320022981901754,0.028972824655245866,0.2537738156166456,0.0322222222222222,3.789755637709665e-07,0.2814852373354517,0.016388888888888897
134,0.3,2,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: There is limited research on the direct impact of the Supplemental Security Income program on reducing disability in the elderly. However, providing financial support through the program can alleviate economic challenges and potentially improve access to healthcare and resources, which may indirectly contribute to better health outcomes for older individuals.","Is there evidence that the Supplemental Security Income program lowers disability rates in elderly populations? While direct studies are scarce, the program's financial support may help mitigate economic difficulties and enhance access to medical care and resources, which could indirectly benefit the health of older adults.",4.500334819780227e-07,0.22225549723436266,0.09274673008323427,0.03445510283085558,0.2709264028783589,0.06320022981901754,0.034405229278104466,0.3212150964121778,0.0322222222222222,4.500334819780227e-07,0.3504781088224034,0.016388888888888897
134,0.3,3,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: There is limited research on the direct impact of the Supplemental Security Income program on reducing disability in the elderly. However, providing financial support through the program can alleviate economic challenges and potentially improve access to healthcare and resources, which may indirectly contribute to better health outcomes for older individuals.","Does the Supplemental Security Income program help reduce disability in elderly individuals? Although research on its direct effects is limited, the program's financial assistance can relieve economic stress and improve access to healthcare and other resources, possibly improving health outcomes for the elderly.",5.210914001850789e-07,0.2912483687213143,0.09274673008323427,0.0398953822252012,0.34154397009231285,0.06320022981901754,0.039837633900963065,0.39353575799180396,0.0322222222222222,5.210914001850789e-07,0.4245860809761268,0.016388888888888897
134,0.3,4,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: There is limited research on the direct impact of the Supplemental Security Income program on reducing disability in the elderly. However, providing financial support through the program can alleviate economic challenges and potentially improve access to healthcare and resources, which may indirectly contribute to better health outcomes for older individuals.","Can the Supplemental Security Income program reduce disability among the elderly? There is limited direct research on this, but the program's financial support may ease economic burdens and increase access to healthcare and resources, which might indirectly improve health for older adults.",5.447773729207643e-07,0.31534592030037434,0.09274673008323427,0.04170880868998307,0.36623658268268455,0.06320022981901754,0.04164843544191593,0.4188535659760957,0.0322222222222222,5.447773729207643e-07,0.4505615673793848,0.016388888888888897
134,0.3,5,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: There is limited research on the direct impact of the Supplemental Security Income program on reducing disability in the elderly. However, providing financial support through the program can alleviate economic challenges and potentially improve access to healthcare and resources, which may indirectly contribute to better health outcomes for older individuals.","Is the Supplemental Security Income program effective in decreasing disability in the elderly? Direct evidence is limited, but by providing financial support, the program can alleviate economic challenges and improve access to healthcare and resources, potentially leading to better health outcomes for seniors.",5.210914001850789e-07,0.2912483687213143,0.09274673008323427,0.0398953822252012,0.34154397009231285,0.06320022981901754,0.039837633900963065,0.39353575799180396,0.0322222222222222,5.210914001850789e-07,0.4245860809761268,0.016388888888888897
134,0.3,6,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: There is limited research on the direct impact of the Supplemental Security Income program on reducing disability in the elderly. However, providing financial support through the program can alleviate economic challenges and potentially improve access to healthcare and resources, which may indirectly contribute to better health outcomes for older individuals.","Does the Supplemental Security Income program contribute to lowering disability rates in elderly people? Research directly linking the program to reduced disability is limited; however, the financial aid offered may reduce economic hardship and enhance access to healthcare and resources, indirectly benefiting older adults' health.",4.737194547137081e-07,0.24472835308642038,0.09274673008323427,0.03626852929563745,0.2939159211030584,0.06320022981901754,0.03621603081905733,0.34474559382237224,0.0322222222222222,4.737194547137081e-07,0.3745756604014634,0.016388888888888897
134,0.3,7,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: There is limited research on the direct impact of the Supplemental Security Income program on reducing disability in the elderly. However, providing financial support through the program can alleviate economic challenges and potentially improve access to healthcare and resources, which may indirectly contribute to better health outcomes for older individuals.","Does the Supplemental Security Income program reduce disability among older adults? Limited research exists on its direct impact, but the program's financial support can help ease economic difficulties and improve access to healthcare and resources, which may indirectly promote better health outcomes for the elderly.",4.737194547137081e-07,0.24472835308642038,0.09274673008323427,0.03626852929563745,0.2939159211030584,0.06320022981901754,0.03621603081905733,0.34474559382237224,0.0322222222222222,4.737194547137081e-07,0.3745756604014634,0.016388888888888897
134,0.3,8,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: There is limited research on the direct impact of the Supplemental Security Income program on reducing disability in the elderly. However, providing financial support through the program can alleviate economic challenges and potentially improve access to healthcare and resources, which may indirectly contribute to better health outcomes for older individuals.","Is there a reduction in disability among the elderly due to the Supplemental Security Income program? While direct research is scarce, the program's financial assistance can alleviate economic challenges and improve access to healthcare and resources, potentially leading to improved health in older individuals.",4.974054274493935e-07,0.2677178713111199,0.09274673008323427,0.038081955760419325,0.31744641851325284,0.06320022981901754,0.0380268323600102,0.36884314540143226,0.0322222222222222,4.974054274493935e-07,0.3992682729918351,0.016388888888888897
134,0.3,9,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: There is limited research on the direct impact of the Supplemental Security Income program on reducing disability in the elderly. However, providing financial support through the program can alleviate economic challenges and potentially improve access to healthcare and resources, which may indirectly contribute to better health outcomes for older individuals.","Does the Supplemental Security Income program lower disability rates in the elderly? Although direct research is limited, the financial support provided can reduce economic strain and improve access to healthcare and resources, which might indirectly enhance health outcomes for seniors.",5.92149318392135e-07,0.36535634087503777,0.09274673008323427,0.045335661619546816,0.41752987707023426,0.06320022981901754,0.045270038523821665,0.47149729946151453,0.0322222222222222,5.921493183921352e-07,0.504628788649661,0.016388888888888897
134,0.3,10,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: There is limited research on the direct impact of the Supplemental Security Income program on reducing disability in the elderly. However, providing financial support through the program can alleviate economic challenges and potentially improve access to healthcare and resources, which may indirectly contribute to better health outcomes for older individuals.","Can disability in elderly populations be reduced by the Supplemental Security Income program? There is limited direct research, but the program's financial aid may ease economic hardships and improve access to healthcare and resources, potentially contributing to better health outcomes for older adults.",5.210914001850789e-07,0.2912483687213143,0.09274673008323427,0.0398953822252012,0.34154397009231285,0.06320022981901754,0.039837633900963065,0.39353575799180396,0.0322222222222222,5.210914001850789e-07,0.4245860809761268,0.016388888888888897
135,0.3,1,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Primary angioplasty is considered a superior alternative to thrombolysis for the treatment of heart attacks. It is a more effective and safer procedure that involves opening blocked arteries with a balloon catheter, resulting in","Is primary angioplasty a viable substitute for thrombolysis? Primary angioplasty is regarded as a better option than thrombolysis for treating heart attacks. It is a safer and more effective method that uses a balloon catheter to open blocked arteries, leading to",7.105791820705622e-08,0.042499213113674106,0.021417388369294285,0.005440279394345618,0.07410797215372344,0.0,0.0054324046228586,0.0759859069779214,0.0,7.105791820705622e-08,0.07796154146971057,0.0
135,0.3,2,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Primary angioplasty is considered a superior alternative to thrombolysis for the treatment of heart attacks. It is a more effective and safer procedure that involves opening blocked arteries with a balloon catheter, resulting in","Can primary angioplasty replace thrombolysis? Primary angioplasty is viewed as a superior treatment compared to thrombolysis for heart attacks. This procedure, which involves opening blocked arteries with a balloon catheter, is both safer and more effective.",1.8948778188548272e-07,0.1809816570279117,0.017854239011628047,0.014507411718254988,0.21130909366720596,0.0,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
135,0.3,3,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Primary angioplasty is considered a superior alternative to thrombolysis for the treatment of heart attacks. It is a more effective and safer procedure that involves opening blocked arteries with a balloon catheter, resulting in","Is primary angioplasty an acceptable alternative to thrombolysis? Yes, primary angioplasty is considered a more effective and safer treatment for heart attacks than thrombolysis. It works by using a balloon catheter to open blocked arteries.",2.1317375462116802e-07,0.2111341471458017,0.01701619515691227,0.016320838183036868,0.24116205681688774,0.0,0.01629721386857582,0.2478361639045814,0.0,2.1317375462116866e-07,0.25489224962878954,0.0
135,0.3,4,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Primary angioplasty is considered a superior alternative to thrombolysis for the treatment of heart attacks. It is a more effective and safer procedure that involves opening blocked arteries with a balloon catheter, resulting in","Does primary angioplasty serve as a good alternative to thrombolysis? Primary angioplasty is often preferred over thrombolysis for heart attack treatment because it is safer and more effective, involving the use of a balloon catheter to unblock arteries.",1.4211583641411212e-07,0.12327081072079071,0.01939477897489004,0.010880558788691236,0.1541506798272576,0.0,0.0108648092457172,0.15822400521489444,0.0,1.4211583641411244e-07,0.16251892949777424,0.0
135,0.3,5,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Primary angioplasty is considered a superior alternative to thrombolysis for the treatment of heart attacks. It is a more effective and safer procedure that involves opening blocked arteries with a balloon catheter, resulting in","Is primary angioplasty better than thrombolysis? Primary angioplasty is seen as a superior and safer alternative to thrombolysis for treating heart attacks, as it opens blocked arteries with a balloon catheter.",3.079176455639092e-07,0.3417337385747885,0.01310725383579929,0.023574544042164386,0.3703737882968947,0.0,0.023540420032387314,0.3813675565291037,0.0,3.079176455639103e-07,0.3930425881096067,0.0
135,0.3,6,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Primary angioplasty is considered a superior alternative to thrombolysis for the treatment of heart attacks. It is a more effective and safer procedure that involves opening blocked arteries with a balloon catheter, resulting in","Can primary angioplasty be used instead of thrombolysis? Primary angioplasty is considered a more effective and safer procedure than thrombolysis for heart attack patients, utilizing a balloon catheter to clear blocked arteries.",2.842316728282239e-07,0.3074532766538183,0.014178729592174005,0.021761117577382506,0.33647223662121295,0.0,0.02172961849143444,0.3462762367178347,0.0,2.8423167282822487e-07,0.356674943938732,0.0
135,0.3,7,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Primary angioplasty is considered a superior alternative to thrombolysis for the treatment of heart attacks. It is a more effective and safer procedure that involves opening blocked arteries with a balloon catheter, resulting in","Is primary angioplasty an effective substitute for thrombolysis? It is regarded as a safer and more efficient method for treating heart attacks, involving balloon catheterization to open blocked arteries.",3.552895910352798e-07,0.3645167980244097,0.046400951814396206,0.027201396971728145,0.4418327522790384,0.0,0.02716202311429306,0.45547552868282537,0.0,3.552895910352811e-07,0.47000362924573613,0.0
135,0.3,8,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Primary angioplasty is considered a superior alternative to thrombolysis for the treatment of heart attacks. It is a more effective and safer procedure that involves opening blocked arteries with a balloon catheter, resulting in","Is primary angioplasty preferable to thrombolysis? Primary angioplasty is a safer and more effective alternative for heart attack treatment, achieved by opening blocked arteries with a balloon catheter.",3.789755637709651e-07,0.4522286777923177,0.00941870329368616,0.029014823436510025,0.4795730802618854,0.0,0.028972824655245935,0.49469624183610783,0.0,3.789755637709665e-07,0.5108256237659909,0.0
135,0.3,9,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Primary angioplasty is considered a superior alternative to thrombolysis for the treatment of heart attacks. It is a more effective and safer procedure that involves opening blocked arteries with a balloon catheter, resulting in","Is primary angioplasty an acceptable replacement for thrombolysis? It is considered a superior and safer treatment option for heart attacks, involving the use of a balloon catheter to open blocked arteries.",3.079176455639092e-07,0.29552392653745896,0.046400951814396206,0.023574544042164386,0.3703737882968947,0.0,0.023540420032387314,0.3813675565291037,0.0,3.079176455639103e-07,0.3930425881096067,0.0
135,0.3,10,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Primary angioplasty is considered a superior alternative to thrombolysis for the treatment of heart attacks. It is a more effective and safer procedure that involves opening blocked arteries with a balloon catheter, resulting in","Is primary angioplasty a better option than thrombolysis? Primary angioplasty is viewed as a safer and more effective treatment for heart attacks, using a balloon catheter to open blocked arteries.",3.316036182995945e-07,0.37722873204486085,0.011962176304192114,0.025387970506946266,0.4054651081081637,0.0,0.025351221573340188,0.4177352006999784,0.0,3.316036182995957e-07,0.43078291609245367,0.0
136,0.3,1,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider the influence of culture, attitudes, and faith as they play a significant role in an individual's journey","Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Absolutely, recovery outcome measures must account for culture, attitudes, and faith since they significantly impact an individual's recovery journey.",9.47438909427412e-08,0.17554530070304653,0.03980435149266319,0.007253705859127518,0.17119079256525804,0.03566256187024015,0.007243206163811494,0.17137295499133653,0.033293697978596916,9.474389094274162e-08,0.12921173148000697,0.0
136,0.3,2,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider the influence of culture, attitudes, and faith as they play a significant role in an individual's journey","Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Indeed, culture, attitudes, and faith are crucial factors that recovery outcome measures should incorporate due to their important role in personal recovery.",2.36859727356853e-08,0.031471577826506,0.002316309400826458,0.0018134264647818796,0.030152490117890007,0.0008380438547157774,0.0018108015409528735,0.029852963149681777,0.0,2.3685972735685406e-08,0.030771658666753687,0.0
136,0.3,3,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider the influence of culture, attitudes, and faith as they play a significant role in an individual's journey","Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, it is essential for recovery outcome measures to include culture, attitudes, and faith because they greatly influence an individual's path to recovery.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
136,0.3,4,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider the influence of culture, attitudes, and faith as they play a significant role in an individual's journey","Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Certainly, recovery outcome measures ought to consider culture, attitudes, and faith as they are vital to an individual's recovery process.",7.10579182070559e-08,0.09751360699811373,0.007355371900826496,0.005440279394345639,0.09332544715697333,0.002670768987034146,0.005432404622858621,0.09237332013101529,0.0,7.105791820705622e-08,0.09531017980432521,0.0
136,0.3,5,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider the influence of culture, attitudes, and faith as they play a significant role in an individual's journey","Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Recovery outcome measures should definitely reflect the impact of culture, attitudes, and faith, given their significant role in one's recovery journey.",4.73719454713706e-08,0.06395397443367212,0.004764320912272885,0.003626852929563759,0.0612410097391578,0.0017267246972318406,0.003621603081905747,0.060624621816435464,0.0,4.737194547137081e-08,0.06252035698133351,0.0
136,0.3,6,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider the influence of culture, attitudes, and faith as they play a significant role in an individual's journey","Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, incorporating culture, attitudes, and faith into recovery outcome measures is important because they play a key role in the recovery experience.",2.36859727356853e-08,0.031471577826506,0.002316309400826458,0.0018134264647818796,0.030152490117890007,0.0008380438547157774,0.0018108015409528735,0.029852963149681777,0.0,2.3685972735685406e-08,0.030771658666753687,0.0
136,0.3,7,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider the influence of culture, attitudes, and faith as they play a significant role in an individual's journey","Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Recovery outcome measures need to consider culture, attitudes, and faith, as these elements significantly shape an individual's recovery journey.",9.47438909427412e-08,0.13222360191804983,0.010102101984060682,0.007253705859127518,0.12647161962590658,0.0036755094194540414,0.007243206163811494,0.125163142954007,0.0,9.474389094274162e-08,0.12921173148000697,0.0
136,0.3,8,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider the influence of culture, attitudes, and faith as they play a significant role in an individual's journey","Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: It is important that recovery outcome measures include culture, attitudes, and faith since they have a profound influence on recovery.",7.10579182070559e-08,0.09751360699811373,0.007355371900826496,0.005440279394345639,0.09332544715697333,0.002670768987034146,0.005432404622858621,0.09237332013101529,0.0,7.105791820705622e-08,0.09531017980432521,0.0
136,0.3,9,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider the influence of culture, attitudes, and faith as they play a significant role in an individual's journey","Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, the role of culture, attitudes, and faith should be acknowledged in recovery outcome measures due to their impact on an individual's recovery path.",2.36859727356853e-08,0.030521258785231264,0.0021948011095541814,0.0018134264647818726,0.02927111058663323,0.0007916107619518296,0.0018108015409528735,0.028987536873251507,0.0,2.3685972735685406e-08,0.029852963149681777,0.0
136,0.3,10,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider the influence of culture, attitudes, and faith as they play a significant role in an individual's journey","Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Recovery outcome measures should embrace the influence of culture, attitudes, and faith as they are significant factors in the recovery journey.",4.73719454713706e-08,0.06395397443367212,0.004764320912272885,0.003626852929563759,0.0612410097391578,0.0017267246972318406,0.003621603081905747,0.060624621816435464,0.0,4.737194547137081e-08,0.06252035698133351,0.0
137,0.3,1,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The indication for concomitant splenectomy in mild hereditary spherocytosis is still a subject of debate among medical professionals. While cholecystectomy may be necessary to treat gallstones in these patients, the need for splenectomy depends on individual factors such as spleen","Is cholecystectomy truly a reason to perform a splenectomy simultaneously in cases of mild hereditary spherocytosis? The decision to do a splenectomy alongside cholecystectomy in mild hereditary spherocytosis remains controversial among clinicians. Although cholecystectomy is often required to address gallstones, the necessity of splenectomy varies based on patient-specific factors like spleen condition.",4.737194547137081e-08,0.06410821870012828,0.0722122534955538,0.0036268529295637453,0.09407682156978359,0.09506564056134,0.003621603081905733,0.0687236348859015,0.07786328655500228,4.737194547137081e-08,0.042355667146938725,0.05975554549569943
137,0.3,2,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The indication for concomitant splenectomy in mild hereditary spherocytosis is still a subject of debate among medical professionals. While cholecystectomy may be necessary to treat gallstones in these patients, the need for splenectomy depends on individual factors such as spleen","Does cholecystectomy warrant a concurrent splenectomy in mild hereditary spherocytosis? The indication for performing splenectomy along with cholecystectomy in mild hereditary spherocytosis is still debated within the medical community. While cholecystectomy treats gallstones, splenectomy is considered depending on individual spleen-related factors.",3.079176455639103e-07,0.19378819321645535,0.06150111166983715,0.023574544042164344,0.18993054698820133,0.06944237186327903,0.023540420032387266,0.18551050349833886,0.07786328655500228,3.079176455639103e-07,0.21792743111672674,0.05975554549569943
137,0.3,3,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The indication for concomitant splenectomy in mild hereditary spherocytosis is still a subject of debate among medical professionals. While cholecystectomy may be necessary to treat gallstones in these patients, the need for splenectomy depends on individual factors such as spleen","Is it justified to do a splenectomy at the same time as cholecystectomy in mild hereditary spherocytosis? Medical experts continue to debate whether splenectomy should accompany cholecystectomy in mild hereditary spherocytosis. Cholecystectomy addresses gallstones, but splenectomy necessity depends on specific patient spleen characteristics.",2.6054570009253947e-07,0.17470433678530828,0.04035669035494918,0.0199476911126006,0.17199823233063372,0.046413438062983654,0.019918816950481533,0.16887456813878554,0.05287972310990036,2.6054570009253947e-07,0.1652836976313079,0.05975554549569943
137,0.3,4,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The indication for concomitant splenectomy in mild hereditary spherocytosis is still a subject of debate among medical professionals. While cholecystectomy may be necessary to treat gallstones in these patients, the need for splenectomy depends on individual factors such as spleen","Should splenectomy be performed concurrently with cholecystectomy in mild hereditary spherocytosis? The role of splenectomy alongside cholecystectomy in mild hereditary spherocytosis is still under discussion. While cholecystectomy is indicated for gallstone treatment, splenectomy depends on individual spleen factors.",3.789755637709662e-07,0.3148372621263804,0.030912780525093136,0.029014823436509962,0.31144359879780126,0.03970231876203202,0.028972824655245866,0.3073570120530231,0.049316573752234125,3.789755637709665e-07,0.3024848191447904,0.05975554549569943
137,0.3,5,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The indication for concomitant splenectomy in mild hereditary spherocytosis is still a subject of debate among medical professionals. While cholecystectomy may be necessary to treat gallstones in these patients, the need for splenectomy depends on individual factors such as spleen","Is concomitant splenectomy indicated when performing cholecystectomy in mild hereditary spherocytosis? The indication for simultaneous splenectomy in mild hereditary spherocytosis remains controversial. Cholecystectomy is needed for gallstones, but splenectomy is considered based on patient-specific spleen conditions.",4.263475092423368e-07,0.337221688420406,0.05442964149083738,0.032641676366073714,0.33235902280454965,0.06568088390385605,0.03259442773715161,0.3265891017582452,0.07786328655500228,4.263475092423373e-07,0.3631094409612259,0.05975554549569943
137,0.3,6,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The indication for concomitant splenectomy in mild hereditary spherocytosis is still a subject of debate among medical professionals. While cholecystectomy may be necessary to treat gallstones in these patients, the need for splenectomy depends on individual factors such as spleen","Does mild hereditary spherocytosis require splenectomy when cholecystectomy is performed? The necessity of concurrent splenectomy during cholecystectomy in mild hereditary spherocytosis is debated among healthcare providers. Cholecystectomy treats gallstones, while splenectomy depends on individual spleen-related factors.",4.263475092423368e-07,0.337221688420406,0.05442964149083738,0.032641676366073714,0.33235902280454965,0.06568088390385605,0.03259442773715161,0.3265891017582452,0.07786328655500228,4.263475092423373e-07,0.3631094409612259,0.05975554549569943
137,0.3,7,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The indication for concomitant splenectomy in mild hereditary spherocytosis is still a subject of debate among medical professionals. While cholecystectomy may be necessary to treat gallstones in these patients, the need for splenectomy depends on individual factors such as spleen","Is it appropriate to perform splenectomy along with cholecystectomy in mild hereditary spherocytosis? The indication for combined splenectomy in mild hereditary spherocytosis is still a matter of debate. Cholecystectomy addresses gallstones, but splenectomy depends on specific patient spleen characteristics.",3.552895910352809e-07,0.2487296306595841,0.058893471712243343,0.02720139697172809,0.24449568637953867,0.06805946772183383,0.027162023114293,0.23957772476861505,0.07786328655500228,3.552895910352811e-07,0.2734972822715389,0.05975554549569943
137,0.3,8,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The indication for concomitant splenectomy in mild hereditary spherocytosis is still a subject of debate among medical professionals. While cholecystectomy may be necessary to treat gallstones in these patients, the need for splenectomy depends on individual factors such as spleen","Is splenectomy a necessary accompaniment to cholecystectomy in mild hereditary spherocytosis? The need for splenectomy alongside cholecystectomy in mild hereditary spherocytosis remains controversial. Cholecystectomy is indicated for gallstones, while splenectomy depends on individual spleen factors.",4.500334819780221e-07,0.4093124953452838,0.02395365850326607,0.034455102830855594,0.4054564624597541,0.03471184243438891,0.034405229278104486,0.40068245920999646,0.04664580476519998,4.500334819780227e-07,0.3948581392758057,0.05975554549569943
137,0.3,9,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The indication for concomitant splenectomy in mild hereditary spherocytosis is still a subject of debate among medical professionals. While cholecystectomy may be necessary to treat gallstones in these patients, the need for splenectomy depends on individual factors such as spleen","Should splenectomy be routinely done with cholecystectomy in mild hereditary spherocytosis? The indication for concomitant splenectomy in mild hereditary spherocytosis is still debated. Cholecystectomy treats gallstones, but the decision for splenectomy depends on patient-specific spleen conditions.",4.263475092423368e-07,0.337221688420406,0.05442964149083738,0.032641676366073714,0.33235902280454965,0.06568088390385605,0.03259442773715161,0.3265891017582452,0.07786328655500228,4.263475092423373e-07,0.3631094409612259,0.05975554549569943
137,0.3,10,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The indication for concomitant splenectomy in mild hereditary spherocytosis is still a subject of debate among medical professionals. While cholecystectomy may be necessary to treat gallstones in these patients, the need for splenectomy depends on individual factors such as spleen","Is splenectomy warranted during cholecystectomy in patients with mild hereditary spherocytosis? The indication for performing splenectomy along with cholecystectomy in mild hereditary spherocytosis remains a topic of debate. While cholecystectomy is necessary for gallstones, splenectomy depends on individual spleen factors.",3.316036182995956e-07,0.22088330166372128,0.06023039422033703,0.025387970506946217,0.18036002413197538,0.09506564056134,0.025351221573340132,0.21217875058049973,0.07786328655500228,3.316036182995957e-07,0.24532640530484207,0.05975554549569943
138,0.3,1,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: The decision to repair aneurysms in patients aged 80 or older after aneurysmal subarachnoid hemorrhage should be based on individual patient factors, overall health, and potential benefits versus risks. A thorough assessment by a healthcare professional is","Is it appropriate to perform aneurysm repair on patients aged 80 or above following an aneurysmal subarachnoid hemorrhage? The choice to repair aneurysms in patients 80 years or older after such hemorrhage depends on individual health status, patient-specific factors, and weighing potential benefits against risks. A comprehensive evaluation by a medical expert is essential.",0.0,0.18309548165734402,0.12901701323251416,0.0,0.15995704166767943,0.113421550094518,0.0,0.1359112118744994,0.09688090737240077,0.0,0.11090354888959109,0.07939508506616257
138,0.3,2,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: The decision to repair aneurysms in patients aged 80 or older after aneurysmal subarachnoid hemorrhage should be based on individual patient factors, overall health, and potential benefits versus risks. A thorough assessment by a healthcare professional is","Should aneurysm repair be conducted in patients aged 80 or older after experiencing an aneurysmal subarachnoid hemorrhage? Repair decisions for aneurysms in this age group should consider the patient's overall health, individual circumstances, and the balance of benefits and risks, with a detailed assessment by healthcare professionals.",1.6580180914979784e-07,0.04144496459431757,0.12901701323251416,0.012693985253473108,0.01537581285657108,0.113421550094518,0.012675610786670066,0.01172478693156398,0.09688090737240077,1.6580180914979784e-07,0.039919340844992046,0.07939508506616257
138,0.3,3,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: The decision to repair aneurysms in patients aged 80 or older after aneurysmal subarachnoid hemorrhage should be based on individual patient factors, overall health, and potential benefits versus risks. A thorough assessment by a healthcare professional is","Is aneurysm repair warranted for patients aged 80+ after aneurysmal subarachnoid hemorrhage? The decision must be individualized, taking into account the patient's health, specific factors, and the potential advantages versus risks, following a thorough medical evaluation.",4.263475092423368e-07,0.23184837040536355,0.12901701323251416,0.032641676366073714,0.26492615229758654,0.113421550094518,0.03259442773715161,0.29940685938334566,0.09688090737240077,4.263475092423373e-07,0.3353835537388279,0.07939508506616257
138,0.3,4,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: The decision to repair aneurysms in patients aged 80 or older after aneurysmal subarachnoid hemorrhage should be based on individual patient factors, overall health, and potential benefits versus risks. A thorough assessment by a healthcare professional is","For patients aged 80 or older who have had an aneurysmal subarachnoid hemorrhage, is aneurysm repair justified? This decision should be personalized, based on the patient's overall health, unique factors, and a careful consideration of benefits and risks, guided by a healthcare professional's assessment.",2.3685972735685406e-07,0.025996316201214675,0.12901701323251416,0.018134264647818726,0.053617058630380576,0.113421550094518,0.018108015409528666,0.08234235414551794,0.09688090737240077,2.3685972735685406e-07,0.11224000242461818,0.07939508506616257
138,0.3,5,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: The decision to repair aneurysms in patients aged 80 or older after aneurysmal subarachnoid hemorrhage should be based on individual patient factors, overall health, and potential benefits versus risks. A thorough assessment by a healthcare professional is","Does aneurysm repair make sense for patients aged 80 and above after aneurysmal subarachnoid hemorrhage? The choice should depend on individual patient health, specific factors, and weighing the potential benefits against risks, with a thorough evaluation by a healthcare provider.",3.316036182995956e-07,0.12363478576513254,0.12901701323251416,0.025387970506946217,0.153700517187362,0.113421550094518,0.025351221573340132,0.1849965082056002,0.09688090737240077,3.316036182995957e-07,0.21760051808244407,0.07939508506616257
138,0.3,6,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: The decision to repair aneurysms in patients aged 80 or older after aneurysmal subarachnoid hemorrhage should be based on individual patient factors, overall health, and potential benefits versus risks. A thorough assessment by a healthcare professional is","Is it justified to repair aneurysms in patients aged 80 or older following aneurysmal subarachnoid hemorrhage? Such decisions should be individualized, considering patient health, unique factors, and the balance of risks and benefits, after a comprehensive assessment by medical professionals.",3.316036182995956e-07,0.12363478576513254,0.12901701323251416,0.025387970506946217,0.153700517187362,0.113421550094518,0.025351221573340132,0.1849965082056002,0.09688090737240077,3.316036182995957e-07,0.21760051808244407,0.07939508506616257
138,0.3,7,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: The decision to repair aneurysms in patients aged 80 or older after aneurysmal subarachnoid hemorrhage should be based on individual patient factors, overall health, and potential benefits versus risks. A thorough assessment by a healthcare professional is","Should aneurysm repair be considered for patients aged 80 or older after aneurysmal subarachnoid hemorrhage? The decision relies on patient-specific factors, overall health, and evaluating benefits versus risks, with a detailed medical evaluation.",4.974054274493927e-07,0.3214605290950505,0.12901701323251416,0.03808195576041935,0.3572994724286018,0.113421550094518,0.03802683236001023,0.39471703918767087,0.09688090737240077,4.974054274493935e-07,0.4338236265520812,0.07939508506616257
138,0.3,8,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: The decision to repair aneurysms in patients aged 80 or older after aneurysmal subarachnoid hemorrhage should be based on individual patient factors, overall health, and potential benefits versus risks. A thorough assessment by a healthcare professional is","Is aneurysm repair appropriate for patients aged 80 or more after aneurysmal subarachnoid hemorrhage? The choice should be based on individual health status, specific patient factors, and a careful weighing of potential benefits and risks, following a thorough healthcare assessment.",3.316036182995956e-07,0.12363478576513254,0.12901701323251416,0.025387970506946217,0.153700517187362,0.113421550094518,0.025351221573340132,0.1849965082056002,0.09688090737240077,3.316036182995957e-07,0.21760051808244407,0.07939508506616257
138,0.3,9,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: The decision to repair aneurysms in patients aged 80 or older after aneurysmal subarachnoid hemorrhage should be based on individual patient factors, overall health, and potential benefits versus risks. A thorough assessment by a healthcare professional is","Is repairing aneurysms justified in patients aged 80 or older after aneurysmal subarachnoid hemorrhage? The decision should be tailored to the individual, considering overall health, patient-specific factors, and balancing benefits against risks, with a professional medical evaluation.",4.026615365066515e-07,0.2036774934386667,0.12901701323251416,0.030828249901291835,0.23593861542433503,0.113421550094518,0.03078362619619874,0.2695538962336639,0.09688090737240077,4.026615365066519e-07,0.3046118950720742,0.07939508506616257
138,0.3,10,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: The decision to repair aneurysms in patients aged 80 or older after aneurysmal subarachnoid hemorrhage should be based on individual patient factors, overall health, and potential benefits versus risks. A thorough assessment by a healthcare professional is","For patients aged 80 or older with aneurysmal subarachnoid hemorrhage, is aneurysm repair advisable? This should be decided based on individual patient health, specific factors, and the potential benefits versus risks, after a comprehensive assessment by healthcare professionals.",3.789755637709662e-07,0.17627851925055138,0.12901701323251416,0.029014823436509962,0.20776773845763818,0.113421550094518,0.028972824655245866,0.24056635936041237,0.09688090737240077,3.789755637709665e-07,0.2747589319223924,0.07939508506616257
139,0.3,1,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control of blood pressure during",Does blood pressure vary in treated hypertensive patients based on whether a physician or a nurse takes the measurement? The systolic blood pressure recorded by nurses in treated hypertensive patients is notably lower than that measured by physicians and closely matches ambulatory blood pressure monitoring. Measuring blood pressure by nurses is recommended not only for diagnosis but also to assess blood pressure control levels.,2.3685972735685406e-07,0.17782800299693946,0.15912972946797538,0.018134264647818782,0.13648864186365284,0.009365679479101045,0.01810801540952868,0.1550068772437161,0.002307256235827672,2.3685972735685406e-07,0.15415067982725894,0.0
139,0.3,2,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control of blood pressure during","In treated hypertensive patients, does blood pressure differ when measured by a physician versus a nurse? Systolic blood pressure readings taken by nurses are significantly lower than those taken by physicians and are nearly identical to ambulatory blood pressure monitoring results. Nurse-measured blood pressure is preferred for both diagnosis and monitoring blood pressure control.",4.737194547137081e-07,0.3129092212915321,0.15996636284722215,0.03626852929563751,0.26766013538796507,0.041587901701323246,0.036216030819057346,0.31132897162516215,0.014081632653061225,4.737194547137081e-07,0.33647223662121295,0.0
139,0.3,3,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control of blood pressure during","Is there a difference in blood pressure readings in treated hypertensive patients depending on whether a physician or nurse performs the measurement? Nurses record significantly lower systolic blood pressure than physicians, with values closely matching ambulatory blood pressure monitoring. Blood pressure measurement by nurses is beneficial for diagnosis and evaluating blood pressure control.",4.974054274493935e-07,0.3087207989849894,0.14303927951388895,0.03808195576041938,0.28707822124506777,0.041587901701323246,0.03802683236001021,0.3311315989213419,0.014081632653061225,4.974054274493935e-07,0.35667494393873156,0.0
139,0.3,4,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control of blood pressure during","For treated hypertensive patients, does blood pressure measurement vary between physicians and nurses? Systolic blood pressure measured by nurses is significantly lower than that measured by physicians and aligns closely with ambulatory blood pressure monitoring. Nurse-based blood pressure measurement is advisable for diagnosis and monitoring control levels.",6.39521263863506e-07,0.4875273132126883,0.09415039062500014,0.04896251454911062,0.4430479055572931,0.019377157899670355,0.04889164160572741,0.4589649704312255,0.014081632653061225,6.39521263863506e-07,0.4872951263557961,0.0
139,0.3,5,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control of blood pressure during","Does the method of measurement by a physician or nurse affect blood pressure readings in treated hypertensive patients? Nurses obtain significantly lower systolic blood pressure readings compared to physicians, which correspond closely with ambulatory blood pressure monitoring. Measuring blood pressure by nurses is valuable for diagnosis and assessing control.",5.921493183921352e-07,0.37841552384882515,0.03565865508780988,0.04533566161954687,0.39825187696401354,0.020321361058601144,0.04527003852382168,0.4145132078603928,0.014081632653061225,5.921493183921352e-07,0.44183275227903884,0.0
139,0.3,6,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control of blood pressure during","In patients treated for hypertension, does blood pressure change depending on whether a nurse or physician measures it? Systolic blood pressure measured by nurses is significantly lower than readings by physicians and nearly matches ambulatory blood pressure monitoring. Nurse measurements are recommended for diagnosis and control evaluation.",6.39521263863506e-07,0.3482181031727998,0.09450663416838843,0.04896251454911062,0.4122413641990734,0.041587901701323246,0.04889164160572741,0.4589649704312255,0.014081632653061225,6.39521263863506e-07,0.4872951263557961,0.0
139,0.3,7,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control of blood pressure during","Does blood pressure in treated hypertensive patients differ when measured by a physician versus a nurse? Nurses record systolic blood pressure significantly lower than physicians, with results almost identical to ambulatory blood pressure monitoring. Blood pressure measurement by nurses is desirable for diagnosis and control assessment.",6.632072365991914e-07,0.42177454780262025,0.025834064094387904,0.05077594101389249,0.43471422005113114,0.041587901701323246,0.05070244314668028,0.48195448865592505,0.014081632653061225,6.632072365991914e-07,0.5108256237659905,0.0
139,0.3,8,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control of blood pressure during","Is blood pressure in treated hypertensive patients influenced by whether a physician or nurse takes the measurement? Nurses measure systolic blood pressure significantly lower than physicians, closely matching ambulatory blood pressure monitoring. Nurse measurement is preferred for diagnosis and evaluating blood pressure control.",7.342651548062476e-07,0.49956928824906477,0.04150246163091728,0.05621622040823811,0.5053317872650851,0.041587901701323246,0.05613484776953888,0.5542751502355512,0.014081632653061225,7.342651548062476e-07,0.584933595919714,0.0
139,0.3,9,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control of blood pressure during","In treated hypertensive patients, does the blood pressure reading depend on whether a nurse or physician measures it? Nurses obtain significantly lower systolic blood pressure than physicians, with values nearly identical to ambulatory blood pressure monitoring. Blood pressure measurement by nurses is beneficial for diagnosis and control evaluation.",6.158352911278206e-07,0.373045769248717,0.016547084839875992,0.047149088084328744,0.3902624574802984,0.041587901701323246,0.047080840064774546,0.4364921145791678,0.014081632653061225,6.158352911278206e-07,0.46430560813109656,0.0
139,0.3,10,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control of blood pressure during",Does blood pressure vary in treated hypertensive patients based on measurement by a nurse or physician? Systolic blood pressure readings by nurses are significantly lower than those by physicians and closely align with ambulatory blood pressure monitoring. Nurse measurement is recommended for diagnosis and monitoring blood pressure control.,6.158352911278206e-07,0.373045769248717,0.016547084839875992,0.047149088084328744,0.3902624574802984,0.041587901701323246,0.047080840064774546,0.4364921145791678,0.014081632653061225,6.158352911278206e-07,0.46430560813109656,0.0
140,0.3,1,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems needs to","Question: Is the use of audits to identify maternal mortality merely a reflection of disparities between the wealthy and the impoverished? Answer: Variations in maternal mortality extend beyond just economic differences. Recognizing the scale of maternal deaths and mobilizing strong political commitment are crucial. Yet, there is no universal solution to lower maternal mortality, and problem identification must be context-specific.",3.316036182995957e-07,0.13429906047677242,0.08059048792630294,0.025387970506946272,0.17771493177186226,0.027755102040816333,0.025351221573340146,0.20010333651493717,0.014081632653061225,3.316036182995957e-07,0.22314355131420882,0.0
140,0.3,2,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems needs to","Question: Does auditing maternal mortality simply highlight the gap between rich and poor? Answer: Maternal mortality differences are more complex than economic status alone. It is vital to understand the extent of the issue and to have robust political will to address it. Nonetheless, no one-size-fits-all approach exists, and identifying problems requires tailored strategies.",4.737194547137081e-07,0.24420457361473868,0.07867365533056245,0.03626852929563751,0.2869142237368534,0.027755102040816333,0.036216030819057346,0.31132897162516215,0.014081632653061225,4.737194547137081e-07,0.33647223662121295,0.0
140,0.3,3,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems needs to","Question: Is auditing maternal mortality just about the divide between affluent and poor populations? Answer: The disparity in maternal mortality involves more than wealth differences. Recognizing the severity of maternal deaths and fostering strong political resolve are key. However, reducing maternal mortality demands multiple approaches, and problem identification must be thorough.",5.447773729207643e-07,0.34223372167917976,0.015937379853902353,0.041708808689983126,0.34633764420765445,0.027755102040816333,0.041648435441915946,0.3719535934415963,0.014081632653061225,5.447773729207643e-07,0.3983476403393005,0.0
140,0.3,4,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems needs to","Question: Does the use of audits to detect maternal mortality simply reflect socioeconomic differences? Answer: Differences in maternal mortality surpass the rich-poor divide. Acknowledging the problem's magnitude and securing political will are essential. Still, no single solution can reduce maternal mortality, and problem identification is necessary.",6.632072365991914e-07,0.41248404137513894,0.07532385827447169,0.05077594101389249,0.45396830840001945,0.027755102040816333,0.05070244314668028,0.48195448865592505,0.014081632653061225,6.632072365991914e-07,0.5108256237659905,0.0
140,0.3,5,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems needs to","Question: Is maternal mortality auditing only a matter of rich versus poor? Answer: Maternal mortality disparities are more complex than just economic status. Recognizing the scale and having strong political commitment are important. However, there is no universal fix, and identifying issues requires careful analysis.",6.868932093348768e-07,0.43565704589442955,0.07481962100527546,0.05258936747867436,0.476957826624719,0.027755102040816333,0.052513244687633145,0.5054849860661195,0.014081632653061225,6.868932093348768e-07,0.5349231753450505,0.0
140,0.3,6,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems needs to","Question: Does auditing maternal mortality just reveal the gap between wealthy and poor communities? Answer: The causes of maternal mortality differences go beyond wealth. Understanding the problem's scale and political determination to solve it are vital. Yet, no single solution exists, and problem identification must be comprehensive.",6.39521263863506e-07,0.3898354272355329,0.07580620701439618,0.04896251454911062,0.43149545254796173,0.027755102040816333,0.04889164160572741,0.4589649704312255,0.014081632653061225,6.39521263863506e-07,0.4872951263557961,0.0
140,0.3,7,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems needs to","Question: Is the difference in maternal mortality identified by audits simply a rich-poor issue? Answer: Maternal mortality variations are more than economic disparities. Recognizing the extent and having strong political will are crucial. However, no single approach can reduce maternal mortality, and identifying problems is essential.",6.632072365991914e-07,0.41248404137513894,0.07532385827447169,0.05077594101389249,0.45396830840001945,0.027755102040816333,0.05070244314668028,0.48195448865592505,0.014081632653061225,6.632072365991914e-07,0.5108256237659905,0.0
140,0.3,8,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems needs to","Question: Does auditing maternal mortality only highlight economic disparities? Answer: Differences in maternal mortality are not solely about wealth. Acknowledging the magnitude and fostering political will are important. Still, there is no one-size-fits-all solution, and problem identification is needed.",8.29009045748989e-07,0.5872352606166387,0.0712380352390172,0.0634699262673656,0.6272400296740557,0.027755102040816333,0.06337805393335035,0.6596356658933771,0.014081632653061225,8.290090457489892e-07,0.693147180559945,0.0
140,0.3,9,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems needs to","Question: Is the use of audit to find maternal mortality just about the rich-poor divide? Answer: Maternal mortality differences involve more than economic status. Recognizing the problem's scale and political commitment are key. However, no single solution exists, and identifying issues is necessary.",7.342651548062476e-07,0.4836773801019625,0.07373924217130602,0.05621622040823811,0.5245858756139734,0.027755102040816333,0.05613484776953888,0.5542751502355512,0.014081632653061225,7.342651548062476e-07,0.584933595919714,0.0
140,0.3,10,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems needs to","Question: Does auditing maternal mortality simply reflect the divide between rich and poor? Answer: Maternal mortality disparities exceed economic differences. Understanding the magnitude and having strong political will are vital. Nonetheless, no universal solution exists, and problem identification is required.",8.053230730133037e-07,0.5603243529170783,0.07191133337806363,0.061656499802583725,0.6005717825918948,0.027755102040816333,0.06156725239239748,0.6322366917052618,0.014081632653061225,8.053230730133038e-07,0.6649763035932481,0.0
141,0.3,1,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above,Is it possible for visceral adipose tissue area measured at a single level to represent the total visceral adipose tissue volume? Measuring VAT area at a single level 3 cm above the lower margin of the L3 vertebra is practical and can indicate changes in VAT volume and body weight. New insights: VAT area on a CT slice 3 cm above the L3 vertebra lower margin can reflect VAT volume.,2.6054570009253947e-07,0.1328033575986889,0.008195013850415461,0.0199476911126006,0.15142016146993909,0.01763322811433002,0.019918816950481533,0.1874695203254957,0.0058428097174535835,2.6054570009253947e-07,0.20752690881431501,0.0181755829903978
141,0.3,2,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above,Can the visceral adipose tissue area measured at one level accurately represent visceral adipose tissue volume? Measuring VAT area at a single slice 3 cm above the lower edge of the L3 vertebra is feasible and correlates with changes in VAT volume and body weight. Knowledge update: VAT area at a CT slice 3 cm above L3 vertebra lower margin reflects VAT volume.,9.474389094274162e-08,0.06568963131854977,0.03342456390174442,0.0072537058591274906,0.051475725816496176,0.011538054613087656,0.007243206163811466,0.07229357234676037,0.0023715969459572536,9.474389094274162e-08,0.09540961069360954,0.0181755829903978
141,0.3,3,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above,Does measuring visceral adipose tissue area at a single level serve as a representation of visceral adipose tissue volume? VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is achievable and can mirror changes in VAT volume and body weight. Advances: VAT area on a CT slice 3 cm above L3 vertebra lower margin corresponds to VAT volume.,1.6580180914979784e-07,0.10090273883927159,0.025639669421487515,0.012693985253473108,0.1264722327705612,0.007553498674894188,0.012675610786670066,0.14528887615479746,0.01979640834807133,1.6580180914979784e-07,0.1450065518329824,0.0181755829903978
141,0.3,4,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above,Is a single-level measurement of visceral adipose tissue area sufficient to represent visceral adipose tissue volume? Measuring VAT area 3 cm above the lower margin of the L3 vertebra is feasible and reflects changes in VAT volume and body weight. New knowledge: VAT area at a CT slice 3 cm above L3 vertebra lower margin can indicate VAT volume.,0.0,0.032923146635938316,0.05598400615148019,0.0,0.04864190740771557,0.0347343985830668,0.0,0.04951051289713959,0.03566529492455417,0.0,0.025205352020361893,0.0181755829903978
141,0.3,5,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above,Can visceral adipose tissue area at one level be used to represent visceral adipose tissue volume? VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is practical and reflects changes in VAT volume and body weight. Advances in understanding: VAT area at a CT slice 3 cm above L3 vertebra lower margin reflects VAT volume.,9.474389094274162e-08,0.06568963131855066,0.03342456390174442,0.0072537058591274906,0.11965413701911354,0.03702651089998914,0.007243206163811466,0.11850338438408947,0.03566529492455417,9.474389094274162e-08,0.09540961069360954,0.0181755829903978
141,0.3,6,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above,Is measuring visceral adipose tissue area at a single level a valid method to estimate visceral adipose tissue volume? VAT area measurement 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Knowledge advancement: VAT area at a CT slice 3 cm above L3 vertebra lower margin correlates with VAT volume.,9.474389094274162e-08,0.06568963131855066,0.03342456390174442,0.0072537058591274906,0.09692799995157442,0.020726969410790608,0.007243206163811466,0.11850338438408947,0.03566529492455417,9.474389094274162e-08,0.09540961069360954,0.0181755829903978
141,0.3,7,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above,Can the area of visceral adipose tissue measured at a single level represent the volume of visceral adipose tissue? Measuring VAT area at a single level 3 cm above the lower margin of the L3 vertebra is feasible and reflects changes in VAT volume and body weight. Scientific progress: VAT area at a CT slice 3 cm above L3 vertebra lower margin reflects VAT volume.,1.4211583641411244e-07,0.030568662903912802,0.04157633136094682,0.010880558788691236,0.06533923898004312,0.024407104587648137,0.0108648092457172,0.10657403426773016,0.0034430727023319688,1.4211583641411244e-07,0.12874603096120119,0.0181755829903978
141,0.3,8,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above,Is it feasible to use visceral adipose tissue area at one level as a proxy for visceral adipose tissue volume? VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is practical and can reflect changes in VAT volume and body weight. Advances: VAT area at a CT slice 3 cm above L3 vertebra lower margin represents VAT volume.,1.6580180914979784e-07,0.12223034439496194,0.03951479591836732,0.012693985253473108,0.1697939315555579,0.03855823910731412,0.012675610786670066,0.16729354855352518,0.03566529492455417,1.6580180914979784e-07,0.1450065518329824,0.0181755829903978
141,0.3,9,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above,Can a single-level measurement of visceral adipose tissue area represent the total visceral adipose tissue volume? VAT area measured 3 cm above the lower margin of the L3 vertebra is feasible and reflects changes in VAT volume and body weight. Knowledge update: VAT area at a CT slice 3 cm above L3 vertebra lower margin corresponds to VAT volume.,0.0,0.032923146635938316,0.05598400615148019,0.0,0.04864190740771557,0.0347343985830668,0.0,0.04951051289713959,0.03566529492455417,0.0,0.025205352020361893,0.0181755829903978
141,0.3,10,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above,Is visceral adipose tissue area measurement at a single level a reliable indicator of visceral adipose tissue volume? Measuring VAT area 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: VAT area at a CT slice 3 cm above L3 vertebra lower margin reflects VAT volume.,7.105791820705622e-08,0.06885629213353717,0.04624051263794943,0.005440279394345618,0.10236729716565174,0.03648202291851949,0.0054324046228586,0.10169626606770876,0.03566529492455417,7.105791820705622e-08,0.07831517733430982,0.0181755829903978
142,0.3,1,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition can affect the quality of life due to symptoms such as hot flashes, mood swings, sleep disturbances, and reduced sexual desire. However, the impact varies for each woman, and","Question: Does menopausal transition affect the quality of life? Answer: Yes, the menopausal transition can influence quality of life because of symptoms like hot flashes, mood changes, sleep problems, and decreased sexual desire. However, the extent of impact differs among women.",2.3685972735685406e-08,0.04124089970679368,0.04655924922451841,0.0018134264647818726,0.043996910071702366,0.049861495844875335,0.0018108015409528666,0.00957052285622595,0.025623268698060954,2.3685972735685406e-08,0.026668247082160867,0.0
142,0.3,2,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition can affect the quality of life due to symptoms such as hot flashes, mood swings, sleep disturbances, and reduced sexual desire. However, the impact varies for each woman, and","Question: Is quality of life affected by menopausal transition? Answer: Yes, menopausal transition may impact quality of life due to symptoms including hot flashes, mood swings, sleep issues, and lowered sexual desire. The degree of effect varies for each individual woman.",2.3685972735685406e-08,0.04124089970679368,0.04655924922451841,0.0018134264647818726,0.008450900812218443,0.02423822714681438,0.0018108015409528666,0.00957052285622595,0.025623268698060954,2.3685972735685406e-08,0.026668247082160867,0.0
142,0.3,3,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition can affect the quality of life due to symptoms such as hot flashes, mood swings, sleep disturbances, and reduced sexual desire. However, the impact varies for each woman, and","Question: Does the menopausal transition impact quality of life? Answer: Yes, it can affect quality of life through symptoms such as hot flashes, mood fluctuations, sleep disturbances, and diminished sexual desire. The impact varies from woman to woman.",9.474389094274131e-08,0.004873338872325217,0.06941457222988758,0.0072537058591274906,0.0360457976018318,0.049861495844875335,0.007243206163811466,0.07266757538074708,0.025623268698060954,9.474389094274162e-08,0.11122563511022454,0.0
142,0.3,4,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition can affect the quality of life due to symptoms such as hot flashes, mood swings, sleep disturbances, and reduced sexual desire. However, the impact varies for each woman, and","Question: Can menopausal transition influence quality of life? Answer: Yes, menopausal transition can affect quality of life because of symptoms like hot flashes, mood swings, sleep disruptions, and reduced sexual desire, but the effect differs for each woman.",9.474389094274131e-08,0.04234075403772852,0.042543194048985565,0.0072537058591274906,0.0360457976018318,0.049861495844875335,0.007243206163811466,0.07266757538074708,0.025623268698060954,9.474389094274162e-08,0.11122563511022454,0.0
142,0.3,5,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition can affect the quality of life due to symptoms such as hot flashes, mood swings, sleep disturbances, and reduced sexual desire. However, the impact varies for each woman, and","Question: Does going through menopausal transition affect quality of life? Answer: Yes, it can impact quality of life due to symptoms including hot flashes, mood swings, sleep disturbances, and decreased sexual desire, although the impact varies among women.",9.474389094274131e-08,0.004873338872325217,0.06941457222988758,0.0072537058591274906,0.0360457976018318,0.049861495844875335,0.007243206163811466,0.07266757538074708,0.025623268698060954,9.474389094274162e-08,0.11122563511022454,0.0
142,0.3,6,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition can affect the quality of life due to symptoms such as hot flashes, mood swings, sleep disturbances, and reduced sexual desire. However, the impact varies for each woman, and","Question: Is the quality of life affected during menopausal transition? Answer: Yes, menopausal transition may influence quality of life because of symptoms such as hot flashes, mood swings, sleep problems, and lowered sexual desire, with varying effects on different women.",4.7371945471370706e-08,0.014145791259527751,0.04528853177501829,0.0036268529295637453,0.01846000688734195,0.02356492900776796,0.003621603081905733,0.017097724225934918,0.025623268698060954,4.737194547137081e-08,0.05406722127027619,0.0
142,0.3,7,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition can affect the quality of life due to symptoms such as hot flashes, mood swings, sleep disturbances, and reduced sexual desire. However, the impact varies for each woman, and","Question: Does menopausal transition have an effect on quality of life? Answer: Yes, it can affect quality of life due to symptoms like hot flashes, mood swings, sleep disturbances, and reduced sexual desire, but the impact varies for each woman.",4.7371945471370706e-08,0.04969180051901212,0.0707974763713328,0.0036268529295637453,0.018021423668444392,0.049861495844875335,0.003621603081905733,0.017097724225934918,0.025623268698060954,4.737194547137081e-08,0.05406722127027619,0.0
142,0.3,8,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition can affect the quality of life due to symptoms such as hot flashes, mood swings, sleep disturbances, and reduced sexual desire. However, the impact varies for each woman, and","Question: Can the menopausal transition affect a woman's quality of life? Answer: Yes, menopausal transition can influence quality of life through symptoms such as hot flashes, mood swings, sleep issues, and decreased sexual desire, with varying degrees of impact.",7.1057918207056e-08,0.013700537736335061,0.0439516092669246,0.005440279394345618,0.008646823413716476,0.049861495844875335,0.0054324046228586,0.04449669841405024,0.025623268698060954,7.105791820705622e-08,0.08223809823697303,0.0
142,0.3,9,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition can affect the quality of life due to symptoms such as hot flashes, mood swings, sleep disturbances, and reduced sexual desire. However, the impact varies for each woman, and","Question: Does the transition through menopause impact quality of life? Answer: Yes, menopausal transition can affect quality of life due to symptoms like hot flashes, mood swings, sleep disturbances, and reduced sexual desire, though the impact varies among women.",7.1057918207056e-08,0.022780892819451726,0.07012417823228637,0.005440279394345618,0.008646823413716476,0.049861495844875335,0.0054324046228586,0.04449669841405024,0.025623268698060954,7.105791820705622e-08,0.08223809823697303,0.0
142,0.3,10,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition can affect the quality of life due to symptoms such as hot flashes, mood swings, sleep disturbances, and reduced sexual desire. However, the impact varies for each woman, and","Question: Is quality of life influenced by menopausal transition? Answer: Yes, menopausal transition can affect quality of life because of symptoms such as hot flashes, mood swings, sleep problems, and decreased sexual desire, but the extent of impact varies for each woman.",0.0,0.06762411517657974,0.0477685425710374,0.0,0.034657359027997714,0.024877932399773414,0.0,0.035546009259483924,0.025623268698060954,0.0,0.0,0.0
143,0.3,1,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"What is the prognosis for low-tone sudden deafness—does it always lead to Meniere's disease? Our conclusion is that not every patient with low-tone sudden deafness (SD) experiences endolymphatic hydrops, even if vertigo occurs at onset, and that electrocochleography (ECochG) serves as a valuable prognostic indicator.",4.737194547137081e-08,0.015684784721507583,0.020673448681217014,0.0036268529295637453,0.014655832718537543,0.02221074380165289,0.003621603081905733,0.04652001563489394,0.0,4.737194547137081e-08,0.047628048989254435,0.0
143,0.3,2,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Does low-tone sudden deafness inevitably develop into Meniere's disease? We found that not all patients with low-tone sudden deafness (SD) have endolymphatic hydrops, even when vertigo attacks happen initially, and that electrocochleography (ECochG) is a helpful prognostic tool.",2.1317375462116834e-07,0.23238464630089695,0.010489121268342054,0.016320838183036854,0.2308451866537644,0.005544358239163438,0.0162972138685758,0.2288415724288484,0.0,2.1317375462116866e-07,0.23483959107740038,0.0
143,0.3,3,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Is progression to Meniere's disease unavoidable in cases of low-tone sudden deafness? Our study shows that some low-tone sudden deafness (SD) patients do not have endolymphatic hydrops despite vertigo at onset, and electrocochleography (ECochG) is useful for prognosis.",2.1317375462116834e-07,0.19491723113549364,0.01638225691255996,0.016320838183036854,0.19233700995598957,0.02221074380165289,0.0162972138685758,0.2288415724288484,0.0,2.1317375462116866e-07,0.23483959107740038,0.0
143,0.3,4,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Does low-tone sudden deafness always progress to Meniere's disease? We concluded that endolymphatic hydrops is not present in all low-tone sudden deafness (SD) patients, even those with initial vertigo attacks, and that electrocochleography (ECochG) is an effective prognostic tool.",1.8948778188548304e-07,0.20374442999950348,0.009080706050403016,0.014507411718254981,0.20240545093327666,0.004795429037853273,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
143,0.3,5,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Is Meniere's disease an inevitable outcome of low-tone sudden deafness? Our findings indicate that not all low-tone sudden deafness (SD) patients suffer from endolymphatic hydrops despite vertigo at onset, and electrocochleography (ECochG) proves to be a useful prognostic method.",1.8948778188548304e-07,0.1672629994437167,0.01709186291495875,0.014507411718254981,0.16493803576787425,0.02221074380165289,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
143,0.3,6,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Does low-tone sudden deafness always lead to Meniere's disease? We conclude that endolymphatic hydrops does not affect all low-tone sudden deafness (SD) patients, even those who experience vertigo initially, and that electrocochleography (ECochG) is a valuable prognostic tool.",2.1317375462116834e-07,0.23238464630089695,0.010489121268342054,0.016320838183036854,0.2308451866537644,0.005544358239163438,0.0162972138685758,0.2288415724288484,0.0,2.1317375462116866e-07,0.23483959107740038,0.0
143,0.3,7,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Is the progression from low-tone sudden deafness to Meniere's disease certain? Our conclusion is that endolymphatic hydrops is not found in all low-tone sudden deafness (SD) patients, even with vertigo attacks at onset, and electrocochleography (ECochG) is a useful prognostic tool.",1.4211583641411244e-07,0.14880299255637475,0.006473066092809211,0.010880558788691236,0.14784031154193933,0.0034125248964080625,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
143,0.3,8,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Does low-tone sudden deafness necessarily develop into Meniere's disease? We determined that not every low-tone sudden deafness (SD) patient has endolymphatic hydrops, even if vertigo occurs at the beginning, and that electrocochleography (ECochG) is an effective prognostic tool.",2.1317375462116834e-07,0.23238464630089695,0.010489121268342054,0.016320838183036854,0.2308451866537644,0.005544358239163438,0.0162972138685758,0.2288415724288484,0.0,2.1317375462116866e-07,0.23483959107740038,0.0
143,0.3,9,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Is Meniere's disease an unavoidable consequence of low-tone sudden deafness? We conclude that endolymphatic hydrops is not present in all low-tone sudden deafness (SD) patients, even those with vertigo at onset, and that electrocochleography (ECochG) serves as a useful prognostic tool.",1.4211583641411244e-07,0.11414563352837703,0.018404866306964203,0.010880558788691236,0.1122943022824554,0.02221074380165289,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
143,0.3,10,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Does low-tone sudden deafness inevitably result in Meniere's disease? Our findings suggest that not all patients with low-tone sudden deafness (SD) experience endolymphatic hydrops, even when vertigo attacks occur initially, and that electrocochleography (ECochG) is a valuable prognostic tool.",1.8948778188548304e-07,0.20374442999950348,0.009080706050403016,0.014507411718254981,0.20240545093327666,0.004795429037853273,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
144,0.3,1,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: There is no direct correlation between a resident's leadership skills and their ratings of technical skill. Leadership skills and technical skills are distinct qualities that contribute to overall competency, but one does not necessarily impact the other.","Question: Is there a connection between a resident's leadership abilities and their technical skill ratings? Answer: No direct link exists between a resident's leadership abilities and their technical skill ratings. Leadership and technical skills are separate attributes that both contribute to overall competence, but one does not inherently influence the other.",4.737194547137081e-08,0.0032026948761529894,0.015873015873015872,0.0036268529295637453,0.06788248107395178,0.07535583103764922,0.003621603081905733,0.13072718072118983,0.12244897959183676,4.737194547137081e-08,0.10399301158365404,0.10487528344671203
144,0.3,2,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: There is no direct correlation between a resident's leadership skills and their ratings of technical skill. Leadership skills and technical skills are distinct qualities that contribute to overall competency, but one does not necessarily impact the other.","Question: Are a resident's leadership skills associated with their technical skill ratings? Answer: There is no direct association between a resident's leadership skills and their technical skill ratings. Leadership and technical skills are distinct traits that both play a role in overall proficiency, yet one does not necessarily affect the other.",4.737194547137081e-08,0.08638035654334608,0.07130259511211887,0.0036268529295637453,0.04528440554808055,0.002568974675436278,0.003621603081905733,0.013678481895465833,0.020823902218198284,4.737194547137081e-08,0.04348511193973836,0.0
144,0.3,3,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: There is no direct correlation between a resident's leadership skills and their ratings of technical skill. Leadership skills and technical skills are distinct qualities that contribute to overall competency, but one does not necessarily impact the other.","Question: Does a resident's leadership capability correlate with their technical skill ratings? Answer: There is no direct correlation between a resident's leadership capability and their technical skill ratings. Leadership and technical skills are different qualities that contribute to overall ability, but one does not directly impact the other.",2.3685972735685406e-08,0.01565626541385523,0.06519274376417229,0.0018134264647818726,0.023429832919094284,0.0013668880654720966,0.0018108015409528666,0.0527854480769947,0.02221074380165289,2.3685972735685406e-08,0.022472855852057716,0.0
144,0.3,4,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: There is no direct correlation between a resident's leadership skills and their ratings of technical skill. Leadership skills and technical skills are distinct qualities that contribute to overall competency, but one does not necessarily impact the other.","Question: Is there a relationship between leadership skills and technical skill ratings in residents? Answer: No direct relationship exists between residents' leadership skills and their technical skill ratings. These two skills are separate competencies that both add to overall effectiveness, but one does not directly influence the other.",2.3685972735685406e-08,0.07464751482321219,0.10653496935964467,0.0018134264647818726,0.03684383495568344,0.041804662789511254,0.0018108015409528666,0.021978906718775004,0.0,2.3685972735685406e-08,0.022472855852057716,0.0
144,0.3,5,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: There is no direct correlation between a resident's leadership skills and their ratings of technical skill. Leadership skills and technical skills are distinct qualities that contribute to overall competency, but one does not necessarily impact the other.","Question: Do residents' leadership skills influence their technical skill ratings? Answer: Residents' leadership skills do not have a direct influence on their technical skill ratings. Leadership and technical skills are distinct areas of competence that both contribute to overall performance, but one does not necessarily affect the other.",2.3685972735685406e-08,0.04515189011853371,0.08569809751915906,0.0018134264647818726,0.006707001018294356,0.020144628099173528,0.0018108015409528666,0.021978906718775004,0.0,2.3685972735685406e-08,0.022472855852057716,0.0
144,0.3,6,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: There is no direct correlation between a resident's leadership skills and their ratings of technical skill. Leadership skills and technical skills are distinct qualities that contribute to overall competency, but one does not necessarily impact the other.","Question: Are leadership skills in residents linked to their technical skill ratings? Answer: There is no direct link between leadership skills and technical skill ratings in residents. Both leadership and technical skills are unique competencies that contribute to overall proficiency, but one does not inherently impact the other.",2.3685972735685406e-08,0.07464751482321219,0.10653496935964467,0.0018134264647818726,0.06698066889307208,0.06353305785123965,0.0018108015409528666,0.021978906718775004,0.0,2.3685972735685406e-08,0.022472855852057716,0.0
144,0.3,7,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: There is no direct correlation between a resident's leadership skills and their ratings of technical skill. Leadership skills and technical skills are distinct qualities that contribute to overall competency, but one does not necessarily impact the other.","Question: Does the leadership ability of a resident affect their technical skill ratings? Answer: The leadership ability of a resident does not directly affect their technical skill ratings. Leadership and technical skills are separate qualities that together contribute to overall competence, but one does not necessarily influence the other.",0.0,0.07574239457489806,0.007446765688523899,0.0,0.08848687411403544,0.06139258164905781,0.0,0.12054733574955545,0.08616780045351476,0.0,0.061613082716439393,0.04434829637641968
144,0.3,8,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: There is no direct correlation between a resident's leadership skills and their ratings of technical skill. Leadership skills and technical skills are distinct qualities that contribute to overall competency, but one does not necessarily impact the other.","Question: Is there a direct correlation between residents' leadership skills and their technical skill ratings? Answer: There is no direct correlation between residents' leadership skills and their technical skill ratings. Leadership and technical skills are distinct attributes that both contribute to overall capability, but one does not directly affect the other.",4.737194547137081e-08,0.024523192346245004,0.001258564103809312,0.0036268529295637453,0.09617420272945942,0.09351631752056279,0.003621603081905733,0.15960831324452096,0.14158239143367046,4.737194547137081e-08,0.13348863628833252,0.12492563950029746
144,0.3,9,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: There is no direct correlation between a resident's leadership skills and their ratings of technical skill. Leadership skills and technical skills are distinct qualities that contribute to overall competency, but one does not necessarily impact the other.","Question: Do leadership skills correlate with technical skill ratings in residents? Answer: Leadership skills do not directly correlate with technical skill ratings in residents. These are separate skill sets that both contribute to overall competency, but one does not necessarily impact the other.",1.4211583641411244e-07,0.14738564607799853,0.031179138321995453,0.010880558788691236,0.18333689124487407,0.03288768721815409,0.0108648092457172,0.2437340194591493,0.07450693937180423,1.4211583641411244e-07,0.2141928621596434,0.05113221329437545
144,0.3,10,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: There is no direct correlation between a resident's leadership skills and their ratings of technical skill. Leadership skills and technical skills are distinct qualities that contribute to overall competency, but one does not necessarily impact the other.","Question: Are a resident's leadership skills related to their technical skill ratings? Answer: A resident's leadership skills are not directly related to their technical skill ratings. Leadership and technical skills are different qualities that both contribute to overall proficiency, but one does not inherently influence the other.",4.737194547137081e-08,0.09946648778282752,0.0038630410612998656,0.0036268529295637453,0.1090309446168014,0.04584194214876035,0.003621603081905733,0.1389718326471896,0.06781677572873293,4.737194547137081e-08,0.07770177782373144,0.023242630385487524
145,0.3,1,ai,Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners may be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies as long as they have been properly trained and have a good,"Can student examiners serve as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies? Yes, provided they are well-trained and competent.",5.447773729207624e-07,0.34594154011336675,0.23140495867768596,0.04170880868998317,0.42460029594031923,0.20761245674740483,0.041648435441916036,0.47531320841680413,0.19463667820069208,5.447773729207642e-07,0.5291745703321866,0.1799307958477509
145,0.3,2,ai,Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners may be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies as long as they have been properly trained and have a good,"Are student examiners acceptable substitutes for faculty in an undergraduate OSCE on medical emergencies? They can be, if adequately trained and skilled.",5.684633456564477e-07,0.3924615557482607,0.23140495867768596,0.04352223515476505,0.4733904601097505,0.20761245674740483,0.04345923698286891,0.5266065028043543,0.19463667820069208,5.684633456564495e-07,0.5832417916024619,0.1799307958477509
145,0.3,3,ai,Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners may be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies as long as they have been properly trained and have a good,"Is it reasonable for student examiners to replace faculty in an undergraduate OSCE on medical emergencies? It is, given proper training and proficiency.",5.447773729207624e-07,0.34594154011336675,0.23140495867768596,0.04170880868998317,0.42460029594031923,0.20761245674740483,0.041648435441916036,0.47531320841680413,0.19463667820069208,5.447773729207642e-07,0.5291745703321866,0.1799307958477509
145,0.3,4,ai,Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners may be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies as long as they have been properly trained and have a good,"May student examiners act as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies? Yes, when they have received appropriate training and demonstrate capability.",4.7371945471370653e-07,0.21810816860348226,0.23140495867768596,0.03626852929563753,0.2910689033157956,0.20761245674740483,0.036216030819057415,0.33555126604164487,0.19463667820069208,4.737194547137081e-07,0.38257109614031126,0.1799307958477509
145,0.3,5,ai,Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners may be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies as long as they have been properly trained and have a good,"Can student examiners reasonably substitute for faculty in an undergraduate OSCE on medical emergencies? They may, assuming they are properly trained and qualified.",5.447773729207624e-07,0.34594154011336675,0.23140495867768596,0.04170880868998317,0.42460029594031923,0.20761245674740483,0.041648435441916036,0.47531320841680413,0.19463667820069208,5.447773729207642e-07,0.5291745703321866,0.1799307958477509
145,0.3,6,ai,Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners may be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies as long as they have been properly trained and have a good,"Are student examiners suitable substitutes for faculty in an undergraduate OSCE on medical emergencies? They can be, if they have undergone sufficient training and are competent.",4.7371945471370653e-07,0.21810816860348226,0.23140495867768596,0.03626852929563753,0.2910689033157956,0.20761245674740483,0.036216030819057415,0.33555126604164487,0.19463667820069208,4.737194547137081e-07,0.38257109614031126,0.1799307958477509
145,0.3,7,ai,Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners may be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies as long as they have been properly trained and have a good,"Is it appropriate for student examiners to substitute for faculty in an undergraduate OSCE on medical emergencies? Yes, as long as they are well-prepared and proficient.",4.7371945471370653e-07,0.21810816860348226,0.23140495867768596,0.03626852929563753,0.2910689033157956,0.20761245674740483,0.036216030819057415,0.33555126604164487,0.19463667820069208,4.737194547137081e-07,0.38257109614031126,0.1799307958477509
145,0.3,8,ai,Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners may be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies as long as they have been properly trained and have a good,"May student examiners be considered reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies? Yes, provided they have proper training and adequate skills.",4.974054274493918e-07,0.25893016312373707,0.23140495867768596,0.03808195576041941,0.33362851773459123,0.20761245674740483,0.03802683236001029,0.3800030286124789,0.19463667820069208,4.974054274493935e-07,0.4290911117752052,0.1799307958477509
145,0.3,9,ai,Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners may be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies as long as they have been properly trained and have a good,"Can student examiners be reasonable replacements for faculty in an undergraduate OSCE on medical emergencies? They can, if they have been thoroughly trained and are capable.",4.7371945471370653e-07,0.21810816860348226,0.23140495867768596,0.03626852929563753,0.2910689033157956,0.20761245674740483,0.036216030819057415,0.33555126604164487,0.19463667820069208,4.737194547137081e-07,0.38257109614031126,0.1799307958477509
145,0.3,10,ai,Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners may be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies as long as they have been properly trained and have a good,"Is it feasible for student examiners to serve as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies? Yes, with proper training and demonstrated competence.",4.5003348197802123e-07,0.1788874554501998,0.23140495867768596,0.03445510283085565,0.2502469087955408,0.20761245674740483,0.03440522927810454,0.29299165162284924,0.19463667820069208,4.500334819780227e-07,0.3381193335694772,0.1799307958477509
146,0.3,1,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policies could be a crucial tool for enhancing population health, particularly among lower-income groups. Despite strong findings, additional studies are necessary to verify their consistency. Future investigations should explore various income support programs and assess a wider spectrum.",2.3685972735685406e-07,0.17391030520141637,0.002890862712185324,0.018134264647818726,0.17284281283941416,0.0,0.018108015409528666,0.1758906664636637,0.0,2.3685972735685406e-07,0.17904823144898518,0.0
146,0.3,2,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Policies providing income support might serve as an important mechanism to improve health outcomes, especially for those with lower incomes. Although the results are compelling, further research is required to confirm their validity. Subsequent studies should consider multiple income support policies and a broader range of factors.",7.105791820705622e-08,0.04907450686140358,0.0007678256487780363,0.005440279394345618,0.04879016416943571,0.0,0.0054324046228586,0.04959694113937285,0.0,7.105791820705622e-08,0.05043085362689137,0.0
146,0.3,3,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support initiatives may represent a vital approach to boosting population health, particularly for economically disadvantaged individuals. While the evidence is strong, more analysis is needed to ensure reliability. Future research should investigate different types of income support policies and a wider array of related issues.",9.474389094274162e-08,0.06598257776373995,0.0010408155303573991,0.0072537058591274906,0.06559728248581642,0.0,0.007243206163811466,0.06669137449867257,0.0,9.474389094274162e-08,0.0678225963387602,0.0
146,0.3,4,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Providing income support could be a key strategy to enhance the health of populations, especially among lower-income people. Despite robust findings, further studies are necessary to confirm these results. Future research should examine various income support policies and consider a broader scope.",1.8948778188548325e-07,0.13662579968059507,0.0022301764293106343,0.014507411718254981,0.13580154115906407,0.0,0.014486412327622933,0.13815033848081626,0.0,1.8948778188548325e-07,0.1405819506211894,0.0
146,0.3,5,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be an effective lever for improving health outcomes in the population, particularly for those with lower incomes. Although the findings are strong, additional research is needed to validate them. Future work should explore a range of income support policies and a wider variety of factors.",2.3685972735685406e-08,0.0380968523730969,0.016090842161662858,0.0018134264647818726,0.01600034134644357,0.0,0.0018108015409528666,0.016260520871781203,0.0,2.3685972735685406e-08,0.01652930195121094,0.0
146,0.3,6,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support programs might be a significant tool for enhancing population health, especially among lower-income individuals. Even with robust findings, further analysis is required to confirm their dependability. Future investigations should assess various income support policies and a broader range of considerations.",1.8948778188548325e-07,0.13662579968059507,0.0022301764293106343,0.014507411718254981,0.13580154115906407,0.0,0.014486412327622933,0.13815033848081626,0.0,1.8948778188548325e-07,0.1405819506211894,0.0
146,0.3,7,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support measures could be a powerful approach to improving health in the population, particularly for lower-income groups. While the findings are strong, more research is necessary to verify their accuracy. Future studies should look into different income support policies and a wider range of related issues.",7.105791820705622e-08,0.0718006439289427,0.01712814675701641,0.005440279394345618,0.04879016416943571,0.0,0.0054324046228586,0.04959694113937285,0.0,7.105791820705622e-08,0.05043085362689137,0.0
146,0.3,8,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Policies that provide income support may be a crucial factor in enhancing population health, especially among economically disadvantaged people. Despite solid findings, further research is needed to confirm their reliability. Future research should explore multiple income support policies and a broader spectrum of factors.",1.4211583641411244e-07,0.10068085033661589,0.0016150093976238285,0.010880558788691236,0.10008345855698497,0.0,0.0108648092457172,0.10178269430994202,0.0,1.4211583641411244e-07,0.10354067894083929,0.0
146,0.3,9,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy could serve as an important mechanism to improve health outcomes, particularly for lower-income populations. Although the evidence is robust, additional studies are necessary to confirm these findings. Future research should examine a variety of income support policies and consider a wider range of issues.",7.105791820705622e-08,0.04907450686140358,0.0007678256487780397,0.005440279394345618,0.04879016416943571,0.0,0.0054324046228586,0.04959694113937285,0.0,7.105791820705622e-08,0.05043085362689137,0.0
146,0.3,10,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support initiatives may be a key lever for enhancing population health, especially among lower-income individuals. Even with strong findings, further analysis is needed to ensure their reliability. Future research should investigate diverse income support policies and a broader array of factors.",1.8948778188548325e-07,0.13662579968059507,0.0022301764293106343,0.014507411718254981,0.13580154115906407,0.0,0.014486412327622933,0.13815033848081626,0.0,1.8948778188548325e-07,0.1405819506211894,0.0
147,0.3,1,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy,Does the radiographic transition zone correspond with the extent of aganglionosis in Hirschsprung's disease specimens? The correlation between the transition zone seen on contrast enema and the length of aganglionosis is minimal. Preoperative biopsy is systematically performed.,2.36859727356853e-08,0.045454333077945996,0.05115642108407126,0.0018134264647818726,0.010337299731077998,0.02775510204081633,0.0018108015409528735,0.028987536873251507,0.0,2.3685972735685406e-08,0.029852963149681777,0.0
147,0.3,2,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy,Is there a correlation between the radiographic transition zone and the level of aganglionosis in Hirschsprung's disease specimens? The link between the transition zone on contrast enema and aganglionosis length is weak. Systematic preoperative biopsy is conducted.,2.36859727356853e-08,0.045454333077945996,0.05115642108407126,0.0018134264647818726,0.010337299731077998,0.02775510204081633,0.0018108015409528735,0.028987536873251507,0.0,2.3685972735685406e-08,0.029852963149681777,0.0
147,0.3,3,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy,Does the radiographic transition zone align with the aganglionosis level in Hirschsprung's disease specimens? The correlation between the transition zone on contrast enema and aganglionosis length remains low. Preoperative biopsy is routinely done.,1.184298636784265e-07,0.03863404796788572,0.07530226109357693,0.009067132323909391,0.1110235572731888,0.02775510204081633,0.009054007704764368,0.1541506798272585,0.0,1.1842986367842703e-07,0.15906469462968875,0.0
147,0.3,4,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy,Is the radiographic transition zone indicative of the aganglionosis level in Hirschsprung's disease? The association between the transition zone on contrast enema and the length of aganglionosis is limited. Systematic preoperative biopsy is performed.,9.47438909427412e-08,0.006549610550070195,0.07624630538337923,0.007253705859127511,0.07927485895860897,0.02775510204081633,0.007243206163811494,0.1213608570042668,0.0,9.474389094274162e-08,0.125163142954007,0.0
147,0.3,5,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy,Does the level of the radiographic transition zone correlate with the extent of aganglionosis in Hirschsprung's disease specimens? The correlation between the transition zone on contrast enema and aganglionosis length is low. Preoperative biopsy is systematically carried out.,0.0,0.11240224549620859,0.07951357004387306,0.0,0.03850817669777484,0.02775510204081633,0.0,0.0,0.0,0.0,0.0,0.0
147,0.3,6,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy,Is there a relationship between the radiographic transition zone and the level of aganglionosis in Hirschsprung's disease? The correlation between the transition zone on contrast enema and aganglionosis length is weak. Systematic preoperative biopsy is standard.,4.73719454713706e-08,0.015082988871376823,0.04958677685950413,0.003626852929563752,0.01865023714217351,0.02775510204081633,0.003621603081905747,0.058840500022933284,0.0,4.737194547137081e-08,0.060624621816435464,0.0
147,0.3,7,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy,Does the radiographic transition zone on contrast enema correspond to the level of aganglionosis in Hirschsprung's disease specimens? The correlation remains low between the transition zone and aganglionosis length. Preoperative biopsy is systematically performed.,9.47438909427412e-08,0.006549610550070195,0.07624630538337923,0.007253705859127511,0.07927485895860897,0.02775510204081633,0.007243206163811494,0.1213608570042668,0.0,9.474389094274162e-08,0.125163142954007,0.0
147,0.3,8,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy,Is the radiographic transition zone a reliable indicator of aganglionosis level in Hirschsprung's disease? The correlation between the transition zone on contrast enema and aganglionosis length is minimal. Systematic preoperative biopsy is done.,1.184298636784265e-07,0.03863404796788572,0.07530226109357693,0.009067132323909391,0.1110235572731888,0.02775510204081633,0.009054007704764368,0.1541506798272585,0.0,1.1842986367842703e-07,0.15906469462968875,0.0
147,0.3,9,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy,Does the radiographic transition zone correlate with the aganglionosis level in Hirschsprung's disease? The correlation between the transition zone on contrast enema and the length of aganglionosis remains low. Preoperative biopsy is systematically conducted.,9.47438909427412e-08,0.006549610550070195,0.07624630538337923,0.007253705859127511,0.07927485895860897,0.02775510204081633,0.007243206163811494,0.1213608570042668,0.0,9.474389094274162e-08,0.125163142954007,0.0
147,0.3,10,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy,Is there a significant correlation between the radiographic transition zone and the level of aganglionosis in Hirschsprung's disease? The correlation between the transition zone on contrast enema and aganglionosis length is low. Systematic preoperative biopsy is performed.,2.36859727356853e-08,0.0069461563801711534,0.02387511478420569,0.0018134264647818726,0.02927111058663323,0.0007916107619518296,0.0018108015409528735,0.028987536873251507,0.0,2.3685972735685406e-08,0.029852963149681777,0.0
148,0.3,1,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Sternal fractures in children are uncommon and frequently missed injuries, typically resulting from age-specific trauma. Ultrasound is effective for detecting these fractures, while X-rays are preferred to assess the degree of displacement.",4.5003348197802176e-07,0.4503099137206008,0.01999167013744273,0.034455102830855615,0.4906229164484719,0.0,0.03440522927810451,0.5039051809214179,0.0,4.500334819780227e-07,0.5179430915348537,0.0
148,0.3,2,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"In growing children, isolated sternal fractures are rare and often go unnoticed, usually caused by trauma related to their age. Ultrasonography helps in diagnosing the fracture, and radiography is best for visualizing the dislocation extent.",3.7897556377096586e-07,0.3579365935895855,0.01999167013744273,0.029014823436509976,0.3953127366441467,0.0,0.028972824655245887,0.4054651081081646,0.0,3.789755637709665e-07,0.41616039722491127,0.0
148,0.3,3,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Isolated sternal fractures in pediatric patients are infrequent and commonly overlooked, often stemming from typical traumatic events for their age group. Ultrasound serves as a valuable diagnostic tool, whereas radiography is ideal for evaluating the dislocation.",3.5528959103528056e-07,0.328949056716334,0.01999167013744273,0.027201396971728097,0.3654597734944649,0.0,0.027162023114293013,0.3746934494414109,0.0,3.552895910352811e-07,0.38441169891033145,0.0
148,0.3,4,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Sternal fractures in children are rare and frequently overlooked injuries, typically associated with age-related trauma. Ultrasonography is useful for detecting fractures, and radiography is the preferred method to visualize dislocation severity.",4.7371945471370706e-07,0.4830997365435925,0.01999167013744273,0.036268529295637494,0.5245244681241537,0.0,0.03621603081905738,0.5389965007326869,0.0,4.737194547137081e-07,0.5543107357057284,0.0
148,0.3,5,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"In children, isolated sternal fractures are uncommon and often missed, usually caused by trauma typical for their age. Ultrasonography is a helpful diagnostic method, while radiography is the standard for assessing dislocation extent.",4.2634750924233646e-07,0.418561215406021,0.01999167013744273,0.032641676366073735,0.4578330936254802,0.0,0.032594427737151634,0.47000362924573613,0.0,4.263475092423373e-07,0.48285177172358473,0.0
148,0.3,6,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Isolated sternal fractures among growing children are rare and often not recognized, generally due to age-specific traumatic incidents. Ultrasound is beneficial for fracture detection, and radiography is the method of choice for viewing dislocation.",4.0266153650665116e-07,0.3877895567392673,0.01999167013744273,0.030828249901291856,0.42608439531090037,0.0,0.03078362619619876,0.43721380642274443,0.0,4.026615365066519e-07,0.44895022004790297,0.0
148,0.3,7,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Sternal fractures in the pediatric population are rare and often overlooked, typically resulting from trauma related to their developmental stage. Ultrasonography is a useful tool for diagnosis, with radiography preferred to determine dislocation extent.",4.0266153650665116e-07,0.3877895567392673,0.01999167013744273,0.030828249901291856,0.42608439531090037,0.0,0.03078362619619876,0.43721380642274443,0.0,4.026615365066519e-07,0.44895022004790297,0.0
148,0.3,8,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"In childhood, isolated sternal fractures are infrequent and frequently missed, commonly caused by trauma typical of their age. Ultrasonography aids in diagnosis, and radiography is the preferred imaging to assess dislocation.",4.7371945471370706e-07,0.4830997365435925,0.01999167013744273,0.036268529295637494,0.5245244681241537,0.0,0.03621603081905738,0.5389965007326869,0.0,4.737194547137081e-07,0.5543107357057284,0.0
148,0.3,9,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Isolated sternal fractures in children are rare and often go undetected, usually due to trauma common in their age group. Ultrasound is effective for detecting fractures, and radiography is the method of choice for evaluating dislocation.",3.5528959103528056e-07,0.328949056716334,0.01999167013744273,0.027201396971728097,0.3654597734944649,0.0,0.027162023114293013,0.3746934494414109,0.0,3.552895910352811e-07,0.38441169891033145,0.0
148,0.3,10,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Sternal fractures in growing children are uncommon and often overlooked, typically arising from age-related traumatic events. Ultrasonography is a valuable diagnostic tool, while radiography is best for visualizing the extent of dislocation.",4.5003348197802176e-07,0.4503099137206008,0.01999167013744273,0.034455102830855615,0.4906229164484719,0.0,0.03440522927810451,0.5039051809214179,0.0,4.500334819780227e-07,0.5179430915348537,0.0
149,0.3,1,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Is aripiprazole a new risk factor for pathological gambling? Answer: Adverse drug reactions were compared with previously published case reports. The dopamine partial agonist action of aripiprazole may explain the development of pathological gambling.,2.36859727356853e-08,0.029852963149681777,0.0,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
149,0.3,2,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Could aripiprazole be a novel risk factor for pathological gambling? Answer: Adverse drug reactions were analyzed alongside other published case reports. The dopamine partial agonist mechanism of aripiprazole might account for the emergence of pathological gambling.,7.10579182070559e-08,0.08701137698963013,0.0,0.005440279394345639,0.08961215868968697,0.0,0.005432404622858621,0.09237332013101529,0.0,7.105791820705622e-08,0.09531017980432521,0.0
149,0.3,3,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Aripiprazole: is it a new risk factor for pathological gambling? Answer: Adverse drug reactions were examined in relation to other published case reports. The dopamine partial agonist property of aripiprazole could clarify the occurrence of pathological gambling.,9.47438909427412e-08,0.11441035117774545,0.0,0.007253705859127511,0.11778303565638382,0.0,0.007243206163811494,0.1213608570042668,0.0,9.474389094274162e-08,0.125163142954007,0.0
149,0.3,4,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Is aripiprazole associated with a new risk of pathological gambling? Answer: Adverse drug reactions were reviewed with other documented case reports. The dopamine partial agonist effect of aripiprazole could explain why pathological gambling occurs.,2.36859727356853e-08,0.029852963149681777,0.0,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
149,0.3,5,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Could aripiprazole represent a new risk factor for pathological gambling? Answer: Adverse drug reactions were considered alongside previously published case reports. The dopamine partial agonist mechanism of aripiprazole might explain the onset of pathological gambling.,4.73719454713706e-08,0.058840500022933284,0.0,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
149,0.3,6,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Question: Does aripiprazole pose a new risk for pathological gambling? Answer: Adverse drug reactions were compared with other published case reports. The dopamine partial agonist action of aripiprazole could be responsible for pathological gambling.,2.36859727356853e-08,0.010920400412667952,0.029384756657483937,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
149,0.3,7,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Is there a new risk factor for pathological gambling in aripiprazole? Answer: Adverse drug reactions were confronted with other case reports in the literature. The dopamine partial agonist mechanism of aripiprazole may explain the occurrence of pathological gambling.,1.184298636784265e-07,0.14107859825990632,0.0,0.009067132323909384,0.14518200984449914,0.0,0.00905400770476436,0.14953173397096364,0.0,1.1842986367842703e-07,0.1541506798272585,0.0
149,0.3,8,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Aripiprazole as a new risk factor for pathological gambling? Answer: Adverse drug reactions were evaluated against other published case reports. The dopamine partial agonist effect of aripiprazole could underlie the development of pathological gambling.,2.36859727356853e-08,0.029852963149681777,0.0,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
149,0.3,9,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Question: Might aripiprazole be a new risk factor for pathological gambling? Answer: Adverse drug reactions were assessed with other published case reports. The dopamine partial agonist mechanism of aripiprazole could explain the manifestation of pathological gambling.,7.10579182070559e-08,0.08701137698963013,0.0,0.005440279394345639,0.08961215868968697,0.0,0.005432404622858621,0.09237332013101529,0.0,7.105791820705622e-08,0.09531017980432521,0.0
149,0.3,10,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Is aripiprazole linked to a new risk factor for pathological gambling? Answer: Adverse drug reactions were analyzed in conjunction with other published case reports. The dopamine partial agonist property of aripiprazole might explain the occurrence of pathological gambling.,1.184298636784265e-07,0.14107859825990632,0.0,0.009067132323909384,0.14518200984449914,0.0,0.00905400770476436,0.14953173397096364,0.0,1.1842986367842703e-07,0.1541506798272585,0.0
150,0.3,1,ai,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: There is evidence that preoperative statin use may reduce the incidence of atrial fibrillation,Do preoperative statins lower the risk of atrial fibrillation following coronary artery bypass grafting? Evidence suggests that using statins before surgery might decrease atrial fibrillation occurrence.,2.36859727356853e-08,0.041353473708850785,0.001530555555555549,0.0018134264647818796,0.04082199452025481,0.0,0.0018108015409528735,0.04255961441879563,0.0,2.3685972735685406e-08,0.04445176257083405,0.0
150,0.3,2,ai,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: There is evidence that preoperative statin use may reduce the incidence of atrial fibrillation,Is atrial fibrillation after coronary artery bypass grafting reduced by preoperative statins? Research indicates that pre-surgery statin use could reduce atrial fibrillation incidence.,9.47438909427412e-08,0.17674845082484447,0.006951473922902497,0.007253705859127518,0.17435338714477844,0.0,0.007243206163811494,0.1823215567939549,0.0,9.474389094274152e-08,0.1910552367627094,0.0
150,0.3,3,ai,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: There is evidence that preoperative statin use may reduce the incidence of atrial fibrillation,Can preoperative statins help prevent atrial fibrillation after coronary artery bypass grafting? There is data supporting that statin use before surgery may lessen atrial fibrillation cases.,2.36859727356853e-08,0.041353473708850785,0.001530555555555549,0.0018134264647818796,0.04082199452025481,0.0,0.0018108015409528735,0.04255961441879563,0.0,2.3685972735685406e-08,0.04445176257083405,0.0
150,0.3,4,ai,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: There is evidence that preoperative statin use may reduce the incidence of atrial fibrillation,Do statins taken before coronary artery bypass grafting reduce atrial fibrillation? Studies show that preoperative statin therapy might lower the chance of atrial fibrillation.,7.10579182070559e-08,0.06928330820310613,0.03840000000000001,0.005440279394345639,0.1278333715098845,0.0,0.005432404622858621,0.13353139262452363,0.0,7.105791820705617e-08,0.13976194237515926,0.0
150,0.3,5,ai,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: There is evidence that preoperative statin use may reduce the incidence of atrial fibrillation,Does the use of statins prior to coronary artery bypass grafting decrease atrial fibrillation rates? Evidence points to a potential reduction in atrial fibrillation with preoperative statin use.,2.36859727356853e-08,0.03971510627504049,0.0014177514792899637,0.0018134264647818796,0.03922071315328246,0.0,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
150,0.3,6,ai,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: There is evidence that preoperative statin use may reduce the incidence of atrial fibrillation,Are preoperative statins effective in reducing atrial fibrillation after coronary artery bypass grafting? There is proof that statins given before surgery can reduce atrial fibrillation incidence.,2.36859727356853e-08,0.041353473708850785,0.001530555555555549,0.0018134264647818796,0.04082199452025481,0.0,0.0018108015409528735,0.04255961441879563,0.0,2.3685972735685406e-08,0.04445176257083405,0.0
150,0.3,7,ai,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: There is evidence that preoperative statin use may reduce the incidence of atrial fibrillation,Is the incidence of atrial fibrillation after coronary artery bypass grafting diminished by preoperative statin use? Research supports that pre-surgical statins may reduce atrial fibrillation.,4.73719454713706e-08,0.026723693784310498,0.03840000000000001,0.003626852929563759,0.08338160893905044,0.0,0.003621603081905747,0.08701137698962969,0.0,4.737194547137081e-08,0.090971778205728,0.0
150,0.3,8,ai,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: There is evidence that preoperative statin use may reduce the incidence of atrial fibrillation,Do patients who take statins before coronary artery bypass grafting experience less atrial fibrillation? Evidence suggests preoperative statin use may lower atrial fibrillation occurrence.,7.10579182070559e-08,0.06928330820310613,0.03840000000000001,0.005440279394345639,0.1278333715098845,0.0,0.005432404622858621,0.13353139262452363,0.0,7.105791820705617e-08,0.13976194237515926,0.0
150,0.3,9,ai,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: There is evidence that preoperative statin use may reduce the incidence of atrial fibrillation,Can the administration of statins before coronary artery bypass grafting reduce atrial fibrillation? Studies indicate that preoperative statins might decrease atrial fibrillation incidence.,9.47438909427412e-08,0.11373507077394018,0.03840000000000001,0.007253705859127518,0.17435338714477844,0.0,0.007243206163811494,0.1823215567939549,0.0,9.474389094274152e-08,0.1910552367627094,0.0
150,0.3,10,ai,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: There is evidence that preoperative statin use may reduce the incidence of atrial fibrillation,Does preoperative statin therapy reduce the frequency of atrial fibrillation following coronary artery bypass grafting? There is evidence that using statins before surgery can reduce atrial fibrillation.,0.0,0.053319013889226774,0.03840000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
151,0.3,1,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve,Are there discrepancies between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology? Significant differences exist regarding the clinical importance of certain RBC morphology terms between clinicians and clinical pathologists. Adding interpretive comments to CBC reports is the best method to guarantee that RBC morphology changes are understood as intended by the clinical pathologist. Reporting methods should be carefully reviewed to enhance accuracy.,7.105791820705622e-08,0.004597673739164421,0.03073822121441168,0.005440279394345618,0.04800921918636103,0.0,0.0054324046228586,0.04879016416943571,0.0,7.105791820705622e-08,0.04959694113937285,0.0
151,0.3,2,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve,Is there a mismatch between clinical pathologists and clinicians when it comes to reporting and interpreting red blood cell morphology? Clinicians and clinical pathologists differ notably in their views on the clinical significance of specific RBC morphology terminology. Including explanatory notes on CBC reports is the most effective way to ensure RBC morphology changes are interpreted correctly by the clinical pathologist. Reporting protocols need critical evaluation for improvement.,1.1842986367842703e-07,0.015485352504684968,0.044677734375,0.009067132323909363,0.07878087785311383,0.0,0.009054007704764333,0.08004270767353727,0.0,1.1842986367842703e-07,0.08134563945395268,0.0
151,0.3,3,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve,Do clinical pathologists and clinicians disagree in their reporting and interpretation of red blood cell morphology? There are important differences in how clinicians and clinical pathologists perceive the clinical relevance of certain RBC morphology terms. The clearest way to ensure RBC morphology changes are interpreted as intended by clinical pathologists is to include interpretive comments on CBC reports. Reporting practices should be critically assessed to improve.,7.105791820705622e-08,0.024779903259057434,0.07830385015608742,0.005440279394345618,0.04800921918636103,0.0,0.0054324046228586,0.04879016416943571,0.0,7.105791820705622e-08,0.04959694113937285,0.0
151,0.3,4,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve,Is there discordance between clinical pathologists and clinicians regarding red blood cell morphology reporting and interpretation? Key differences exist between clinicians and clinical pathologists about the clinical relevance of some RBC morphology terms. The inclusion of interpretive comments on CBC reports is the most straightforward way to ensure RBC morphology changes are understood as intended by clinical pathologists. Reporting procedures should be critically reviewed for enhancement.,7.105791820705622e-08,0.004597673739164421,0.030738221214411676,0.005440279394345618,0.04800921918636103,0.0,0.0054324046228586,0.04879016416943571,0.0,7.105791820705622e-08,0.04959694113937285,0.0
151,0.3,5,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve,Are clinical pathologists and clinicians aligned in their reporting and interpretation of red blood cell morphology? Important differences about the clinical relevance of certain RBC morphology terms exist between these groups. Adding interpretive comments to CBC reports is the clearest method to ensure RBC morphology changes are interpreted as clinical pathologists intend. Reporting practices should be examined critically to improve outcomes.,4.737194547137081e-08,0.07899963486032124,0.033293697978596916,0.0036268529295637453,0.03333642026759165,0.0,0.003621603081905733,0.03390155167568043,0.0,4.737194547137081e-08,0.03448617607116855,0.0
151,0.3,6,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve,Is there a difference in how clinical pathologists and clinicians report and interpret red blood cell morphology? Significant discrepancies exist regarding the clinical relevance of specific RBC morphology terms between clinicians and clinical pathologists. The best way to ensure RBC morphology changes are interpreted as intended by clinical pathologists is to include interpretive comments on CBC reports. Reporting methods should be critically evaluated for improvement.,4.737194547137081e-08,0.011573000470415096,0.03121748178980229,0.0036268529295637453,0.03226086221822477,0.0,0.003621603081905733,0.03278982282299214,0.0,4.737194547137081e-08,0.03333642026759165,0.0
151,0.3,7,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve,Do clinical pathologists and clinicians have differing views on reporting and interpreting red blood cell morphology? There are notable differences in the clinical relevance attributed to certain RBC morphology terms by clinicians and clinical pathologists. Including interpretive comments on CBC reports is the clearest approach to ensure RBC morphology changes are interpreted as intended by clinical pathologists. Reporting practices require critical examination to enhance accuracy.,4.737194547137081e-08,0.011573000470415096,0.03121748178980229,0.0036268529295637453,0.03226086221822477,0.0,0.003621603081905733,0.03278982282299214,0.0,4.737194547137081e-08,0.03333642026759165,0.0
151,0.3,8,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve,Is there a gap between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology? Important differences exist between these groups regarding the clinical significance of certain RBC morphology terms. The inclusion of interpretive comments on CBC reports is the clearest way to ensure RBC morphology changes are understood as clinical pathologists intend. Reporting protocols should be critically reviewed for improvement.,0.0,0.04471917293935146,0.032222222222222215,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
151,0.3,9,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve,Are there inconsistencies between clinical pathologists and clinicians in the reporting and interpretation of red blood cell morphology? Significant differences about the clinical relevance of some RBC morphology terms exist between clinicians and clinical pathologists. Adding interpretive comments on CBC reports is the clearest way to ensure RBC morphology changes are interpreted as intended by clinical pathologists. Reporting practices should be critically assessed to improve.,4.737194547137081e-08,0.011573000470415096,0.03121748178980229,0.0036268529295637453,0.03226086221822477,0.0,0.003621603081905733,0.03278982282299214,0.0,4.737194547137081e-08,0.03333642026759165,0.0
151,0.3,10,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve,Is there a divergence between clinical pathologists and clinicians in how red blood cell morphology is reported and interpreted? Key differences exist in the clinical relevance attributed to certain RBC morphology terms by clinicians versus clinical pathologists. Including interpretive comments on CBC reports is the clearest means to ensure RBC morphology changes are interpreted as intended by clinical pathologists. Reporting methods should be critically examined to enhance quality.,1.1842986367842703e-07,0.03617631311841407,0.02982248520710059,0.009067132323909363,0.07878087785311383,0.0,0.009054007704764333,0.08004270767353727,0.0,1.1842986367842703e-07,0.08134563945395268,0.0
152,0.3,1,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: The exact cause of benign paroxysmal positional vertigo (BPPV) is not fully understood, but viral infections are not believed to have a direct role in its development. BPPV is typically caused by problems in the inner ear, such as","Question: Are viral infections involved in benign paroxysmal positional vertigo? Answer: The precise cause of benign paroxysmal positional vertigo (BPPV) remains unclear, but viral infections are generally not considered a direct factor in its onset. BPPV usually results from inner ear issues, such as",1.8948778188548325e-07,0.13143251639718656,0.027505907372400773,0.014507411718254981,0.17963450852047114,0.0038036897673758216,0.014486412327622933,0.17824823140631896,0.0,1.8948778188548325e-07,0.1823215567939549,0.0
152,0.3,2,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: The exact cause of benign paroxysmal positional vertigo (BPPV) is not fully understood, but viral infections are not believed to have a direct role in its development. BPPV is typically caused by problems in the inner ear, such as","Question: Can viral infections contribute to benign paroxysmal positional vertigo? Answer: While the exact cause of benign paroxysmal positional vertigo (BPPV) is not completely known, viral infections are not thought to play a direct role in its development. BPPV is most often caused by inner ear problems, including",9.474389094274162e-08,0.03425369325380334,0.03334784952116111,0.0072537058591274906,0.08579255565404154,0.0017367249242856639,0.007243206163811466,0.08515780834030728,0.0,9.474389094274162e-08,0.08701137698962924,0.0
152,0.3,3,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: The exact cause of benign paroxysmal positional vertigo (BPPV) is not fully understood, but viral infections are not believed to have a direct role in its development. BPPV is typically caused by problems in the inner ear, such as","Question: Do viral infections play a part in benign paroxysmal positional vertigo? Answer: The cause of benign paroxysmal positional vertigo (BPPV) is not entirely understood, but viral infections are not believed to directly cause it. BPPV typically arises from issues within the inner ear, such as",1.4211583641411244e-07,0.08167155515416535,0.030554376760155877,0.010880558788691236,0.1316141743129382,0.002723310933406376,0.0108648092457172,0.13062018241706452,0.0,1.4211583641411244e-07,0.13353139262452318,0.0
152,0.3,4,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: The exact cause of benign paroxysmal positional vertigo (BPPV) is not fully understood, but viral infections are not believed to have a direct role in its development. BPPV is typically caused by problems in the inner ear, such as","Question: Is there a connection between viral infections and benign paroxysmal positional vertigo? Answer: The exact cause of benign paroxysmal positional vertigo (BPPV) is not fully known, and viral infections are not considered a direct cause. BPPV is usually linked to inner ear disturbances, such as",1.4211583641411244e-07,0.08167155515416535,0.030554376760155877,0.010880558788691236,0.1316141743129382,0.002723310933406376,0.0108648092457172,0.13062018241706452,0.0,1.4211583641411244e-07,0.13353139262452318,0.0
152,0.3,5,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: The exact cause of benign paroxysmal positional vertigo (BPPV) is not fully understood, but viral infections are not believed to have a direct role in its development. BPPV is typically caused by problems in the inner ear, such as","Question: Are viral infections a factor in benign paroxysmal positional vertigo? Answer: Although the precise cause of benign paroxysmal positional vertigo (BPPV) is not completely understood, viral infections are not regarded as a direct cause. BPPV generally stems from inner ear problems, including",2.1317375462116866e-07,0.15726582836073666,0.025874990212637464,0.016320838183036854,0.20453710908972944,0.004383329862557267,0.0162972138685758,0.20294084399669066,0.0,2.1317375462116866e-07,0.20763936477824663,0.0
152,0.3,6,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: The exact cause of benign paroxysmal positional vertigo (BPPV) is not fully understood, but viral infections are not believed to have a direct role in its development. BPPV is typically caused by problems in the inner ear, such as","Question: Do viral infections influence benign paroxysmal positional vertigo? Answer: The exact cause of benign paroxysmal positional vertigo (BPPV) remains uncertain, but viral infections are not thought to directly contribute to it. BPPV is commonly caused by inner ear abnormalities, such as",2.3685972735685406e-07,0.18377852691038798,0.02416622593195754,0.018134264647818726,0.23007502311980765,0.004991893307659187,0.018108015409528666,0.22825865198098239,0.0,2.3685972735685406e-07,0.2336148511815046,0.0
152,0.3,7,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: The exact cause of benign paroxysmal positional vertigo (BPPV) is not fully understood, but viral infections are not believed to have a direct role in its development. BPPV is typically caused by problems in the inner ear, such as","Question: Could viral infections cause benign paroxysmal positional vertigo? Answer: The cause of benign paroxysmal positional vertigo (BPPV) is not fully understood, however, viral infections are not believed to be a direct cause. BPPV is typically due to inner ear issues, such as",2.1317375462116866e-07,0.15726582836073666,0.025874990212637464,0.016320838183036854,0.20453710908972944,0.004383329862557267,0.0162972138685758,0.20294084399669066,0.0,2.1317375462116866e-07,0.20763936477824663,0.0
152,0.3,8,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: The exact cause of benign paroxysmal positional vertigo (BPPV) is not fully understood, but viral infections are not believed to have a direct role in its development. BPPV is typically caused by problems in the inner ear, such as","Question: Is benign paroxysmal positional vertigo related to viral infections? Answer: The exact cause of benign paroxysmal positional vertigo (BPPV) is unclear, but viral infections are not thought to have a direct role in causing it. BPPV usually results from inner ear problems, such as",1.6580180914979784e-07,0.10624485700792086,0.029064131643667834,0.012693985253473108,0.18757581000613355,0.026409281676953472,0.012675610786670066,0.18715768842535052,0.023795359904818555,1.6580180914979784e-07,0.1576289442035832,0.0
152,0.3,9,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: The exact cause of benign paroxysmal positional vertigo (BPPV) is not fully understood, but viral infections are not believed to have a direct role in its development. BPPV is typically caused by problems in the inner ear, such as","Question: Do viral infections have an impact on benign paroxysmal positional vertigo? Answer: The precise cause of benign paroxysmal positional vertigo (BPPV) is not fully known, and viral infections are not believed to directly cause it. BPPV is often caused by inner ear issues, including",1.6580180914979784e-07,0.10624485700792086,0.029064131643667834,0.012693985253473108,0.15533640625915934,0.0032509602480447902,0.012675610786670066,0.15415067982725894,0.0,1.6580180914979784e-07,0.1576289442035832,0.0
152,0.3,10,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: The exact cause of benign paroxysmal positional vertigo (BPPV) is not fully understood, but viral infections are not believed to have a direct role in its development. BPPV is typically caused by problems in the inner ear, such as","Question: Are viral infections implicated in benign paroxysmal positional vertigo? Answer: The exact cause of benign paroxysmal positional vertigo (BPPV) is not completely understood, but viral infections are generally not considered a direct cause. BPPV commonly arises from inner ear problems, such as",2.1317375462116866e-07,0.15726582836073666,0.025874990212637464,0.016320838183036854,0.20453710908972944,0.004383329862557267,0.0162972138685758,0.20294084399669066,0.0,2.1317375462116866e-07,0.20763936477824663,0.0
153,0.3,1,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: The role of polymorphisms in beta-adrenergic receptor encoding genes in transient tachypnea of the newborn (TTN) is currently being,Question: Could polymorphisms in the beta-adrenergic receptor (ADRB) genes play a role in transient tachypnea of the newborn (TTN)? Answer: The involvement of polymorphisms in beta-adrenergic receptor encoding genes in TTN is under investigation.,9.47438909427412e-08,0.026376299746796672,0.09573361082206044,0.007253705859127511,0.0022585055630592876,0.08264462809917354,0.007243206163811494,0.042144036368844784,0.056932966023875105,9.474389094274162e-08,0.08438977939165726,0.029384756657483937
153,0.3,2,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: The role of polymorphisms in beta-adrenergic receptor encoding genes in transient tachypnea of the newborn (TTN) is currently being,Question: Is there a connection between polymorphisms in beta-adrenergic receptor (ADRB) genes and transient tachypnea of the newborn (TTN)? Answer: Research is ongoing regarding the role of polymorphisms in beta-adrenergic receptor genes in TTN.,9.47438909427412e-08,0.015632620287139076,0.06608740894901148,0.007253705859127511,0.08890190313305357,0.020422405876951315,0.007243206163811494,0.0868632093081958,0.024710743801652904,9.474389094274162e-08,0.08438977939165726,0.029384756657483937
153,0.3,3,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: The role of polymorphisms in beta-adrenergic receptor encoding genes in transient tachypnea of the newborn (TTN) is currently being,Question: Do polymorphisms in the beta-adrenergic receptor (ADRB) genes contribute to transient tachypnea of the newborn (TTN)? Answer: The potential role of beta-adrenergic receptor gene polymorphisms in TTN is currently being studied.,1.421158364141118e-07,0.04156456304536693,0.0918781342760032,0.01088055878869127,0.06679702670063081,0.08264462809917354,0.010864809245717241,0.10883541086751825,0.056932966023875105,1.4211583641411244e-07,0.15338265087860803,0.029384756657483937
153,0.3,4,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: The role of polymorphisms in beta-adrenergic receptor encoding genes in transient tachypnea of the newborn (TTN) is currently being,Question: Transient tachypnea of the newborn (TTN): could polymorphisms in beta-adrenergic receptor (ADRB) genes be involved? Answer: Studies are examining the role of polymorphisms in beta-adrenergic receptor genes in TTN.,1.894877818854824e-07,0.1622273531604983,0.05401640303185175,0.01450741171825503,0.23481092398186032,0.011638710939410213,0.014486412327622988,0.2316386104466952,0.019950717503165058,1.8948778188548325e-07,0.2274906230323297,0.029384756657483937
153,0.3,5,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: The role of polymorphisms in beta-adrenergic receptor encoding genes in transient tachypnea of the newborn (TTN) is currently being,Question: Is transient tachypnea of the newborn (TTN) influenced by polymorphisms in beta-adrenergic receptor (ADRB) encoding genes? Answer: The role of these polymorphisms in TTN is presently under research.,2.131737546211677e-07,0.10341942437374607,0.12042211402445735,0.01632083818303691,0.17215754235845626,0.08264462809917354,0.016297213868575862,0.21803470283250892,0.056932966023875105,2.1317375462116866e-07,0.26671133618561216,0.029384756657483937
153,0.3,6,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: The role of polymorphisms in beta-adrenergic receptor encoding genes in transient tachypnea of the newborn (TTN) is currently being,Question: Could polymorphisms in beta-adrenergic receptor (ADRB) genes affect transient tachypnea of the newborn (TTN)? Answer: The involvement of polymorphisms in beta-adrenergic receptor genes in TTN is being explored.,2.131737546211677e-07,0.20244045016802437,0.05048740894901149,0.01632083818303691,0.2748460135525228,0.009044628099173557,0.016297213868575862,0.2713537167217357,0.018532966023875094,2.1317375462116866e-07,0.26671133618561216,0.029384756657483937
153,0.3,7,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: The role of polymorphisms in beta-adrenergic receptor encoding genes in transient tachypnea of the newborn (TTN) is currently being,Question: Question: Does transient tachypnea of the newborn (TTN) involve polymorphisms in beta-adrenergic receptor (ADRB) encoding genes? Answer: The role of such polymorphisms in TTN is currently being investigated.,2.131737546211677e-07,0.10341942437374607,0.12042211402445735,0.01632083818303691,0.17215754235845626,0.08264462809917354,0.016297213868575862,0.21803470283250892,0.056932966023875105,2.1317375462116866e-07,0.26671133618561216,0.029384756657483937
153,0.3,8,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: The role of polymorphisms in beta-adrenergic receptor encoding genes in transient tachypnea of the newborn (TTN) is currently being,Question: Is there a role for polymorphisms in beta-adrenergic receptor (ADRB) genes in transient tachypnea of the newborn (TTN)? Answer: Research is ongoing into the involvement of these polymorphisms in TTN.,1.658018091497971e-07,0.0311258520269857,0.12279371097041461,0.01269398525347315,0.10069857837631258,0.08264462809917354,0.012675610786670115,0.14392673067878725,0.056932966023875105,1.6580180914979784e-07,0.1897502950494827,0.029384756657483937
153,0.3,9,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: The role of polymorphisms in beta-adrenergic receptor encoding genes in transient tachypnea of the newborn (TTN) is currently being,Question: Transient tachypnea of the newborn (TTN): investigating the role of polymorphisms in beta-adrenergic receptor (ADRB) encoding genes. Answer: The contribution of these polymorphisms to TTN is currently under study.,1.894877818854824e-07,0.01881759166533792,0.15608740894901152,0.01450741171825503,0.13578989818758158,0.08264462809917354,0.014486412327622988,0.18029437484966193,0.056932966023875105,1.8948778188548325e-07,0.2274906230323297,0.029384756657483937
153,0.3,10,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: The role of polymorphisms in beta-adrenergic receptor encoding genes in transient tachypnea of the newborn (TTN) is currently being,Question: Are polymorphisms in beta-adrenergic receptor (ADRB) genes implicated in transient tachypnea of the newborn (TTN)? Answer: The role of such polymorphisms in TTN is being actively researched.,2.36859727356853e-07,0.14162079124451488,0.11910516042830147,0.01813426464781879,0.20989787034130325,0.08264462809917354,0.018108015409528735,0.2572554159857914,0.056932966023875105,2.3685972735685406e-07,0.30753333070586697,0.029384756657483937
154,0.3,1,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Research suggests that parents, their children, and their children's physicians may have different perceptions of body image. Factors such as societal influences, personal biases, and medical expertise can contribute to these varying perceptions. Further studies are needed to gain a","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Research indicates that parents, their children, and the children's doctors might view body image in distinct ways. Various factors including societal norms, individual biases, and medical knowledge play a role in these differing views. Additional research is necessary to better understand this.",4.737194547137081e-08,0.08966637990881798,0.037679506091638254,0.0036268529295637453,0.11521772026631849,0.05596319320539171,0.003621603081905733,0.11646190917847044,0.05679318002501245,4.737194547137081e-08,0.1177188488166876,0.057476051645147866
154,0.3,2,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Research suggests that parents, their children, and their children's physicians may have different perceptions of body image. Factors such as societal influences, personal biases, and medical expertise can contribute to these varying perceptions. Further studies are needed to gain a","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Studies show that parents, their offspring, and their children's healthcare providers may have differing perspectives on body image. Influences such as cultural factors, personal prejudices, and clinical expertise contribute to these differences. More research is required to explore this further.",0.0,0.07561605606108524,0.053091321663310855,0.0,0.10268847119406699,0.0731165621776497,0.0,0.10462598951848223,0.07496876301541025,0.0,0.07997852083384016,0.057476051645147866
154,0.3,3,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Research suggests that parents, their children, and their children's physicians may have different perceptions of body image. Factors such as societal influences, personal biases, and medical expertise can contribute to these varying perceptions. Further studies are needed to gain a","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Evidence suggests that parents, their children, and their children's medical professionals perceive body image differently. This variation is influenced by societal pressures, individual viewpoints, and medical training. Further investigation is needed to deepen understanding.",1.4211583641411244e-07,0.1623228265882295,0.031433661900134205,0.010880558788691236,0.13382810928045563,0.011129759571514339,0.0108648092457172,0.1040051964376163,0.011435705164170598,1.4211583641411244e-07,0.10289746913327091,0.014087621893081742
154,0.3,4,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Research suggests that parents, their children, and their children's physicians may have different perceptions of body image. Factors such as societal influences, personal biases, and medical expertise can contribute to these varying perceptions. Further studies are needed to gain a","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Research findings imply that parents, their children, and the children's physicians have distinct perceptions of body image. These differences arise from social influences, personal biases, and professional medical insights. Continued studies are essential for more clarity.",9.474389094274162e-08,0.03300440988557529,0.02959194043375238,0.0072537058591274906,0.00405222658834159,0.051697932574390315,0.007243206163811466,0.0021373475785200213,0.0545694574598547,9.474389094274162e-08,6.418683969666716e-05,0.057476051645147866
154,0.3,5,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Research suggests that parents, their children, and their children's physicians may have different perceptions of body image. Factors such as societal influences, personal biases, and medical expertise can contribute to these varying perceptions. Further studies are needed to gain a","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: It appears that parents, their children, and their children's doctors may hold different views on body image. Factors such as societal expectations, individual biases, and medical expertise contribute to these differing perceptions. More research is needed to fully understand this phenomenon.",2.3685972735685406e-08,0.045474335382001296,0.019027699114860006,0.0018134264647818726,0.04588831957933248,0.019348595780849395,0.0018108015409528666,0.046301769135086435,0.01960544121610229,2.3685972735685406e-08,0.04671372104529192,0.01979823542061885
154,0.3,6,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Research suggests that parents, their children, and their children's physicians may have different perceptions of body image. Factors such as societal influences, personal biases, and medical expertise can contribute to these varying perceptions. Further studies are needed to gain a","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Research suggests that perceptions of body image vary among parents, their children, and their children's physicians. These differences are influenced by societal norms, personal biases, and medical knowledge. Further studies are required to gain deeper insights.",9.474389094274162e-08,0.08736889463537434,0.008100328566800902,0.0072537058591274906,0.05950400103313713,0.012233403063783316,0.007243206163811466,0.058720790889535746,0.014004679839606876,9.474389094274162e-08,0.05782645188635849,0.015888149943824606
154,0.3,7,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Research suggests that parents, their children, and their children's physicians may have different perceptions of body image. Factors such as societal influences, personal biases, and medical expertise can contribute to these varying perceptions. Further studies are needed to gain a","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Parents, their children, and the children's healthcare providers may perceive body image in different ways, according to research. Various factors including societal influences, individual prejudices, and medical expertise contribute to these differences. Additional research is needed for better understanding.",2.3685972735685406e-08,0.00452238446139086,0.015826738858808795,0.0018134264647818726,0.03119896384156773,0.035228488129945855,0.0018108015409528666,0.058918287603175745,0.05574538739065054,2.3685972735685406e-08,0.060560434976737465,0.057476051645147866
154,0.3,8,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Research suggests that parents, their children, and their children's physicians may have different perceptions of body image. Factors such as societal influences, personal biases, and medical expertise can contribute to these varying perceptions. Further studies are needed to gain a","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Studies suggest that parents, their children, and their children's physicians have varying perceptions of body image. Influences such as societal pressures, personal biases, and medical knowledge play a role in these differences. Further research is necessary to explore this topic.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
154,0.3,9,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Research suggests that parents, their children, and their children's physicians may have different perceptions of body image. Factors such as societal influences, personal biases, and medical expertise can contribute to these varying perceptions. Further studies are needed to gain a","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Research indicates that there are differing perceptions of body image among parents, their children, and their children's doctors. These differences stem from societal factors, individual biases, and medical expertise. More studies are needed to understand this better.",7.105791820705622e-08,0.06481439619655216,0.005966323105763338,0.005440279394345618,0.03752679434696615,0.013765201574943597,0.0054324046228586,0.03682058027268642,0.015213217519710817,7.105791820705622e-08,0.03602834294797663,0.01673363426171643
154,0.3,10,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Research suggests that parents, their children, and their children's physicians may have different perceptions of body image. Factors such as societal influences, personal biases, and medical expertise can contribute to these varying perceptions. Further studies are needed to gain a","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: It is suggested by research that parents, their children, and their children's physicians may have distinct views on body image. Factors such as social influences, personal biases, and medical knowledge contribute to these differing perceptions. Further research is essential to gain more insight.",7.105791820705622e-08,0.06093217594095712,0.005384221071594919,0.005440279394345618,0.06082304174356912,0.004720204106277187,0.0054324046228586,0.060664740907232506,0.003962845855646935,7.105791820705622e-08,0.06045193142379812,0.003112146319704065
155,0.3,1,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, neck pain is associated with worse health-related quality of life 6 months later. Studies have shown that persistent neck pain can result in decreased physical functioning and overall reduced quality of life.","Is neck pain linked to a poorer health-related quality of life six months afterward? Yes, neck pain is connected to a decline in health-related quality of life six months later. Research indicates that ongoing neck pain can lead to diminished physical functioning and a generally lower quality of life.",2.3685972735685406e-08,0.08603896070719408,0.043223573672291515,0.0018134264647818726,0.11448154396397259,0.06290160219519124,0.0018108015409528666,0.11640765305592726,0.06527756887618771,2.3685972735685406e-08,0.11839322326287727,0.06742027693061517
155,0.3,2,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, neck pain is associated with worse health-related quality of life 6 months later. Studies have shown that persistent neck pain can result in decreased physical functioning and overall reduced quality of life.","Does neck pain correlate with a worse health-related quality of life after six months? Indeed, neck pain is associated with a reduced health-related quality of life six months later. Studies have demonstrated that persistent neck pain may cause decreased physical capabilities and an overall decline in quality of life.",2.3685972735685406e-08,0.1438012257538559,0.0841591020923759,0.0018134264647818726,0.17347279337332955,0.10480239608444736,0.0018108015409528666,0.17668132093070543,0.10844911973117106,2.3685972735685406e-08,0.18000630597931666,0.11176857330703485
155,0.3,3,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, neck pain is associated with worse health-related quality of life 6 months later. Studies have shown that persistent neck pain can result in decreased physical functioning and overall reduced quality of life.","Is there an association between neck pain and poorer health-related quality of life six months later? Yes, neck pain is linked to worse health-related quality of life half a year later. Research has found that chronic neck pain can impair physical function and reduce overall quality of life.",0.0,0.1474781235233924,0.10081585402574894,0.0,0.15068416968694542,0.10388310213485037,0.0,0.15403270679109937,0.10796677099124657,0.0,0.15753345012725894,0.11176857330703485
155,0.3,4,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, neck pain is associated with worse health-related quality of life 6 months later. Studies have shown that persistent neck pain can result in decreased physical functioning and overall reduced quality of life.","Can neck pain lead to a decline in health-related quality of life six months later? Yes, neck pain is related to a worse health-related quality of life six months afterward. Studies show that persistent neck pain results in lower physical functioning and an overall diminished quality of life.",0.0,0.058991249409357405,0.037291388803392556,0.0,0.0904105018121677,0.06110373143340174,0.0,0.09241962407465998,0.06385098418065457,0.0,0.09452007007635421,0.06641709938413236
155,0.3,5,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, neck pain is associated with worse health-related quality of life 6 months later. Studies have shown that persistent neck pain can result in decreased physical functioning and overall reduced quality of life.","Is neck pain related to a decrease in health-related quality of life six months later? Yes, neck pain is associated with a decline in health-related quality of life six months later. Research suggests that ongoing neck pain can reduce physical functioning and overall quality of life.",4.737194547137081e-08,0.0027182929896110153,0.024691358024691357,0.0036268529295637453,0.008972624863631484,0.035502958579881644,0.003621603081905733,0.010419259084665455,0.03813280736357663,4.737194547137081e-08,0.011992408698086265,0.04076265614727155
155,0.3,6,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, neck pain is associated with worse health-related quality of life 6 months later. Studies have shown that persistent neck pain can result in decreased physical functioning and overall reduced quality of life.","Does experiencing neck pain affect health-related quality of life six months later? Yes, neck pain is linked to poorer health-related quality of life six months later. Studies indicate that chronic neck pain can lead to decreased physical function and a lower overall quality of life.",7.105791820705622e-08,0.00492225567936444,0.039351851851851805,0.005440279394345618,0.014558941778294532,0.055226824457593665,0.0054324046228586,0.016825350868088673,0.05917159763313616,7.105791820705622e-08,0.01929176773672525,0.06311637080867852
155,0.3,7,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, neck pain is associated with worse health-related quality of life 6 months later. Studies have shown that persistent neck pain can result in decreased physical functioning and overall reduced quality of life.","Is there a connection between neck pain and worse health-related quality of life after six months? Yes, neck pain is connected with reduced health-related quality of life six months later. Research has shown that persistent neck pain may cause diminished physical functioning and overall quality of life.",2.3685972735685406e-08,0.12164062207012272,0.09580246913580248,0.0018134264647818726,0.12736584812650875,0.10292323551049681,0.0018108015409528666,0.13085970227180876,0.10746253372205035,2.3685972735685406e-08,0.13454393190255942,0.11176857330703485
155,0.3,8,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, neck pain is associated with worse health-related quality of life 6 months later. Studies have shown that persistent neck pain can result in decreased physical functioning and overall reduced quality of life.","Is neck pain associated with a decline in health-related quality of life six months later? Yes, neck pain correlates with worse health-related quality of life six months afterward. Studies have demonstrated that ongoing neck pain can impair physical function and reduce overall quality of life.",7.105791820705622e-08,0.004922255679365328,0.039351851851851805,0.005440279394345618,0.014558941778294532,0.055226824457593665,0.0054324046228586,0.016825350868088673,0.05917159763313616,7.105791820705622e-08,0.01929176773672525,0.06311637080867852
155,0.3,9,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, neck pain is associated with worse health-related quality of life 6 months later. Studies have shown that persistent neck pain can result in decreased physical functioning and overall reduced quality of life.","Does neck pain impact health-related quality of life six months later? Yes, neck pain is associated with poorer health-related quality of life six months later. Research indicates that chronic neck pain leads to decreased physical functioning and an overall decline in quality of life.",9.474389094274162e-08,0.024482088748552844,0.032690224237843124,0.0072537058591274906,0.012041975036374719,0.05308870640215198,0.007243206163811466,0.009687347681562208,0.057462833352456236,9.474389094274162e-08,0.007091447733060807,0.06190707746215952
155,0.3,10,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, neck pain is associated with worse health-related quality of life 6 months later. Studies have shown that persistent neck pain can result in decreased physical functioning and overall reduced quality of life.","Is neck pain linked to worse health-related quality of life six months later? Yes, neck pain is connected to a decline in health-related quality of life six months later. Studies show that persistent neck pain results in reduced physical function and overall quality of life.",7.105791820705622e-08,0.004922255679364884,0.039351851851851805,0.005440279394345618,0.014558941778294532,0.055226824457593665,0.0054324046228586,0.016825350868088673,0.05917159763313616,7.105791820705622e-08,0.01929176773672525,0.06311637080867852
156,0.3,1,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is used to measure glucose metabolism in tumors, not oxygen levels.","Is (18)F-FDG used as a surrogate tracer for assessing tumor hypoxia? No, (18)F-FDG does not serve as a surrogate tracer for tumor hypoxia; it measures glucose metabolism instead of oxygen levels in tumors.",2.36859727356853e-08,0.06385107075337704,0.12446460065507689,0.0018134264647818796,0.007380578007353478,0.02678571428571426,0.0018108015409528735,0.008948071920403144,0.029336734693877597,2.3685972735685406e-08,0.0107148185672572,0.03188775510204078
156,0.3,2,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is used to measure glucose metabolism in tumors, not oxygen levels.","Can (18)F-FDG act as a surrogate tracer to evaluate tumor hypoxia? No, (18)F-FDG is not suitable as a surrogate tracer for tumor hypoxia since it tracks glucose metabolism, not oxygen concentration.",7.10579182070559e-08,0.033969908643804114,0.14814814814814817,0.005440279394345639,0.020759785336706305,0.05386187396769407,0.005432404622858621,0.01713568838902768,0.059997970381568295,7.105791820705622e-08,0.012940891583166358,0.06632653061224487
156,0.3,3,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is used to measure glucose metabolism in tumors, not oxygen levels.","Does (18)F-FDG function as a surrogate tracer for tumor hypoxia? No, (18)F-FDG is not a surrogate tracer for tumor hypoxia; it is employed to assess glucose metabolism in tumors rather than oxygen levels.",2.36859727356853e-08,0.06385107075337704,0.12446460065507689,0.0018134264647818796,0.007380578007353478,0.02678571428571426,0.0018108015409528735,0.008948071920403144,0.029336734693877597,2.3685972735685406e-08,0.0107148185672572,0.03188775510204078
156,0.3,4,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is used to measure glucose metabolism in tumors, not oxygen levels.","Is (18)F-FDG a surrogate tracer for measuring tumor hypoxia? No, (18)F-FDG cannot be used as a surrogate tracer for tumor hypoxia because it measures glucose metabolism, not tumor oxygenation.",1.184298636784265e-07,0.04492506542257546,0.1413135802469136,0.009067132323909398,0.09930071284947628,0.04884897959183675,0.009054007704764368,0.09505216153483698,0.05726326530612246,1.1842986367842703e-07,0.08990193271929581,0.06632653061224487
156,0.3,5,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is used to measure glucose metabolism in tumors, not oxygen levels.","Can (18)F-FDG be used as a surrogate tracer to measure tumor hypoxia? No, (18)F-FDG is not a surrogate tracer for tumor hypoxia; it is designed to measure glucose metabolism in tumors, not oxygen levels.",0.0,0.14188276445830983,0.1569135802469136,0.0,0.12996509635498965,0.09123149780203443,0.0,0.13415751881805393,0.09566326530612247,0.0,0.09241962407465909,0.06632653061224487
156,0.3,6,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is used to measure glucose metabolism in tumors, not oxygen levels.","Is (18)F-FDG considered a surrogate tracer for tumor hypoxia measurement? No, (18)F-FDG does not serve as a surrogate tracer for tumor hypoxia, as it measures glucose metabolism rather than oxygen levels.",7.10579182070559e-08,0.012239903393525875,0.11673606545401419,0.005440279394345639,0.06856303916842643,0.02037797367467696,0.005432404622858621,0.06664620128616727,0.024657348146359143,7.105791820705622e-08,0.06428512718019963,0.029344282091534828
156,0.3,7,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is used to measure glucose metabolism in tumors, not oxygen levels.","Does (18)F-FDG serve as a surrogate tracer to measure tumor hypoxia? No, (18)F-FDG is not used as a surrogate tracer for tumor hypoxia; it detects glucose metabolism, not oxygen content in tumors.",4.73719454713706e-08,0.07123164876073051,0.15125031494079116,0.003626852929563759,0.016328649927756622,0.05612244897959186,0.003621603081905747,0.019662890487660345,0.06122448979591838,4.737194547137081e-08,0.02342675258770832,0.06632653061224487
156,0.3,8,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is used to measure glucose metabolism in tumors, not oxygen levels.","Is (18)F-FDG a valid surrogate tracer for tumor hypoxia? No, (18)F-FDG is not valid as a surrogate tracer for tumor hypoxia since it measures glucose metabolism, not oxygen levels.",1.184298636784265e-07,0.04492506542257457,0.1413135802469136,0.009067132323909398,0.09930071284947628,0.04884897959183675,0.009054007704764368,0.09505216153483698,0.05726326530612246,1.1842986367842703e-07,0.08990193271929581,0.06632653061224487
156,0.3,9,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is used to measure glucose metabolism in tumors, not oxygen levels.","Can (18)F-FDG be a surrogate tracer for tumor hypoxia? No, (18)F-FDG is not a surrogate tracer for tumor hypoxia; it is used to monitor glucose metabolism in tumors, not their oxygen levels.",4.73719454713706e-08,0.026512475821379056,0.12071330589849114,0.003626852929563759,0.029881162109572923,0.023683547493071277,0.003621603081905747,0.028140363344059782,0.02707615968197981,4.737194547137081e-08,0.026083760309430826,0.030661235687690698
156,0.3,10,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is used to measure glucose metabolism in tumors, not oxygen levels.","Is (18)F-FDG employed as a surrogate tracer to assess tumor hypoxia? No, (18)F-FDG is not employed as a surrogate tracer for tumor hypoxia because it measures glucose metabolism instead of oxygen levels.",4.73719454713706e-08,0.026512475821379056,0.12071330589849111,0.003626852929563759,0.029881162109572923,0.023683547493071277,0.003621603081905747,0.028140363344059782,0.02707615968197981,4.737194547137081e-08,0.026083760309430826,0.030661235687690698
157,0.3,1,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.,"Is pain considered a clinically significant issue in general adult psychiatry? Our research indicates that pain is indeed a notable clinical concern among psychiatric patients, often underestimated within psychiatry. Patients in general adult psychiatry exhibit unique risk factors distinct from those in other medical specialties' clinical subpopulations.",1.4211583641411244e-07,0.10289746913327091,0.014087621893081742,0.010880558788691236,0.12878744193732583,0.002610743801652899,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
157,0.3,2,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.,"Does pain represent a clinically relevant challenge in general adult psychiatry? Evidence suggests that pain is a considerable clinical problem for psychiatric patients, frequently underrecognized in psychiatric practice. The patients studied in general adult psychiatry possess specific risk factors that differ from those found in other clinical disciplines.",1.1842986367842703e-07,0.08010884544688679,0.015006915842678735,0.009067132323909363,0.10613882779771977,0.0021283950617284053,0.009054007704764333,0.10536051565782589,0.0,1.1842986367842703e-07,0.107630664192365,0.0
157,0.3,3,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.,"Is pain a clinically important problem in the field of general adult psychiatry? Findings show that pain can be a major clinical issue for psychiatric patients, which appears to be undervalued in psychiatry. The patients examined in general adult psychiatry have particular risk factors that are different from those in other medical specialties.",0.0,0.053319013889226774,0.038252676020388156,0.0,0.027182242374899523,0.019599999999999992,0.0,0.0,0.0,0.0,0.0,0.0
157,0.3,4,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.,Is pain a significant clinical concern in general adult psychiatry? Our findings reveal that pain is a clinically relevant problem among psychiatric patients and is often underestimated in psychiatric care. The patients studied in general adult psychiatry have distinct risk factors compared to clinical subgroups in other disciplines.,1.1842986367842703e-07,0.08010884544688679,0.015006915842678735,0.009067132323909363,0.10613882779771977,0.0021283950617284053,0.009054007704764333,0.10536051565782589,0.0,1.1842986367842703e-07,0.107630664192365,0.0
157,0.3,5,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.,Is pain a clinically relevant issue in general adult psychiatry? We found that pain can be a substantial clinical problem in psychiatric patients and is seemingly underappreciated in psychiatry. The patients investigated in general adult psychiatry show specific risk factors that differ from those in other clinical fields.,1.1842986367842703e-07,0.08010884544688679,0.015006915842678735,0.009067132323909363,0.10613882779771977,0.0021283950617284053,0.009054007704764333,0.10536051565782589,0.0,1.1842986367842703e-07,0.107630664192365,0.0
157,0.3,6,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.,"Is pain a notable clinical problem in general adult psychiatry? Evidence indicates that pain is a significant clinical issue for psychiatric patients, often overlooked in psychiatry. The patients in general adult psychiatry are characterized by unique risk factors unlike those in other clinical specialties.",2.1317375462116866e-07,0.17454388954797384,0.01107509983075166,0.016320838183036854,0.19998078066414937,0.004195359904818563,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
157,0.3,7,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.,"Is pain clinically relevant in the context of general adult psychiatry? Our study found that pain is a significant clinical problem among psychiatric patients, which tends to be underestimated in psychiatry. The patients assessed in general adult psychiatry have specific risk factors distinct from those in other medical disciplines.",9.474389094274162e-08,0.028945319363027355,0.03665214942694958,0.0072537058591274906,0.05449578863936777,0.019599999999999992,0.007243206163811466,0.08338160893905089,0.0,9.474389094274162e-08,0.08515780834030728,0.0
157,0.3,8,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.,Is pain an important clinical problem in general adult psychiatry? Research shows that pain can be a major clinical issue for psychiatric patients and is often underestimated within psychiatry. The patients examined in general adult psychiatry possess unique risk factors different from those in other clinical areas.,1.4211583641411244e-07,0.10289746913327091,0.014087621893081742,0.010880558788691236,0.12878744193732583,0.002610743801652899,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
157,0.3,9,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.,Is pain a clinically meaningful problem in general adult psychiatry? We discovered that pain is a significant clinical concern among psychiatric patients and appears to be underestimated in psychiatry. The patients studied in general adult psychiatry have particular risk factors that differ from clinical subpopulations in other disciplines.,1.1842986367842703e-07,0.08010884544688679,0.015006915842678735,0.009067132323909363,0.10613882779771977,0.0021283950617284053,0.009054007704764333,0.10536051565782589,0.0,1.1842986367842703e-07,0.107630664192365,0.0
157,0.3,10,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.,Is pain a relevant clinical issue in general adult psychiatry? Findings demonstrate that pain can be a considerable clinical problem in psychiatric patients and is often underestimated in psychiatry. The patients investigated in general adult psychiatry exhibit specific risk factors distinct from those in other clinical specialties.,1.4211583641411244e-07,0.10289746913327091,0.014087621893081742,0.010880558788691236,0.12878744193732583,0.002610743801652899,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
158,0.3,1,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: The adequacy of clinical predictors for cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism is,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: The adequacy of clinical predictors for cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism is,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
158,0.3,2,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: The adequacy of clinical predictors for cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism is,Question: Are clinical predictors sufficient for detecting cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms? Answer: The sufficiency of clinical predictors for cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms is,4.73719454713706e-08,0.07981028248569855,0.0063691650230111585,0.003626852929563759,0.07804457775273299,0.009095198902606322,0.003621603081905747,0.07846296837496336,0.00955610425240061,4.737194547137081e-08,0.07878187441382511,0.009560493827160482
158,0.3,3,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: The adequacy of clinical predictors for cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism is,"Question: In geriatric blunt trauma patients with low-energy mechanisms, are clinical predictors reliable for cervical spine fractures? Answer: The reliability of clinical predictors for cervical spine fractures in geriatric blunt trauma patients with low-energy mechanisms is",2.36859727356853e-08,0.08024547963734907,0.01672419460881,0.0018134264647818796,0.1212841420470725,0.04923265306122446,0.0018108015409528735,0.16598787002598536,0.08269393579072533,2.3685972735685406e-08,0.1700986395956976,0.08965326991676573
158,0.3,4,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: The adequacy of clinical predictors for cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism is,Question: Do clinical predictors adequately identify cervical spine fractures in elderly patients with blunt trauma from low-energy mechanisms? Answer: The adequacy of clinical predictors in identifying cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms is,7.10579182070559e-08,0.23001911749374404,0.0641666666666667,0.005440279394345632,0.30755820716779425,0.13495537190082646,0.005432404622858621,0.31364722954924096,0.14466703397612493,7.105791820705622e-08,0.3199149942047739,0.15301524334251604
158,0.3,5,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: The adequacy of clinical predictors for cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism is,Question: Are clinical predictors effective for cervical spine fractures in geriatric patients experiencing blunt trauma via low-energy mechanisms? Answer: The effectiveness of clinical predictors for cervical spine fractures in geriatric blunt trauma patients with low-energy mechanisms is,4.73719454713706e-08,0.19533481257902308,0.05994021667327262,0.003626852929563759,0.23647821902357746,0.1052170655567118,0.003621603081905747,0.24155642262436317,0.11419105098855362,4.737194547137081e-08,0.24681755454956944,0.1220462018730489
158,0.3,6,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: The adequacy of clinical predictors for cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism is,Question: Can clinical predictors accurately detect cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms? Answer: The accuracy of clinical predictors for cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms is,2.36859727356853e-08,0.040637069319638286,0.0030555555555555614,0.0018134264647818796,0.039737414922372594,0.004582248520710125,0.0018108015409528735,0.039961109924176785,0.0048544378698225366,2.3685972735685406e-08,0.04013354324070839,0.004885207100591704
158,0.3,7,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: The adequacy of clinical predictors for cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism is,Question: Is the use of clinical predictors sufficient for cervical spine fracture diagnosis in geriatric blunt trauma patients with low-energy mechanisms? Answer: The sufficiency of clinical predictors for cervical spine fracture diagnosis in geriatric blunt trauma patients with low-energy mechanisms is,1.421158364141118e-07,0.11970689775730836,0.006601508916323745,0.01088055878869125,0.11211934308032623,0.020920408163265236,0.01086480924571722,0.14676927341955626,0.012430915576694401,1.4211583641411244e-07,0.1455064244719675,0.017362187871581447
158,0.3,8,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: The adequacy of clinical predictors for cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism is,Question: Are clinical predictors adequate to assess cervical spine fractures in elderly patients suffering blunt trauma from low-energy mechanisms? Answer: The adequacy of clinical predictors to assess cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms is,9.47438909427412e-08,0.22710782628742932,0.04750000000000004,0.007253705859127504,0.2631446356222207,0.08576406250000002,0.007243206163811487,0.26700222036026044,0.09222500000000003,9.474389094274162e-08,0.2708506636872414,0.09743906249999998
158,0.3,9,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: The adequacy of clinical predictors for cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism is,Question: How adequate are clinical predictors for cervical spine fractures in geriatric blunt trauma patients with low-energy mechanisms? Answer: The adequacy of clinical predictors for cervical spine fractures in geriatric blunt trauma patients with low-energy mechanisms is,4.73719454713706e-08,0.002793929090148861,0.0069444444444444475,0.003626852929563759,0.040780653200400696,0.030663888888888824,0.003621603081905747,0.04385712231208627,0.04145555555555552,4.737194547137081e-08,0.047244885687982574,0.05197500000000002
158,0.3,10,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: The adequacy of clinical predictors for cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism is,"Question: In elderly blunt trauma patients with low-energy mechanisms, are clinical predictors adequate for cervical spine fracture evaluation? Answer: The adequacy of clinical predictors for cervical spine fracture evaluation in elderly blunt trauma patients with low-energy mechanisms is",7.10579182070559e-08,0.11761687199753634,0.00985939643347053,0.005440279394345632,0.15352550037669577,0.034484661117717086,0.005432404622858621,0.19482199859610727,0.06271111111111116,7.105791820705622e-08,0.2383682670800753,0.09499105098855357
159,0.3,1,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Question: Does the interfractional motion of the prostate bed target, assessed using RTOG consensus definitions and daily CT on rails, vary between the superior and inferior parts of the clinical target volume? Answer: No significant motion differences are observed between the superior CTV (SUP-CTV) and inferior CTV (INF-CTV). The existing uniform planning target volume (PTV) margins sufficiently cover both CTV regions.",7.105791820705622e-08,0.007515577720608846,0.03128520829819529,0.005440279394345618,0.053444495023886596,0.0009071255195998509,0.0054324046228586,0.05310982531394792,0.0,7.105791820705622e-08,0.05406722127027486,0.0
159,0.3,2,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Question: Using RTOG consensus definitions and daily CT on rails, is there a difference in interfractional motion between the superior and inferior sections of the prostate bed clinical target volume? Answer: There is no statistically significant difference in motion between the SUP-CTV and INF-CTV. The current uniform PTV margins adequately encompass both areas of the CTV.",4.737194547137081e-08,0.08789758327581021,0.03723857003504689,0.0036268529295637453,0.0372845055208213,0.000660686282874693,0.003621603081905733,0.037041271680350096,0.0,4.737194547137081e-08,0.03774032798284743,0.0
159,0.3,3,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Question: When evaluating prostate bed target interfractional motion with RTOG consensus guidelines and daily CT on rails, does target motion differ between the superior and inferior portions of the clinical target volume? Answer: No statistically significant motion differences exist between the superior and inferior CTV. Uniform PTV margins currently in use are sufficient to cover both parts of the CTV.",4.737194547137081e-08,0.03435448949737552,0.048977882075525093,0.0036268529295637453,0.011858304487742277,0.03371900826446281,0.003621603081905733,0.012923824805636919,0.0350413223140496,4.737194547137081e-08,0.01161238772230444,0.017851239669421492
159,0.3,4,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,Question: Does interfractional motion of the prostate bed target differ between the superior and inferior clinical target volume regions according to RTOG consensus definitions and daily CT on rails? Answer: There are no statistically significant differences in motion between SUP-CTV and INF-CTV. The uniform planning target volume margins currently applied are adequate for both CTV portions.,4.737194547137081e-08,0.012281527214724974,0.016865739323651797,0.0036268529295637453,0.01161238772230444,0.017851239669421492,0.003621603081905733,0.037041271680350096,0.0,4.737194547137081e-08,0.03774032798284743,0.0
159,0.3,5,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Question: Using daily CT on rails and RTOG consensus definitions, is there a difference in interfractional motion between the superior and inferior parts of the prostate bed clinical target volume? Answer: No significant motion differences were found between the superior and inferior CTV. The current uniform PTV margins are sufficient to cover both regions of the CTV.",2.3685972735685406e-08,0.09283395193453226,0.05338620555984506,0.0018134264647818726,0.06887930511519391,0.036512665656022306,0.0018108015409528666,0.06969337426522904,0.036982248520710054,2.3685972735685406e-08,0.044848630391775224,0.018860946745562133
159,0.3,6,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,Question: Does the interfractional motion of the prostate bed clinical target volume vary between its superior and inferior segments based on RTOG consensus definitions and daily CT on rails? Answer: No statistically significant differences in motion were detected between SUP-CTV and INF-CTV. The uniform PTV margins currently used adequately cover both segments.,1.4211583641411244e-07,0.06258372770250897,0.0350413223140496,0.010880558788691236,0.08857342885843433,0.017851239669421492,0.0108648092457172,0.11551288712184427,0.0,1.4211583641411244e-07,0.11778303565638426,0.0
159,0.3,7,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Question: According to RTOG consensus definitions and daily CT on rails, is there a difference in interfractional motion between the superior and inferior portions of the prostate bed clinical target volume? Answer: There are no statistically apparent differences in motion between the superior and inferior CTV. The uniform planning target volume margins are adequate to cover both parts.",0.0,0.07296286111157357,0.051866961709619096,0.0,0.0742657693457085,0.05315467749034182,0.0,0.07561605606108524,0.0543639053254438,0.0,0.05134423559703327,0.036982248520710054
159,0.3,8,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,Question: Does the prostate bed target's interfractional motion differ between the superior and inferior clinical target volume areas when assessed with RTOG consensus definitions and daily CT on rails? Answer: No statistically significant motion differences exist between SUP-CTV and INF-CTV. Current uniform PTV margins sufficiently cover both areas.,2.3685972735685406e-07,0.14426175871677627,0.0350413223140496,0.018134264647818726,0.17195503779748522,0.017851239669421492,0.018108015409528666,0.20067069546215155,0.0,2.3685972735685406e-07,0.2047944126460135,0.0
159,0.3,9,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Question: Using RTOG consensus definitions and daily CT on rails, is there a difference in interfractional motion between the superior and inferior portions of the prostate bed clinical target volume? Answer: No statistically significant motion differences were observed between the superior and inferior CTV. The existing uniform PTV margins adequately cover both portions.",1.1842986367842703e-07,0.14980366962385983,0.04134756657483928,0.009067132323909363,0.15031752868695403,0.040742510330578505,0.009054007704764333,0.1507619542491212,0.03993055555555556,1.1842986367842703e-07,0.12545547010915659,0.020399305555555556
159,0.3,10,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,Question: Is there a difference in interfractional motion between the superior and inferior parts of the prostate bed clinical target volume using RTOG consensus definitions and daily CT on rails? Answer: No statistically significant differences in motion were found between SUP-CTV and INF-CTV. The current uniform planning target volume margins are sufficient to cover both parts of the CTV.,2.3685972735685406e-08,0.005671230627996238,0.01652892561983471,0.0018134264647818726,0.018133879844112855,0.00031297436329903727,0.0018108015409528666,0.018018505502678472,0.0,2.3685972735685406e-08,0.018349138668195764,0.0
160,0.3,1,ai,Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: It is crucial for laboratories to accurately report serum quantitative hCG results to ensure reliable diagnostic information. Regular quality control measures and adherence to established guidelines and protocols can help ensure accurate reporting.,Are laboratories accurately reporting serum quantitative hCG results? It is essential for labs to provide precise serum quantitative hCG measurements to guarantee dependable diagnostic data. Consistent quality control and following established protocols are key to accurate reporting.,1.42115836414112e-07,0.13214600742852856,0.015642595360455328,0.010880558788691236,0.13020830035602593,0.02010548969558818,0.010864809245717207,0.12786157046977786,0.02498356344510192,1.4211583641411244e-07,0.1670540846631643,0.0
160,0.3,2,ai,Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: It is crucial for laboratories to accurately report serum quantitative hCG results to ensure reliable diagnostic information. Regular quality control measures and adherence to established guidelines and protocols can help ensure accurate reporting.,Do laboratories correctly report serum quantitative hCG results? Accurate reporting of serum quantitative hCG by laboratories is vital for reliable diagnostic outcomes. Implementing routine quality checks and adhering to guidelines ensures precision.,2.605457000925385e-07,0.294099733882645,0.006796642486754989,0.019947691112600634,0.29096038190290274,0.015358504519759425,0.019918816950481574,0.2869262650994666,0.02498356344510192,2.6054570009253947e-07,0.3313571359544403,0.0
160,0.3,3,ai,Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: It is crucial for laboratories to accurately report serum quantitative hCG results to ensure reliable diagnostic information. Regular quality control measures and adherence to established guidelines and protocols can help ensure accurate reporting.,Are serum quantitative hCG results being reported correctly by laboratories? Laboratories must report serum quantitative hCG results accurately to maintain trustworthy diagnostic information. Regular quality assurance and compliance with protocols support this accuracy.,2.3685972735685321e-07,0.3028777860443532,0.02174081292347095,0.018134264647818754,0.301399092921284,0.015557072174651972,0.0181080154095287,0.2992345254611144,0.008310134533494995,2.3685972735685406e-07,0.29626581614317127,0.0
160,0.3,4,ai,Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: It is crucial for laboratories to accurately report serum quantitative hCG results to ensure reliable diagnostic information. Regular quality control measures and adherence to established guidelines and protocols can help ensure accurate reporting.,"Is the reporting of serum quantitative hCG results by laboratories accurate? For dependable diagnostics, laboratories need to report serum quantitative hCG results precisely. This can be achieved through ongoing quality control and strict adherence to established procedures.",1.42115836414112e-07,0.1706541841263034,0.01163871093941024,0.010880558788691236,0.16981671067373671,0.008280763525518764,0.010864809245717207,0.1686349340321276,0.004401193212382016,1.4211583641411244e-07,0.1670540846631643,0.0
160,0.3,5,ai,Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: It is crucial for laboratories to accurately report serum quantitative hCG results to ensure reliable diagnostic information. Regular quality control measures and adherence to established guidelines and protocols can help ensure accurate reporting.,Are laboratories providing correct serum quantitative hCG results? Accurate serum quantitative hCG reporting is critical for reliable diagnosis. Laboratories should maintain quality control and follow established guidelines to ensure this accuracy.,2.842316728282238e-07,0.3298708349015933,0.004679386547518427,0.021761117577382513,0.3264553753729751,0.014213426988152249,0.021729618491434448,0.3220175849107356,0.02498356344510192,2.8423167282822487e-07,0.36772478012531495,0.0
160,0.3,6,ai,Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: It is crucial for laboratories to accurately report serum quantitative hCG results to ensure reliable diagnostic information. Regular quality control measures and adherence to established guidelines and protocols can help ensure accurate reporting.,"Do labs report serum quantitative hCG results with accuracy? To ensure reliable diagnostic information, it is important that laboratories report serum quantitative hCG results correctly. Regular quality assessments and protocol compliance aid in this process.",1.8948778188548261e-07,0.2753815221223257,0.04454963839579229,0.014507411718254995,0.2754671501630561,0.0413477975016437,0.014486412327622954,0.2751295898562076,0.037238658777120306,1.8948778188548325e-07,0.2742936145838488,0.0322222222222222
160,0.3,7,ai,Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: It is crucial for laboratories to accurately report serum quantitative hCG results to ensure reliable diagnostic information. Regular quality control measures and adherence to established guidelines and protocols can help ensure accurate reporting.,"Are serum quantitative hCG results from laboratories reported accurately? Accurate reporting of these results is crucial for dependable diagnostics, which can be ensured by consistent quality control and adherence to protocols.",2.842316728282238e-07,0.2374512108269342,0.0710059171597633,0.021761117577382513,0.27865212154125496,0.04865220249835634,0.021729618491434448,0.3220175849107356,0.02498356344510192,2.8423167282822487e-07,0.36772478012531495,0.0
160,0.3,8,ai,Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: It is crucial for laboratories to accurately report serum quantitative hCG results to ensure reliable diagnostic information. Regular quality control measures and adherence to established guidelines and protocols can help ensure accurate reporting.,"Is the accuracy of serum quantitative hCG result reporting by laboratories ensured? Laboratories must accurately report serum quantitative hCG to provide reliable diagnostic data, supported by routine quality control and guideline compliance.",2.605457000925385e-07,0.294099733882645,0.006796642486754989,0.019947691112600634,0.29096038190290274,0.015358504519759425,0.019918816950481574,0.2869262650994666,0.02498356344510192,2.6054570009253947e-07,0.3313571359544403,0.0
160,0.3,9,ai,Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: It is crucial for laboratories to accurately report serum quantitative hCG results to ensure reliable diagnostic information. Regular quality control measures and adherence to established guidelines and protocols can help ensure accurate reporting.,"Are laboratories correctly reporting serum quantitative hCG measurements? Precise reporting of serum quantitative hCG is essential for trustworthy diagnostics, achievable through regular quality control and following established protocols.",3.552895910352797e-07,0.4455001976788262,0.0025940828402366833,0.027201396971728152,0.4411704273954724,0.01025220249835633,0.02716202311429307,0.43534627021773975,0.02498356344510192,3.552895910352811e-07,0.4855078157816992,0.0
160,0.3,10,ai,Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: It is crucial for laboratories to accurately report serum quantitative hCG results to ensure reliable diagnostic information. Regular quality control measures and adherence to established guidelines and protocols can help ensure accurate reporting.,"Are serum quantitative hCG results being accurately reported by laboratories? It is important for laboratories to ensure precise serum quantitative hCG reporting to maintain reliable diagnostic information, supported by continuous quality control and adherence to standards.",1.6580180914979731e-07,0.16251735163509773,0.014072951135888197,0.012693985253473115,0.16036079047391594,0.019267445840872404,0.01267561078667008,0.15771453361945964,0.02498356344510192,1.6580180914979784e-07,0.19782574332991798,0.0
161,0.3,1,ai,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Current research suggests that there may be additional prognostic factors for hepatorenal syndrome that have not yet been identified. Further studies are needed to explore these potential factors and improve the understanding and management of this condition.,Question: Hepatorenal syndrome: are there prognostic factors we haven't identified? Answer: Recent studies indicate that there could be more prognostic factors for hepatorenal syndrome that remain undiscovered. Additional research is necessary to investigate these possible factors and enhance the comprehension and treatment of this syndrome.,4.737194547137081e-08,0.07595845259628531,0.02271498107084911,0.0036268529295637453,0.04546237407675724,0.0,0.003621603081905733,0.04652001563489394,0.0,4.737194547137081e-08,0.047628048989254435,0.0
161,0.3,2,ai,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Current research suggests that there may be additional prognostic factors for hepatorenal syndrome that have not yet been identified. Further studies are needed to explore these potential factors and improve the understanding and management of this condition.,Question: Hepatorenal syndrome: might we be overlooking some prognostic indicators? Answer: Current evidence points to the existence of further prognostic factors for hepatorenal syndrome that have yet to be recognized. More research is required to uncover these factors and advance the understanding and management of the disease.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
161,0.3,3,ai,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Current research suggests that there may be additional prognostic factors for hepatorenal syndrome that have not yet been identified. Further studies are needed to explore these potential factors and improve the understanding and management of this condition.,Question: Hepatorenal syndrome: could some prognostic factors be missing? Answer: Ongoing research suggests that there are potentially unknown prognostic factors for hepatorenal syndrome. Further investigation is essential to identify these factors and improve disease management and knowledge.,2.3685972735685364e-07,0.2836306347307591,0.02775510204081633,0.018134264647818726,0.2513144282809061,0.0,0.018108015409528673,0.2578291093020999,0.0,2.3685972735685406e-07,0.26469255422708216,0.0
161,0.3,4,ai,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Current research suggests that there may be additional prognostic factors for hepatorenal syndrome that have not yet been identified. Further studies are needed to explore these potential factors and improve the understanding and management of this condition.,Question: Hepatorenal syndrome: are additional prognostic factors being missed? Answer: Studies to date imply that additional prognostic factors for hepatorenal syndrome might exist but have not been identified. Continued research is needed to explore these factors and better understand and treat the condition.,9.474389094274162e-08,0.1569857954019107,0.047500000000000014,0.0072537058591274906,0.12690248065430154,0.024375,0.007243206163811466,0.09531017980432566,0.0,9.474389094274162e-08,0.09763846956391786,0.0
161,0.3,5,ai,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Current research suggests that there may be additional prognostic factors for hepatorenal syndrome that have not yet been identified. Further studies are needed to explore these potential factors and improve the understanding and management of this condition.,Question: Hepatorenal syndrome: is there a gap in known prognostic factors? Answer: Current research indicates that some prognostic factors for hepatorenal syndrome may still be undiscovered. Further studies are necessary to find these factors and enhance clinical understanding and care.,1.6580180914979774e-07,0.1650797503594501,0.0,0.012693985253473108,0.16907633004393308,0.0,0.012675610786670066,0.17327172127403623,0.0,1.6580180914979784e-07,0.17768117723745203,0.0
161,0.3,6,ai,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Current research suggests that there may be additional prognostic factors for hepatorenal syndrome that have not yet been identified. Further studies are needed to explore these potential factors and improve the understanding and management of this condition.,Question: Hepatorenal syndrome: have we overlooked some prognostic factors? Answer: Evidence suggests that there may be prognostic factors related to hepatorenal syndrome that remain unknown. More research is needed to investigate these and improve management and understanding of the syndrome.,1.6580180914979774e-07,0.1650797503594501,0.0,0.012693985253473108,0.16907633004393308,0.0,0.012675610786670066,0.17327172127403623,0.0,1.6580180914979784e-07,0.17768117723745203,0.0
161,0.3,7,ai,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Current research suggests that there may be additional prognostic factors for hepatorenal syndrome that have not yet been identified. Further studies are needed to explore these potential factors and improve the understanding and management of this condition.,Question: Hepatorenal syndrome: are we missing key prognostic factors? Answer: Research so far suggests that additional prognostic factors for hepatorenal syndrome might exist but have not yet been identified. Further studies are required to explore these and improve treatment approaches.,1.6580180914979774e-07,0.1650797503594501,0.0,0.012693985253473108,0.16907633004393308,0.0,0.012675610786670066,0.17327172127403623,0.0,1.6580180914979784e-07,0.17768117723745203,0.0
161,0.3,8,ai,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Current research suggests that there may be additional prognostic factors for hepatorenal syndrome that have not yet been identified. Further studies are needed to explore these potential factors and improve the understanding and management of this condition.,Question: Hepatorenal syndrome: could there be unidentified prognostic factors? Answer: Current findings propose that there may be prognostic factors for hepatorenal syndrome that have not been discovered. Additional research is needed to clarify these factors and enhance disease management.,1.8948778188548304e-07,0.19105523676270808,0.0,0.014507411718254981,0.19574457712609394,0.0,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
161,0.3,9,ai,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Current research suggests that there may be additional prognostic factors for hepatorenal syndrome that have not yet been identified. Further studies are needed to explore these potential factors and improve the understanding and management of this condition.,Question: Hepatorenal syndrome: are some prognostic factors still unknown? Answer: Recent research suggests that there could be unknown prognostic factors influencing hepatorenal syndrome. More studies are necessary to identify these and improve understanding and care.,2.8423167282822424e-07,0.34305423543528235,0.029384756657483937,0.021761117577382486,0.3101549283038394,0.0,0.02172961849143442,0.31845373111853537,0.0,2.8423167282822487e-07,0.32721291120841567,0.0
161,0.3,10,ai,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Current research suggests that there may be additional prognostic factors for hepatorenal syndrome that have not yet been identified. Further studies are needed to explore these potential factors and improve the understanding and management of this condition.,Question: Hepatorenal syndrome: might there be missing prognostic factors? Answer: Evidence from current studies indicates that some prognostic factors for hepatorenal syndrome may not yet be known. Further research is essential to uncover these factors and advance management and knowledge.,1.6580180914979774e-07,0.1650797503594501,0.0,0.012693985253473108,0.16907633004393308,0.0,0.012675610786670066,0.17327172127403623,0.0,1.6580180914979784e-07,0.17768117723745203,0.0
162,0.3,1,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening,"Does cup-cage reconstruction using oversized cups ensure initial stability in total hip arthroplasty (THA) for osteoporotic acetabular fractures? Most acetabular components in this group remained stable despite limited contact area with the pelvic bone, though 3 out of 10 showed migration beyond thresholds indicating potential future loosening.",1.1842986367842703e-07,0.10318423623523065,0.0,0.009067132323909363,0.10536051565782589,0.0,0.009054007704764333,0.107630664192365,0.0,1.1842986367842703e-07,0.11000089521432876,0.0
162,0.3,2,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening,"In THA for osteoporotic acetabular fractures, does employing oversized cups in cup-cage reconstruction provide initial stability? The majority of acetabular components were stable despite minimal contact with the pelvic bone; however, 3 of 10 migrated beyond limits that suggest later loosening.",2.6054570009253947e-07,0.24294617861038903,0.0,0.0199476911126006,0.248461359298501,0.0,0.019918816950481533,0.25423413838424036,0.0,2.6054570009253947e-07,0.26028309826366547,0.0
162,0.3,3,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening,"Is initial stability achieved in THA for osteoporotic acetabular fractures when using oversized cups in cup-cage reconstruction? Most acetabular components remained stable despite a small contact surface with the pelvic bone, but 3 out of 10 migrated past the limits predictive of loosening.",2.1317375462116866e-07,0.19415601444095731,0.0,0.016320838183036854,0.19845093872383757,0.0,0.0162972138685758,0.20294084399669066,0.0,2.1317375462116866e-07,0.20763936477824663,0.0
162,0.3,4,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening,"Does the use of oversized cups in cup-cage reconstruction offer initial stability in THA for osteoporotic acetabular fractures? Although the contact surface between the component and pelvic bone was small, most acetabular components were stable, with 3 of 10 migrating beyond loosening prediction limits.",1.8948778188548325e-07,0.1706255170307629,0.0,0.014507411718254981,0.17435338714477755,0.0,0.014486412327622933,0.17824823140631896,0.0,1.8948778188548325e-07,0.1823215567939549,0.0
162,0.3,5,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening,"Can cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Despite limited contact between the acetabular component and pelvic bone, most components were stable; however, 3 out of 10 migrated beyond the threshold indicating future loosening.",2.6054570009253947e-07,0.24294617861038903,0.0,0.0199476911126006,0.248461359298501,0.0,0.019918816950481533,0.25423413838424036,0.0,2.6054570009253947e-07,0.26028309826366547,0.0
162,0.3,6,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening,"In the context of THA for osteoporotic acetabular fractures, does cup-cage reconstruction with oversized cups ensure initial stability? The majority of acetabular components were stable despite small contact surfaces, though 3 of 10 migrated beyond the limits that forecast loosening.",2.8423167282822477e-07,0.26826398659468076,0.0,0.02176111757738247,0.27443684570175897,0.0,0.0217296184914344,0.2809023854664012,0.0,2.8423167282822487e-07,0.2876820724517808,0.0
162,0.3,7,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening,"Does using oversized cups in cup-cage reconstruction achieve initial stability in THA for osteoporotic acetabular fractures? Most components remained stable despite minimal contact with pelvic bone, but 3 out of 10 migrated beyond the limits predictive of loosening.",3.3160361829959537e-07,0.3209077200800996,0.0,0.025387970506946217,0.32850406697203516,0.0,0.025351221573340132,0.3364722366212134,0.0,3.316036182995957e-07,0.34484048629172914,0.0
162,0.3,8,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening,"Is initial stability provided by cup-cage reconstruction with oversized cups in THA for osteoporotic acetabular fractures? Despite a small contact area between the component and pelvic bone, most acetabular components were stable, with 3 of 10 migrating beyond loosening prediction thresholds.",2.6054570009253947e-07,0.24294617861038903,0.0,0.0199476911126006,0.248461359298501,0.0,0.019918816950481533,0.25423413838424036,0.0,2.6054570009253947e-07,0.26028309826366547,0.0
162,0.3,9,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening,"Does cup-cage reconstruction with oversized cups guarantee initial stability in THA for osteoporotic acetabular fractures? Although the contact surface was limited, most acetabular components were stable, but 3 out of 10 migrated beyond limits that predict loosening.",3.5528959103528067e-07,0.3483066942682149,0.0,0.02720139697172809,0.356674943938732,0.0,0.027162023114293006,0.3654597734944649,0.0,3.552895910352811e-07,0.3746934494414109,0.0
162,0.3,10,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening,"In THA for osteoporotic acetabular fractures, does the use of oversized cups in cup-cage reconstruction provide initial stability? Most acetabular components remained stable despite the small contact surface with the pelvic bone, though 3 of 10 migrated beyond the limits indicating potential loosening.",2.1317375462116866e-07,0.19415601444095731,0.0,0.016320838183036854,0.19845093872383757,0.0,0.0162972138685758,0.20294084399669066,0.0,2.1317375462116866e-07,0.20763936477824663,0.0
163,0.3,1,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Is there a connection between cervical cord plaques and discopathy in multiple sclerosis patients? The study data indicates a potential correlation between cervical discopathy and cervical MS plaques.,7.10579182070559e-08,0.11049493921752918,0.003688550542113131,0.005440279394345639,0.10919929196499067,0.0,0.005432404622858621,0.11332868530700413,0.0,7.105791820705622e-08,0.11778303565638426,0.0
163,0.3,2,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,"Does a relationship exist between cervical cord plaques and discopathy in patients with multiple sclerosis? According to the study data, there may be a correlation between cervical discopathy and cervical MS plaques.",2.36859727356853e-08,0.03428046192097023,0.0010714757563747151,0.0018134264647818796,0.03390155167568176,0.0,0.0018108015409528735,0.035091319811269006,0.0,2.3685972735685406e-08,0.03636764417087468,0.0
163,0.3,3,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Are cervical cord plaques related to discopathy in individuals with multiple sclerosis? The study findings suggest a possible link between cervical discopathy and cervical MS plaques.,1.184298636784265e-07,0.13611174475662535,0.033293697978596916,0.009067132323909398,0.18924199963852795,0.0,0.009054007704764368,0.19671029424605457,0.0,1.1842986367842703e-07,0.20479441264601395,0.0
163,0.3,4,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Is there an association between cervical cord plaques and discopathy in multiple sclerosis patients? The data from the study points to a potential correlation between cervical discopathy and cervical MS plaques.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
163,0.3,5,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Do cervical cord plaques have any relation to discopathy in patients with multiple sclerosis? Study data suggests a possible connection between cervical discopathy and cervical MS plaques.,9.47438909427412e-08,0.09689103160334289,0.033293697978596916,0.007253705859127518,0.14842000511827314,0.0,0.007243206163811494,0.15415067982725894,0.0,9.474389094274162e-08,0.1603426500751799,0.0
163,0.3,6,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Is there any link between cervical cord plaques and discopathy in multiple sclerosis patients? The study data implies a possible correlation between cervical discopathy and cervical MS plaques.,7.10579182070559e-08,0.11049493921752918,0.003688550542113131,0.005440279394345639,0.10919929196499067,0.0,0.005432404622858621,0.11332868530700413,0.0,7.105791820705622e-08,0.11778303565638426,0.0
163,0.3,7,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Can cervical cord plaques be related to discopathy in patients with multiple sclerosis? The study results suggest a potential association between cervical discopathy and cervical MS plaques.,9.47438909427412e-08,0.09689103160334289,0.033293697978596916,0.007253705859127518,0.14842000511827314,0.0,0.007243206163811494,0.15415067982725894,0.0,9.474389094274162e-08,0.1603426500751799,0.0
163,0.3,8,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Is there a correlation between cervical cord plaques and discopathy in multiple sclerosis patients? The study data indicates a possible relationship between cervical discopathy and cervical MS plaques.,7.10579182070559e-08,0.11049493921752918,0.003688550542113131,0.005440279394345639,0.10919929196499067,0.0,0.005432404622858621,0.11332868530700413,0.0,7.105791820705622e-08,0.11778303565638426,0.0
163,0.3,9,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Are cervical cord plaques and discopathy connected in patients with multiple sclerosis? Study data suggests a potential correlation between cervical discopathy and cervical MS plaques.,1.421158364141118e-07,0.17693373927688016,0.033293697978596916,0.010880558788691277,0.23180161405732358,0.0,0.010864809245717241,0.24116205681688863,0.0,1.4211583641411244e-07,0.2513144282809079,0.0
163,0.3,10,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Is there any relationship between cervical cord plaques and discopathy in multiple sclerosis patients? The study data suggests a possible link between cervical discopathy and cervical MS plaques.,7.10579182070559e-08,0.11049493921752918,0.003688550542113131,0.005440279394345639,0.10919929196499067,0.0,0.005432404622858621,0.11332868530700413,0.0,7.105791820705622e-08,0.11778303565638426,0.0
164,0.3,1,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Is aneurysm repair warranted for patients aged 80 or above following aneurysmal subarachnoid hemorrhage? The study shows improved outcomes when ruptured aneurysms in elderly patients are surgically repaired compared to conservative treatment. Therefore, definitive surgery should be confidently offered to elderly patients with aSAH.",2.3685972735685406e-07,0.18901820684629156,0.0144351858390415,0.018134264647818726,0.21357410029806,0.0,0.018108015409528666,0.21825356602001733,0.0,2.3685972735685406e-07,0.22314355131420927,0.0
164,0.3,2,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Should aneurysm repair be performed on patients 80 years or older after aneurysmal subarachnoid hemorrhage? Findings indicate that elderly patients have better prognoses when ruptured aneurysms are surgically treated rather than managed conservatively. Hence, definitive surgery is recommended for elderly aSAH patients.",2.8423167282822487e-07,0.2044068520885718,0.03767781622452902,0.02176111757738247,0.2623642644674917,0.0,0.0217296184914344,0.26826398659468076,0.0,2.8423167282822487e-07,0.27443684570175897,0.0
164,0.3,3,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Is it appropriate to repair aneurysms in patients aged 80 or older after aneurysmal subarachnoid hemorrhage? This study found that elderly patients who underwent aneurysm repair had better outcomes than those treated conservatively, suggesting surgery should not be withheld from this group.",2.8423167282822487e-07,0.2044068520885718,0.03767781622452902,0.02176111757738247,0.2623642644674917,0.0,0.0217296184914344,0.26826398659468076,0.0,2.8423167282822487e-07,0.27443684570175897,0.0
164,0.3,4,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","For patients aged 80 and above with aneurysmal subarachnoid hemorrhage, is aneurysm repair justified? The results demonstrate that surgical repair leads to better prognosis in elderly patients compared to conservative management, supporting the use of definitive surgery in these cases.",3.316036182995956e-07,0.2544172726632352,0.03767781622452902,0.025387970506946217,0.31365755885504143,0.0,0.025351221573340132,0.3209077200800996,0.0,3.316036182995957e-07,0.32850406697203516,0.0
164,0.3,5,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Does aneurysm repair benefit patients aged 80 or older after aneurysmal subarachnoid hemorrhage? The study reveals improved prognosis with surgical repair over conservative treatment in the elderly, indicating that definitive surgery should be offered without hesitation.",4.263475092423368e-07,0.3626308573034662,0.03767781622452902,0.032641676366073714,0.42488319396526597,0.0,0.03259442773715161,0.43531807125784505,0.0,4.263475092423373e-07,0.446287102628419,0.0
164,0.3,6,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Is surgical repair of aneurysms justified in patients 80 years or older following aneurysmal subarachnoid hemorrhage? Evidence from this study shows better outcomes with repair than conservative care in elderly patients, advocating for offering definitive surgery to this population.",3.552895910352809e-07,0.2803927590664932,0.03767781622452902,0.02720139697172809,0.3403258059372023,0.0,0.027162023114293,0.3483066942682149,0.0,3.552895910352811e-07,0.356674943938732,0.0
164,0.3,7,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Should elderly patients aged 80 or more with aneurysmal subarachnoid hemorrhage undergo aneurysm repair? The findings suggest a superior prognosis with surgical intervention compared to conservative treatment, supporting definitive surgery for elderly aSAH patients.",4.737194547137074e-07,0.4214713573263995,0.03767781622452902,0.036268529295637474,0.48550781578170144,0.0,0.03621603081905736,0.49783842823917857,0.0,4.737194547137081e-07,0.5108256237659905,0.0
164,0.3,8,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Is it justified to perform aneurysm repair on patients aged 80 or older after aneurysmal subarachnoid hemorrhage? The study indicates that elderly patients have better outcomes with surgical repair than with conservative treatment, so definitive surgery should be considered.",3.552895910352809e-07,0.2803927590664932,0.03767781622452902,0.02720139697172809,0.3403258059372023,0.0,0.027162023114293,0.3483066942682149,0.0,3.552895910352811e-07,0.356674943938732,0.0
164,0.3,9,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Is aneurysm repair advisable for patients aged 80 and above after aneurysmal subarachnoid hemorrhage? Results show that elderly patients benefit more from surgical repair than conservative management, thus definitive surgery should be offered to them.",4.500334819780221e-07,0.39161839417671773,0.03767781622452902,0.034455102830855594,0.45473615711494775,0.0,0.034405229278104486,0.46608972992459874,0.0,4.500334819780227e-07,0.4780358009429988,0.0
164,0.3,10,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","For patients aged 80 or older with aneurysmal subarachnoid hemorrhage, is aneurysm repair warranted? The study's outcomes reveal better prognosis with surgical repair compared to conservative treatment in the elderly, supporting the use of definitive surgery in these cases.",3.552895910352809e-07,0.2803927590664932,0.03767781622452902,0.02720139697172809,0.3403258059372023,0.0,0.027162023114293,0.3483066942682149,0.0,3.552895910352811e-07,0.356674943938732,0.0
165,0.3,1,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these","Do individuals with episodic migraines specifically focus on visual stimuli related to headaches? Based on the extensive sample size and previous pilot testing of the images shown, findings indicate that episodic migraine sufferers do not show selective attention to headache-related facial images. While there is some limited evidence of attentional biases in chronic headache groups, these results suggest otherwise.",2.3685972735685406e-07,0.2758853972085209,0.06222222222222222,0.018134264647818726,0.22239929082917076,0.0212665406427221,0.018108015409528666,0.19671029424605502,0.0,2.3685972735685406e-07,0.20067069546215155,0.0
165,0.3,2,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these","Are people with episodic migraines more likely to pay attention to headache-related visual cues? Considering the large participant pool and earlier pilot studies of the images, the data imply that episodic migraineurs do not preferentially attend to facial stimuli associated with headaches. Although modest signs of attentional bias exist in chronic headache populations, these findings do not support that for episodic cases.",3.079176455639103e-07,0.30359011376787315,0.04583333333333332,0.023574544042164344,0.27369258521672,0.0212665406427221,0.023540420032387266,0.2488960474166242,0.0,3.079176455639103e-07,0.25378052077609947,0.0
165,0.3,3,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these","Do episodic migraine patients selectively focus on headache-related visual stimuli? Given the substantial sample size and prior pilot testing of the images, the results indicate that episodic migraineurs do not exhibit differential attention to headache-related facial stimuli. There is only limited evidence of attentional biases in chronic headache sufferers, which contrasts with these findings.",1.1842986367842703e-07,0.18573430021422288,0.06222222222222222,0.009067132323909363,0.13059174157604847,0.0212665406427221,0.009054007704764333,0.10318423623523065,0.0,1.1842986367842703e-07,0.10536051565782589,0.0
165,0.3,4,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these","Is selective attention to headache-related visual stimuli present in episodic migraineurs? With a large sample and previous pilot testing of the images, results suggest that episodic migraine patients do not show a preference for headache-related facial stimuli. While some modest attentional biases have been noted in chronic headache groups, this study does not find the same for episodic migraineurs.",2.3685972735685406e-07,0.2758853972085209,0.06222222222222222,0.018134264647818726,0.22239929082917076,0.0212665406427221,0.018108015409528666,0.19671029424605502,0.0,2.3685972735685406e-07,0.20067069546215155,0.0
165,0.3,5,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these","Do people experiencing episodic migraines focus more on headache-related visual stimuli? Based on the large sample size and earlier pilot testing of the images, the findings suggest that episodic migraineurs do not selectively attend to headache-related facial images. There is only modest evidence of attentional biases among chronic headache sufferers, which differs from these results.",1.4211583641411244e-07,0.2044264332263772,0.06222222222222222,0.010880558788691236,0.14963993654674157,0.0212665406427221,0.0108648092457172,0.12260232209233335,0.0,1.4211583641411244e-07,0.12516314295400566,0.0
165,0.3,6,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these","Are headache-related visual stimuli selectively attended to by episodic migraineurs? Considering the large sample and prior pilot testing of the images, the evidence suggests that episodic migraine patients do not differentially attend to headache-related facial stimuli. Although some modest attentional biases have been found in chronic headache samples, these results do not confirm that for episodic migraineurs.",1.8948778188548325e-07,0.21603882094868165,0.044370982552800725,0.014507411718254981,0.18668120822709167,0.0212665406427221,0.014486412327622933,0.16034265007518078,0.0,1.8948778188548325e-07,0.16362942378180145,0.0
165,0.3,7,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these","Do episodic migraine sufferers show selective attention to headache-related visual cues? Given the extensive sample size and previous pilot testing of the images, results indicate that episodic migraineurs do not preferentially attend to headache-related facial stimuli. There is limited evidence of attentional biases in chronic headache sufferers, contrasting with these findings.",4.737194547137081e-08,0.09973950486784933,0.04223055208477949,0.0036268529295637453,0.0711683211052474,0.0212665406427221,0.003621603081905733,0.04255961441879652,0.0,4.737194547137081e-08,0.04348511193973836,0.0
165,0.3,8,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these","Is there selective attention to headache-related visual stimuli among episodic migraineurs? With a large sample and prior pilot testing of images, the results suggest episodic migraine patients do not differentially focus on headache-related facial stimuli. While modest attentional biases exist in chronic headache populations, these findings do not support such biases in episodic migraineurs.",1.1842986367842703e-07,0.159577802834602,0.04336127547666009,0.009067132323909363,0.13059174157604847,0.0212665406427221,0.009054007704764333,0.10318423623523065,0.0,1.1842986367842703e-07,0.10536051565782589,0.0
165,0.3,9,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these","Do individuals with episodic migraines exhibit selective attention to headache-related visual stimuli? Based on the large sample size and earlier pilot testing of the presented images, findings suggest that episodic migraineurs do not selectively attend to headache-related facial stimuli. There is modest evidence of attentional biases in chronic headache samples, but these results do not align with that.",2.1317375462116866e-07,0.20985174708893606,0.027180899908172615,0.016320838183036854,0.20469971372977014,0.0212665406427221,0.0162972138685758,0.17869178874337655,0.0,2.1317375462116866e-07,0.18232155679395579,0.0
165,0.3,10,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these","Are episodic migraineurs more attentive to headache-related visual stimuli? Considering the large sample size and prior pilot testing of images, the data suggest that episodic migraine sufferers do not show differential attention to headache-related facial stimuli. Although modest attentional biases have been observed in chronic headache groups, these results indicate otherwise.",4.737194547137081e-08,0.09973950486784933,0.04223055208477949,0.0036268529295637453,0.0711683211052474,0.0212665406427221,0.003621603081905733,0.04255961441879652,0.0,4.737194547137081e-08,0.04348511193973836,0.0
166,0.3,1,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The distribution of health care benefits in Kenya does not fully meet the principles of universal coverage. While efforts have been made to expand access to health services, there are still significant gaps in coverage, particularly for vulnerable populations and those in remote areas.","Does Kenya's health care benefits distribution align with universal coverage principles? The distribution in Kenya falls short of fully meeting universal coverage principles. Despite efforts to broaden health service access, notable coverage gaps remain, especially for vulnerable groups and remote regions.",4.737194547137081e-07,0.18596850093084738,0.1491105640017952,0.03626852929563745,0.20250716641880295,0.1476,0.03621603081905733,0.2555454624090112,0.11841599384851978,4.737194547137081e-07,0.310528586671035,0.0869082840236687
166,0.3,2,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The distribution of health care benefits in Kenya does not fully meet the principles of universal coverage. While efforts have been made to expand access to health services, there are still significant gaps in coverage, particularly for vulnerable populations and those in remote areas.","Is the allocation of health care benefits in Kenya consistent with universal coverage principles? Kenya's health care benefits distribution does not completely adhere to universal coverage principles. Although access to health services has been expanded, significant coverage gaps persist, particularly affecting vulnerable populations and those living in remote areas.",2.8423167282822487e-07,0.055632982678889054,0.1118719052246749,0.02176111757738247,0.04541683554306797,0.1263334593572779,0.0217296184914344,0.06449022564630313,0.11841599384851978,2.8423167282822487e-07,0.11478400954494106,0.0869082840236687
166,0.3,3,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The distribution of health care benefits in Kenya does not fully meet the principles of universal coverage. While efforts have been made to expand access to health services, there are still significant gaps in coverage, particularly for vulnerable populations and those in remote areas.","Does Kenya's health care benefits distribution satisfy the criteria for universal coverage? The distribution does not entirely satisfy universal coverage criteria. While access to health services has improved, substantial gaps remain, especially for vulnerable and remote populations.",5.684633456564493e-07,0.2566716575606769,0.17409412744689712,0.04352223515476494,0.31072075105903396,0.1476,0.043459236982868805,0.36677109751923576,0.11841599384851978,5.684633456564497e-07,0.42493893784878045,0.0869082840236687
166,0.3,4,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The distribution of health care benefits in Kenya does not fully meet the principles of universal coverage. While efforts have been made to expand access to health services, there are still significant gaps in coverage, particularly for vulnerable populations and those in remote areas.","Is the distribution of health care benefits in Kenya in line with universal coverage principles? Kenya's health care benefits distribution does not fully comply with universal coverage principles. Efforts to increase access have been made, yet significant coverage gaps exist, notably for vulnerable groups and remote communities.",3.316036182995957e-07,0.13209653527724807,0.08792632699338236,0.025387970506946217,0.12101940549456724,0.10325170362358033,0.025351221573340132,0.10894198821713585,0.11841599384851978,3.316036182995957e-07,0.1602463836216983,0.0869082840236687
166,0.3,5,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The distribution of health care benefits in Kenya does not fully meet the principles of universal coverage. While efforts have been made to expand access to health services, there are still significant gaps in coverage, particularly for vulnerable populations and those in remote areas.","Does the way health care benefits are distributed in Kenya meet universal coverage standards? The distribution in Kenya does not completely meet universal coverage standards. Despite initiatives to expand health service access, there are still major gaps in coverage, particularly for vulnerable and remote populations.",3.789755637709665e-07,0.15052103217488222,0.10627735171816419,0.029014823436509962,0.1371081006018593,0.12435736961451249,0.028972824655245866,0.1554620038520298,0.11841599384851978,3.789755637709665e-07,0.20787443261095273,0.0869082840236687
166,0.3,6,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The distribution of health care benefits in Kenya does not fully meet the principles of universal coverage. While efforts have been made to expand access to health services, there are still significant gaps in coverage, particularly for vulnerable populations and those in remote areas.","Is the health care benefits distribution in Kenya aligned with the principles of universal coverage? The distribution does not fully align with universal coverage principles. Although access has been broadened, significant gaps remain, especially among vulnerable groups and those in remote locations.",4.500334819780227e-07,0.1266185293124793,0.17409412744689712,0.03445510283085558,0.17718935843451122,0.1476,0.034405229278104466,0.22956997600575324,0.11841599384851978,4.500334819780227e-07,0.28386033958887413,0.0869082840236687
166,0.3,7,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The distribution of health care benefits in Kenya does not fully meet the principles of universal coverage. While efforts have been made to expand access to health services, there are still significant gaps in coverage, particularly for vulnerable populations and those in remote areas.","Does Kenya's distribution of health care benefits conform to universal coverage principles? The distribution does not fully conform to universal coverage principles. Efforts to expand health service access have been made, but notable gaps persist, particularly for vulnerable and remote populations.",4.737194547137081e-07,0.2552832189868419,0.09958718807509288,0.03626852929563745,0.27359918493777124,0.09646778670562456,0.03621603081905733,0.29202689296479756,0.0921194270114124,4.737194547137081e-07,0.310528586671035,0.0869082840236687
166,0.3,8,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The distribution of health care benefits in Kenya does not fully meet the principles of universal coverage. While efforts have been made to expand access to health services, there are still significant gaps in coverage, particularly for vulnerable populations and those in remote areas.","Is the distribution of health care benefits in Kenya consistent with universal coverage principles? Kenya's distribution is not entirely consistent with universal coverage principles. While access to health services has increased, significant coverage gaps remain, especially for vulnerable and remote groups.",4.737194547137081e-07,0.2552832189868419,0.09958718807509288,0.03626852929563745,0.27359918493777124,0.09646778670562456,0.03621603081905733,0.29202689296479756,0.0921194270114124,4.737194547137081e-07,0.310528586671035,0.0869082840236687
166,0.3,9,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The distribution of health care benefits in Kenya does not fully meet the principles of universal coverage. While efforts have been made to expand access to health services, there are still significant gaps in coverage, particularly for vulnerable populations and those in remote areas.","Does the distribution of health care benefits in Kenya fulfill the principles of universal coverage? The distribution does not completely fulfill universal coverage principles. Despite efforts to improve access, there are still considerable gaps in coverage, particularly for vulnerable populations and those in remote areas.",3.789755637709665e-07,0.08750765212397793,0.15137914637604802,0.029014823436509962,0.10486869685488509,0.1476,0.028972824655245866,0.1554620038520298,0.11841599384851978,3.789755637709665e-07,0.20787443261095273,0.0869082840236687
166,0.3,10,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The distribution of health care benefits in Kenya does not fully meet the principles of universal coverage. While efforts have been made to expand access to health services, there are still significant gaps in coverage, particularly for vulnerable populations and those in remote areas.","Is the allocation of health care benefits in Kenya adequate according to universal coverage principles? The allocation does not fully meet universal coverage principles. Although access to health services has been expanded, significant gaps remain, especially for vulnerable and remote populations.",4.737194547137081e-07,0.2206258599588451,0.12423263160202178,0.03626852929563745,0.20250716641880295,0.1476,0.03621603081905733,0.2555454624090112,0.11841599384851978,4.737194547137081e-07,0.310528586671035,0.0869082840236687
167,0.3,1,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: Yes, a novel surgical approach to the temporomandibular joint has the potential to improve access and reduce complications by providing better visualization, precise instrumentation, and less tissue trauma. However, more research and clinical","Can a new surgical technique for the temporomandibular joint enhance access and minimize complications? Yes, this innovative approach can improve access and lower complication rates through improved visualization, precise tools, and reduced tissue damage. Further research and clinical studies are needed.",1.8948778188548325e-07,0.0718324094113596,0.16892225372941336,0.014507411718254981,0.04937904205701438,0.16305062458908606,0.014486412327622933,0.010234233138374904,0.1275,1.8948778188548325e-07,0.07251841169321516,0.08804283164782867
167,0.3,2,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: Yes, a novel surgical approach to the temporomandibular joint has the potential to improve access and reduce complications by providing better visualization, precise instrumentation, and less tissue trauma. However, more research and clinical","Is it possible for a novel surgical method targeting the temporomandibular joint to improve access and decrease complications? Indeed, such a technique offers better visualization, more accurate instrumentation, and less trauma to tissues, potentially improving outcomes. Additional research and clinical validation are required.",1.4211583641411244e-07,0.1552799326087877,0.19390581717451527,0.010880558788691236,0.0993894626316778,0.16305062458908606,0.0108648092457172,0.0410590612491748,0.1275,1.4211583641411244e-07,0.019874678207796315,0.08804283164782867
167,0.3,3,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: Yes, a novel surgical approach to the temporomandibular joint has the potential to improve access and reduce complications by providing better visualization, precise instrumentation, and less tissue trauma. However, more research and clinical","Could an innovative surgical approach to the temporomandibular joint enhance surgical access and reduce complications? Yes, by enabling superior visualization, precise instruments, and minimizing tissue injury, this new method shows promise. Nonetheless, further clinical research is necessary.",2.8423167282822445e-07,0.001129252781530088,0.19390581717451527,0.02176111757738247,0.05883454258321663,0.16305062458908606,0.021729618491434406,0.12145986824859945,0.1275,2.8423167282822487e-07,0.1869287628709606,0.08804283164782867
167,0.3,4,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: Yes, a novel surgical approach to the temporomandibular joint has the potential to improve access and reduce complications by providing better visualization, precise instrumentation, and less tissue trauma. However, more research and clinical","Does a novel surgical approach to the temporomandibular joint have the ability to improve access and reduce complications? Yes, it can provide enhanced visualization, precise instrumentation, and less tissue trauma, which may lead to better outcomes. More clinical studies are still needed.",1.6580180914979784e-07,0.13118238102972768,0.19390581717451527,0.012693985253473108,0.0746968500413061,0.16305062458908606,0.012675610786670066,0.01574125326488307,0.1275,1.6580180914979784e-07,0.04585016461105429,0.08804283164782867
167,0.3,5,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: Yes, a novel surgical approach to the temporomandibular joint has the potential to improve access and reduce complications by providing better visualization, precise instrumentation, and less tissue trauma. However, more research and clinical","Can a new surgical technique for the temporomandibular joint improve access and lower complication risks? Yes, this approach can offer improved visualization, accurate instrumentation, and reduced tissue trauma, but further research is required.",3.7897556377096565e-07,0.11665378287485373,0.19390581717451527,0.02901482343650999,0.18019539958748343,0.16305062458908606,0.0289728246552459,0.24662301120260643,0.1275,3.789755637709665e-07,0.3161404943509676,0.08804283164782867
167,0.3,6,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: Yes, a novel surgical approach to the temporomandibular joint has the potential to improve access and reduce complications by providing better visualization, precise instrumentation, and less tissue trauma. However, more research and clinical","Is a novel surgical method for the temporomandibular joint capable of improving access and minimizing complications? Yes, it potentially enhances access and reduces complications by offering better visualization, precise tools, and less tissue damage, though more clinical research is essential.",2.1317375462116855e-07,0.04562595119558033,0.16828254847645432,0.016320838183036854,0.023403555653756403,0.16305062458908606,0.0162972138685758,0.03690248022053577,0.1275,2.1317375462116866e-07,0.09991738588133048,0.08804283164782867
167,0.3,7,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: Yes, a novel surgical approach to the temporomandibular joint has the potential to improve access and reduce complications by providing better visualization, precise instrumentation, and less tissue trauma. However, more research and clinical","Could a novel surgical approach to the temporomandibular joint improve surgical access and decrease complications? Yes, by providing improved visualization, precise instrumentation, and less trauma to tissues, it holds potential, but additional research is needed.",3.3160361829959505e-07,0.056029161058418264,0.19390581717451527,0.02538797050694623,0.11767504260614992,0.16305062458908606,0.025351221573340153,0.1820844900650349,0.1275,3.316036182995957e-07,0.24944911985229412,0.08804283164782867
167,0.3,8,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: Yes, a novel surgical approach to the temporomandibular joint has the potential to improve access and reduce complications by providing better visualization, precise instrumentation, and less tissue trauma. However, more research and clinical","Does a new surgical technique for the temporomandibular joint improve access and reduce complications? Yes, it can enhance visualization, allow for precise instrumentation, and cause less tissue trauma, although further clinical studies are necessary.",3.5528959103528035e-07,0.08588212420810004,0.19390581717451527,0.02720139697172811,0.1484467012729036,0.16305062458908606,0.027162023114293027,0.21383318837961474,0.1275,3.552895910352811e-07,0.2822389426752858,0.08804283164782867
167,0.3,9,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: Yes, a novel surgical approach to the temporomandibular joint has the potential to improve access and reduce complications by providing better visualization, precise instrumentation, and less tissue trauma. However, more research and clinical","Is it feasible that a novel surgical approach to the temporomandibular joint can improve access and reduce complications? Yes, this method offers better visualization, precise instruments, and less tissue injury, but more research and clinical trials are required.",2.6054570009253915e-07,0.02852822696964541,0.19390581717451527,0.0199476911126006,0.030663665616519786,0.16305062458908606,0.019918816950481533,0.09247233137534794,0.1275,2.6054570009253947e-07,0.15707579972127883,0.08804283164782867
167,0.3,10,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: Yes, a novel surgical approach to the temporomandibular joint has the potential to improve access and reduce complications by providing better visualization, precise instrumentation, and less tissue trauma. However, more research and clinical","Can an innovative surgical approach to the temporomandibular joint enhance access and lower complication rates? Yes, by improving visualization, enabling precise instrumentation, and minimizing tissue trauma, it shows promise, yet further clinical research is needed.",3.3160361829959505e-07,0.056029161058418264,0.19390581717451527,0.02538797050694623,0.11767504260614992,0.16305062458908606,0.025351221573340153,0.1820844900650349,0.1275,3.316036182995957e-07,0.24944911985229412,0.08804283164782867
168,0.3,1,ai,Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: There is limited evidence suggesting that head positioning may have an influence on anterior chamber depth in pseudoexfoliation syndrome. Further research is needed to confirm these findings and determine the extent of the relationship.,Question: Does head positioning affect anterior chamber depth in pseudoexfoliation syndrome? Answer: Current evidence is limited but indicates that head positioning might impact anterior chamber depth in pseudoexfoliation syndrome. More studies are required to verify these results and clarify the relationship.,1.1842986367842703e-07,0.13703712400527035,0.013073979591836732,0.009067132323909363,0.13274594549071272,0.008572113160155964,0.009054007704764333,0.13209800958480056,0.006068183988072934,1.1842986367842703e-07,0.13121211220645312,0.003210812934687609
168,0.3,2,ai,Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: There is limited evidence suggesting that head positioning may have an influence on anterior chamber depth in pseudoexfoliation syndrome. Further research is needed to confirm these findings and determine the extent of the relationship.,Question: Is anterior chamber depth in pseudoexfoliation syndrome influenced by head positioning? Answer: There is some limited evidence that head positioning could influence anterior chamber depth in pseudoexfoliation syndrome. Additional research is necessary to confirm and understand this potential connection.,1.4211583641411233e-07,0.13125217388751276,0.008150510204081599,0.010880558788691236,0.16152769578287884,0.010550571210042575,0.0108648092457172,0.16073822588619402,0.007476599206011972,1.4211583641411244e-07,0.15965184792694087,0.003959742135997774
168,0.3,3,ai,Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: There is limited evidence suggesting that head positioning may have an influence on anterior chamber depth in pseudoexfoliation syndrome. Further research is needed to confirm these findings and determine the extent of the relationship.,"Question: Can head positioning alter anterior chamber depth in pseudoexfoliation syndrome? Answer: Limited data suggest a possible effect of head positioning on anterior chamber depth in pseudoexfoliation syndrome, but further investigation is needed to confirm and quantify this effect.",1.6580180914979763e-07,0.19745077603176808,0.01918331037649218,0.012693985253473108,0.19115389669388794,0.012633051260886416,0.012675610786670066,0.1902187231390533,0.008962369984911768,1.6580180914979784e-07,0.1889229585135741,0.004751352897949604
168,0.3,4,ai,Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: There is limited evidence suggesting that head positioning may have an influence on anterior chamber depth in pseudoexfoliation syndrome. Further research is needed to confirm these findings and determine the extent of the relationship.,Question: Does the position of the head impact the anterior chamber depth in pseudoexfoliation syndrome? Answer: Evidence is scarce but suggests that head position may influence anterior chamber depth in pseudoexfoliation syndrome. More research is essential to establish and detail this relationship.,9.474389094274162e-08,0.07430594662807266,0.012954254930606257,0.0072537058591274906,0.1047621868119597,0.0066901636430713035,0.007243206163811466,0.10425168058893775,0.004731261479979244,9.474389094274162e-08,0.10355788051467618,0.002501206932288818
168,0.3,5,ai,Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: There is limited evidence suggesting that head positioning may have an influence on anterior chamber depth in pseudoexfoliation syndrome. Further research is needed to confirm these findings and determine the extent of the relationship.,"Question: Is there an effect of head positioning on anterior chamber depth in pseudoexfoliation syndrome? Answer: Although evidence is limited, it points to a potential influence of head positioning on anterior chamber depth in pseudoexfoliation syndrome. Further studies are required to confirm these findings.",4.737194547137081e-08,0.1493448972614524,0.0669515306122449,0.0036268529295637453,0.18304900574518568,0.0921832242712671,0.003621603081905733,0.18602158702504568,0.09563986451213444,4.737194547137081e-08,0.1890699507113256,0.09865361968701818
168,0.3,6,ai,Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: There is limited evidence suggesting that head positioning may have an influence on anterior chamber depth in pseudoexfoliation syndrome. Further research is needed to confirm these findings and determine the extent of the relationship.,Question: Does head posture affect anterior chamber depth in pseudoexfoliation syndrome? Answer: Limited evidence indicates that head posture might affect anterior chamber depth in pseudoexfoliation syndrome. Additional research is needed to validate and explore this association.,2.3685972735685353e-07,0.33493218339607456,0.054715368608799025,0.018134264647818733,0.3264024934751415,0.04773877982682266,0.01810801540952868,0.3262405068349419,0.04359904818560383,2.3685972735685406e-07,0.32557010445554413,0.03842686231740367
168,0.3,7,ai,Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: There is limited evidence suggesting that head positioning may have an influence on anterior chamber depth in pseudoexfoliation syndrome. Further research is needed to confirm these findings and determine the extent of the relationship.,"Question: Could head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: There is limited evidence suggesting that head positioning may influence anterior chamber depth in pseudoexfoliation syndrome, but further research is necessary to confirm and understand this relationship.",1.6580180914979763e-07,0.23393220658755487,0.04296875,0.012693985253473108,0.22862131185929035,0.0387029671546463,0.012675610786670066,0.22872689983682815,0.036243676284777336,1.6580180914979784e-07,0.2285313688312849,0.03313760611905655
168,0.3,8,ai,Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: There is limited evidence suggesting that head positioning may have an influence on anterior chamber depth in pseudoexfoliation syndrome. Further research is needed to confirm these findings and determine the extent of the relationship.,Question: Is anterior chamber depth in pseudoexfoliation syndrome dependent on head positioning? Answer: The evidence is limited but suggests a possible dependency of anterior chamber depth on head positioning in pseudoexfoliation syndrome. More research is needed to confirm and elaborate on this.,9.474389094274162e-08,0.07430594662807266,0.012954254930606257,0.0072537058591274906,0.03544746875596516,0.04283321228363101,0.007243206163811466,0.03315966206996945,0.046400951814396206,9.474389094274162e-08,0.06707644995888984,0.023795359904818555
168,0.3,9,ai,Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: There is limited evidence suggesting that head positioning may have an influence on anterior chamber depth in pseudoexfoliation syndrome. Further research is needed to confirm these findings and determine the extent of the relationship.,"Question: Does changing head position affect anterior chamber depth in pseudoexfoliation syndrome? Answer: Limited evidence suggests that changes in head position might affect anterior chamber depth in pseudoexfoliation syndrome, warranting further research to confirm these findings.",2.3685972735685353e-07,0.33493218339607456,0.054715368608799025,0.018134264647818733,0.3264024934751415,0.04773877982682266,0.01810801540952868,0.3262405068349419,0.04359904818560383,2.3685972735685406e-07,0.32557010445554413,0.03842686231740367
168,0.3,10,ai,Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: There is limited evidence suggesting that head positioning may have an influence on anterior chamber depth in pseudoexfoliation syndrome. Further research is needed to confirm these findings and determine the extent of the relationship.,"Question: Is there a relationship between head positioning and anterior chamber depth in pseudoexfoliation syndrome? Answer: Current limited evidence suggests a relationship between head positioning and anterior chamber depth in pseudoexfoliation syndrome, but more research is needed to confirm and define this link.",7.105791820705622e-08,0.24503025067677875,0.10546875,0.005440279394345618,0.2804060154322068,0.13433166177126707,0.0054324046228586,0.2851007263096559,0.1410990481856038,7.105791820705622e-08,0.2899230283720202,0.14710307759518143
169,0.3,1,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"Is there a link between the CYP2D6*4 allele and breast cancer risk? It is suggested that CYP2D6*4 poor metabolizers may have reduced activation of procarcinogens, potentially offering protection against carcinogens.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
169,0.3,2,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,Does the CYP2D6*4 allele influence breast cancer risk? Reduced conversion of procarcinogens by CYP2D6*4 poor metabolizers might provide a protective effect against carcinogens.,1.658018091497971e-07,0.27625337662815763,0.0,0.012693985253473157,0.28768207245178257,0.0,0.012675610786670115,0.30010459245033916,0.0,1.6580180914979774e-07,0.3136575588550423,0.0
169,0.3,3,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"Is there any association between the CYP2D6*4 allele and breast cancer risk? CYP2D6*4 poor metabolizers could have decreased procarcinogen activation, possibly leading to protection from carcinogens.",9.47438909427412e-08,0.14842000511827314,0.0,0.007253705859127518,0.15415067982725894,0.0,0.007243206163811494,0.1603426500751799,0.0,9.474389094274162e-08,0.16705408466316696,0.0
169,0.3,4,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,What is the relationship between the CYP2D6*4 allele and breast cancer risk? The diminished transformation of procarcinogens in CYP2D6*4 poor metabolizers may confer a protective effect against carcinogens.,4.73719454713706e-08,0.07145896398214369,0.0,0.003626852929563759,0.07410797215372167,0.0,0.003621603081905747,0.07696104113612945,0.0,4.737194547137081e-08,0.08004270767353727,0.0
169,0.3,5,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,Can the CYP2D6*4 allele affect breast cancer risk? A potential reduction in procarcinogen metabolism by CYP2D6*4 poor metabolizers might result in protection against carcinogens.,1.421158364141118e-07,0.23180161405732358,0.0,0.010880558788691277,0.24116205681688863,0.0,0.010864809245717241,0.2513144282809079,0.0,1.4211583641411238e-07,0.26236426446749217,0.0
169,0.3,6,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"Is there an association between CYP2D6*4 allele and breast cancer risk? CYP2D6*4 poor metabolizers may exhibit decreased procarcinogen transformation, which could protect against carcinogens.",1.421158364141118e-07,0.23180161405732358,0.0,0.010880558788691277,0.24116205681688863,0.0,0.010864809245717241,0.2513144282809079,0.0,1.4211583641411238e-07,0.26236426446749217,0.0
169,0.3,7,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"How does the CYP2D6*4 allele relate to breast cancer risk? Poor metabolizers with CYP2D6*4 might have lower procarcinogen activation, potentially reducing carcinogen effects.",1.658018091497971e-07,0.27625337662815763,0.0,0.012693985253473157,0.28768207245178257,0.0,0.012675610786670115,0.30010459245033916,0.0,1.6580180914979774e-07,0.3136575588550423,0.0
169,0.3,8,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"Does carrying the CYP2D6*4 allele impact breast cancer risk? The allele's poor metabolizer status may lead to less procarcinogen transformation, offering a protective effect.",1.421158364141118e-07,0.23180161405732358,0.0,0.010880558788691277,0.24116205681688863,0.0,0.010864809245717241,0.2513144282809079,0.0,1.4211583641411238e-07,0.26236426446749217,0.0
169,0.3,9,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,Is breast cancer risk associated with the CYP2D6*4 allele? Reduced procarcinogen metabolism by CYP2D6*4 poor metabolizers could provide protection against carcinogens.,2.1317375462116776e-07,0.37156355643248284,0.0,0.016320838183036916,0.387765531008764,0.0,0.016297213868575862,0.4054651081081646,0.0,2.1317375462116844e-07,0.4248831939652664,0.0
169,0.3,10,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,What association exists between CYP2D6*4 allele and breast cancer risk? The decreased activation of procarcinogens in CYP2D6*4 poor metabolizers might result in a protective effect against carcinogens.,7.10579182070559e-08,0.10919929196499067,0.0,0.005440279394345639,0.11332868530700413,0.0,0.005432404622858621,0.11778303565638426,0.0,7.105791820705622e-08,0.1226023220923329,0.0
170,0.3,1,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could","Did the boycott call by Catholic bishops impact polio vaccination rates in Kenya in 2015? The boycott call did not significantly influence the campaign. However, a future repetition of the boycott call might have an effect.",1.421158364141119e-07,0.07158668775336441,0.09855020541607107,0.010880558788691243,0.09466346460945063,0.08878279320987656,0.010864809245717214,0.08254544707331046,0.1051862673484295,1.4211583641411244e-07,0.17185025692666,0.0
170,0.3,2,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could","Was polio vaccination coverage in Kenya in 2015 affected by the Catholic bishops' boycott call? The boycott call did not notably affect the campaign. Yet, if repeated in the future, it could have consequences.",1.894877818854825e-07,0.05790634742394962,0.33996539792387537,0.014507411718255002,0.05835170801399414,0.20987654320987656,0.01448641232762296,0.14506580405464398,0.1051862673484295,1.8948778188548325e-07,0.23638877806423153,0.0
170,0.3,3,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could","Did the Catholic bishops' boycott appeal influence the 2015 polio vaccination campaign in Kenya? The boycott appeal had no significant impact on the campaign. Still, a future recurrence could potentially affect it.",2.368597273568531e-07,0.049333182496734906,0.30774317570165316,0.01813426464781876,0.12289022915156567,0.20987654320987656,0.018108015409528708,0.21175717855331744,0.1051862673484295,2.3685972735685406e-07,0.3053816495511823,0.0
170,0.3,4,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could","Did the boycott urged by Catholic bishops alter polio vaccination coverage in Kenya during 2015? The boycott did not significantly change the campaign outcomes. However, a similar call in the future might cause effects.",1.894877818854825e-07,0.015897427390013874,0.30969196042387537,0.014507411718255002,0.05835170801399414,0.20987654320987656,0.01448641232762296,0.14506580405464398,0.1051862673484295,1.8948778188548325e-07,0.23638877806423153,0.0
170,0.3,5,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could","Did the Catholic bishops' boycott call affect Kenya's polio vaccination coverage in 2015? The boycott call did not have a major impact on the campaign. Nonetheless, if repeated later, it could influence the campaign.",1.894877818854825e-07,0.026111492643922762,0.2796115997969243,0.014507411718255002,0.05835170801399414,0.20987654320987656,0.01448641232762296,0.14506580405464398,0.1051862673484295,1.8948778188548325e-07,0.23638877806423153,0.0
170,0.3,6,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could","Was the 2015 polio vaccination campaign in Kenya significantly affected by the Catholic bishops' boycott call? The boycott call did not substantially impact the campaign. However, future repetitions could potentially affect it.",2.368597273568531e-07,0.004614009557383891,0.33996539792387537,0.01813426464781876,0.12289022915156567,0.20987654320987656,0.018108015409528708,0.21175717855331744,0.1051862673484295,2.3685972735685406e-07,0.3053816495511823,0.0
170,0.3,7,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could","Did the boycott call from Catholic bishops impact the polio vaccination efforts in Kenya in 2015? The boycott call did not significantly affect the campaign. But if repeated in the future, it might have an impact.",1.421158364141119e-07,0.03753002681146089,0.28303243190000027,0.010880558788691243,0.038500449759908406,0.18049178655239262,0.010864809245717214,0.08254544707331046,0.1051862673484295,1.4211583641411244e-07,0.17185025692666,0.0
170,0.3,8,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could","Did the Catholic bishops' call for a boycott influence polio vaccination coverage in Kenya in 2015? The boycott call did not significantly affect the campaign. However, if repeated, it could have effects in the future.",1.658018091497972e-07,0.0877593105736314,0.33996539792387537,0.012693985253473122,0.027580049347240454,0.20987654320987656,0.012675610786670087,0.11331710574006415,0.1051862673484295,1.6580180914979784e-07,0.20359895524123983,0.0
170,0.3,9,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could","Did the boycott called by Catholic bishops affect the 2015 polio vaccination coverage in Kenya? The boycott did not significantly impact the campaign. Still, if repeated in the future, it might affect it.",2.131737546211678e-07,0.01618701002780165,0.30874791613407304,0.01632083818303688,0.09010040632857397,0.20987654320987656,0.016297213868575834,0.17785562687763568,0.1051862673484295,2.1317375462116866e-07,0.2702903297399133,0.0
170,0.3,10,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could","Did the Catholic bishops' boycott call have an effect on polio vaccination coverage in Kenya in 2015? The call did not significantly affect the campaign, but a future repetition could potentially have an impact.",1.894877818854825e-07,0.015897427390013874,0.30969196042387537,0.014507411718255002,0.05835170801399414,0.20987654320987656,0.01448641232762296,0.14506580405464398,0.1051862673484295,1.8948778188548325e-07,0.23638877806423153,0.0
171,0.3,1,ai,Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: The stretch-sensitive KCNQ1 mutation may indicate a connection between genetic and environmental factors in the development of atrial fibrillation. Further research is needed to fully understand the role of this mutation in the pathogenesis of the condition.,The stretch-sensitive KCNQ1 mutation might suggest a link between genetic and environmental influences in atrial fibrillation development.,9.000669639560431e-07,0.8986401303022116,0.25170068027210885,0.06891020566171129,1.0529897334129457,0.14617283950617282,0.06881045855620907,1.1788888542431035,0.09506564056134,9.00066963956045e-07,1.285329548138089,0.05859375
171,0.3,2,ai,Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: The stretch-sensitive KCNQ1 mutation may indicate a connection between genetic and environmental factors in the development of atrial fibrillation. Further research is needed to fully understand the role of this mutation in the pathogenesis of the condition.,A connection between genetic and environmental factors in atrial fibrillation pathogenesis may be indicated by the stretch-sensitive KCNQ1 mutation.,8.526950184846725e-07,0.7808570946458278,0.25170068027210885,0.06528335273214754,0.92782659045894,0.14617283950617282,0.06518885547430332,1.0453574616185808,0.09506564056134,8.526950184846743e-07,1.1422287044974158,0.05859375
171,0.3,3,ai,Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: The stretch-sensitive KCNQ1 mutation may indicate a connection between genetic and environmental factors in the development of atrial fibrillation. Further research is needed to fully understand the role of this mutation in the pathogenesis of the condition.,The mutation in stretch-sensitive KCNQ1 could represent an association between genetic and environmental contributors to atrial fibrillation.,9.000669639560431e-07,0.8986401303022116,0.25170068027210885,0.06891020566171129,1.0529897334129457,0.14617283950617282,0.06881045855620907,1.1788888542431035,0.09506564056134,9.00066963956045e-07,1.285329548138089,0.05859375
171,0.3,4,ai,Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: The stretch-sensitive KCNQ1 mutation may indicate a connection between genetic and environmental factors in the development of atrial fibrillation. Further research is needed to fully understand the role of this mutation in the pathogenesis of the condition.,Stretch-sensitive KCNQ1 mutation potentially highlights the interplay of genetic and environmental elements in atrial fibrillation onset.,9.237529366917285e-07,0.9631786514397822,0.25170068027210885,0.07072363212649316,1.1219826048998978,0.14617283950617282,0.07062126009716195,1.2529968263968247,0.09506564056134,9.237529366917304e-07,1.3653722558116255,0.05859375
171,0.3,5,ai,Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: The stretch-sensitive KCNQ1 mutation may indicate a connection between genetic and environmental factors in the development of atrial fibrillation. Further research is needed to fully understand the role of this mutation in the pathogenesis of the condition.,There may be a relationship between genetic and environmental factors in atrial fibrillation caused by the stretch-sensitive KCNQ1 mutation.,8.526950184846725e-07,0.7808570946458278,0.25170068027210885,0.06528335273214754,0.92782659045894,0.14617283950617282,0.06518885547430332,1.0453574616185808,0.09506564056134,8.526950184846743e-07,1.1422287044974158,0.05859375
171,0.3,6,ai,Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: The stretch-sensitive KCNQ1 mutation may indicate a connection between genetic and environmental factors in the development of atrial fibrillation. Further research is needed to fully understand the role of this mutation in the pathogenesis of the condition.,The role of the stretch-sensitive KCNQ1 mutation suggests a genetic-environmental link in atrial fibrillation pathogenesis.,9.474389094274139e-07,1.0321715229267343,0.25170068027210885,0.07253705859127504,1.196090577053619,0.14617283950617282,0.07243206163811482,1.3330395340703611,0.09506564056134,9.474389094274157e-07,1.4523836328012556,0.05859375
171,0.3,7,ai,Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: The stretch-sensitive KCNQ1 mutation may indicate a connection between genetic and environmental factors in the development of atrial fibrillation. Further research is needed to fully understand the role of this mutation in the pathogenesis of the condition.,Genetic and environmental factors might be connected through the stretch-sensitive KCNQ1 mutation in atrial fibrillation development.,9.237529366917285e-07,0.9631786514397822,0.25170068027210885,0.07072363212649316,1.1219826048998978,0.14617283950617282,0.07062126009716195,1.2529968263968247,0.09506564056134,9.237529366917304e-07,1.3653722558116255,0.05859375
171,0.3,8,ai,Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: The stretch-sensitive KCNQ1 mutation may indicate a connection between genetic and environmental factors in the development of atrial fibrillation. Further research is needed to fully understand the role of this mutation in the pathogenesis of the condition.,The stretch-sensitive KCNQ1 mutation may reveal how genetic and environmental factors combine in atrial fibrillation.,9.474389094274139e-07,1.0321715229267343,0.25170068027210885,0.07253705859127504,1.196090577053619,0.14617283950617282,0.07243206163811482,1.3330395340703611,0.09506564056134,9.474389094274157e-07,1.4523836328012556,0.05859375
171,0.3,9,ai,Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: The stretch-sensitive KCNQ1 mutation may indicate a connection between genetic and environmental factors in the development of atrial fibrillation. Further research is needed to fully understand the role of this mutation in the pathogenesis of the condition.,Atrial fibrillation pathogenesis could involve genetic and environmental interactions indicated by the stretch-sensitive KCNQ1 mutation.,9.474389094274139e-07,1.0321715229267343,0.25170068027210885,0.07253705859127504,1.196090577053619,0.14617283950617282,0.07243206163811482,1.3330395340703611,0.09506564056134,9.474389094274157e-07,1.4523836328012556,0.05859375
171,0.3,10,ai,Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: The stretch-sensitive KCNQ1 mutation may indicate a connection between genetic and environmental factors in the development of atrial fibrillation. Further research is needed to fully understand the role of this mutation in the pathogenesis of the condition.,Further investigation is required to clarify how the stretch-sensitive KCNQ1 mutation links genetic and environmental factors in atrial fibrillation.,8.526950184846725e-07,0.7808570946458278,0.25170068027210885,0.06528335273214754,0.92782659045894,0.14617283950617282,0.06518885547430332,1.0453574616185808,0.09506564056134,8.526950184846743e-07,1.1422287044974158,0.05859375
172,0.3,1,ai,"Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery is often effective in relieving the symptoms of compressive cervical myelopathy caused by spinal cord sarcoidosis. However, the success of the surgery depends on various","Is decompressive surgery beneficial for spinal cord sarcoidosis with compressive cervical myelopathy? Decompressive surgery frequently helps alleviate symptoms of compressive cervical myelopathy due to spinal cord sarcoidosis, though its success varies based on several factors.",1.658018091497972e-07,0.2080954600103242,0.0146942675710032,0.012693985253473122,0.19237189264745602,0.0,0.012675610786670087,0.19782574332991798,0.0,1.6580180914979784e-07,0.20359895524123983,0.0
172,0.3,2,ai,"Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery is often effective in relieving the symptoms of compressive cervical myelopathy caused by spinal cord sarcoidosis. However, the success of the surgery depends on various","Does decompressive surgery work for spinal cord sarcoidosis accompanied by compressive cervical myelopathy? It is often effective in reducing symptoms caused by compressive cervical myelopathy from spinal cord sarcoidosis, but the outcome depends on multiple variables.",1.421158364141119e-07,0.17561306340315763,0.012246256059556773,0.010880558788691243,0.20329229306012397,0.029384756657483937,0.010864809245717214,0.1670540846631643,0.0,1.4211583641411244e-07,0.17185025692666,0.0
172,0.3,3,ai,"Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery is often effective in relieving the symptoms of compressive cervical myelopathy caused by spinal cord sarcoidosis. However, the success of the surgery depends on various","Can decompressive surgery effectively treat spinal cord sarcoidosis with compressive cervical myelopathy? This surgery is commonly successful in easing symptoms related to compressive cervical myelopathy caused by spinal cord sarcoidosis, although results depend on various factors.",1.421158364141119e-07,0.1360046530854464,0.015781715416568122,0.010880558788691243,0.16251892949777424,0.0,0.010864809245717214,0.1670540846631643,0.0,1.4211583641411244e-07,0.17185025692666,0.0
172,0.3,4,ai,"Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery is often effective in relieving the symptoms of compressive cervical myelopathy caused by spinal cord sarcoidosis. However, the success of the surgery depends on various","Is decompressive surgery an effective treatment for spinal cord sarcoidosis with compressive cervical myelopathy? It often relieves symptoms of compressive cervical myelopathy due to spinal cord sarcoidosis, but the effectiveness depends on different factors.",1.894877818854825e-07,0.19964617254083006,0.012360883313492145,0.014507411718255002,0.2231435513142097,0.0,0.01448641232762296,0.2295744416444978,0.0,1.8948778188548325e-07,0.23638877806423153,0.0
172,0.3,5,ai,"Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery is often effective in relieving the symptoms of compressive cervical myelopathy caused by spinal cord sarcoidosis. However, the success of the surgery depends on various","How effective is decompressive surgery for spinal cord sarcoidosis accompanied by compressive cervical myelopathy? The surgery is frequently effective in symptom relief for compressive cervical myelopathy caused by spinal cord sarcoidosis, yet success depends on several conditions.",1.1842986367842661e-07,0.10563330887887723,0.017351359641135253,0.009067132323909363,0.13353139262452274,0.0,0.00905400770476434,0.13720112151348252,0.0,1.1842986367842703e-07,0.14107859825990632,0.0
172,0.3,6,ai,"Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery is often effective in relieving the symptoms of compressive cervical myelopathy caused by spinal cord sarcoidosis. However, the success of the surgery depends on various","Is decompressive surgery a good option for spinal cord sarcoidosis with compressive cervical myelopathy? It is often effective in alleviating symptoms of compressive cervical myelopathy from spinal cord sarcoidosis, though its success is influenced by various factors.",1.1842986367842661e-07,0.10563330887887723,0.017351359641135253,0.009067132323909363,0.13353139262452274,0.0,0.00905400770476434,0.13720112151348252,0.0,1.1842986367842703e-07,0.14107859825990632,0.0
172,0.3,7,ai,"Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery is often effective in relieving the symptoms of compressive cervical myelopathy caused by spinal cord sarcoidosis. However, the success of the surgery depends on various","Does decompressive surgery provide symptom relief for spinal cord sarcoidosis with compressive cervical myelopathy? It commonly helps relieve symptoms caused by compressive cervical myelopathy due to spinal cord sarcoidosis, but the success rate depends on multiple factors.",1.1842986367842661e-07,0.10563330887887723,0.017351359641135253,0.009067132323909363,0.13353139262452274,0.0,0.00905400770476434,0.13720112151348252,0.0,1.1842986367842703e-07,0.14107859825990632,0.0
172,0.3,8,ai,"Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery is often effective in relieving the symptoms of compressive cervical myelopathy caused by spinal cord sarcoidosis. However, the success of the surgery depends on various","Is decompressive surgery effective in managing spinal cord sarcoidosis accompanied by compressive cervical myelopathy? It often successfully reduces symptoms of compressive cervical myelopathy from spinal cord sarcoidosis, although outcomes depend on several variables.",2.131737546211678e-07,0.23304338870970565,0.010492459218221,0.01632083818303688,0.25489224962878954,0.0,0.016297213868575834,0.2623642644674895,0.0,2.1317375462116866e-07,0.2702903297399133,0.0
172,0.3,9,ai,"Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery is often effective in relieving the symptoms of compressive cervical myelopathy caused by spinal cord sarcoidosis. However, the success of the surgery depends on various","Can decompressive surgery relieve symptoms of spinal cord sarcoidosis with compressive cervical myelopathy? This surgical approach is often effective in symptom relief for compressive cervical myelopathy caused by spinal cord sarcoidosis, but its success depends on various factors.",9.474389094274131e-08,0.07615281162601795,0.01883713042003505,0.0072537058591274906,0.10536051565782589,0.0,0.007243206163811466,0.10821358464023101,0.0,9.474389094274162e-08,0.11122563511022454,0.0
172,0.3,10,ai,"Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery is often effective in relieving the symptoms of compressive cervical myelopathy caused by spinal cord sarcoidosis. However, the success of the surgery depends on various","Is decompressive surgery beneficial for patients with spinal cord sarcoidosis and compressive cervical myelopathy? It frequently alleviates symptoms of compressive cervical myelopathy due to spinal cord sarcoidosis, though the success depends on different factors.",1.894877818854825e-07,0.19964617254083006,0.012360883313492145,0.014507411718255002,0.2231435513142097,0.0,0.01448641232762296,0.2295744416444978,0.0,1.8948778188548325e-07,0.23638877806423153,0.0
173,0.3,1,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be,Does the study support the notion that Indigenous Australians age prematurely? The research on various specific conditions does not strongly back this idea. The aged care sector's current emphasis and service types might not be appropriate.,1.6580180914979731e-07,0.18232155679395445,0.0,0.012693985253473115,0.18721154208814594,0.0,0.01267561078667008,0.19237189264745602,0.0,1.6580180914979784e-07,0.19782574332991798,0.0
173,0.3,2,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be,Is premature aging among Indigenous Australians confirmed? This study examining several distinct conditions does not provide strong evidence for premature aging. The aged care services offered currently may not align with actual needs.,2.3685972735685321e-07,0.2719337154836414,0.0,0.018134264647818754,0.27958486221916123,0.0,0.0181080154095287,0.28768207245178123,0.0,2.3685972735685406e-07,0.29626581614317127,0.0
173,0.3,3,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be,Do Indigenous Australians show signs of early aging? The study of multiple separate conditions does not convincingly support this concept. The existing aged care system's focus and services might be misaligned.,2.842316728282238e-07,0.33647223662121295,0.0,0.021761117577382513,0.3462762367178347,0.0,0.021729618491434448,0.356674943938732,0.0,2.8423167282822487e-07,0.36772478012531495,0.0
173,0.3,4,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be,Is there proof that Indigenous Australians age faster? Research into a range of specific conditions does not strongly support premature aging. The current aged care sector may not be providing suitable services.,2.605457000925385e-07,0.30368241379822125,0.0,0.019947691112600634,0.31237468504215293,0.0,0.019918816950481574,0.321583624127463,0.0,2.6054570009253947e-07,0.3313571359544403,0.0
173,0.3,5,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be,Does evidence suggest Indigenous Australians age prematurely? This investigation into various isolated conditions does not firmly uphold that claim. The aged care services presently offered might not be fully appropriate.,3.079176455639091e-07,0.3703737882968947,0.0,0.023574544042164393,0.3813675565291037,0.0,0.02354042003238732,0.3930425881096067,0.0,3.079176455639103e-07,0.40546510810816194,0.0
173,0.3,6,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be,Are Indigenous Australians prone to premature aging? The study of discrete health conditions does not strongly endorse this idea. The aged care sector's current focus and services may not be well matched to needs.,2.1317375462116791e-07,0.24116205681688774,0.0,0.016320838183036875,0.2478361639045814,0.0,0.016297213868575827,0.25489224962878954,0.0,2.1317375462116866e-07,0.2623642644674895,0.0
173,0.3,7,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be,Is premature aging a fact for Indigenous Australians? The research on several distinct conditions does not robustly support this notion. The aged care sector's current approach and services might be inadequate.,2.842316728282238e-07,0.33647223662121295,0.0,0.021761117577382513,0.3462762367178347,0.0,0.021729618491434448,0.356674943938732,0.0,2.8423167282822487e-07,0.36772478012531495,0.0
173,0.3,8,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be,Does premature aging affect Indigenous Australians? The study of a series of separate conditions does not strongly confirm this. The aged care sector's current service focus may be misplaced.,3.316036182995944e-07,0.4054651081081637,0.0,0.025387970506946272,0.4177352006999784,0.0,0.025351221573340195,0.43078291609245367,0.0,3.316036182995957e-07,0.4446858212614444,0.0
173,0.3,9,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be,Is there evidence of early aging in Indigenous Australians? This study of various discrete conditions does not strongly back the idea. The aged care services currently provided may not be suitable.,2.842316728282238e-07,0.33647223662121295,0.0,0.021761117577382513,0.3462762367178347,0.0,0.021729618491434448,0.356674943938732,0.0,2.8423167282822487e-07,0.36772478012531495,0.0
173,0.3,10,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be,Do Indigenous Australians experience premature aging? The research into a set of distinct conditions does not strongly support this belief. The aged care sector's current focus and types of services might not be appropriate.,2.1317375462116791e-07,0.24116205681688774,0.0,0.016320838183036875,0.2478361639045814,0.0,0.016297213868575827,0.25489224962878954,0.0,2.1317375462116866e-07,0.2623642644674895,0.0
174,0.3,1,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is it possible to maintain a zero central line-associated bloodstream infection rate? Effective training, adherence to evidence-based protocols, and meticulous documentation contribute to major decreases in CLABSIs. Thoughtful organization can enhance comprehension of a unit's capacity to manage peak workloads and uphold exceptional performance over time.",1.6580180914979784e-07,0.14458122881110835,0.0,0.012693985253473108,0.14763599880606337,0.0,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
174,0.3,2,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Can a zero rate of central line-associated bloodstream infections be sustained? Comprehensive training, strict adherence to proven guidelines, and detailed record-keeping are linked to significant CLABSI reductions. Careful structuring may improve insight into a unit's ability to meet peak demands and maintain outstanding long-term performance.",1.8948778188548325e-07,0.16705408466316607,0.0,0.014507411718254981,0.1706255170307629,0.0,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
174,0.3,3,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is sustaining a zero central line-associated bloodstream infection rate achievable? High-quality education, rigorous compliance with evidence-based standards, and thorough documentation correlate with notable CLABSI declines. Mindful management can foster a deeper understanding of how a unit handles peak pressures and sustains exceptional performance over the long haul.",1.4211583641411244e-07,0.12260232209233335,0.0,0.010880558788691236,0.12516314295400566,0.0,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
174,0.3,4,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is a zero central line-associated bloodstream infection rate maintainable? Quality training, strict observance of evidence-based recommendations, and comprehensive documentation are associated with significant CLABSI reductions. Thoughtful organization might lead to better insight into a unit's capacity to manage peak demand and sustain superior long-term performance.",1.8948778188548325e-07,0.16705408466316607,0.0,0.014507411718254981,0.1706255170307629,0.0,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
174,0.3,5,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Can zero central line-associated bloodstream infections be consistently maintained? Intensive training, adherence to evidence-based protocols, and detailed documentation contribute to major CLABSI decreases. Mindful coordination may enhance understanding of a unit's ability to handle peak workloads and sustain exceptional performance over time.",2.6054570009253947e-07,0.23767165187712003,0.0,0.0199476911126006,0.24294617861038903,0.0,0.019918816950481533,0.248461359298501,0.0,2.6054570009253947e-07,0.25423413838424036,0.0
174,0.3,6,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is it feasible to sustain a zero central line-associated bloodstream infection rate? High-level training, strict compliance with evidence-based guidelines, and thorough documentation are linked to significant reductions in CLABSIs. Careful organization can improve understanding of how a unit manages peak demands and maintains extraordinary long-term performance.",1.6580180914979784e-07,0.14458122881110835,0.0,0.012693985253473108,0.14763599880606337,0.0,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
174,0.3,7,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is maintaining a zero central line-associated bloodstream infection rate possible? Effective training, strict adherence to evidence-based guidelines, and detailed documentation are associated with substantial CLABSI reductions. Mindful structuring may lead to better comprehension of a unit's capacity to handle peak demands and sustain exceptional performance long-term.",1.6580180914979784e-07,0.14458122881110835,0.0,0.012693985253473108,0.14763599880606337,0.0,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
174,0.3,8,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Can a zero central line-associated bloodstream infection rate be upheld? Quality training, rigorous compliance with evidence-based protocols, and comprehensive documentation correlate with significant CLABSI decreases. Thoughtful organization might foster improved understanding of a unit's ability to manage peak demand and maintain outstanding performance over time.",1.8948778188548325e-07,0.16705408466316607,0.0,0.014507411718254981,0.1706255170307629,0.0,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
174,0.3,9,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is sustaining zero central line-associated bloodstream infections achievable? High-quality training, strict adherence to evidence-based guidelines, and meticulous documentation are linked to significant CLABSI reductions. Mindful management may enhance insight into how a unit handles peak workloads and sustains exceptional long-term performance.",2.8423167282822487e-07,0.2623642644674917,0.0,0.02176111757738247,0.26826398659468076,0.0,0.0217296184914344,0.27443684570175897,0.0,2.8423167282822487e-07,0.2809023854664012,0.0
174,0.3,10,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is it sustainable to have a zero central line-associated bloodstream infection rate? Intensive training, strict compliance with evidence-based standards, and thorough documentation contribute to major reductions in CLABSIs. Careful organization can lead to better understanding of a unit's ability to meet peak demands and maintain extraordinary performance over the long term.",4.737194547137081e-08,0.03922071315328246,0.0,0.0036268529295637453,0.04000533461369837,0.0,0.003621603081905733,0.04082199452025437,0.0,4.737194547137081e-08,0.04167269640056892,0.0
175,0.3,1,ai,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: The study aims to determine whether pretreatment with estradiol and antagonist prior to microdose leuprolide in IVF improves outcomes in poor responders compared to oral contraceptive pill.,Does pretreatment with estradiol and antagonist before microdose leuprolide enhance IVF results in poor responders compared to oral contraceptive pills?,8.290090457489871e-07,0.7364796538156368,0.20408163265306117,0.06346992626736567,0.8706681766189912,0.14617283950617285,0.06337805393335046,1.0113923467467583,0.07638888888888888,8.29009045748989e-07,1.1320546681096446,0.019599999999999992
175,0.3,2,ai,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: The study aims to determine whether pretreatment with estradiol and antagonist prior to microdose leuprolide in IVF improves outcomes in poor responders compared to oral contraceptive pill.,Is the use of estradiol and antagonist prior to microdose leuprolide in IVF more effective for poor responders than oral contraceptive pill pretreatment?,7.579511275419311e-07,0.5898761796237615,0.20408163265306117,0.05802964687302002,0.7165174967917345,0.14617283950617285,0.057945649310491835,0.848873417248984,0.07638888888888888,7.579511275419329e-07,0.9602044111829855,0.019599999999999992
175,0.3,3,ai,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: The study aims to determine whether pretreatment with estradiol and antagonist prior to microdose leuprolide in IVF improves outcomes in poor responders compared to oral contraceptive pill.,Does administering estradiol and antagonist before microdose leuprolide improve IVF outcomes in poor responders versus oral contraceptive pills?,8.763809912203578e-07,0.847705288925861,0.20408163265306117,0.06709677919692941,0.988451212275375,0.14617283950617285,0.0669996570152562,1.136555489700764,0.07638888888888888,8.763809912203596e-07,1.2655860607341674,0.019599999999999992
175,0.3,4,ai,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: The study aims to determine whether pretreatment with estradiol and antagonist prior to microdose leuprolide in IVF improves outcomes in poor responders compared to oral contraceptive pill.,Can pretreatment with estradiol and antagonist before microdose leuprolide lead to better IVF results in poor responders compared to oral contraceptive pills?,7.816371002776164e-07,0.6363961952586554,0.20408163265306117,0.0598430733378019,0.7653076609611658,0.14617283950617285,0.05975645085144471,0.9001667116365342,0.07638888888888888,7.816371002776182e-07,1.0142716324532608,0.019599999999999992
175,0.3,5,ai,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: The study aims to determine whether pretreatment with estradiol and antagonist prior to microdose leuprolide in IVF improves outcomes in poor responders compared to oral contraceptive pill.,Is IVF success in poor responders improved by estradiol and antagonist pretreatment prior to microdose leuprolide compared to oral contraceptive pills?,8.053230730133017e-07,0.6851863594280867,0.20408163265306117,0.06165649980258378,0.8166009553487159,0.14617283950617285,0.06156725239239758,0.9542339329068095,0.07638888888888888,8.053230730133036e-07,1.0714300462932096,0.019599999999999992
175,0.3,6,ai,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: The study aims to determine whether pretreatment with estradiol and antagonist prior to microdose leuprolide in IVF improves outcomes in poor responders compared to oral contraceptive pill.,Does using estradiol and antagonist before microdose leuprolide in IVF yield better outcomes for poor responders than oral contraceptive pill use?,8.053230730133017e-07,0.6851863594280867,0.20408163265306117,0.06165649980258378,0.8166009553487159,0.14617283950617285,0.06156725239239758,0.9542339329068095,0.07638888888888888,8.053230730133036e-07,1.0714300462932096,0.019599999999999992
175,0.3,7,ai,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: The study aims to determine whether pretreatment with estradiol and antagonist prior to microdose leuprolide in IVF improves outcomes in poor responders compared to oral contraceptive pill.,Is pretreatment with estradiol and antagonist prior to microdose leuprolide superior to oral contraceptive pills in improving IVF outcomes for poor responders?,7.816371002776164e-07,0.6363961952586554,0.20408163265306117,0.0598430733378019,0.7653076609611658,0.14617283950617285,0.05975645085144471,0.9001667116365342,0.07638888888888888,7.816371002776182e-07,1.0142716324532608,0.019599999999999992
175,0.3,8,ai,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: The study aims to determine whether pretreatment with estradiol and antagonist prior to microdose leuprolide in IVF improves outcomes in poor responders compared to oral contraceptive pill.,Does estradiol and antagonist pretreatment before microdose leuprolide enhance IVF success rates in poor responders compared to oral contraceptive pills?,8.290090457489871e-07,0.7364796538156368,0.20408163265306117,0.06346992626736567,0.8706681766189912,0.14617283950617285,0.06337805393335046,1.0113923467467583,0.07638888888888888,8.29009045748989e-07,1.1320546681096446,0.019599999999999992
175,0.3,9,ai,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: The study aims to determine whether pretreatment with estradiol and antagonist prior to microdose leuprolide in IVF improves outcomes in poor responders compared to oral contraceptive pill.,Is the IVF outcome in poor responders better with estradiol and antagonist pretreatment before microdose leuprolide than with oral contraceptive pills?,8.053230730133017e-07,0.6851863594280867,0.20408163265306117,0.06165649980258378,0.8166009553487159,0.14617283950617285,0.06156725239239758,0.9542339329068095,0.07638888888888888,8.053230730133036e-07,1.0714300462932096,0.019599999999999992
175,0.3,10,ai,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: The study aims to determine whether pretreatment with estradiol and antagonist prior to microdose leuprolide in IVF improves outcomes in poor responders compared to oral contraceptive pill.,Does pretreatment involving estradiol and antagonist prior to microdose leuprolide improve IVF outcomes in poor responders relative to oral contraceptive pill use?,7.816371002776164e-07,0.6363961952586554,0.20408163265306117,0.0598430733378019,0.7653076609611658,0.14617283950617285,0.05975645085144471,0.9001667116365342,0.07638888888888888,7.816371002776182e-07,1.0142716324532608,0.019599999999999992
176,0.3,1,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Is the preoperative platelet count a prognostic indicator in esophageal squamous cell carcinoma? The preoperative platelet count serves as a predictor for long-term survival in ESCC, particularly in patients with positive lymph nodes. We suggest that a platelet count of 205 (×10(9)/L) is the optimal cutoff for survival prediction in ESCC patients.",2.3685972735685406e-08,0.022726046884164575,0.002850708301243926,0.0018134264647818726,0.02133437618373879,0.0008118618278758691,0.0018108015409528666,0.007672434452772325,0.020399305555555556,2.3685972735685406e-08,0.02105340919783316,0.0
176,0.3,2,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Does preoperative platelet count predict outcomes in esophageal squamous cell carcinoma? Preoperative platelet levels are predictive of long-term survival in ESCC, especially among nodal-positive cases. Our findings indicate that 205 (×10(9)/L) is the best cutoff value for platelet count to forecast survival in ESCC patients.",1.4211583641411244e-07,0.07325904259896099,0.07539310081447699,0.010880558788691236,0.0740367391060488,0.040742417383431435,0.0108648092457172,0.13353139262452318,0.0,1.4211583641411244e-07,0.13657553500575004,0.0
176,0.3,3,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Can preoperative platelet count serve as a prognostic factor in esophageal squamous cell carcinoma? The platelet count before surgery predicts long-term survival in ESCC, notably in patients with nodal involvement. We identify 205 (×10(9)/L) as the optimal platelet count threshold for survival prediction in ESCC.",1.4211583641411244e-07,0.053644355840885005,0.05023935500125981,0.010880558788691236,0.0740367391060488,0.040742417383431435,0.0108648092457172,0.13353139262452318,0.0,1.4211583641411244e-07,0.13657553500575004,0.0
176,0.3,4,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Is preoperative platelet count a useful prognostic marker in esophageal squamous cell carcinoma? Preoperative platelet count is linked to long-term survival outcomes in ESCC, particularly in those with positive lymph nodes. We conclude that a cutoff of 205 (×10(9)/L) platelet count best predicts survival in ESCC patients.",9.474389094274162e-08,0.03607267141099335,0.0317983027195214,0.0072537058591274906,0.059380906387511256,0.018531673581778544,0.007243206163811466,0.08701137698962924,0.0,9.474389094274162e-08,0.0889474860164956,0.0
176,0.3,5,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Does the preoperative platelet count have prognostic value in esophageal squamous cell carcinoma? It is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. The optimal platelet count cutoff for survival prediction appears to be 205 (×10(9)/L).",2.6054570009253936e-07,0.13491296957070542,0.11758660784514896,0.0199476911126006,0.19765069507322464,0.040742417383431435,0.019918816950481533,0.26028309826366547,0.0,2.6054570009253947e-07,0.26662866325394763,0.0
176,0.3,6,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Is platelet count before surgery a prognostic factor in esophageal squamous cell carcinoma? Preoperative platelet count predicts long-term survival in ESCC, mainly in patients with nodal metastasis. We propose 205 (×10(9)/L) as the ideal cutoff point for platelet count in predicting survival.",2.1317375462116866e-07,0.1297428047610536,0.04327562276280224,0.016320838183036854,0.14635740068567493,0.040742417383431435,0.0162972138685758,0.20763936477824663,0.0,2.1317375462116866e-07,0.21256144198367144,0.0
176,0.3,7,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Can preoperative platelet count predict prognosis in esophageal squamous cell carcinoma? It is a significant predictor of long-term survival in ESCC, particularly in nodal-positive patients. The recommended cutoff for platelet count is 205 (×10(9)/L) for survival prediction.",3.3160361829959526e-07,0.2179178446825305,0.11545477450239358,0.025387970506946217,0.27988879331019767,0.040742417383431435,0.02535122157334014,0.34484048629172914,0.0,3.316036182995957e-07,0.35364004024357776,0.0
176,0.3,8,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Is the platelet count prior to surgery a prognostic factor in esophageal squamous cell carcinoma? Preoperative platelet count forecasts long-term survival in ESCC, especially in patients with positive lymph nodes. We determine that 205 (×10(9)/L) is the optimal cutoff for platelet count in survival prediction.",1.4211583641411244e-07,0.08515104586633715,0.026612613009598968,0.010880558788691236,0.0740367391060488,0.040742417383431435,0.0108648092457172,0.13353139262452318,0.0,1.4211583641411244e-07,0.13657553500575004,0.0
176,0.3,9,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Does preoperative platelet count serve as a prognostic factor in esophageal squamous cell carcinoma? It is a predictive marker for long-term survival in ESCC, notably in nodal-positive patients. The cutoff point of 205 (×10(9)/L) platelet count is suggested for survival prediction.",2.3685972735685406e-07,0.10870651135492615,0.118226313098108,0.018134264647818726,0.17167520866996666,0.040742417383431435,0.018108015409528666,0.2336148511815046,0.0,2.3685972735685406e-07,0.2392296890658323,0.0
176,0.3,10,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Is the preoperative platelet count an indicator of prognosis in esophageal squamous cell carcinoma? Preoperative platelet count is a predictor of long-term survival in ESCC, particularly in patients with nodal involvement. We conclude that 205 (×10(9)/L) is the optimal cutoff for platelet count in predicting survival.",1.1842986367842703e-07,0.09112001863152619,0.006386557090503148,0.009067132323909363,0.08255391090680186,0.018027436312582325,0.009054007704764333,0.11000089521432876,0.0,1.1842986367842703e-07,0.11247798342669002,0.0
177,0.3,1,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Is cholecystectomy truly a reason to perform a simultaneous splenectomy in mild hereditary spherocytosis? The recommendation to do a splenectomy alongside cholecystectomy in children with mild HS who have symptomatic gallstones requires reevaluation. With minimal access surgery now common, the decision for splenectomy in these children should be considered independently.",9.474389094274162e-08,0.018421238472017265,0.07600069444444443,0.0072537058591274906,0.05338320072892344,0.01922337562475971,0.007243206163811466,0.0816780310142673,0.0,9.474389094274162e-08,0.08338160893905089,0.0
177,0.3,2,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Does cholecystectomy warrant a concurrent splenectomy in cases of mild hereditary spherocytosis? The suggestion to carry out splenectomy during cholecystectomy in children with mild HS and symptomatic gallstones should be reconsidered. Given the advances in minimally invasive surgery, splenectomy needs to be assessed on its own criteria.",1.6580180914979784e-07,0.05330841843804146,0.09639999999999999,0.012693985253473108,0.11792172186649497,0.01922337562475971,0.012675610786670066,0.14763599880606337,0.0,1.6580180914979784e-07,0.15082288973458313,0.0
177,0.3,3,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Is performing a splenectomy alongside cholecystectomy justified in mild hereditary spherocytosis? The current guidance recommending concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones should be reviewed. With the advent of minimally invasive techniques, the necessity of splenectomy should be evaluated independently.",2.1317375462116866e-07,0.12926687103432677,0.07368501892915089,0.016320838183036854,0.1633840959432522,0.01922337562475971,0.0162972138685758,0.19415601444095731,0.0,2.1317375462116866e-07,0.19845093872383757,0.0
177,0.3,4,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Should cholecystectomy be an indication for simultaneous splenectomy in mild hereditary spherocytosis? The advice to perform splenectomy at the time of cholecystectomy in children with mild HS and symptomatic gallstones merits reconsideration. In the context of minimal access surgery, the decision for splenectomy should be made based on its own indications.",7.105791820705622e-08,0.030073190501009428,0.09639999999999999,0.005440279394345618,0.03276391352618768,0.01922337562475971,0.0054324046228586,0.06062462181643413,0.0,7.105791820705622e-08,0.06187540371808753,0.0
177,0.3,5,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Is concomitant splenectomy indicated during cholecystectomy for mild hereditary spherocytosis? The recommendation to conduct a splenectomy alongside cholecystectomy in children with mild HS who have symptomatic gallstones needs to be revisited. With minimally invasive surgery now prevalent, splenectomy should be judged on its individual merits.",2.1317375462116866e-07,0.09776018100887418,0.09639999999999999,0.016320838183036854,0.1633840959432522,0.01922337562475971,0.0162972138685758,0.19415601444095731,0.0,2.1317375462116866e-07,0.19845093872383757,0.0
177,0.3,6,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Does mild hereditary spherocytosis justify a splenectomy at the time of cholecystectomy? The advice to perform concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones requires reassessment. Given the rise of minimal access surgery, the need for splenectomy should be evaluated independently.",2.1317375462116866e-07,0.09776018100887418,0.09639999999999999,0.016320838183036854,0.1633840959432522,0.01922337562475971,0.0162972138685758,0.19415601444095731,0.0,2.1317375462116866e-07,0.19845093872383757,0.0
177,0.3,7,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Is it necessary to perform splenectomy concurrently with cholecystectomy in mild hereditary spherocytosis? The guidance recommending splenectomy during cholecystectomy in children with mild HS and symptomatic gallstones should be reconsidered. With minimal access surgery techniques available, splenectomy should be considered on its own merits.",2.3685972735685406e-07,0.1852285067275221,0.04999904818560378,0.018134264647818726,0.18691459335344662,0.01922337562475971,0.018108015409528666,0.21825356602001733,0.0,2.3685972735685406e-07,0.22314355131420927,0.0
177,0.3,8,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Should a splenectomy be performed alongside cholecystectomy in children with mild hereditary spherocytosis? The advice to do so in cases of mild HS with symptomatic gallstones needs to be reexamined. In the era of minimally invasive surgery, the indication for splenectomy should be independently assessed.",2.1317375462116866e-07,0.09776018100887418,0.09639999999999999,0.016320838183036854,0.1633840959432522,0.01922337562475971,0.0162972138685758,0.19415601444095731,0.0,2.1317375462116866e-07,0.19845093872383757,0.0
177,0.3,9,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Is splenectomy truly indicated during cholecystectomy for mild hereditary spherocytosis? The recommendation for concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones should be reviewed. With minimal access surgery advancements, the necessity of splenectomy should be judged on its own.",2.6054570009253947e-07,0.21029421383995217,0.04889999999999998,0.0199476911126006,0.21101214493250664,0.01922337562475971,0.019918816950481533,0.24294617861038903,0.0,2.6054570009253947e-07,0.248461359298501,0.0
177,0.3,10,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Does undergoing cholecystectomy in mild hereditary spherocytosis patients require a simultaneous splenectomy? The current advice to perform splenectomy in children with mild HS and symptomatic gallstones during cholecystectomy needs reconsideration. With the availability of minimal access surgery, the need for splenectomy should be evaluated separately.",2.1317375462116866e-07,0.09776018100887418,0.09639999999999999,0.016320838183036854,0.1633840959432522,0.01922337562475971,0.0162972138685758,0.19415601444095731,0.0,2.1317375462116866e-07,0.19845093872383757,0.0
178,0.3,1,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an estimate of visceral adipose tissue volume, but it may not accurately represent the entire volume. Multiple level measurements or additional imaging techniques are needed for a more comprehensive assessment.","Does measuring visceral adipose tissue area at one level accurately reflect its total volume? While a single-level measurement can estimate visceral adipose tissue volume, it may not fully capture the entire volume. A more thorough evaluation requires measurements at multiple levels or other imaging methods.",3.316036182995957e-07,0.028545606772878873,0.38923431150036564,0.025387970506946217,0.09520197255324225,0.23581609514554114,0.025351221573340132,0.16390579020893403,0.08842752787389466,3.316036182995957e-07,0.1929397104467161,0.07227989234909649
178,0.3,2,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an estimate of visceral adipose tissue volume, but it may not accurately represent the entire volume. Multiple level measurements or additional imaging techniques are needed for a more comprehensive assessment.",Can a single-level measurement of visceral adipose tissue area represent the total visceral adipose tissue volume? Measuring at one level might give an estimate but may not precisely represent the full volume. Comprehensive assessment needs multiple measurements or additional imaging techniques.,4.263475092423373e-07,0.16481448361029072,0.3600788460514639,0.03264167636607371,0.19614704762966984,0.2334354568329677,0.0325944277371516,0.26398924876591545,0.08842752787389466,4.263475092423373e-07,0.29559386450679836,0.07227989234909649
178,0.3,3,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an estimate of visceral adipose tissue volume, but it may not accurately represent the entire volume. Multiple level measurements or additional imaging techniques are needed for a more comprehensive assessment.","Is it possible for a single-level visceral adipose tissue area measurement to represent the entire visceral adipose tissue volume? Although it may provide an estimate, it does not reliably reflect the total volume. More detailed analysis involves multiple levels or supplementary imaging.",4.026615365066519e-07,0.10377390911250783,0.3859335829249118,0.030828249901291835,0.16994058941389056,0.23407516208592674,0.030783626196198732,0.23801376236265748,0.08842752787389466,4.026615365066519e-07,0.2689256174246375,0.07227989234909649
178,0.3,4,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an estimate of visceral adipose tissue volume, but it may not accurately represent the entire volume. Multiple level measurements or additional imaging techniques are needed for a more comprehensive assessment.",Does visceral adipose tissue area measured at a single level correspond to the total volume? Such a measurement can estimate volume but might not accurately represent the whole. A complete evaluation requires multiple level measurements or other imaging approaches.,4.737194547137079e-07,0.1121357009138495,0.43458578542326814,0.03626852929563745,0.21324477185560475,0.25905872553102866,0.03621603081905733,0.31805647003619164,0.08842752787389466,4.737194547137081e-07,0.35116371566161053,0.07227989234909649
178,0.3,5,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an estimate of visceral adipose tissue volume, but it may not accurately represent the entire volume. Multiple level measurements or additional imaging techniques are needed for a more comprehensive assessment.",Can the area of visceral adipose tissue measured at one level serve as a proxy for its volume? It may offer an estimate but is unlikely to fully represent the total volume. A more accurate assessment involves multiple levels or additional imaging techniques.,3.789755637709665e-07,0.012052242356868081,0.43458578542326814,0.029014823436509962,0.11059061779552248,0.25905872553102866,0.028972824655245866,0.21269595437836575,0.08842752787389466,3.789755637709665e-07,0.24295013102137952,0.07227989234909649
178,0.3,6,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an estimate of visceral adipose tissue volume, but it may not accurately represent the entire volume. Multiple level measurements or additional imaging techniques are needed for a more comprehensive assessment.","Is a single-level measurement of visceral adipose tissue area sufficient to represent its volume? While it can estimate the volume, it may not comprehensively reflect the entire amount. Multiple measurements or further imaging are necessary for thorough evaluation.",4.974054274493932e-07,0.13880394799601037,0.43458578542326814,0.038081955760419325,0.24064374604372007,0.25905872553102866,0.0380268323600102,0.3462273470028885,0.08842752787389466,4.974054274493935e-07,0.38015125253486204,0.07227989234909649
178,0.3,7,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an estimate of visceral adipose tissue volume, but it may not accurately represent the entire volume. Multiple level measurements or additional imaging techniques are needed for a more comprehensive assessment.",Does measuring visceral adipose tissue area at one level provide an accurate volume representation? It might estimate the volume but may not capture the full extent. More comprehensive assessment requires multiple levels or other imaging methods.,5.447773729207638e-07,0.19437379915082253,0.43458578542326814,0.04170880868998308,0.2978021598836684,0.25905872553102866,0.041648435441915946,0.40506784702582177,0.08842752787389466,5.447773729207643e-07,0.4407758743512975,0.07227989234909649
178,0.3,8,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an estimate of visceral adipose tissue volume, but it may not accurately represent the entire volume. Multiple level measurements or additional imaging techniques are needed for a more comprehensive assessment.",Can visceral adipose tissue volume be inferred from a single-level area measurement? This approach may estimate volume but is not fully representative. A more complete assessment involves multiple measurements or additional imaging.,6.39521263863505e-07,0.31573465615508933,0.43458578542326814,0.048962514549110596,0.4229653028376754,0.25905872553102866,0.04889164160572744,0.5342795785058287,0.08842752787389466,6.39521263863506e-07,0.5743072669758198,0.07227989234909649
178,0.3,9,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an estimate of visceral adipose tissue volume, but it may not accurately represent the entire volume. Multiple level measurements or additional imaging techniques are needed for a more comprehensive assessment.",Is a single-level visceral adipose tissue area measurement an accurate indicator of total volume? It can provide an estimate but may not accurately represent the entire volume. More detailed evaluation requires multiple levels or supplementary imaging.,5.447773729207638e-07,0.19437379915082253,0.43458578542326814,0.04170880868998308,0.2978021598836684,0.25905872553102866,0.041648435441915946,0.40506784702582177,0.08842752787389466,5.447773729207643e-07,0.4407758743512975,0.07227989234909649
178,0.3,10,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an estimate of visceral adipose tissue volume, but it may not accurately represent the entire volume. Multiple level measurements or additional imaging techniques are needed for a more comprehensive assessment.",Can the measurement of visceral adipose tissue area at one level stand in for the total volume? It may offer an estimate but does not fully represent the volume. Comprehensive assessment needs measurements at multiple levels or other imaging techniques.,4.500334819780226e-07,0.08616021451059153,0.43458578542326814,0.03445510283085558,0.18657652477344389,0.25905872553102866,0.034405229278104466,0.2906574958480763,0.08842752787389466,4.500334819780227e-07,0.3229928386949137,0.07227989234909649
179,0.3,1,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT facilitates localized entry of chemotherapy drugs into brain tissue, which could be beneficial for brain tumor treatment.",1.1842986367842703e-07,0.11778303565638337,0.0,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
179,0.3,2,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Can Nd:YAG laser-induced thermo therapy open the rodent blood-brain barrier locally for paclitaxel delivery as a novel adjuvant glioma treatment? Answer: LITT promotes targeted passage of chemotherapeutic agents into brain tissue, offering potential advantages in brain tumor therapy.",1.6580180914979763e-07,0.16907633004393308,0.0,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
179,0.3,3,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Is locoregional disruption of the rodent blood-brain barrier by Nd:YAG laser-induced thermo therapy a new approach for adjuvant glioma treatment with paclitaxel? Answer: LITT enables localized chemotherapeutic drug penetration into brain tissue, which may improve brain tumor treatment outcomes.",1.4211583641411233e-07,0.1431008436406751,0.0,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
179,0.3,4,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Does Nd:YAG laser-induced thermo therapy open the rodent blood-brain barrier locally for paclitaxel, suggesting a new adjuvant glioma therapy? Answer: LITT causes a locoregional passage of chemotherapy agents into brain tissue, presenting a promising strategy for brain tumor therapy.",1.4211583641411233e-07,0.1431008436406751,0.0,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
179,0.3,5,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Locoregional opening of the rodent blood-brain barrier via Nd:YAG laser-induced thermo therapy for paclitaxel: a novel adjuvant glioma treatment concept? Answer: LITT induces localized delivery of chemotherapeutic drugs into brain tissue, which is potentially useful for treating brain tumors.",1.4211583641411233e-07,0.1431008436406751,0.0,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
179,0.3,6,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Can Nd:YAG laser-induced thermo therapy locally open the rodent blood-brain barrier to allow paclitaxel passage as a new adjuvant glioma therapy? Answer: LITT facilitates targeted entry of chemotherapy agents into brain tissue, which may benefit brain tumor treatment.",1.6580180914979763e-07,0.16907633004393308,0.0,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
179,0.3,7,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Is the locoregional opening of the rodent blood-brain barrier by Nd:YAG laser-induced thermo therapy a new concept for adjuvant glioma therapy with paclitaxel? Answer: LITT promotes localized passage of chemotherapeutic drugs into brain tissue, offering potential for brain tumor treatment.",1.1842986367842703e-07,0.11778303565638337,0.0,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
179,0.3,8,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Nd:YAG laser-induced thermo therapy for locoregional opening of the rodent blood-brain barrier to deliver paclitaxel: a novel adjuvant glioma therapy? Answer: LITT enables targeted chemotherapeutic agent delivery into brain tissue, which could be advantageous in brain tumor therapy.",1.6580180914979763e-07,0.16907633004393308,0.0,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
179,0.3,9,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Does locoregional opening of the rodent blood-brain barrier by Nd:YAG laser-induced thermo therapy represent a new adjuvant glioma therapy approach for paclitaxel? Answer: LITT allows localized passage of chemotherapy drugs into brain tissue, which holds promise for brain tumor treatment.",1.1842986367842703e-07,0.11778303565638337,0.0,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
179,0.3,10,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Locoregional disruption of the rodent blood-brain barrier using Nd:YAG laser-induced thermo therapy for paclitaxel: a new adjuvant glioma treatment concept? Answer: LITT induces localized chemotherapeutic agent penetration into brain tissue, potentially improving brain tumor therapy outcomes.",2.1317375462116823e-07,0.22314355131420927,0.0,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
180,0.3,1,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation takes into consideration the unique needs and circumstances of older adults, such as their overall health, comorbidities, and functional","Does a geriatric oncology consultation change the cancer treatment plan for elderly patients? Yes, it can alter the treatment approach by addressing the specific needs and conditions of older adults, including their general health, comorbidities, and functional status.",3.0791764556390996e-07,0.05157210778233967,0.17132659131469363,0.023574544042164344,0.11025930806596085,0.13888888888888887,0.023540420032387266,0.17144728680182242,0.10275824770146022,3.079176455639103e-07,0.23530020297986054,0.06353305785123965
180,0.3,2,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation takes into consideration the unique needs and circumstances of older adults, such as their overall health, comorbidities, and functional","Can a geriatric oncology consultation influence the cancer treatment plan for elderly patients? Indeed, such a consultation can adjust the treatment plan by considering the unique health factors and circumstances of older patients, like their overall health and comorbid conditions.",2.6054570009253936e-07,0.03447438355640475,0.14570332261663269,0.0199476911126006,0.05619208679568466,0.13888888888888887,0.019918816950481533,0.11587743564701025,0.10275824770146022,2.6054570009253947e-07,0.1781417891399122,0.06353305785123965
180,0.3,3,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation takes into consideration the unique needs and circumstances of older adults, such as their overall health, comorbidities, and functional","Is the cancer treatment plan for elderly patients modified by a geriatric oncology consultation? Yes, these consultations can lead to changes in the treatment plan by taking into account the distinct needs of older adults, including their health status and coexisting medical issues.",1.8948778188548325e-07,0.042172589258711035,0.14753123140987506,0.014507411718254981,0.019793820182236743,0.13888888888888887,0.014486412327622933,0.03791589417729968,0.10275824770146022,1.8948778188548325e-07,0.09809908146637802,0.06353305785123965
180,0.3,4,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation takes into consideration the unique needs and circumstances of older adults, such as their overall health, comorbidities, and functional","Does consulting a geriatric oncologist affect the cancer treatment plan for elderly patients? Yes, it can modify the plan by factoring in the specific health challenges and functional abilities of older patients.",4.5003348197802176e-07,0.22850281594141864,0.17132659131469363,0.034455102830855615,0.2925808648599162,0.13888888888888887,0.03440522927810451,0.3594995183047627,0.10275824770146022,4.500334819780227e-07,0.4294562174208183,0.06353305785123965
180,0.3,5,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation takes into consideration the unique needs and circumstances of older adults, such as their overall health, comorbidities, and functional","Will a geriatric oncology consultation alter the cancer treatment plan for elderly patients? Yes, because it evaluates the unique health profile, comorbidities, and functional capacity of elderly individuals to tailor the treatment accordingly.",4.2634750924233646e-07,0.1967541176268388,0.17132659131469363,0.032641676366073735,0.2597910420369245,0.13888888888888887,0.032594427737151634,0.3255979666290809,0.10275824770146022,4.263475092423373e-07,0.3943648976095493,0.06353305785123965
180,0.3,6,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation takes into consideration the unique needs and circumstances of older adults, such as their overall health, comorbidities, and functional","Can a geriatric oncology consultation impact the cancer treatment plan for elderly patients? Yes, it considers the particular health conditions and overall functionality of older adults, potentially leading to modifications in their treatment plan.",4.0266153650665116e-07,0.16598245896008512,0.17132659131469363,0.030828249901291856,0.22804234372234466,0.13888888888888887,0.03078362619619876,0.2928081438060892,0.10275824770146022,4.026615365066519e-07,0.36046334593386753,0.06353305785123965
180,0.3,7,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation takes into consideration the unique needs and circumstances of older adults, such as their overall health, comorbidities, and functional","Does a geriatric oncology consultation result in changes to the cancer treatment plan for elderly patients? Yes, it adapts the plan by assessing the comprehensive health and comorbidities specific to older patients.",4.5003348197802176e-07,0.22850281594141864,0.17132659131469363,0.034455102830855615,0.2925808648599162,0.13888888888888887,0.03440522927810451,0.3594995183047627,0.10275824770146022,4.500334819780227e-07,0.4294562174208183,0.06353305785123965
180,0.3,8,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation takes into consideration the unique needs and circumstances of older adults, such as their overall health, comorbidities, and functional","Is the cancer treatment plan for elderly patients influenced by a geriatric oncology consultation? Yes, this specialized consultation reviews the patient's overall health, comorbidities, and functional status to adjust the treatment plan.",4.5003348197802176e-07,0.22850281594141864,0.17132659131469363,0.034455102830855615,0.2925808648599162,0.13888888888888887,0.03440522927810451,0.3594995183047627,0.10275824770146022,4.500334819780227e-07,0.4294562174208183,0.06353305785123965
180,0.3,9,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation takes into consideration the unique needs and circumstances of older adults, such as their overall health, comorbidities, and functional","Can the cancer treatment plan for elderly patients be modified through a geriatric oncology consultation? Yes, as this consultation addresses the unique health needs and functional conditions of older adults.",4.974054274493924e-07,0.2951941904400921,0.17132659131469363,0.038081955760419374,0.36157373634686696,0.13888888888888887,0.038026832360010254,0.43095848228690636,0.10275824770146022,4.974054274493935e-07,0.50356418957454,0.06353305785123965
180,0.3,10,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation takes into consideration the unique needs and circumstances of older adults, such as their overall health, comorbidities, and functional","Does a geriatric oncology consultation modify cancer treatment strategies for elderly patients? Yes, it does so by considering the patient's overall health, existing comorbidities, and functional abilities unique to the elderly.",4.7371945471370706e-07,0.26129263876441033,0.17132659131469363,0.036268529295637494,0.32648241653559795,0.13888888888888887,0.03621603081905738,0.3945908381160317,0.10275824770146022,4.737194547137081e-07,0.465823861591693,0.06353305785123965
181,0.3,1,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Can an advance care planning model be implemented in community palliative care? Answer: Implementing an advance care planning model is achievable within community palliative care services. Quality audit procedures are crucial to the model, with documentation of advance care planning discussions recognized as a key outcome metric.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
181,0.3,2,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Is it possible to apply an advance care planning model in community palliative care? Answer: An advance care planning model can be effectively applied in community palliative care services. Integral to the model are quality audit processes, with the recording of advance care planning conversations serving as an important outcome indicator.",9.474389094274162e-08,0.07243580835629304,8.146295294744754e-05,0.0072537058591274906,0.06620950534838155,0.009423028470647549,0.007243206163811466,0.09018744774573095,0.003605878992988247,9.474389094274162e-08,0.08963693449175114,0.0018910788526508258
181,0.3,3,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Does an advance care planning model work in community palliative care? Answer: Yes, an advance care planning model is workable in community palliative care services. Essential to this model are quality audit processes, and documenting advance care planning discussions is a significant outcome measure.",7.105791820705622e-08,0.11306024313935037,0.03957561728395059,0.005440279394345618,0.1088845656166888,0.03311065885264533,0.0054324046228586,0.07339380596669631,0.003151703623580332,7.105791820705622e-08,0.07292293477679124,0.0016600189291508909
181,0.3,4,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Is the use of an advance care planning model viable in community palliative care? Answer: The use of an advance care planning model is viable for community palliative care services. Quality audit processes form a vital part of the model, with the documentation of advance care planning discussions being an important outcome metric.",1.4211583641411244e-07,0.06756937646442474,0.02712310708491067,0.010880558788691236,0.05784560457348675,0.04201562106324008,0.0108648092457172,0.05086501379594566,0.05253261099598108,1.4211583641411244e-07,0.04843651264574511,0.05668010399531345
181,0.3,5,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Can community palliative care incorporate an advance care planning model? Answer: Community palliative care services can incorporate an advance care planning model. Quality audit processes are a key element of the model, and documenting advance care planning discussions is an important outcome measure.",9.474389094274162e-08,0.1424645875672681,0.04623724489795922,0.0072537058591274906,0.13654281493683085,0.03714083636863558,0.007243206163811466,0.09910145552615202,0.004303906121936658,9.474389094274162e-08,0.09846084880686945,0.002268582374252811
181,0.3,6,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Is adopting an advance care planning model feasible in community palliative care? Answer: Adopting an advance care planning model is feasible within community palliative care services. The model relies on quality audit processes, with documentation of advance care planning discussions as a critical outcome measure.",4.737194547137081e-08,0.08445766447088454,0.03319987216946674,0.0036268529295637453,0.08195492056885767,0.029263776516523787,0.003621603081905733,0.0805675026012409,0.02502670362358031,4.737194547137081e-08,0.0810273428056254,0.024785018929150904
181,0.3,7,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Is an advance care planning model practical in community palliative care? Answer: An advance care planning model is practical for community palliative care services. Quality audit processes are essential to the model, and documenting advance care planning discussions is a key outcome measure.",9.474389094274162e-08,0.11022518382029345,0.023371913580246872,0.0072537058591274906,0.10353580633873838,0.013027556359570563,0.007243206163811466,0.09910145552615202,0.004303906121936658,9.474389094274162e-08,0.09846084880686945,0.002268582374252811
181,0.3,8,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Can an advance care planning model be successfully used in community palliative care? Answer: Yes, an advance care planning model can be successfully used in community palliative care services. Quality audit processes are fundamental to the model, with documentation of advance care planning discussions recognized as an important outcome measure.",7.105791820705622e-08,0.035304030088055605,0.0606874589086126,0.005440279394345618,0.04191110977213608,0.07204301510411815,0.0054324046228586,0.0182540587626443,0.05840995132504054,7.105791820705622e-08,0.008977783703213227,0.04081807678039054
181,0.3,9,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Is the implementation of an advance care planning model possible in community palliative care? Answer: Implementation of an advance care planning model is possible in community palliative care services. Quality audit processes are a crucial component of the model, with documentation of advance care planning discussions serving as an important outcome measure.",1.1842986367842703e-07,0.016451863265109168,0.04949769482450922,0.009067132323909363,0.007388825107847552,0.06415798697340841,0.009054007704764333,0.028344162262276207,0.05441713572234577,1.1842986367842703e-07,0.05426218925129378,0.03824910210495426
181,0.3,10,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Is an advance care planning model suitable for community palliative care? Answer: An advance care planning model is suitable for community palliative care services. Quality audit processes are an integral part of the model, with documentation of advance care planning discussions considered an important outcome measure.",2.3685972735685406e-08,0.08675237856076023,0.047809075967859715,0.0018134264647818726,0.08652359599958448,0.0476727180023884,0.0018108015409528666,0.0553798432119752,0.02346847935231325,2.3685972735685406e-08,0.02372223194622114,0.0005276493146384141
182,0.3,1,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) is a poor predictor of fluid responsiveness. Multiple studies have shown that other parameters such as stroke volume variation (SVV), pulse pressure",Question: Can central venous pressure indicate fluid responsiveness? Answer: Central venous pressure (CVP) is an unreliable indicator of fluid responsiveness. Numerous studies have demonstrated that other measures like stroke volume variation (SVV) and pulse pressure are better predictors.,4.73719454713706e-08,0.059851841459428456,0.003055415003466927,0.003626852929563752,0.05942360070452324,0.001629654616667607,0.003621603081905747,0.058840500022933284,0.0,4.737194547137081e-08,0.060624621816435464,0.0
182,0.3,2,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) is a poor predictor of fluid responsiveness. Multiple studies have shown that other parameters such as stroke volume variation (SVV), pulse pressure",Question: Is central venous pressure a reliable predictor of fluid responsiveness? Answer: Central venous pressure (CVP) does not reliably predict fluid responsiveness. Research has shown that parameters such as stroke volume variation (SVV) and pulse pressure are more accurate.,7.10579182070559e-08,0.08849205776082192,0.004463830221405965,0.005440279394345625,0.08786333642501098,0.0023785838179777724,0.005432404622858614,0.08701137698963013,0.0,7.105791820705622e-08,0.08961215868968697,0.0
182,0.3,3,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) is a poor predictor of fluid responsiveness. Multiple studies have shown that other parameters such as stroke volume variation (SVV), pulse pressure","Question: Does measuring central venous pressure help predict fluid responsiveness? Answer: Central venous pressure (CVP) is a poor predictor of fluid responsiveness. Studies indicate that other indicators, including stroke volume variation (SVV) and pulse pressure, are superior.",2.36859727356853e-08,0.030371344206569173,0.0015696442245671308,0.0018134264647818796,0.030152490117890007,0.0008380438547157774,0.0018108015409528735,0.029852963149681777,0.0,2.3685972735685406e-08,0.030771658666753687,0.0
182,0.3,4,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) is a poor predictor of fluid responsiveness. Multiple studies have shown that other parameters such as stroke volume variation (SVV), pulse pressure",Question: Can fluid responsiveness be predicted by central venous pressure? Answer: Central venous pressure (CVP) is not a good predictor of fluid responsiveness. Multiple studies suggest that parameters like stroke volume variation (SVV) and pulse pressure provide better prediction.,7.10579182070559e-08,0.1249734883166087,0.03063639918676773,0.005440279394345625,0.1253307515904134,0.029384756657483937,0.005432404622858614,0.08701137698963013,0.0,7.105791820705622e-08,0.08961215868968697,0.0
182,0.3,5,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) is a poor predictor of fluid responsiveness. Multiple studies have shown that other parameters such as stroke volume variation (SVV), pulse pressure",Question: Is central venous pressure effective in predicting fluid responsiveness? Answer: Central venous pressure (CVP) is ineffective as a predictor of fluid responsiveness. Evidence points to other parameters such as stroke volume variation (SVV) and pulse pressure as more reliable.,9.47438909427412e-08,0.11633838675668473,0.005800752729499654,0.0072537058591274975,0.11551756811678793,0.0030881898203765634,0.00724320616381148,0.11441035117774545,0.0,9.474389094274162e-08,0.11778303565638382,0.0
182,0.3,6,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) is a poor predictor of fluid responsiveness. Multiple studies have shown that other parameters such as stroke volume variation (SVV), pulse pressure",Question: Does central venous pressure serve as a predictor for fluid responsiveness? Answer: Central venous pressure (CVP) poorly predicts fluid responsiveness. Research supports that other measures like stroke volume variation (SVV) and pulse pressure are more dependable.,2.36859727356853e-08,0.030371344206569173,0.0015696442245671308,0.0018134264647818796,0.030152490117890007,0.0008380438547157774,0.0018108015409528735,0.029852963149681777,0.0,2.3685972735685406e-08,0.030771658666753687,0.0
182,0.3,7,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) is a poor predictor of fluid responsiveness. Multiple studies have shown that other parameters such as stroke volume variation (SVV), pulse pressure",Question: Is central venous pressure a good measure for predicting fluid responsiveness? Answer: Central venous pressure (CVP) is not a good measure for predicting fluid responsiveness. Studies have found that stroke volume variation (SVV) and pulse pressure are better indicators.,9.47438909427412e-08,0.06139165954073533,0.1139654714761249,0.0072537058591274975,0.03040815410635922,0.09917355371900824,0.00724320616381148,0.0020081056815368648,0.08044982698961935,9.474389094274162e-08,0.04076668226083413,0.055363321799307974
182,0.3,8,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) is a poor predictor of fluid responsiveness. Multiple studies have shown that other parameters such as stroke volume variation (SVV), pulse pressure","Question: Can central venous pressure predict how a patient will respond to fluids? Answer: Central venous pressure (CVP) is a weak predictor of fluid responsiveness. Other parameters, including stroke volume variation (SVV) and pulse pressure, have been shown to be more effective.",1.421158364141119e-07,0.16981671067373671,0.008280763525518764,0.010880558788691243,0.1686349340321276,0.004401193212382016,0.010864809245717214,0.1670540846631643,0.0,1.4211583641411244e-07,0.17185025692666,0.0
182,0.3,9,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) is a poor predictor of fluid responsiveness. Multiple studies have shown that other parameters such as stroke volume variation (SVV), pulse pressure",Question: Does central venous pressure accurately predict fluid responsiveness? Answer: Central venous pressure (CVP) is an inaccurate predictor of fluid responsiveness. Multiple studies have identified stroke volume variation (SVV) and pulse pressure as superior parameters.,2.36859727356853e-08,0.031317443362529396,0.0016607839761248952,0.0018134264647818796,0.031088519621267796,0.0008886808425160632,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
182,0.3,10,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) is a poor predictor of fluid responsiveness. Multiple studies have shown that other parameters such as stroke volume variation (SVV), pulse pressure",Question: Is central venous pressure a dependable predictor of fluid responsiveness? Answer: Central venous pressure (CVP) is not dependable for predicting fluid responsiveness. Research indicates that stroke volume variation (SVV) and pulse pressure are more reliable predictors.,2.36859727356853e-08,0.030371344206569173,0.0015696442245671308,0.0018134264647818796,0.030152490117890007,0.0008380438547157774,0.0018108015409528735,0.029852963149681777,0.0,2.3685972735685406e-08,0.030771658666753687,0.0
183,0.3,1,ai,Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: There is no consensus on the routine insertion of a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision,Is it essential to routinely place a nasobiliary drainage tube following endoscopic clearance of the common bile duct in patients with cholangitis caused by choledocholithiasis? There is no agreement on routinely inserting a nasobiliary drainage tube after endoscopic clearance of the common bile duct in such patients. The choice,9.474389094274162e-08,0.004379064317738823,0.0387811634349029,0.0072537058591274906,0.008543879847103142,0.049967126890203856,0.007243206163811466,0.013056259660594538,0.06,9.474389094274162e-08,0.017949799470877714,0.06900654372397381
183,0.3,2,ai,Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: There is no consensus on the routine insertion of a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision,Should a nasobiliary drainage tube be routinely inserted after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? There is no consensus about routinely placing a nasobiliary drainage tube post-endoscopic clearance in these cases. The decision,3.316036182995955e-07,0.04986875329781615,0.15431963367064266,0.025387970506946217,0.06965564191210705,0.15914020045888178,0.025351221573340132,0.08975337144583184,0.15974489795918367,3.316036182995957e-07,0.11013846337714961,0.15704937537180247
183,0.3,3,ai,Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: There is no consensus on the routine insertion of a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision,Is routine insertion of a nasobiliary drainage tube necessary after endoscopic clearance of the common bile duct in patients suffering from choledocholithiasis-related cholangitis? No consensus exists regarding this routine practice. The decision,4.974054274493926e-07,0.14402341687169562,0.23268698060941817,0.03808195576041936,0.20444134256337199,0.21301775147928995,0.03802683236001024,0.2674683032176941,0.1875,4.974054274493935e-07,0.3332820146913589,0.15704937537180247
183,0.3,4,ai,Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: There is no consensus on the routine insertion of a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision,Does one need to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with cholangitis due to choledocholithiasis? There is no clear consensus on this routine procedure. The decision,4.026615365066514e-07,0.022662559867428822,0.23268698060941817,0.030828249901291842,0.079278199609365,0.21301775147928995,0.030783626196198746,0.13825657173768713,0.1875,4.026615365066519e-07,0.19975062206683658,0.15704937537180247
183,0.3,5,ai,Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: There is no consensus on the routine insertion of a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision,Is it standard practice to insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? There is no agreement on routine insertion after the procedure. The decision,4.263475092423367e-07,0.05165009674068033,0.23268698060941817,0.03264167636607372,0.10913116275904677,0.21301775147928995,0.03259442773715162,0.16902823040444082,0.1875,4.263475092423373e-07,0.2314993203814164,0.15704937537180247
183,0.3,6,ai,Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: There is no consensus on the routine insertion of a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision,Is routine nasobiliary drainage tube placement required following endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? No consensus has been reached on this matter. The decision,5.447773729207632e-07,0.21071479137036908,0.23268698060941817,0.04170880868998312,0.27343421405032275,0.21301775147928995,0.04164843544191599,0.3389272671998378,0.1875,5.447773729207643e-07,0.40738998684508054,0.15704937537180247
183,0.3,7,ai,Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: There is no consensus on the routine insertion of a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision,Should nasobiliary drainage tubes be routinely placed after endoscopic clearance of the common bile duct in patients with cholangitis caused by choledocholithiasis? There is no consensus on this routine intervention. The decision,4.974054274493926e-07,0.14402341687169562,0.23268698060941817,0.03808195576041936,0.20444134256337199,0.21301775147928995,0.03802683236001024,0.2674683032176941,0.1875,4.974054274493935e-07,0.3332820146913589,0.15704937537180247
183,0.3,8,ai,Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: There is no consensus on the routine insertion of a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision,Is it necessary to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? There is no consensus on this routine practice. The decision,4.737194547137073e-07,0.1122747185571158,0.23268698060941817,0.03626852929563748,0.1716515197403803,0.21301775147928995,0.03621603081905737,0.23356675154201234,0.1875,4.737194547137081e-07,0.29819069488008987,0.15704937537180247
183,0.3,9,ai,Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: There is no consensus on the routine insertion of a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision,Is the routine insertion of a nasobiliary drainage tube indicated after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? There is no consensus on this routine step. The decision,4.737194547137073e-07,0.1122747185571158,0.23268698060941817,0.03626852929563748,0.1716515197403803,0.21301775147928995,0.03621603081905737,0.23356675154201234,0.1875,4.737194547137081e-07,0.29819069488008987,0.15704937537180247
183,0.3,10,ai,Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: There is no consensus on the routine insertion of a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision,Is it customary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? There is no consensus on routinely doing so. The decision,4.737194547137073e-07,0.1122747185571158,0.23268698060941817,0.03626852929563748,0.1716515197403803,0.21301775147928995,0.03621603081905737,0.23356675154201234,0.1875,4.737194547137081e-07,0.29819069488008987,0.15704937537180247
184,0.3,1,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether the trend towards lower intensity treatments is associated","Question: Does the length of psychological treatment for depression influence the likelihood of returning to treatment? Answer: Findings indicate that extended treatment duration might reduce the chance of returning to mental health services for certain groups. However, due to the study's design, no causal conclusions can be made. Additional research, ideally through randomized controlled trials, is necessary to explore if lower intensity treatments correlate with this trend.",2.3685972735685406e-08,0.037241368763923255,0.015772348139958384,0.0018134264647818726,0.0058234190197259394,0.015380859375,0.0018108015409528666,0.015748356968136257,0.0,2.3685972735685406e-08,0.01600034134644357,0.0
184,0.3,2,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether the trend towards lower intensity treatments is associated","Question: Is there a connection between the duration of psychological treatment for depression and the probability of re-entering treatment? Answer: The results imply that longer treatment periods could help prevent some individuals from needing further mental health care. Nonetheless, the study design does not allow for causal claims. More research, preferably randomized controlled trials, is required to confirm if lower intensity treatments are linked to this pattern.",2.3685972735685406e-08,0.07925028879785856,0.046045785639958384,0.0018134264647818726,0.015504186535965303,0.0,0.0018108015409528666,0.015748356968136257,0.0,2.3685972735685406e-08,0.01600034134644357,0.0
184,0.3,3,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether the trend towards lower intensity treatments is associated","Question: Does the duration of psychological treatment for depression affect the likelihood of returning to treatment? Answer: The study suggests that longer treatment durations may reduce the risk of returning to mental health care in certain populations. However, no causal relationship can be established due to the study design. Further investigations, ideally randomized controlled trials, are needed to assess whether lower intensity treatments are associated with this trend.",4.737194547137081e-08,0.0322152843212109,0.0013680512649583837,0.0036268529295637453,0.009767198649785591,0.01514792899408284,0.003621603081905733,0.03125254350410156,0.0,4.737194547137081e-08,0.031748698314579826,0.0
184,0.3,4,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether the trend towards lower intensity treatments is associated","Question: Is the length of psychological treatment for depression related to the chance of returning to treatment? Answer: Results suggest that longer treatment may help prevent return to mental health care in some groups. However, the study's design prevents causal conclusions. Additional research, preferably randomized controlled trials, is necessary to determine if lower intensity treatments are linked to this trend.",1.4211583641411244e-07,0.03286700932284692,0.046045785639958384,0.010880558788691236,0.0984400728132524,0.0,0.0108648092457172,0.10008345855698497,0.0,1.4211583641411244e-07,0.10178269430994202,0.0
184,0.3,5,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether the trend towards lower intensity treatments is associated","Question: Does the duration of psychological treatment for depression influence the likelihood of re-entering treatment? Answer: Findings suggest that extended treatment duration might reduce the need for further mental health care in some groups. However, due to the study design, causal inferences cannot be drawn. More research, ideally randomized controlled trials, is needed to explore the association with lower intensity treatments.",1.1842986367842703e-07,0.01605989100646621,0.046045785639958384,0.009067132323909363,0.08134563945395268,0.0,0.009054007704764333,0.08269171584511614,0.0,1.1842986367842703e-07,0.0840831172105414,0.0
184,0.3,6,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether the trend towards lower intensity treatments is associated","Question: Is there an association between the duration of psychological treatment for depression and return to treatment? Answer: The results indicate that longer treatment durations may prevent some groups from returning to mental health care. However, no causal inference can be made due to the study design. Further research, preferably randomized controlled trials, is required to determine if lower intensity treatments are connected to this trend.",0.0,0.06398281666707106,0.046045785639958384,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
184,0.3,7,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether the trend towards lower intensity treatments is associated","Question: Does the length of psychological treatment for depression impact the likelihood of returning to treatment? Answer: The study suggests that longer treatment may reduce the chance of returning to mental health services for certain groups. However, because of the study design, no causal conclusions can be drawn. Additional research, ideally randomized controlled trials, is needed to confirm if lower intensity treatments are associated.",4.737194547137081e-08,0.03328374403321632,0.0014542143600416307,0.0036268529295637453,0.054108284784256,0.016124697661918846,0.003621603081905733,0.03226086221822477,0.0,4.737194547137081e-08,0.03278982282299214,0.0
184,0.3,8,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether the trend towards lower intensity treatments is associated","Question: Is the duration of psychological treatment for depression linked to the probability of re-entering treatment? Answer: Results suggest that longer treatment duration could help prevent return to mental health care in some populations. However, the study design does not support causal inference. Further studies, preferably randomized controlled trials, are necessary to assess the connection with lower intensity treatments.",1.6580180914979784e-07,0.04996144268214664,0.046045785639958384,0.012693985253473108,0.11583181552512123,0.0,0.012675610786670066,0.11778303565638559,0.0,1.6580180914979784e-07,0.1198011998126205,0.0
184,0.3,9,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether the trend towards lower intensity treatments is associated","Question: Does the length of psychological treatment for depression relate to the likelihood of returning to treatment? Answer: Findings indicate that longer treatment durations may reduce the risk of returning to mental health care in some groups. However, no causal inference can be made due to the study design. More research, ideally randomized controlled trials, is needed to explore if lower intensity treatments are associated.",2.3685972735685406e-08,0.01650391804638751,0.0007158375796062488,0.0018134264647818726,0.03775302936686398,0.01586888657648284,0.0018108015409528666,0.01600034134644357,0.0,2.3685972735685406e-08,0.016260520871781203,0.0
184,0.3,10,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether the trend towards lower intensity treatments is associated","Question: Is there a relationship between the duration of psychological treatment for depression and return to treatment? Answer: The results suggest that longer treatment may prevent some groups from returning to mental health care. However, the study design limits causal conclusions. Further research, preferably randomized controlled trials, is required to determine if lower intensity treatments are linked to this trend.",1.4211583641411244e-07,0.03286700932284692,0.046045785639958384,0.010880558788691236,0.0984400728132524,0.0,0.0108648092457172,0.10008345855698497,0.0,1.4211583641411244e-07,0.10178269430994202,0.0
185,0.3,1,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborns is not always predictable, as it can vary depending on various factors such as gestational age, presence of middle ear fluid, and individual variability in auditory system maturation.","Is it possible to predict discordance between TEOAE and AABR results in newborns? Discordance between Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborns is not reliably predictable, as it depends on factors like gestational age, middle ear fluid presence, and individual auditory system development variability.",1.1842986367842703e-07,0.09783071500636176,0.0018160871470449327,0.009067132323909363,0.0971637484536485,0.0,0.009054007704764333,0.09909090264422993,0.0,1.1842986367842703e-07,0.10109611687136999,0.0
185,0.3,2,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborns is not always predictable, as it can vary depending on various factors such as gestational age, presence of middle ear fluid, and individual variability in auditory system maturation.","Can discordance in TEOAE and AABR test results be anticipated in newborns? The discordance in TEOAE and AABR outcomes among newborns cannot always be predicted because it is influenced by multiple factors including gestational age, middle ear fluid, and differences in auditory system maturation.",2.8423167282822487e-07,0.34988533250644327,0.07386912443892503,0.02176111757738247,0.3503354540751862,0.0710059171597633,0.0217296184914344,0.32434396202439286,0.04865220249835634,2.8423167282822487e-07,0.2970216234954881,0.02498356344510192
185,0.3,3,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborns is not always predictable, as it can vary depending on various factors such as gestational age, presence of middle ear fluid, and individual variability in auditory system maturation.","Is discordance between TEOAE and AABR outcomes in newborns foreseeable? The discordance in Transient Evoked Otoacoustic Emissions and Automated Auditory Brainstem Response results in newborns is unpredictable due to factors such as gestational age, middle ear fluid, and individual variability in auditory development.",3.079176455639103e-07,0.2774652235268329,0.005619776914420754,0.023574544042164344,0.27541197985996746,0.0,0.023540420032387266,0.2814124594381848,0.0,3.079176455639103e-07,0.28768207245178345,0.0
185,0.3,4,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborns is not always predictable, as it can vary depending on various factors such as gestational age, presence of middle ear fluid, and individual variability in auditory system maturation.","Are discordant results in TEOAE and AABR tests predictable in newborn infants? Discordance in TEOAE and AABR outcomes in newborns is not consistently predictable, as it varies with gestational age, presence of middle ear fluid, and individual differences in auditory system maturation.",3.316036182995957e-07,0.3699919392726714,0.054539098450045426,0.025387970506946217,0.36941931050633325,0.049861495844875335,0.025351221573340132,0.3422762766819605,0.025623268698060954,3.316036182995957e-07,0.31365755885504143,0.0
185,0.3,5,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborns is not always predictable, as it can vary depending on various factors such as gestational age, presence of middle ear fluid, and individual variability in auditory system maturation.","Can we predict when TEOAE and AABR results will be discordant in newborns? Predicting discordance in Transient Evoked Otoacoustic Emissions and Automated Auditory Brainstem Response outcomes in newborns is challenging because it depends on gestational age, middle ear fluid, and individual auditory maturation variability.",2.8423167282822487e-07,0.2209277175185469,0.0181755829903978,0.02176111757738247,0.25131442828090744,0.0,0.0217296184914344,0.2567198468478131,0.0,2.8423167282822487e-07,0.2623642644674917,0.0
185,0.3,6,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborns is not always predictable, as it can vary depending on various factors such as gestational age, presence of middle ear fluid, and individual variability in auditory system maturation.","Is it feasible to foresee discordance in TEOAE and AABR outcomes in newborns? Discordance between TEOAE and AABR results in newborns is not always foreseeable, influenced by factors such as gestational age, middle ear fluid, and individual auditory system maturation differences.",3.552895910352811e-07,0.3625630971541671,0.031685912854477534,0.02720139697172809,0.3609684096941148,0.025623268698060954,0.027162023114293,0.33270575382573453,0.0,3.552895910352811e-07,0.3403258059372023,0.0
185,0.3,7,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborns is not always predictable, as it can vary depending on various factors such as gestational age, presence of middle ear fluid, and individual variability in auditory system maturation.","Can discordance in newborns’ TEOAE and AABR outcomes be predicted? The discordance in TEOAE and AABR outcomes in newborns cannot be reliably predicted due to factors like gestational age, middle ear fluid presence, and variability in auditory system maturation.",4.026615365066517e-07,0.4904673957088699,0.08563064538330462,0.030828249901291835,0.45300096425085545,0.05387755102040818,0.030783626196198732,0.42528115179378556,0.02775510204081633,4.026615365066519e-07,0.39589565709201446,0.0
185,0.3,8,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborns is not always predictable, as it can vary depending on various factors such as gestational age, presence of middle ear fluid, and individual variability in auditory system maturation.","Is predicting discordance in TEOAE and AABR test outcomes in newborns possible? Discordance in Transient Evoked Otoacoustic Emissions and Automated Auditory Brainstem Response outcomes among newborns is not always predictable, as it depends on gestational age, middle ear fluid, and individual auditory development variability.",2.8423167282822487e-07,0.2531671212655211,0.005067047395089723,0.02176111757738247,0.25131442828090744,0.0,0.0217296184914344,0.2567198468478131,0.0,2.8423167282822487e-07,0.2623642644674917,0.0
185,0.3,9,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborns is not always predictable, as it can vary depending on various factors such as gestational age, presence of middle ear fluid, and individual variability in auditory system maturation.","Are discordant TEOAE and AABR results in newborns predictable? Discordance in TEOAE and AABR outcomes in newborns is unpredictable at times, influenced by factors including gestational age, middle ear fluid, and individual differences in auditory system maturation.",4.500334819780223e-07,0.5141334248493235,0.06446904510877574,0.03445510283085558,0.4732443953925731,0.02854671280276816,0.03440522927810447,0.44393138893595907,0.0,4.500334819780227e-07,0.45473615711494775,0.0
185,0.3,10,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborns is not always predictable, as it can vary depending on various factors such as gestational age, presence of middle ear fluid, and individual variability in auditory system maturation.","Is it possible to anticipate discordance in TEOAE and AABR outcomes in newborns? Predicting discordance between Transient Evoked Otoacoustic Emissions and Automated Auditory Brainstem Response results in newborns is not always possible due to factors such as gestational age, presence of middle ear fluid, and individual variability in auditory system maturation.",1.1842986367842703e-07,0.07010482778396376,0.0181755829903978,0.009067132323909363,0.0971637484536485,0.0,0.009054007704764333,0.09909090264422993,0.0,1.1842986367842703e-07,0.10109611687136999,0.0
186,0.3,1,ai,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: There is limited evidence to suggest that laparoscopic cholecystectomy may influence peri-sinusoidal cell activity. Further research is needed to fully understand the potential impact of this surgical procedure on liver function.,"Does laparoscopic cholecystectomy affect peri-sinusoidal cell activity? Current evidence is limited, indicating a possible influence, but more studies are required to clarify its impact on liver function.",3.079176455639089e-07,0.2988270803297097,0.0763888888888889,0.023574544042164414,0.3822289043024001,0.026296566837107373,0.023540420032387342,0.4328640822962804,0.0,3.079176455639103e-07,0.4480247225269607,0.0
186,0.3,2,ai,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: There is limited evidence to suggest that laparoscopic cholecystectomy may influence peri-sinusoidal cell activity. Further research is needed to fully understand the potential impact of this surgical procedure on liver function.,"Is peri-sinusoidal cell activity altered by laparoscopic cholecystectomy? Available data is scarce, suggesting a potential effect, yet further research is necessary to understand its implications for liver function.",2.842316728282236e-07,0.26108675234686274,0.0763888888888889,0.021761117577382534,0.3430081911491176,0.026296566837107373,0.02172961849143447,0.39204208777602556,0.0,2.8423167282822487e-07,0.40546510810816505,0.0
186,0.3,3,ai,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: There is limited evidence to suggest that laparoscopic cholecystectomy may influence peri-sinusoidal cell activity. Further research is needed to fully understand the potential impact of this surgical procedure on liver function.,"Can laparoscopic cholecystectomy impact peri-sinusoidal cell activity? There is some limited evidence pointing to an influence, but additional investigation is needed to fully grasp its effects on liver function.",2.605457000925383e-07,0.22471910817598806,0.0763888888888889,0.019947691112600655,0.30526786316627064,0.026296566837107373,0.019918816950481595,0.3528213746227431,0.0,2.6054570009253947e-07,0.36464311358791024,0.0
186,0.3,4,ai,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: There is limited evidence to suggest that laparoscopic cholecystectomy may influence peri-sinusoidal cell activity. Further research is needed to fully understand the potential impact of this surgical procedure on liver function.,Does undergoing laparoscopic cholecystectomy change peri-sinusoidal cell activity? Evidence is minimal but suggests a possible effect; more research is essential to determine its significance for liver function.,3.079176455639089e-07,0.2988270803297097,0.0763888888888889,0.023574544042164414,0.3822289043024001,0.026296566837107373,0.023540420032387342,0.4328640822962804,0.0,3.079176455639103e-07,0.4480247225269607,0.0
186,0.3,5,ai,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: There is limited evidence to suggest that laparoscopic cholecystectomy may influence peri-sinusoidal cell activity. Further research is needed to fully understand the potential impact of this surgical procedure on liver function.,"Is there an effect of laparoscopic cholecystectomy on peri-sinusoidal cell activity? Limited studies hint at a potential influence, though further research is required to comprehend its full impact on liver function.",2.131737546211677e-07,0.1557262366890373,0.0763888888888889,0.016320838183036895,0.23380889918412695,0.026296566837107373,0.016297213868575848,0.27871340246902143,0.0,2.1317375462116866e-07,0.2876820724517808,0.0
186,0.3,6,ai,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: There is limited evidence to suggest that laparoscopic cholecystectomy may influence peri-sinusoidal cell activity. Further research is needed to fully understand the potential impact of this surgical procedure on liver function.,"Does laparoscopic cholecystectomy have an influence on peri-sinusoidal cell activity? The evidence is limited but indicates a possible effect, necessitating more research to understand its consequences for liver function.",2.605457000925383e-07,0.22471910817598806,0.0763888888888889,0.019947691112600655,0.30526786316627064,0.026296566837107373,0.019918816950481595,0.3528213746227431,0.0,2.6054570009253947e-07,0.36464311358791024,0.0
186,0.3,7,ai,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: There is limited evidence to suggest that laparoscopic cholecystectomy may influence peri-sinusoidal cell activity. Further research is needed to fully understand the potential impact of this surgical procedure on liver function.,"Might laparoscopic cholecystectomy modify peri-sinusoidal cell activity? Current limited evidence suggests it may, but further studies are needed to fully understand its impact on liver function.",3.316036182995942e-07,0.3380477934829922,0.0763888888888889,0.025387970506946293,0.4230508988226549,0.026296566837107373,0.025351221573340216,0.475423696715076,0.0,3.316036182995957e-07,0.49247648509779474,0.0
186,0.3,8,ai,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: There is limited evidence to suggest that laparoscopic cholecystectomy may influence peri-sinusoidal cell activity. Further research is needed to fully understand the potential impact of this surgical procedure on liver function.,Does the surgical procedure of laparoscopic cholecystectomy affect peri-sinusoidal cell activity? Evidence is scarce but implies a potential influence; additional research is needed to clarify its effects on liver function.,2.36859727356853e-07,0.18962778836471905,0.0763888888888889,0.018134264647818775,0.26890021899539596,0.026296566837107373,0.01810801540952872,0.3150810466398961,0.0,2.3685972735685406e-07,0.3254224004346278,0.0
186,0.3,9,ai,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: There is limited evidence to suggest that laparoscopic cholecystectomy may influence peri-sinusoidal cell activity. Further research is needed to fully understand the potential impact of this surgical procedure on liver function.,"Is peri-sinusoidal cell activity influenced by laparoscopic cholecystectomy? There is limited evidence suggesting a possible effect, and more research is required to fully understand its impact on liver function.",2.605457000925383e-07,0.22471910817598806,0.0763888888888889,0.019947691112600655,0.30526786316627064,0.026296566837107373,0.019918816950481595,0.3528213746227431,0.0,2.6054570009253947e-07,0.36464311358791024,0.0
186,0.3,10,ai,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: There is limited evidence to suggest that laparoscopic cholecystectomy may influence peri-sinusoidal cell activity. Further research is needed to fully understand the potential impact of this surgical procedure on liver function.,"Could laparoscopic cholecystectomy alter peri-sinusoidal cell activity? Limited evidence points to a potential influence, but further investigation is necessary to comprehend its full effect on liver function.",3.079176455639089e-07,0.2988270803297097,0.0763888888888889,0.023574544042164414,0.3822289043024001,0.026296566837107373,0.023540420032387342,0.4328640822962804,0.0,3.079176455639103e-07,0.4480247225269607,0.0
187,0.3,1,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Case-mix based reimbursement can stimulate the development of process-oriented care delivery by incentivizing healthcare providers to focus on delivering efficient and effective care. By linking reimbursement to patient complexity and outcomes, healthcare organizations are encouraged to improve their processes, coordination, and quality of care to receive appropriate reimbursement.","Does case-mix based reimbursement encourage the advancement of process-oriented care delivery? Case-mix based reimbursement can promote process-oriented care by motivating healthcare providers to deliver efficient and effective care. By tying reimbursement to patient complexity and outcomes, healthcare organizations are incentivized to enhance their care processes, coordination, and quality to obtain suitable reimbursement.",2.1317375462116866e-07,0.08233131449182052,0.05603779147383414,0.016320838183036854,0.07575775272371121,0.06402753425213195,0.0162972138685758,0.09691783168821066,0.051570247933884296,2.1317375462116866e-07,0.1232083495189431,0.035041322314049606
187,0.3,2,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Case-mix based reimbursement can stimulate the development of process-oriented care delivery by incentivizing healthcare providers to focus on delivering efficient and effective care. By linking reimbursement to patient complexity and outcomes, healthcare organizations are encouraged to improve their processes, coordination, and quality of care to receive appropriate reimbursement.","Is the development of process-oriented care delivery stimulated by case-mix based reimbursement? Case-mix based reimbursement may drive the growth of process-oriented care by encouraging healthcare providers to focus on efficient and effective care delivery. Linking reimbursement to patient complexity and outcomes pushes healthcare organizations to improve care coordination, processes, and quality to secure appropriate reimbursement.",1.4211583641411244e-07,0.020642526922721505,0.05926821967452618,0.010880558788691236,0.01591945475695855,0.06515825764401255,0.0108648092457172,0.037494411217409596,0.051570247933884296,1.4211583641411244e-07,0.06258372770250897,0.035041322314049606
187,0.3,3,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Case-mix based reimbursement can stimulate the development of process-oriented care delivery by incentivizing healthcare providers to focus on delivering efficient and effective care. By linking reimbursement to patient complexity and outcomes, healthcare organizations are encouraged to improve their processes, coordination, and quality of care to receive appropriate reimbursement.","Does reimbursement based on case-mix foster the development of process-oriented care delivery? Case-mix based reimbursement can encourage process-oriented care by incentivizing providers to prioritize efficient and effective care. By associating reimbursement with patient complexity and outcomes, healthcare organizations are motivated to refine their care processes, coordination, and quality to achieve proper reimbursement.",2.1317375462116866e-07,0.027966829742020582,0.09503154147383415,0.016320838183036854,0.04803186550131322,0.08401920438957468,0.0162972138685758,0.09691783168821066,0.051570247933884296,2.1317375462116866e-07,0.1232083495189431,0.035041322314049606
187,0.3,4,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Case-mix based reimbursement can stimulate the development of process-oriented care delivery by incentivizing healthcare providers to focus on delivering efficient and effective care. By linking reimbursement to patient complexity and outcomes, healthcare organizations are encouraged to improve their processes, coordination, and quality of care to receive appropriate reimbursement.","Can case-mix based reimbursement promote the development of process-oriented care delivery? Yes, it can stimulate process-oriented care by encouraging healthcare providers to deliver care that is both efficient and effective. When reimbursement is linked to patient complexity and outcomes, healthcare organizations are driven to enhance their processes, coordination, and quality of care to earn appropriate reimbursement.",1.1842986367842703e-07,0.04951761312066294,0.09645595848343634,0.009067132323909363,0.028929175634816673,0.08401920438957468,0.009054007704764333,0.018446216246716496,0.051570247933884296,1.1842986367842703e-07,0.04316564184540628,0.035041322314049606
187,0.3,5,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Case-mix based reimbursement can stimulate the development of process-oriented care delivery by incentivizing healthcare providers to focus on delivering efficient and effective care. By linking reimbursement to patient complexity and outcomes, healthcare organizations are encouraged to improve their processes, coordination, and quality of care to receive appropriate reimbursement.","Does case-mix based reimbursement act as a catalyst for process-oriented care delivery development? It can, by incentivizing healthcare providers to focus on efficient and effective care delivery. By connecting reimbursement to patient complexity and outcomes, healthcare organizations are encouraged to improve their care coordination, processes, and quality to receive proper reimbursement.",2.3685972735685406e-07,0.020587214663300824,0.11463154147383414,0.018134264647818726,0.06823457281883183,0.08401920438957468,0.018108015409528666,0.11753711889094642,0.051570247933884296,2.3685972735685406e-07,0.14426175871677627,0.035041322314049606
187,0.3,6,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Case-mix based reimbursement can stimulate the development of process-oriented care delivery by incentivizing healthcare providers to focus on delivering efficient and effective care. By linking reimbursement to patient complexity and outcomes, healthcare organizations are encouraged to improve their processes, coordination, and quality of care to receive appropriate reimbursement.","Is process-oriented care delivery development stimulated by case-mix based reimbursement? Case-mix based reimbursement can incentivize healthcare providers to deliver efficient and effective care. By linking reimbursement to patient complexity and outcomes, healthcare organizations are motivated to enhance their processes, coordination, and quality of care to obtain appropriate reimbursement.",3.079176455639103e-07,0.11195824308606683,0.09336500083111204,0.023574544042164344,0.1314134744403641,0.08401920438957468,0.023540420032387266,0.18207564002851795,0.051570247933884296,3.079176455639103e-07,0.21021972650857235,0.035041322314049606
187,0.3,7,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Case-mix based reimbursement can stimulate the development of process-oriented care delivery by incentivizing healthcare providers to focus on delivering efficient and effective care. By linking reimbursement to patient complexity and outcomes, healthcare organizations are encouraged to improve their processes, coordination, and quality of care to receive appropriate reimbursement.","Does the use of case-mix based reimbursement encourage process-oriented care delivery? It can stimulate such development by motivating healthcare providers to focus on efficient and effective care. By tying reimbursement to patient complexity and outcomes, healthcare organizations are encouraged to improve care processes, coordination, and quality to secure proper reimbursement.",2.6054570009253947e-07,0.04078992198081943,0.11463154147383414,0.0199476911126006,0.08885386002156759,0.08401920438957468,0.019918816950481533,0.13859052808877959,0.051570247933884296,2.6054570009253947e-07,0.16576796393773963,0.035041322314049606
187,0.3,8,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Case-mix based reimbursement can stimulate the development of process-oriented care delivery by incentivizing healthcare providers to focus on delivering efficient and effective care. By linking reimbursement to patient complexity and outcomes, healthcare organizations are encouraged to improve their processes, coordination, and quality of care to receive appropriate reimbursement.","Can the development of process-oriented care delivery be stimulated by case-mix based reimbursement? Yes, because it incentivizes healthcare providers to deliver care efficiently and effectively. Linking reimbursement to patient complexity and outcomes encourages healthcare organizations to refine their care processes, coordination, and quality to receive appropriate reimbursement.",3.316036182995957e-07,0.10396882360235171,0.11463154147383414,0.025387970506946217,0.1533923811591391,0.08401920438957468,0.025351221573340132,0.20454849588057566,0.051570247933884296,3.316036182995957e-07,0.23320924473327187,0.035041322314049606
187,0.3,9,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Case-mix based reimbursement can stimulate the development of process-oriented care delivery by incentivizing healthcare providers to focus on delivering efficient and effective care. By linking reimbursement to patient complexity and outcomes, healthcare organizations are encouraged to improve their processes, coordination, and quality of care to receive appropriate reimbursement.","Does case-mix based reimbursement encourage the advancement of process-oriented care delivery? It can, by incentivizing healthcare providers to focus on efficient and effective care delivery. By associating reimbursement with patient complexity and outcomes, healthcare organizations are motivated to improve their processes, coordination, and quality of care to obtain suitable reimbursement.",2.6054570009253947e-07,0.04078992198081943,0.11463154147383414,0.0199476911126006,0.08885386002156759,0.08401920438957468,0.019918816950481533,0.13859052808877959,0.051570247933884296,2.6054570009253947e-07,0.16576796393773963,0.035041322314049606
187,0.3,10,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Case-mix based reimbursement can stimulate the development of process-oriented care delivery by incentivizing healthcare providers to focus on delivering efficient and effective care. By linking reimbursement to patient complexity and outcomes, healthcare organizations are encouraged to improve their processes, coordination, and quality of care to receive appropriate reimbursement.","Is the development of process-oriented care delivery influenced by case-mix based reimbursement? Case-mix based reimbursement can stimulate this development by encouraging healthcare providers to deliver care efficiently and effectively. Linking reimbursement to patient complexity and outcomes drives healthcare organizations to enhance their care coordination, processes, and quality to receive appropriate reimbursement.",2.3685972735685406e-07,0.04831310188569882,0.0946398713363914,0.018134264647818726,0.06823457281883183,0.08401920438957468,0.018108015409528666,0.11753711889094642,0.051570247933884296,2.3685972735685406e-07,0.14426175871677627,0.035041322314049606
188,0.3,1,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold","Question: Is bedside assessment a reliable method to rule out aspiration after an acute stroke? Answer: Bedside swallowing assessments do not have sufficient sensitivity to serve as a screening tool in acute stroke, and there are also concerns regarding the use of videofluoroscopy as the gold standard.",1.4211583641411244e-07,0.20907666043115247,0.049861495844875335,0.010880558788691236,0.1431008436406751,0.0,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
188,0.3,2,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold","Question: Can aspiration be reliably excluded after an acute stroke using bedside assessment? Answer: Bedside swallowing assessments lack the sensitivity required for screening in acute stroke, and the use of videofluoroscopy as the definitive test raises some concerns.",7.10579182070559e-08,0.008646823413716476,0.049861495844875335,0.005440279394345618,0.08004270767353416,0.0,0.0054324046228586,0.08223809823697303,0.0,7.105791820705622e-08,0.08455738802806367,0.0
188,0.3,3,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold","Question: Does bedside assessment effectively exclude aspiration following an acute stroke? Answer: Bedside swallowing assessments are not sensitive enough to be used as screening tools in acute stroke, and there are issues with considering videofluoroscopy as the gold standard.",4.73719454713706e-08,0.018021423668444392,0.049861495844875335,0.0036268529295637453,0.05264373348541884,0.0,0.003621603081905733,0.05406722127027619,0.0,4.737194547137081e-08,0.055569851154812167,0.0
188,0.3,4,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold","Question: Is bedside swallowing assessment dependable for ruling out aspiration after acute stroke? Answer: Bedside assessments lack the necessary sensitivity for screening in acute stroke, and the use of videofluoroscopy as the gold standard is questioned.",1.184298636784265e-07,0.06421667456852864,0.049861495844875335,0.00906713232390937,0.13720112151348252,0.0,0.009054007704764347,0.14107859825990632,0.0,1.1842986367842703e-07,0.14518200984449914,0.0
188,0.3,5,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold","Question: Can bedside evaluation reliably exclude aspiration post-acute stroke? Answer: Bedside swallowing assessments do not possess adequate sensitivity for screening acute stroke patients, and concerns exist about using videofluoroscopy as the gold standard.",1.894877818854824e-07,0.1538288332582156,0.049861495844875335,0.014507411718255009,0.2295744416444978,0.0,0.014486412327622968,0.23638877806423153,0.0,1.8948778188548325e-07,0.24362208265775243,0.0
188,0.3,6,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold","Question: Is bedside assessment a reliable screening tool to exclude aspiration after acute stroke? Answer: Bedside swallowing assessments are insufficiently sensitive for screening in acute stroke, and videofluoroscopy as a gold standard is controversial.",1.658018091497971e-07,0.12305717459146193,0.049861495844875335,0.01269398525347313,0.19782574332991798,0.0,0.012675610786670094,0.20359895524123983,0.0,1.6580180914979784e-07,0.20972053098207066,0.0
188,0.3,7,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold","Question: Can aspiration be ruled out reliably by bedside assessment following acute stroke? Answer: Bedside swallowing assessments lack the sensitivity needed for screening in acute stroke, and there are doubts about videofluoroscopy's role as the gold standard.",9.47438909427412e-08,0.0360457976018318,0.049861495844875335,0.0072537058591274906,0.10821358464023101,0.0,0.007243206163811473,0.11122563511022454,0.0,9.474389094274162e-08,0.11441035117774545,0.0
188,0.3,8,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold","Question: Does bedside assessment have the sensitivity to exclude aspiration after acute stroke? Answer: Bedside swallowing assessments are not sensitive enough for screening acute stroke patients, and videofluoroscopy's status as the gold standard is debated.",1.421158364141118e-07,0.09320421144178015,0.049861495844875335,0.01088055878869125,0.1670540846631643,0.0,0.01086480924571722,0.17185025692666,0.0,1.4211583641411244e-07,0.17693070815907896,0.0
188,0.3,9,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold","Question: Is bedside swallowing assessment effective in excluding aspiration post-acute stroke? Answer: Bedside assessments lack the sensitivity required for acute stroke screening, and the use of videofluoroscopy as the gold standard is problematic.",1.894877818854824e-07,0.1538288332582156,0.049861495844875335,0.014507411718255009,0.2295744416444978,0.0,0.014486412327622968,0.23638877806423153,0.0,1.8948778188548325e-07,0.24362208265775243,0.0
188,0.3,10,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold","Question: Can bedside assessment be trusted to exclude aspiration after an acute stroke? Answer: Bedside swallowing assessments do not have the sensitivity needed for screening in acute stroke, and there are concerns about relying on videofluoroscopy as the gold standard.",2.36859727356853e-08,0.043996910071702366,0.049861495844875335,0.0018134264647818726,0.025975486403257975,0.0,0.0018108015409528666,0.026668247082160867,0.0,2.3685972735685406e-08,0.02739897418811532,0.0
189,0.3,1,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend,Question: Are musculoskeletal symptoms related to aromatase inhibitors primarily prevented by addressing osteoporosis? Answer: Patients undergoing AI therapy who develop osteoporosis face a higher risk of musculoskeletal symptoms and bone fractures. Using calcium and bisphosphonates concurrently lowers the chances of osteoporosis and these symptoms. Those treated with tamoxifen prior to AIs show a reduced risk of AI-related musculoskeletal symptoms. Our recommendation is,9.474389094274162e-08,0.04669127590753952,0.01521094469100482,0.0072537058591274906,0.06899287148694988,0.0,0.007243206163811466,0.07020425867324764,0.0,9.474389094274162e-08,0.07145896398214369,0.0
189,0.3,2,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend,Question: Is preventing osteoporosis the key to avoiding musculoskeletal symptoms caused by aromatase inhibitors? Answer: Patients on aromatase inhibitors who develop osteoporosis have an increased risk of musculoskeletal symptoms and fractures. Co-treatment with calcium and bisphosphonates decreases the risk of osteoporosis and related musculoskeletal issues. Patients previously treated with tamoxifen are less prone to AI-induced musculoskeletal symptoms. We suggest,2.3685972735685406e-08,0.006090557415993736,0.016900510204081634,0.0018134264647818726,0.01769957709940062,0.0,0.0018108015409528666,0.018018505502678472,0.0,2.3685972735685406e-08,0.018349138668195764,0.0
189,0.3,3,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend,Question: Does preventing osteoporosis help eliminate musculoskeletal symptoms associated with aromatase inhibitors? Answer: Patients receiving AIs who develop osteoporosis are more likely to experience musculoskeletal symptoms and bone fractures. Combining calcium and bisphosphonate therapy reduces the risk of osteoporosis and these symptoms. Prior tamoxifen treatment is linked to a lower incidence of AI-related musculoskeletal symptoms. Our advice is,0.0,0.0,3.469446951953614e-18,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
189,0.3,4,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend,Question: Are aromatase inhibitor-related musculoskeletal symptoms prevented by managing osteoporosis? Answer: Patients treated with AIs who develop osteoporosis have a higher chance of musculoskeletal symptoms and fractures. Co-administration of calcium and bisphosphonates reduces the likelihood of osteoporosis and musculoskeletal complaints. Those who had tamoxifen before AIs tend to have fewer AI-related musculoskeletal symptoms. We recommend,7.105791820705622e-08,0.05541838536493415,0.0009736606461737303,0.005440279394345618,0.05505977718302857,0.0,0.0054324046228586,0.056089466651043196,0.0,7.105791820705622e-08,0.05715841383995013,0.0
189,0.3,5,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend,Question: Is osteoporosis prevention crucial to eliminating musculoskeletal symptoms from aromatase inhibitors? Answer: Patients on aromatase inhibitors who develop osteoporosis face increased risks of musculoskeletal symptoms and fractures. Co-medication with calcium and bisphosphonates lowers the risk of osteoporosis and related symptoms. Patients with prior tamoxifen therapy are less likely to develop AI-related musculoskeletal symptoms. We advise,4.737194547137081e-08,0.036602480918583424,0.00063731768427535,0.0036268529295637453,0.036367644170874236,0.0,0.003621603081905733,0.037041271680350096,0.0,4.737194547137081e-08,0.03774032798284743,0.0
189,0.3,6,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend,Question: Can preventing osteoporosis reduce musculoskeletal symptoms linked to aromatase inhibitors? Answer: Patients receiving AIs who develop osteoporosis are at greater risk for musculoskeletal symptoms and bone fractures. Using calcium and bisphosphonates together decreases the chance of osteoporosis and musculoskeletal symptoms. Patients previously treated with tamoxifen show reduced AI-related musculoskeletal symptoms. Our recommendation is,9.474389094274162e-08,0.10075139533781297,0.020139550918406572,0.0072537058591274906,0.07410797215372167,0.0,0.007243206163811466,0.07550755250814589,0.0,9.474389094274162e-08,0.07696104113612989,0.0
189,0.3,7,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend,Question: Is the key to eliminating aromatase inhibitor-induced musculoskeletal symptoms the prevention of osteoporosis? Answer: Patients on AIs who develop osteoporosis have an elevated risk of musculoskeletal symptoms and fractures. Co-treatment with calcium and bisphosphonates reduces the risk of osteoporosis and musculoskeletal symptoms. Prior tamoxifen use is associated with fewer AI-related musculoskeletal symptoms. We recommend,7.105791820705622e-08,0.10676262096196698,0.0378250564931855,0.005440279394345618,0.05505977718302857,0.0,0.0054324046228586,0.056089466651043196,0.0,7.105791820705622e-08,0.05715841383995013,0.0
189,0.3,8,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend,Question: Does managing osteoporosis prevent musculoskeletal symptoms in patients on aromatase inhibitors? Answer: Patients treated with AIs who develop osteoporosis are more susceptible to musculoskeletal symptoms and bone fractures. Co-administration of calcium and bisphosphonates reduces the risk of osteoporosis and related symptoms. Patients who received tamoxifen before AIs are less likely to develop AI-related musculoskeletal symptoms. Our recommendation is,2.3685972735685406e-08,0.017811069499866328,0.000302192668387765,0.0018134264647818726,0.01769957709940062,0.0,0.0018108015409528666,0.018018505502678472,0.0,2.3685972735685406e-08,0.018349138668195764,0.0
189,0.3,9,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend,Question: Is preventing osteoporosis essential to avoid musculoskeletal symptoms caused by aromatase inhibitors? Answer: Patients on aromatase inhibitors who develop osteoporosis are at increased risk for musculoskeletal symptoms and fractures. Co-medication with calcium and bisphosphonates lowers the likelihood of osteoporosis and musculoskeletal symptoms. Patients with prior tamoxifen therapy have a reduced risk of AI-related musculoskeletal symptoms. We suggest,0.0,0.02432095370385845,0.017503057007927147,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
189,0.3,10,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend,Question: Does osteoporosis prevention play a key role in eliminating musculoskeletal symptoms related to aromatase inhibitors? Answer: Patients receiving AIs who develop osteoporosis have a higher risk of musculoskeletal symptoms and bone fractures. Co-treatment with calcium and bisphosphonates decreases the risk of osteoporosis and musculoskeletal symptoms. Prior tamoxifen treatment is linked to a lower incidence of AI-related musculoskeletal symptoms. Our recommendation is,9.474389094274162e-08,0.0239651388400004,0.03151048618020335,0.0072537058591274906,0.06899287148694988,0.0,0.007243206163811466,0.07020425867324764,0.0,9.474389094274162e-08,0.07145896398214369,0.0
190,0.3,1,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Question: Do differences in symptom reporting explain the higher rates of depression in women? Answer: In this community sample, men and women reported similar depressive symptom patterns, with no evidence of gender differences in symptom presentation.",1.184298636784265e-07,0.17809085423194837,0.031949402578773184,0.00906713232390937,0.17797448507583224,0.029384756657483937,0.009054007704764347,0.14107859825990632,0.0,1.1842986367842703e-07,0.14518200984449914,0.0
190,0.3,2,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Question: Are elevated depression rates in women due to different symptom reporting? Answer: Both men and women in this community sample showed similar depressive symptom patterns, with no gender-based differences in symptom presentation found.",1.658018091497971e-07,0.15771453361945964,0.024983563445101917,0.01269398525347313,0.19782574332991798,0.0,0.012675610786670094,0.20359895524123983,0.0,1.6580180914979784e-07,0.20972053098207066,0.0
190,0.3,3,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Question: Is the higher prevalence of depression in women explained by how symptoms are reported? Answer: Men and women from this community sample reported depressive symptoms similarly, with no indication that symptom presentation varies by gender.",1.184298636784265e-07,0.09887403359652636,0.024983563445101917,0.00906713232390937,0.13720112151348252,0.0,0.009054007704764347,0.14107859825990632,0.0,1.1842986367842703e-07,0.14518200984449914,0.0
190,0.3,4,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Question: Could differential symptom reporting account for increased depression rates in women? Answer: This community sample showed men and women reporting depressive symptoms in similar ways, with no evidence of gender differences in symptom presentation.",1.421158364141118e-07,0.12786157046977786,0.024983563445101917,0.01088055878869125,0.1670540846631643,0.0,0.01086480924571722,0.17185025692666,0.0,1.4211583641411244e-07,0.17693070815907896,0.0
190,0.3,5,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Question: Are women's higher depression rates due to differences in symptom reporting? Answer: Men and women in this community sample exhibited similar patterns of depressive symptoms, and no gender differences in symptom presentation were observed.",1.421158364141118e-07,0.20940829759447777,0.033610186554898086,0.01088055878869125,0.20906300469710004,0.0302734375,0.01086480924571722,0.17185025692666,0.0,1.4211583641411244e-07,0.17693070815907896,0.0
190,0.3,6,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Question: Does symptom reporting explain why women have higher depression rates? Answer: In this community sample, men and women reported depressive symptoms similarly, with no evidence that symptom presentation differs by gender.",2.131737546211677e-07,0.22023489060079315,0.024983563445101917,0.01632083818303689,0.2623642644674895,0.0,0.01629721386857584,0.2702903297399133,0.0,2.1317375462116866e-07,0.27871340246902143,0.0
190,0.3,7,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Question: Are higher depression rates in women linked to how symptoms are reported differently? Answer: Men and women in this community sample reported depressive symptoms in comparable patterns, with no gender differences found in symptom presentation.",1.184298636784265e-07,0.09887403359652636,0.024983563445101917,0.00906713232390937,0.13720112151348252,0.0,0.009054007704764347,0.14107859825990632,0.0,1.1842986367842703e-07,0.14518200984449914,0.0
190,0.3,8,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Question: Is the increased depression in women due to differential reporting of symptoms? Answer: Men and women from this community sample showed similar depressive symptom patterns, with no evidence that symptom presentation varies by gender.",1.421158364141118e-07,0.12786157046977786,0.024983563445101917,0.01088055878869125,0.1670540846631643,0.0,0.01086480924571722,0.17185025692666,0.0,1.4211583641411244e-07,0.17693070815907896,0.0
190,0.3,9,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Question: Could the higher depression rates among women be explained by differences in symptom reporting? Answer: Men and women in this community sample reported depressive symptoms similarly, with no indication of gender differences in symptom presentation.",1.184298636784265e-07,0.17809085423194837,0.031949402578773184,0.00906713232390937,0.17797448507583224,0.029384756657483937,0.009054007704764347,0.14107859825990632,0.0,1.1842986367842703e-07,0.14518200984449914,0.0
190,0.3,10,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Question: Are women's higher depression rates a result of reporting symptoms differently? Answer: This community sample revealed men and women have similar depressive symptom patterns, with no evidence of gender-based differences in symptom presentation.",1.658018091497971e-07,0.15771453361945964,0.024983563445101917,0.01269398525347313,0.19782574332991798,0.0,0.012675610786670094,0.20359895524123983,0.0,1.6580180914979784e-07,0.20972053098207066,0.0
191,0.3,1,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It helps individuals make decisions about their future healthcare and ensures their preferences are respected, even if they are unable to communicate them","Question: Can an advance care planning model be effectively implemented in community palliative care? Answer: Yes, implementing an advance care planning model in community palliative care is feasible. It assists individuals in making decisions about their future healthcare and guarantees their preferences are honored, even if they cannot express them.",4.737194547137081e-08,0.07839173940027022,0.02431010005408328,0.0036268529295637453,0.07771925401241653,0.024434491472509978,0.003621603081905733,0.07691348660504049,0.023857394809775757,4.737194547137081e-08,0.04582161865889667,0.0009865860091207122
191,0.3,2,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It helps individuals make decisions about their future healthcare and ensures their preferences are respected, even if they are unable to communicate them","Question: Is it possible to use an advance care planning model in community palliative care? Answer: Yes, an advance care planning model can be successfully used in community palliative care. It supports individuals in deciding their future healthcare and ensures their wishes are respected, even if they are unable to communicate them.",9.474389094274162e-08,0.1250539496976173,0.028819444444444425,0.0072537058591274906,0.1231622297364039,0.02768403450552097,0.007243206163811466,0.12099398910395065,0.025584113228813453,9.474389094274162e-08,0.08963693449175114,0.0018910788526508258
191,0.3,3,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It helps individuals make decisions about their future healthcare and ensures their preferences are respected, even if they are unable to communicate them","Question: Can community palliative care adopt an advance care planning model? Answer: Yes, an advance care planning model is practical in community palliative care. It enables individuals to make future healthcare decisions and ensures their preferences are upheld, even if they cannot communicate them.",9.474389094274162e-08,0.011435728071642615,0.05233029257067717,0.0072537058591274906,0.006301625714966619,0.05957911957168352,0.007243206163811466,0.03448285657964245,0.04195153061224489,9.474389094274162e-08,0.06380348977887307,0.02271498107084911
191,0.3,4,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It helps individuals make decisions about their future healthcare and ensures their preferences are respected, even if they are unable to communicate them","Question: Is the use of an advance care planning model viable in community palliative care? Answer: Yes, using an advance care planning model in community palliative care is viable. It helps individuals plan their future healthcare and guarantees their preferences are respected, even if they are unable to express them.",4.737194547137081e-08,0.07839173940027022,0.02431010005408331,0.0036268529295637453,0.07771925401241653,0.024434491472509978,0.003621603081905733,0.07691348660504049,0.023857394809775757,4.737194547137081e-08,0.04582161865889667,0.0009865860091207122
191,0.3,5,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It helps individuals make decisions about their future healthcare and ensures their preferences are respected, even if they are unable to communicate them","Question: Could an advance care planning model be applied in community palliative care? Answer: Yes, an advance care planning model can be applied in community palliative care. It aids individuals in making decisions about their future healthcare and ensures their wishes are honored, even if they cannot communicate them.",2.3685972735685406e-08,0.00352627805606609,0.015625000000000056,0.0018134264647818726,0.004783373320163431,0.017846519928613927,0.0018108015409528666,0.0061488049561213565,0.019841269841269868,2.3685972735685406e-08,0.007633536838929089,0.021633315305570573
191,0.3,6,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It helps individuals make decisions about their future healthcare and ensures their preferences are respected, even if they are unable to communicate them","Question: Is an advance care planning model workable in community palliative care? Answer: Yes, an advance care planning model is workable in community palliative care. It assists individuals in planning their future healthcare and ensures their preferences are respected, even if they are unable to communicate them.",2.3685972735685406e-08,0.025994669849937146,0.0028965318869164924,0.0018134264647818726,0.025327443822929396,0.0022958804283164658,0.0018108015409528666,0.024573301853755503,0.0014902451164880426,2.3685972735685406e-08,0.02372223194622114,0.0005276493146384141
191,0.3,7,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It helps individuals make decisions about their future healthcare and ensures their preferences are respected, even if they are unable to communicate them","Question: Is it feasible to implement an advance care planning model in community palliative care? Answer: Yes, implementing an advance care planning model in community palliative care is feasible. It supports individuals in making decisions about their future healthcare and ensures their wishes are upheld, even if they cannot communicate them.",7.105791820705622e-08,0.07426356609405271,0.008085113574905323,0.005440279394345618,0.04411274137542831,0.01298578037423316,0.0054324046228586,0.012552482595575398,0.03643171708921533,7.105791820705622e-08,0.020517841001465253,0.06165494862087614
191,0.3,8,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It helps individuals make decisions about their future healthcare and ensures their preferences are respected, even if they are unable to communicate them","Question: Can an advance care planning model be integrated into community palliative care? Answer: Yes, an advance care planning model can be integrated into community palliative care. It helps individuals make informed decisions about their future healthcare and guarantees their preferences are respected, even if they are unable to communicate them.",7.105791820705622e-08,0.04653767887165472,0.009820011337868445,0.005440279394345618,0.04411274137542831,0.01298578037423316,0.0054324046228586,0.04143361511890653,0.016318097486928668,7.105791820705622e-08,0.03847340840789171,0.01975415473162002
191,0.3,9,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It helps individuals make decisions about their future healthcare and ensures their preferences are respected, even if they are unable to communicate them","Question: Is the adoption of an advance care planning model possible in community palliative care? Answer: Yes, adopting an advance care planning model is possible in community palliative care. It enables individuals to decide on their future healthcare and ensures their wishes are honored, even if they cannot communicate them.",4.737194547137081e-08,0.05010001774476214,0.005486111111111136,0.0036268529295637453,0.048838121489085395,0.004320871870223314,0.003621603081905733,0.04741786190036201,0.0027934727610052362,4.737194547137081e-08,0.04582161865889667,0.0009865860091207122
191,0.3,10,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It helps individuals make decisions about their future healthcare and ensures their preferences are respected, even if they are unable to communicate them","Question: Is an advance care planning model suitable for community palliative care? Answer: Yes, an advance care planning model is suitable for community palliative care. It assists individuals in making future healthcare decisions and ensures their preferences are respected, even if they are unable to communicate them.",2.3685972735685406e-08,0.025994669849937146,0.0028965318869164924,0.0018134264647818726,0.025327443822929396,0.0022958804283164658,0.0018108015409528666,0.024573301853755503,0.0014902451164880426,2.3685972735685406e-08,0.02372223194622114,0.0005276493146384141
192,0.3,1,ai,"Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The decision to offer second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women should be carefully considered, weighing the potential benefits against the risks and","Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The decision to offer second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women should be carefully considered, weighing the potential benefits against the risks and",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
192,0.3,2,ai,"Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The decision to offer second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women should be carefully considered, weighing the potential benefits against the risks and","Question: Advanced epithelial ovarian carcinoma in Thai women: is it advisable to keep offering second-look laparotomy? Answer: When deciding on second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women, one must carefully balance the potential advantages with the associated risks and",0.0,0.06762411517658062,0.04389604425648251,0.0,0.03465735902799727,0.023683547493071264,0.0,0.0,0.0,0.0,0.0,0.0
192,0.3,3,ai,"Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The decision to offer second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women should be carefully considered, weighing the potential benefits against the risks and",Question: Advanced epithelial ovarian carcinoma in Thai women: should second-look laparotomy still be offered? Answer: The choice to perform second-look laparotomy in cases of advanced epithelial ovarian carcinoma among Thai women requires careful evaluation of the benefits versus the risks and,2.3685972735685406e-08,0.07336235441567007,0.06472937758981587,0.0018134264647818726,0.07687696863672544,0.07131676629746128,0.0018108015409528666,0.0441811108194079,0.05009232205178152,2.3685972735685406e-08,0.04629461402941226,0.05246913580246914
192,0.3,4,ai,"Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The decision to offer second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women should be carefully considered, weighing the potential benefits against the risks and",Question: Advanced epithelial ovarian carcinoma in Thai women: is continuing second-look laparotomy justified? Answer: Offering second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women should involve a thorough assessment of the potential benefits against the risks and,9.474389094274131e-08,0.09077424193446681,0.007407400739569803,0.0072537058591274906,0.0861064273089398,0.013073979591836732,0.007243206163811466,0.12040078781491248,0.008572048611111105,9.474389094274162e-08,0.11980950112335131,0.00612461419753086
192,0.3,5,ai,"Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The decision to offer second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women should be carefully considered, weighing the potential benefits against the risks and",Question: Advanced epithelial ovarian carcinoma in Thai women: should second-look laparotomy remain an option? Answer: The decision to proceed with second-look laparotomy in advanced epithelial ovarian carcinoma in Thai women must carefully weigh the possible benefits against the risks and,4.7371945471370706e-08,0.026602073013537897,0.014734479110068949,0.0036268529295637453,0.02393222147071139,0.018642751218134315,0.003621603081905733,0.05840795120317521,0.004060938100730452,4.737194547137081e-08,0.058120713554252745,0.002894185996838834
192,0.3,6,ai,"Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The decision to offer second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women should be carefully considered, weighing the potential benefits against the risks and",Question: Advanced epithelial ovarian carcinoma in Thai women: is it appropriate to continue second-look laparotomy? Answer: Careful consideration of the risks and benefits is essential when deciding to offer second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women and,4.7371945471370706e-08,0.008943936245946027,0.03806228373702428,0.0036268529295637453,0.02393222147071139,0.018642751218134315,0.003621603081905733,0.05840795120317521,0.004060938100730452,4.737194547137081e-08,0.058120713554252745,0.002894185996838834
192,0.3,7,ai,"Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The decision to offer second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women should be carefully considered, weighing the potential benefits against the risks and",Question: Advanced epithelial ovarian carcinoma in Thai women: should second-look laparotomy be routinely offered? Answer: The decision to offer second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women should involve a careful balance of potential benefits and risks and,4.7371945471370706e-08,0.026602073013537897,0.014734479110068949,0.0036268529295637453,0.02393222147071139,0.018642751218134315,0.003621603081905733,0.05840795120317521,0.004060938100730452,4.737194547137081e-08,0.058120713554252745,0.002894185996838834
192,0.3,8,ai,"Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The decision to offer second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women should be carefully considered, weighing the potential benefits against the risks and","Question: Advanced epithelial ovarian carcinoma in Thai women: is second-look laparotomy still recommended? Answer: When considering second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women, the potential benefits must be weighed carefully against the risks and",1.1842986367842661e-07,0.1244177853168158,0.0034948096885812907,0.009067132323909363,0.11867823875538175,0.010066045148548516,0.00905400770476434,0.1528831844220786,0.011020060122557518,1.1842986367842703e-07,0.15213357721620557,0.007884662324481942
192,0.3,9,ai,"Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The decision to offer second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women should be carefully considered, weighing the potential benefits against the risks and",Question: Advanced epithelial ovarian carcinoma in Thai women: should we maintain the practice of second-look laparotomy? Answer: The choice to continue offering second-look laparotomy in advanced epithelial ovarian carcinoma among Thai women requires a careful evaluation of benefits versus risks and,2.3685972735685406e-08,0.10801971344366734,0.08898787031677709,0.0018134264647818726,0.07687696863672544,0.07131676629746128,0.0018108015409528666,0.0441811108194079,0.05009232205178152,2.3685972735685406e-08,0.04629461402941226,0.05246913580246914
192,0.3,10,ai,"Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The decision to offer second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women should be carefully considered, weighing the potential benefits against the risks and",Question: Advanced epithelial ovarian carcinoma in Thai women: is it necessary to continue second-look laparotomy? Answer: Deciding to offer second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women should be done with careful consideration of the potential benefits and risks and,0.0,0.06762411517658062,0.04389604425648251,0.0,0.03465735902799727,0.023683547493071264,0.0,0.0,0.0,0.0,0.0,0.0
193,0.3,1,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It is characterized by repeated interruptions in breathing during sleep, leading to decreased oxygen supply to the body. This can result in fatigue, reduced endurance, and impaired aerobic performance. Treatment of sleep apnea can help improve aerobic fitness.","Does obstructive sleep apnea impact aerobic fitness? Yes, it can. This condition involves repeated breathing interruptions during sleep, reducing oxygen delivery to the body, which may cause fatigue, lower endurance, and diminished aerobic capacity. Treating sleep apnea can enhance aerobic fitness.",3.316036182995957e-07,0.17103946424715044,0.12605810322156474,0.025387970506946217,0.25441727266323566,0.03767781622452903,0.025351221573340132,0.31365755885504143,0.0,3.316036182995957e-07,0.3209077200800996,0.0
193,0.3,2,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It is characterized by repeated interruptions in breathing during sleep, leading to decreased oxygen supply to the body. This can result in fatigue, reduced endurance, and impaired aerobic performance. Treatment of sleep apnea can help improve aerobic fitness.","Is aerobic fitness affected by obstructive sleep apnea? Indeed, obstructive sleep apnea can impair aerobic fitness. It causes frequent breathing pauses during sleep, decreasing oxygen levels in the body, leading to tiredness, reduced stamina, and weaker aerobic performance. Managing sleep apnea can improve aerobic fitness.",2.3685972735685406e-07,0.16709868551663742,0.06104166666666666,0.018134264647818726,0.189018206846292,0.014435185839041506,0.018108015409528666,0.21357410029806,0.0,2.3685972735685406e-07,0.21825356602001733,0.0
193,0.3,3,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It is characterized by repeated interruptions in breathing during sleep, leading to decreased oxygen supply to the body. This can result in fatigue, reduced endurance, and impaired aerobic performance. Treatment of sleep apnea can help improve aerobic fitness.","Can obstructive sleep apnea influence aerobic fitness? Yes, it can have an effect. The disorder causes repeated breathing disruptions during sleep, which lowers oxygen supply, resulting in fatigue, decreased endurance, and impaired aerobic function. Treatment can help restore aerobic fitness.",3.55289591035281e-07,0.1616999132034458,0.15104166666666666,0.02720139697172809,0.28039275906649364,0.03767781622452903,0.027162023114293,0.3403258059372023,0.0,3.552895910352811e-07,0.3483066942682149,0.0
193,0.3,4,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It is characterized by repeated interruptions in breathing during sleep, leading to decreased oxygen supply to the body. This can result in fatigue, reduced endurance, and impaired aerobic performance. Treatment of sleep apnea can help improve aerobic fitness.","Does obstructive sleep apnea have an effect on aerobic fitness? Yes, it does. This condition is marked by repeated breathing interruptions during sleep that reduce oxygen availability, causing fatigue, less endurance, and poorer aerobic performance. Addressing sleep apnea can improve aerobic fitness.",3.079176455639103e-07,0.14550155021707223,0.12666666666666665,0.023574544042164344,0.22909946467894393,0.03767781622452903,0.023540420032387266,0.28768207245178345,0.0,3.079176455639103e-07,0.29423947299793873,0.0
193,0.3,5,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It is characterized by repeated interruptions in breathing during sleep, leading to decreased oxygen supply to the body. This can result in fatigue, reduced endurance, and impaired aerobic performance. Treatment of sleep apnea can help improve aerobic fitness.","Is aerobic fitness compromised by obstructive sleep apnea? Yes, obstructive sleep apnea negatively affects aerobic fitness. It involves recurrent breathing pauses during sleep, leading to reduced oxygen intake, fatigue, decreased stamina, and diminished aerobic ability. Treatment can enhance aerobic fitness.",3.55289591035281e-07,0.23279193172241408,0.09990945337229122,0.02720139697172809,0.28039275906649364,0.03767781622452903,0.027162023114293,0.3403258059372023,0.0,3.552895910352811e-07,0.3483066942682149,0.0
193,0.3,6,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It is characterized by repeated interruptions in breathing during sleep, leading to decreased oxygen supply to the body. This can result in fatigue, reduced endurance, and impaired aerobic performance. Treatment of sleep apnea can help improve aerobic fitness.","Can aerobic fitness be affected by obstructive sleep apnea? Yes, it can. Obstructive sleep apnea causes repeated breathing interruptions during sleep, which decreases oxygen supply to the body, resulting in fatigue, lowered endurance, and impaired aerobic performance. Treating the condition can improve aerobic fitness.",2.6054570009253947e-07,0.09630084738650213,0.12779903628117914,0.0199476911126006,0.18030930050951222,0.03767781622452903,0.019918816950481533,0.23767165187712003,0.0,2.6054570009253947e-07,0.24294617861038903,0.0
193,0.3,7,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It is characterized by repeated interruptions in breathing during sleep, leading to decreased oxygen supply to the body. This can result in fatigue, reduced endurance, and impaired aerobic performance. Treatment of sleep apnea can help improve aerobic fitness.","Does obstructive sleep apnea reduce aerobic fitness? Yes, it can. The condition causes frequent breathing interruptions during sleep, leading to decreased oxygen levels, fatigue, reduced stamina, and impaired aerobic capacity. Effective treatment can help improve aerobic fitness.",4.263475092423369e-07,0.24174262087697995,0.15104166666666666,0.03264167636607371,0.36263085730346667,0.03767781622452903,0.032594427737151606,0.42488319396526597,0.0,4.263475092423373e-07,0.43531807125784505,0.0
193,0.3,8,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It is characterized by repeated interruptions in breathing during sleep, leading to decreased oxygen supply to the body. This can result in fatigue, reduced endurance, and impaired aerobic performance. Treatment of sleep apnea can help improve aerobic fitness.","Is there an impact of obstructive sleep apnea on aerobic fitness? Yes, obstructive sleep apnea can impair aerobic fitness by causing repeated breathing interruptions during sleep, which reduce oxygen supply, leading to fatigue, diminished endurance, and weaker aerobic performance. Treatment can improve fitness levels.",2.6054570009253947e-07,0.12854025113347634,0.10464071485227044,0.0199476911126006,0.2133163091076038,0.013882456319710475,0.019918816950481533,0.23767165187712003,0.0,2.6054570009253947e-07,0.24294617861038903,0.0
193,0.3,9,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It is characterized by repeated interruptions in breathing during sleep, leading to decreased oxygen supply to the body. This can result in fatigue, reduced endurance, and impaired aerobic performance. Treatment of sleep apnea can help improve aerobic fitness.","Does obstructive sleep apnea influence aerobic fitness? Yes, it does. This disorder involves repeated breathing pauses during sleep, reducing oxygen delivery to the body, which can cause fatigue, decreased endurance, and impaired aerobic function. Treating sleep apnea can enhance aerobic fitness.",3.316036182995957e-07,0.17103946424715044,0.12605810322156474,0.025387970506946217,0.25441727266323566,0.03767781622452903,0.025351221573340132,0.31365755885504143,0.0,3.316036182995957e-07,0.3209077200800996,0.0
193,0.3,10,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It is characterized by repeated interruptions in breathing during sleep, leading to decreased oxygen supply to the body. This can result in fatigue, reduced endurance, and impaired aerobic performance. Treatment of sleep apnea can help improve aerobic fitness.","Can obstructive sleep apnea affect aerobic fitness? Yes, it can. It is characterized by repeated breathing interruptions during sleep that lower oxygen supply to the body, resulting in fatigue, reduced endurance, and impaired aerobic performance. Treatment can help improve aerobic fitness.",3.316036182995957e-07,0.13638210521915406,0.15104166666666666,0.025387970506946217,0.25441727266323566,0.03767781622452903,0.025351221573340132,0.31365755885504143,0.0,3.316036182995957e-07,0.3209077200800996,0.0
194,0.3,1,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Advanced age is not necessarily a contraindication to GERD laparoscopic surgery. However, the decision to undergo surgery should be made on an individual basis, considering the patient's overall health and any","Is advanced age a contraindication for laparoscopic surgery for GERD? Advanced age does not automatically rule out laparoscopic surgery for GERD. The choice to proceed should be personalized, taking into account the patient's general health and other factors.",1.1842986367842671e-07,0.0741189081448872,0.03642380339752453,0.009067132323909363,0.06712513218110283,0.0449595793996269,0.009054007704764333,0.06421667456852864,0.049861495844875335,1.1842986367842703e-07,0.10165511225399859,0.025623268698060954
194,0.3,2,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Advanced age is not necessarily a contraindication to GERD laparoscopic surgery. However, the decision to undergo surgery should be made on an individual basis, considering the patient's overall health and any",Does advanced age contraindicate laparoscopic surgery for GERD? Being elderly is not inherently a contraindication for GERD laparoscopic surgery. Decisions should be individualized based on the patient's overall health status.,3.079176455639091e-07,0.20533874530643104,0.11687363038714388,0.023574544042164393,0.2799313837642341,0.07271468144044323,0.02354042003238732,0.3237278700536126,0.049861495844875335,3.079176455639103e-07,0.369919098848678,0.025623268698060954
194,0.3,3,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Advanced age is not necessarily a contraindication to GERD laparoscopic surgery. However, the decision to undergo surgery should be made on an individual basis, considering the patient's overall health and any",Is laparoscopic surgery for GERD contraindicated in elderly patients? Advanced age alone is not a contraindication for GERD laparoscopic surgery. Surgical decisions must consider the patient's overall health condition.,3.316036182995944e-07,0.2899405780148392,0.08120833546258971,0.025387970506946272,0.3162990279351088,0.07271468144044323,0.025351221573340195,0.3614681980364596,0.049861495844875335,3.316036182995957e-07,0.4091398120019605,0.025623268698060954
194,0.3,4,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Advanced age is not necessarily a contraindication to GERD laparoscopic surgery. However, the decision to undergo surgery should be made on an individual basis, considering the patient's overall health and any",Is advanced age a reason to avoid GERD laparoscopic surgery? Advanced age by itself does not contraindicate laparoscopic surgery for GERD. The decision should be tailored to the patient's health profile.,2.842316728282238e-07,0.21764700566807882,0.08357993240854697,0.021761117577382513,0.2448400639529651,0.07271468144044323,0.021729618491434448,0.2873602258827379,0.049861495844875335,2.8423167282822487e-07,0.33217877086583103,0.025623268698060954
194,0.3,5,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Advanced age is not necessarily a contraindication to GERD laparoscopic surgery. However, the decision to undergo surgery should be made on an individual basis, considering the patient's overall health and any","Does being of advanced age prevent undergoing laparoscopic surgery for GERD? Advanced age is not necessarily a barrier to GERD laparoscopic surgery. Each case should be evaluated individually, considering the patient's health.",2.605457000925385e-07,0.1833665437471086,0.08465140816492167,0.019947691112600634,0.21093851227728333,0.07271468144044323,0.019918816950481574,0.2522689060714689,0.049861495844875335,2.6054570009253947e-07,0.29581112669495635,0.025623268698060954
194,0.3,6,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Advanced age is not necessarily a contraindication to GERD laparoscopic surgery. However, the decision to undergo surgery should be made on an individual basis, considering the patient's overall health and any",Is advanced age a contraindication for GERD laparoscopic surgery? Advanced age is not automatically a contraindication for GERD laparoscopic surgery. The decision should be made based on the patient's overall health and other considerations.,2.1317375462116791e-07,0.2861716139961046,0.02981004308224383,0.016320838183036875,0.2763650874947028,0.020032048642791025,0.016297213868575827,0.2750158774514979,0.014347778828132977,2.1317375462116866e-07,0.2730280672453351,0.007670429280535962
194,0.3,7,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Advanced age is not necessarily a contraindication to GERD laparoscopic surgery. However, the decision to undergo surgery should be made on an individual basis, considering the patient's overall health and any",Is elderly age a contraindication to laparoscopic surgery for GERD? Advanced age does not inherently contraindicate GERD laparoscopic surgery. The decision should be individualized based on the patient's health.,3.316036182995944e-07,0.24043006511770004,0.11687363038714388,0.025387970506946272,0.3162990279351088,0.07271468144044323,0.025351221573340195,0.3614681980364596,0.049861495844875335,3.316036182995957e-07,0.4091398120019605,0.025623268698060954
194,0.3,8,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Advanced age is not necessarily a contraindication to GERD laparoscopic surgery. However, the decision to undergo surgery should be made on an individual basis, considering the patient's overall health and any",Is advanced age a limiting factor for GERD laparoscopic surgery? Advanced age is not necessarily a limiting factor for laparoscopic surgery in GERD patients. The choice should depend on the patient's overall health.,2.3685972735685321e-07,0.280185467633165,0.005575349204692853,0.018134264647818754,0.2675870353329941,0.008505406767434914,0.0181080154095287,0.2645771664331167,0.01656779786627842,2.3685972735685406e-07,0.26071980688368734,0.025623268698060954
194,0.3,9,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Advanced age is not necessarily a contraindication to GERD laparoscopic surgery. However, the decision to undergo surgery should be made on an individual basis, considering the patient's overall health and any","Is GERD laparoscopic surgery contraindicated in older patients? Advanced age alone is not a contraindication for GERD laparoscopic surgery. The decision should be personalized, considering the patient's health status.",3.316036182995944e-07,0.2899405780148392,0.08120833546258971,0.025387970506946272,0.3162990279351088,0.07271468144044323,0.025351221573340195,0.3614681980364596,0.049861495844875335,3.316036182995957e-07,0.4091398120019605,0.025623268698060954
194,0.3,10,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Advanced age is not necessarily a contraindication to GERD laparoscopic surgery. However, the decision to undergo surgery should be made on an individual basis, considering the patient's overall health and any","Does advanced age contraindicate laparoscopic surgery for GERD? Advanced age is not an absolute contraindication for GERD laparoscopic surgery. The decision should be individualized, taking into account the patient's overall health.",2.842316728282238e-07,0.21764700566807882,0.08357993240854697,0.021761117577382513,0.2448400639529651,0.07271468144044323,0.021729618491434448,0.2873602258827379,0.049861495844875335,2.8423167282822487e-07,0.33217877086583103,0.025623268698060954
195,0.3,1,human,Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional,Is there a link between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Korean individuals? Both hsCRP levels and carotid intima-media thickness (IMT) showed a strong correlation with traditional factors.,1.184298636784265e-07,0.14143874580680782,0.03443877551020409,0.009067132323909398,0.19671029424605457,0.0,0.009054007704764368,0.20479441264601395,0.0,1.1842986367842703e-07,0.2135741002980609,0.0
195,0.3,2,human,Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional,Does high-sensitivity C-reactive protein relate to carotid atherosclerosis among healthy Koreans? The levels of hsCRP and carotid IMT were both highly correlated with conventional indicators.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
195,0.3,3,human,Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional,Is high-sensitivity C-reactive protein connected to carotid atherosclerosis in healthy Korean people? Both hsCRP and carotid IMT demonstrated a strong association with standard measures.,2.36859727356853e-08,0.04255961441879563,0.0,0.0018134264647818796,0.04445176257083405,0.0,0.0018108015409528735,0.04652001563489394,0.0,2.3685972735685353e-08,0.04879016416943127,0.0
195,0.3,4,human,Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional,"In healthy Koreans, is there an association between high-sensitivity C-reactive protein and carotid atherosclerosis? Both hsCRP levels and carotid IMT were strongly linked to conventional factors.",2.36859727356853e-08,0.014629779924540287,0.03993055555555556,0.0018134264647818796,0.04255961441879563,0.0,0.0018108015409528735,0.04445176257083405,0.0,2.3685972735685406e-08,0.04652001563489394,0.0
195,0.3,5,human,Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional,Is there an association between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Korean subjects? Both hsCRP and carotid IMT were closely correlated with traditional markers.,2.36859727356853e-08,0.014629779924540287,0.03993055555555556,0.0018134264647818796,0.04255961441879563,0.0,0.0018108015409528735,0.04445176257083405,0.0,2.3685972735685406e-08,0.04652001563489394,0.0
195,0.3,6,human,Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional,Does high-sensitivity C-reactive protein have a relationship with carotid atherosclerosis in healthy Koreans? Both hsCRP levels and carotid IMT were strongly associated with conventional parameters.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
195,0.3,7,human,Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional,Is high-sensitivity C-reactive protein related to carotid atherosclerosis in healthy Korean individuals? Both hsCRP and carotid IMT showed strong correlations with standard factors.,4.73719454713706e-08,0.08701137698962969,0.0,0.003626852929563759,0.090971778205728,0.0,0.003621603081905747,0.09531017980432521,0.0,4.7371945471370706e-08,0.10008345855698142,0.0
195,0.3,8,human,Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional,"Among healthy Koreans, is high-sensitivity C-reactive protein associated with carotid atherosclerosis? Both hsCRP levels and carotid IMT were strongly correlated with conventional indicators.",4.73719454713706e-08,0.08701137698962969,0.0,0.003626852929563759,0.090971778205728,0.0,0.003621603081905747,0.09531017980432521,0.0,4.7371945471370706e-08,0.10008345855698142,0.0
195,0.3,9,human,Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional,Is there a significant association between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Koreans? Both hsCRP and carotid IMT were strongly linked to traditional factors.,2.36859727356853e-08,0.014629779924540287,0.03993055555555556,0.0018134264647818796,0.04255961441879563,0.0,0.0018108015409528735,0.04445176257083405,0.0,2.3685972735685406e-08,0.04652001563489394,0.0
195,0.3,10,human,Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional,"In healthy Korean populations, is high-sensitivity C-reactive protein linked to carotid atherosclerosis? Both hsCRP levels and carotid IMT showed strong correlations with conventional measures.",2.36859727356853e-08,0.04255961441879563,0.0,0.0018134264647818796,0.04445176257083405,0.0,0.0018108015409528735,0.04652001563489394,0.0,2.3685972735685353e-08,0.04879016416943127,0.0
196,0.3,1,ai,Question: Is there a role for fondaparinux in perioperative bridging? Answer: Fondaparinux has been shown to be effective in perioperative bridging for patients at high risk of thromboembolic events. Its safety profile and ease of use make,"Is fondaparinux useful for perioperative bridging? It has proven effective for patients at high risk of thromboembolic events, with a favorable safety profile and ease of administration.",2.36859727356853e-07,0.28691422373685294,0.02775510204081633,0.018134264647818796,0.3364722366212134,0.0,0.018108015409528735,0.3483066942682167,0.0,2.3685972735685406e-07,0.36101334553733055,0.0
196,0.3,2,ai,Question: Is there a role for fondaparinux in perioperative bridging? Answer: Fondaparinux has been shown to be effective in perioperative bridging for patients at high risk of thromboembolic events. Its safety profile and ease of use make,"Does fondaparinux have a role in perioperative bridging? Studies show it is effective for high thromboembolic risk patients, offering safety and convenience.",3.552895910352795e-07,0.5004883240349138,0.02775510204081633,0.027201396971728194,0.5596157879354231,0.0,0.027162023114293103,0.5819215454497217,0.0,3.5528959103528093e-07,0.6061358035703153,0.0
196,0.3,3,ai,Question: Is there a role for fondaparinux in perioperative bridging? Answer: Fondaparinux has been shown to be effective in perioperative bridging for patients at high risk of thromboembolic events. Its safety profile and ease of use make,Can fondaparinux be used in perioperative bridging? It is effective for patients at elevated thromboembolic risk and is known for its safety and simplicity.,3.079176455639089e-07,0.40951654582918584,0.02775510204081633,0.023574544042164434,0.4643056081310979,0.0,0.023540420032387356,0.4818380868927403,0.0,3.0791764556391023e-07,0.5007752879124898,0.0
196,0.3,4,ai,Question: Is there a role for fondaparinux in perioperative bridging? Answer: Fondaparinux has been shown to be effective in perioperative bridging for patients at high risk of thromboembolic events. Its safety profile and ease of use make,"Is fondaparinux appropriate for perioperative bridging? It has demonstrated efficacy in high-risk thromboembolic patients, with a good safety record and user-friendly administration.",3.552895910352795e-07,0.5004883240349138,0.02775510204081633,0.027201396971728194,0.5596157879354231,0.0,0.027162023114293103,0.5819215454497217,0.0,3.5528959103528093e-07,0.6061358035703153,0.0
196,0.3,5,ai,Question: Is there a role for fondaparinux in perioperative bridging? Answer: Fondaparinux has been shown to be effective in perioperative bridging for patients at high risk of thromboembolic events. Its safety profile and ease of use make,"What is the role of fondaparinux in perioperative bridging? It is effective for patients at high thromboembolic risk, combining safety and ease of use.",3.079176455639089e-07,0.40951654582918584,0.02775510204081633,0.023574544042164434,0.4643056081310979,0.0,0.023540420032387356,0.4818380868927403,0.0,3.0791764556391023e-07,0.5007752879124898,0.0
196,0.3,6,ai,Question: Is there a role for fondaparinux in perioperative bridging? Answer: Fondaparinux has been shown to be effective in perioperative bridging for patients at high risk of thromboembolic events. Its safety profile and ease of use make,"Does fondaparinux play a role in perioperative bridging? It has been shown to work well for patients at high risk of thromboembolism, with a safe and easy-to-use profile.",2.131737546211677e-07,0.24917389575400595,0.02775510204081633,0.016320838183036916,0.29725152346793093,0.0,0.016297213868575862,0.3074846997479619,0.0,2.1317375462116866e-07,0.3184537311185349,0.0
196,0.3,7,ai,Question: Is there a role for fondaparinux in perioperative bridging? Answer: Fondaparinux has been shown to be effective in perioperative bridging for patients at high risk of thromboembolic events. Its safety profile and ease of use make,"Is fondaparinux indicated for perioperative bridging? Evidence supports its effectiveness in high thromboembolic risk patients, along with safety and ease of use.",3.552895910352795e-07,0.5004883240349138,0.02775510204081633,0.027201396971728194,0.5596157879354231,0.0,0.027162023114293103,0.5819215454497217,0.0,3.5528959103528093e-07,0.6061358035703153,0.0
196,0.3,8,ai,Question: Is there a role for fondaparinux in perioperative bridging? Answer: Fondaparinux has been shown to be effective in perioperative bridging for patients at high risk of thromboembolic events. Its safety profile and ease of use make,How does fondaparinux fit into perioperative bridging? It is effective for patients with high thromboembolic risk and is safe and easy to administer.,3.316036182995942e-07,0.4539683084000199,0.02775510204081633,0.025387970506946314,0.5108256237659918,0.0,0.02535122157334023,0.5306282510621716,0.0,3.316036182995956e-07,0.55206858230004,0.0
196,0.3,9,ai,Question: Is there a role for fondaparinux in perioperative bridging? Answer: Fondaparinux has been shown to be effective in perioperative bridging for patients at high risk of thromboembolic events. Its safety profile and ease of use make,"Is fondaparinux beneficial in perioperative bridging? It has demonstrated effectiveness in patients at high risk for thromboembolic events, with a favorable safety and usability profile.",2.842316728282236e-07,0.3669569314103902,0.02775510204081633,0.021761117577382555,0.41985384556026384,0.0,0.021729618491434483,0.4353180712578464,0.0,2.8423167282822487e-07,0.45198512374305855,0.0
196,0.3,10,ai,Question: Is there a role for fondaparinux in perioperative bridging? Answer: Fondaparinux has been shown to be effective in perioperative bridging for patients at high risk of thromboembolic events. Its safety profile and ease of use make,What role does fondaparinux have in perioperative bridging? It is effective for high-risk thromboembolic patients and is known for its safety and ease of use.,2.842316728282236e-07,0.3669569314103902,0.02775510204081633,0.021761117577382555,0.41985384556026384,0.0,0.021729618491434483,0.4353180712578464,0.0,2.8423167282822487e-07,0.45198512374305855,0.0
197,0.3,1,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors have been found to play a role in the development and progression of primary systemic vasculitis. These factors can include exposure to","Are environmental factors significant in primary systemic vasculitis? Yes, they contribute to its development and progression, including exposure to certain elements.",3.3160361829959426e-07,0.4490815239374717,0.05859375,0.025387970506946314,0.55206858230004,0.0,0.02535122157334023,0.5753641449035616,0.0,3.316036182995955e-07,0.6007738604289306,0.0
197,0.3,2,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors have been found to play a role in the development and progression of primary systemic vasculitis. These factors can include exposure to","Do environmental factors matter in primary systemic vasculitis? Indeed, they influence the disease's onset and course, involving exposure to specific agents.",3.3160361829959426e-07,0.4490815239374717,0.05859375,0.025387970506946314,0.55206858230004,0.0,0.02535122157334023,0.5753641449035616,0.0,3.316036182995955e-07,0.6007738604289306,0.0
197,0.3,3,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors have been found to play a role in the development and progression of primary systemic vasculitis. These factors can include exposure to","Is there an importance of environmental factors in primary systemic vasculitis? Yes, these factors affect its development and progression, such as exposure to various substances.",2.36859727356853e-07,0.2667599671435168,0.05859375,0.018134264647818796,0.36101334553733055,0.0,0.018108015409528735,0.3746934494414109,0.0,2.3685972735685406e-07,0.38946476676172503,0.0
197,0.3,4,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors have been found to play a role in the development and progression of primary systemic vasculitis. These factors can include exposure to","Are environmental influences relevant in primary systemic vasculitis? Yes, they play a role in how the disease develops and progresses, including contact with certain environmental elements.",2.131737546211677e-07,0.22593797262326198,0.05859375,0.016320838183036916,0.3184537311185349,0.0,0.016297213868575862,0.33024168687057687,0.0,2.1317375462116866e-07,0.3429447511268311,0.0
197,0.3,5,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors have been found to play a role in the development and progression of primary systemic vasculitis. These factors can include exposure to","Do environmental factors have a role in primary systemic vasculitis? Yes, they are involved in the disease’s development and progression, including exposure to particular factors.",2.36859727356853e-07,0.2667599671435168,0.05859375,0.018134264647818796,0.36101334553733055,0.0,0.018108015409528735,0.3746934494414109,0.0,2.3685972735685406e-07,0.38946476676172503,0.0
197,0.3,6,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors have been found to play a role in the development and progression of primary systemic vasculitis. These factors can include exposure to","Is the impact of environmental factors notable in primary systemic vasculitis? Yes, they contribute to the disease’s onset and progression, involving exposure to certain conditions.",2.36859727356853e-07,0.2667599671435168,0.05859375,0.018134264647818796,0.36101334553733055,0.0,0.018108015409528735,0.3746934494414109,0.0,2.3685972735685406e-07,0.38946476676172503,0.0
197,0.3,7,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors have been found to play a role in the development and progression of primary systemic vasculitis. These factors can include exposure to","Are environmental factors crucial in primary systemic vasculitis? Yes, they influence the development and progression of the disease, including exposure to specific environmental triggers.",2.605457000925383e-07,0.30931958156231243,0.05859375,0.019947691112600675,0.4054651081081646,0.0,0.01991881695048161,0.42121346507630486,0.0,2.605457000925394e-07,0.4382549309311563,0.0
197,0.3,8,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors have been found to play a role in the development and progression of primary systemic vasculitis. These factors can include exposure to","Do environmental factors affect primary systemic vasculitis? Yes, they play a part in the disease’s development and progression, including exposure to certain environmental agents.",2.605457000925383e-07,0.30931958156231243,0.05859375,0.019947691112600675,0.4054651081081646,0.0,0.01991881695048161,0.42121346507630486,0.0,2.605457000925394e-07,0.4382549309311563,0.0
197,0.3,9,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors have been found to play a role in the development and progression of primary systemic vasculitis. These factors can include exposure to","Is the role of environmental factors important in primary systemic vasculitis? Yes, these factors contribute to the disease’s development and progression, including exposure to various environmental elements.",1.894877818854824e-07,0.18671725946997952,0.05859375,0.014507411718255037,0.2776317365982801,0.0,0.014486412327622988,0.28768207245178123,0.0,1.8948778188548325e-07,0.29849298855599704,0.0
197,0.3,10,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors have been found to play a role in the development and progression of primary systemic vasculitis. These factors can include exposure to","Are environmental factors key in primary systemic vasculitis? Yes, they have been found to influence the development and progression of the disease, including exposure to particular environmental factors.",1.658018091497971e-07,0.14897693148713254,0.05859375,0.012693985253473157,0.23841102344499765,0.0,0.012675610786670115,0.24686007793152642,0.0,1.6580180914979784e-07,0.2559333741372014,0.0
199,0.3,1,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity (defined as giving birth to 5 or more children) has been identified as an independent risk factor for adverse perinatal outcomes, including preterm birth, low birth weight, and","Is grandmultiparity an independent risk factor for negative perinatal outcomes? Yes, having given birth to five or more children, known as grandmultiparity, is recognized as an independent risk factor for adverse perinatal outcomes such as preterm birth and low birth weight.",2.3685972735685406e-08,0.03955029682737976,0.043275384227765196,0.0018134264647818726,0.041330959377241516,0.04606009070294784,0.0018108015409528666,0.043245689523105035,0.04875535399344926,2.3685972735685406e-08,0.045308629419797075,0.05136117409926934
199,0.3,2,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity (defined as giving birth to 5 or more children) has been identified as an independent risk factor for adverse perinatal outcomes, including preterm birth, low birth weight, and","Does grandmultiparity independently increase the risk of adverse perinatal outcomes? Yes, grandmultiparity, defined as delivering five or more children, is an independent risk factor for negative perinatal outcomes including preterm delivery and low birth weight.",1.658018091497972e-07,0.015660803441593707,0.14204081632653065,0.012693985253473122,0.01908509750747056,0.12244897959183673,0.012675610786670087,0.05564170629198184,0.1012244897959184,1.6580180914979784e-07,0.09415466357387947,0.0783673469387755
199,0.3,3,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity (defined as giving birth to 5 or more children) has been identified as an independent risk factor for adverse perinatal outcomes, including preterm birth, low birth weight, and","Is giving birth to five or more children an independent risk factor for poor perinatal outcomes? Yes, grandmultiparity has been identified as an independent risk factor for adverse perinatal outcomes like preterm birth and low birth weight.",1.1842986367842661e-07,0.08121348950955731,0.03266581632653065,0.009067132323909363,0.07906982843767096,0.03748804209183673,0.00905400770476434,0.07656381160024628,0.0426307397959184,1.1842986367842703e-07,0.0736432266264817,0.048093909438775506
199,0.3,4,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity (defined as giving birth to 5 or more children) has been identified as an independent risk factor for adverse perinatal outcomes, including preterm birth, low birth weight, and","Can grandmultiparity be considered an independent risk factor for unfavorable perinatal outcomes? Yes, grandmultiparity, which means having five or more births, is an independent risk factor for adverse outcomes such as preterm birth and low birth weight.",1.1842986367842661e-07,0.08121348950955731,0.03266581632653065,0.009067132323909363,0.07906982843767096,0.03748804209183673,0.00905400770476434,0.07656381160024628,0.0426307397959184,1.1842986367842703e-07,0.0736432266264817,0.048093909438775506
199,0.3,5,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity (defined as giving birth to 5 or more children) has been identified as an independent risk factor for adverse perinatal outcomes, including preterm birth, low birth weight, and","Is grandmultiparity a standalone risk factor for adverse perinatal outcomes? Yes, grandmultiparity, defined as childbirth of five or more children, independently increases the risk of negative perinatal outcomes including preterm birth and low birth weight.",1.658018091497972e-07,0.015660803441593707,0.14204081632653065,0.012693985253473122,0.01908509750747056,0.12244897959183673,0.012675610786670087,0.05564170629198184,0.1012244897959184,1.6580180914979784e-07,0.09415466357387947,0.0783673469387755
199,0.3,6,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity (defined as giving birth to 5 or more children) has been identified as an independent risk factor for adverse perinatal outcomes, including preterm birth, low birth weight, and","Does grandmultiparity independently contribute to the risk of adverse perinatal outcomes? Yes, grandmultiparity, meaning five or more births, is an independent risk factor for outcomes like preterm birth and low birth weight.",2.368597273568531e-07,0.07671251668942158,0.14204081632653065,0.01813426464781876,0.11439527731179577,0.12244897959183673,0.018108015409528708,0.15408177910523513,0.1012244897959184,2.3685972735685406e-07,0.19593735788382194,0.0783673469387755
199,0.3,7,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity (defined as giving birth to 5 or more children) has been identified as an independent risk factor for adverse perinatal outcomes, including preterm birth, low birth weight, and","Is grandmultiparity an independent predictor of adverse perinatal outcomes? Yes, having five or more children, termed grandmultiparity, is independently linked to increased risk of adverse perinatal outcomes such as preterm birth and low birth weight.",1.658018091497972e-07,0.0658859236831062,0.08344706632653065,0.012693985253473122,0.06109401754140631,0.09217554209183673,0.012675610786670087,0.05564170629198184,0.1012244897959184,1.6580180914979784e-07,0.09415466357387947,0.0783673469387755
199,0.3,8,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity (defined as giving birth to 5 or more children) has been identified as an independent risk factor for adverse perinatal outcomes, including preterm birth, low birth weight, and","Is grandmultiparity independently associated with adverse perinatal outcomes? Yes, grandmultiparity, defined as giving birth to five or more children, is an independent risk factor for negative perinatal outcomes including preterm birth and low birth weight.",1.658018091497972e-07,0.015660803441593707,0.14204081632653065,0.012693985253473122,0.01908509750747056,0.12244897959183673,0.012675610786670087,0.05564170629198184,0.1012244897959184,1.6580180914979784e-07,0.09415466357387947,0.0783673469387755
199,0.3,9,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity (defined as giving birth to 5 or more children) has been identified as an independent risk factor for adverse perinatal outcomes, including preterm birth, low birth weight, and","Is grandmultiparity an independent risk factor for poor perinatal outcomes? Yes, grandmultiparity, which refers to having five or more children, has been identified as an independent risk factor for adverse perinatal outcomes like preterm birth and low birth weight.",7.1057918207056e-08,0.0190392836713289,0.03823458795282822,0.005440279394345618,0.017076991825933696,0.041999152602217385,0.0054324046228586,0.01487502403114771,0.04586116799661043,7.105791820705622e-08,0.012402216887323902,0.04982063413600735
199,0.3,10,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity (defined as giving birth to 5 or more children) has been identified as an independent risk factor for adverse perinatal outcomes, including preterm birth, low birth weight, and","Does grandmultiparity independently raise the risk of adverse perinatal outcomes? Yes, grandmultiparity, defined as delivering five or more children, is an independent risk factor for negative perinatal outcomes such as preterm birth and low birth weight.",1.421158364141119e-07,0.044648340314845214,0.14204081632653065,0.010880558788691243,0.010767865642211216,0.12244897959183673,0.010864809245717214,0.024870047625228153,0.1012244897959184,1.4211583641411244e-07,0.062405965259299645,0.0783673469387755
200,0.3,1,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for","Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: Currently, the newly formulated Singapore equation stands as the most precise BMR prediction model for Chinese individuals and is suitable for use.",4.73719454713706e-08,0.05715841383994835,0.0,0.003626852929563759,0.058840500022933284,0.0,0.003621603081905747,0.060624621816435464,0.0,4.737194547137081e-08,0.06252035698133351,0.0
200,0.3,2,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for","Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: Up to now, the Singapore equation, recently developed, is the most accurate for predicting BMR in Chinese populations and is applicable.",2.36859727356853e-08,0.028987536873251507,0.0,0.0018134264647818796,0.029852963149681777,0.0,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
200,0.3,3,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for",Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The latest Singapore equation is presently the most reliable BMR prediction formula for Chinese people and can be applied effectively.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
200,0.3,4,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for","Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the Singapore equation, newly created, offers the most accurate BMR prediction for Chinese and is valid for use.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
200,0.3,5,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for","Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: So far, the Singapore equation developed recently is the best BMR prediction equation for Chinese and is applicable.",4.73719454713706e-08,0.060624621816435464,0.0,0.003626852929563759,0.06252035698133351,0.0,0.003621603081905747,0.06453852113757153,0.0,4.737194547137081e-08,0.06669137449867346,0.0
200,0.3,6,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for","Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: At present, the newly developed Singapore equation is the most precise for estimating BMR in Chinese individuals and is applicable.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
200,0.3,7,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for","Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The Singapore equation, newly developed, currently provides the most accurate BMR predictions for Chinese and is applicable.",7.10579182070559e-08,0.09237332013101529,0.0,0.005440279394345639,0.09531017980432521,0.0,0.005432404622858621,0.09844007281325329,0.0,7.105791820705622e-08,0.10178269430994247,0.0
200,0.3,8,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for","Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: As of now, the newly created Singapore equation is the most accurate BMR prediction tool for Chinese and is applicable.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
200,0.3,9,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for","Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The most accurate BMR prediction equation for Chinese to date is the newly developed Singapore equation, which is applicable.",2.36859727356853e-08,0.029852963149681777,0.0,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
200,0.3,10,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for","Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the Singapore equation recently developed is the most accurate and applicable BMR prediction equation for Chinese.",4.73719454713706e-08,0.060624621816435464,0.0,0.003626852929563759,0.06252035698133351,0.0,0.003621603081905747,0.06453852113757153,0.0,4.737194547137081e-08,0.06669137449867346,0.0
201,0.3,1,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is it essential to routinely place a nasobiliary drainage tube after endoscopic removal of common bile duct stones in patients with cholangitis caused by choledocholithiasis? A routinely placed ENBD tube did not enhance the clinical outcome and only led to longer procedures and increased patient discomfort, making its routine use unnecessary.",4.737194547137081e-08,0.03922071315328246,0.0,0.0036268529295637453,0.04000533461369837,0.0,0.003621603081905733,0.04082199452025437,0.0,4.737194547137081e-08,0.04167269640056892,0.0
201,0.3,2,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Should a nasobiliary drainage tube be routinely inserted following endoscopic clearance of the common bile duct in patients with cholangitis due to choledocholithiasis? Routine insertion of an ENBD tube did not improve clinical outcomes and resulted in longer procedure times and more discomfort, thus it is not required.",1.1842986367842703e-07,0.10109611687136999,0.0,0.009067132323909363,0.10318423623523065,0.0,0.009054007704764333,0.10536051565782589,0.0,1.1842986367842703e-07,0.107630664192365,0.0
201,0.3,3,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is routine insertion of a nasobiliary drainage tube after endoscopic clearance of the common bile duct necessary in patients with choledocholithiasis-induced cholangitis? The routine use of an ENBD tube did not benefit the clinical course and caused increased procedure duration and patient discomfort, so it is unnecessary.",1.4211583641411244e-07,0.12260232209233335,0.0,0.010880558788691236,0.12516314295400566,0.0,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
201,0.3,4,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Does routine placement of a nasobiliary drainage tube after endoscopic clearance of the common bile duct improve outcomes in patients with cholangitis from choledocholithiasis? Routine ENBD tube insertion did not improve clinical progress and led to longer procedures and more discomfort, indicating it is not needed.",1.6580180914979784e-07,0.14458122881110835,0.0,0.012693985253473108,0.14763599880606337,0.0,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
201,0.3,5,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is it necessary to routinely insert a nasobiliary drainage tube after endoscopic common bile duct clearance in patients with cholangitis caused by choledocholithiasis? Routine ENBD tube insertion did not enhance the clinical course and only increased procedure time and patient discomfort, making it unnecessary.",2.1317375462116866e-07,0.1900436028878656,0.0,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
201,0.3,6,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Should nasobiliary drainage tubes be routinely placed after endoscopic clearance of the common bile duct in patients suffering from choledocholithiasis-induced cholangitis? Routine insertion of an ENBD tube did not improve clinical outcomes and caused longer procedures and discomfort, so it is unnecessary.",2.6054570009253947e-07,0.23767165187712003,0.0,0.0199476911126006,0.24294617861038903,0.0,0.019918816950481533,0.248461359298501,0.0,2.6054570009253947e-07,0.25423413838424036,0.0
201,0.3,7,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is the routine use of a nasobiliary drainage tube after endoscopic clearance of the common bile duct necessary in patients with cholangitis due to choledocholithiasis? Routine ENBD tube placement did not improve clinical outcomes and resulted in longer procedure times and increased discomfort, thus it is not required.",1.1842986367842703e-07,0.10109611687136999,0.0,0.009067132323909363,0.10318423623523065,0.0,0.009054007704764333,0.10536051565782589,0.0,1.1842986367842703e-07,0.107630664192365,0.0
201,0.3,8,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is it required to routinely insert a nasobiliary drainage tube following endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Routine ENBD tube insertion did not improve the clinical course and caused longer procedures and more discomfort, making it unnecessary.",2.3685972735685406e-07,0.21357410029806,0.0,0.018134264647818726,0.21825356602001733,0.0,0.018108015409528666,0.22314355131420927,0.0,2.3685972735685406e-07,0.22825865198098239,0.0
201,0.3,9,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is routine nasobiliary drainage tube insertion after endoscopic common bile duct clearance necessary in patients with cholangitis caused by choledocholithiasis? Routine ENBD tube use did not improve clinical outcomes and increased procedure time and discomfort, so it is unnecessary.",3.316036182995955e-07,0.31365755885504143,0.0,0.025387970506946217,0.3209077200800996,0.0,0.025351221573340132,0.32850406697203516,0.0,3.316036182995957e-07,0.3364722366212134,0.0
201,0.3,10,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is it advisable to routinely place a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Routinely inserting an ENBD tube did not improve the clinical course and only prolonged the procedure and increased patient discomfort, thus it is unnecessary.",1.4211583641411244e-07,0.12260232209233335,0.0,0.010880558788691236,0.12516314295400566,0.0,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
202,0.3,1,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS","Are Pap smears with glandular cell abnormalities identified through rapid prescreening? Yes, rapid prescreening (RPS) frequently flags Pap smears with glandular cell abnormalities as abnormal, achieving a sensitivity of 36.4% at the AGC threshold. Notably, RPS detects some cases of AGC on Pap smears.",1.8948778188548325e-07,0.1856515563663388,0.026093240264126724,0.014507411718254981,0.22320375986995566,0.03442727998906507,0.014486412327622933,0.22310096086017284,0.03197226405701179,1.8948778188548325e-07,0.2227551423266183,0.02903759362667705
202,0.3,2,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS","Can rapid prescreening detect glandular cell abnormalities in Pap smears? Pap smears showing glandular cell abnormalities are often marked abnormal by RPS, with a sensitivity rate of 36.4% at the AGC cutoff. Importantly, RPS identifies certain AGC cases on Pap smears.",2.6054570009253947e-07,0.16608991726708844,0.09049767239709064,0.0199476911126006,0.20082970689079183,0.03413227679763848,0.019918816950481533,0.19765069507322464,0.040742417383431435,2.6054570009253947e-07,0.23140196574033478,0.020823902218198284
202,0.3,3,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS","Do Pap smears with glandular cell abnormalities get detected by rapid prescreening? Yes, RPS commonly flags these smears as abnormal, yielding a sensitivity of 36.4% at the AGC threshold. Crucially, some AGC cases are detected on Pap smears via RPS.",2.8423167282822477e-07,0.15763901645487,0.11473589954390503,0.02176111757738247,0.19125918403456588,0.05975554549569943,0.0217296184914344,0.2243189421553855,0.040742417383431435,2.8423167282822487e-07,0.2588009399284501,0.020823902218198284
202,0.3,4,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS","Is rapid prescreening effective in detecting glandular cell abnormalities in Pap smears? Pap smears with glandular cell abnormalities are frequently detected as abnormal by RPS, showing a sensitivity of 36.4% at the AGC threshold. Significantly, some AGC cases are identified on Pap smears by RPS.",1.6580180914979784e-07,0.09598508948312556,0.07254239251323305,0.012693985253473108,0.09988463181436424,0.03651291511021191,0.012675610786670066,0.09756723651624322,0.040742417383431435,1.6580180914979784e-07,0.1287478116802525,0.020823902218198284
202,0.3,5,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS","Are glandular cell abnormalities in Pap smears detected by rapid prescreening? RPS often flags Pap smears with glandular abnormalities as abnormal, achieving a sensitivity of 36.4% at the AGC threshold. Importantly, some AGC cases are detected on Pap smears through RPS.",2.6054570009253947e-07,0.17917112086120213,0.037866093449722166,0.0199476911126006,0.1652836976313079,0.05975554549569943,0.019918816950481533,0.19765069507322464,0.040742417383431435,2.6054570009253947e-07,0.23140196574033478,0.020823902218198284
202,0.3,6,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS","Does rapid prescreening detect glandular cell abnormalities in Pap smears? Pap smears with glandular cell abnormalities are often identified as abnormal by RPS, resulting in a sensitivity of 36.4% at the AGC threshold. Notably, some AGC cases are detected on Pap smears by RPS.",1.8948778188548325e-07,0.12117274887239127,0.07098416824196599,0.014507411718254981,0.12418273407567604,0.03596018559088088,0.014486412327622933,0.12166478809530323,0.040742417383431435,1.8948778188548325e-07,0.1534404242706242,0.020823902218198284
202,0.3,7,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS","Are Pap smears with glandular cell abnormalities picked up by rapid prescreening? Yes, RPS frequently flags these smears as abnormal, with a sensitivity of 36.4% at the AGC threshold. Crucially, some AGC cases are detected on Pap smears using RPS.",2.8423167282822477e-07,0.15763901645487,0.11473589954390503,0.02176111757738247,0.19125918403456588,0.05975554549569943,0.0217296184914344,0.2243189421553855,0.040742417383431435,2.8423167282822487e-07,0.2588009399284501,0.020823902218198284
202,0.3,8,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS","Can rapid prescreening identify glandular cell abnormalities in Pap smears? Pap smears exhibiting glandular cell abnormalities are often flagged as abnormal by RPS, with a sensitivity of 36.4% at the AGC threshold. Importantly, RPS detects some AGC cases on Pap smears.",2.6054570009253947e-07,0.16608991726708844,0.09049767239709064,0.0199476911126006,0.20082970689079183,0.03413227679763848,0.019918816950481533,0.19765069507322464,0.040742417383431435,2.6054570009253947e-07,0.23140196574033478,0.020823902218198284
202,0.3,9,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS","Is detection of glandular cell abnormalities in Pap smears possible through rapid prescreening? RPS often marks Pap smears with glandular cell abnormalities as abnormal, resulting in a sensitivity of 36.4% at the AGC threshold. Significantly, some AGC cases are detected on Pap smears by RPS.",1.6580180914979784e-07,0.13938378277595387,0.0003591682419659403,0.012693985253473108,0.09988463181436424,0.03651291511021191,0.012675610786670066,0.09756723651624322,0.040742417383431435,1.6580180914979784e-07,0.1287478116802525,0.020823902218198284
202,0.3,10,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS","Do rapid prescreening methods detect glandular cell abnormalities in Pap smears? Pap smears with glandular cell abnormalities are frequently flagged as abnormal by RPS, achieving a sensitivity of 36.4% at the AGC threshold. Most importantly, some AGC cases are detected on Pap smears by RPS.",1.6580180914979784e-07,0.09598508948312556,0.07254239251323305,0.012693985253473108,0.09988463181436424,0.03651291511021191,0.012675610786670066,0.09756723651624322,0.040742417383431435,1.6580180914979784e-07,0.1287478116802525,0.020823902218198284
204,0.3,1,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Current evidence suggests that cup-cage reconstruction with oversized cups can provide initial stability in total hip arthroplasty (THA) for osteoporotic acetabular fractures. However, further research is needed to fully understand its effectiveness and long-term outcomes.","Does cup-cage reconstruction using oversized cups offer initial stability in total hip arthroplasty (THA) for osteoporotic acetabular fractures? Current evidence indicates it can provide such stability, but more studies are required to confirm its long-term effectiveness.",3.7897556377096597e-07,0.13183738986081384,0.16836734693877556,0.02901482343650997,0.21930715747759644,0.1177685950413223,0.02897282465524588,0.31043757167762287,0.060964083175803374,3.789755637709665e-07,0.3765839755848339,0.020823902218198284
204,0.3,2,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Current evidence suggests that cup-cage reconstruction with oversized cups can provide initial stability in total hip arthroplasty (THA) for osteoporotic acetabular fractures. However, further research is needed to fully understand its effectiveness and long-term outcomes.","Can cup-cage reconstruction with oversized cups ensure initial stability in THA for patients with osteoporotic acetabular fractures? Existing data suggests it does, though additional research is necessary to evaluate its sustained outcomes.",4.7371945471370717e-07,0.25319824686508063,0.16836734693877556,0.03626852929563749,0.3444703004316034,0.1177685950413223,0.036216030819057374,0.43964930315762984,0.060964083175803374,4.737194547137081e-07,0.5101153682093562,0.020823902218198284
204,0.3,3,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Current evidence suggests that cup-cage reconstruction with oversized cups can provide initial stability in total hip arthroplasty (THA) for osteoporotic acetabular fractures. However, further research is needed to fully understand its effectiveness and long-term outcomes.","Is initial stability achieved in THA for osteoporotic acetabular fractures through cup-cage reconstruction with oversized cups? Present findings support this, but further investigation is needed to assess long-term results.",5.447773729207631e-07,0.3549809411750231,0.16836734693877556,0.041708808689983126,0.4498308160894289,0.1177685950413223,0.041648435441915994,0.5488485951226205,0.060964083175803374,5.447773729207643e-07,0.6234440535163603,0.020823902218198284
204,0.3,4,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Current evidence suggests that cup-cage reconstruction with oversized cups can provide initial stability in total hip arthroplasty (THA) for osteoporotic acetabular fractures. However, further research is needed to fully understand its effectiveness and long-term outcomes.","Does the use of oversized cups in cup-cage reconstruction provide initial stability in total hip arthroplasty for osteoporotic acetabular fractures? Current studies suggest yes, but more research is essential to understand its long-term efficacy.",4.2634750924233657e-07,0.19067788988374712,0.16836734693877556,0.03264167636607373,0.2799317792940319,0.1177685950413223,0.03259442773715163,0.3729579286589564,0.060964083175803374,4.263475092423373e-07,0.44112249672240544,0.020823902218198284
204,0.3,5,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Current evidence suggests that cup-cage reconstruction with oversized cups can provide initial stability in total hip arthroplasty (THA) for osteoporotic acetabular fractures. However, further research is needed to fully understand its effectiveness and long-term outcomes.","Can initial stability be attained in THA for osteoporotic acetabular fractures by employing cup-cage reconstruction with oversized cups? Evidence so far indicates it can, yet further research is required to confirm lasting outcomes.",4.5003348197802187e-07,0.2214495485505008,0.16836734693877556,0.03445510283085561,0.31168047760861173,0.1177685950413223,0.0344052292781045,0.4057477514819481,0.060964083175803374,4.500334819780227e-07,0.4750240483980872,0.020823902218198284
204,0.3,6,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Current evidence suggests that cup-cage reconstruction with oversized cups can provide initial stability in total hip arthroplasty (THA) for osteoporotic acetabular fractures. However, further research is needed to fully understand its effectiveness and long-term outcomes.","Is cup-cage reconstruction with oversized cups effective in providing initial stability during THA for osteoporotic acetabular fractures? Current evidence points to its effectiveness, but additional studies are needed to fully evaluate long-term benefits.",4.5003348197802187e-07,0.2214495485505008,0.16836734693877556,0.03445510283085561,0.31168047760861173,0.1177685950413223,0.0344052292781045,0.4057477514819481,0.060964083175803374,4.500334819780227e-07,0.4750240483980872,0.020823902218198284
204,0.3,7,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Current evidence suggests that cup-cage reconstruction with oversized cups can provide initial stability in total hip arthroplasty (THA) for osteoporotic acetabular fractures. However, further research is needed to fully understand its effectiveness and long-term outcomes.","Does employing oversized cups in cup-cage reconstruction offer initial stability in total hip arthroplasty for osteoporotic acetabular fractures? Available evidence suggests it does, although more research is needed to verify long-term success.",4.7371945471370717e-07,0.25319824686508063,0.16836734693877556,0.03626852929563749,0.3444703004316034,0.1177685950413223,0.036216030819057374,0.43964930315762984,0.060964083175803374,4.737194547137081e-07,0.5101153682093562,0.020823902218198284
204,0.3,8,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Current evidence suggests that cup-cage reconstruction with oversized cups can provide initial stability in total hip arthroplasty (THA) for osteoporotic acetabular fractures. However, further research is needed to fully understand its effectiveness and long-term outcomes.","Can oversized cups in cup-cage reconstruction provide the necessary initial stability in THA for osteoporotic acetabular fractures? Existing research supports this, but further investigation is required to determine long-term outcomes.",5.210914001850778e-07,0.3198896213637541,0.16836734693877556,0.03989538222520125,0.4134631719185542,0.1177685950413223,0.03983763390096312,0.5111082671397735,0.060964083175803374,5.210914001850789e-07,0.5842233403630779,0.020823902218198284
204,0.3,9,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Current evidence suggests that cup-cage reconstruction with oversized cups can provide initial stability in total hip arthroplasty (THA) for osteoporotic acetabular fractures. However, further research is needed to fully understand its effectiveness and long-term outcomes.","Is initial stability in THA for osteoporotic acetabular fractures achievable through cup-cage reconstruction with oversized cups? Current findings suggest so, but more studies are necessary to understand its long-term impact.",5.210914001850778e-07,0.3198896213637541,0.16836734693877556,0.03989538222520125,0.4134631719185542,0.1177685950413223,0.03983763390096312,0.5111082671397735,0.060964083175803374,5.210914001850789e-07,0.5842233403630779,0.020823902218198284
204,0.3,10,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Current evidence suggests that cup-cage reconstruction with oversized cups can provide initial stability in total hip arthroplasty (THA) for osteoporotic acetabular fractures. However, further research is needed to fully understand its effectiveness and long-term outcomes.","Does cup-cage reconstruction with oversized cups deliver initial stability in total hip arthroplasty for osteoporotic acetabular fractures? Present evidence indicates it can, yet further research is needed to assess its long-term effectiveness.",4.7371945471370717e-07,0.25319824686508063,0.16836734693877556,0.03626852929563749,0.3444703004316034,0.1177685950413223,0.036216030819057374,0.43964930315762984,0.060964083175803374,4.737194547137081e-07,0.5101153682093562,0.020823902218198284
205,0.3,1,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is typically required to diagnose appendicitis in children. Common imaging techniques include ultrasound and computed tomography (CT) scans. These tests help to visualize the inflamed appendix and provide a more accurate diagnosis.","Is imaging necessary for diagnosing appendicitis in children? Yes, imaging is generally needed to diagnose appendicitis in pediatric patients. Ultrasound and CT scans are common methods used to visualize the inflamed appendix and ensure an accurate diagnosis.",1.8948778188548283e-07,0.14465880208356952,0.040061673687916605,0.014507411718254981,0.14137324671020046,0.046400951814396206,0.01448641232762294,0.17830208506911438,0.023795359904818555,1.8948778188548325e-07,0.21706450523782772,0.0
205,0.3,2,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is typically required to diagnose appendicitis in children. Common imaging techniques include ultrasound and computed tomography (CT) scans. These tests help to visualize the inflamed appendix and provide a more accurate diagnosis.","Do children require imaging to diagnose appendicitis? Yes, imaging is usually essential for diagnosing appendicitis in children. Techniques like ultrasound and computed tomography (CT) scans are commonly employed to detect inflammation in the appendix and confirm the diagnosis.",1.6580180914979753e-07,0.07875165119767935,0.06781677572873293,0.012693985253473108,0.11320236974350362,0.046400951814396206,0.012675610786670066,0.14931454819586287,0.023795359904818555,1.6580180914979784e-07,0.18721154208814594,0.0
205,0.3,3,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is typically required to diagnose appendicitis in children. Common imaging techniques include ultrasound and computed tomography (CT) scans. These tests help to visualize the inflamed appendix and provide a more accurate diagnosis.","Is imaging required to diagnose appendicitis in children? Yes, imaging is typically necessary to diagnose appendicitis in children. Ultrasound and CT scans are frequently used to visualize the inflamed appendix and provide a precise diagnosis.",2.3685972735685343e-07,0.2856291299127913,0.019592173282713482,0.01813426464781874,0.28423158680100613,0.013952846312554876,0.018108015409528687,0.28224840567054743,0.00742212188498375,2.3685972735685406e-07,0.27958486221916123,0.0
205,0.3,4,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is typically required to diagnose appendicitis in children. Common imaging techniques include ultrasound and computed tomography (CT) scans. These tests help to visualize the inflamed appendix and provide a more accurate diagnosis.","Do we need to use imaging to diagnose appendicitis in pediatric cases? Yes, imaging is commonly required for diagnosing appendicitis in children. Ultrasound and CT scans are standard imaging techniques that help identify the inflamed appendix for accurate diagnosis.",1.4211583641411222e-07,0.08856483467130483,0.041520208891625554,0.010880558788691236,0.0858033955553883,0.046400951814396206,0.0108648092457172,0.12114367122916603,0.023795359904818555,1.4211583641411244e-07,0.15822400521489444,0.0
205,0.3,5,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is typically required to diagnose appendicitis in children. Common imaging techniques include ultrasound and computed tomography (CT) scans. These tests help to visualize the inflamed appendix and provide a more accurate diagnosis.","Is it necessary to perform imaging to diagnose appendicitis in children? Yes, imaging is often required to diagnose appendicitis in children. Ultrasound and CT imaging are commonly used to view the inflamed appendix and make a reliable diagnosis.",1.6580180914979753e-07,0.19115389669388794,0.012633051260886416,0.012693985253473108,0.1902187231390533,0.008962369984911768,0.012675610786670066,0.1889229585135741,0.004751352897949604,1.6580180914979784e-07,0.18721154208814594,0.0
205,0.3,6,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is typically required to diagnose appendicitis in children. Common imaging techniques include ultrasound and computed tomography (CT) scans. These tests help to visualize the inflamed appendix and provide a more accurate diagnosis.","Are imaging studies needed to diagnose appendicitis in children? Yes, imaging is typically necessary for diagnosing appendicitis in pediatric patients. Common imaging modalities include ultrasound and CT scans, which help visualize the inflamed appendix for accurate diagnosis.",1.8948778188548283e-07,0.14465880208356952,0.040061673687916605,0.014507411718254981,0.14137324671020046,0.046400951814396206,0.01448641232762294,0.17830208506911438,0.023795359904818555,1.8948778188548325e-07,0.21706450523782772,0.0
205,0.3,7,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is typically required to diagnose appendicitis in children. Common imaging techniques include ultrasound and computed tomography (CT) scans. These tests help to visualize the inflamed appendix and provide a more accurate diagnosis.","Do children need imaging to confirm appendicitis? Yes, imaging is generally required to diagnose appendicitis in children. Ultrasound and computed tomography scans are commonly used to detect inflammation in the appendix and ensure an accurate diagnosis.",2.1317375462116813e-07,0.13432150235249152,0.06781677572873293,0.01632083818303686,0.17036078358345197,0.046400951814396206,0.016297213868575813,0.20815504821879616,0.023795359904818555,2.1317375462116866e-07,0.2478361639045814,0.0
205,0.3,8,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is typically required to diagnose appendicitis in children. Common imaging techniques include ultrasound and computed tomography (CT) scans. These tests help to visualize the inflamed appendix and provide a more accurate diagnosis.","Is imaging a necessary step in diagnosing appendicitis in children? Yes, imaging is usually essential for diagnosing appendicitis in children. Ultrasound and CT scans are common techniques that help visualize the inflamed appendix and confirm the diagnosis.",1.8948778188548283e-07,0.18316697878134436,0.012453453929424957,0.014507411718254981,0.1809816570279117,0.017854239011628047,0.01448641232762294,0.17830208506911438,0.023795359904818555,1.8948778188548325e-07,0.21706450523782772,0.0
205,0.3,9,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is typically required to diagnose appendicitis in children. Common imaging techniques include ultrasound and computed tomography (CT) scans. These tests help to visualize the inflamed appendix and provide a more accurate diagnosis.","Should imaging be performed to diagnose appendicitis in children? Yes, imaging is typically needed to diagnose appendicitis in children. Ultrasound and CT scans are standard methods used to identify the inflamed appendix and provide an accurate diagnosis.",1.8948778188548283e-07,0.2216751554791192,0.014827852370440611,0.014507411718254981,0.22059006734562248,0.010532014209478899,0.01448641232762294,0.2190754486314641,0.005589396752665381,1.8948778188548325e-07,0.21706450523782772,0.0
205,0.3,10,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is typically required to diagnose appendicitis in children. Common imaging techniques include ultrasound and computed tomography (CT) scans. These tests help to visualize the inflamed appendix and provide a more accurate diagnosis.","Is it required to use imaging to diagnose appendicitis in children? Yes, imaging is often necessary to diagnose appendicitis in children. Common imaging techniques include ultrasound and computed tomography scans, which assist in visualizing the inflamed appendix for a precise diagnosis.",9.474389094274162e-08,0.1047621868119597,0.0066901636430713035,0.0072537058591274906,0.10425168058893775,0.004731261479979244,0.007243206163811466,0.10355788051467618,0.002501206932288818,9.474389094274162e-08,0.10265415406008227,0.0
206,0.3,1,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, studies have shown that cognitive function does play a role in predicting frequency compressed speech recognition in listeners with normal hearing and normal cognition.","Does cognitive ability forecast how well individuals with normal hearing and cognition recognize frequency compressed speech? Yes, research indicates cognitive ability influences recognition of frequency compressed speech in such listeners.",3.079176455639091e-07,0.10290320138131515,0.16034109416774076,0.023574544042164393,0.077059038234494,0.2021484375,0.02354042003238732,0.11578371588562852,0.1875,3.079176455639103e-07,0.1566430432917736,0.1708984375
206,0.3,2,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, studies have shown that cognitive function does play a role in predicting frequency compressed speech recognition in listeners with normal hearing and normal cognition.","Is there a predictive relationship between cognitive function and frequency compressed speech recognition in people with normal hearing and cognition? Yes, studies confirm cognitive function affects this recognition.",3.552895910352797e-07,0.13009989329705185,0.19194595127117337,0.027201396971728152,0.15116701038821567,0.2021484375,0.02716202311429307,0.19274475702175797,0.1875,3.552895910352811e-07,0.23668575096531086,0.1708984375
206,0.3,3,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, studies have shown that cognitive function does play a role in predicting frequency compressed speech recognition in listeners with normal hearing and normal cognition.","Can cognitive function predict frequency compressed speech recognition in listeners who have normal hearing and cognition? Yes, evidence shows cognitive function is a predictor.",4.500334819780209e-07,0.29937197564997664,0.18553977003981728,0.03445510283085567,0.31822109505138263,0.2021484375,0.03440522927810456,0.3670981441665364,0.1875,4.5003348197802266e-07,0.41900730775926576,0.1708984375
206,0.3,4,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, studies have shown that cognitive function does play a role in predicting frequency compressed speech recognition in listeners with normal hearing and normal cognition.","Does cognitive function serve as a predictor for frequency compressed speech recognition in listeners with normal hearing and normal cognition? Yes, research supports this role.",4.263475092423356e-07,0.19653869335640284,0.22892819979188342,0.03264167636607379,0.2737693324805486,0.2021484375,0.03259442773715169,0.32057812853164247,0.1875,4.263475092423373e-07,0.3702171435898345,0.1708984375
206,0.3,5,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, studies have shown that cognitive function does play a role in predicting frequency compressed speech recognition in listeners with normal hearing and normal cognition.","Is frequency compressed speech recognition in normal hearing and cognitively normal listeners predicted by cognitive function? Yes, studies demonstrate cognitive function's predictive role.",4.737194547137062e-07,0.2835500703460325,0.22892819979188342,0.03626852929563755,0.36474111068627657,0.2021484375,0.036216030819057436,0.4158883083359677,0.1875,4.73719454713708e-07,0.4703006021468159,0.1708984375
206,0.3,6,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, studies have shown that cognitive function does play a role in predicting frequency compressed speech recognition in listeners with normal hearing and normal cognition.","Does cognitive function influence the ability to recognize frequency compressed speech in individuals with normal hearing and cognition? Yes, it has been shown to predict recognition.",4.026615365066503e-07,0.15571669883614803,0.22892819979188342,0.03082824990129191,0.23120971806175294,0.2021484375,0.030783626196198816,0.2761263659608084,0.1875,4.026615365066519e-07,0.32369712795494054,0.1708984375
206,0.3,7,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, studies have shown that cognitive function does play a role in predicting frequency compressed speech recognition in listeners with normal hearing and normal cognition.","Can the recognition of frequency compressed speech by listeners with normal hearing and cognition be predicted by cognitive function? Yes, studies have established this link.",4.263475092423356e-07,0.19653869335640284,0.22892819979188342,0.03264167636607379,0.2737693324805486,0.2021484375,0.03259442773715169,0.32057812853164247,0.1875,4.263475092423373e-07,0.3702171435898345,0.1708984375
206,0.3,8,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, studies have shown that cognitive function does play a role in predicting frequency compressed speech recognition in listeners with normal hearing and normal cognition.","Is cognitive function a factor in predicting frequency compressed speech recognition in listeners with normal hearing and cognition? Yes, research has shown it plays a role.",4.026615365066503e-07,0.15571669883614803,0.22892819979188342,0.03082824990129191,0.23120971806175294,0.2021484375,0.030783626196198816,0.2761263659608084,0.1875,4.026615365066519e-07,0.32369712795494054,0.1708984375
206,0.3,9,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, studies have shown that cognitive function does play a role in predicting frequency compressed speech recognition in listeners with normal hearing and normal cognition.","Does cognitive function predict how well listeners with normal hearing and cognition recognize frequency compressed speech? Yes, studies have found cognitive function to be predictive.",4.263475092423356e-07,0.2543009584030633,0.18734029809056016,0.03264167636607379,0.2737693324805486,0.2021484375,0.03259442773715169,0.32057812853164247,0.1875,4.263475092423373e-07,0.3702171435898345,0.1708984375
206,0.3,10,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, studies have shown that cognitive function does play a role in predicting frequency compressed speech recognition in listeners with normal hearing and normal cognition.","Is there evidence that cognitive function predicts frequency compressed speech recognition in listeners with normal hearing and normal cognition? Yes, studies confirm this relationship.",4.500334819780209e-07,0.23909830777519847,0.22892819979188342,0.03445510283085567,0.31822109505138263,0.2021484375,0.03440522927810456,0.3670981441665364,0.1875,4.5003348197802266e-07,0.41900730775926576,0.1708984375
207,0.3,1,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not,Are biochemical markers of bone turnover indicative of bone histomorphometry in 370 postmenopausal women? Bone turnover markers showed a significant yet modest correlation with bone turnover parameters assessed in iliac cancellous bone. The iliac crest bone might not be representative.,2.36859727356853e-08,0.029134819215083763,0.0035657596371881373,0.0018134264647818726,0.026668247082160867,0.0,0.0018108015409528666,0.02739897418811532,0.0,2.3685972735685406e-08,0.028170876966696845,0.0
207,0.3,2,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not,Do biochemical markers of bone turnover reflect bone histomorphometry in 370 postmenopausal women? Bone turnover markers were significantly but moderately linked to bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not fully represent this.,0.0,0.03648143055578679,0.027485512723607983,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
207,0.3,3,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not,"In 370 postmenopausal women, are biochemical markers of bone turnover representative of bone histomorphometry? There was a significant but modest association between bone turnover markers and bone turnover parameters measured in iliac cancellous bone. The iliac crest bone might not be entirely representative.",9.474389094274141e-08,0.11181812328661556,0.013222235639818017,0.0072537058591274906,0.10265415406008227,0.0,0.007243206163811466,0.10536051565782589,0.0,9.474389094274162e-08,0.10821358464023101,0.0
207,0.3,4,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not,"Are biochemical markers of bone turnover accurate indicators of bone histomorphometry in 370 postmenopausal women? Bone turnover markers were significantly, though modestly, associated with bone turnover parameters in iliac cancellous bone. The iliac crest bone may not be fully representative.",2.36859727356853e-08,0.029134819215083763,0.0035657596371881373,0.0018134264647818726,0.026668247082160867,0.0,0.0018108015409528666,0.02739897418811532,0.0,2.3685972735685406e-08,0.028170876966696845,0.0
207,0.3,5,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not,Do biochemical markers of bone turnover correspond to bone histomorphometry in 370 postmenopausal women? Bone turnover markers had a significant but modest association with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone might not be representative.,2.36859727356853e-08,0.06468082847456813,0.030323936733203147,0.0018134264647818726,0.026668247082160867,0.0,0.0018108015409528666,0.02739897418811532,0.0,2.3685972735685406e-08,0.028170876966696845,0.0
207,0.3,6,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not,Are biochemical markers of bone turnover reflective of bone histomorphometry in 370 postmenopausal women? Bone turnover markers showed a significant yet modest correlation with bone turnover parameters in iliac cancellous bone. The iliac crest bone may not be representative.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
207,0.3,7,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not,"In 370 postmenopausal women, do biochemical markers of bone turnover represent bone histomorphometry? Bone turnover markers were significantly but modestly linked to bone turnover parameters measured in iliac cancellous bone. The iliac crest bone might not be fully representative.",0.0,0.03648143055578679,0.027485512723607983,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
207,0.3,8,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not,"Are biochemical markers of bone turnover valid indicators of bone histomorphometry in 370 postmenopausal women? Bone turnover markers were significantly, though modestly, associated with bone turnover parameters in iliac cancellous bone. The iliac crest bone may not be fully representative.",2.36859727356853e-08,0.029134819215083763,0.0035657596371881373,0.0018134264647818726,0.026668247082160867,0.0,0.0018108015409528666,0.02739897418811532,0.0,2.3685972735685406e-08,0.028170876966696845,0.0
207,0.3,9,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not,Do biochemical markers of bone turnover serve as representatives of bone histomorphometry in 370 postmenopausal women? Bone turnover markers had a significant but modest association with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone might not be representative.,7.1057918207056e-08,0.08500156402629955,0.010163943693821037,0.005440279394345618,0.07796154146971057,0.0,0.0054324046228586,0.08004270767353416,0.0,7.105791820705622e-08,0.08223809823697303,0.0
207,0.3,10,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not,Are biochemical markers of bone turnover indicative of bone histomorphometry parameters in 370 postmenopausal women? Bone turnover markers were significantly but modestly associated with bone turnover parameters in iliac cancellous bone. The iliac crest bone may not be fully representative.,2.36859727356853e-08,0.006411190044400161,0.02285714285714291,0.0018134264647818726,0.026668247082160867,0.0,0.0018108015409528666,0.02739897418811532,0.0,2.3685972735685406e-08,0.028170876966696845,0.0
208,0.3,1,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events","Does profound hypotension trigger myocardial ischemic events in patients with coronary disease? Evidence shows that in ischemic heart disease patients, both symptomatic and silent ischemia are temporally linked to hypotension, especially low diastolic pressure, indicating susceptibility to ischemic events.",3.0791764556391007e-07,0.17525073597354401,0.12041647804436403,0.023574544042164344,0.2456533183391243,0.039930555555555566,0.023540420032387266,0.30830135965451655,0.0,3.079176455639103e-07,0.31585294941847764,0.0
208,0.3,2,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events","Can severe hypotensive episodes cause myocardial ischemia in coronary disease patients? Studies indicate that ischemic heart disease patients experience symptomatic and silent ischemia in close temporal association with hypotension, notably diastolic hypotension, suggesting vulnerability to ischemic events.",3.5528959103528067e-07,0.26782613394159505,0.09266137600354771,0.02720139697172809,0.30122316949393646,0.039930555555555566,0.027162023114293006,0.3654597734944649,0.0,3.552895910352811e-07,0.3746934494414109,0.0
208,0.3,3,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events","In patients with coronary disease, do profound hypotensive events lead to myocardial ischemic episodes? Data reveal that ischemic heart disease patients develop both symptomatic and silent ischemia temporally related to hypotension, particularly diastolic pressure drops, implying increased risk of ischemic events.",2.6054570009253947e-07,0.12395744158599431,0.12041647804436403,0.0199476911126006,0.19300958485370545,0.039930555555555566,0.019918816950481533,0.25423413838424036,0.0,2.6054570009253947e-07,0.26028309826366547,0.0
208,0.3,4,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events","Is there a causal link between profound hypotension and myocardial ischemic events in coronary disease patients? Findings suggest that in ischemic heart disease, symptomatic and silent ischemia occur in temporal connection with hypotension, especially low diastolic pressures, indicating susceptibility to ischemic episodes.",2.3685972735685406e-07,0.09926482899562261,0.12041647804436403,0.018134264647818726,0.16769177686941372,0.039930555555555566,0.018108015409528666,0.22825865198098239,0.0,2.3685972735685406e-07,0.2336148511815046,0.0
208,0.3,5,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events","Can myocardial ischemic events be caused by severe hypotension in patients with coronary disease? Evidence demonstrates that ischemic heart disease patients experience symptomatic and silent ischemia temporally associated with hypotension, mainly diastolic hypotension, suggesting they are prone to ischemic events.",2.8423167282822477e-07,0.14927524957028604,0.12041647804436403,0.02176111757738247,0.21898507125696343,0.039930555555555566,0.0217296184914344,0.2809023854664012,0.0,2.8423167282822487e-07,0.2876820724517808,0.0
208,0.3,6,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events","Does hypotension provoke myocardial ischemia in patients suffering from coronary disease? Research shows a temporal causal relationship between hypotension and both symptomatic and silent ischemia in ischemic heart disease patients, particularly linked to diastolic pressure, indicating susceptibility to ischemic events.",2.8423167282822477e-07,0.18482125882976996,0.09479320934630309,0.02176111757738247,0.21898507125696343,0.039930555555555566,0.0217296184914344,0.2809023854664012,0.0,2.8423167282822487e-07,0.2876820724517808,0.0
208,0.3,7,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events","Are profound hypotensive events capable of causing myocardial ischemic episodes in patients with coronary disease? Data indicate that symptomatic and silent ischemia in ischemic heart disease patients occur in temporal relation to hypotension, especially diastolic hypotension, suggesting vulnerability to ischemic events.",2.6054570009253947e-07,0.12395744158599431,0.12041647804436403,0.0199476911126006,0.19300958485370545,0.039930555555555566,0.019918816950481533,0.25423413838424036,0.0,2.6054570009253947e-07,0.26028309826366547,0.0
208,0.3,8,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events","In coronary disease patients, can severe hypotension induce myocardial ischemic events? Observations reveal that ischemic heart disease patients have symptomatic and silent ischemia temporally linked to hypotension, notably low diastolic pressure, implying increased susceptibility to ischemic events.",3.5528959103528067e-07,0.2293179572438202,0.12041647804436403,0.02720139697172809,0.30122316949393646,0.039930555555555566,0.027162023114293006,0.3654597734944649,0.0,3.552895910352811e-07,0.3746934494414109,0.0
208,0.3,9,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events","Do profound hypotensive episodes cause myocardial ischemia in patients with coronary disease? Evidence points to a temporal causal association between hypotension and ischemia, both symptomatic and silent, in ischemic heart disease patients, particularly with diastolic pressure drops, suggesting susceptibility to ischemic events.",2.3685972735685406e-07,0.09926482899562261,0.12041647804436403,0.018134264647818726,0.16769177686941372,0.039930555555555566,0.018108015409528666,0.22825865198098239,0.0,2.3685972735685406e-07,0.2336148511815046,0.0
208,0.3,10,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events","Is myocardial ischemia triggered by profound hypotension in coronary disease patients? Studies show that in ischemic heart disease, symptomatic and silent ischemia occur in temporal connection with hypotension, especially diastolic hypotension, indicating these patients may be prone to ischemic events.",2.8423167282822477e-07,0.14927524957028604,0.12041647804436403,0.02176111757738247,0.21898507125696343,0.039930555555555566,0.0217296184914344,0.2809023854664012,0.0,2.8423167282822487e-07,0.2876820724517808,0.0
209,0.3,1,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had,Does cognitive ability forecast the recognition of frequency compressed speech in individuals with normal hearing and cognition? The study found no significant statistical link between cognitive function and recognizing frequency compressed speech in noisy environments. Results might have varied with different participants.,2.3685972735685406e-08,0.09252671574583848,0.04891932153562467,0.0018134264647818726,0.0940073306463658,0.049861495844875335,0.0018108015409528666,0.06086381724377565,0.025623268698060954,2.3685972735685406e-08,0.025975486403257975,0.0
209,0.3,2,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had,Is there a predictive relationship between cognitive function and frequency compressed speech recognition in listeners with normal hearing and cognition? The data showed no statistically significant correlation between cognitive performance and speech recognition under frequency compression in noise. Different participant groups might have yielded other outcomes.,7.105791820705622e-08,0.040386797368603844,0.020552936471601127,0.005440279394345618,0.07061756721395396,0.0,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
209,0.3,3,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had,Can cognitive function predict how well listeners with normal hearing and cognition recognize frequency compressed speech? The analysis revealed no significant statistical association between cognitive abilities and recognition of frequency compressed speech in noise. The results could differ if the sample included other participants.,2.3685972735685406e-08,0.024298102261311794,0.0005527295193310314,0.0018134264647818726,0.024097551579060017,0.0,0.0018108015409528666,0.0246926125903717,0.0,2.3685972735685406e-08,0.02531780798429173,0.0
209,0.3,4,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had,Does cognitive functioning serve as a predictor for frequency compressed speech recognition among normal hearing and cognitively typical listeners? No statistically significant relationship was found between cognitive function and speech recognition of frequency compressed speech in noise. Findings might have changed with different participant demographics.,4.737194547137081e-08,0.014993045843371355,0.044021415823914375,0.0036268529295637453,0.01538864524228023,0.023242630385487524,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
209,0.3,5,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had,Is cognitive function an indicator of frequency compressed speech recognition in listeners with normal hearing and cognition? The study did not find a statistically significant relationship between cognitive function and recognition of frequency compressed speech in noisy settings. Different participant profiles might have influenced the results.,7.105791820705622e-08,0.02122628534783555,0.0642474717430101,0.005440279394345618,0.007604187163049225,0.045351473922902494,0.0054324046228586,0.04008125783265193,0.023242630385487524,7.105791820705622e-08,0.07410797215372344,0.0
209,0.3,6,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had,Does cognitive ability predict recognition of frequency compressed speech in noise for listeners with normal hearing and cognition? There was no statistically significant correlation observed between cognitive function and speech recognition under frequency compression in noise. The findings might differ with other participant samples.,2.3685972735685406e-08,0.056537506008286,0.023795359904818555,0.0018134264647818726,0.024097551579060017,0.0,0.0018108015409528666,0.0246926125903717,0.0,2.3685972735685406e-08,0.02531780798429173,0.0
209,0.3,7,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had,Can cognitive function predict frequency compressed speech recognition in individuals with normal hearing and cognition? The relationship between cognitive function and recognition of frequency compressed speech in noise was not statistically significant. The outcome might have been different with other participants.,4.737194547137081e-08,0.11975523265533106,0.05071157946698568,0.0036268529295637453,0.08555642983414735,0.025623268698060954,0.003621603081905733,0.051293294387549704,0.0,4.737194547137081e-08,0.05264373348541884,0.0
209,0.3,8,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had,Is there a significant link between cognitive function and frequency compressed speech recognition in listeners with normal hearing and cognition? The study found no statistically significant association between cognitive function and recognition of frequency compressed speech in noisy conditions. Different participants might have led to different findings.,9.474389094274162e-08,0.02670538288312585,0.08328375966686498,0.0072537058591274906,0.0006707989913525836,0.06632653061224489,0.007243206163811466,0.06380348977887307,0.02271498107084911,9.474389094274162e-08,0.09763846956391786,0.0
209,0.3,9,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had,Does cognitive functioning predict how well listeners with normal hearing and normal cognition recognize frequency compressed speech? The findings showed no statistically significant relationship between cognitive function and recognition of frequency compressed speech in noise. The results may have varied with a different participant group.,4.737194547137081e-08,0.04802033420753293,0.0010803788339694455,0.0036268529295637453,0.047628048989254435,0.0,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
209,0.3,10,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had,Is cognitive function predictive of frequency compressed speech recognition in normal hearing and cognitively typical listeners? No statistically significant relationship was found between cognitive function and recognition of frequency compressed speech in noise. The findings could have differed if the participant sample was different.,2.3685972735685406e-08,0.07242010897961038,0.06824934752450428,0.0018134264647818726,0.04191646561712403,0.047500000000000014,0.0018108015409528666,0.009119444997918169,0.024375,2.3685972735685406e-08,0.02531780798429173,0.0
210,0.3,1,human,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may,Question: Does increased neutrophil migratory activity following major trauma contribute to the development of acute respiratory distress syndrome? Answer: The findings suggest that major blunt trauma boosts the migratory ability of circulating neutrophils. This effect is evident within 2 hours of admission and may,2.3685972735685406e-08,0.023530497410194418,0.0,0.0018134264647818726,0.024097551579060017,0.0,0.0018108015409528666,0.0246926125903717,0.0,2.3685972735685406e-08,0.02531780798429173,0.0
210,0.3,2,human,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may,Question: Is heightened neutrophil migration after significant trauma a factor in causing acute respiratory distress syndrome? Answer: The data show that major blunt trauma increases the migratory potential of circulating neutrophils. This occurs within 2 hours of admission and may,7.105791820705611e-08,0.07410797215372344,0.0,0.005440279394345618,0.0759859069779214,0.0,0.0054324046228586,0.07796154146971057,0.0,7.105791820705622e-08,0.08004270767353416,0.0
210,0.3,3,human,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may,Question: Could increased neutrophil migration post-major trauma be involved in the etiology of acute respiratory distress syndrome? Answer: These results indicate that major blunt trauma enhances the migration capacity of circulating neutrophils. This is observable within 2 hours of admission and may,2.3685972735685406e-08,0.024097551579060017,0.0,0.0018134264647818726,0.0246926125903717,0.0,0.0018108015409528666,0.02531780798429173,0.0,2.3685972735685406e-08,0.025975486403257975,0.0
210,0.3,4,human,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may,Question: Does major trauma-induced neutrophil migratory activity play a role in acute respiratory distress syndrome development? Answer: The evidence suggests that major blunt trauma elevates the migratory function of circulating neutrophils. This is apparent within 2 hours of admission and may,4.737194547137081e-08,0.048790164169431716,0.0,0.0036268529295637453,0.05001042057466343,0.0,0.003621603081905733,0.051293294387549704,0.0,4.737194547137081e-08,0.05264373348541884,0.0
210,0.3,5,human,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may,Question: Is the increase in neutrophil migration after major trauma a contributing factor to acute respiratory distress syndrome? Answer: Data indicate that major blunt trauma augments the migratory ability of circulating neutrophils. This manifests within 2 hours of admission and may,4.737194547137081e-08,0.048790164169431716,0.0,0.0036268529295637453,0.05001042057466343,0.0,0.003621603081905733,0.051293294387549704,0.0,4.737194547137081e-08,0.05264373348541884,0.0
210,0.3,6,human,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may,Question: Could the enhanced migratory activity of neutrophils after major trauma be a cause of acute respiratory distress syndrome? Answer: Findings reveal that major blunt trauma improves the migratory capacity of circulating neutrophils. This is seen within 2 hours of admission and may,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
210,0.3,7,human,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may,Question: Does the rise in neutrophil migration following major trauma influence the onset of acute respiratory distress syndrome? Answer: The data indicate that major blunt trauma increases the migratory capacity of circulating neutrophils. This is evident within 2 hours of admission and may,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
210,0.3,8,human,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may,"Question: Is neutrophil migratory activity increased after major trauma, contributing to acute respiratory distress syndrome? Answer: These findings demonstrate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This occurs within 2 hours of admission and may",9.474389094274141e-08,0.10008345855698142,0.0,0.0072537058591274906,0.10265415406008227,0.0,0.007243206163811466,0.10536051565782589,0.0,9.474389094274162e-08,0.10821358464023101,0.0
210,0.3,9,human,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may,Question: Could the elevated neutrophil migration after major trauma be a factor in the pathogenesis of acute respiratory distress syndrome? Answer: The results suggest that major blunt trauma boosts the migratory ability of circulating neutrophils. This is detectable within 2 hours of admission and may,4.737194547137081e-08,0.04652001563489394,0.0,0.0036268529295637453,0.047628048989254435,0.0,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
210,0.3,10,human,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may,Question: Does increased neutrophil migration post-major trauma play a role in acute respiratory distress syndrome development? Answer: The data show that major blunt trauma enhances the migratory function of circulating neutrophils. This is apparent within 2 hours of admission and may,4.737194547137081e-08,0.048790164169431716,0.0,0.0036268529295637453,0.05001042057466343,0.0,0.003621603081905733,0.051293294387549704,0.0,4.737194547137081e-08,0.05264373348541884,0.0
211,0.3,1,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: MPH programs in low- and middle-income countries have a significant impact on health system strengthening. These programs equip students with essential public health knowledge, skills, and tools to address healthcare challenges. Graduates can contribute to policy development, program implementation, and research, ultimately improving health outcomes and strengthening health systems in these countries.",MPH programs in low- and middle-income countries play a crucial role in enhancing health systems by providing students with vital public health expertise and skills to tackle healthcare issues.,9.237529366917296e-07,0.7897242667608424,0.05946082136558325,0.07072363212649309,0.8518089559881594,0.0302734375,0.07062126009716185,0.894963126318463,0.015380859375,9.237529366917308e-07,0.9400072584914714,0.0
211,0.3,2,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: MPH programs in low- and middle-income countries have a significant impact on health system strengthening. These programs equip students with essential public health knowledge, skills, and tools to address healthcare challenges. Graduates can contribute to policy development, program implementation, and research, ultimately improving health outcomes and strengthening health systems in these countries.","In low- and middle-income countries, MPH programs significantly bolster health systems by training students in essential public health knowledge and practical tools.",1.0895547458415266e-06,1.077406339212625,0.05946082136558325,0.08341761737996625,1.1519135484384986,0.0302734375,0.08329687088383197,1.2086206851735053,0.015380859375,1.0895547458415285e-06,1.2685113254635065,0.0
211,0.3,3,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: MPH programs in low- and middle-income countries have a significant impact on health system strengthening. These programs equip students with essential public health knowledge, skills, and tools to address healthcare challenges. Graduates can contribute to policy development, program implementation, and research, ultimately improving health outcomes and strengthening health systems in these countries.","The impact of MPH programs in low- and middle-income countries is profound, as they prepare graduates to improve health systems through policy, program, and research contributions.",9.948108548987854e-07,0.9030529520678465,0.05946082136558325,0.07616391152083873,0.9695919916445437,0.0302734375,0.07605366472002048,1.0175654484107959,0.015380859375,9.94810854898787e-07,1.0678406300013559,0.0
211,0.3,4,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: MPH programs in low- and middle-income countries have a significant impact on health system strengthening. These programs equip students with essential public health knowledge, skills, and tools to address healthcare challenges. Graduates can contribute to policy development, program implementation, and research, ultimately improving health outcomes and strengthening health systems in these countries.","By equipping students with critical public health competencies, MPH programs help strengthen health systems in low- and middle-income countries.",1.1606126640485828e-06,1.2315570190398817,0.05946082136558325,0.08885789677431188,1.3144324779362728,0.0302734375,0.08872927550669059,1.3804709421001644,0.015380859375,1.1606126640485847e-06,1.450832882257461,0.0
211,0.3,5,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: MPH programs in low- and middle-income countries have a significant impact on health system strengthening. These programs equip students with essential public health knowledge, skills, and tools to address healthcare challenges. Graduates can contribute to policy development, program implementation, and research, ultimately improving health outcomes and strengthening health systems in these countries.",Graduates of MPH programs in low- and middle-income countries contribute to health system strengthening by applying their knowledge to policy development and healthcare improvement.,1.0421828003701562e-06,0.986434561006897,0.05946082136558325,0.07979076445040248,1.0566033686341734,0.0302734375,0.07967526780192623,1.1085372266165239,0.015380859375,1.0421828003701579e-06,1.163150809805681,0.0
211,0.3,6,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: MPH programs in low- and middle-income countries have a significant impact on health system strengthening. These programs equip students with essential public health knowledge, skills, and tools to address healthcare challenges. Graduates can contribute to policy development, program implementation, and research, ultimately improving health outcomes and strengthening health systems in these countries.",MPH programs provide essential training that enables students in low- and middle-income countries to address health challenges and reinforce health systems.,1.113240718577212e-06,1.1261965033820562,0.05946082136558325,0.08523104384474813,1.2032068428260487,0.0302734375,0.08510767242478484,1.2626879064437806,0.015380859375,1.1132407185772139e-06,1.3256697393034553,0.0
211,0.3,7,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: MPH programs in low- and middle-income countries have a significant impact on health system strengthening. These programs equip students with essential public health knowledge, skills, and tools to address healthcare challenges. Graduates can contribute to policy development, program implementation, and research, ultimately improving health outcomes and strengthening health systems in these countries.","The contribution of MPH programs to health system strengthening in low- and middle-income countries is significant, as they prepare students to influence health policies and programs.",9.948108548987854e-07,0.9030529520678465,0.05946082136558325,0.07616391152083873,0.9695919916445437,0.0302734375,0.07605366472002048,1.0175654484107959,0.015380859375,9.94810854898787e-07,1.0678406300013559,0.0
211,0.3,8,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: MPH programs in low- and middle-income countries have a significant impact on health system strengthening. These programs equip students with essential public health knowledge, skills, and tools to address healthcare challenges. Graduates can contribute to policy development, program implementation, and research, ultimately improving health outcomes and strengthening health systems in these countries.","In low- and middle-income countries, MPH graduates play a key role in enhancing health outcomes and fortifying health systems through their acquired skills and knowledge.",1.0184968276344708e-06,0.9438749465881013,0.05946082136558325,0.0779773379856206,1.0121516060633393,0.0302734375,0.07786446626097335,1.06201721098163,0.015380859375,1.0184968276344725e-06,1.1143606456362498,0.0
211,0.3,9,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: MPH programs in low- and middle-income countries have a significant impact on health system strengthening. These programs equip students with essential public health knowledge, skills, and tools to address healthcare challenges. Graduates can contribute to policy development, program implementation, and research, ultimately improving health outcomes and strengthening health systems in these countries.",MPH programs in these countries equip students with the tools necessary to improve health systems and tackle public health challenges effectively.,1.113240718577212e-06,1.1261965033820562,0.05946082136558325,0.08523104384474813,1.2032068428260487,0.0302734375,0.08510767242478484,1.2626879064437806,0.015380859375,1.1132407185772139e-06,1.3256697393034553,0.0
211,0.3,10,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: MPH programs in low- and middle-income countries have a significant impact on health system strengthening. These programs equip students with essential public health knowledge, skills, and tools to address healthcare challenges. Graduates can contribute to policy development, program implementation, and research, ultimately improving health outcomes and strengthening health systems in these countries.","Through comprehensive training, MPH programs empower students in low- and middle-income countries to strengthen health systems and improve population health outcomes.",1.113240718577212e-06,1.1261965033820562,0.05946082136558325,0.08523104384474813,1.2032068428260487,0.0302734375,0.08510767242478484,1.2626879064437806,0.015380859375,1.1132407185772139e-06,1.3256697393034553,0.0
212,0.3,1,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Transient tachypnea of the newborn (TTN): could polymorphisms in the beta-adrenergic receptor (ADRB) genes be involved? Answer: Our findings suggest that beta1Gly49 homozygosity and the TACC haplotype of the ADRB2 gene, both representing loss-of-function mutations, might increase susceptibility to TTN.",7.10579182070559e-08,0.04330418244171419,0.02498356344510192,0.005440279394345618,0.08004270767353416,0.0,0.0054324046228586,0.08223809823697303,0.0,7.105791820705622e-08,0.08455738802806367,0.0
212,0.3,2,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Is there a role for beta-adrenergic receptor (ADRB) gene polymorphisms in transient tachypnea of the newborn (TTN)? Answer: We conclude that the beta1Gly49 homozygous genotype and the TACC haplotype of the ADRB2 gene, both loss-of-function variants, may contribute to the risk of TTN.",1.4211583641411212e-07,0.1180427993023625,0.023242630385487524,0.010880558788691236,0.1541506798272576,0.0,0.0108648092457172,0.15822400521489444,0.0,1.4211583641411244e-07,0.16251892949777424,0.0
212,0.3,3,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Transient tachypnea of the newborn (TTN): are polymorphisms in beta-adrenergic receptor (ADRB) genes implicated? Answer: Our conclusion is that beta1Gly49 homozygosity and the TACC haplotype in the ADRB2 gene, both loss-of-function genetic variants, could predispose individuals to TTN.",2.36859727356853e-08,0.026668247082160867,0.0,0.0018134264647818726,0.02739897418811532,0.0,0.0018108015409528666,0.028170876966696845,0.0,2.3685972735685406e-08,0.028987536873251507,0.0
212,0.3,4,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Could polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes play a role in transient tachypnea of the newborn (TTN)? Answer: We found that beta1Gly49 homozygosity and the TACC haplotype of the ADRB2 gene, both loss-of-function variants, may increase the likelihood of TTN.",1.1842986367842671e-07,0.0937446970410507,0.023795359904818555,0.009067132323909363,0.1300531282481976,0.0,0.009054007704764333,0.13353139262452274,0.0,1.1842986367842703e-07,0.13720112151348252,0.0
212,0.3,5,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Transient tachypnea of the newborn (TTN): does the beta-adrenergic receptor (ADRB) gene polymorphism have a role? Answer: It appears that beta1Gly49 homozygosity and the TACC haplotype in the ADRB2 gene, both loss-of-function mutations, may predispose to TTN.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
212,0.3,6,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Is there a connection between polymorphisms in beta-adrenergic receptor (ADRB) genes and transient tachypnea of the newborn (TTN)? Answer: We conclude that beta1Gly49 homozygosity and the TACC haplotype of the ADRB2 gene, both loss-of-function genetic variations, might increase susceptibility to TTN.",9.474389094274131e-08,0.0688420964717924,0.024375,0.0072537058591274906,0.10536051565782589,0.0,0.007243206163811466,0.10821358464023101,0.0,9.474389094274162e-08,0.11122563511022454,0.0
212,0.3,7,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Transient tachypnea of the newborn (TTN): investigating the role of beta-adrenergic receptor (ADRB) gene polymorphisms? Answer: Our results indicate that beta1Gly49 homozygosity and the TACC haplotype of the ADRB2 gene, both loss-of-function variants, may predispose to TTN.",0.0,0.03746741516540242,0.027006172839506164,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
212,0.3,8,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Does transient tachypnea of the newborn (TTN) involve polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and the TACC haplotype of the ADRB2 gene, both loss-of-function genetic variants, may increase the risk of TTN.",7.10579182070559e-08,0.04330418244171419,0.02498356344510192,0.005440279394345618,0.08004270767353416,0.0,0.0054324046228586,0.08223809823697303,0.0,7.105791820705622e-08,0.08455738802806367,0.0
212,0.3,9,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Transient tachypnea of the newborn (TTN): assessing the impact of polymorphisms in beta-adrenergic receptor (ADRB) genes? Answer: Findings suggest that beta1Gly49 homozygosity and the TACC haplotype of the ADRB2 gene, both loss-of-function mutations, may predispose individuals to TTN.",2.36859727356853e-08,0.009813183473625475,0.026296566837107373,0.0018134264647818726,0.02739897418811532,0.0,0.0018108015409528666,0.028170876966696845,0.0,2.3685972735685406e-08,0.028987536873251507,0.0
212,0.3,10,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Are polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes linked to transient tachypnea of the newborn (TTN)? Answer: We conclude that beta1Gly49 homozygosity and the TACC haplotype of the ADRB2 gene, both loss-of-function variants, may increase susceptibility to TTN.",4.73719454713706e-08,0.017097724225934918,0.025623268698060954,0.0036268529295637453,0.05406722127027619,0.0,0.003621603081905733,0.055569851154812167,0.0,4.737194547137081e-08,0.05715841383994835,0.0
213,0.3,1,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Does the ""Treatment of Early Age Mania (TEAM)"" sample generalize to the diagnostic characteristics of child bipolar I disorder? Generalization of the RCT sample was supported since only 7.8% of Phenomenology subjects failed to meet RCT criteria. However, because RCT subjects were more severely ill, it remains uncertain if RCT treatment findings apply to children with milder mania.",1.6580180914979784e-07,0.02918841795512961,0.1451222789572694,0.012693985253473108,0.11778303565638559,0.0,0.012675610786670066,0.1198011998126205,0.0,1.6580180914979784e-07,0.12188981760903506,0.0
213,0.3,2,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Are the diagnostic characteristics of child bipolar I disorder in the ""Treatment of Early Age Mania (TEAM)"" sample generalizable? The RCT sample generalizes well as only 7.8% of Phenomenology subjects did not meet RCT criteria. Still, due to greater severity in RCT subjects, it is unclear if RCT treatment results apply to children with less severe mania.",1.8948778188548325e-07,0.04688799505453023,0.1451222789572694,0.014507411718254981,0.13580154115906407,0.0,0.014486412327622933,0.13815033848081626,0.0,1.8948778188548325e-07,0.1405819506211894,0.0
213,0.3,3,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Does the ""Treatment of Early Age Mania (TEAM)"" sample generalize regarding child bipolar I disorder diagnostics? Generalization is supported since only 7.8% of Phenomenology subjects did not fit RCT criteria. Yet, because RCT subjects were more severely ill, applicability of RCT treatment findings to children with milder mania is uncertain.",3.552895910352811e-07,0.18041938767905297,0.1451222789572694,0.02720139697172809,0.2719337154836441,0.0,0.027162023114293,0.2769867833350337,0.0,3.552895910352811e-07,0.28223246768421584,0.0
213,0.3,4,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Is the ""Treatment of Early Age Mania (TEAM)"" sample representative of child bipolar I disorder diagnostic characteristics? Generalization is supported as only 7.8% of Phenomenology subjects failed to meet RCT criteria. However, since RCT subjects were more severely ill, it is unclear if treatment findings from the RCT apply to children with less severe mania.",2.3685972735685406e-07,0.08325563922540447,0.1451222789572694,0.018134264647818726,0.17284281283941416,0.0,0.018108015409528666,0.1758906664636637,0.0,2.3685972735685406e-07,0.17904823144898518,0.0
213,0.3,5,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Do the diagnostic characteristics of child bipolar I disorder generalize from the ""Treatment of Early Age Mania (TEAM)"" sample? The RCT sample generalizes well because only 7.8% of Phenomenology subjects did not meet RCT criteria. Nonetheless, due to higher illness severity in RCT subjects, it is uncertain if RCT treatment findings apply to children with less severe mania.",1.6580180914979784e-07,0.02918841795512961,0.1451222789572694,0.012693985253473108,0.11778303565638559,0.0,0.012675610786670066,0.1198011998126205,0.0,1.6580180914979784e-07,0.12188981760903506,0.0
213,0.3,6,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Can the ""Treatment of Early Age Mania (TEAM)"" sample be generalized for child bipolar I disorder diagnosis? Generalization is supported since only 7.8% of Phenomenology subjects did not meet RCT criteria. Still, because RCT subjects were more severely ill, it is unclear if RCT treatment findings are applicable to children with milder mania.",2.8423167282822487e-07,0.1209959672082519,0.1451222789572694,0.02176111757738247,0.21130909366720996,0.0,0.0217296184914344,0.21511137961694615,0.0,2.8423167282822487e-07,0.21905356606268356,0.0
213,0.3,7,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Does the ""Treatment of Early Age Mania (TEAM)"" sample generalize to child bipolar I disorder diagnostics? Generalization is supported as only 7.8% of Phenomenology subjects failed to meet RCT criteria. However, since RCT subjects were more severely ill, it is uncertain if RCT treatment findings apply to children with less severe mania.",3.079176455639103e-07,0.1404140530653546,0.1451222789572694,0.023574544042164344,0.23111172096338972,0.0,0.023540420032387266,0.23531408693446476,0.0,3.079176455639103e-07,0.23967285326541932,0.0
213,0.3,8,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Is the ""Treatment of Early Age Mania (TEAM)"" sample generalizable for child bipolar I disorder diagnostic characteristics? Generalization is supported because only 7.8% of Phenomenology subjects did not meet RCT criteria. Yet, due to greater severity in RCT subjects, it is unclear if treatment findings from the RCT apply to children with milder mania.",2.6054570009253947e-07,0.1019477722375588,0.1451222789572694,0.0199476911126006,0.19189100781010726,0.0,0.019918816950481533,0.1953087523207664,0.0,2.6054570009253947e-07,0.19885085874516495,0.0
213,0.3,9,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Are the diagnostic features of child bipolar I disorder generalizable from the ""Treatment of Early Age Mania (TEAM)"" sample? The RCT sample generalizes well since only 7.8% of Phenomenology subjects failed to meet RCT criteria. Nonetheless, because RCT subjects were more severely ill, it is uncertain if RCT treatment findings apply to children with less severe mania.",1.8948778188548325e-07,0.04688799505453023,0.1451222789572694,0.014507411718254981,0.13580154115906407,0.0,0.014486412327622933,0.13815033848081626,0.0,1.8948778188548325e-07,0.1405819506211894,0.0
213,0.3,10,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Does the ""Treatment of Early Age Mania (TEAM)"" sample generalize for the diagnosis of child bipolar I disorder? Generalization is supported as only 7.8% of Phenomenology subjects did not meet RCT criteria. However, since RCT subjects were more severely ill, it remains unclear if treatment findings from the RCT are applicable to children with milder mania.",2.1317375462116866e-07,0.0649065005572087,0.1451222789572694,0.016320838183036854,0.15415067982725983,0.0,0.0162972138685758,0.1568424714929706,0.0,2.1317375462116866e-07,0.1596301455918825,0.0
214,0.3,1,ai,Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: The effectiveness of external palliative radiotherapy for gallbladder carcinoma can vary depending on factors such as the stage of the cancer and the overall health of the patient. It can provide relief from symptoms and,"Is external palliative radiotherapy effective for gallbladder carcinoma? The effectiveness depends on factors like cancer stage and patient health, and it can help alleviate symptoms.",4.7371945471370643e-07,0.4170956634176046,0.13296398891966763,0.036268529295637536,0.49674828477651634,0.09204470742932283,0.03621603081905742,0.5476061391307736,0.0710059171597633,4.737194547137081e-07,0.6014255138043065,0.04865220249835634
214,0.3,2,ai,Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: The effectiveness of external palliative radiotherapy for gallbladder carcinoma can vary depending on factors such as the stage of the cancer and the overall health of the patient. It can provide relief from symptoms and,"Does external palliative radiotherapy work for gallbladder carcinoma? Its success varies with cancer progression and patient condition, offering symptom relief.",5.92149318392133e-07,0.6507105145991097,0.13296398891966763,0.045335661619546934,0.741870742809501,0.09204470742932283,0.04527003852382179,0.8054352484328731,0.0710059171597633,5.921493183921349e-07,0.8733592292879471,0.04865220249835634
214,0.3,3,ai,Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: The effectiveness of external palliative radiotherapy for gallbladder carcinoma can vary depending on factors such as the stage of the cancer and the overall health of the patient. It can provide relief from symptoms and,"How effective is external palliative radiotherapy in treating gallbladder carcinoma? Effectiveness varies based on cancer stage and patient health, providing symptom management.",5.447773729207623e-07,0.5506270560421282,0.13296398891966763,0.041708808689983175,0.6365102271516756,0.09204470742932283,0.04164843544191604,0.694209613322649,0.0710059171597633,5.447773729207641e-07,0.7555761936315633,0.04865220249835634
214,0.3,4,ai,Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: The effectiveness of external palliative radiotherapy for gallbladder carcinoma can vary depending on factors such as the stage of the cancer and the overall health of the patient. It can provide relief from symptoms and,"Can external palliative radiotherapy benefit gallbladder carcinoma patients? Its efficacy depends on cancer severity and patient health, helping to ease symptoms.",5.684633456564476e-07,0.5994172202115595,0.13296398891966763,0.043522235154765054,0.6878035215392257,0.09204470742932283,0.043459236982868917,0.7482768345929243,0.0710059171597633,5.684633456564495e-07,0.812734607471512,0.04865220249835634
214,0.3,5,ai,Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: The effectiveness of external palliative radiotherapy for gallbladder carcinoma can vary depending on factors such as the stage of the cancer and the overall health of the patient. It can provide relief from symptoms and,"Is external palliative radiotherapy a useful treatment for gallbladder carcinoma? Effectiveness is influenced by cancer stage and patient health, with potential symptom relief.",5.21091400185077e-07,0.5041070404072343,0.13296398891966763,0.039895382225201295,0.5877200629822443,0.09204470742932283,0.03983763390096317,0.6429163189350988,0.0710059171597633,5.210914001850788e-07,0.701508972361288,0.04865220249835634
214,0.3,6,ai,Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: The effectiveness of external palliative radiotherapy for gallbladder carcinoma can vary depending on factors such as the stage of the cancer and the overall health of the patient. It can provide relief from symptoms and,What is the effectiveness of external palliative radiotherapy for gallbladder carcinoma? It varies by cancer stage and patient health and can reduce symptoms.,5.21091400185077e-07,0.5041070404072343,0.13296398891966763,0.039895382225201295,0.5877200629822443,0.09204470742932283,0.03983763390096317,0.6429163189350988,0.0710059171597633,5.210914001850788e-07,0.701508972361288,0.04865220249835634
214,0.3,7,ai,Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: The effectiveness of external palliative radiotherapy for gallbladder carcinoma can vary depending on factors such as the stage of the cancer and the overall health of the patient. It can provide relief from symptoms and,"Does external palliative radiotherapy provide benefits for gallbladder carcinoma? Its effectiveness depends on cancer progression and patient condition, aiding symptom control.",5.684633456564476e-07,0.5994172202115595,0.13296398891966763,0.043522235154765054,0.6878035215392257,0.09204470742932283,0.043459236982868917,0.7482768345929243,0.0710059171597633,5.684633456564495e-07,0.812734607471512,0.04865220249835634
214,0.3,8,ai,Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: The effectiveness of external palliative radiotherapy for gallbladder carcinoma can vary depending on factors such as the stage of the cancer and the overall health of the patient. It can provide relief from symptoms and,"Is external palliative radiotherapy effective in managing gallbladder carcinoma? Effectiveness varies with cancer stage and patient health, offering symptom relief.",5.92149318392133e-07,0.6507105145991097,0.13296398891966763,0.045335661619546934,0.741870742809501,0.09204470742932283,0.04527003852382179,0.8054352484328731,0.0710059171597633,5.921493183921349e-07,0.8733592292879471,0.04865220249835634
214,0.3,9,ai,Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: The effectiveness of external palliative radiotherapy for gallbladder carcinoma can vary depending on factors such as the stage of the cancer and the overall health of the patient. It can provide relief from symptoms and,"How well does external palliative radiotherapy work for gallbladder carcinoma? Its success depends on cancer stage and overall health, helping to alleviate symptoms.",5.21091400185077e-07,0.5041070404072343,0.13296398891966763,0.039895382225201295,0.5877200629822443,0.09204470742932283,0.03983763390096317,0.6429163189350988,0.0710059171597633,5.210914001850788e-07,0.701508972361288,0.04865220249835634
214,0.3,10,ai,Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: The effectiveness of external palliative radiotherapy for gallbladder carcinoma can vary depending on factors such as the stage of the cancer and the overall health of the patient. It can provide relief from symptoms and,"Is external palliative radiotherapy beneficial for gallbladder carcinoma? The effectiveness depends on cancer stage and patient health, providing symptom relief.",5.92149318392133e-07,0.6507105145991097,0.13296398891966763,0.045335661619546934,0.741870742809501,0.09204470742932283,0.04527003852382179,0.8054352484328731,0.0710059171597633,5.921493183921349e-07,0.8733592292879471,0.04865220249835634
215,0.3,1,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral","Is antral follicle assessment a superior predictor of IVF outcomes compared to age and FSH? The success of in vitro fertilization is closely linked to maternal age, basal cycle day 3 follicle count, stimulated hormone levels, and antral follicle assessment. Among these, antral follicle assessment predicts IVF outcomes better than age or FSH levels.",2.1317375462116866e-07,0.08402488955041987,0.04745222183943697,0.016320838183036854,0.0953851042663394,0.046027470789521595,0.0162972138685758,0.1394140234791097,0.016661878770468257,2.1317375462116866e-07,0.1655144384775733,0.0
215,0.3,2,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral","Can antral follicle assessment predict IVF results more accurately than age and FSH? IVF success correlates strongly with maternal age, basal cycle day 3 follicle count, stimulated hormone levels, and antral follicle assessment, with antral follicle assessment outperforming age and FSH as a predictor.",4.500334819780227e-07,0.31974426787516563,0.019910552674085397,0.03445510283085558,0.3153067062178776,0.04145548650946275,0.034405229278104466,0.357667589499127,0.016661878770468257,4.500334819780227e-07,0.38865798979178257,0.0
215,0.3,3,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral","Does antral follicle assessment provide a better prediction of IVF outcomes than age and FSH? The outcome of in vitro fertilization is closely associated with maternal age, basal cycle day 3 follicle count, stimulated hormone, and antral follicle assessment, with antral follicle assessment being the superior predictor.",3.789755637709665e-07,0.2129622720680624,0.05182573756177096,0.029014823436509962,0.24411336749105406,0.04304010261262842,0.028972824655245866,0.28705002228517307,0.016661878770468257,3.789755637709665e-07,0.31633732821215643,0.0
215,0.3,4,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral","Is antral follicle assessment a more reliable indicator of IVF success than age and FSH? IVF outcomes are strongly linked to maternal age, basal cycle day 3 follicle count, stimulated hormone, and antral follicle assessment, with antral follicle assessment proving to be the best predictor.",4.263475092423373e-07,0.2620406465234062,0.046640047851848526,0.03264167636607371,0.2910086039565658,0.04200821602879378,0.0325944277371516,0.333570037920067,0.016661878770468257,4.263475092423373e-07,0.36396537720141087,0.0
215,0.3,5,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral","How effective is antral follicle assessment compared to age and FSH in forecasting IVF results? In vitro fertilization outcomes are significantly correlated with maternal age, basal cycle day 3 follicle count, stimulated hormone, and antral follicle assessment, with antral follicle assessment being the most accurate predictor.",4.026615365066519e-07,0.23720307793037554,0.04929173315416695,0.030828249901291835,0.26728637201034466,0.04253586534343219,0.030783626196198732,0.3100395405098726,0.016661878770468257,4.026615365066519e-07,0.33986782562235085,0.0
215,0.3,6,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral","Does antral follicle assessment outperform age and FSH in predicting IVF outcomes? IVF success is strongly associated with maternal age, basal cycle day 3 follicle count, stimulated hormone levels, and antral follicle assessment, with antral follicle assessment providing better predictive value.",5.210914001850789e-07,0.3679920336621034,0.03467631795960119,0.0398953822252012,0.3919536790329934,0.03962757771622035,0.039837633900963065,0.43365349647704843,0.016661878770468257,5.210914001850789e-07,0.46661953126149314,0.0
215,0.3,7,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral","Is antral follicle assessment a better predictor of IVF success than age and FSH? The outcome of in vitro fertilization correlates strongly with maternal age, basal cycle day 3 follicle count, stimulated hormone, and antral follicle assessment, with antral follicle assessment being the superior predictor.",4.263475092423373e-07,0.2620406465234062,0.046640047851848526,0.03264167636607371,0.2910086039565658,0.04200821602879378,0.0325944277371516,0.333570037920067,0.016661878770468257,4.263475092423373e-07,0.36396537720141087,0.0
215,0.3,8,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral","Can antral follicle assessment more accurately predict IVF outcomes than age and FSH? IVF results are closely linked to maternal age, basal cycle day 3 follicle count, stimulated hormone levels, and antral follicle assessment, with antral follicle assessment showing better predictive ability.",4.974054274493935e-07,0.3404444630064125,0.03789105099764786,0.038081955760419325,0.3657472208172141,0.040267282969179384,0.0380268323600102,0.40767801007379045,0.016661878770468257,4.974054274493935e-07,0.43995128417933227,0.0
215,0.3,9,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral","Is antral follicle assessment a more precise predictor of IVF outcomes than age and FSH? The success of in vitro fertilization is strongly correlated with maternal age, basal cycle day 3 follicle count, stimulated hormone, and antral follicle assessment, with antral follicle assessment being the best predictor.",3.789755637709665e-07,0.2129622720680624,0.05182573756177096,0.029014823436509962,0.24411336749105406,0.04304010261262842,0.028972824655245866,0.28705002228517307,0.016661878770468257,3.789755637709665e-07,0.31633732821215643,0.0
215,0.3,10,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral","Does antral follicle assessment serve as a better predictor of IVF outcomes compared to age and FSH? IVF success is strongly related to maternal age, basal cycle day 3 follicle count, stimulated hormone, and antral follicle assessment, with antral follicle assessment outperforming age and FSH as a predictor.",3.552895910352811e-07,0.2482816681403026,0.010742980319699807,0.02720139697172809,0.221464753351448,0.04352245135255291,0.027162023114293,0.26457716643311535,0.016661878770468257,3.552895910352811e-07,0.2933478099874569,0.0
216,0.3,1,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive","Are the home blood pressure readings reported by stroke patients dependable? This cohort of elderly stroke patients successfully recorded their blood pressures accurately at home. Any bias present was minimal and unlikely to influence treatment decisions. Given that blood pressure measurements taken in a GP's office often do not reflect true blood pressure, GPs might consider adopting hypertensive monitoring at home.",7.105791820705622e-08,0.018021423668444392,0.049861495844875335,0.005440279394345618,0.05218575317056917,0.0,0.0054324046228586,0.05310982531394792,0.0,7.105791820705622e-08,0.05406722127027486,0.0
216,0.3,2,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive","Can stroke patients reliably report their home blood pressure measurements? This group of elderly stroke patients demonstrated the ability to accurately record their blood pressure at home. Any bias detected was minor and unlikely to impact clinical management. Since blood pressure readings in a general practitioner's office often fail to represent true blood pressure, GPs might consider home monitoring for hypertension.",7.105791820705622e-08,0.02674222606452048,0.084949215143121,0.005440279394345618,0.05218575317056917,0.0,0.0054324046228586,0.05310982531394792,0.0,7.105791820705622e-08,0.05406722127027486,0.0
216,0.3,3,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive","Are home blood pressure readings reported by stroke patients trustworthy? Elderly stroke patients in this study were able to reliably measure their blood pressure at home. The bias was minimal and unlikely to affect treatment plans. Because blood pressure readings taken at a GP's office often do not accurately reflect true blood pressure, GPs may want to consider home-based hypertensive monitoring.",7.105791820705622e-08,0.049847132083183254,0.10204081632653063,0.005440279394345618,0.0286892385753168,0.01694411414982164,0.0054324046228586,0.05310982531394792,0.0,7.105791820705622e-08,0.05406722127027486,0.0
216,0.3,4,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive","Do stroke patients provide reliable reports of their home blood pressure readings? This elderly stroke patient group was capable of accurately recording their blood pressures at home. Any bias was small and unlikely to influence management decisions. Since blood pressure readings in GP surgeries often poorly indicate true blood pressure, GPs might consider using home monitoring for hypertension.",0.0,0.024320953703857562,0.017538265306122455,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
216,0.3,5,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive","Is the self-reported home blood pressure data from stroke patients accurate? The elderly stroke patients in this group reliably recorded their blood pressure at home. Any bias was minimal and unlikely to affect clinical management. As blood pressure measurements in GP surgeries often do not reflect true blood pressure, GPs might consider home monitoring for hypertensive patients.",2.3685972735685406e-08,0.10130906329804823,0.09113563545745816,0.0018134264647818726,0.018018505502678472,0.0,0.0018108015409528666,0.018349138668195764,0.0,2.3685972735685406e-08,0.018692133012154333,0.0
216,0.3,6,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive","Can elderly stroke patients reliably record their home blood pressure readings? This group demonstrated dependable home blood pressure measurements. The bias was minor and unlikely to impact management. Given that GP surgery blood pressure readings often poorly represent true blood pressure, GPs might consider home blood pressure monitoring for hypertension.",1.8948778188548325e-07,0.3316598332031866,0.2825413223140496,0.014507411718254981,0.2228139478690152,0.08506616257088842,0.014486412327622933,0.15718558352241319,0.0,1.8948778188548325e-07,0.16034265007518078,0.0
216,0.3,7,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive","Are reports of home blood pressure readings from stroke patients reliable? Elderly stroke patients in this study were able to accurately record their blood pressure at home. Any bias was small and unlikely to affect treatment decisions. Since blood pressure readings taken at GP surgeries often do not accurately reflect true blood pressure, GPs might consider home monitoring for hypertension.",4.737194547137081e-08,0.06836849491601882,0.10380165289256203,0.0036268529295637453,0.011189692895409387,0.017236072637734686,0.003621603081905733,0.03571808260207909,0.0,4.737194547137081e-08,0.036367644170874236,0.0
216,0.3,8,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive","How reliable are stroke patients' reports of their home blood pressure readings? The elderly stroke patients in this group reliably recorded their blood pressure at home. Any bias was minimal and unlikely to influence management. Because blood pressure readings in GP surgeries often poorly indicate true blood pressure, GPs might consider home hypertensive monitoring.",9.474389094274162e-08,0.13494495552779417,0.07689350249903884,0.0072537058591274906,0.07410797215372167,0.0,0.007243206163811466,0.07550755250814589,0.0,9.474389094274162e-08,0.07696104113612989,0.0
216,0.3,9,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive","Are home blood pressure readings reported by elderly stroke patients accurate? This group was able to reliably measure their blood pressure at home. Any bias was small and unlikely to affect clinical management. Since blood pressure readings in GP surgeries often do not reflect true blood pressure, GPs might consider home monitoring for hypertension.",9.474389094274162e-08,0.16110145290741418,0.09639999999999999,0.0072537058591274906,0.10076747909833506,0.01922337562475971,0.007243206163811466,0.07550755250814589,0.0,9.474389094274162e-08,0.07696104113612989,0.0
216,0.3,10,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive","Is the home blood pressure monitoring by stroke patients dependable? The elderly stroke patients in this group successfully recorded their blood pressure at home with reliability. Any bias was minor and unlikely to impact treatment. Given that blood pressure readings in GP surgeries often poorly represent true blood pressure, GPs might consider home-based hypertensive monitoring.",7.105791820705622e-08,0.14077335510590938,0.09457900807381774,0.005440279394345618,0.05505977718302857,0.0,0.0054324046228586,0.056089466651043196,0.0,7.105791820705622e-08,0.05715841383995013,0.0
217,0.3,1,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The decision to untether a patient with myelomeningocele prior to scoliosis correction depends on several factors including the severity of the tethered cord, the associated neurological symptoms, and the goals of treatment. It is important to consult with","Is untethering required before scoliosis correction in a patient with myelomeningocele? The choice to untether depends on factors such as the severity of the tethered cord, neurological symptoms, and treatment objectives. Consultation with specialists is crucial.",3.5528959103528056e-07,0.24577139504914092,0.07939508506616258,0.027201396971728097,0.3088763301834492,0.040742417383431435,0.027162023114293013,0.3746934494414109,0.0,3.552895910352811e-07,0.38441169891033145,0.0
217,0.3,2,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The decision to untether a patient with myelomeningocele prior to scoliosis correction depends on several factors including the severity of the tethered cord, the associated neurological symptoms, and the goals of treatment. It is important to consult with","For a patient with myelomeningocele, should untethering be done before scoliosis correction? The necessity depends on the tethered cord's severity, neurological signs, and treatment goals, making specialist consultation important.",5.210914001850777e-07,0.4689149463633502,0.07939508506616258,0.039895382225201254,0.5393999887952816,0.040742417383431435,0.03983763390096313,0.6131044728864086,0.0,5.210914001850789e-07,0.6312717768418579,0.0
217,0.3,3,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The decision to untether a patient with myelomeningocele prior to scoliosis correction depends on several factors including the severity of the tethered cord, the associated neurological symptoms, and the goals of treatment. It is important to consult with","In patients with myelomeningocele, is untethering necessary prior to correcting scoliosis? This decision relies on the tethered cord severity, neurological symptoms, and treatment aims, so consulting experts is essential.",5.210914001850777e-07,0.4689149463633502,0.07939508506616258,0.039895382225201254,0.5393999887952816,0.040742417383431435,0.03983763390096313,0.6131044728864086,0.0,5.210914001850789e-07,0.6312717768418579,0.0
217,0.3,4,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The decision to untether a patient with myelomeningocele prior to scoliosis correction depends on several factors including the severity of the tethered cord, the associated neurological symptoms, and the goals of treatment. It is important to consult with","Does a patient with myelomeningocele need untethering before scoliosis correction? The decision is influenced by the severity of tethering, neurological symptoms, and treatment goals, requiring professional consultation.",5.684633456564483e-07,0.5430229185170719,0.07939508506616258,0.04352223515476501,0.6163610299314111,0.040742417383431435,0.043459236982868875,0.6931471805599458,0.0,5.684633456564497e-07,0.7146533857809083,0.0
217,0.3,5,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The decision to untether a patient with myelomeningocele prior to scoliosis correction depends on several factors including the severity of the tethered cord, the associated neurological symptoms, and the goals of treatment. It is important to consult with","Should untethering be performed before scoliosis correction in myelomeningocele patients? It depends on the severity of the tethered cord, neurological manifestations, and treatment goals, highlighting the need for expert advice.",4.974054274493924e-07,0.4338236265520812,0.07939508506616258,0.038081955760419374,0.5030323446244069,0.040742417383431435,0.038026832360010254,0.5753641449035616,0.0,4.974054274493935e-07,0.5920510636885754,0.0
217,0.3,6,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The decision to untether a patient with myelomeningocele prior to scoliosis correction depends on several factors including the severity of the tethered cord, the associated neurological symptoms, and the goals of treatment. It is important to consult with","Is it necessary to untether a patient with myelomeningocele before scoliosis surgery? The choice depends on tethered cord severity, neurological symptoms, and treatment objectives, so consultation with specialists is important.",4.974054274493924e-07,0.4338236265520812,0.07939508506616258,0.038081955760419374,0.5030323446244069,0.040742417383431435,0.038026832360010254,0.5753641449035616,0.0,4.974054274493935e-07,0.5920510636885754,0.0
217,0.3,7,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The decision to untether a patient with myelomeningocele prior to scoliosis correction depends on several factors including the severity of the tethered cord, the associated neurological symptoms, and the goals of treatment. It is important to consult with","When managing scoliosis in myelomeningocele patients, is untethering needed beforehand? This depends on the severity of the tethered cord, neurological symptoms, and treatment goals, necessitating expert consultation.",5.684633456564483e-07,0.5430229185170719,0.07939508506616258,0.04352223515476501,0.6163610299314111,0.040742417383431435,0.043459236982868875,0.6931471805599458,0.0,5.684633456564497e-07,0.7146533857809083,0.0
217,0.3,8,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The decision to untether a patient with myelomeningocele prior to scoliosis correction depends on several factors including the severity of the tethered cord, the associated neurological symptoms, and the goals of treatment. It is important to consult with","For scoliosis correction in a patient with myelomeningocele, is untethering required first? The decision hinges on the severity of the tethered cord, neurological symptoms, and treatment goals, making consultation vital.",4.974054274493924e-07,0.4338236265520812,0.07939508506616258,0.038081955760419374,0.5030323446244069,0.040742417383431435,0.038026832360010254,0.5753641449035616,0.0,4.974054274493935e-07,0.5920510636885754,0.0
217,0.3,9,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The decision to untether a patient with myelomeningocele prior to scoliosis correction depends on several factors including the severity of the tethered cord, the associated neurological symptoms, and the goals of treatment. It is important to consult with","In cases of myelomeningocele, should untethering precede scoliosis correction? The decision depends on tethered cord severity, neurological symptoms, and treatment goals, so consulting with specialists is important.",5.684633456564483e-07,0.5430229185170719,0.07939508506616258,0.04352223515476501,0.6163610299314111,0.040742417383431435,0.043459236982868875,0.6931471805599458,0.0,5.684633456564497e-07,0.7146533857809083,0.0
217,0.3,10,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The decision to untether a patient with myelomeningocele prior to scoliosis correction depends on several factors including the severity of the tethered cord, the associated neurological symptoms, and the goals of treatment. It is important to consult with","Is untethering necessary before scoliosis correction in a myelomeningocele patient? This depends on the severity of the tethered cord, neurological symptoms, and treatment goals, emphasizing the importance of consultation.",5.210914001850777e-07,0.4689149463633502,0.07939508506616258,0.039895382225201254,0.5393999887952816,0.040742417383431435,0.03983763390096313,0.6131044728864086,0.0,5.210914001850789e-07,0.6312717768418579,0.0
218,0.3,1,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: Reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not considered a waste of time. It is an essential procedure that helps to ensure adequate blood supply to the spinal cord, reducing the risk of paraplegia and other complications.","Is reimplanting spinal cord arteries during thoracic and thoracoabdominal aneurysm repair pointless? No, it is a crucial step to maintain spinal cord blood flow and prevent paraplegia and complications.",7.105791820705609e-07,0.5626343710256125,0.11427223110626636,0.054402793943456235,0.6012886796070744,0.10380622837370242,0.05432404622858606,0.6929893833679581,0.0533997864008544,7.105791820705622e-07,0.7632520083439092,0.0181755829903978
218,0.3,2,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: Reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not considered a waste of time. It is an essential procedure that helps to ensure adequate blood supply to the spinal cord, reducing the risk of paraplegia and other complications.","During thoracic and thoracoabdominal aneurysm repair, reimplantation of spinal cord arteries is vital, not a waste, as it preserves spinal cord perfusion and lowers the risk of paralysis.",7.342651548062462e-07,0.6008357378963813,0.11295527751011047,0.056216220408238114,0.6390290075899214,0.10380622837370242,0.056134847769538934,0.7322100965212406,0.0533997864008544,7.342651548062476e-07,0.804074002864164,0.0181755829903978
218,0.3,3,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: Reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not considered a waste of time. It is an essential procedure that helps to ensure adequate blood supply to the spinal cord, reducing the risk of paraplegia and other complications.","Reimplanting spinal cord arteries in thoracic and thoracoabdominal aneurysm surgery is an important procedure that safeguards spinal cord blood supply and minimizes paraplegia risk, not a futile effort.",7.342651548062462e-07,0.6008357378963813,0.11295527751011047,0.056216220408238114,0.6390290075899214,0.10380622837370242,0.056134847769538934,0.7322100965212406,0.0533997864008544,7.342651548062476e-07,0.804074002864164,0.0181755829903978
218,0.3,4,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: Reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not considered a waste of time. It is an essential procedure that helps to ensure adequate blood supply to the spinal cord, reducing the risk of paraplegia and other complications.","The reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is essential to protect spinal cord circulation and avoid complications, thus not a waste of time.",7.342651548062462e-07,0.6008357378963813,0.11295527751011047,0.056216220408238114,0.6390290075899214,0.10380622837370242,0.056134847769538934,0.7322100965212406,0.0533997864008544,7.342651548062476e-07,0.804074002864164,0.0181755829903978
218,0.3,5,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: Reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not considered a waste of time. It is an essential procedure that helps to ensure adequate blood supply to the spinal cord, reducing the risk of paraplegia and other complications.","In thoracic and thoracoabdominal aneurysm repair, reimplanting spinal cord arteries is necessary to maintain adequate blood flow and reduce the chance of paraplegia, making it a valuable procedure.",7.342651548062462e-07,0.5494915022993481,0.14993752603082053,0.056216220408238114,0.6390290075899214,0.10380622837370242,0.056134847769538934,0.7322100965212406,0.0533997864008544,7.342651548062476e-07,0.804074002864164,0.0181755829903978
218,0.3,6,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: Reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not considered a waste of time. It is an essential procedure that helps to ensure adequate blood supply to the spinal cord, reducing the risk of paraplegia and other complications.","Reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is a key technique that prevents spinal cord ischemia and related complications, not a time-wasting step.",7.579511275419315e-07,0.6405508441714218,0.11153752603082051,0.058029646873019994,0.6782497207432039,0.10380622837370242,0.05794564931049181,0.7730320910414954,0.0533997864008544,7.57951127541933e-07,0.8466336172829596,0.0181755829903978
218,0.3,7,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: Reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not considered a waste of time. It is an essential procedure that helps to ensure adequate blood supply to the spinal cord, reducing the risk of paraplegia and other complications.",It is not a waste of time to reimplant spinal cord arteries during thoracic and thoracoabdominal aneurysm repair; this procedure is critical to ensure sufficient spinal cord blood supply and prevent paralysis.,6.39521263863505e-07,0.45606033675788193,0.11771530380859832,0.048962514549110596,0.495928163949249,0.10380622837370242,0.04889164160572744,0.5837900914029674,0.0533997864008544,6.39521263863506e-07,0.649923323036905,0.0181755829903978
218,0.3,8,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: Reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not considered a waste of time. It is an essential procedure that helps to ensure adequate blood supply to the spinal cord, reducing the risk of paraplegia and other complications.",Reimplanting spinal cord arteries in the context of thoracic and thoracoabdominal aneurysm repair is an indispensable measure to reduce the risk of spinal cord injury and paraplegia.,7.579511275419315e-07,0.6405508441714218,0.11153752603082051,0.058029646873019994,0.6782497207432039,0.10380622837370242,0.05794564931049181,0.7730320910414954,0.0533997864008544,7.57951127541933e-07,0.8466336172829596,0.0181755829903978
218,0.3,9,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: Reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not considered a waste of time. It is an essential procedure that helps to ensure adequate blood supply to the spinal cord, reducing the risk of paraplegia and other complications.","The procedure of reimplanting spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is important for maintaining spinal cord perfusion and preventing neurological complications, thus not futile.",7.579511275419315e-07,0.6405508441714218,0.11153752603082051,0.058029646873019994,0.6782497207432039,0.10380622837370242,0.05794564931049181,0.7730320910414954,0.0533997864008544,7.57951127541933e-07,0.8466336172829596,0.0181755829903978
218,0.3,10,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: Reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not considered a waste of time. It is an essential procedure that helps to ensure adequate blood supply to the spinal cord, reducing the risk of paraplegia and other complications.",Reimplantation of spinal cord arteries is a necessary and effective part of thoracic and thoracoabdominal aneurysm repair to safeguard spinal cord blood flow and minimize the risk of paraplegia.,7.105791820705609e-07,0.5626343710256125,0.11427223110626636,0.054402793943456235,0.6012886796070744,0.10380622837370242,0.05432404622858606,0.6929893833679581,0.0533997864008544,7.105791820705622e-07,0.7632520083439092,0.0181755829903978
219,0.3,1,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Does a preoperative medically supervised weight loss program enhance bariatric surgery results? MSWM seems to offer no extra advantage over the usual preoperative bariatric surgery protocol regarding weight loss and most behavioral outcomes following LAGB in our patients.,1.8948778188548293e-07,0.20906632474046027,0.009529254643988495,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
219,0.3,2,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Is there an improvement in bariatric surgery outcomes with a preoperative medically supervised weight loss program? Our patient data indicates MSWM does not provide added benefits compared to the standard preoperative protocol in weight loss and behavioral outcomes after LAGB.,1.4211583641411233e-07,0.11703377018371963,0.01872502767835873,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
219,0.3,3,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,"Does undergoing a medically supervised weight loss program before surgery improve outcomes of bariatric surgery? According to our findings, MSWM does not yield additional benefits beyond the standard preoperative protocol for weight loss and behavioral results post-LAGB.",2.1317375462116823e-07,0.20003864529554471,0.016593194335603353,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
219,0.3,4,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,"Can a preoperative medically supervised weight loss program improve the results of bariatric surgery? In our patient group, MSWM does not seem to offer any further benefit over the standard preoperative bariatric surgery protocol in terms of weight loss and behavioral outcomes after LAGB.",4.737194547137081e-08,0.01608869510729205,0.02110566599093216,0.0036268529295637453,0.04652001563489394,0.0,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
219,0.3,5,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Does a medically supervised weight loss program before bariatric surgery lead to better outcomes? Our study shows that MSWM does not provide more benefit than the standard preoperative protocol for weight loss and most behavioral outcomes after LAGB.,1.8948778188548293e-07,0.17159890957505697,0.017342123536913518,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
219,0.3,6,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Is a preoperative medically supervised weight loss program effective in improving bariatric surgery outcomes? MSWM appears to have no additional advantage compared to the standard preoperative bariatric surgery protocol regarding weight loss and behavioral outcomes post-LAGB in our patients.,1.6580180914979763e-07,0.1804261084390668,0.008120839426049457,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
219,0.3,7,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,"Does preoperative medically supervised weight loss improve bariatric surgery results? In our patient population, MSWM does not seem to confer extra benefits beyond the standard preoperative protocol for weight loss and behavioral outcomes after LAGB.",2.6054570009253883e-07,0.25946224600006795,0.014963539718935746,0.019947691112600613,0.2876820724517817,0.0,0.019918816950481553,0.29546421289383584,0.0,2.6054570009253947e-07,0.30368241379822125,0.0
219,0.3,8,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Does participating in a medically supervised weight loss program before bariatric surgery enhance surgical outcomes? Our findings suggest MSWM offers no additional benefits compared to the standard preoperative bariatric surgery protocol in weight loss and behavioral outcomes after LAGB.,1.6580180914979763e-07,0.1804261084390668,0.008120839426049457,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
219,0.3,9,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Does a preoperative medically supervised weight loss program provide better outcomes for bariatric surgery patients? MSWM does not appear to improve weight loss or behavioral outcomes beyond the standard preoperative protocol after LAGB in our patient cohort.,2.1317375462116823e-07,0.20003864529554471,0.016593194335603353,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
219,0.3,10,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,"Does a medically supervised weight loss program prior to bariatric surgery improve outcomes? According to our data, MSWM does not confer any additional benefit over the standard preoperative bariatric surgery protocol in terms of weight loss and behavioral outcomes after LAGB.",1.1842986367842703e-07,0.12548467099593807,0.005513199468455653,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
220,0.3,1,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: Does receiving birth center care during a woman's first pregnancy influence her future reproductive outcomes? Answer: In Sweden, the type of care a woman receives, including birth center care, during her first pregnancy does not appear to significantly impact her later reproductive behavior.",7.105791820705622e-08,0.04150958647731384,0.018498994102315543,0.005440279394345618,0.06899287148695166,0.0,0.0054324046228586,0.07061756721395396,0.0,7.105791820705622e-08,0.07232066157962613,0.0
220,0.3,2,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: Is there an effect of birth center care during a woman's initial pregnancy on her future reproduction? Answer: Evidence from Sweden suggests that the model of care, like birth center care, during a woman's first pregnancy is not a major factor influencing subsequent reproduction.",4.737194547137081e-08,0.04856133083502279,0.002916829812021182,0.0036268529295637453,0.07770177782373144,0.023242630385487524,0.003621603081905733,0.04652001563489394,0.0,4.737194547137081e-08,0.047628048989254435,0.0
220,0.3,3,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: Does care at a birth center during a woman's first pregnancy affect her future reproductive patterns? Answer: In Sweden, the care model during the first pregnancy, including birth center care, does not seem to play a significant role in future reproduction.",1.1842986367842703e-07,0.058470885560909736,0.04052494591671175,0.009067132323909363,0.11778303565638337,0.0,0.009054007704764333,0.12062798778861739,0.0,1.1842986367842703e-07,0.12361395596717584,0.0
220,0.3,4,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: Can birth center care during a woman's first pregnancy impact her later reproductive choices? Answer: The model of care, such as birth center care, during the first pregnancy in Sweden does not appear to be an important determinant of future reproduction.",1.1842986367842703e-07,0.0922829431491996,0.016247743418355408,0.009067132323909363,0.11778303565638337,0.0,0.009054007704764333,0.12062798778861739,0.0,1.1842986367842703e-07,0.12361395596717584,0.0
220,0.3,5,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: Does the type of care, specifically birth center care, during a woman's first pregnancy influence her subsequent reproduction? Answer: In Sweden, birth center care during the initial pregnancy does not seem to be a critical factor affecting later reproductive outcomes.",1.4211583641411244e-07,0.08400879959098795,0.03991638247160983,0.010880558788691236,0.1431008436406751,0.0,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
220,0.3,6,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: Is there a relationship between birth center care in a woman's first pregnancy and her future reproduction? Answer: The model of care during the first pregnancy, including birth center care, does not seem to significantly affect later reproduction in Sweden.",1.4211583641411244e-07,0.08400879959098795,0.03991638247160983,0.010880558788691236,0.1431008436406751,0.0,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
220,0.3,7,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: Does birth center care during a woman's first pregnancy have any bearing on her future reproductive behavior? Answer: In Sweden, the care model during the first pregnancy, such as birth center care, is not considered a significant factor influencing subsequent reproduction.",1.1842986367842703e-07,0.058470885560909736,0.04052494591671175,0.009067132323909363,0.11778303565638337,0.0,0.009054007704764333,0.12062798778861739,0.0,1.1842986367842703e-07,0.12361395596717584,0.0
220,0.3,8,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.",Question: Does receiving birth center care in the first pregnancy influence a woman's future reproduction? Answer: The evidence from Sweden indicates that birth center care during the first pregnancy is not a sufficiently important factor to affect later reproductive outcomes.,1.6580180914979774e-07,0.21685328558521944,0.03632454387920665,0.012693985253473108,0.2420391911555062,0.05246913580246914,0.012675610786670066,0.17327172127403623,0.0,1.6580180914979784e-07,0.17768117723745203,0.0
220,0.3,9,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: Does the model of care, like birth center care, during a woman's first pregnancy affect her future reproduction? Answer: In Sweden, birth center care during the first pregnancy does not appear to be a key factor impacting subsequent reproduction.",1.6580180914979774e-07,0.1457612670662516,0.013767732622336298,0.012693985253473108,0.16907633004393308,0.0,0.012675610786670066,0.17327172127403623,0.0,1.6580180914979784e-07,0.17768117723745203,0.0
220,0.3,10,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: Is birth center care during a woman's first pregnancy a factor in her future reproductive decisions? Answer: The type of care provided during the first pregnancy, including birth center care, does not seem to significantly influence later reproduction in Sweden.",1.4211583641411244e-07,0.08400879959098795,0.03991638247160983,0.010880558788691236,0.1431008436406751,0.0,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
221,0.3,1,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia has been associated with increased complications and mortality rates in colon and rectal surgery, including higher rates of infection, longer hospital stays, and higher readmission rates. Proper management and treatment","Does anemia before surgery negatively impact the results of colon and rectal operations? Yes, preoperative anemia is linked to more complications and higher death rates in colon and rectal surgeries, such as increased infections, extended hospitalizations, and more frequent readmissions. Effective management and treatment are essential.",2.3685972735685406e-08,0.0553798432119752,0.02346847935231325,0.0018134264647818726,0.02372223194622114,0.0005276493146384141,0.0018108015409528666,0.023530497410194418,0.0,2.3685972735685406e-08,0.024097551579060017,0.0
221,0.3,2,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia has been associated with increased complications and mortality rates in colon and rectal surgery, including higher rates of infection, longer hospital stays, and higher readmission rates. Proper management and treatment","Is there a detrimental effect of preoperative anemia on the outcomes of colon and rectal surgery? Indeed, anemia prior to surgery correlates with elevated complication and mortality rates in these procedures, including greater infection risks, prolonged hospital stays, and increased readmission occurrences. Proper treatment and management are crucial.",7.105791820705622e-08,0.16047803786815296,0.06781677572873293,0.005440279394345618,0.09968068454250645,0.023242630385487524,0.0054324046228586,0.06899287148695166,0.0,7.105791820705622e-08,0.07061756721395396,0.0
221,0.3,3,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia has been associated with increased complications and mortality rates in colon and rectal surgery, including higher rates of infection, longer hospital stays, and higher readmission rates. Proper management and treatment","Does having anemia before colon and rectal surgery worsen surgical outcomes? Yes, preoperative anemia is associated with a rise in complications and mortality, including higher infection rates, longer hospital stays, and more readmissions. Appropriate management and treatment are important.",1.4211583641411222e-07,0.052083404115518483,0.06781677572873293,0.010880558788691236,0.1180427993023625,0.023242630385487524,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
221,0.3,4,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia has been associated with increased complications and mortality rates in colon and rectal surgery, including higher rates of infection, longer hospital stays, and higher readmission rates. Proper management and treatment","Can preoperative anemia negatively influence the results of colon and rectal surgeries? Yes, anemia before surgery has been shown to increase complications and mortality rates, such as more infections, extended hospitalization, and higher chances of readmission. Proper treatment and management are necessary.",7.105791820705622e-08,0.02390250286240292,0.06781677572873293,0.005440279394345618,0.04008125783265193,0.023242630385487524,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
221,0.3,5,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia has been associated with increased complications and mortality rates in colon and rectal surgery, including higher rates of infection, longer hospital stays, and higher readmission rates. Proper management and treatment","Is preoperative anemia a risk factor for poorer outcomes in colon and rectal surgery? Yes, it is linked to increased complications and mortality, including higher infection rates, longer hospital stays, and elevated readmission rates. Effective management and treatment are needed.",1.1842986367842692e-07,0.02610791771226051,0.06781677572873293,0.009067132323909363,0.09137455222020163,0.023242630385487524,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
221,0.3,6,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia has been associated with increased complications and mortality rates in colon and rectal surgery, including higher rates of infection, longer hospital stays, and higher readmission rates. Proper management and treatment","Does anemia before surgery adversely affect colon and rectal surgery outcomes? Yes, it is associated with increased complications and mortality, including more infections, prolonged hospital stays, and higher readmission rates. Proper management and treatment are vital.",2.1317375462116813e-07,0.13432150235249152,0.06781677572873293,0.01632083818303686,0.20260018733042617,0.023242630385487524,0.016297213868575813,0.24116205681688774,0.0,2.1317375462116866e-07,0.2478361639045814,0.0
221,0.3,7,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia has been associated with increased complications and mortality rates in colon and rectal surgery, including higher rates of infection, longer hospital stays, and higher readmission rates. Proper management and treatment","Does preoperative anemia lead to worse outcomes in colon and rectal surgery? Yes, it has been connected to higher complication and mortality rates, including increased infections, longer hospital stays, and more frequent readmissions. Appropriate management and treatment are important.",1.4211583641411222e-07,0.052083404115518483,0.06781677572873293,0.010880558788691236,0.1180427993023625,0.023242630385487524,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
221,0.3,8,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia has been associated with increased complications and mortality rates in colon and rectal surgery, including higher rates of infection, longer hospital stays, and higher readmission rates. Proper management and treatment","Is there an adverse impact of preoperative anemia on colon and rectal surgery results? Yes, anemia before surgery correlates with increased complications and mortality, such as higher infection rates, extended hospital stays, and elevated readmission rates. Proper management and treatment are essential.",7.105791820705622e-08,0.02390250286240292,0.06781677572873293,0.005440279394345618,0.04008125783265193,0.023242630385487524,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
221,0.3,9,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia has been associated with increased complications and mortality rates in colon and rectal surgery, including higher rates of infection, longer hospital stays, and higher readmission rates. Proper management and treatment","Does having anemia prior to colon and rectal surgery increase the risk of poor outcomes? Yes, preoperative anemia is associated with higher complication and mortality rates, including more infections, longer hospital stays, and increased readmissions. Effective management and treatment are necessary.",9.474389094274162e-08,0.0007901097279687797,0.06781677572873293,0.0072537058591274906,0.06539906581694366,0.023242630385487524,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
221,0.3,10,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia has been associated with increased complications and mortality rates in colon and rectal surgery, including higher rates of infection, longer hospital stays, and higher readmission rates. Proper management and treatment","Does preoperative anemia negatively affect the outcomes of colon and rectal surgeries? Yes, it has been linked to increased complications and mortality, including higher infection rates, prolonged hospital stays, and greater readmission rates. Proper treatment and management are crucial.",1.4211583641411222e-07,0.052083404115518483,0.06781677572873293,0.010880558788691236,0.1180427993023625,0.023242630385487524,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
222,0.3,1,ai,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: The relationship between Alveolar Macrophage Phagocytic Dysfunction in children with Protracted Bacterial Bronchitis and Bronchiectasis is still being studied and there is no definitive answer at this time. Further research is needed to determine if there is a causal,"Question: Could Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis Precede Bronchiectasis? Answer: The connection between Alveolar Macrophage Phagocytic Dysfunction in children suffering from Protracted Bacterial Bronchitis and the development of Bronchiectasis remains under investigation, with no conclusive evidence yet. Additional studies are required to establish any causal link.",1.1842986367842703e-07,0.037337870157493125,0.036549619747744816,0.009067132323909363,0.03324541434305628,0.04294415629052176,0.009054007704764333,0.0026388185568788636,0.06679479101029194,1.1842986367842703e-07,0.00013032461304751664,0.07095241429204888
222,0.3,2,ai,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: The relationship between Alveolar Macrophage Phagocytic Dysfunction in children with Protracted Bacterial Bronchitis and Bronchiectasis is still being studied and there is no definitive answer at this time. Further research is needed to determine if there is a causal,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis an Early Indicator of Bronchiectasis? Answer: Research is ongoing regarding the association between Alveolar Macrophage Phagocytic Dysfunction in children with Protracted Bacterial Bronchitis and Bronchiectasis, and no definitive conclusions have been reached. More research is necessary to clarify any causal relationship.",7.105791820705622e-08,0.07063101589355947,0.008566389518770479,0.005440279394345618,0.06923941045101634,0.007765910352604544,0.0054324046228586,0.06925463702341572,0.00727287319258052,7.105791820705622e-08,0.0692167087361697,0.006643349851398694
222,0.3,3,ai,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: The relationship between Alveolar Macrophage Phagocytic Dysfunction in children with Protracted Bacterial Bronchitis and Bronchiectasis is still being studied and there is no definitive answer at this time. Further research is needed to determine if there is a causal,"Question: Does Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis Lead to Bronchiectasis? Answer: The relationship between Alveolar Macrophage Phagocytic Dysfunction in children with Protracted Bacterial Bronchitis and Bronchiectasis is still unclear, with no definitive answers currently available. Further investigation is needed to determine causality.",2.1317375462116866e-07,0.19786977397626027,0.011236461686912114,0.016320838183036854,0.22339694527158205,0.025799467274969207,0.0162972138685758,0.22355362815467972,0.024379626650612163,2.1317375462116866e-07,0.22352298370203139,0.022444045230536794
222,0.3,4,ai,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: The relationship between Alveolar Macrophage Phagocytic Dysfunction in children with Protracted Bacterial Bronchitis and Bronchiectasis is still being studied and there is no definitive answer at this time. Further research is needed to determine if there is a causal,"Question: Is There a Link Between Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis and Bronchiectasis? Answer: The potential link between Alveolar Macrophage Phagocytic Dysfunction in children with Protracted Bacterial Bronchitis and Bronchiectasis is still being explored, and no firm conclusions have been drawn. Additional research is essential to understand any causal connection.",2.3685972735685406e-08,0.0743610320467778,0.031242126480221732,0.0018134264647818726,0.10103666179984838,0.049643360809982384,0.0018108015409528666,0.10254778275948206,0.052388882459095815,2.3685972735685406e-08,0.1041012255635212,0.05494579684425756
222,0.3,5,ai,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: The relationship between Alveolar Macrophage Phagocytic Dysfunction in children with Protracted Bacterial Bronchitis and Bronchiectasis is still being studied and there is no definitive answer at this time. Further research is needed to determine if there is a causal,"Question: Could Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis Be a Precursor to Bronchiectasis? Answer: The association between Alveolar Macrophage Phagocytic Dysfunction in children with Protracted Bacterial Bronchitis and Bronchiectasis is currently under study, with no definitive answers yet. More research is needed to confirm any causal link.",1.1842986367842703e-07,0.09278964460228911,0.001512914858145864,0.009067132323909363,0.11812057930958009,0.01338207858541296,0.009054007704764333,0.11816334865020339,0.012565378201156302,1.1842986367842703e-07,0.11811282343176144,0.01150408940577946
222,0.3,6,ai,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: The relationship between Alveolar Macrophage Phagocytic Dysfunction in children with Protracted Bacterial Bronchitis and Bronchiectasis is still being studied and there is no definitive answer at this time. Further research is needed to determine if there is a causal,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Potential Early Sign of Bronchiectasis? Answer: The connection between Alveolar Macrophage Phagocytic Dysfunction in children with Protracted Bacterial Bronchitis and Bronchiectasis remains uncertain, and no conclusive evidence is available at this time. Further studies are required to establish causality.",9.474389094274162e-08,0.06809421367862711,0.004472159234063938,0.0072537058591274906,0.09339119652717986,0.010527714551478967,0.007243206163811466,0.0934181853727063,0.009871875656374707,9.474389094274162e-08,0.09337246114584374,0.009027429497318759
222,0.3,7,ai,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: The relationship between Alveolar Macrophage Phagocytic Dysfunction in children with Protracted Bacterial Bronchitis and Bronchiectasis is still being studied and there is no definitive answer at this time. Further research is needed to determine if there is a causal,"Question: Does Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis Predict Bronchiectasis? Answer: The relationship between Alveolar Macrophage Phagocytic Dysfunction in children with Protracted Bacterial Bronchitis and Bronchiectasis is still being researched, with no definitive conclusions yet. Additional investigation is necessary to determine any causal association.",1.8948778188548325e-07,0.1705926856609028,0.007908416264833601,0.014507411718254981,0.19606037918616037,0.022537689363194974,0.014486412327622933,0.1961797316319962,0.021259995077735128,1.8948778188548325e-07,0.1961371831481986,0.019542438825149624
222,0.3,8,ai,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: The relationship between Alveolar Macrophage Phagocytic Dysfunction in children with Protracted Bacterial Bronchitis and Bronchiectasis is still being studied and there is no definitive answer at this time. Further research is needed to determine if there is a causal,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis an Early Marker for Bronchiectasis? Answer: Research into the link between Alveolar Macrophage Phagocytic Dysfunction in children with Protracted Bacterial Bronchitis and Bronchiectasis is ongoing, and no definitive answers have been found. More research is needed to clarify causality.",1.1842986367842703e-07,0.09278964460228911,0.001512914858145864,0.009067132323909363,0.11812057930958009,0.01338207858541296,0.009054007704764333,0.11816334865020339,0.012565378201156302,1.1842986367842703e-07,0.11811282343176144,0.01150408940577946
222,0.3,9,ai,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: The relationship between Alveolar Macrophage Phagocytic Dysfunction in children with Protracted Bacterial Bronchitis and Bronchiectasis is still being studied and there is no definitive answer at this time. Further research is needed to determine if there is a causal,"Question: Could Dysfunction of Alveolar Macrophage Phagocytosis in Children With Protracted Bacterial Bronchitis Lead to Bronchiectasis? Answer: The association between Alveolar Macrophage Phagocytic Dysfunction in children with Protracted Bacterial Bronchitis and Bronchiectasis is still under investigation, with no conclusive evidence at present. Further studies are required to determine causality.",1.6580180914979784e-07,0.057365449260949664,0.05039052658100274,0.012693985253473108,0.051442001284799144,0.059297367094664225,0.012675610786670066,0.04896553721784924,0.06411706731580241,1.6580180914979784e-07,0.04623726985986831,0.06907325371809832
222,0.3,10,ai,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: The relationship between Alveolar Macrophage Phagocytic Dysfunction in children with Protracted Bacterial Bronchitis and Bronchiectasis is still being studied and there is no definitive answer at this time. Further research is needed to determine if there is a causal,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Precursor to Bronchiectasis? Answer: The link between Alveolar Macrophage Phagocytic Dysfunction in children with Protracted Bacterial Bronchitis and Bronchiectasis remains unclear, and no definitive conclusions have been reached. More research is needed to establish any causal relationship.",1.4211583641411244e-07,0.11808486181779942,0.0015354938271605056,0.010880558788691236,0.14345515345490067,0.016332703213610578,0.0108648092457172,0.14351820311746843,0.015357986767485843,1.4211583641411244e-07,0.1434662840489871,0.014078449905482002
223,0.3,1,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In cases of metastatic carcinoma to the cervical nodes from an unknown head and neck primary site, a neck dissection may be necessary to remove the affected lymph nodes and determine the primary source of the cancer. This procedure can help guide further treatment decisions and improve patient outcomes.","Is neck dissection required for metastatic carcinoma in cervical nodes when the primary head and neck site is unknown? In such cases, neck dissection might be essential to excise the involved lymph nodes and identify the cancer's origin, aiding in treatment planning and enhancing patient prognosis.",6.158352911278206e-07,0.2525206563272633,0.13981166355255573,0.047149088084328716,0.2464593513836868,0.1516805515656421,0.04708084006477453,0.2719941626544373,0.14076414823326625,6.158352911278206e-07,0.2983579508621652,0.1292731973570813
223,0.3,2,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In cases of metastatic carcinoma to the cervical nodes from an unknown head and neck primary site, a neck dissection may be necessary to remove the affected lymph nodes and determine the primary source of the cancer. This procedure can help guide further treatment decisions and improve patient outcomes.","For metastatic carcinoma found in cervical lymph nodes with an unknown primary head and neck tumor, is neck dissection warranted? Performing neck dissection can be crucial to remove affected nodes and locate the primary cancer source, which helps direct subsequent therapy and improve outcomes.",6.632072365991914e-07,0.29941589279277503,0.1387797769687211,0.05077594101389246,0.29297936701858074,0.1516805515656421,0.050702443146680265,0.31962221164369176,0.14076414823326625,6.632072365991914e-07,0.3471481150315969,0.1292731973570813
223,0.3,3,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In cases of metastatic carcinoma to the cervical nodes from an unknown head and neck primary site, a neck dissection may be necessary to remove the affected lymph nodes and determine the primary source of the cancer. This procedure can help guide further treatment decisions and improve patient outcomes.","When metastatic carcinoma affects cervical nodes from an unidentified head and neck primary site, should neck dissection be performed? Neck dissection may be needed to eliminate involved lymph nodes and discover the primary tumor, facilitating treatment decisions and better patient results.",7.342651548062476e-07,0.37415450965342334,0.1370388439091067,0.05621622040823808,0.3670873391723042,0.1516805515656421,0.056134847769538865,0.39560811862161316,0.14076414823326625,7.342651548062476e-07,0.4251096565013075,0.1292731973570813
223,0.3,4,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In cases of metastatic carcinoma to the cervical nodes from an unknown head and neck primary site, a neck dissection may be necessary to remove the affected lymph nodes and determine the primary source of the cancer. This procedure can help guide further treatment decisions and improve patient outcomes.","Does metastatic carcinoma to cervical lymph nodes from an unknown primary in the head and neck region require neck dissection? This surgical procedure can be necessary to remove cancerous nodes and identify the primary site, guiding further treatment and improving prognosis.",7.342651548062476e-07,0.33949715062542696,0.16202240735420861,0.05621622040823808,0.3670873391723042,0.1516805515656421,0.056134847769538865,0.39560811862161316,0.14076414823326625,7.342651548062476e-07,0.4251096565013075,0.1292731973570813
223,0.3,5,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In cases of metastatic carcinoma to the cervical nodes from an unknown head and neck primary site, a neck dissection may be necessary to remove the affected lymph nodes and determine the primary source of the cancer. This procedure can help guide further treatment decisions and improve patient outcomes.","In cases where metastatic carcinoma involves cervical nodes but the primary head and neck tumor is unknown, is neck dissection indicated? Neck dissection may help remove affected lymph nodes and determine the cancer origin, assisting in treatment planning and enhancing patient outcomes.",7.105791820705622e-07,0.3486165956233451,0.1376474073542086,0.05440279394345621,0.34176953118801245,0.1516805515656421,0.054324046228586,0.3696326322183552,0.14076414823326625,7.105791820705622e-07,0.39844140941914663,0.1292731973570813
223,0.3,6,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In cases of metastatic carcinoma to the cervical nodes from an unknown head and neck primary site, a neck dissection may be necessary to remove the affected lymph nodes and determine the primary source of the cancer. This procedure can help guide further treatment decisions and improve patient outcomes.","Is neck dissection necessary for metastatic carcinoma to cervical nodes when the primary site in the head and neck is unknown? It may be required to excise involved lymph nodes and identify the primary cancer source, which supports treatment decisions and improves patient prognosis.",6.632072365991914e-07,0.29941589279277503,0.1387797769687211,0.05077594101389246,0.29297936701858074,0.1516805515656421,0.050702443146680265,0.31962221164369176,0.14076414823326625,6.632072365991914e-07,0.3471481150315969,0.1292731973570813
223,0.3,7,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In cases of metastatic carcinoma to the cervical nodes from an unknown head and neck primary site, a neck dissection may be necessary to remove the affected lymph nodes and determine the primary source of the cancer. This procedure can help guide further treatment decisions and improve patient outcomes.","For metastatic carcinoma in cervical lymph nodes with an unknown head and neck primary, is neck dissection needed? This procedure can remove affected nodes and help locate the primary tumor, guiding therapy and improving outcomes.",8.763809912203594e-07,0.5020160801232012,0.16202240735420861,0.06709677919692933,0.5341414238354685,0.1516805515656421,0.06699965701525609,0.5674583755482732,0.14076414823326625,8.7638099122036e-07,0.6020403646603865,0.1292731973570813
223,0.3,8,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In cases of metastatic carcinoma to the cervical nodes from an unknown head and neck primary site, a neck dissection may be necessary to remove the affected lymph nodes and determine the primary source of the cancer. This procedure can help guide further treatment decisions and improve patient outcomes.","Should neck dissection be performed in cases of metastatic carcinoma to cervical nodes from an unknown primary head and neck site? Neck dissection may be essential to remove involved lymph nodes and find the primary cancer source, aiding treatment planning and patient prognosis.",6.868932093348768e-07,0.3237139950540868,0.13822704744939007,0.052589367478674334,0.31707691859764076,0.1516805515656421,0.05251324468763313,0.34431482423406345,0.14076414823326625,6.868932093348768e-07,0.37246592301588866,0.1292731973570813
223,0.3,9,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In cases of metastatic carcinoma to the cervical nodes from an unknown head and neck primary site, a neck dissection may be necessary to remove the affected lymph nodes and determine the primary source of the cancer. This procedure can help guide further treatment decisions and improve patient outcomes.","When metastatic carcinoma is present in cervical nodes from an unknown head and neck primary site, is neck dissection necessary? Neck dissection can remove affected lymph nodes and identify the primary tumor, which helps guide further treatment and improve patient outcomes.",7.342651548062476e-07,0.37415450965342334,0.1370388439091067,0.05621622040823808,0.3670873391723042,0.1516805515656421,0.056134847769538865,0.39560811862161316,0.14076414823326625,7.342651548062476e-07,0.4251096565013075,0.1292731973570813
223,0.3,10,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In cases of metastatic carcinoma to the cervical nodes from an unknown head and neck primary site, a neck dissection may be necessary to remove the affected lymph nodes and determine the primary source of the cancer. This procedure can help guide further treatment decisions and improve patient outcomes.","Is neck dissection required for metastatic carcinoma to cervical nodes originating from an unknown primary site in the head and neck? This surgical approach may be needed to excise involved lymph nodes and determine the primary cancer source, facilitating treatment decisions and enhancing patient prognosis.",6.39521263863506e-07,0.2441869708211013,0.16202240735420861,0.04896251454911059,0.2694488696083863,0.1516805515656421,0.0488916416057274,0.29552466006463174,0.14076414823326625,6.39521263863506e-07,0.32245550244122523,0.1292731973570813
224,0.3,1,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes,","Emergency laparotomy has a high mortality rate, particularly in patients older than 70, indicating a need for better outcome improvements.",5.92149318392133e-07,0.8397506547518216,0.0,0.045335661619546934,0.8708283577973974,0.0,0.04527003852382179,0.9044562742271518,0.0,5.921493183921349e-07,0.9409833444645268,0.0
224,0.3,2,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes,","The mortality rate for emergency laparotomy is notably high, especially among those above 70 years, highlighting the necessity for enhanced care.",5.684633456564476e-07,0.7884573603642715,0.0,0.043522235154765054,0.8167611365271221,0.0,0.043459236982868917,0.847297860387203,0.0,5.684633456564495e-07,0.8803587226480918,0.0
224,0.3,3,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes,","High mortality rates in emergency laparotomies, especially in individuals over 70, point to a critical need for improvement.",6.395212638635037e-07,0.9509762898620457,0.0,0.048962514549110686,0.9886113934537812,0.0,0.04889164160572754,1.0296194171811575,0.0,6.395212638635055e-07,1.0745147370890495,0.0
224,0.3,4,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes,","Patients over 70 undergoing emergency laparotomy face significant mortality risks, underscoring the importance of improving outcomes.",6.868932093348744e-07,1.0761394328160514,0.0,0.05258936747867444,1.122142786078304,0.0,0.052513244687633284,1.1727202608218308,0.0,6.868932093348764e-07,1.2286654169163072,0.0
224,0.3,5,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes,","There is a concerningly high death rate following emergency laparotomy, particularly in the elderly, which calls for better intervention strategies.",5.92149318392133e-07,0.8397506547518216,0.0,0.045335661619546934,0.8708283577973974,0.0,0.04527003852382179,0.9044562742271518,0.0,5.921493183921349e-07,0.9409833444645268,0.0
224,0.3,6,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes,","Mortality after emergency laparotomy is alarmingly high in those aged over 70, emphasizing the need for advancements in treatment.",6.158352911278184e-07,0.893817876022097,0.0,0.047149088084328813,0.9279867716373462,0.0,0.04708084006477466,0.9650808960435868,0.0,6.158352911278202e-07,1.0055218656020974,0.0
224,0.3,7,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes,","Emergency general surgery laparotomies show elevated mortality rates in patients older than 70, revealing an urgent need for outcome enhancements.",5.92149318392133e-07,0.8397506547518216,0.0,0.045335661619546934,0.8708283577973974,0.0,0.04527003852382179,0.9044562742271518,0.0,5.921493183921349e-07,0.9409833444645268,0.0
224,0.3,8,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes,","The high death rate in emergency laparotomies, especially among seniors over 70, signals a pressing need for improvement.",6.395212638635037e-07,0.9509762898620457,0.0,0.048962514549110686,0.9886113934537812,0.0,0.04889164160572754,1.0296194171811575,0.0,6.395212638635055e-07,1.0745147370890495,0.0
224,0.3,9,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes,","Outcomes of emergency laparotomies remain poor, particularly for patients over 70, necessitating focused efforts to reduce mortality.",6.63207236599189e-07,1.0116009116784808,0.0,0.05077594101389256,1.0531499145913519,0.0,0.050702443146680404,1.0986122886681096,0.0,6.63207236599191e-07,1.1486227092427708,0.0
224,0.3,10,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes,","Improving survival rates after emergency laparotomy is crucial, given the high mortality observed in patients older than 70.",6.395212638635037e-07,0.9509762898620457,0.0,0.048962514549110686,0.9886113934537812,0.0,0.04889164160572754,1.0296194171811575,0.0,6.395212638635055e-07,1.0745147370890495,0.0
225,0.3,1,ai,"Question: Amblyopia: is visual loss permanent? Answer: Visual loss from amblyopia can be permanent if left untreated for a prolonged period. However, if detected early and treated promptly, especially in children, there is a higher chance of improving vision and reducing permanent visual loss.","Is the visual loss caused by amblyopia permanent? Visual loss due to amblyopia may become permanent if not treated over a long time. However, early detection and timely treatment, particularly in children, can significantly improve vision and minimize permanent damage.",9.474389094274152e-08,0.10094507507642758,0.00238063831257343,0.0072537058591274906,0.10008345855698142,0.0,0.007243206163811466,0.10265415406008227,0.0,9.474389094274162e-08,0.10536051565782589,0.0
225,0.3,2,ai,"Question: Amblyopia: is visual loss permanent? Answer: Visual loss from amblyopia can be permanent if left untreated for a prolonged period. However, if detected early and treated promptly, especially in children, there is a higher chance of improving vision and reducing permanent visual loss.","Does amblyopia result in permanent vision loss? If amblyopia is untreated for an extended period, the vision loss can be permanent. Early diagnosis and prompt treatment, especially in children, increase the likelihood of vision improvement and reduce permanent loss.",1.1842986367842682e-07,0.09137455222020163,0.023242630385487524,0.009067132323909363,0.1267517056391423,0.0,0.009054007704764333,0.1300531282481976,0.0,1.1842986367842703e-07,0.13353139262452274,0.0
225,0.3,3,ai,"Question: Amblyopia: is visual loss permanent? Answer: Visual loss from amblyopia can be permanent if left untreated for a prolonged period. However, if detected early and treated promptly, especially in children, there is a higher chance of improving vision and reducing permanent visual loss.","Can visual loss from amblyopia be permanent? Visual impairment from amblyopia can become permanent if left untreated for a long duration. Early identification and treatment, particularly in pediatric cases, enhance the chances of vision recovery and limit permanent damage.",1.1842986367842682e-07,0.12785598277598798,0.0030539364516198493,0.009067132323909363,0.1267517056391423,0.0,0.009054007704764333,0.1300531282481976,0.0,1.1842986367842703e-07,0.13353139262452274,0.0
225,0.3,4,ai,"Question: Amblyopia: is visual loss permanent? Answer: Visual loss from amblyopia can be permanent if left untreated for a prolonged period. However, if detected early and treated promptly, especially in children, there is a higher chance of improving vision and reducing permanent visual loss.","Is vision loss from amblyopia irreversible? If amblyopia remains untreated for a prolonged time, the vision loss may be permanent. Early detection and timely intervention, especially in children, improve the prospects of restoring vision and preventing permanent loss.",1.4211583641411212e-07,0.15551021446776492,0.0037635424540186403,0.010880558788691236,0.1541506798272576,0.0,0.0108648092457172,0.15822400521489444,0.0,1.4211583641411244e-07,0.16251892949777424,0.0
225,0.3,5,ai,"Question: Amblyopia: is visual loss permanent? Answer: Visual loss from amblyopia can be permanent if left untreated for a prolonged period. However, if detected early and treated promptly, especially in children, there is a higher chance of improving vision and reducing permanent visual loss.","Does amblyopia cause lasting visual loss? Visual loss caused by amblyopia can be permanent if treatment is delayed for a long period. However, early detection and prompt treatment, especially in children, can lead to better vision outcomes and reduce permanent impairment.",7.105791820705622e-08,0.04008125783265193,0.023242630385487524,0.005440279394345618,0.07410797215372344,0.0,0.0054324046228586,0.0759859069779214,0.0,7.105791820705622e-08,0.07796154146971057,0.0
225,0.3,6,ai,"Question: Amblyopia: is visual loss permanent? Answer: Visual loss from amblyopia can be permanent if left untreated for a prolonged period. However, if detected early and treated promptly, especially in children, there is a higher chance of improving vision and reducing permanent visual loss.","Is the vision loss associated with amblyopia permanent? If amblyopia is not treated promptly and is left untreated for a long time, the visual loss can become permanent. Early diagnosis and treatment, particularly in children, increase the chances of vision improvement and reduce permanent loss.",2.3685972735685406e-08,0.05522892197167373,0.023242630385487524,0.0018134264647818726,0.023530497410194418,0.0,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
225,0.3,7,ai,"Question: Amblyopia: is visual loss permanent? Answer: Visual loss from amblyopia can be permanent if left untreated for a prolonged period. However, if detected early and treated promptly, especially in children, there is a higher chance of improving vision and reducing permanent visual loss.","Can amblyopia lead to permanent vision loss? Yes, if amblyopia is untreated for an extended period, the visual loss may be permanent. Early detection and treatment, especially in children, offer a better chance of improving vision and preventing permanent damage.",9.474389094274152e-08,0.06539906581694366,0.023242630385487524,0.0072537058591274906,0.10008345855698142,0.0,0.007243206163811466,0.10265415406008227,0.0,9.474389094274162e-08,0.10536051565782589,0.0
225,0.3,8,ai,"Question: Amblyopia: is visual loss permanent? Answer: Visual loss from amblyopia can be permanent if left untreated for a prolonged period. However, if detected early and treated promptly, especially in children, there is a higher chance of improving vision and reducing permanent visual loss.","Is the visual impairment from amblyopia permanent? Visual loss from amblyopia can be permanent if it is not treated over a long period. Early diagnosis and timely treatment, particularly in children, improve the likelihood of vision recovery and reduce permanent loss.",7.105791820705622e-08,0.07473861686064831,0.0017409330596143968,0.005440279394345618,0.07410797215372344,0.0,0.0054324046228586,0.0759859069779214,0.0,7.105791820705622e-08,0.07796154146971057,0.0
225,0.3,9,ai,"Question: Amblyopia: is visual loss permanent? Answer: Visual loss from amblyopia can be permanent if left untreated for a prolonged period. However, if detected early and treated promptly, especially in children, there is a higher chance of improving vision and reducing permanent visual loss.","Does untreated amblyopia cause permanent vision loss? If amblyopia is left untreated for a prolonged time, the vision loss can become permanent. Early detection and prompt treatment, especially in children, increase the chances of improving vision and minimizing permanent damage.",9.474389094274152e-08,0.06539906581694366,0.023242630385487524,0.0072537058591274906,0.10008345855698142,0.0,0.007243206163811466,0.10265415406008227,0.0,9.474389094274162e-08,0.10536051565782589,0.0
225,0.3,10,ai,"Question: Amblyopia: is visual loss permanent? Answer: Visual loss from amblyopia can be permanent if left untreated for a prolonged period. However, if detected early and treated promptly, especially in children, there is a higher chance of improving vision and reducing permanent visual loss.","Is vision loss due to amblyopia permanent? Visual loss from amblyopia can become permanent if treatment is delayed for a long time. However, early detection and timely treatment, particularly in children, can improve vision and reduce the risk of permanent loss.",7.105791820705622e-08,0.04008125783265193,0.023242630385487524,0.005440279394345618,0.07410797215372344,0.0,0.0054324046228586,0.0759859069779214,0.0,7.105791820705622e-08,0.07796154146971057,0.0
226,0.3,1,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Can student examiners serve as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies? It appears acceptable and justified to have medical students act as examiners in formative OSCE assessments for emergency medicine, though this may not be appropriate for summative evaluations.",4.737194547137081e-08,0.04546237407675724,0.0,0.0036268529295637453,0.04652001563489394,0.0,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
226,0.3,2,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Is it reasonable for student examiners to replace faculty in an undergraduate OSCE focused on medical emergencies? Encouraging medical students to officiate as examiners in formative emergency medicine OSCEs seems justified, but their role in summative assessments is less certain.",1.4211583641411233e-07,0.1431008436406751,0.0,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
226,0.3,3,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Are student examiners suitable substitutes for faculty in undergraduate OSCEs on medical emergencies? It seems permissible and justified to involve medical students as examiners in formative OSCE testing, but not necessarily in summative assessments.",2.8423167282822413e-07,0.3101549283038394,0.0,0.021761117577382492,0.31845373111853537,0.0,0.021729618491434427,0.32721291120841567,0.0,2.8423167282822487e-07,0.33647223662121295,0.0
226,0.3,4,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","May medical students act as reasonable substitute examiners for faculty during undergraduate OSCEs on medical emergencies? It appears valid and justified to encourage their participation in formative OSCEs, though not necessarily in summative evaluations.",2.8423167282822413e-07,0.3101549283038394,0.0,0.021761117577382492,0.31845373111853537,0.0,0.021729618491434427,0.32721291120841567,0.0,2.8423167282822487e-07,0.33647223662121295,0.0
226,0.3,5,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Can medical students reasonably substitute for faculty examiners in undergraduate emergency medicine OSCEs? It is generally acceptable and justified to have students officiate in formative OSCE testing, but this may not extend to summative assessments.",2.6054570009253883e-07,0.2803019651541576,0.0,0.019947691112600613,0.2876820724517817,0.0,0.019918816950481553,0.29546421289383584,0.0,2.6054570009253947e-07,0.30368241379822125,0.0
226,0.3,6,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Is it justifiable to have student examiners replace faculty in an undergraduate OSCE on medical emergencies? Encouraging medical students to serve as examiners in formative emergency medicine OSCEs seems appropriate, but not necessarily in summative evaluations.",2.3685972735685353e-07,0.2513144282809061,0.0,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
226,0.3,7,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Are student examiners a reasonable alternative to faculty in undergraduate OSCEs on medical emergencies? It seems justified and acceptable to involve students in formative OSCE assessments, though their role in summative assessments is questionable.",2.8423167282822413e-07,0.3101549283038394,0.0,0.021761117577382492,0.31845373111853537,0.0,0.021729618491434427,0.32721291120841567,0.0,2.8423167282822487e-07,0.33647223662121295,0.0
226,0.3,8,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Could student examiners be reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies? It appears justified to encourage medical students to act as examiners in formative OSCEs, but not necessarily in summative assessments.",2.6054570009253883e-07,0.2803019651541576,0.0,0.019947691112600613,0.2876820724517817,0.0,0.019918816950481553,0.29546421289383584,0.0,2.6054570009253947e-07,0.30368241379822125,0.0
226,0.3,9,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Is it appropriate for student examiners to substitute for faculty in an undergraduate OSCE on medical emergencies? It seems reasonable and justified to have medical students officiate in formative OSCE testing, but their involvement in summative assessments is less clear.",1.4211583641411233e-07,0.1431008436406751,0.0,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
226,0.3,10,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","May student examiners reasonably replace faculty in an undergraduate OSCE on medical emergencies? It seems acceptable and justified to encourage medical students to serve as examiners in formative OSCEs, but this may not be suitable for summative evaluations.",1.8948778188548293e-07,0.19574457712609394,0.0,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
227,0.3,1,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Do high flow nasal cannulae produce more noise than bubble CPAP in preterm infants? Answer: At the gas flow rates examined, HFNC are not louder than BCPAP for preterm infants.",7.10579182070559e-08,0.208048986851892,0.07359999999999998,0.005440279394345639,0.10919929196499067,0.0,0.005432404622858621,0.11332868530700413,0.0,7.105791820705622e-08,0.11778303565638426,0.0
227,0.3,2,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Is the noise level of high flow nasal cannulae greater than that of bubble CPAP for preterm infants? Answer: At the studied gas flows, HFNC are not noisier than BCPAP for preterm infants.",1.421158364141118e-07,0.26135024662228146,0.043326562499999985,0.010880558788691277,0.20763936477824396,0.0,0.010864809245717241,0.2151113796169466,0.0,1.4211583641411244e-07,0.2231435513142097,0.0
227,0.3,3,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Are high flow nasal cannulae louder compared to bubble CPAP in preterm infants? Answer: Based on the gas flows analyzed, HFNC do not generate more noise than BCPAP for preterm infants.",9.47438909427412e-08,0.2408388096748837,0.07359999999999998,0.007253705859127518,0.14310084364067244,0.0,0.007243206163811494,0.14842000511827314,0.0,9.474389094274162e-08,0.15415067982725894,0.0
227,0.3,4,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Do high flow nasal cannulae emit more noise than bubble CPAP when used with preterm infants? Answer: At the gas flow rates studied, HFNC are not noisier than BCPAP for preterm infants.",1.184298636784265e-07,0.2725875079894635,0.07359999999999998,0.009067132323909398,0.17589066646366414,0.0,0.009054007704764368,0.1823215567939549,0.0,1.1842986367842703e-07,0.18924199963852795,0.0
227,0.3,5,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Are high flow nasal cannulae noisier than bubble CPAP in the treatment of preterm infants? Answer: At the gas flows examined, HFNC are not louder than BCPAP for preterm infants.",7.10579182070559e-08,0.208048986851892,0.07359999999999998,0.005440279394345639,0.10919929196499067,0.0,0.005432404622858621,0.11332868530700413,0.0,7.105791820705622e-08,0.11778303565638426,0.0
227,0.3,6,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Is there more noise from high flow nasal cannulae than from bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.",9.47438909427412e-08,0.19611963673553268,0.041377777777777784,0.007253705859127518,0.14310084364067244,0.0,0.007243206163811494,0.14842000511827314,0.0,9.474389094274162e-08,0.15415067982725894,0.0
227,0.3,7,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Do high flow nasal cannulae create more noise than bubble CPAP for preterm infants? Answer: At the gas flow rates tested, HFNC are not noisier than BCPAP for preterm infants.",7.10579182070559e-08,0.16183917481456245,0.04030630202140307,0.005440279394345639,0.10919929196499067,0.0,0.005432404622858621,0.11332868530700413,0.0,7.105791820705622e-08,0.11778303565638426,0.0
227,0.3,8,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.",Question: Are high flow nasal cannulae noisier than bubble CPAP in preterm infants? Answer: HFNC are not louder than BCPAP at the gas flows studied for preterm infants.,0.0,0.10268847119406654,0.07359999999999998,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
227,0.3,9,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Is the noise produced by high flow nasal cannulae greater than that of bubble CPAP in preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.",1.421158364141118e-07,0.3033591666562172,0.07359999999999998,0.010880558788691277,0.20763936477824396,0.0,0.010864809245717241,0.2151113796169466,0.0,1.4211583641411244e-07,0.2231435513142097,0.0
227,0.3,10,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flow rates studied, HFNC are not louder than BCPAP for preterm infants.",2.36859727356853e-08,0.08954560246780208,0.03793470507544581,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
228,0.3,1,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Comorbidity of major depression and alcohol use disorder in adolescence can lead to poorer outcomes of depression, as the two conditions can exacerbate each other and prolong the duration of depressive episodes. Treatment should address both conditions simultaneously to achieve better outcomes.","Does the coexistence of major depression and alcohol use disorder during adolescence result in worse depression outcomes? The presence of both conditions can intensify symptoms and extend depressive episodes, so treating both concurrently is essential for improved recovery.",5.210914001850786e-07,0.23165438530896942,0.1624323198667222,0.0398953822252012,0.28571105676342734,0.13440000000000002,0.039837633900963065,0.3417774841219905,0.10380622837370242,5.210914001850789e-07,0.39997014032470934,0.07100591715976332
228,0.3,2,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Comorbidity of major depression and alcohol use disorder in adolescence can lead to poorer outcomes of depression, as the two conditions can exacerbate each other and prolong the duration of depressive episodes. Treatment should address both conditions simultaneously to achieve better outcomes.","In adolescents, does having both major depression and alcohol use disorder cause more severe depression outcomes? These disorders can worsen each other, leading to longer depressive periods, thus simultaneous treatment is recommended for better results.",5.921493183921345e-07,0.3162117733370331,0.1624323198667222,0.04533566161954683,0.37272243375305747,0.13440000000000002,0.045270038523821686,0.43138964281167747,0.10380622837370242,5.921493183921352e-07,0.49234346045572464,0.07100591715976332
228,0.3,3,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Comorbidity of major depression and alcohol use disorder in adolescence can lead to poorer outcomes of depression, as the two conditions can exacerbate each other and prolong the duration of depressive episodes. Treatment should address both conditions simultaneously to achieve better outcomes.","Is depression outcome poorer in adolescents when major depression co-occurs with alcohol use disorder? The interaction between these conditions can aggravate depression and lengthen its course, so addressing both together is crucial for effective treatment.",5.921493183921345e-07,0.3162117733370331,0.1624323198667222,0.04533566161954683,0.37272243375305747,0.13440000000000002,0.045270038523821686,0.43138964281167747,0.10380622837370242,5.921493183921352e-07,0.49234346045572464,0.07100591715976332
228,0.3,4,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Comorbidity of major depression and alcohol use disorder in adolescence can lead to poorer outcomes of depression, as the two conditions can exacerbate each other and prolong the duration of depressive episodes. Treatment should address both conditions simultaneously to achieve better outcomes.","When major depression and alcohol use disorder occur together in adolescence, does it lead to worse depression outcomes? Their comorbidity can amplify symptoms and prolong depression, making dual-focused treatment necessary for improved outcomes.",6.395212638635051e-07,0.37683639515346856,0.1624323198667222,0.04896251454911059,0.435242790734391,0.13440000000000002,0.04889164160572743,0.495928163949249,0.10380622837370242,6.39521263863506e-07,0.5590348349543981,0.07100591715976332
228,0.3,5,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Comorbidity of major depression and alcohol use disorder in adolescence can lead to poorer outcomes of depression, as the two conditions can exacerbate each other and prolong the duration of depressive episodes. Treatment should address both conditions simultaneously to achieve better outcomes.","Does comorbidity of major depression and alcohol use disorder in adolescence worsen depression outcomes? The two disorders can mutually exacerbate symptoms and extend depressive episodes, so treating both simultaneously is important for better prognosis.",6.158352911278198e-07,0.3460647364867149,0.1624323198667222,0.04714908808432871,0.40349409241981116,0.13440000000000002,0.04708084006477456,0.4631383411262573,0.10380622837370242,6.158352911278206e-07,0.5251332832787163,0.07100591715976332
228,0.3,6,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Comorbidity of major depression and alcohol use disorder in adolescence can lead to poorer outcomes of depression, as the two conditions can exacerbate each other and prolong the duration of depressive episodes. Treatment should address both conditions simultaneously to achieve better outcomes.","In adolescent patients, does the combination of major depression and alcohol use disorder result in poorer depression outcomes? These conditions can intensify each other and lengthen depressive phases, thus integrated treatment is key to better outcomes.",5.684633456564492e-07,0.2872242364637816,0.1624323198667222,0.04352223515476495,0.3428694706033757,0.13440000000000002,0.04345923698286881,0.4006179841449238,0.10380622837370242,5.684633456564497e-07,0.4605947621411448,0.07100591715976332
228,0.3,7,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Comorbidity of major depression and alcohol use disorder in adolescence can lead to poorer outcomes of depression, as the two conditions can exacerbate each other and prolong the duration of depressive episodes. Treatment should address both conditions simultaneously to achieve better outcomes.","Are depression outcomes poorer in adolescents with both major depression and alcohol use disorder? The coexistence can worsen symptoms and prolong depression, so comprehensive treatment addressing both is essential.",7.342651548062463e-07,0.5103677877779909,0.1624323198667222,0.05621622040823811,0.5733931292152081,0.13440000000000002,0.05613484776953893,0.6390290075899214,0.10380622837370242,7.342651548062476e-07,0.7074548400726712,0.07100591715976332
228,0.3,8,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Comorbidity of major depression and alcohol use disorder in adolescence can lead to poorer outcomes of depression, as the two conditions can exacerbate each other and prolong the duration of depressive episodes. Treatment should address both conditions simultaneously to achieve better outcomes.","Does having both major depression and alcohol use disorder in adolescence lead to more adverse depression outcomes? The interplay between the two can exacerbate depression and extend its duration, requiring simultaneous treatment for improved recovery.",5.921493183921345e-07,0.3569851368993828,0.13304756320923827,0.04533566161954683,0.37272243375305747,0.13440000000000002,0.045270038523821686,0.43138964281167747,0.10380622837370242,5.921493183921352e-07,0.49234346045572464,0.07100591715976332
228,0.3,9,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Comorbidity of major depression and alcohol use disorder in adolescence can lead to poorer outcomes of depression, as the two conditions can exacerbate each other and prolong the duration of depressive episodes. Treatment should address both conditions simultaneously to achieve better outcomes.","Is the outcome of depression worse in adolescents with comorbid major depression and alcohol use disorder? These conditions can compound each other’s effects and lengthen depressive episodes, so treating both at once is beneficial.",6.158352911278198e-07,0.3460647364867149,0.1624323198667222,0.04714908808432871,0.40349409241981116,0.13440000000000002,0.04708084006477456,0.4631383411262573,0.10380622837370242,6.158352911278206e-07,0.5251332832787163,0.07100591715976332
228,0.3,10,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Comorbidity of major depression and alcohol use disorder in adolescence can lead to poorer outcomes of depression, as the two conditions can exacerbate each other and prolong the duration of depressive episodes. Treatment should address both conditions simultaneously to achieve better outcomes.","In adolescence, does the presence of both major depression and alcohol use disorder cause poorer depression outcomes? The comorbidity can intensify symptoms and prolong depression, making dual treatment necessary for better results.",6.632072365991904e-07,0.4085850934680484,0.1624323198667222,0.05077594101389247,0.4680326135573827,0.13440000000000002,0.05070244314668031,0.5298297156249308,0.10380622837370242,6.632072365991914e-07,0.5941261547656671,0.07100591715976332
229,0.3,1,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Hypotensive events in patients with coronary disease can potentially lead to myocardial ischemic events. Profound drops in blood pressure can decrease the oxygen supply to the heart, resulting in ischemia and potentially triggering a heart attack.","Can severe hypotension in coronary disease patients trigger myocardial ischemic events? Yes, significant blood pressure drops may reduce oxygen delivery to the heart, causing ischemia and possibly a heart attack.",5.210914001850778e-07,0.45580083323825216,0.07786328655500228,0.03989538222520125,0.5243667208081457,0.039930555555555566,0.03983763390096312,0.5676917104507893,0.020399305555555556,5.210914001850789e-07,0.6131044728864086,0.0
229,0.3,2,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Hypotensive events in patients with coronary disease can potentially lead to myocardial ischemic events. Profound drops in blood pressure can decrease the oxygen supply to the heart, resulting in ischemia and potentially triggering a heart attack.","In patients with coronary disease, can profound hypotensive episodes cause myocardial ischemia? Indeed, drastic decreases in blood pressure can limit oxygen supply to the myocardium, leading to ischemic events and potential heart attacks.",4.5003348197802187e-07,0.35736076042499887,0.07786328655500228,0.03445510283085561,0.42258402649820326,0.039930555555555566,0.0344052292781045,0.4623311947929638,0.020399305555555556,4.500334819780227e-07,0.5039051809214179,0.0
229,0.3,3,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Hypotensive events in patients with coronary disease can potentially lead to myocardial ischemic events. Profound drops in blood pressure can decrease the oxygen supply to the heart, resulting in ischemia and potentially triggering a heart attack.","Do profound hypotensive events in coronary disease patients cause myocardial ischemic incidents? Such events may reduce cardiac oxygenation, resulting in ischemia and increasing heart attack risk.",6.15835291127819e-07,0.6042208383565253,0.07786328655500228,0.047149088084328765,0.6785174006354047,0.039930555555555566,0.047080840064774615,0.7280343605259691,0.020399305555555556,6.158352911278206e-07,0.7801585575495755,0.0
229,0.3,4,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Hypotensive events in patients with coronary disease can potentially lead to myocardial ischemic events. Profound drops in blood pressure can decrease the oxygen supply to the heart, resulting in ischemia and potentially triggering a heart attack.","Is there a risk of myocardial ischemia from severe hypotension in coronary disease? Yes, marked hypotension can impair oxygen flow to the heart muscle, causing ischemia and possibly precipitating a heart attack.",4.7371945471370717e-07,0.3891094587395787,0.07786328655500228,0.03626852929563749,0.45537384932119496,0.039930555555555566,0.036216030819057374,0.49623274646864557,0.020399305555555556,4.737194547137081e-07,0.5389965007326869,0.0
229,0.3,5,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Hypotensive events in patients with coronary disease can potentially lead to myocardial ischemic events. Profound drops in blood pressure can decrease the oxygen supply to the heart, resulting in ischemia and potentially triggering a heart attack.","Can myocardial ischemic events be induced by profound hypotension in patients with coronary disease? Significant blood pressure falls can diminish oxygen delivery to the heart, leading to ischemia and heart attacks.",4.974054274493925e-07,0.4218992815625704,0.07786328655500228,0.03808195576041937,0.4892754009968767,0.039930555555555566,0.03802683236001025,0.5313240662799146,0.020399305555555556,4.974054274493935e-07,0.5753641449035616,0.0
229,0.3,6,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Hypotensive events in patients with coronary disease can potentially lead to myocardial ischemic events. Profound drops in blood pressure can decrease the oxygen supply to the heart, resulting in ischemia and potentially triggering a heart attack.","Does profound hypotension in coronary disease patients lead to myocardial ischemia? Severe drops in blood pressure may reduce oxygen supply to cardiac tissue, resulting in ischemic damage and potential heart attacks.",4.974054274493925e-07,0.4218992815625704,0.07786328655500228,0.03808195576041937,0.4892754009968767,0.039930555555555566,0.03802683236001025,0.5313240662799146,0.020399305555555556,4.974054274493935e-07,0.5753641449035616,0.0
229,0.3,7,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Hypotensive events in patients with coronary disease can potentially lead to myocardial ischemic events. Profound drops in blood pressure can decrease the oxygen supply to the heart, resulting in ischemia and potentially triggering a heart attack.","Are myocardial ischemic events caused by profound hypotensive episodes in coronary disease? Yes, such hypotension can decrease oxygen availability to the heart, causing ischemia and possibly a heart attack.",5.447773729207631e-07,0.49089215304952116,0.07786328655500228,0.041708808689983126,0.5607343649790204,0.039930555555555566,0.041648435441915994,0.6054320384336362,0.020399305555555556,5.447773729207643e-07,0.652325186039691,0.0
229,0.3,8,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Hypotensive events in patients with coronary disease can potentially lead to myocardial ischemic events. Profound drops in blood pressure can decrease the oxygen supply to the heart, resulting in ischemia and potentially triggering a heart attack.","In coronary disease patients, can severe hypotension trigger myocardial ischemic events? Profound blood pressure declines can limit oxygen supply to the heart, resulting in ischemia and heart attacks.",5.684633456564484e-07,0.5272597972203958,0.07786328655500228,0.043522235154765006,0.5984746929618674,0.039930555555555566,0.04345923698286887,0.6446527515869187,0.020399305555555556,5.684633456564497e-07,0.6931471805599458,0.0
229,0.3,9,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Hypotensive events in patients with coronary disease can potentially lead to myocardial ischemic events. Profound drops in blood pressure can decrease the oxygen supply to the heart, resulting in ischemia and potentially triggering a heart attack.","Can profound hypotensive events cause myocardial ischemia in coronary disease patients? Yes, these events can reduce oxygen delivery to the myocardium, leading to ischemic injury and heart attacks.",5.684633456564484e-07,0.5272597972203958,0.07786328655500228,0.043522235154765006,0.5984746929618674,0.039930555555555566,0.04345923698286887,0.6446527515869187,0.020399305555555556,5.684633456564497e-07,0.6931471805599458,0.0
229,0.3,10,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Hypotensive events in patients with coronary disease can potentially lead to myocardial ischemic events. Profound drops in blood pressure can decrease the oxygen supply to the heart, resulting in ischemia and potentially triggering a heart attack.","Is myocardial ischemia a consequence of profound hypotension in coronary disease? Significant hypotensive episodes can impair oxygen supply to the heart, causing ischemia and potentially triggering heart attacks.",5.684633456564484e-07,0.5272597972203958,0.07786328655500228,0.043522235154765006,0.5984746929618674,0.039930555555555566,0.04345923698286887,0.6446527515869187,0.020399305555555556,5.684633456564497e-07,0.6931471805599458,0.0
230,0.3,1,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using","Should male HIV-infected patients over 52 years old with at least two additional cardiovascular risk factors be screened for silent myocardial ischemia using gated myocardial perfusion SPECT? Screening in this group was about four times more likely to detect SMI compared to the general population, suggesting physicians might recommend more systematic SMI screening for these patients.",2.6054570009253947e-07,0.09830371672608162,0.060353798126951096,0.0199476911126006,0.14274801221998068,0.03073822121441168,0.019918816950481533,0.16693032041505385,0.015621063240110858,2.6054570009253947e-07,0.19189100781010726,0.0
230,0.3,2,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using","In male HIV-positive patients older than 52 with two or more cardiovascular risk factors, the likelihood of a positive silent myocardial ischemia screening via gated myocardial perfusion SPECT was approximately four times higher than in the general population, indicating that doctors may encourage more routine SMI screening in this group.",4.026615365066519e-07,0.2138166038479259,0.060353798126951096,0.030828249901291835,0.26053104787636494,0.03073822121441168,0.030783626196198732,0.28707463225711694,0.015621063240110858,4.026615365066519e-07,0.3144933299024406,0.0
230,0.3,3,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using","Male HIV-infected patients above 52 years of age who have at least two other cardiovascular risk factors show about a fourfold increase in positive silent myocardial ischemia results when screened with myocardial SPECT compared to the general population, which may prompt physicians to recommend systematic SMI screening.",4.737194547137081e-07,0.27699550546945817,0.060353798126951096,0.03626852929563745,0.32506956901393647,0.03073822121441168,0.03621603081905733,0.353032600048913,0.015621063240110858,4.737194547137081e-07,0.38193461069797285,0.0
230,0.3,4,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using","Screening for silent myocardial ischemia using gated myocardial perfusion SPECT in HIV-infected men older than 52 years with two or more cardiovascular risk factors is roughly four times more likely to yield positive results than in the general population, potentially motivating healthcare providers to suggest more consistent screening.",4.500334819780227e-07,0.2554893002484948,0.060353798126951096,0.03445510283085558,0.30309066229516146,0.03073822121441168,0.034405229278104466,0.3305597441968553,0.015621063240110858,4.500334819780227e-07,0.35894509247327333,0.0
230,0.3,5,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using","Among male HIV-infected patients aged over 52 with at least two additional cardiovascular risk factors, the chance of detecting silent myocardial ischemia via myocardial SPECT screening is about four times greater than in the general population, which may lead physicians to advocate for more systematic screening.",4.974054274493935e-07,0.2989744121882332,0.060353798126951096,0.038081955760419325,0.3475424248659942,0.03073822121441168,0.0380268323600102,0.37602211827361254,0.015621063240110858,4.974054274493935e-07,0.40546510810816727,0.0
230,0.3,6,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using","HIV-positive men older than 52 years with two or more cardiovascular risk factors have about a fourfold higher likelihood of positive silent myocardial ischemia screening using gated myocardial perfusion SPECT compared to the general population, encouraging physicians to consider more regular SMI screening.",5.684633456564497e-07,0.36796728367518483,0.060353798126951096,0.04352223515476494,0.41815999207994814,0.03073822121441168,0.0434592369828688,0.44834277985323867,0.015621063240110858,5.684633456564497e-07,0.4795730802618907,0.0
230,0.3,7,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using","In male HIV-infected patients older than 52 who possess at least two other cardiovascular risk factors, screening for silent myocardial ischemia with myocardial SPECT is approximately four times more likely to be positive than in the general population, which might motivate doctors to recommend more systematic screening.",4.737194547137081e-07,0.27699550546945817,0.060353798126951096,0.03626852929563745,0.32506956901393647,0.03073822121441168,0.03621603081905733,0.353032600048913,0.015621063240110858,4.737194547137081e-07,0.38193461069797285,0.0
230,0.3,8,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using","The probability of positive silent myocardial ischemia screening using gated myocardial perfusion SPECT is about four times higher in male HIV-infected patients over 52 years old with two or more cardiovascular risk factors than in the general population, suggesting that physicians may advise more systematic screening.",4.974054274493935e-07,0.2989744121882332,0.060353798126951096,0.038081955760419325,0.3475424248659942,0.03073822121441168,0.0380268323600102,0.37602211827361254,0.015621063240110858,4.974054274493935e-07,0.40546510810816727,0.0
230,0.3,9,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using","Male HIV-infected patients older than 52 years with at least two additional cardiovascular risk factors have a roughly fourfold increased chance of positive silent myocardial ischemia detection via myocardial SPECT compared to the general population, potentially prompting physicians to recommend more systematic screening.",5.684633456564497e-07,0.36796728367518483,0.060353798126951096,0.04352223515476494,0.41815999207994814,0.03073822121441168,0.0434592369828688,0.44834277985323867,0.015621063240110858,5.684633456564497e-07,0.4795730802618907,0.0
230,0.3,10,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using","Screening for silent myocardial ischemia using gated myocardial perfusion SPECT in male HIV-infected patients over 52 with two or more cardiovascular risk factors is about four times more likely to be positive than in the general population, which may encourage physicians to advise more systematic screening.",4.974054274493935e-07,0.2989744121882332,0.060353798126951096,0.038081955760419325,0.3475424248659942,0.03073822121441168,0.0380268323600102,0.37602211827361254,0.015621063240110858,4.974054274493935e-07,0.40546510810816727,0.0
231,0.3,1,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is generally considered to be less invasive than retropubic","Is robotically assisted laparoscopic radical prostatectomy less invasive compared to retropubic radical prostatectomy? Yes, it is typically regarded as less invasive than the retropubic approach.",9.47438909427412e-08,0.13466064540605283,0.18063432052089884,0.007253705859127518,0.09637852790998469,0.17561983471074386,0.007243206163811494,0.007097042995488412,0.11342155009451795,9.474389094274162e-08,0.11890161269998334,0.03993055555555556
231,0.3,2,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is generally considered to be less invasive than retropubic","Does robotically assisted laparoscopic radical prostatectomy involve less invasiveness than retropubic radical prostatectomy? Yes, it is usually seen as less invasive than retropubic surgery.",1.184298636784265e-07,0.08958962815913951,0.17883379247015596,0.009067132323909398,0.05192676533915064,0.17561983471074386,0.009054007704764368,0.05361705863038235,0.11342155009451795,1.1842986367842698e-07,0.1676917768694146,0.03993055555555556
231,0.3,3,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is generally considered to be less invasive than retropubic","Is the robotically assisted laparoscopic radical prostatectomy a less invasive procedure than retropubic radical prostatectomy? Yes, it is generally considered less invasive.",1.658018091497971e-07,0.05889151782818969,0.2222222222222221,0.012693985253473157,0.043383414465174575,0.17561983471074386,0.012675610786670115,0.15370051718736377,0.11342155009451795,1.6580180914979768e-07,0.27305229252724006,0.03993055555555556
231,0.3,4,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is generally considered to be less invasive than retropubic","Is robotically assisted laparoscopic radical prostatectomy less invasive than the retropubic method? Yes, it is commonly viewed as less invasive.",2.131737546211678e-07,0.04119194072879173,0.2222222222222221,0.016320838183036916,0.14874393012300002,0.17561983471074386,0.01629721386857586,0.26492615229758787,0.11342155009451795,2.131737546211684e-07,0.3908353281836239,0.03993055555555556
231,0.3,5,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is generally considered to be less invasive than retropubic","Is the invasiveness of robotically assisted laparoscopic radical prostatectomy lower than that of retropubic radical prostatectomy? Yes, it is generally less invasive.",1.658018091497971e-07,0.05889151782818969,0.2222222222222221,0.012693985253473157,0.043383414465174575,0.17561983471074386,0.012675610786670115,0.15370051718736377,0.11342155009451795,1.6580180914979768e-07,0.27305229252724006,0.03993055555555556
231,0.3,6,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is generally considered to be less invasive than retropubic","Is robotically assisted laparoscopic radical prostatectomy considered less invasive than retropubic radical prostatectomy? Yes, it is typically less invasive.",2.3685972735685316e-07,0.09525916199906703,0.2222222222222221,0.018134264647818792,0.20590234396294882,0.17561983471074386,0.018108015409528732,0.3255507741140229,0.11342155009451795,2.3685972735685374e-07,0.4553738493211945,0.03993055555555556
231,0.3,7,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is generally considered to be less invasive than retropubic","Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Yes, it is often regarded as less invasive.",2.131737546211678e-07,0.04119194072879173,0.2222222222222221,0.016320838183036916,0.14874393012300002,0.17561983471074386,0.01629721386857586,0.26492615229758787,0.11342155009451795,2.131737546211684e-07,0.3908353281836239,0.03993055555555556
231,0.3,8,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is generally considered to be less invasive than retropubic","Is robotically assisted laparoscopic radical prostatectomy a less invasive option than retropubic radical prostatectomy? Yes, it is generally considered to be less invasive.",1.421158364141118e-07,0.10541153346308363,0.2222222222222221,0.010880558788691277,0.005406749704256697,0.17561983471074386,0.010864809245717241,0.10240722279981362,0.11342155009451795,1.4211583641411233e-07,0.21898507125696476,0.03993055555555556
231,0.3,9,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is generally considered to be less invasive than retropubic","Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Yes, it is usually considered less invasive.",2.3685972735685316e-07,0.09525916199906703,0.2222222222222221,0.018134264647818792,0.20590234396294882,0.17561983471074386,0.018108015409528732,0.3255507741140229,0.11342155009451795,2.3685972735685374e-07,0.4553738493211945,0.03993055555555556
231,0.3,10,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is generally considered to be less invasive than retropubic","Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Yes, it is widely accepted as less invasive.",2.131737546211678e-07,0.04119194072879173,0.2222222222222221,0.016320838183036916,0.14874393012300002,0.17561983471074386,0.01629721386857586,0.26492615229758787,0.11342155009451795,2.131737546211684e-07,0.3908353281836239,0.03993055555555556
232,0.3,1,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The study explores the potential of using Nd:YAG laser-induced thermo therapy to locally open the blood-brain barrier in rodents, allowing for better delivery","Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The study explores the potential of using Nd:YAG laser-induced thermo therapy to locally open the blood-brain barrier in rodents, allowing for better delivery",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
232,0.3,2,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The study explores the potential of using Nd:YAG laser-induced thermo therapy to locally open the blood-brain barrier in rodents, allowing for better delivery",Question: Can Nd:YAG laser-induced thermo therapy locally open the rodent blood-brain barrier for paclitaxel administration as a novel adjuvant glioma treatment? Answer: This research investigates Nd:YAG laser-induced thermo therapy to transiently open the blood-brain barrier in rodents to enhance drug delivery.,1.1842986367842703e-07,0.16784366536349005,0.034406147944008064,0.009067132323909363,0.12870662625668094,0.005780739371472957,0.009054007704764333,0.12785598277598798,0.0030539364516198493,1.1842986367842703e-07,0.1267517056391423,0.0
232,0.3,3,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The study explores the potential of using Nd:YAG laser-induced thermo therapy to locally open the blood-brain barrier in rodents, allowing for better delivery",Question: Is locoregional opening of the rodent blood-brain barrier with Nd:YAG laser-induced thermo therapy a new approach for adjuvant glioma therapy using paclitaxel? Answer: The study examines Nd:YAG laser-induced thermo therapy's ability to locally disrupt the blood-brain barrier in rodents to improve paclitaxel delivery.,4.737194547137081e-08,0.01895441988480151,0.018667831647828675,0.0036268529295637453,0.01651364418208079,0.02155611401808394,0.003621603081905733,0.01538864524228023,0.023242630385487524,4.737194547137081e-08,0.048790164169431716,0.0
232,0.3,4,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The study explores the potential of using Nd:YAG laser-induced thermo therapy to locally open the blood-brain barrier in rodents, allowing for better delivery",Question: Does Nd:YAG laser-induced thermo therapy enable locoregional opening of the rodent blood-brain barrier for paclitaxel in adjuvant glioma therapy? Answer: This study evaluates the use of Nd:YAG laser-induced thermo therapy to facilitate localized blood-brain barrier opening in rodents for enhanced drug penetration.,7.105791820705622e-08,0.07779474044644408,0.006139993836935864,0.005440279394345618,0.07522830233962896,0.003300728575453847,0.0054324046228586,0.07473861686064831,0.0017409330596143968,7.105791820705622e-08,0.07410797215372344,0.0
232,0.3,5,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The study explores the potential of using Nd:YAG laser-induced thermo therapy to locally open the blood-brain barrier in rodents, allowing for better delivery",Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel via Nd:YAG laser-induced thermo therapy: a novel adjuvant glioma treatment? Answer: The research focuses on using Nd:YAG laser-induced thermo therapy to transiently open the blood-brain barrier in rodents to improve paclitaxel delivery.,9.474389094274162e-08,0.07130043039800293,0.015328150207385441,0.0072537058591274906,0.0669541587814173,0.020367910477800573,0.007243206163811466,0.06539906581694366,0.023242630385487524,9.474389094274162e-08,0.10008345855698142,0.0
232,0.3,6,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The study explores the potential of using Nd:YAG laser-induced thermo therapy to locally open the blood-brain barrier in rodents, allowing for better delivery","Question: Can Nd:YAG laser-induced thermo therapy locally disrupt the rodent blood-brain barrier to aid paclitaxel delivery in glioma therapy? Answer: The study explores this laser technique to achieve localized blood-brain barrier opening in rodents, enhancing therapeutic drug access.",1.8948778188548293e-07,0.10998582685861757,0.0610366588083225,0.014507411718254981,0.13765731541124682,0.045351473922902494,0.014486412327622933,0.17361265045717467,0.023242630385487524,1.8948778188548325e-07,0.21130909366720596,0.0
232,0.3,7,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The study explores the potential of using Nd:YAG laser-induced thermo therapy to locally open the blood-brain barrier in rodents, allowing for better delivery",Question: Is the use of Nd:YAG laser-induced thermo therapy for locoregional opening of the rodent blood-brain barrier a new strategy for adjuvant glioma therapy with paclitaxel? Answer: This study investigates the potential of Nd:YAG laser-induced thermo therapy to improve drug delivery by opening the blood-brain barrier locally in rodents.,7.105791820705622e-08,0.043359023953795095,0.014715416053631553,0.005440279394345618,0.04048447372866537,0.01818158392833716,0.0054324046228586,0.03940701666772872,0.0201457993665786,7.105791820705622e-08,0.03818633012873196,0.02221074380165289
232,0.3,8,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The study explores the potential of using Nd:YAG laser-induced thermo therapy to locally open the blood-brain barrier in rodents, allowing for better delivery",Question: Locoregional blood-brain barrier opening in rodents using Nd:YAG laser-induced thermo therapy for paclitaxel: a new adjuvant glioma therapy concept? Answer: The research evaluates Nd:YAG laser-induced thermo therapy as a method to locally open the blood-brain barrier for enhanced paclitaxel delivery.,1.1842986367842703e-07,0.13318630633549278,0.010722600450936787,0.009067132323909363,0.12870662625668094,0.005780739371472957,0.009054007704764333,0.12785598277598798,0.0030539364516198493,1.1842986367842703e-07,0.1267517056391423,0.0
232,0.3,9,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The study explores the potential of using Nd:YAG laser-induced thermo therapy to locally open the blood-brain barrier in rodents, allowing for better delivery",Question: Could Nd:YAG laser-induced thermo therapy serve as a novel method to locally open the rodent blood-brain barrier for paclitaxel in glioma treatment? Answer: This study assesses the feasibility of using this laser therapy to transiently disrupt the blood-brain barrier in rodents to improve drug delivery.,0.0,0.09241962407465909,0.06583208784617578,0.0,0.06301338005090473,0.045351473922902494,0.0,0.032239403746974205,0.023242630385487524,0.0,0.0,0.0
232,0.3,10,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The study explores the potential of using Nd:YAG laser-induced thermo therapy to locally open the blood-brain barrier in rodents, allowing for better delivery","Question: Exploring Nd:YAG laser-induced thermo therapy for locoregional opening of the rodent blood-brain barrier to enhance paclitaxel delivery in glioma therapy? Answer: The study investigates the use of this laser technique to facilitate localized blood-brain barrier opening in rodents, improving therapeutic outcomes.",9.474389094274162e-08,0.0036763152214227546,0.06366783164782866,0.0072537058591274906,0.032296799753420924,0.045351473922902494,0.007243206163811466,0.06539906581694366,0.023242630385487524,9.474389094274162e-08,0.10008345855698142,0.0
233,0.3,1,ai,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: There is ongoing research to determine if colorectal cancer in young patients is a distinct clinical entity. Some studies suggest there are differences in tumor characteristics and,Question: Is colorectal cancer in young patients a unique clinical entity? Answer: Research is ongoing to find out if colorectal cancer in young patients represents a distinct clinical entity. Some studies indicate differences in tumor features and,7.10579182070559e-08,0.05634536816721303,0.016057525951557072,0.005440279394345618,0.09161903752274592,0.006593590561224494,0.005432404622858607,0.12863669998736116,0.03158757716049383,7.105791820705622e-08,0.12902029702356588,0.0302734375
233,0.3,2,ai,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: There is ongoing research to determine if colorectal cancer in young patients is a distinct clinical entity. Some studies suggest there are differences in tumor characteristics and,Question: Does colorectal cancer in young patients constitute a separate clinical entity? Answer: Investigations continue to assess whether colorectal cancer in young patients is a distinct clinical entity. Certain studies point to variations in tumor characteristics and,7.10579182070559e-08,0.05634536816721303,0.016057525951557072,0.005440279394345618,0.09161903752274592,0.006593590561224494,0.005432404622858607,0.12863669998736116,0.03158757716049383,7.105791820705622e-08,0.12902029702356588,0.0302734375
233,0.3,3,ai,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: There is ongoing research to determine if colorectal cancer in young patients is a distinct clinical entity. Some studies suggest there are differences in tumor characteristics and,Question: Is colorectal cancer among young patients a distinct clinical condition? Answer: Current research aims to determine if colorectal cancer in young patients is a unique clinical entity. Some research highlights differences in tumor traits and,9.47438909427412e-08,0.009700358978232515,0.06849955992768197,0.0072537058591274975,0.0017813434428641806,0.0783673469387755,0.00724320616381148,0.07694293601234303,0.027006172839506164,9.474389094274162e-08,0.11778303565638382,0.0
233,0.3,4,ai,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: There is ongoing research to determine if colorectal cancer in young patients is a distinct clinical entity. Some studies suggest there are differences in tumor characteristics and,Question: Could colorectal cancer in young individuals be considered a distinct clinical entity? Answer: There is active research exploring whether colorectal cancer in young patients forms a distinct clinical entity. Some studies reveal differences in tumor properties and,4.73719454713706e-08,0.062250763015011756,0.006403411548442928,0.0036268529295637453,0.06014745969624036,0.004277281160398036,0.003621603081905733,0.05771084630712098,0.001540539963261995,4.737194547137081e-08,0.05715841383994835,0.0
233,0.3,5,ai,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: There is ongoing research to determine if colorectal cancer in young patients is a distinct clinical entity. Some studies suggest there are differences in tumor characteristics and,Question: Is colorectal cancer in younger patients a separate clinical entity? Answer: Ongoing studies seek to establish if colorectal cancer in young patients is a distinct clinical entity. Some findings suggest variations in tumor characteristics and,9.47438909427412e-08,0.009700358978232515,0.06849955992768197,0.0072537058591274975,0.04255470700521391,0.048982590281291566,0.00724320616381148,0.07694293601234303,0.027006172839506164,9.474389094274162e-08,0.11778303565638382,0.0
233,0.3,6,ai,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: There is ongoing research to determine if colorectal cancer in young patients is a distinct clinical entity. Some studies suggest there are differences in tumor characteristics and,Question: Is colorectal cancer in young patients a clinically distinct entity? Answer: Research efforts are underway to determine if colorectal cancer in young patients constitutes a distinct clinical entity. Some evidence points to differences in tumor features and,4.73719454713706e-08,0.02478334784960934,0.01891278306817784,0.0036268529295637453,0.06014745969624036,0.004277281160398036,0.003621603081905733,0.09731925662483176,0.02992679318436894,4.737194547137081e-08,0.09793177740229808,0.029384756657483937
233,0.3,7,ai,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: There is ongoing research to determine if colorectal cancer in young patients is a distinct clinical entity. Some studies suggest there are differences in tumor characteristics and,Question: Does colorectal cancer in young patients represent a distinct clinical entity? Answer: There is continuing research to clarify if colorectal cancer in young patients is a unique clinical entity. Some studies report differences in tumor characteristics and,4.73719454713706e-08,0.02478334784960934,0.01891278306817784,0.0036268529295637453,0.06014745969624036,0.004277281160398036,0.003621603081905733,0.09731925662483176,0.02992679318436894,4.737194547137081e-08,0.09793177740229808,0.029384756657483937
233,0.3,8,ai,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: There is ongoing research to determine if colorectal cancer in young patients is a distinct clinical entity. Some studies suggest there are differences in tumor characteristics and,Question: Is colorectal cancer in young patients characterized as a distinct clinical entity? Answer: Studies are ongoing to investigate whether colorectal cancer in young patients is a distinct clinical entity. Some research suggests differences in tumor features and,4.73719454713706e-08,0.09971817818041284,0.030654882997454447,0.0036268529295637453,0.0986556363940152,0.031007653061224494,0.003621603081905733,0.09731925662483176,0.02992679318436894,4.737194547137081e-08,0.09793177740229808,0.029384756657483937
233,0.3,9,ai,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: There is ongoing research to determine if colorectal cancer in young patients is a distinct clinical entity. Some studies suggest there are differences in tumor characteristics and,Question: Is colorectal cancer in young patients considered a separate clinical entity? Answer: Research is ongoing to determine if colorectal cancer in young patients represents a distinct clinical entity. Certain studies indicate differences in tumor characteristics and,7.10579182070559e-08,0.05634536816721303,0.016057525951557072,0.005440279394345618,0.09161903752274592,0.006593590561224494,0.005432404622858607,0.12863669998736116,0.03158757716049383,7.105791820705622e-08,0.12902029702356588,0.0302734375
233,0.3,10,ai,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: There is ongoing research to determine if colorectal cancer in young patients is a distinct clinical entity. Some studies suggest there are differences in tumor characteristics and,Question: Is colorectal cancer in young patients identified as a distinct clinical entity? Answer: There is ongoing investigation to find out if colorectal cancer in young patients is a distinct clinical entity. Some studies highlight differences in tumor characteristics and,0.0,0.035546009259483924,0.02332780462695533,0.0,0.03648143055578679,0.02543888143492691,0.0,0.037467415165403306,0.026871378180902013,0.0,0.03850817669777484,0.02775510204081633
234,0.3,1,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can help in determining the appropriate therapeutic approach for individuals with familial adenomatous polyposis. It can provide valuable information about the specific mutation present, which can guide treatment decisions such as the use of targeted therapies or surgical interventions.",Can analyzing APC mutations aid in making treatment choices for familial adenomatous polyposis?,1.0421828003701553e-06,1.46617927160144,0.05339978640085441,0.07979076445040253,1.5842325604137386,0.0181755829903978,0.0796752678019263,1.68639895357023,0.0,1.0421828003701572e-06,1.7730673362159015,0.0
234,0.3,2,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can help in determining the appropriate therapeutic approach for individuals with familial adenomatous polyposis. It can provide valuable information about the specific mutation present, which can guide treatment decisions such as the use of targeted therapies or surgical interventions.",Is APC mutation testing useful for guiding therapy in familial adenomatous polyposis?,1.0658687731058407e-06,1.55319064859107,0.05339978640085441,0.08160419091518442,1.6795427402180638,0.0181755829903978,0.08148606934287918,1.7917594692280558,0.0,1.0658687731058426e-06,1.8908503718722853,0.0
234,0.3,3,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can help in determining the appropriate therapeutic approach for individuals with familial adenomatous polyposis. It can provide valuable information about the specific mutation present, which can guide treatment decisions such as the use of targeted therapies or surgical interventions.",Does APC mutation analysis play a role in therapeutic decision-making for familial adenomatous polyposis?,1.0184968276344701e-06,1.3861365639279035,0.05339978640085441,0.07797733798562066,1.4972211834241085,0.0181755829903978,0.07786446626097343,1.5910887737659047,0.0,1.0184968276344718e-06,1.6677068205580756,0.0
234,0.3,4,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can help in determining the appropriate therapeutic approach for individuals with familial adenomatous polyposis. It can provide valuable information about the specific mutation present, which can guide treatment decisions such as the use of targeted therapies or surgical interventions.",Can the study of APC mutations inform treatment strategies in familial adenomatous polyposis?,1.0421828003701553e-06,1.46617927160144,0.05339978640085441,0.07979076445040253,1.5842325604137386,0.0181755829903978,0.0796752678019263,1.68639895357023,0.0,1.0421828003701572e-06,1.7730673362159015,0.0
234,0.3,5,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can help in determining the appropriate therapeutic approach for individuals with familial adenomatous polyposis. It can provide valuable information about the specific mutation present, which can guide treatment decisions such as the use of targeted therapies or surgical interventions.",Is it possible for APC mutation analysis to influence therapeutic plans in familial adenomatous polyposis?,9.948108548987847e-07,1.3120285917741823,0.05339978640085441,0.07616391152083879,1.417178475750572,0.0181755829903978,0.07605366472002055,1.5040773967762746,0.0,9.948108548987866e-07,1.5723966407537504,0.0
234,0.3,6,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can help in determining the appropriate therapeutic approach for individuals with familial adenomatous polyposis. It can provide valuable information about the specific mutation present, which can guide treatment decisions such as the use of targeted therapies or surgical interventions.",How can APC mutation analysis assist in selecting treatments for familial adenomatous polyposis?,1.0421828003701553e-06,1.46617927160144,0.05339978640085441,0.07979076445040253,1.5842325604137386,0.0181755829903978,0.0796752678019263,1.68639895357023,0.0,1.0421828003701572e-06,1.7730673362159015,0.0
234,0.3,7,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can help in determining the appropriate therapeutic approach for individuals with familial adenomatous polyposis. It can provide valuable information about the specific mutation present, which can guide treatment decisions such as the use of targeted therapies or surgical interventions.",Can identifying APC mutations help determine the best therapeutic options for familial adenomatous polyposis?,1.0184968276344701e-06,1.3861365639279035,0.05339978640085441,0.07797733798562066,1.4972211834241085,0.0181755829903978,0.07786446626097343,1.5910887737659047,0.0,1.0184968276344718e-06,1.6677068205580756,0.0
234,0.3,8,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can help in determining the appropriate therapeutic approach for individuals with familial adenomatous polyposis. It can provide valuable information about the specific mutation present, which can guide treatment decisions such as the use of targeted therapies or surgical interventions.",Does evaluating APC mutations contribute to choosing therapies for familial adenomatous polyposis?,1.0658687731058407e-06,1.55319064859107,0.05339978640085441,0.08160419091518442,1.6795427402180638,0.0181755829903978,0.08148606934287918,1.7917594692280558,0.0,1.0658687731058426e-06,1.8908503718722853,0.0
234,0.3,9,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can help in determining the appropriate therapeutic approach for individuals with familial adenomatous polyposis. It can provide valuable information about the specific mutation present, which can guide treatment decisions such as the use of targeted therapies or surgical interventions.",Can APC mutation analysis guide clinical decisions regarding therapy in familial adenomatous polyposis?,1.0421828003701553e-06,1.46617927160144,0.05339978640085441,0.07979076445040253,1.5842325604137386,0.0181755829903978,0.0796752678019263,1.68639895357023,0.0,1.0421828003701572e-06,1.7730673362159015,0.0
234,0.3,10,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can help in determining the appropriate therapeutic approach for individuals with familial adenomatous polyposis. It can provide valuable information about the specific mutation present, which can guide treatment decisions such as the use of targeted therapies or surgical interventions.",Is APC mutation testing beneficial for deciding on treatment approaches in familial adenomatous polyposis?,1.0184968276344701e-06,1.3861365639279035,0.05339978640085441,0.07797733798562066,1.4972211834241085,0.0181755829903978,0.07786446626097343,1.5910887737659047,0.0,1.0184968276344718e-06,1.6677068205580756,0.0
235,0.3,1,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Are symptoms important when selecting patients for phase I clinical trials? Answer: Older adults participating in PICT who have more symptoms might compromise their quality of life for the sake of experimental treatment.,1.658018091497971e-07,0.23841102344499765,0.0,0.012693985253473157,0.24686007793152642,0.0,0.012675610786670115,0.2559333741372014,0.0,1.6580180914979784e-07,0.26570316573300534,0.0
235,0.3,2,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Should symptoms be considered in patient selection for phase I clinical trials? Answer: Older adults enrolled in PICT with a higher symptom burden may trade off quality of life to undergo experimental treatment.,1.658018091497971e-07,0.23841102344499765,0.0,0.012693985253473157,0.24686007793152642,0.0,0.012675610786670115,0.2559333741372014,0.0,1.6580180914979784e-07,0.26570316573300534,0.0
235,0.3,3,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Do symptoms play a role in deciding patients for phase I clinical trials? Answer: Older adults in PICT experiencing more symptoms might accept a reduction in quality of life to receive experimental therapies.,1.658018091497971e-07,0.23841102344499765,0.0,0.012693985253473157,0.24686007793152642,0.0,0.012675610786670115,0.2559333741372014,0.0,1.6580180914979784e-07,0.26570316573300534,0.0
235,0.3,4,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Is symptom presence relevant when choosing patients for phase I clinical trials? Answer: Older adults taking part in PICT with increased symptoms may sacrifice their quality of life for experimental interventions.,1.184298636784265e-07,0.17589066646366414,0.0,0.009067132323909398,0.1823215567939549,0.0,0.009054007704764368,0.18924199963852795,0.0,1.1842986367842703e-07,0.19671029424605457,0.0
235,0.3,5,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Are symptoms a factor when evaluating patients for phase I clinical trials? Answer: Older adults enrolled in PICT who report more symptoms could compromise quality of life in pursuit of experimental treatment.,1.421158364141118e-07,0.20763936477824396,0.0,0.010880558788691277,0.2151113796169466,0.0,0.010864809245717241,0.2231435513142097,0.0,1.4211583641411244e-07,0.23180161405732358,0.0
235,0.3,6,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Do symptoms influence patient selection for phase I clinical trials? Answer: Older adults in PICT with greater symptom severity might give up quality of life to try experimental treatments.,7.10579182070559e-08,0.10919929196499067,0.0,0.005440279394345639,0.11332868530700413,0.0,0.005432404622858621,0.11778303565638426,0.0,7.105791820705622e-08,0.1226023220923329,0.0
235,0.3,7,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Should symptom status be considered when enrolling patients in phase I clinical trials? Answer: Older adults with more symptoms in PICT may trade quality of life for access to experimental therapies.,1.184298636784265e-07,0.17589066646366414,0.0,0.009067132323909398,0.1823215567939549,0.0,0.009054007704764368,0.18924199963852795,0.0,1.1842986367842703e-07,0.19671029424605457,0.0
235,0.3,8,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Does symptom burden matter when considering patients for phase I clinical trials? Answer: Older adults participating in PICT with more symptoms may sacrifice quality of life to receive experimental treatment.,9.47438909427412e-08,0.14310084364067244,0.0,0.007253705859127518,0.14842000511827314,0.0,0.007243206163811494,0.15415067982725894,0.0,9.474389094274162e-08,0.1603426500751799,0.0
235,0.3,9,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Are symptoms significant in selecting patients for phase I clinical trials? Answer: Older adults enrolled in PICT who have more symptoms might accept a decline in quality of life for experimental treatment.,1.421158364141118e-07,0.20763936477824396,0.0,0.010880558788691277,0.2151113796169466,0.0,0.010864809245717241,0.2231435513142097,0.0,1.4211583641411244e-07,0.23180161405732358,0.0
235,0.3,10,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Is symptom evaluation important when choosing patients for phase I clinical trials? Answer: Older adults in PICT with increased symptoms may compromise their quality of life to undergo experimental treatment.,9.47438909427412e-08,0.14310084364067244,0.0,0.007253705859127518,0.14842000511827314,0.0,0.007243206163811494,0.15415067982725894,0.0,9.474389094274162e-08,0.1603426500751799,0.0
236,0.3,1,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or","Is the surgeon's prior experience a factor in their ability to perform transurethral resection of the prostate? The senior urologist was able to resect tissue at a rate four times higher than less experienced surgeons, suggesting that experience might be crucial in lowering the risk of secondary TURP caused by recurring adenomas.",9.474389094274162e-08,0.07550755250814589,0.0,0.0072537058591274906,0.07696104113612989,0.0,0.007243206163811466,0.07847161544149417,0.0,9.474389094274162e-08,0.08004270767353683,0.0
236,0.3,2,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or","Does a surgeon's previous experience affect their proficiency in performing transurethral resection of the prostate? The senior urologist resected tissue four times faster than the less experienced surgeons, indicating that experience could be key to minimizing the chance of secondary TURP due to adenoma recurrence.",2.6054570009253947e-07,0.22314355131420927,0.0,0.0199476911126006,0.22778393087071303,0.0,0.019918816950481533,0.2326222952687531,0.0,2.6054570009253947e-07,0.23767165187712003,0.0
236,0.3,3,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or","Is the skill to perform transurethral resection of the prostate dependent on the surgeon's past experience? The senior urologist removed tissue at a rate four times greater than that of the less experienced surgeons, implying that experience may play an important role in decreasing the risk of secondary TURP from recurring adenomas.",9.474389094274162e-08,0.10268979488304542,0.019599999999999992,0.0072537058591274906,0.07696104113612989,0.0,0.007243206163811466,0.07847161544149417,0.0,9.474389094274162e-08,0.08004270767353683,0.0
236,0.3,4,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or","Does the surgeon's experience influence their ability to carry out transurethral resection of the prostate? The senior urologist resected four times more tissue per unit time compared to the less experienced surgeons, suggesting that experience is important for reducing the risk of secondary TURP caused by recurrent adenomas.",1.8948778188548325e-07,0.15718558352241319,0.0,0.014507411718254981,0.16034265007518078,0.0,0.014486412327622933,0.16362942378180145,0.0,1.8948778188548325e-07,0.16705408466316607,0.0
236,0.3,5,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or","Is the capability to perform transurethral resection of the prostate affected by the surgeon's prior experience? The senior urologist was able to resect tissue four times faster than less experienced surgeons, which indicates that experience might be vital to lower the risk of secondary TURP due to recurring adenomas.",1.6580180914979784e-07,0.13613217432458002,0.0,0.012693985253473108,0.13883644485421742,0.0,0.012675610786670066,0.14165051706302645,0.0,1.6580180914979784e-07,0.14458122881110835,0.0
236,0.3,6,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or","Does previous surgical experience impact the ability to perform transurethral resection of the prostate? The senior urologist resected tissue at a rate four times that of the less experienced surgeons, suggesting that experience may be essential to reduce the risk of secondary TURP from adenoma recurrence.",2.3685972735685406e-07,0.23147723682037125,0.02221074380165289,0.018134264647818726,0.2047944126460135,0.0,0.018108015409528666,0.2090917978585587,0.0,2.3685972735685406e-07,0.21357410029806,0.0
236,0.3,7,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or","Is the proficiency in performing transurethral resection of the prostate influenced by the surgeon's earlier experience? The senior urologist resected four times more tissue per time unit than less experienced surgeons, indicating that experience could be important to decrease the risk of secondary TURP caused by recurring adenomas.",1.8948778188548325e-07,0.15718558352241319,0.0,0.014507411718254981,0.16034265007518078,0.0,0.014486412327622933,0.16362942378180145,0.0,1.8948778188548325e-07,0.16705408466316607,0.0
236,0.3,8,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or","Does the surgeon's experience level affect their ability to perform transurethral resection of the prostate? The senior urologist was capable of resecting tissue four times faster than less experienced surgeons, implying that experience might be crucial in lowering the risk of secondary TURP due to recurring adenomas.",2.1317375462116866e-07,0.17869178874337655,0.0,0.016320838183036854,0.18232155679395579,0.0,0.0162972138685758,0.18610227963385917,0.0,2.1317375462116866e-07,0.1900436028878656,0.0
236,0.3,9,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or","Is the ability to perform transurethral resection of the prostate linked to the surgeon's previous experience? The senior urologist resected four times more tissue per unit time than less experienced surgeons, suggesting that experience may be significant in reducing the risk of secondary TURP from recurring adenomas.",2.1317375462116866e-07,0.17869178874337655,0.0,0.016320838183036854,0.18232155679395579,0.0,0.0162972138685758,0.18610227963385917,0.0,2.1317375462116866e-07,0.1900436028878656,0.0
236,0.3,10,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or","Does the surgeon's prior experience influence their capability to perform transurethral resection of the prostate? The senior urologist resected tissue at a rate four times higher than less experienced surgeons, indicating that experience might be important to minimize the risk of secondary TURP caused by recurring adenomas.",2.1317375462116866e-07,0.17869178874337655,0.0,0.016320838183036854,0.18232155679395579,0.0,0.0162972138685758,0.18610227963385917,0.0,2.1317375462116866e-07,0.1900436028878656,0.0
237,0.3,1,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to,"Does pretreatment with estradiol and antagonist before microdose leuprolide enhance IVF outcomes in poor responders compared to oral contraceptive pills? Evidence suggests E2 plus antagonist pretreatment does not improve IVF results over standard OCP in poor responders, based on current data from randomized trials.",2.6054570009253947e-07,0.13166274562510383,0.06838585774445835,0.0199476911126006,0.18030930050951177,0.03767781622452902,0.019918816950481533,0.21101214493250664,0.01922337562475971,2.6054570009253947e-07,0.24294617861038903,0.0
237,0.3,2,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to,"In poor responders undergoing IVF, does estradiol and antagonist pretreatment before microdose leuprolide yield better outcomes than oral contraceptive pills? Studies indicate no significant improvement with E2 and antagonist pretreatment compared to OCP in the microdose leuprolide protocol.",4.026615365066516e-07,0.3621077904236749,0.011178661140326535,0.030828249901291835,0.3729681570345442,0.009922714183712694,0.030783626196198732,0.3692361501474011,0.01922337562475971,4.026615365066519e-07,0.4054651081081633,0.0
237,0.3,3,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to,Is IVF success improved in poor responders by using estradiol and antagonist pretreatment prior to microdose leuprolide versus oral contraceptive pills? Research shows that E2 plus antagonist pretreatment does not enhance IVF outcomes relative to standard OCP treatment.,4.026615365066516e-07,0.28717296009286875,0.06462231529043971,0.030828249901291835,0.3344599803367694,0.03767781622452902,0.030783626196198732,0.3692361501474011,0.01922337562475971,4.026615365066519e-07,0.4054651081081633,0.0
237,0.3,4,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to,Does administering estradiol and antagonist before microdose leuprolide improve IVF outcomes for poor responders compared to oral contraceptive pills? The evidence suggests no benefit of E2 and antagonist pretreatment over OCP in poor responders undergoing IVF.,4.500334819780222e-07,0.3844922167177005,0.03469552210607078,0.03445510283085559,0.39161839417671773,0.03767781622452902,0.03440522927810448,0.42807665017033436,0.01922337562475971,4.500334819780227e-07,0.46608972992459874,0.0
237,0.3,5,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to,"For poor responders in IVF, does pretreatment with estradiol and antagonist prior to microdose leuprolide improve results compared to oral contraceptive pills? Current randomized trials indicate no improvement with E2 plus antagonist pretreatment versus OCP.",4.737194547137075e-07,0.33426293295553,0.09162848812994588,0.03626852929563747,0.4214713573263995,0.03767781622452902,0.03621603081905735,0.45884830883708805,0.01922337562475971,4.737194547137081e-07,0.49783842823917857,0.0
237,0.3,6,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to,Does estradiol and antagonist pretreatment before microdose leuprolide protocol improve IVF outcomes in poor responders compared to oral contraceptive pill use? Data shows no significant advantage of E2 and antagonist pretreatment over standard OCP in poor responders.,4.263475092423369e-07,0.3926290492089062,0.00898386003077234,0.03264167636607371,0.40223926762117745,0.009131103421760864,0.032594427737151606,0.3982236870206526,0.01922337562475971,4.263475092423373e-07,0.43531807125784505,0.0
237,0.3,7,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to,"In IVF treatment of poor responders, is estradiol and antagonist pretreatment prior to microdose leuprolide more effective than oral contraceptive pills? Findings suggest no improvement in IVF outcomes with E2 plus antagonist pretreatment compared to OCP.",4.500334819780222e-07,0.3844922167177005,0.03469552210607078,0.03445510283085559,0.39161839417671773,0.03767781622452902,0.03440522927810448,0.42807665017033436,0.01922337562475971,4.500334819780227e-07,0.46608972992459874,0.0
237,0.3,8,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to,Does pretreatment with estradiol and antagonist before microdose leuprolide enhance IVF success in poor responders compared to oral contraceptive pills? Evidence indicates that E2 and antagonist pretreatment does not improve outcomes relative to OCP in poor responders.,4.263475092423369e-07,0.3541208725111318,0.036265166330637914,0.03264167636607371,0.3626308573034662,0.03767781622452902,0.032594427737151606,0.3982236870206526,0.01922337562475971,4.263475092423373e-07,0.43531807125784505,0.0
237,0.3,9,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to,Is there an improvement in IVF outcomes for poor responders using estradiol and antagonist pretreatment prior to microdose leuprolide versus oral contraceptive pills? Research demonstrates no benefit of E2 plus antagonist pretreatment over OCP in this patient group.,4.026615365066516e-07,0.28717296009286875,0.06462231529043971,0.030828249901291835,0.3344599803367694,0.03767781622452902,0.030783626196198732,0.3692361501474011,0.01922337562475971,4.026615365066519e-07,0.4054651081081633,0.0
237,0.3,10,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to,Does estradiol and antagonist pretreatment before microdose leuprolide protocol improve IVF results in poor responders compared to oral contraceptive pills? Current evidence from randomized trials shows no improvement with E2 and antagonist pretreatment over standard OCP.,4.500334819780222e-07,0.3844922167177005,0.03469552210607078,0.03445510283085559,0.43239175773906746,0.008293059567045086,0.03440522927810448,0.42807665017033436,0.01922337562475971,4.500334819780227e-07,0.46608972992459874,0.0
238,0.3,1,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is associated with less pain compared to traditional open surgery. The smaller incisions and use,Does minimal access major surgery in newborns cause less pain? Minimal access major surgery in newborns results in less pain than traditional open surgery due to smaller incisions and techniques used.,4.73719454713706e-08,0.1223007861842329,0.03755102040816327,0.003626852929563759,0.12374687100750004,0.03873673469387749,0.003621603081905747,0.12510478610370823,0.03927346938775517,4.737194547137081e-08,0.1263441813444901,0.03916122448979589
238,0.3,2,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is associated with less pain compared to traditional open surgery. The smaller incisions and use,Is pain reduced in newborns undergoing minimal access major surgery? Newborns experience less pain with minimal access major surgery compared to conventional open surgery because of smaller incisions.,1.184298636784265e-07,0.09930071284947628,0.04884897959183675,0.009067132323909398,0.09505216153483698,0.05726326530612246,0.009054007704764368,0.08990193271929581,0.06632653061224487,1.1842986367842703e-07,0.14143874580680782,0.03443877551020409
238,0.3,3,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is associated with less pain compared to traditional open surgery. The smaller incisions and use,"Does minimal access surgery in newborns lead to less pain? Minimal access major surgery in newborns is linked to reduced pain relative to open surgery, thanks to smaller incisions and advanced methods.",2.36859727356853e-08,0.007380578007353478,0.02678571428571426,0.0018134264647818796,0.05515788395773269,0.062369567327525556,0.0018108015409528735,0.05851807239897733,0.06632653061224487,2.3685972735685406e-08,0.012711934020451121,0.03443877551020409
238,0.3,4,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is associated with less pain compared to traditional open surgery. The smaller incisions and use,Is there less pain with minimal access major surgery in newborns? Minimal access major surgery in newborns causes less pain than traditional open surgery due to smaller incisions.,1.184298636784265e-07,0.2533334196405743,0.05317085511890712,0.009067132323909398,0.2016901893132892,0.017758284788395473,0.009054007704764368,0.20080548160888778,0.013068554453917719,1.1842986367842703e-07,0.1992010108534683,0.007149126191119168
238,0.3,5,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is associated with less pain compared to traditional open surgery. The smaller incisions and use,Do newborns feel less pain after minimal access major surgery? Minimal access major surgery in newborns is associated with less pain compared to open surgery because it involves smaller incisions.,7.10579182070559e-08,0.06856303916842643,0.02037797367467696,0.005440279394345639,0.01713568838902768,0.059997970381568295,0.005432404622858621,0.012940891583166358,0.06632653061224487,7.105791820705622e-08,0.06139603813327055,0.03443877551020409
238,0.3,6,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is associated with less pain compared to traditional open surgery. The smaller incisions and use,Does minimal access surgery cause less pain in newborns? Minimal access major surgery in newborns leads to less pain than traditional open surgery owing to smaller incisions and surgical techniques.,7.10579182070559e-08,0.020759785336706305,0.05386187396769407,0.005440279394345639,0.032374824508111466,0.09566326530612247,0.005432404622858621,0.012940891583166358,0.06632653061224487,7.105791820705622e-08,0.06139603813327055,0.03443877551020409
238,0.3,7,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is associated with less pain compared to traditional open surgery. The smaller incisions and use,Is pain less severe in newborns after minimal access major surgery? Minimal access major surgery in newborns is linked to reduced pain compared to open surgery due to smaller incisions.,7.10579182070559e-08,0.06856303916842643,0.02037797367467696,0.005440279394345639,0.01713568838902768,0.059997970381568295,0.005432404622858621,0.012940891583166358,0.06632653061224487,7.105791820705622e-08,0.06139603813327055,0.03443877551020409
238,0.3,8,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is associated with less pain compared to traditional open surgery. The smaller incisions and use,Are newborns less painful after minimal access major surgery? Minimal access major surgery in newborns results in less pain than traditional open surgery because of smaller incisions and surgical approach.,7.10579182070559e-08,0.020759785336706305,0.05386187396769407,0.005440279394345639,0.01713568838902768,0.059997970381568295,0.005432404622858621,0.012940891583166358,0.06632653061224487,7.105791820705622e-08,0.06139603813327055,0.03443877551020409
238,0.3,9,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is associated with less pain compared to traditional open surgery. The smaller incisions and use,Does minimal access major surgery reduce pain in newborns? Minimal access major surgery in newborns is associated with less pain than traditional open surgery as it uses smaller incisions.,9.47438909427412e-08,0.10877613617595161,0.01684897959183669,0.007253705859127518,0.10668129085682976,0.022063265306122487,0.007243206163811494,0.10400023345524012,0.027926530612244864,9.474389094274162e-08,0.10061675128655301,0.03443877551020409
238,0.3,10,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is associated with less pain compared to traditional open surgery. The smaller incisions and use,Is minimal access major surgery less painful for newborns? Minimal access major surgery in newborns causes less pain compared to traditional open surgery due to the use of smaller incisions.,7.10579182070559e-08,0.06856303916842643,0.02037797367467696,0.005440279394345639,0.06664620128616727,0.024657348146359143,0.005432404622858621,0.06428512718019963,0.029344282091534828,7.105791820705622e-08,0.06139603813327055,0.03443877551020409
239,0.3,1,ai,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: There is evidence suggesting that certain polymorphisms in the ACE-1 gene may increase the risk of developing chronic kidney disease in hypertensive patients.,Does the ACE-1 gene polymorphism contribute to chronic kidney disease in patients with hypertension? Evidence indicates that specific ACE-1 gene polymorphisms might raise the risk of chronic kidney disease among hypertensive individuals.,1.658018091497971e-07,0.26479361294772064,0.04319412950365333,0.012693985253473143,0.2184629278539978,0.0062875251390907515,0.012675610786670108,0.2162231084696371,0.0,1.6580180914979784e-07,0.22314355131420927,0.0
239,0.3,2,ai,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: There is evidence suggesting that certain polymorphisms in the ACE-1 gene may increase the risk of developing chronic kidney disease in hypertensive patients.,Is there a link between ACE-1 gene polymorphism and chronic kidney disease in hypertensive patients? Research suggests that certain polymorphisms in the ACE-1 gene could increase the likelihood of chronic kidney disease in those with hypertension.,7.10579182070559e-08,0.16770887839624438,0.059913798640819076,0.005440279394345625,0.12863669998736116,0.03158757716049383,0.005432404622858614,0.12902029702356588,0.0302734375,7.105791820705622e-08,0.08961215868968697,0.0
239,0.3,3,ai,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: There is evidence suggesting that certain polymorphisms in the ACE-1 gene may increase the risk of developing chronic kidney disease in hypertensive patients.,Can polymorphisms in the angiotensin-converting enzyme-1 gene cause chronic kidney disease in hypertensive patients? Studies show that some ACE-1 gene polymorphisms may elevate the risk of chronic kidney disease in hypertensive patients.,1.658018091497971e-07,0.3095127858870721,0.07373113854595337,0.012693985253473143,0.3108825519286573,0.07175925925925929,0.012675610786670108,0.31182961613307736,0.06858710562414266,1.6580180914979784e-07,0.2726540642113484,0.035665294924554176
239,0.3,4,ai,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: There is evidence suggesting that certain polymorphisms in the ACE-1 gene may increase the risk of developing chronic kidney disease in hypertensive patients.,Does the presence of ACE-1 gene polymorphism lead to chronic kidney disease in patients with high blood pressure? There is evidence that specific ACE-1 gene polymorphisms are associated with a higher risk of chronic kidney disease among hypertensive patients.,0.0,0.03648143055578723,0.025898211136306366,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
239,0.3,5,ai,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: There is evidence suggesting that certain polymorphisms in the ACE-1 gene may increase the risk of developing chronic kidney disease in hypertensive patients.,Is chronic kidney disease among hypertensive patients influenced by polymorphisms in the ACE-1 gene? Evidence suggests that certain ACE-1 gene polymorphisms may increase the risk of developing chronic kidney disease in hypertensive individuals.,1.421158364141118e-07,0.18553079338508116,0.009753086419753088,0.010880558788691264,0.18418246593302756,0.005216049382716036,0.010864809245717234,0.18232155679395534,0.0,1.4211583641411244e-07,0.18805223150294026,0.0
239,0.3,6,ai,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: There is evidence suggesting that certain polymorphisms in the ACE-1 gene may increase the risk of developing chronic kidney disease in hypertensive patients.,Do polymorphisms in the ACE-1 gene contribute to the development of chronic kidney disease in hypertensive patients? Research indicates that some ACE-1 gene polymorphisms might increase the risk of chronic kidney disease in these patients.,9.47438909427412e-08,0.2421295918103996,0.09021814124866043,0.007253705859127504,0.20296969611415117,0.06299382716049387,0.007243206163811487,0.2044264332263781,0.06222222222222223,9.474389094274162e-08,0.1660800299436178,0.0322222222222222
239,0.3,7,ai,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: There is evidence suggesting that certain polymorphisms in the ACE-1 gene may increase the risk of developing chronic kidney disease in hypertensive patients.,Are hypertensive patients with ACE-1 gene polymorphisms at greater risk for chronic kidney disease? There is evidence suggesting that specific polymorphisms in the ACE-1 gene may heighten the risk of chronic kidney disease in hypertensive patients.,7.10579182070559e-08,0.08849205776082192,0.004463830221405965,0.005440279394345625,0.047089972862661256,0.027006172839506164,0.005432404622858614,0.08701137698963013,0.0,7.105791820705622e-08,0.08961215868968697,0.0
239,0.3,8,ai,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: There is evidence suggesting that certain polymorphisms in the ACE-1 gene may increase the risk of developing chronic kidney disease in hypertensive patients.,Could ACE-1 gene polymorphism be a factor in chronic kidney disease among patients with hypertension? Studies suggest that certain polymorphisms in the ACE-1 gene may raise the risk of chronic kidney disease in hypertensive individuals.,9.47438909427412e-08,0.1605828646856997,0.03493981320897729,0.007253705859127504,0.11895185604627878,0.0032672646604938356,0.007243206163811487,0.11778303565638382,0.0,9.474389094274162e-08,0.1213608570042668,0.0
239,0.3,9,ai,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: There is evidence suggesting that certain polymorphisms in the ACE-1 gene may increase the risk of developing chronic kidney disease in hypertensive patients.,Is there an association between ACE-1 gene polymorphism and chronic kidney disease in hypertensive patients? Evidence points to some ACE-1 gene polymorphisms increasing the risk of chronic kidney disease in those with hypertension.,1.421158364141118e-07,0.2721741909550741,0.06997984378936759,0.010880558788691264,0.22890163887237902,0.037203101833502145,0.010864809245717234,0.2285313688312849,0.033293697978596916,1.4211583641411244e-07,0.18805223150294026,0.0
239,0.3,10,ai,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: There is evidence suggesting that certain polymorphisms in the ACE-1 gene may increase the risk of developing chronic kidney disease in hypertensive patients.,Does the ACE-1 gene polymorphism increase the risk of chronic kidney disease in hypertensive patients? Research supports that specific polymorphisms in the ACE-1 gene may contribute to the development of chronic kidney disease in hypertensive patients.,7.10579182070559e-08,0.2865341093493776,0.13503086419753085,0.005440279394345625,0.25095679067440946,0.1156811042116234,0.005432404622858614,0.21303813709143826,0.09000000000000004,7.105791820705622e-08,0.17625555625968126,0.06222222222222223
240,0.3,1,ai,Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: The impact of birth center care during a woman's first pregnancy on her future reproduction is not yet well-documented. Further research is needed to determine if there are any,Does receiving birth center care during a woman's initial pregnancy affect her subsequent reproductive outcomes? The influence of birth center care during a first pregnancy on future reproduction remains insufficiently studied. Additional research is necessary to clarify any potential effects.,1.6580180914979774e-07,0.036032281960885815,0.08285147806383321,0.012693985253473108,0.06287483220375467,0.07190966137147378,0.012675610786670066,0.09067310147758256,0.057891022286626674,1.6580180914979784e-07,0.0872317389473305,0.0642896053885065
240,0.3,2,ai,Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: The impact of birth center care during a woman's first pregnancy on her future reproduction is not yet well-documented. Further research is needed to determine if there are any,Is there an effect of birth center care during a woman's first pregnancy on her later reproductive health? The impact of birth center care in a first pregnancy on future reproductive outcomes is currently not well understood. More studies are required to establish any connections.,4.737194547137081e-08,0.06924629273840877,0.07230739455271676,0.0036268529295637453,0.07346520418985847,0.0809020083102493,0.003621603081905733,0.07800642589427387,0.0879732134022163,4.737194547137081e-08,0.08132956599864194,0.09204470742932283
240,0.3,3,ai,Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: The impact of birth center care during a woman's first pregnancy on her future reproduction is not yet well-documented. Further research is needed to determine if there are any,How does birth center care during a woman's first pregnancy influence her future reproductive possibilities? The effects of birth center care during a first pregnancy on subsequent reproduction have not been thoroughly documented. Further investigation is needed to identify any impacts.,1.4211583641411244e-07,0.04181723207864341,0.06162698826791488,0.010880558788691236,0.03409308191158855,0.0738881194213604,0.0108648092457172,0.0620328851761891,0.05929943750456571,1.4211583641411244e-07,0.05879200322684275,0.06503853458981666
240,0.3,4,ai,Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: The impact of birth center care during a woman's first pregnancy on her future reproduction is not yet well-documented. Further research is needed to determine if there are any,Does care at a birth center during a woman's first pregnancy influence her future reproductive health? The consequences of birth center care in a first pregnancy on future reproduction are not yet clearly documented. More research is needed to determine any effects.,1.1842986367842703e-07,0.08853806047513402,0.13542376536139528,0.009067132323909363,0.09786275385115539,0.1502770083102493,0.009054007704764333,0.036905462338642,0.11176857330703485,1.1842986367842703e-07,0.005343659020720537,0.09204470742932283
240,0.3,5,ai,Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: The impact of birth center care during a woman's first pregnancy on her future reproduction is not yet well-documented. Further research is needed to determine if there are any,What is the impact of birth center care during a woman's initial pregnancy on her future reproductive outcomes? The role of birth center care during a first pregnancy in shaping future reproduction is not well established. Additional research is required to understand any potential influence.,4.737194547137081e-08,0.06924629273840877,0.07230739455271676,0.0036268529295637453,0.04122580044288515,0.05823230088092646,0.003621603081905733,0.01199240869808671,0.04076265614727155,4.737194547137081e-08,0.013705450822062204,0.04339250493096649
240,0.3,6,ai,Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: The impact of birth center care during a woman's first pregnancy on her future reproduction is not yet well-documented. Further research is needed to determine if there are any,Can birth center care during a woman's first pregnancy affect her future reproductive health? The impact of birth center care during a first pregnancy on later reproduction is not well documented at this time. Further studies are necessary to explore any effects.,1.1842986367842703e-07,0.012898112289735586,0.0644772024276528,0.009067132323909363,0.0061093232328355285,0.07577006893844505,0.009054007704764333,0.03418655618032629,0.0606363600126594,1.1842986367842703e-07,0.031137771535065806,0.06574814059221545
240,0.3,7,ai,Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: The impact of birth center care during a woman's first pregnancy on her future reproduction is not yet well-documented. Further research is needed to determine if there are any,Does receiving care at a birth center during a woman's first pregnancy have any bearing on her future reproduction? The influence of birth center care during a first pregnancy on subsequent reproductive outcomes is currently unclear. More research is needed to assess any impact.,7.105791820705622e-08,0.10707201340004513,0.11470096785975162,0.005440279394345618,0.1466529180205871,0.1502770083102493,0.0054324046228586,0.08691588291330543,0.11176857330703485,7.105791820705622e-08,0.05663695340827024,0.09204470742932283
240,0.3,8,ai,Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: The impact of birth center care during a woman's first pregnancy on her future reproduction is not yet well-documented. Further research is needed to determine if there are any,Is there a relationship between birth center care during a woman's first pregnancy and her future reproductive health? The effect of birth center care in a first pregnancy on later reproduction has not been well documented. Further research is essential to determine any connections.,7.105791820705622e-08,0.10707201340004513,0.11470096785975162,0.005440279394345618,0.11364590942249553,0.12648164840543075,0.0054324046228586,0.08691588291330543,0.11176857330703485,7.105791820705622e-08,0.05663695340827024,0.09204470742932283
240,0.3,9,ai,Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: The impact of birth center care during a woman's first pregnancy on her future reproduction is not yet well-documented. Further research is needed to determine if there are any,How might birth center care during a woman's first pregnancy impact her future reproductive outcomes? The impact of birth center care during a first pregnancy on subsequent reproduction remains poorly documented. Additional research is needed to clarify any effects.,1.8948778188548304e-07,0.10223088410514114,0.05551765748325943,0.014507411718254981,0.09250103311476376,0.06982718132062994,0.014486412327622933,0.12015359873044185,0.05640525150772688,1.8948778188548325e-07,0.11650284953396373,0.06349799462655467
240,0.3,10,ai,Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: The impact of birth center care during a woman's first pregnancy on her future reproduction is not yet well-documented. Further research is needed to determine if there are any,Does care at a birth center during a woman's first pregnancy have an impact on her future reproductive health? The influence of birth center care during a first pregnancy on future reproduction is not yet well documented. More research is required to establish any effects.,4.737194547137081e-08,0.13225967278931083,0.11625919213101868,0.0036268529295637453,0.17018341543078153,0.1502770083102493,0.003621603081905733,0.11101343449236545,0.11176857330703485,4.737194547137081e-08,0.08132956599864194,0.09204470742932283
241,0.3,1,ai,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: There is currently no evidence to suggest a direct association between the CYP2D6*4 allele and breast cancer risk.,"Is there a link between the CYP2D6*4 allele and breast cancer risk? Currently, no evidence supports a direct connection between the CYP2D6*4 allele and breast cancer risk.",7.10579182070559e-08,0.23790035997346903,0.0756,0.005440279394345639,0.24205601883956573,0.08189999999999996,0.005432404622858621,0.246143624648965,0.08640000000000005,7.105791820705622e-08,0.25010431182743975,0.08909999999999998
241,0.3,2,ai,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: There is currently no evidence to suggest a direct association between the CYP2D6*4 allele and breast cancer risk.,"Does the CYP2D6*4 allele influence breast cancer risk? At present, no data indicate a direct association between the CYP2D6*4 allele and breast cancer risk.",1.421158364141118e-07,0.2214096023547767,0.006899999999999962,0.010880558788691277,0.15564389817637636,0.06024852607709753,0.010864809245717241,0.14862595708684134,0.07359999999999998,1.4211583641411238e-07,0.2090452505782654,0.03840000000000001
241,0.3,3,ai,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: There is currently no evidence to suggest a direct association between the CYP2D6*4 allele and breast cancer risk.,Is the CYP2D6*4 allele associated with breast cancer risk? There is no current evidence suggesting a direct relationship between the CYP2D6*4 allele and breast cancer risk.,9.47438909427412e-08,0.12356231312578059,0.016631404958677695,0.007253705859127518,0.06338140618250288,0.06401209829867678,0.007243206163811494,0.05765417888111335,0.07359999999999998,9.474389094274162e-08,0.11373507077394018,0.03840000000000001
241,0.3,4,ai,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: There is currently no evidence to suggest a direct association between the CYP2D6*4 allele and breast cancer risk.,"Can the CYP2D6*4 allele affect breast cancer risk? Currently, no proof exists that directly links the CYP2D6*4 allele to breast cancer risk.",1.894877818854824e-07,0.3296024285247259,0.004488888888888903,0.014507411718255037,0.2572554159857918,0.055738504155124706,0.014486412327622988,0.24870941564382276,0.07359999999999998,1.894877818854831e-07,0.31440576623609084,0.03840000000000001
241,0.3,5,ai,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: There is currently no evidence to suggest a direct association between the CYP2D6*4 allele and breast cancer risk.,"Is there any correlation between the CYP2D6*4 allele and breast cancer risk? Presently, no evidence shows a direct association between the CYP2D6*4 allele and breast cancer risk.",7.10579182070559e-08,0.23790035997346903,0.0756,0.005440279394345639,0.24205601883956573,0.08189999999999996,0.005432404622858621,0.246143624648965,0.08640000000000005,7.105791820705622e-08,0.25010431182743975,0.08909999999999998
241,0.3,6,ai,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: There is currently no evidence to suggest a direct association between the CYP2D6*4 allele and breast cancer risk.,"Does carrying the CYP2D6*4 allele increase breast cancer risk? To date, no evidence supports a direct connection between the CYP2D6*4 allele and breast cancer risk.",1.184298636784265e-07,0.17131577945163246,0.01195102040816326,0.009067132323909398,0.10845242342941619,0.06221157024793391,0.009054007704764368,0.1021059414519474,0.07359999999999998,1.1842986367842703e-07,0.16025508640883412,0.03840000000000001
241,0.3,7,ai,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: There is currently no evidence to suggest a direct association between the CYP2D6*4 allele and breast cancer risk.,Is breast cancer risk related to the CYP2D6*4 allele? There is no current evidence of a direct association between the CYP2D6*4 allele and breast cancer risk.,9.47438909427412e-08,0.0681105386809846,0.05500491493383737,0.007253705859127518,0.005619141135842387,0.10560000000000004,0.007243206163811494,0.05765417888111335,0.07359999999999998,9.474389094274162e-08,0.11373507077394018,0.03840000000000001
241,0.3,8,ai,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: There is currently no evidence to suggest a direct association between the CYP2D6*4 allele and breast cancer risk.,"Is the CYP2D6*4 allele linked to breast cancer risk? At this time, no evidence suggests a direct link between the CYP2D6*4 allele and breast cancer risk.",9.47438909427412e-08,0.12356231312578059,0.016631404958677695,0.007253705859127518,0.06338140618250288,0.06401209829867678,0.007243206163811494,0.05765417888111335,0.07359999999999998,9.474389094274162e-08,0.11373507077394018,0.03840000000000001
241,0.3,9,ai,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: There is currently no evidence to suggest a direct association between the CYP2D6*4 allele and breast cancer risk.,"Is there an association between the CYP2D6*4 allele and breast cancer risk? Currently, no evidence indicates a direct association between the CYP2D6*4 allele and breast cancer risk.",7.10579182070559e-08,0.2912193738626958,0.09828698060941835,0.005440279394345639,0.29750779328436083,0.11046648199445976,0.005432404622858621,0.30390588969562726,0.12030581717451529,7.105791820705622e-08,0.3103779797022175,0.1278049861495845
241,0.3,10,ai,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: There is currently no evidence to suggest a direct association between the CYP2D6*4 allele and breast cancer risk.,Does the CYP2D6*4 allele have any impact on breast cancer risk? There is presently no evidence to suggest a direct association between the CYP2D6*4 allele and breast cancer risk.,2.36859727356853e-08,0.007590156824194949,0.028799999999999923,0.0018134264647818796,0.0608196589235086,0.06861775147929,0.0018108015409528735,0.06494814321121956,0.07359999999999998,2.3685972735685406e-08,0.014098300735944314,0.03840000000000001
242,0.3,1,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, high-sensitivity C-reactive protein is associated with carotid atherosclerosis in healthy Koreans.","Question: Is high-sensitivity C-reactive protein linked to carotid atherosclerosis in healthy Koreans? Answer: Yes, high-sensitivity C-reactive protein is linked to carotid atherosclerosis in healthy Koreans.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
242,0.3,2,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, high-sensitivity C-reactive protein is associated with carotid atherosclerosis in healthy Koreans.","Question: Does high-sensitivity C-reactive protein correlate with carotid atherosclerosis in healthy Koreans? Answer: Yes, high-sensitivity C-reactive protein correlates with carotid atherosclerosis in healthy Koreans.",2.36859727356853e-08,0.00013423365917120123,0.01384083044982698,0.0018134264647818796,0.004863056599439197,0.027777777777777762,0.0018108015409528735,0.010492090125448161,0.03878116343490301,2.3685972735685353e-08,0.013923152166944064,0.044321329639889225
242,0.3,3,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, high-sensitivity C-reactive protein is associated with carotid atherosclerosis in healthy Koreans.","Question: Is there an association between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Koreans? Answer: Yes, there is an association between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Koreans.",1.421158364141118e-07,0.16538128626754656,0.007785467128027662,0.010880558788691277,0.10294066894572973,0.04688271604938271,0.010864809245717241,0.0341180937924892,0.10703601108033248,1.4211583641411244e-07,0.023932813494046634,0.13331717451523553
242,0.3,4,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, high-sensitivity C-reactive protein is associated with carotid atherosclerosis in healthy Koreans.","Question: Is high-sensitivity C-reactive protein related to carotid atherosclerosis in healthy Koreans? Answer: Yes, high-sensitivity C-reactive protein is related to carotid atherosclerosis in healthy Koreans.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
242,0.3,5,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, high-sensitivity C-reactive protein is associated with carotid atherosclerosis in healthy Koreans.","Question: Does high-sensitivity C-reactive protein have a connection with carotid atherosclerosis in healthy Koreans? Answer: Yes, high-sensitivity C-reactive protein has a connection with carotid atherosclerosis in healthy Koreans.",7.10579182070559e-08,0.11136500620675438,0.0015527801474182479,0.005440279394345639,0.10405657813086311,0.009382716049382706,0.005432404622858621,0.09506641388341341,0.021231022418200934,7.105791820705622e-08,0.09227263187690848,0.028266154107072144
242,0.3,6,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, high-sensitivity C-reactive protein is associated with carotid atherosclerosis in healthy Koreans.","Question: Is high-sensitivity C-reactive protein associated with carotid artery atherosclerosis in healthy Koreans? Answer: Yes, high-sensitivity C-reactive protein is associated with carotid artery atherosclerosis in healthy Koreans.",4.73719454713706e-08,0.05782645188635893,0.0046990473749412565,0.003626852929563759,0.05203930164416626,0.015449198043842538,0.003621603081905747,0.04500245695569438,0.02703601108033246,4.737194547137081e-08,0.04217880897376425,0.03331717451523544
242,0.3,7,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, high-sensitivity C-reactive protein is associated with carotid atherosclerosis in healthy Koreans.","Question: Is there a link between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Koreans? Answer: Yes, there is a link between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Koreans.",1.421158364141118e-07,0.16538128626754656,0.007785467128027662,0.010880558788691277,0.10294066894572973,0.04688271604938271,0.010864809245717241,0.0341180937924892,0.10703601108033248,1.4211583641411244e-07,0.023932813494046634,0.13331717451523553
242,0.3,8,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, high-sensitivity C-reactive protein is associated with carotid atherosclerosis in healthy Koreans.","Question: Is high-sensitivity C-reactive protein connected to carotid atherosclerosis in healthy Koreans? Answer: Yes, high-sensitivity C-reactive protein is connected to carotid atherosclerosis in healthy Koreans.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
242,0.3,9,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, high-sensitivity C-reactive protein is associated with carotid atherosclerosis in healthy Koreans.","Question: Does high-sensitivity C-reactive protein show an association with carotid atherosclerosis in healthy Koreans? Answer: Yes, high-sensitivity C-reactive protein shows an association with carotid atherosclerosis in healthy Koreans.",7.10579182070559e-08,0.11136500620675438,0.0015527801474182479,0.005440279394345639,0.10405657813086311,0.009382716049382706,0.005432404622858621,0.09506641388341341,0.021231022418200934,7.105791820705622e-08,0.09227263187690848,0.028266154107072144
242,0.3,10,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, high-sensitivity C-reactive protein is associated with carotid atherosclerosis in healthy Koreans.","Question: Is high-sensitivity C-reactive protein a marker for carotid atherosclerosis in healthy Koreans? Answer: Yes, high-sensitivity C-reactive protein is a marker for carotid atherosclerosis in healthy Koreans.",4.73719454713706e-08,0.05782645188635893,0.0046990473749412565,0.003626852929563759,0.05203930164416626,0.015449198043842538,0.003621603081905747,0.04500245695569438,0.02703601108033246,4.737194547137081e-08,0.04217880897376425,0.03331717451523544
243,0.3,1,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other",Is the fragility of the esophageal mucosa a definitive endoscopic indicator of primary eosinophilic esophagitis? Primary eosinophilic esophagitis features an esophageal mucosa that is delicate and tears easily with minimal trauma during routine diagnostic endoscopy. This 'crêpe-paper' appearance can help endoscopists recognize the disease even when other signs are absent.,2.3685972735685406e-08,0.02133437618373879,0.0008118618278758691,0.0018134264647818726,0.02061928720273576,0.0,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
243,0.3,2,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other","Question: Does the fragile nature of the esophageal mucosa serve as a pathognomonic endoscopic sign for primary eosinophilic esophagitis? Answer: In primary eosinophilic esophagitis, the esophageal mucosa is notably fragile and prone to tearing with slight trauma during otherwise normal diagnostic endoscopy. This 'crêpe-paper' sign can alert endoscopists to the disease's presence when other indicators are lacking.",1.4211583641411244e-07,0.09451469040609073,0.013469230845298837,0.010880558788691236,0.09030753510148237,0.0181755829903978,0.0108648092457172,0.11778303565638426,0.0,1.4211583641411244e-07,0.12014431184206309,0.0
243,0.3,3,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other",Is the fragility of the esophageal lining a specific endoscopic marker for primary eosinophilic esophagitis? Primary eosinophilic esophagitis is marked by an esophageal mucosa that easily tears upon minor trauma during routine diagnostic endoscopy. This characteristic 'crêpe-paper' sign may help endoscopists identify the disease even if other signs are not evident.,0.0,0.02772588722239755,0.019938885418112832,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
243,0.3,4,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other",Question: Can the fragile esophageal mucosa be considered a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis presents with an esophageal mucosa that is fragile and tears easily during minor trauma in otherwise uneventful diagnostic endoscopy. This 'crêpe-paper' sign may alert endoscopists to the disease when other signs are not present.,7.105791820705622e-08,0.061407687809529765,0.00225273933102655,0.005440279394345618,0.05942342047080107,0.0,0.0054324046228586,0.06062462181643413,0.0,7.105791820705622e-08,0.06187540371808753,0.0
243,0.3,5,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other",Is the delicate nature of the esophageal mucosa a definitive endoscopic sign of primary eosinophilic esophagitis? The disease is characterized by an esophageal mucosa that tears easily with slight trauma during routine diagnostic endoscopy. This 'crêpe-paper' sign can help endoscopists detect the disease when other signs are absent.,7.105791820705622e-08,0.06541487868264895,0.0025385802469135646,0.005440279394345618,0.06317890162153228,0.0,0.0054324046228586,0.06453852113757153,0.0,7.105791820705622e-08,0.06595796779179608,0.0
243,0.3,6,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other",Question: Does fragile esophageal mucosa indicate primary eosinophilic esophagitis in endoscopy? Answer: Primary eosinophilic esophagitis is identified by an esophageal mucosa that is fragile and tears readily with minor trauma during otherwise normal diagnostic endoscopy. This 'crêpe-paper' sign may alert endoscopists to the disease even when other signs are missing.,2.3685972735685406e-08,0.049626097839246874,0.021033527620247808,0.0018134264647818726,0.04950041972606645,0.020823902218198284,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
243,0.3,7,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other",Is the fragility of the esophageal mucosa a hallmark endoscopic sign of primary eosinophilic esophagitis? Primary eosinophilic esophagitis features a fragile esophageal mucosa that tears easily during minor trauma in routine diagnostic endoscopy. This 'crêpe-paper' sign can help endoscopists recognize the disease when other signs are not apparent.,7.105791820705622e-08,0.06541487868264895,0.0025385802469135646,0.005440279394345618,0.06317890162153228,0.0,0.0054324046228586,0.06453852113757153,0.0,7.105791820705622e-08,0.06595796779179608,0.0
243,0.3,8,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other",Question: Is fragile esophageal mucosa a pathognomonic endoscopic feature of primary eosinophilic esophagitis? Answer: The disease is characterized by an esophageal mucosa that is fragile and tears easily with minor trauma during otherwise uneventful diagnostic endoscopy. This 'crêpe-paper' sign may alert endoscopists to the presence of the disease when other signs are absent.,4.737194547137081e-08,0.014693966764237842,0.0175454960895923,0.0036268529295637453,0.04000533461369837,0.0,0.003621603081905733,0.04082199452025437,0.0,4.737194547137081e-08,0.04167269640056892,0.0
243,0.3,9,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other",Is fragile esophageal mucosa a specific endoscopic sign of primary eosinophilic esophagitis? Primary eosinophilic esophagitis is marked by an esophageal mucosa that tears easily with slight trauma during routine diagnostic endoscopy. This 'crêpe-paper' sign may help endoscopists identify the disease even if other signs are not visible.,9.474389094274162e-08,0.08820350236903307,0.0034578741965105575,0.0072537058591274906,0.08515780834030728,0.0,0.007243206163811466,0.08701137698962924,0.0,9.474389094274162e-08,0.0889474860164956,0.0
243,0.3,10,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other",Question: Can fragile esophageal mucosa be considered a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by an esophageal mucosa that is fragile and tears readily with minor trauma during otherwise uneventful diagnostic endoscopy. This 'crêpe-paper' sign may alert endoscopists to the disease when other signs are not evident.,7.105791820705622e-08,0.061407687809529765,0.00225273933102655,0.005440279394345618,0.05942342047080107,0.0,0.0054324046228586,0.06062462181643413,0.0,7.105791820705622e-08,0.06187540371808753,0.0
244,0.3,1,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: The impact of discharging patients earlier from Winnipeg hospitals on the quality of care is a complex issue that requires further investigation. While it may lead to increased patient satisfaction and reduced healthcare costs, potential risks such as inadequate follow-up care and readmission","Question: Does discharging patients earlier from Winnipeg hospitals negatively impact the quality of care? Answer: The effect of earlier patient discharge from Winnipeg hospitals on care quality is a multifaceted matter needing more research. Although it might boost patient satisfaction and lower healthcare expenses, there are risks like insufficient follow-up and readmissions.",1.4211583641411244e-07,0.04398535134073489,0.04775793000450997,0.010880558788691236,0.06678880318369318,0.03340811626341167,0.0108648092457172,0.06510218308112092,0.03631185475258099,1.4211583641411244e-07,0.0921109178578674,0.01851192595229618
244,0.3,2,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: The impact of discharging patients earlier from Winnipeg hospitals on the quality of care is a complex issue that requires further investigation. While it may lead to increased patient satisfaction and reduced healthcare costs, potential risks such as inadequate follow-up care and readmission","Question: Is early discharge from Winnipeg hospitals detrimental to care quality? Answer: The consequences of earlier discharge from Winnipeg hospitals on care quality are complex and warrant further study. It could increase patient satisfaction and reduce costs, but risks such as poor follow-up and readmission remain.",2.8423167282822487e-07,0.20720363361960015,0.020581753411423778,0.02176111757738247,0.22990966752208353,0.008048312477951909,0.0217296184914344,0.22796176924515965,0.013069224367093464,2.8423167282822487e-07,0.22564231048239058,0.01851192595229618
244,0.3,3,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: The impact of discharging patients earlier from Winnipeg hospitals on the quality of care is a complex issue that requires further investigation. While it may lead to increased patient satisfaction and reduced healthcare costs, potential risks such as inadequate follow-up care and readmission","Question: Does releasing patients sooner from Winnipeg hospitals harm the quality of care? Answer: The influence of earlier patient discharge on care quality in Winnipeg hospitals is intricate and requires additional research. While it may enhance patient satisfaction and cut healthcare costs, risks like inadequate follow-up care and readmissions exist.",1.8948778188548325e-07,0.05791792286014186,0.06650897846811311,0.014507411718254981,0.07988491048154955,0.0533997864008544,0.014486412327622933,0.10677487948168984,0.03631185475258099,1.8948778188548325e-07,0.13467053227666392,0.01851192595229618
244,0.3,4,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: The impact of discharging patients earlier from Winnipeg hospitals on the quality of care is a complex issue that requires further investigation. While it may lead to increased patient satisfaction and reduced healthcare costs, potential risks such as inadequate follow-up care and readmission","Question: How does discharging patients earlier from Winnipeg hospitals affect care quality? Answer: The impact of earlier discharge on the quality of care in Winnipeg hospitals is complicated and needs more investigation. It might improve patient satisfaction and reduce costs, but potential dangers include insufficient follow-up and readmission.",2.3685972735685406e-07,0.10079452230988117,0.06564174338094657,0.018134264647818726,0.12244452490034607,0.0533997864008544,0.018108015409528666,0.1502599914214282,0.03631185475258099,2.3685972735685406e-07,0.17912229484749664,0.01851192595229618
244,0.3,5,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: The impact of discharging patients earlier from Winnipeg hospitals on the quality of care is a complex issue that requires further investigation. While it may lead to increased patient satisfaction and reduced healthcare costs, potential risks such as inadequate follow-up care and readmission","Question: Does earlier discharge from Winnipeg hospitals compromise the quality of care? Answer: The effect of early patient discharge on care quality in Winnipeg hospitals is a complex issue that calls for further study. It could lead to higher patient satisfaction and lower healthcare costs, yet risks such as inadequate follow-up and readmission are possible.",7.105791820705622e-08,0.04186542945049787,0.06839635807137248,0.005440279394345618,0.019205992162680374,0.0533997864008544,0.0054324046228586,0.005678762610319854,0.03631185475258099,7.105791820705622e-08,0.03148629604143327,0.01851192595229618
244,0.3,6,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: The impact of discharging patients earlier from Winnipeg hospitals on the quality of care is a complex issue that requires further investigation. While it may lead to increased patient satisfaction and reduced healthcare costs, potential risks such as inadequate follow-up care and readmission","Question: Is the quality of care affected by earlier discharge from Winnipeg hospitals? Answer: The relationship between earlier discharge and care quality in Winnipeg hospitals is complex and requires more research. While it may increase patient satisfaction and reduce costs, there are potential risks like poor follow-up care and readmission.",1.8948778188548325e-07,0.05791792286014186,0.06650897846811311,0.014507411718254981,0.07988491048154955,0.0533997864008544,0.014486412327622933,0.10677487948168984,0.03631185475258099,1.8948778188548325e-07,0.13467053227666392,0.01851192595229618
244,0.3,7,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: The impact of discharging patients earlier from Winnipeg hospitals on the quality of care is a complex issue that requires further investigation. While it may lead to increased patient satisfaction and reduced healthcare costs, potential risks such as inadequate follow-up care and readmission","Question: What is the impact of discharging patients earlier from Winnipeg hospitals on care quality? Answer: The impact is multifaceted and needs further investigation. Early discharge might improve patient satisfaction and reduce healthcare costs, but it also poses risks such as insufficient follow-up and readmission.",3.079176455639103e-07,0.16876355542245136,0.06419330295281955,0.023574544042164344,0.18988580569587832,0.0533997864008544,0.023540420032387266,0.21925286290837986,0.03631185475258099,3.079176455639103e-07,0.2497398620614506,0.01851192595229618
244,0.3,8,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: The impact of discharging patients earlier from Winnipeg hospitals on the quality of care is a complex issue that requires further investigation. While it may lead to increased patient satisfaction and reduced healthcare costs, potential risks such as inadequate follow-up care and readmission","Question: Does earlier patient discharge from Winnipeg hospitals adversely affect care quality? Answer: The issue is complex and requires more study. Although early discharge can enhance patient satisfaction and lower costs, it carries risks including inadequate follow-up and readmission.",4.500334819780225e-07,0.28386033958887413,0.08690828402366867,0.03445510283085558,0.340168008745215,0.0533997864008544,0.034405229278104466,0.3734035427356375,0.03631185475258099,4.500334819780227e-07,0.40796386727634504,0.01851192595229618
244,0.3,9,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: The impact of discharging patients earlier from Winnipeg hospitals on the quality of care is a complex issue that requires further investigation. While it may lead to increased patient satisfaction and reduced healthcare costs, potential risks such as inadequate follow-up care and readmission","Question: Can discharging patients earlier from Winnipeg hospitals negatively influence the quality of care? Answer: The effect is complicated and calls for further research. Early discharge may boost patient satisfaction and reduce expenses, but risks like insufficient follow-up and readmission remain.",4.026615365066519e-07,0.23256704520132443,0.08690828402366867,0.030828249901291835,0.2875242752597962,0.0533997864008544,0.030783626196198732,0.3193363214653613,0.03631185475258099,4.026615365066519e-07,0.35239401612153287,0.01851192595229618
244,0.3,10,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: The impact of discharging patients earlier from Winnipeg hospitals on the quality of care is a complex issue that requires further investigation. While it may lead to increased patient satisfaction and reduced healthcare costs, potential risks such as inadequate follow-up care and readmission","Question: Does releasing patients earlier from Winnipeg hospitals impact the quality of care negatively? Answer: The impact is complex and needs more investigation. While early discharge might increase patient satisfaction and reduce healthcare costs, potential risks such as inadequate follow-up care and readmission exist.",3.316036182995957e-07,0.1602463836216983,0.08690828402366867,0.025387970506946217,0.21341630310607274,0.0533997864008544,0.025351221573340132,0.24335041448743988,0.03631185475258099,3.316036182995957e-07,0.2744324746518223,0.01851192595229618
245,0.3,1,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.",Is there a link between androgens and sexual desire in women? The current study found that FT and androstenedione were significantly correlated with sexual desire across the entire group of women. ADT-G did not show a stronger correlation than circulating androgens and thus is not a better measure than mass spectrometry of circulating androgens.,7.105791820705622e-08,0.05050248360208576,0.10792218377547103,0.005440279394345618,0.005678762610319854,0.036311854752580995,0.0054324046228586,0.05715841383995013,0.0,7.105791820705622e-08,0.05826890812397556,0.0
245,0.3,2,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.",Does a relationship exist between androgens and sexual desire in women? This study demonstrated that FT and androstenedione had a statistically significant association with sexual desire in the full cohort of women. ADT-G was not more strongly correlated than circulating androgens and therefore does not surpass mass spectrometry measurement of circulating androgens.,1.1842986367842703e-07,0.017197529591167715,0.08700625000000003,0.009067132323909363,0.07262536298600031,0.01632018461513826,0.009054007704764333,0.0971637484536485,0.0,1.1842986367842703e-07,0.09909090264422993,0.0
245,0.3,3,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.","Is there an association between androgens and female sexual desire? The present research revealed that FT and androstenedione were significantly linked to sexual desire in the entire female cohort. ADT-G did not correlate more strongly than circulating androgens, indicating it is not superior to mass spectrometry-based measurement of circulating androgens.",1.6580180914979784e-07,0.024343862919832926,0.14560000000000003,0.012693985253473108,0.08572147028385668,0.036311854752580995,0.012675610786670066,0.13883644485421742,0.0,1.6580180914979784e-07,0.14165051706302645,0.0
245,0.3,4,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.",Are androgens correlated with sexual desire in women? Findings from this study show that FT and androstenedione had a statistically significant correlation with sexual desire in the total group of women. ADT-G did not demonstrate a stronger correlation than circulating androgens and is thus not better than measuring circulating androgens via mass spectrometry.,9.474389094274162e-08,0.022870744387819553,0.06921111111111115,0.0072537058591274906,0.07946133321722204,0.0028384992665776987,0.007243206163811466,0.10468692835852789,0.019991670137442734,9.474389094274162e-08,0.07847161544149417,0.0
245,0.3,5,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.","Is there a correlation between androgens and sexual desire among women? The study found that FT and androstenedione were significantly associated with sexual desire in the overall female cohort. ADT-G was not more strongly correlated than circulating androgens, so it is not superior to mass spectrometry measurement of circulating androgens.",1.6580180914979784e-07,0.003947858735675158,0.12520069444444448,0.012693985253473108,0.08572147028385668,0.036311854752580995,0.012675610786670066,0.13883644485421742,0.0,1.6580180914979784e-07,0.14165051706302645,0.0
245,0.3,6,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.","Does sexual desire in women correlate with androgens? In this study, FT and androstenedione showed a statistically significant correlation with sexual desire in the total cohort of women. ADT-G did not have a stronger correlation than circulating androgens and is therefore not a better marker than mass spectrometry measurement of circulating androgens.",1.1842986367842703e-07,0.009984712783731808,0.10644964598084133,0.009067132323909363,0.07262536298600031,0.01632018461513826,0.009054007704764333,0.0971637484536485,0.0,1.1842986367842703e-07,0.09909090264422993,0.0
245,0.3,7,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.",Is sexual desire in women linked to androgens? The current study identified a significant correlation between FT and androstenedione and sexual desire in the entire cohort of women. ADT-G did not correlate more strongly than circulating androgens and is not superior to measuring circulating androgens by mass spectrometry.,2.1317375462116866e-07,0.10581570759477144,0.08206694214876038,0.016320838183036854,0.15841791864004184,0.014583459690852597,0.0162972138685758,0.18232155679395579,0.0,2.1317375462116866e-07,0.18610227963385917,0.0
245,0.3,8,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.",Are androgens associated with sexual desire in women? The present study showed that FT and androstenedione were statistically significantly correlated with sexual desire in the total female cohort. ADT-G did not correlate more strongly than circulating androgens and thus is not better than mass spectrometry analysis of circulating androgens.,1.8948778188548325e-07,0.08291882185289579,0.08337777777777781,0.014507411718254981,0.1657661288910468,0.006157281049888136,0.014486412327622933,0.19047948401256942,0.021728395061728398,1.8948778188548325e-07,0.16362942378180145,0.0
245,0.3,9,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.",Is there a statistical correlation between androgens and sexual desire in women? This study found that FT and androstenedione were significantly correlated with sexual desire in the full cohort of women. ADT-G did not show a stronger correlation than circulating androgens and is therefore not superior to mass spectrometry measurement of circulating androgens.,9.474389094274162e-08,0.0037887625567938343,0.08812394835485217,0.0072537058591274906,0.052279090842322073,0.016711854752581003,0.007243206163811466,0.07696104113612989,0.0,9.474389094274162e-08,0.07847161544149417,0.0
245,0.3,10,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.",Does the level of androgens relate to sexual desire in women? The study demonstrated that FT and androstenedione had a statistically significant correlation with sexual desire in the total group of women. ADT-G did not correlate more strongly than circulating androgens and is not superior to measuring circulating androgens by mass spectrometry.,1.1842986367842703e-07,0.017197529591167715,0.08700625000000003,0.009067132323909363,0.07262536298600031,0.01632018461513826,0.009054007704764333,0.0971637484536485,0.0,1.1842986367842703e-07,0.09909090264422993,0.0
246,0.3,1,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: There is evidence to suggest that a preoperative medically supervised weight loss program can improve outcomes for bariatric surgery. It can help patients achieve weight loss, reduce surgical risks, and improve long-term","Question: Can a medically supervised weight loss program before surgery enhance the results of bariatric surgery? Answer: Evidence indicates that undergoing a medically supervised weight loss program prior to bariatric surgery can lead to better outcomes by aiding weight loss, lowering surgical risks, and improving long-term results.",2.3685972735685406e-08,0.05613398518114998,0.023098395221215928,0.0018134264647818726,0.05678014054643832,0.023725741659206184,0.0018108015409528666,0.05742706313623902,0.0242279317005899,2.3685972735685406e-08,0.05807271571052475,0.024604965345367096
246,0.3,2,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: There is evidence to suggest that a preoperative medically supervised weight loss program can improve outcomes for bariatric surgery. It can help patients achieve weight loss, reduce surgical risks, and improve long-term","Question: Does participating in a preoperative medically supervised weight loss program benefit bariatric surgery outcomes? Answer: Research suggests that a medically supervised weight loss program before bariatric surgery can improve patient outcomes by facilitating weight loss, minimizing surgical risks, and enhancing long-term success.",7.105791820705622e-08,0.049188666328096264,0.013303884405755584,0.005440279394345618,0.014520289851564616,0.039053891866591625,0.0054324046228586,0.012677764647723855,0.042183211584447496,7.105791820705622e-08,0.01063295561892863,0.04538264846170235
246,0.3,3,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: There is evidence to suggest that a preoperative medically supervised weight loss program can improve outcomes for bariatric surgery. It can help patients achieve weight loss, reduce surgical risks, and improve long-term","Question: Is there an improvement in bariatric surgery outcomes with a preoperative medically supervised weight loss program? Answer: Studies show that a medically supervised weight loss regimen before bariatric surgery can help patients lose weight, reduce the risks associated with surgery, and improve long-term outcomes.",2.3685972735685406e-08,0.03633963219545233,0.040177514792899466,0.0018134264647818726,0.07006512440861146,0.06536762149263864,0.0018108015409528666,0.07242010897961038,0.06824934752450428,2.3685972735685406e-08,0.07492347421521872,0.0710059171597633
246,0.3,4,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: There is evidence to suggest that a preoperative medically supervised weight loss program can improve outcomes for bariatric surgery. It can help patients achieve weight loss, reduce surgical risks, and improve long-term","Question: Does a pre-surgery medically supervised weight loss program positively affect bariatric surgery results? Answer: Evidence supports that engaging in a medically supervised weight loss program before bariatric surgery can lead to weight loss, decreased surgical risks, and better long-term outcomes.",1.1842986367842703e-07,0.10623058264704976,0.007728535201062731,0.009067132323909363,0.06973256543981021,0.03537968441814596,0.009054007704764333,0.06761920209085259,0.03957557162685369,1.1842986367842703e-07,0.06519809501026597,0.043999744320257134
246,0.3,5,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: There is evidence to suggest that a preoperative medically supervised weight loss program can improve outcomes for bariatric surgery. It can help patients achieve weight loss, reduce surgical risks, and improve long-term","Question: Can bariatric surgery outcomes be improved by a preoperative medically supervised weight loss program? Answer: There is evidence that a medically supervised weight loss program prior to bariatric surgery can help patients lose weight, lower surgical risks, and improve long-term results.",9.474389094274162e-08,0.04349940526985252,0.03375676972350573,0.0072537058591274906,0.007091447733060363,0.06190707746215952,0.007243206163811466,0.004226863835505412,0.06642143873126188,9.474389094274162e-08,0.0010624327627026808,0.0710059171597633
246,0.3,6,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: There is evidence to suggest that a preoperative medically supervised weight loss program can improve outcomes for bariatric surgery. It can help patients achieve weight loss, reduce surgical risks, and improve long-term","Question: Does undergoing a medically supervised weight loss program before bariatric surgery improve surgical outcomes? Answer: Data suggests that preoperative medically supervised weight loss can enhance bariatric surgery outcomes by promoting weight loss, reducing surgical complications, and improving long-term health.",1.4211583641411233e-07,0.10044563252929217,0.02895302499698106,0.010880558788691236,0.0620328851761891,0.05929943750456571,0.0108648092457172,0.05879200322684275,0.06503853458981666,1.4211583641411244e-07,0.05512965403297887,0.0710059171597633
246,0.3,7,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: There is evidence to suggest that a preoperative medically supervised weight loss program can improve outcomes for bariatric surgery. It can help patients achieve weight loss, reduce surgical risks, and improve long-term","Question: Is a medically supervised weight loss program before bariatric surgery effective in improving outcomes? Answer: Evidence indicates that such a program can assist patients in losing weight, decreasing surgical risks, and achieving better long-term results after bariatric surgery.",1.6580180914979763e-07,0.015762918105385992,0.13017751479289946,0.012693985253473108,0.01573827114677684,0.11176857330703485,0.012675610786670066,0.04872356224955565,0.09204470742932283,1.6580180914979784e-07,0.08330053099967571,0.0710059171597633
246,0.3,8,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: There is evidence to suggest that a preoperative medically supervised weight loss program can improve outcomes for bariatric surgery. It can help patients achieve weight loss, reduce surgical risks, and improve long-term","Question: Does a preoperative medically supervised weight loss program contribute to better bariatric surgery outcomes? Answer: Research shows that it can help patients lose weight, reduce the risk of surgery, and improve long-term success following bariatric surgery.",2.1317375462116823e-07,0.0383043031648902,0.13017751479289946,0.016320838183036854,0.071308122301589,0.11176857330703485,0.016297213868575806,0.105881976089504,0.09204470742932283,2.1317375462116866e-07,0.142141031022609,0.0710059171597633
246,0.3,9,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: There is evidence to suggest that a preoperative medically supervised weight loss program can improve outcomes for bariatric surgery. It can help patients achieve weight loss, reduce surgical risks, and improve long-term","Question: Can a medically supervised weight loss program before surgery improve the results of bariatric surgery? Answer: There is evidence suggesting that preoperative medically supervised weight loss aids in weight reduction, lowers surgical risks, and enhances long-term outcomes in bariatric surgery.",1.1842986367842703e-07,0.036915864591055225,0.05567057542109523,0.009067132323909363,0.03418655618032629,0.0606363600126594,0.009054007704764333,0.031137771535065806,0.06574814059221545,1.1842986367842703e-07,0.02773067984486355,0.0710059171597633
246,0.3,10,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: There is evidence to suggest that a preoperative medically supervised weight loss program can improve outcomes for bariatric surgery. It can help patients achieve weight loss, reduce surgical risks, and improve long-term","Question: Does preoperative medically supervised weight loss improve the outcomes of bariatric surgery? Answer: Studies suggest that engaging in a medically supervised weight loss program before bariatric surgery can lead to weight loss, reduced surgical risks, and improved long-term outcomes.",1.4211583641411233e-07,0.06489962326980825,0.05378862590401057,0.010880558788691236,0.0620328851761891,0.05929943750456571,0.0108648092457172,0.05879200322684275,0.06503853458981666,1.4211583641411244e-07,0.05512965403297887,0.0710059171597633
247,0.3,1,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample may not generalize to all cases of child bipolar I disorder. Diagnostic characteristics may vary among individuals, and further research is needed to determine if the findings of the TEAM sample can be applied to a broader population.","Does the ""Treatment of Early Age Mania (TEAM)"" sample generalize to diagnostic characteristics of child bipolar I disorder? The TEAM sample might not be representative of all child bipolar I disorder cases, as diagnostic traits can differ among individuals, and more research is necessary to assess its broader applicability.",3.789755637709665e-07,0.1071749941809621,0.12288344041330834,0.029014823436509962,0.14644537019632864,0.10303098001843491,0.028972824655245866,0.16433546973794222,0.09566326530612247,3.789755637709665e-07,0.21330682613283436,0.06525084641428129
247,0.3,2,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample may not generalize to all cases of child bipolar I disorder. Diagnostic characteristics may vary among individuals, and further research is needed to determine if the findings of the TEAM sample can be applied to a broader population.","Is the ""Treatment of Early Age Mania (TEAM)"" sample applicable to the diagnostic features of child bipolar I disorder? The TEAM sample may not reflect all instances of child bipolar I disorder, since diagnostic characteristics vary and further studies are required to confirm its generalizability.",4.737194547137081e-07,0.2309441762002864,0.09665456638589869,0.03626852929563745,0.27037603900209417,0.0778965688467608,0.03621603081905733,0.28831425654176046,0.07186790540130392,4.737194547137081e-07,0.30639724919884603,0.06525084641428129
247,0.3,3,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample may not generalize to all cases of child bipolar I disorder. Diagnostic characteristics may vary among individuals, and further research is needed to determine if the findings of the TEAM sample can be applied to a broader population.","Can the diagnostic characteristics of child bipolar I disorder from the ""Treatment of Early Age Mania (TEAM)"" sample be generalized? The TEAM sample may not represent all child bipolar I disorder cases due to individual differences, and additional research is needed to verify its wider relevance.",4.500334819780227e-07,0.2063708743465309,0.09814481150238671,0.03445510283085558,0.24592109333435097,0.07894604673825452,0.034405229278104466,0.26401615428044867,0.07242063492063494,4.500334819780227e-07,0.282299697619786,0.06525084641428129
247,0.3,4,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample may not generalize to all cases of child bipolar I disorder. Diagnostic characteristics may vary among individuals, and further research is needed to determine if the findings of the TEAM sample can be applied to a broader population.","Does the ""Treatment of Early Age Mania (TEAM)"" sample generalize to all child bipolar I disorder diagnostic features? Diagnostic traits may differ among children, so the TEAM sample might not be universally applicable, necessitating further investigation.",6.868932093348762e-07,0.3652656785527779,0.1644713421146316,0.05258936747867431,0.44073682258554614,0.12429752066115701,0.052513244687633145,0.4964693047605566,0.09566326530612247,6.868932093348768e-07,0.5542334131034274,0.06525084641428129
247,0.3,5,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample may not generalize to all cases of child bipolar I disorder. Diagnostic characteristics may vary among individuals, and further research is needed to determine if the findings of the TEAM sample can be applied to a broader population.","Is the ""Treatment of Early Age Mania (TEAM)"" sample generalizable for diagnosing child bipolar I disorder? Variability in diagnostic characteristics suggests the TEAM sample may not cover all cases, and more research is essential to determine its broader use.",6.158352911278203e-07,0.2830275803158049,0.1644713421146316,0.04714908808432869,0.35617943455748247,0.12429752066115701,0.04708084006477453,0.4094579277709265,0.09566326530612247,6.158352911278206e-07,0.46462125441374047,0.06525084641428129
247,0.3,6,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample may not generalize to all cases of child bipolar I disorder. Diagnostic characteristics may vary among individuals, and further research is needed to determine if the findings of the TEAM sample can be applied to a broader population.","Are the diagnostic characteristics of child bipolar I disorder from the ""Treatment of Early Age Mania (TEAM)"" sample generalizable? Due to individual variation, the TEAM sample might not apply to all cases, highlighting the need for further study.",6.395212638635056e-07,0.30969582739796575,0.1644713421146316,0.04896251454911056,0.3835784087455978,0.12429752066115701,0.0488916416057274,0.43762880473762333,0.09566326530612247,6.39521263863506e-07,0.493608791286992,0.06525084641428129
247,0.3,7,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample may not generalize to all cases of child bipolar I disorder. Diagnostic characteristics may vary among individuals, and further research is needed to determine if the findings of the TEAM sample can be applied to a broader population.","Does the ""Treatment of Early Age Mania (TEAM)"" sample reflect the diagnostic characteristics of child bipolar I disorder broadly? Since diagnostic features can vary, the TEAM sample may not be generalizable, and additional research is needed.",6.868932093348762e-07,0.3652656785527779,0.1644713421146316,0.05258936747867431,0.44073682258554614,0.12429752066115701,0.052513244687633145,0.4964693047605566,0.09566326530612247,6.868932093348768e-07,0.5542334131034274,0.06525084641428129
247,0.3,8,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample may not generalize to all cases of child bipolar I disorder. Diagnostic characteristics may vary among individuals, and further research is needed to determine if the findings of the TEAM sample can be applied to a broader population.","Can findings from the ""Treatment of Early Age Mania (TEAM)"" sample be generalized to child bipolar I disorder diagnostics? The sample may not represent all cases due to variability in characteristics, requiring further research.",7.342651548062468e-07,0.4241061785757112,0.1644713421146316,0.05621622040823807,0.5013614444019816,0.12429752066115701,0.05613484776953889,0.5589896617418901,0.09566326530612247,7.342651548062476e-07,0.618771934240999,0.06525084641428129
247,0.3,9,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample may not generalize to all cases of child bipolar I disorder. Diagnostic characteristics may vary among individuals, and further research is needed to determine if the findings of the TEAM sample can be applied to a broader population.","Is the ""Treatment of Early Age Mania (TEAM)"" sample representative of diagnostic traits in child bipolar I disorder? Variations among individuals suggest it may not generalize, and further studies are necessary.",8.053230730133027e-07,0.5194163583800364,0.1644713421146316,0.06165649980258371,0.5998015172152349,0.12429752066115701,0.06156725239239751,0.6607723560518326,0.09566326530612247,8.053230730133038e-07,0.7241324498988244,0.06525084641428129
247,0.3,10,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample may not generalize to all cases of child bipolar I disorder. Diagnostic characteristics may vary among individuals, and further research is needed to determine if the findings of the TEAM sample can be applied to a broader population.","Does the ""Treatment of Early Age Mania (TEAM)"" sample generalize to child bipolar I disorder diagnostic criteria? Because diagnostic features differ among individuals, the TEAM sample may not be broadly applicable, and more research is needed.",6.868932093348762e-07,0.3652656785527779,0.1644713421146316,0.05258936747867431,0.44073682258554614,0.12429752066115701,0.052513244687633145,0.4964693047605566,0.09566326530612247,6.868932093348768e-07,0.5542334131034274,0.06525084641428129
248,0.3,1,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be considered early signs of vascular abnormalities in young obese males. These abnormalities may indicate an increased risk of developing cardiovascular diseases in the future.","Are elevated carotid artery pulsatility and resistance indexes early indicators of vascular issues in young obese males? Yes, higher carotid artery pulsatility and resistance indexes may signal early vascular abnormalities in young obese males, suggesting a heightened risk for future cardiovascular diseases.",2.6054570009253947e-07,0.12778246471517773,0.05872741253364089,0.0199476911126006,0.11722830762647707,0.07692602040816329,0.019918816950481533,0.10556640207537304,0.09493770242580479,2.6054570009253947e-07,0.1291549479072578,0.08641975308641975
248,0.3,2,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be considered early signs of vascular abnormalities in young obese males. These abnormalities may indicate an increased risk of developing cardiovascular diseases in the future.","Do increased carotid artery pulsatility and resistance indexes serve as early markers of vascular abnormalities in young obese males? Indeed, elevated carotid artery pulsatility and resistance indexes can be early signs of vascular problems in young obese males, potentially indicating an increased risk of cardiovascular disease later on.",1.1842986367842703e-07,0.009512475771174422,0.05917159763313615,0.009067132323909363,0.04513626020172268,0.09229588042831649,0.009054007704764333,0.05175284526909518,0.1050000607024488,1.1842986367842703e-07,0.02739800734528597,0.0935374149659864
248,0.3,3,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be considered early signs of vascular abnormalities in young obese males. These abnormalities may indicate an increased risk of developing cardiovascular diseases in the future.","Is an increase in carotid artery pulsatility and resistance indexes an early sign of vascular abnormalities in young obese males? Yes, such increases are considered early indicators of vascular abnormalities in this group, which may point to a greater risk of cardiovascular diseases in the future.",1.6580180914979784e-07,0.10957273739420481,0.15589569160997732,0.012693985253473108,0.08835528726692932,0.15402352607709752,0.012675610786670066,0.06647069152002283,0.14808396092920617,1.6580180914979784e-07,0.04389137176129676,0.1388888888888889
248,0.3,4,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be considered early signs of vascular abnormalities in young obese males. These abnormalities may indicate an increased risk of developing cardiovascular diseases in the future.","Can higher carotid artery pulsatility and resistance indexes be early signs of vascular abnormalities in young obese males? Yes, elevated levels of these indexes are regarded as early signs of vascular abnormalities in young obese males, implying a possible increased risk for cardiovascular diseases down the line.",1.4211583641411244e-07,0.013013430625915756,0.07495069033530571,0.010880558788691236,0.010997724979427304,0.06919748520710056,0.0108648092457172,0.03583383663556283,0.059558018007658836,1.4211583641411244e-07,0.061535745816405196,0.046844181459566064
248,0.3,5,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be considered early signs of vascular abnormalities in young obese males. These abnormalities may indicate an increased risk of developing cardiovascular diseases in the future.","Are increased carotid artery pulsatility and resistance indexes early signs of vascular problems in young obese males? Yes, these elevated indexes can indicate early vascular abnormalities in young obese males, which may suggest a higher likelihood of developing cardiovascular diseases later.",2.8423167282822487e-07,0.014894607756486433,0.17236072637734687,0.02176111757738247,0.00480532973026726,0.17375173130193908,0.0217296184914344,0.024903860700178804,0.1713265913146937,2.8423167282822487e-07,0.08286033387784553,0.1388888888888889
248,0.3,6,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be considered early signs of vascular abnormalities in young obese males. These abnormalities may indicate an increased risk of developing cardiovascular diseases in the future.","Do young obese males with increased carotid artery pulsatility and resistance indexes show early signs of vascular abnormalities? Yes, such increases are early indicators of vascular abnormalities and may signal an elevated risk for future cardiovascular disease.",3.789755637709661e-07,0.05965936654312021,0.19446712018140588,0.029014823436509962,0.07747290511101435,0.19937500000000002,0.028972824655245873,0.13612949581040334,0.1713265913146937,3.789755637709665e-07,0.19727068505559098,0.1388888888888889
248,0.3,7,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be considered early signs of vascular abnormalities in young obese males. These abnormalities may indicate an increased risk of developing cardiovascular diseases in the future.","Is an elevation in carotid artery pulsatility and resistance indexes an early indicator of vascular abnormalities in young obese males? Yes, increased pulsatility and resistance indexes can be early signs of vascular abnormalities in young obese males, indicating a potential increased risk of cardiovascular disease.",1.8948778188548325e-07,0.07253401458681052,0.04938271604938271,0.014507411718254981,0.06505727338871026,0.06350940467494523,0.014486412327622933,0.05684843653556859,0.07714376582992916,1.8948778188548325e-07,0.04783029499434299,0.09023668639053256
248,0.3,8,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be considered early signs of vascular abnormalities in young obese males. These abnormalities may indicate an increased risk of developing cardiovascular diseases in the future.","Are increased carotid artery pulsatility and resistance indexes considered early signs of vascular abnormalities in young obese males? Yes, these increased indexes are early markers of vascular abnormalities in young obese males, which may point to a higher risk of cardiovascular diseases in the future.",1.8948778188548325e-07,0.02198605548954724,0.11045364891518736,0.014507411718254981,0.0005784658947618482,0.1073302925706772,0.014486412327622933,0.023841427937476123,0.10032067415493039,1.8948778188548325e-07,0.04783029499434299,0.09023668639053256
248,0.3,9,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be considered early signs of vascular abnormalities in young obese males. These abnormalities may indicate an increased risk of developing cardiovascular diseases in the future.","Can increased carotid artery pulsatility and resistance indexes be used as early signs of vascular abnormalities in young obese males? Yes, elevated carotid artery pulsatility and resistance indexes are considered early signs of vascular abnormalities in young obese males, suggesting an increased risk for cardiovascular diseases.",1.6580180914979784e-07,0.16768613482977335,0.009182736455463747,0.012693985253473108,0.16369823293668695,0.008237456747404837,0.012675610786670066,0.1592051347087966,0.004999939297551215,1.6580180914979784e-07,0.15415067982725938,0.0
248,0.3,10,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be considered early signs of vascular abnormalities in young obese males. These abnormalities may indicate an increased risk of developing cardiovascular diseases in the future.","Are higher carotid artery pulsatility and resistance indexes early indicators of vascular abnormalities in young obese males? Yes, increased carotid artery pulsatility and resistance indexes can be early signs of vascular abnormalities in young obese males, indicating a greater risk of developing cardiovascular diseases later on.",1.6580180914979784e-07,0.10607305211333395,0.01814058956916098,0.012693985253473108,0.10068485288578266,0.026535493827160528,0.012675610786670066,0.0947263272148482,0.035460995989638894,1.6580180914979784e-07,0.08813666263107445,0.04470606340412436
249,0.3,1,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal","Question: Should neck dissection be performed for metastatic carcinoma in cervical nodes when the primary head and neck site is unknown? Answer: Based on our experience, definitive radiotherapy targeting the neck and possible mucosal sites, with or without prior neck dissection, effectively achieves good local control in unknown primary head and neck cancers. The role of neck dissection, especially for early nodal disease, is considered accordingly.",1.4211583641411244e-07,0.11502721129295335,0.019102570838475018,0.010880558788691264,0.1329338574746819,0.031217481789802295,0.0108648092457172,0.11297645060445483,0.01586888657648284,1.4211583641411244e-07,0.09237332013101707,0.0
249,0.3,2,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal","Question: Is neck dissection necessary for metastatic carcinoma to cervical nodes from an unknown primary head and neck tumor? Answer: Our experience shows that definitive radiotherapy to the neck and potential mucosal sites, regardless of preceding neck dissection, is effective in securing good local control in unknown primary head and neck cancers. Neck dissection indications, particularly in early nodal involvement, are evaluated carefully.",2.1317375462116866e-07,0.18876760626911615,0.03785334268409447,0.01632083818303688,0.20579978907866536,0.049048751486325794,0.0162972138685758,0.18597175441249192,0.033293697978596916,2.1317375462116866e-07,0.1654667758656423,0.01694411414982164
249,0.3,3,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal","Question: For metastatic carcinoma in cervical nodes with an unknown head and neck primary, is neck dissection required? Answer: We have found that definitive radiotherapy to the neck and possible mucosal regions, whether or not neck dissection is performed first, effectively achieves good local control in cases of unknown primary head and neck cancer. Neck dissection is considered especially for early nodal disease.",2.1317375462116866e-07,0.19720709245886603,0.07294106198234007,0.01632083818303688,0.18307365201112624,0.03274920999712727,0.0162972138685758,0.13976194237516282,0.0,2.1317375462116866e-07,0.14197026127038992,0.0
249,0.3,4,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal","Question: Metastatic carcinoma to cervical nodes from an unknown head and neck primary: does it warrant neck dissection? Answer: Our experience indicates that definitive radiotherapy to the neck and potential mucosal sites, with or without prior neck dissection, effectively ensures good local control in unknown primary head and neck cancers. Neck dissection is particularly indicated for early nodal disease.",3.079176455639103e-07,0.19146430225112976,0.007732504766612504,0.023574544042164372,0.22976492791866576,0.017538265306122455,0.023540420032387266,0.2087548138621127,0.0,3.079176455639103e-07,0.21217451994363756,0.0
249,0.3,5,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal","Question: Is neck dissection necessary for metastatic carcinoma in cervical nodes when the primary head and neck site is unknown? Answer: According to our experience, definitive radiotherapy to the neck and possible mucosal sites, whether preceded by neck dissection or not, effectively achieves good local control in unknown primary head and neck cancers. The indication for neck dissection, especially in early nodal disease, is carefully considered.",1.4211583641411244e-07,0.11502721129295335,0.019102570838475025,0.010880558788691264,0.1329338574746819,0.031217481789802295,0.0108648092457172,0.11297645060445483,0.01586888657648284,1.4211583641411244e-07,0.09237332013101707,0.0
249,0.3,6,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal","Question: Should neck dissection be done for metastatic carcinoma to cervical nodes from an unknown primary head and neck tumor? Answer: From our experience, definitive radiotherapy targeting the neck and potential mucosal sites, regardless of prior neck dissection, is effective in achieving good local control in unknown primary head and neck cancers. Neck dissection is particularly indicated for early nodal involvement.",2.6054570009253947e-07,0.2252840268370524,0.04047334782235692,0.019947691112600627,0.24144734192939676,0.0507015306122449,0.019918816950481533,0.22146674788256338,0.03443877551020409,2.6054570009253947e-07,0.20077739104541603,0.017538265306122455
249,0.3,7,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal","Question: For metastatic carcinoma in cervical nodes with an unknown primary site in the head and neck, is neck dissection needed? Answer: Our experience suggests that definitive radiotherapy to the neck and possible mucosal sites, whether or not preceded by neck dissection, effectively achieves good local control in unknown primary head and neck cancers. Neck dissection is especially considered for early nodal disease.",2.1317375462116866e-07,0.1440484333297647,0.006090713403160419,0.01632083818303688,0.137621377876048,0.0,0.0162972138685758,0.13976194237516282,0.0,2.1317375462116866e-07,0.14197026127038992,0.0
249,0.3,8,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal","Question: Metastatic carcinoma to cervical nodes from an unknown head and neck primary: is neck dissection required? Answer: Based on our experience, definitive radiotherapy to the neck and potential mucosal sites, with or without prior neck dissection, effectively ensures good local control in unknown primary head and neck cancers. Neck dissection is particularly indicated in early nodal cases.",3.316036182995957e-07,0.23401565224285203,0.010297855525652516,0.025387970506946245,0.24789880776277862,0.017851239669421492,0.025351221573340132,0.22677331936479117,0.0,3.316036182995957e-07,0.23052365861183333,0.0
249,0.3,9,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal","Question: Is neck dissection indicated for metastatic carcinoma to cervical nodes from an unknown primary head and neck cancer? Answer: Our experience shows that definitive radiotherapy to the neck and possible mucosal sites, whether preceded by neck dissection or not, effectively achieves good local control in unknown primary head and neck cancers. Neck dissection is especially considered for early nodal disease.",2.6054570009253947e-07,0.25710973525179304,0.09363118885898589,0.019947691112600627,0.24144734192939676,0.0507015306122449,0.019918816950481533,0.22146674788256338,0.03443877551020409,2.6054570009253947e-07,0.20077739104541603,0.017538265306122455
249,0.3,10,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal","Question: Should neck dissection be performed for metastatic carcinoma in cervical nodes from an unknown primary site in the head and neck? Answer: According to our experience, definitive radiotherapy to the neck and potential mucosal sites, regardless of prior neck dissection, effectively achieves good local control in unknown primary head and neck cancers. Neck dissection is particularly indicated for early nodal involvement.",2.3685972735685406e-07,0.16140860599513562,0.006877471209509198,0.018134264647818754,0.15415067982725894,0.0,0.018108015409528666,0.15656906069154353,0.0,2.3685972735685406e-07,0.15906469462968964,0.0
250,0.3,1,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical,"Does laparoscopic cholecystectomy affect the activity of peri-sinusoidal cells? Laparoscopic surgery results in noticeable harm to Kupffer and endothelial cells, indicated by increased post-operative HA serum levels. However, the injury to liver hepatocytes and perisinusoidal cells does not have clinical significance.",2.36859727356853e-08,0.06086381724377565,0.025623268698060954,0.0018134264647818726,0.025975486403257975,0.0,0.0018108015409528666,0.026668247082160867,0.0,2.3685972735685406e-08,0.02739897418811532,0.0
250,0.3,2,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical,"Is peri-sinusoidal cell activity impacted by laparoscopic cholecystectomy? The laparoscopic approach causes measurable damage to Kupffer and endothelial cells, as shown by elevated HA serum levels after surgery, but the liver hepatocytes and perisinusoidal cell damage lack clinical consequences.",2.36859727356853e-08,0.00957052285622595,0.025623268698060954,0.0018134264647818726,0.026668247082160867,0.0,0.0018108015409528666,0.02739897418811532,0.0,2.3685972735685406e-08,0.028170876966696845,0.0
250,0.3,3,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical,"Does undergoing laparoscopic cholecystectomy alter peri-sinusoidal cell function? This procedure leads to detectable injury in Kupffer and endothelial cells, evidenced by raised post-operative HA serum levels, though the damage to liver hepatocytes and perisinusoidal cells is clinically insignificant.",4.73719454713706e-08,0.017097724225934918,0.025623268698060954,0.0036268529295637453,0.05406722127027619,0.0,0.003621603081905733,0.055569851154812167,0.0,4.737194547137081e-08,0.05715841383994835,0.0
250,0.3,4,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical,"How does laparoscopic cholecystectomy affect peri-sinusoidal cell activity? Laparoscopic techniques induce damage to Kupffer and endothelial cells, reflected by increased HA serum levels post-operation, but the resulting harm to liver hepatocytes and perisinusoidal cells shows no clinical impact.",4.73719454713706e-08,0.017097724225934918,0.025623268698060954,0.0036268529295637453,0.05406722127027619,0.0,0.003621603081905733,0.055569851154812167,0.0,4.737194547137081e-08,0.05715841383994835,0.0
250,0.3,5,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical,"Does laparoscopic cholecystectomy influence the function of peri-sinusoidal cells? The procedure causes observable damage to Kupffer and endothelial cells, as indicated by elevated post-operative HA serum levels, yet the injury to liver hepatocytes and perisinusoidal cells has no clinical relevance.",0.0,0.035546009259483924,0.025623268698060954,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
250,0.3,6,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical,"Is there an effect of laparoscopic cholecystectomy on peri-sinusoidal cell activity? Laparoscopic surgery damages Kupffer and endothelial cells, demonstrated by higher HA serum levels after the operation, but the damage to liver hepatocytes and perisinusoidal cells is not clinically significant.",0.0,0.035546009259483924,0.025623268698060954,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
250,0.3,7,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical,"Does laparoscopic cholecystectomy impact peri-sinusoidal cell activity? The procedure results in detectable damage to Kupffer and endothelial cells, reflected by increased post-operative HA serum levels, while the injury to liver hepatocytes and perisinusoidal cells remains clinically insignificant.",7.10579182070559e-08,0.04449669841405024,0.025623268698060954,0.005440279394345618,0.08223809823697303,0.0,0.005432404622858607,0.08455738802806367,0.0,7.105791820705622e-08,0.08701137698963013,0.0
250,0.3,8,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical,"What is the effect of laparoscopic cholecystectomy on peri-sinusoidal cell activity? Laparoscopic methods cause measurable injury to Kupffer and endothelial cells, shown by elevated HA serum levels post-surgery, but the damage to liver hepatocytes and perisinusoidal cells lacks clinical importance.",0.0,0.035546009259483924,0.025623268698060954,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
250,0.3,9,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical,"Does laparoscopic cholecystectomy cause changes in peri-sinusoidal cell activity? It leads to detectable damage to Kupffer and endothelial cells, indicated by increased post-operative HA serum levels, although the damage to liver hepatocytes and perisinusoidal cells has no clinical effect.",2.36859727356853e-08,0.026910907699560394,0.0006732981390464195,0.0018134264647818726,0.026668247082160867,0.0,0.0018108015409528666,0.02739897418811532,0.0,2.3685972735685406e-08,0.028170876966696845,0.0
250,0.3,10,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical,"Can laparoscopic cholecystectomy alter peri-sinusoidal cell activity? This surgery causes measurable harm to Kupffer and endothelial cells, as evidenced by elevated HA serum levels after the procedure, but the damage to liver hepatocytes and perisinusoidal cells is clinically irrelevant.",2.36859727356853e-08,0.00957052285622595,0.025623268698060954,0.0018134264647818726,0.026668247082160867,0.0,0.0018108015409528666,0.02739897418811532,0.0,2.3685972735685406e-08,0.028170876966696845,0.0
251,0.3,1,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing,Does losing consciousness indicate neuropsychological decline following a concussion? The findings of this research question the significance of LOC as a predictor of neuropsychological test outcomes in the early recovery period after mild traumatic brain injury. Neuropsychological testing,1.1842986367842671e-07,0.1267517056391423,0.0,0.009067132323909363,0.1300531282481976,0.0,0.009054007704764333,0.13353139262452274,0.0,1.1842986367842703e-07,0.13720112151348252,0.0
251,0.3,2,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing,Is loss of consciousness a predictor of neuropsychological impairments after a concussion? This study's results challenge the role of LOC in forecasting neuropsychological test performance during the acute recovery phase from mild traumatic brain injury. Neuropsychological testing,1.42115836414112e-07,0.1541506798272576,0.0,0.010880558788691236,0.15822400521489444,0.0,0.010864809245717207,0.16251892949777424,0.0,1.4211583641411244e-07,0.1670540846631643,0.0
251,0.3,3,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing,Can loss of consciousness predict neuropsychological deficits post-concussion? The study's findings undermine the importance of LOC as a predictor for neuropsychological test results in the acute phase following mild traumatic brain injury. Neuropsychological testing,2.1317375462116791e-07,0.24116205681688774,0.0,0.016320838183036875,0.2478361639045814,0.0,0.016297213868575827,0.25489224962878954,0.0,2.1317375462116866e-07,0.2623642644674895,0.0
251,0.3,4,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing,Does loss of consciousness forecast neuropsychological decline after a concussion? The results from this study question the relevance of LOC in predicting neuropsychological test performance during the initial recovery phase from mild traumatic brain injury. Neuropsychological testing,1.42115836414112e-07,0.1541506798272576,0.0,0.010880558788691236,0.15822400521489444,0.0,0.010864809245717207,0.16251892949777424,0.0,1.4211583641411244e-07,0.1670540846631643,0.0
251,0.3,5,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing,Is loss of consciousness an indicator of neuropsychological decrements after concussion? The study's findings cast doubt on LOC's predictive value for neuropsychological test performance in the acute recovery period following mild traumatic brain injury. Neuropsychological testing,1.6580180914979731e-07,0.18232155679395445,0.0,0.012693985253473115,0.18721154208814594,0.0,0.01267561078667008,0.19237189264745602,0.0,1.6580180914979784e-07,0.19782574332991798,0.0
251,0.3,6,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing,Does experiencing loss of consciousness predict neuropsychological impairments after a concussion? The research results challenge the importance of LOC as a predictor of neuropsychological test outcomes during the early recovery phase from mild traumatic brain injury. Neuropsychological testing,1.1842986367842671e-07,0.1267517056391423,0.0,0.009067132323909363,0.1300531282481976,0.0,0.009054007704764333,0.13353139262452274,0.0,1.1842986367842703e-07,0.13720112151348252,0.0
251,0.3,7,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing,Does loss of consciousness serve as a predictor for neuropsychological deficits after concussion? The findings of this study question the significance of LOC in predicting neuropsychological test performance in the acute phase of mild traumatic brain injury recovery. Neuropsychological testing,7.105791820705611e-08,0.07410797215372344,0.0,0.005440279394345618,0.0759859069779214,0.0,0.0054324046228586,0.07796154146971057,0.0,7.105791820705622e-08,0.08004270767353416,0.0
251,0.3,8,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing,Is loss of consciousness a reliable predictor of neuropsychological decline following concussion? The study results cast doubt on the predictive value of LOC for neuropsychological test performance during the acute recovery phase from mild traumatic brain injury. Neuropsychological testing,9.474389094274141e-08,0.10008345855698142,0.0,0.0072537058591274906,0.10265415406008227,0.0,0.007243206163811466,0.10536051565782589,0.0,9.474389094274162e-08,0.10821358464023101,0.0
251,0.3,9,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing,Does loss of consciousness predict neuropsychological test performance decrements after concussion? The findings from this study challenge the importance of LOC as a predictor during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing,1.42115836414112e-07,0.1541506798272576,0.0,0.010880558788691236,0.15822400521489444,0.0,0.010864809245717207,0.16251892949777424,0.0,1.4211583641411244e-07,0.1670540846631643,0.0
251,0.3,10,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing,Can loss of consciousness be used to predict neuropsychological impairments after concussion? The study results question the role of LOC as a predictor of neuropsychological test outcomes in the early recovery phase following mild traumatic brain injury. Neuropsychological testing,9.474389094274141e-08,0.10008345855698142,0.0,0.0072537058591274906,0.10265415406008227,0.0,0.007243206163811466,0.10536051565782589,0.0,9.474389094274162e-08,0.10821358464023101,0.0
252,0.3,1,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are","Question: Preoperative staging of patients with liver metastases from colorectal cancer. Does PET/CT provide additional value over multidetector CT? Answer: PET/CT plays a limited role in hepatic staging of liver metastases from colorectal carcinoma. While PET/CT shows higher sensitivity in detecting extrahepatic disease in certain anatomical sites, its findings are",4.737194547137081e-08,0.04199856551678449,0.05972111367826556,0.0036268529295637453,0.0152026506278653,0.04158790170132326,0.003621603081905733,0.013989487235059883,0.0212665406427221,4.737194547137081e-08,0.04445176257083272,0.0
252,0.3,2,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are","Question: In preoperative staging of colorectal carcinoma patients with liver metastases, does PET/CT offer benefits beyond multidetector CT? Answer: PET/CT has a restricted role in staging liver metastases from colorectal cancer. Although it is more sensitive in identifying extrahepatic disease in some locations, its results are",4.737194547137081e-08,0.013989487235059883,0.0212665406427221,0.0036268529295637453,0.04445176257083272,0.0,0.003621603081905733,0.04546237407675724,0.0,4.737194547137081e-08,0.04652001563489394,0.0
252,0.3,3,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are","Question: For preoperative staging of liver metastases in colorectal cancer patients, does PET/CT add value compared to multidetector CT? Answer: PET/CT is of limited use in hepatic staging of colorectal liver metastases. It has higher sensitivity for detecting extrahepatic disease in certain anatomical areas, but its results are",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
252,0.3,4,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are","Question: Does PET/CT contribute additional information to multidetector CT in preoperative staging of colorectal carcinoma liver metastases? Answer: PET/CT has a limited role in the hepatic staging of liver metastases from colorectal cancer. Although it detects extrahepatic disease with greater sensitivity in some anatomical regions, its results are",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
252,0.3,5,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are","Question: In the preoperative staging of colorectal carcinoma patients with liver metastases, is PET/CT superior to multidetector CT? Answer: PET/CT's role in hepatic staging of liver metastases from colorectal cancer is limited. It shows higher sensitivity for extrahepatic disease detection in certain anatomical sites, but its results are",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
252,0.3,6,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are","Question: For staging liver metastases from colorectal carcinoma before surgery, does PET/CT add value over multidetector CT? Answer: PET/CT has a limited role in hepatic staging of colorectal liver metastases. It is more sensitive in detecting extrahepatic disease in some anatomical locations, yet its results are",4.737194547137081e-08,0.013989487235059883,0.0212665406427221,0.0036268529295637453,0.04445176257083272,0.0,0.003621603081905733,0.04546237407675724,0.0,4.737194547137081e-08,0.04652001563489394,0.0
252,0.3,7,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are","Question: Does PET/CT enhance preoperative staging of colorectal carcinoma liver metastases compared to multidetector CT? Answer: PET/CT's role is limited in hepatic staging of liver metastases from colorectal cancer. It offers higher sensitivity for extrahepatic disease detection in certain anatomical areas, but its results are",7.105791820705622e-08,0.09947572313802233,0.024084933280180392,0.005440279394345618,0.06744128079553224,0.0,0.0054324046228586,0.06899287148695166,0.0,7.105791820705622e-08,0.07061756721395396,0.0
252,0.3,8,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are","Question: In patients with colorectal carcinoma liver metastases, does PET/CT improve preoperative staging beyond multidetector CT? Answer: PET/CT has a limited role in hepatic staging of liver metastases. While it is more sensitive for detecting extrahepatic disease in some anatomical locations, its results are",9.474389094274162e-08,0.05945186131181712,0.0212665406427221,0.0072537058591274906,0.09097177820572666,0.0,0.007243206163811466,0.09309042306601167,0.0,9.474389094274162e-08,0.09531017980432566,0.0
252,0.3,9,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are","Question: Is PET/CT beneficial over multidetector CT in preoperative staging of colorectal carcinoma liver metastases? Answer: PET/CT plays a limited role in hepatic staging of colorectal liver metastases. It has higher sensitivity for extrahepatic disease detection in some anatomical regions, but its results are",9.474389094274162e-08,0.12393066880576553,0.025134411171674104,0.0072537058591274906,0.12397878680381824,0.023795359904818555,0.007243206163811466,0.09309042306601167,0.0,9.474389094274162e-08,0.09531017980432566,0.0
252,0.3,10,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are","Question: Does PET/CT add significant value to multidetector CT in preoperative staging of liver metastases from colorectal carcinoma? Answer: PET/CT has a limited role in hepatic staging of liver metastases from colorectal cancer. Although it detects extrahepatic disease with greater sensitivity in certain anatomical sites, its results are",0.0,0.11798249881871392,0.08360874280398993,0.0,0.12054733574955545,0.08616780045351476,0.0,0.09241962407465909,0.06632653061224489,0.0,0.06301338005090473,0.045351473922902494
253,0.3,1,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,"Is screening for coeliac disease in high-risk groups warranted? Long-term adherence to diet among patients identified through screening was satisfactory. Their quality of life and bone mineral density matched those of individuals without coeliac disease and the general population. Therefore, proactive screening in at-risk groups appears to be beneficial rather than detrimental.",4.737194547137081e-08,0.09769825720532266,0.04136408317580338,0.0036268529295637453,0.04082199452025437,0.0,0.003621603081905733,0.04167269640056892,0.0,4.737194547137081e-08,0.04255961441879652,0.0
253,0.3,2,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,"Does screening for coeliac disease in risk populations make sense? Patients detected via screening maintained good long-term dietary compliance. Their quality of life and bone density were similar to non-coeliac individuals and the general population. Hence, active screening in coeliac risk groups seems justified and not harmful.",7.105791820705622e-08,0.02169626334499153,0.060964083175803374,0.005440279394345618,0.06453852113757153,0.0,0.0054324046228586,0.06595796779179608,0.0,7.105791820705622e-08,0.06744128079553224,0.0
253,0.3,3,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,Is it justified to screen for coeliac disease in groups at risk? Those diagnosed through screening showed good long-term adherence to dietary restrictions. Their quality of life and bone mineral density were on par with non-coeliac subjects and the general population. Active screening in these risk groups appears reasonable and safe.,2.3685972735685406e-08,0.10507787228404242,0.060964083175803374,0.0018134264647818726,0.02061928720273576,0.0,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
253,0.3,4,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,Should coeliac disease screening be conducted in risk groups? Screen-detected patients demonstrated strong long-term dietary compliance. Their quality of life and bone mineral density were comparable to those without coeliac disease and the general population. Active screening in coeliac risk groups seems appropriate rather than harmful.,9.474389094274162e-08,0.031089184732003172,0.038753339374150486,0.0072537058591274906,0.08701137698962924,0.0,0.007243206163811466,0.0889474860164956,0.0,9.474389094274162e-08,0.09097177820572666,0.0
253,0.3,5,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,"Is coeliac disease screening justified among at-risk groups? Patients identified by screening adhered well to dietary guidelines over the long term. Their quality of life and bone mineral density were similar to non-coeliac individuals and the general population. Therefore, active screening in coeliac risk groups is likely beneficial rather than harmful.",2.3685972735685406e-08,0.10507787228404242,0.060964083175803374,0.0018134264647818726,0.02061928720273576,0.0,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
253,0.3,6,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,Is it reasonable to screen for coeliac disease in risk groups? Long-term dietary compliance was good among patients detected by screening. Their quality of life and bone mineral density matched those of non-coeliac subjects and the general population. Active screening in coeliac disease risk groups appears to be advantageous rather than harmful.,4.737194547137081e-08,0.09769825720532266,0.04136408317580338,0.0036268529295637453,0.04082199452025437,0.0,0.003621603081905733,0.04167269640056892,0.0,4.737194547137081e-08,0.04255961441879652,0.0
253,0.3,7,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,Does screening for coeliac disease in risk groups have justification? Screen-detected patients maintained good long-term dietary adherence. Their quality of life and bone mineral density were comparable to those without coeliac disease and the general population. Active screening in these groups seems reasonable and not harmful.,9.474389094274162e-08,0.031089184732003172,0.038753339374150486,0.0072537058591274906,0.08701137698962924,0.0,0.007243206163811466,0.0889474860164956,0.0,9.474389094274162e-08,0.09097177820572666,0.0
253,0.3,8,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,Is screening for coeliac disease in risk groups appropriate? Patients identified through screening showed good long-term compliance with diet. Their quality of life and bone mineral density were similar to non-coeliac individuals and the general population. Active screening in coeliac risk groups seems justified rather than harmful.,7.105791820705622e-08,0.008440570592397112,0.039235688114074976,0.005440279394345618,0.06453852113757153,0.0,0.0054324046228586,0.06595796779179608,0.0,7.105791820705622e-08,0.06744128079553224,0.0
253,0.3,9,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,Is coeliac disease screening warranted in risk groups? Those detected by screening exhibited good long-term dietary adherence. Their quality of life and bone mineral density were comparable to non-coeliac subjects and the general population. Active screening in coeliac disease risk groups appears sensible rather than harmful.,9.474389094274162e-08,0.031089184732003172,0.038753339374150486,0.0072537058591274906,0.08701137698962924,0.0,0.007243206163811466,0.0889474860164956,0.0,9.474389094274162e-08,0.09097177820572666,0.0
253,0.3,10,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,Is it justified to conduct coeliac disease screening in risk groups? Screen-detected patients had good long-term compliance with dietary recommendations. Their quality of life and bone mineral density were on par with non-coeliac individuals and the general population. Active screening in coeliac risk groups seems reasonable and not harmful.,2.3685972735685406e-08,0.03537474524045736,0.04014018095760509,0.0018134264647818726,0.02105340919783316,0.0,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
254,0.3,1,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Is the insertion allele of the ACE gene I/D polymorphism a candidate gene for insulin resistance? Answer: Our conclusion is that the heightened cardiovascular risk associated with the DD genotype is not due to insulin resistance or fibrinolysis abnormalities. However, we observe increased sensitivity in NIDDM patients carrying the ACE DD genotype.",4.737194547137081e-08,0.06801298065346462,0.020707179930795856,0.0036268529295637453,0.04000533461369837,0.0,0.003621603081905733,0.04082199452025437,0.0,4.737194547137081e-08,0.04167269640056892,0.0
254,0.3,2,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Could the insertion allele of the ACE gene I/D polymorphism be linked to insulin resistance? Answer: We find that the elevated cardiovascular risk in individuals with the DD genotype is not caused by insulin resistance or fibrinolysis issues. On the other hand, there is increased sensitivity in NIDDM subjects with the ACE DD genotype.",9.474389094274162e-08,0.08106857998389172,0.0029483070348455126,0.0072537058591274906,0.07847161544149417,0.0,0.007243206163811466,0.08004270767353683,0.0,9.474389094274162e-08,0.0816780310142673,0.0
254,0.3,3,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Is the ACE gene I/D polymorphism insertion allele a potential gene for insulin resistance? Answer: We conclude that the increased cardiovascular risk seen in the DD genotype is not mediated by insulin resistance or fibrinolysis abnormalities. Conversely, NIDDM subjects with the ACE DD genotype show increased sensitivity.",7.105791820705622e-08,0.06541487868264895,0.0025385802469135715,0.005440279394345618,0.06317890162153228,0.0,0.0054324046228586,0.06453852113757153,0.0,7.105791820705622e-08,0.06595796779179608,0.0
254,0.3,4,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Does the insertion allele of the ACE gene I/D polymorphism serve as a candidate gene for insulin resistance? Answer: Our findings suggest that the higher cardiovascular risk in the DD genotype is not due to insulin resistance or fibrinolysis abnormalities. In contrast, NIDDM patients with the ACE DD genotype exhibit increased sensitivity.",4.737194547137081e-08,0.04135347370885123,0.0015305555555555558,0.0036268529295637453,0.04000533461369837,0.0,0.003621603081905733,0.04082199452025437,0.0,4.737194547137081e-08,0.04167269640056892,0.0
254,0.3,5,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Is the insertion allele of the ACE gene I/D polymorphism associated with insulin resistance? Answer: We conclude that the DD genotype's increased cardiovascular risk is not mediated through insulin resistance or fibrinolysis abnormalities. Conversely, NIDDM subjects with the ACE DD genotype demonstrate increased sensitivity.",1.4211583641411244e-07,0.10388828709054065,0.017215574484706456,0.010880558788691236,0.13062018241706452,0.0,0.0108648092457172,0.13353139262452318,0.0,1.4211583641411244e-07,0.13657553500575004,0.0
254,0.3,6,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Could the ACE gene I/D polymorphism insertion allele be a candidate gene for insulin resistance? Answer: We determine that the increased cardiovascular risk linked to the DD genotype is not caused by insulin resistance or fibrinolysis abnormalities. However, NIDDM subjects with the ACE DD genotype show increased sensitivity.",4.737194547137081e-08,0.043132485122120645,0.0016573461457676936,0.0036268529295637453,0.04167269640056892,0.0,0.003621603081905733,0.04255961441879652,0.0,4.737194547137081e-08,0.04348511193973836,0.0
254,0.3,7,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Is the insertion allele of the ACE gene I/D polymorphism implicated in insulin resistance? Answer: Our conclusion is that the elevated cardiovascular risk of the DD genotype is not mediated by insulin resistance or fibrinolysis abnormalities. Conversely, NIDDM patients with the ACE DD genotype have increased sensitivity.",7.105791820705622e-08,0.09491050338732743,0.023602502295684086,0.005440279394345618,0.06317890162153228,0.0,0.0054324046228586,0.06453852113757153,0.0,7.105791820705622e-08,0.06595796779179608,0.0
254,0.3,8,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Is the ACE gene I/D polymorphism insertion allele a candidate gene for insulin resistance? Answer: We conclude that the increased cardiovascular risk associated with the DD genotype is not due to insulin resistance or fibrinolysis abnormalities. Conversely, NIDDM subjects with the ACE DD genotype exhibit increased sensitivity.",7.105791820705622e-08,0.09491050338732743,0.0236025022956841,0.005440279394345618,0.06317890162153228,0.0,0.0054324046228586,0.06453852113757153,0.0,7.105791820705622e-08,0.06595796779179608,0.0
254,0.3,9,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Does the insertion allele of the ACE gene I/D polymorphism contribute to insulin resistance? Answer: We find that the increased cardiovascular risk in the DD genotype is not mediated through insulin resistance or fibrinolysis abnormalities. However, there is increased sensitivity in NIDDM subjects with the ACE DD genotype.",4.737194547137081e-08,0.014251352598789513,0.019106653337357282,0.0036268529295637453,0.04167269640056892,0.0,0.003621603081905733,0.04255961441879652,0.0,4.737194547137081e-08,0.04348511193973836,0.0
254,0.3,10,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Is the insertion allele of the ACE gene I/D polymorphism a factor in insulin resistance? Answer: Our results indicate that the DD genotype's increased cardiovascular risk is not mediated by insulin resistance or fibrinolysis abnormalities. Conversely, NIDDM subjects with the ACE DD genotype show increased sensitivity.",9.474389094274162e-08,0.058066668431643986,0.01820216049382717,0.0072537058591274906,0.08515780834030728,0.0,0.007243206163811466,0.08701137698962924,0.0,9.474389094274162e-08,0.0889474860164956,0.0
255,0.3,1,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical",Question: Does using a neuroendoscope simultaneously affect the rate of ventriculoperitoneal shunt infections? Answer: This study found that employing an endoscope during VPS surgeries did not raise the infection risk.,1.184298636784265e-07,0.11829133106733902,0.029384756657483937,0.009067132323909398,0.16430305129127598,0.0,0.009054007704764368,0.16989903679539697,0.0,1.1842986367842703e-07,0.17589066646366414,0.0
255,0.3,2,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical",Question: Is the simultaneous use of a neuroendoscope linked to higher ventriculoperitoneal shunt infection rates? Answer: Our research indicates that endoscope use during VPS operations does not increase infection incidence.,1.184298636784265e-07,0.11829133106733902,0.029384756657483937,0.009067132323909398,0.16430305129127598,0.0,0.009054007704764368,0.16989903679539697,0.0,1.1842986367842703e-07,0.17589066646366414,0.0
255,0.3,3,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical",Question: Does simultaneous neuroendoscope usage impact ventriculoperitoneal shunt infection occurrence? Answer: The current study shows no increased infection risk when an endoscope is used during VPS procedures.,1.894877818854824e-07,0.2274906230323297,0.029384756657483937,0.014507411718255037,0.2776317365982801,0.0,0.014486412327622988,0.28768207245178123,0.0,1.8948778188548325e-07,0.29849298855599704,0.0
255,0.3,4,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical",Question: Does the concurrent use of a neuroendoscope affect the frequency of ventriculoperitoneal shunt infections? Answer: Findings reveal that endoscope application during VPS surgeries does not elevate infection risk.,1.421158364141118e-07,0.15338265087860803,0.029384756657483937,0.010880558788691277,0.20067069546215066,0.0,0.010864809245717241,0.20763936477824396,0.0,1.4211583641411244e-07,0.2151113796169466,0.0
255,0.3,5,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical",Question: Is there an influence of simultaneous neuroendoscope use on ventriculoperitoneal shunt infection rates? Answer: The study demonstrates that using an endoscope during VPS does not heighten the chance of infection.,9.47438909427412e-08,0.08438977939165726,0.029384756657483937,0.007253705859127518,0.12921173148000697,0.0,0.007243206163811494,0.1335313926245223,0.0,9.474389094274162e-08,0.13815033848081715,0.0
255,0.3,6,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical",Question: Does employing a neuroendoscope at the same time impact ventriculoperitoneal shunt infection rates? Answer: Results from this study suggest no increased infection risk with endoscope use during VPS procedures.,1.184298636784265e-07,0.11829133106733902,0.029384756657483937,0.009067132323909398,0.16430305129127598,0.0,0.009054007704764368,0.16989903679539697,0.0,1.1842986367842703e-07,0.17589066646366414,0.0
255,0.3,7,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical","Question: Does the use of a neuroendoscope during VPS surgeries raise the risk of shunt infections? Answer: According to this study, endoscope use in VPS does not increase infection incidence.",1.184298636784265e-07,0.11829133106733902,0.029384756657483937,0.009067132323909398,0.16430305129127598,0.0,0.009054007704764368,0.16989903679539697,0.0,1.1842986367842703e-07,0.17589066646366414,0.0
255,0.3,8,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical",Question: Is the incidence of ventriculoperitoneal shunt infection affected by simultaneous neuroendoscope use? Answer: The present research found no higher infection risk when an endoscope is used during VPS.,1.421158364141118e-07,0.15338265087860803,0.029384756657483937,0.010880558788691277,0.20067069546215066,0.0,0.010864809245717241,0.20763936477824396,0.0,1.4211583641411244e-07,0.2151113796169466,0.0
255,0.3,9,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical",Question: Does simultaneous neuroendoscope application influence ventriculoperitoneal shunt infection rates? Answer: This study indicates that using an endoscope during VPS does not increase infection risk.,2.36859727356853e-07,0.30753333070586697,0.029384756657483937,0.018134264647818796,0.36101334553733055,0.0,0.018108015409528735,0.3746934494414109,0.0,2.3685972735685406e-07,0.38946476676172503,0.0
255,0.3,10,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical",Question: Does the concurrent use of a neuroendoscope during VPS procedures affect infection rates? Answer: The study concludes that endoscope use does not raise the risk of ventriculoperitoneal shunt infections.,1.184298636784265e-07,0.11829133106733902,0.029384756657483937,0.009067132323909398,0.16430305129127598,0.0,0.009054007704764368,0.16989903679539697,0.0,1.1842986367842703e-07,0.17589066646366414,0.0
256,0.3,1,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations","Can analyzing APC mutations aid in making treatment choices for familial adenomatous polyposis? Since the age of onset and disease progression can vary widely even among individuals with the same germline mutation, treatment decisions should rely on colonoscopy results for each patient instead of mutation location. However, in cases with specific mutations...",1.1842986367842703e-07,0.06877080156225457,0.017851239669421492,0.009067132323909363,0.09531017980432566,0.0,0.009054007704764333,0.0971637484536485,0.0,1.1842986367842703e-07,0.09909090264422993,0.0
256,0.3,2,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations","Is APC mutation analysis useful for guiding therapy in familial adenomatous polyposis? Because the disease's manifestation age and progression differ even among carriers of identical mutations, therapeutic strategies should be determined by colonoscopic evaluation of each patient rather than mutation site. Nevertheless, in patients with certain mutations...",2.3685972735685406e-07,0.17195503779748522,0.017851239669421492,0.018134264647818726,0.20067069546215155,0.0,0.018108015409528666,0.2047944126460135,0.0,2.3685972735685406e-07,0.2090917978585587,0.0
256,0.3,3,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations","Does APC mutation testing help inform treatment plans in familial adenomatous polyposis? Given that disease onset and course can vary significantly among individuals with the same germline mutation, treatment decisions ought to be based on colonoscopy findings per patient instead of mutation position. Still, patients with particular mutations...",2.1317375462116866e-07,0.15044883257652186,0.017851239669421492,0.016320838183036854,0.17869178874337655,0.0,0.0162972138685758,0.18232155679395579,0.0,2.1317375462116866e-07,0.18610227963385917,0.0
256,0.3,4,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations","Can APC mutation analysis influence treatment decisions in familial adenomatous polyposis? Since the age at which symptoms appear and disease progression may vary even among those with identical germline mutations, therapy should be guided by individual colonoscopic findings rather than mutation location. However, in patients harboring mutations...",2.3685972735685406e-07,0.17195503779748522,0.017851239669421492,0.018134264647818726,0.20067069546215155,0.0,0.018108015409528666,0.2047944126460135,0.0,2.3685972735685406e-07,0.2090917978585587,0.0
256,0.3,5,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations","Is it possible for APC mutation analysis to impact therapeutic choices in familial adenomatous polyposis? Because the timing and course of the disease can be quite variable even among carriers of the same germline mutation, treatment should be based on colonoscopy results for each patient rather than mutation site. That said, in patients with mutations...",4.737194547137081e-08,0.0372845055208213,0.000660686282874693,0.0036268529295637453,0.037041271680350096,0.0,0.003621603081905733,0.03774032798284743,0.0,4.737194547137081e-08,0.038466280827795796,0.0
256,0.3,6,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations","Could APC mutation analysis play a role in therapeutic decision-making for familial adenomatous polyposis? As the age of onset and disease progression may differ even among individuals with identical germline mutations, treatment decisions should depend on colonoscopic findings in each patient rather than mutation location. However, in patients with mutations...",1.6580180914979784e-07,0.10877613617595294,0.017851239669421492,0.012693985253473108,0.13613217432458002,0.0,0.012675610786670066,0.13883644485421742,0.0,1.6580180914979784e-07,0.14165051706302645,0.0
256,0.3,7,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations","Does analyzing APC mutations contribute to treatment decisions in familial adenomatous polyposis? Since the age of disease manifestation and progression can vary among carriers of the same germline mutation, therapy should be based on colonoscopy findings for each patient rather than mutation site. Nonetheless, in patients with mutations...",2.1317375462116866e-07,0.15044883257652186,0.017851239669421492,0.016320838183036854,0.17869178874337655,0.0,0.0162972138685758,0.18232155679395579,0.0,2.1317375462116866e-07,0.18610227963385917,0.0
256,0.3,8,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations","Can APC mutation analysis be used to guide therapy in familial adenomatous polyposis? Given that the age at disease onset and its course may vary even among individuals with identical germline mutations, treatment decisions should rely on colonoscopic findings for each patient rather than mutation location. However, for patients with mutations...",1.4211583641411244e-07,0.08857342885843433,0.017851239669421492,0.010880558788691236,0.11551288712184427,0.0,0.0108648092457172,0.11778303565638426,0.0,1.4211583641411244e-07,0.12014431184206309,0.0
256,0.3,9,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations","Is APC mutation analysis relevant for therapeutic decision-making in familial adenomatous polyposis? Because the age at which the disease manifests and its progression can be variable even among carriers of the same germline mutation, treatment should be based on colonoscopy findings in individual patients rather than mutation site. Still, in patients with mutations...",9.474389094274162e-08,0.04935271570515187,0.017851239669421492,0.0072537058591274906,0.07550755250814589,0.0,0.007243206163811466,0.07696104113612989,0.0,9.474389094274162e-08,0.07847161544149417,0.0
256,0.3,10,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations","Can the analysis of APC mutations assist in making therapeutic decisions for familial adenomatous polyposis? Since the age at which symptoms appear and the disease course may vary even among those with identical germline mutations, treatment decisions should be guided by colonoscopic findings in each patient rather than mutation location. However, in patients with mutations...",4.737194547137081e-08,0.01161238772230444,0.017851239669421492,0.0036268529295637453,0.037041271680350096,0.0,0.003621603081905733,0.03774032798284743,0.0,4.737194547137081e-08,0.038466280827795796,0.0
257,0.3,1,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in","Do the features of general practices affect the adoption of IT innovations in primary care? The analysis indicates that structural features of a practice do not correlate with the adoption of new IT tools, but usage may be impacted by post-graduate training in the related clinical area. Specifically for this diabetes system, the involvement of practice nurses was essential.",9.474389094274162e-08,0.09367708230690219,0.01934802571166211,0.0072537058591274906,0.09214355004261776,0.017538265306122455,0.007243206163811466,0.06899287148694988,0.0,9.474389094274162e-08,0.07020425867324764,0.0
257,0.3,2,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in","Are general practice characteristics linked to the adoption of IT innovations in primary care? Findings reveal that the structural aspects of a practice do not influence the uptake of new IT facilities, though post-graduate education in the relevant clinical field may affect usage. In the case of this diabetes system, practice nurse participation was crucial.",1.8948778188548325e-07,0.11910328333998166,0.013710296269926016,0.014507411718254981,0.1405819506211894,0.0,0.014486412327622933,0.14310084364067155,0.0,1.8948778188548325e-07,0.14571181118139354,0.0
257,0.3,3,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in","Does the nature of general practice impact the uptake of IT innovations in primary care? Analyses demonstrate that structural practice characteristics are not connected to the adoption of new IT systems, but usage might be shaped by post-graduate education in the pertinent clinical condition. For this diabetes system, the role of practice nurses was vital.",1.8948778188548325e-07,0.0934311655414648,0.0322222222222222,0.014507411718254981,0.1405819506211894,0.0,0.014486412327622933,0.14310084364067155,0.0,1.8948778188548325e-07,0.14571181118139354,0.0
257,0.3,4,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in","Do characteristics of general practices determine the adoption of IT innovations in primary care? The study shows that structural features of a practice are unrelated to the uptake of new IT facilities, but usage could be influenced by post-graduate education in the relevant clinical area. Practice nurse involvement was key for this diabetes system.",2.1317375462116866e-07,0.11212329855361913,0.0322222222222222,0.016320838183036854,0.1596301455918825,0.0,0.0162972138685758,0.16251892949777424,0.0,2.1317375462116866e-07,0.1655144384775733,0.0
257,0.3,5,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in","Is the adoption of IT innovations in primary care influenced by general practice characteristics? The analysis suggests that structural characteristics of a practice do not affect uptake of new IT tools, but usage may depend on post-graduate education in the related clinical condition. For this diabetes system, practice nurse use was critical.",2.6054570009253947e-07,0.15058957938141493,0.0322222222222222,0.0199476911126006,0.19885085874516495,0.0,0.019918816950481533,0.20252426411147262,0.0,2.6054570009253947e-07,0.20633643299782767,0.0
257,0.3,6,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in","Are the structural features of general practices associated with the uptake of IT innovations in primary care? Results indicate no link between practice structure and adoption of new IT facilities, but usage may be affected by post-graduate education in the relevant clinical field. Practice nurses played a crucial role in this diabetes system.",2.3685972735685406e-07,0.13117149352431223,0.0322222222222222,0.018134264647818726,0.17904823144898518,0.0,0.018108015409528666,0.182321556793954,0.0,2.3685972735685406e-07,0.1857171457950919,0.0
257,0.3,7,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in","Do general practice structural traits influence the adoption of IT innovations in primary care? The findings show no association between practice structure and uptake of new IT systems, but usage might be influenced by post-graduate education in the clinical condition concerned. Practice nurse involvement was essential for this diabetes system.",3.079176455639103e-07,0.1905949139951133,0.0322222222222222,0.023574544042164344,0.23967285326541932,0.0,0.023540420032387266,0.24419696051204154,0.0,3.079176455639103e-07,0.2488960474166242,0.0
257,0.3,8,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in","Does the uptake of IT innovations in primary care depend on general practice characteristics? Analyses reveal that structural characteristics of a practice are not related to adoption of new IT tools, but usage may be shaped by post-graduate education in the relevant clinical area. Practice nurses were critical users in this diabetes system.",2.3685972735685406e-07,0.13117149352431223,0.0322222222222222,0.018134264647818726,0.17904823144898518,0.0,0.018108015409528666,0.182321556793954,0.0,2.3685972735685406e-07,0.1857171457950919,0.0
257,0.3,9,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in","Are general practice features a factor in the adoption of IT innovations in primary care? The study finds no association between structural practice characteristics and uptake of new IT facilities, but usage might be influenced by post-graduate education in the relevant clinical condition. Practice nurse participation was vital for this diabetes system.",2.6054570009253947e-07,0.17777182175631445,0.012622222222222208,0.0199476911126006,0.19885085874516495,0.0,0.019918816950481533,0.20252426411147262,0.0,2.6054570009253947e-07,0.20633643299782767,0.0
257,0.3,10,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in","Is the use of IT innovations in primary care affected by general practice characteristics? The analyses indicate that structural features of a practice do not correlate with uptake of new IT systems, but usage may be influenced by post-graduate education in the pertinent clinical field. Practice nurse use was key in this diabetes system.",2.1317375462116866e-07,0.11212329855361913,0.0322222222222222,0.016320838183036854,0.1596301455918825,0.0,0.0162972138685758,0.16251892949777424,0.0,2.1317375462116866e-07,0.1655144384775733,0.0
258,0.3,1,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Timing does matter when it comes to living in an urban environment and the risk of non-communicable diseases in Thailand. Factors such as the duration of exposure, time spent outdoors, and the timing of activities can all play a role in determining the impact on an individual's health.","Does timing influence the relationship between living in an urban environment and non-communicable disease risk in Thailand? Yes, timing is important, as factors like exposure duration, outdoor time, and activity timing affect health outcomes.",7.105791820705614e-07,0.5145991305326816,0.09418282548476452,0.0544027939434562,0.5719601363666613,0.06420927467300831,0.054324046228586026,0.6087082484855464,0.049048751486325794,7.105791820705622e-07,0.6469373685226154,0.033293697978596916
258,0.3,2,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Timing does matter when it comes to living in an urban environment and the risk of non-communicable diseases in Thailand. Factors such as the duration of exposure, time spent outdoors, and the timing of activities can all play a role in determining the impact on an individual's health.","In Thailand, does the timing of living in an urban area affect non-communicable disease risk? Indeed, timing matters, with exposure length, outdoor activity duration, and timing influencing health risks.",8.290090457489879e-07,0.6789021818239576,0.09418282548476452,0.0634699262673656,0.7418591731620583,0.06420927467300831,0.06337805393335039,0.7845989149492105,0.049048751486325794,8.290090457489892e-07,0.8292589253165703,0.033293697978596916
258,0.3,3,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Timing does matter when it comes to living in an urban environment and the risk of non-communicable diseases in Thailand. Factors such as the duration of exposure, time spent outdoors, and the timing of activities can all play a role in determining the impact on an individual's health.","Is timing significant for non-communicable disease risk linked to urban living in Thailand? Timing plays a crucial role, considering exposure period, outdoor time, and activity schedules impact health.",8.526950184846732e-07,0.7152698259948322,0.09418282548476452,0.06528335273214747,0.7795995011449053,0.06420927467300831,0.06518885547430327,0.823819628102493,0.049048751486325794,8.526950184846746e-07,0.8700809198368251,0.033293697978596916
258,0.3,4,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Timing does matter when it comes to living in an urban environment and the risk of non-communicable diseases in Thailand. Factors such as the duration of exposure, time spent outdoors, and the timing of activities can all play a role in determining the impact on an individual's health.","Regarding urban living and non-communicable diseases in Thailand, does timing matter? Yes, the timing of exposure, outdoor activities, and daily routines influences disease risk.",9.474389094274144e-07,0.8756124760700121,0.09418282548476452,0.07253705859127499,0.9466535858080722,0.06420927467300831,0.07243206163811476,0.9981730152472714,0.049048751486325794,9.474389094274162e-07,1.05240247663078,0.033293697978596916
258,0.3,5,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Timing does matter when it comes to living in an urban environment and the risk of non-communicable diseases in Thailand. Factors such as the duration of exposure, time spent outdoors, and the timing of activities can all play a role in determining the impact on an individual's health.","Does the timing of urban exposure affect non-communicable disease risk in Thailand? Timing is key, as how long one is exposed, time outdoors, and activity timing all affect health.",8.290090457489879e-07,0.6789021818239576,0.09418282548476452,0.0634699262673656,0.7418591731620583,0.06420927467300831,0.06337805393335039,0.7845989149492105,0.049048751486325794,8.290090457489892e-07,0.8292589253165703,0.033293697978596916
258,0.3,6,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Timing does matter when it comes to living in an urban environment and the risk of non-communicable diseases in Thailand. Factors such as the duration of exposure, time spent outdoors, and the timing of activities can all play a role in determining the impact on an individual's health.","In Thailand, does when you live in an urban environment influence non-communicable disease risk? Timing is important, with exposure duration, outdoor time, and activity timing shaping health outcomes.",8.526950184846732e-07,0.7152698259948322,0.09418282548476452,0.06528335273214747,0.7795995011449053,0.06420927467300831,0.06518885547430327,0.823819628102493,0.049048751486325794,8.526950184846746e-07,0.8700809198368251,0.033293697978596916
258,0.3,7,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Timing does matter when it comes to living in an urban environment and the risk of non-communicable diseases in Thailand. Factors such as the duration of exposure, time spent outdoors, and the timing of activities can all play a role in determining the impact on an individual's health.","Is the timing of living in an urban setting linked to non-communicable disease risk in Thailand? Yes, timing matters through factors like exposure length, outdoor time, and activity timing.",8.290090457489879e-07,0.6789021818239576,0.09418282548476452,0.0634699262673656,0.7418591731620583,0.06420927467300831,0.06337805393335039,0.7845989149492105,0.049048751486325794,8.290090457489892e-07,0.8292589253165703,0.033293697978596916
258,0.3,8,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Timing does matter when it comes to living in an urban environment and the risk of non-communicable diseases in Thailand. Factors such as the duration of exposure, time spent outdoors, and the timing of activities can all play a role in determining the impact on an individual's health.","Does timing impact the risk of non-communicable diseases for urban dwellers in Thailand? Timing is relevant, as exposure duration, outdoor activities, and timing affect health.",9.237529366917291e-07,0.8330528616512165,0.09418282548476452,0.07072363212649312,0.9022018232372382,0.06420927467300831,0.07062126009716188,0.9516529996123775,0.049048751486325794,9.237529366917308e-07,1.0036123124613487,0.033293697978596916
258,0.3,9,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Timing does matter when it comes to living in an urban environment and the risk of non-communicable diseases in Thailand. Factors such as the duration of exposure, time spent outdoors, and the timing of activities can all play a role in determining the impact on an individual's health.","For non-communicable disease risk in Thailand's urban areas, does timing play a role? Timing is significant, with exposure time, outdoor activity, and timing influencing health.",9.237529366917291e-07,0.8330528616512165,0.09418282548476452,0.07072363212649312,0.9022018232372382,0.06420927467300831,0.07062126009716188,0.9516529996123775,0.049048751486325794,9.237529366917308e-07,1.0036123124613487,0.033293697978596916
258,0.3,10,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Timing does matter when it comes to living in an urban environment and the risk of non-communicable diseases in Thailand. Factors such as the duration of exposure, time spent outdoors, and the timing of activities can all play a role in determining the impact on an individual's health.","When considering urban living and non-communicable disease risk in Thailand, does timing matter? Yes, timing affects health through exposure duration, outdoor time, and activity timing.",9.237529366917291e-07,0.8330528616512165,0.09418282548476452,0.07072363212649312,0.9022018232372382,0.06420927467300831,0.07062126009716188,0.9516529996123775,0.049048751486325794,9.237529366917308e-07,1.0036123124613487,0.033293697978596916
259,0.3,1,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Question: Is anxiety caused by withdrawal in alcoholism linked to a deficiency in beta-endorphin? Answer: Our findings provide the first evidence that reduced beta-endorphin levels during alcohol withdrawal may play a role in the anxiety commonly experienced in this condition.,1.421158364141118e-07,0.1670540846631643,0.0,0.010880558788691257,0.17185025692666,0.0,0.010864809245717227,0.17693070815907896,0.0,1.4211583641411244e-07,0.18232155679395534,0.0
259,0.3,2,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Question: Does beta-endorphin deficiency underlie withdrawal-induced anxiety in alcoholism? Answer: Our results offer initial proof that decreased beta-endorphin during alcohol withdrawal could contribute to the anxiety frequently observed in this state.,7.10579182070559e-08,0.09531017980432521,0.0,0.005440279394345639,0.09844007281325329,0.0,0.005432404622858621,0.10178269430994247,0.0,7.105791820705622e-08,0.10536051565782545,0.0
259,0.3,3,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Question: Is withdrawal-related anxiety in alcoholism due to a lack of beta-endorphin? Answer: Our study presents the first evidence suggesting that lowered beta-endorphin during alcohol withdrawal may be a factor in the anxiety commonly seen during this phase.,9.47438909427412e-08,0.11441035117774545,0.0,0.007253705859127511,0.11778303565638382,0.0,0.007243206163811494,0.1213608570042668,0.0,9.474389094274162e-08,0.125163142954007,0.0
259,0.3,4,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,"Question: Is beta-endorphin deficiency responsible for anxiety during alcohol withdrawal in alcoholism? Answer: Our data provide the first indication that reduced beta-endorphin levels during withdrawal may lead to anxiety, a common symptom in this condition.",2.36859727356853e-08,0.029852963149681777,0.0,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
259,0.3,5,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Question: Does a deficiency in beta-endorphin cause anxiety during alcohol withdrawal in alcoholism? Answer: Our findings give initial evidence that decreased beta-endorphin during withdrawal might contribute to the anxiety often experienced in this state.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
259,0.3,6,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Question: Is the anxiety experienced during alcohol withdrawal in alcoholism caused by beta-endorphin deficiency? Answer: Our results show for the first time that lowered beta-endorphin levels during withdrawal may be linked to anxiety as a frequent disturbance in this condition.,1.421158364141118e-07,0.1670540846631643,0.0,0.010880558788691257,0.17185025692666,0.0,0.010864809245717227,0.17693070815907896,0.0,1.4211583641411244e-07,0.18232155679395534,0.0
259,0.3,7,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Question: Is withdrawal-induced anxiety in alcoholism associated with a deficit in beta-endorphin? Answer: Our research provides the first evidence that reduced beta-endorphin during alcohol withdrawal may contribute to the anxiety commonly observed.,4.73719454713706e-08,0.06252035698133351,0.0,0.003626852929563759,0.06453852113757153,0.0,0.003621603081905747,0.06669137449867346,0.0,4.737194547137081e-08,0.06899287148695077,0.0
259,0.3,8,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Question: Is beta-endorphin shortage the basis for anxiety during alcohol withdrawal in alcoholism? Answer: Our results offer the first proof that lowered beta-endorphin levels during withdrawal could be responsible for anxiety as a common issue in this state.,9.47438909427412e-08,0.07694293601234303,0.027006172839506164,0.007253705859127511,0.11778303565638382,0.0,0.007243206163811494,0.1213608570042668,0.0,9.474389094274162e-08,0.125163142954007,0.0
259,0.3,9,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Question: Is anxiety during alcohol withdrawal in alcoholism caused by beta-endorphin deficiency? Answer: Our findings provide the first evidence that decreased beta-endorphin during withdrawal may play a role in the anxiety frequently seen in this condition.,4.73719454713706e-08,0.058840500022933284,0.0,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
259,0.3,10,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Question: Is the anxiety linked to alcohol withdrawal in alcoholism due to a lack of beta-endorphin? Answer: Our study presents initial evidence that reduced beta-endorphin during withdrawal might contribute to the anxiety commonly experienced during this phase.,7.10579182070559e-08,0.048503200291855286,0.02775510204081633,0.005440279394345639,0.08961215868968697,0.0,0.005432404622858621,0.09237332013101529,0.0,7.105791820705622e-08,0.09531017980432521,0.0
260,0.3,1,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.","Question: Are globulomaxillary cysts a real entity? Answer: Based on our study's findings and international literature, the concept of a globulomaxillary cyst is no longer supported.",7.10579182070559e-08,0.11332868530700413,0.0,0.005440279394345639,0.11778303565638426,0.0,0.005432404622858621,0.1226023220923329,0.0,7.105791820705622e-08,0.1278333715098845,0.0
260,0.3,2,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Do globulomaxillary cysts truly exist? Answer: Our research and global studies indicate that the term globulomaxillary cyst is no longer valid.,1.658018091497971e-07,0.28768207245178257,0.0,0.012693985253473157,0.30010459245033916,0.0,0.012675610786670115,0.3136575588550423,0.0,1.6580180914979768e-07,0.32850406697203516,0.0
260,0.3,3,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.","Question: Is the globulomaxillary cyst a genuine condition? Answer: According to our study and worldwide literature, the existence of the globulomaxillary cyst is not justified anymore.",7.10579182070559e-08,0.2242322341965961,0.0793950850661626,0.005440279394345639,0.17554530070304475,0.04158790170132326,0.005432404622858621,0.1226023220923329,0.0,7.105791820705622e-08,0.1278333715098845,0.0
260,0.3,4,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Are globulomaxillary cysts actually present? Answer: The results from our investigation and international sources show that the globulomaxillary cyst entity is no longer warranted.,9.47438909427412e-08,0.15415067982725894,0.0,0.007253705859127518,0.1603426500751799,0.0,0.007243206163811494,0.16705408466316696,0.0,9.474389094274162e-08,0.17435338714477844,0.0
260,0.3,5,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Do globulomaxillary cysts really exist? Answer: Our study's outcomes and data from international research suggest that the globulomaxillary cyst is no longer a justified diagnosis.,7.10579182070559e-08,0.11332868530700413,0.0,0.005440279394345639,0.11778303565638426,0.0,0.005432404622858621,0.1226023220923329,0.0,7.105791820705622e-08,0.1278333715098845,0.0
260,0.3,6,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Is there such a thing as a globulomaxillary cyst? Answer: Findings from our study and global literature confirm that the globulomaxillary cyst entity is no longer valid.,2.36859727356853e-08,0.03636764417087468,0.0,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
260,0.3,7,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.","Question: Are globulomaxillary cysts a recognized condition? Answer: Based on our research and international literature, the globulomaxillary cyst is no longer a justified entity.",1.184298636784265e-07,0.19671029424605457,0.0,0.009067132323909398,0.20479441264601395,0.0,0.009054007704764368,0.2135741002980609,0.0,1.1842986367842698e-07,0.2231435513142097,0.0
260,0.3,8,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.","Question: Do globulomaxillary cysts exist in reality? Answer: According to our study and international data, the globulomaxillary cyst is no longer considered a valid entity.",9.47438909427412e-08,0.15415067982725894,0.0,0.007253705859127518,0.1603426500751799,0.0,0.007243206163811494,0.16705408466316696,0.0,9.474389094274162e-08,0.17435338714477844,0.0
260,0.3,9,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Is the globulomaxillary cyst an actual medical entity? Answer: Our study results and international literature indicate that the globulomaxillary cyst is no longer justified.,9.47438909427412e-08,0.2696752099205817,0.08264462809917354,0.007253705859127518,0.22061631794995806,0.04338842975206613,0.007243206163811494,0.16705408466316696,0.0,9.474389094274162e-08,0.17435338714477844,0.0
260,0.3,10,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Are globulomaxillary cysts a legitimate diagnosis? Answer: The evidence from our study and international literature shows that the globulomaxillary cyst is no longer justified.,9.47438909427412e-08,0.15415067982725894,0.0,0.007253705859127518,0.1603426500751799,0.0,0.007243206163811494,0.16705408466316696,0.0,9.474389094274162e-08,0.17435338714477844,0.0
261,0.3,1,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study","Does obstructive sleep apnea impact aerobic fitness? In a US Air Force cohort, OSA generally does not predict reduced aerobic fitness based on cycle ergometry tests. However, individuals with an apnea-hypopnea index above 20 show a statistically significant decline in aerobic fitness compared to normal controls. This study",1.6580180914979784e-07,0.09131571616334622,0.034096781156585855,0.012693985253473108,0.08933752230378511,0.03767781622452902,0.012675610786670066,0.11792172186649497,0.01922337562475971,1.6580180914979784e-07,0.14763599880606337,0.0
261,0.3,2,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study","Is aerobic fitness affected by obstructive sleep apnea? Among US Air Force personnel, OSA overall does not indicate lower aerobic fitness as measured by cycle ergometry. Yet, those with an apnea-hypopnea index exceeding 20 exhibit a significant reduction in aerobic fitness relative to the normal population. This study",1.6580180914979784e-07,0.13194428009705783,0.03155025844760563,0.012693985253473108,0.08933752230378511,0.03767781622452902,0.012675610786670066,0.11792172186649497,0.01922337562475971,1.6580180914979784e-07,0.14763599880606337,0.0
261,0.3,3,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study","Does obstructive sleep apnea influence aerobic fitness? In a study of US Air Force members, OSA was not found to predict decreased aerobic fitness via cycle ergometry. Nevertheless, patients with an apnea-hypopnea index over 20 demonstrated a statistically significant drop in aerobic fitness compared to normal individuals. This study",1.4211583641411244e-07,0.06964781478416526,0.034539419581109676,0.010880558788691236,0.06783131708282175,0.03767781622452902,0.0108648092457172,0.09594281514771996,0.01922337562475971,1.4211583641411244e-07,0.12516314295400566,0.0
261,0.3,4,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study","How does obstructive sleep apnea affect aerobic fitness? Research in a US Air Force group shows that OSA does not generally predict a decline in aerobic fitness measured by cycle ergometry. However, those with an apnea-hypopnea index greater than 20 have a statistically significant lower aerobic fitness than the normal population. This study",4.737194547137081e-08,0.012616518468088866,0.03613994617454825,0.0036268529295637453,0.013846713931445542,0.03767781622452902,0.003621603081905733,0.012561206208669073,0.01922337562475971,4.737194547137081e-08,0.04000533461369837,0.0
261,0.3,5,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study","Does obstructive sleep apnea reduce aerobic fitness? In a US Air Force population, OSA overall does not predict diminished aerobic fitness as assessed by cycle ergometry. Still, patients with an apnea-hypopnea index above 20 have a statistically significant decrease in aerobic fitness compared to normal subjects. This study",1.6580180914979784e-07,0.09131571616334622,0.034096781156585855,0.012693985253473108,0.08933752230378511,0.03767781622452902,0.012675610786670066,0.11792172186649497,0.01922337562475971,1.6580180914979784e-07,0.14763599880606337,0.0
261,0.3,6,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study","Is there an effect of obstructive sleep apnea on aerobic fitness? Among US Air Force personnel, OSA does not typically predict a decline in aerobic fitness measured by cycle ergometry. However, individuals with an apnea-hypopnea index higher than 20 show a significant reduction in aerobic fitness compared to normal controls. This study",7.105791820705622e-08,0.034506545194199933,0.016212967780149266,0.005440279394345618,0.033681800587132216,0.01768614608708629,0.0054324046228586,0.03276391352618768,0.01922337562475971,7.105791820705622e-08,0.06062462181643413,0.0
261,0.3,7,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study","Does obstructive sleep apnea cause a decrease in aerobic fitness? In a US Air Force population, OSA generally does not predict reduced aerobic fitness via cycle ergometry. Yet, patients with an apnea-hypopnea index greater than 20 have a statistically significant lower aerobic fitness compared to the normal population. This study",1.1842986367842703e-07,0.0484391167136069,0.03496401624375241,0.009067132323909363,0.04677790788498859,0.03767781622452902,0.009054007704764333,0.0744366099267566,0.01922337562475971,1.1842986367842703e-07,0.10318423623523065,0.0
261,0.3,8,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study","What is the impact of obstructive sleep apnea on aerobic fitness? In a US Air Force cohort, OSA does not overall predict decreased aerobic fitness as measured by cycle ergometry. However, those with an apnea-hypopnea index exceeding 20 show a statistically significant reduction in aerobic fitness compared to normal individuals. This study",7.105791820705622e-08,0.007324302819299966,0.03576332179930797,0.005440279394345618,0.005955913364734222,0.03767781622452902,0.0054324046228586,0.03276391352618768,0.01922337562475971,7.105791820705622e-08,0.06062462181643413,0.0
261,0.3,9,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study","Does obstructive sleep apnea have an effect on aerobic fitness? Research involving US Air Force members indicates that OSA does not predict a decrease in aerobic fitness measured by cycle ergometry. Nonetheless, patients with an apnea-hypopnea index over 20 have a statistically significant decline in aerobic fitness relative to the normal population. This study",2.3685972735685406e-08,0.006011225624154015,0.017685505574778937,0.0018134264647818726,0.006605292843934851,0.018454440599769313,0.0018108015409528666,0.007241421087510691,0.01922337562475971,2.3685972735685406e-08,0.019802627296179764,0.0
261,0.3,10,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study","How does obstructive sleep apnea influence aerobic fitness? Among US Air Force personnel, OSA generally does not predict lower aerobic fitness as assessed by cycle ergometry. However, those with an apnea-hypopnea index above 20 exhibit a statistically significant decrease in aerobic fitness compared to normal controls. This study",1.6580180914979784e-07,0.09131571616334622,0.034096781156585855,0.012693985253473108,0.08933752230378511,0.03767781622452902,0.012675610786670066,0.11792172186649497,0.01922337562475971,1.6580180914979784e-07,0.14763599880606337,0.0
262,0.3,1,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Yes, globulomaxillary cysts do exist. They are rare, benign lesions that occur between the roots of the maxillary lateral incisor and canine","Question: Are globulomaxillary cysts real? Answer: Yes, globulomaxillary cysts are real. They are uncommon, non-cancerous growths found between the roots of the maxillary lateral incisor and canine.",4.73719454713706e-08,0.12742698604294844,0.03840000000000001,0.003626852929563759,0.07696104113612945,0.0,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
262,0.3,2,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Yes, globulomaxillary cysts do exist. They are rare, benign lesions that occur between the roots of the maxillary lateral incisor and canine","Question: Do globulomaxillary cysts actually exist? Answer: Indeed, globulomaxillary cysts exist. These are rare, benign lesions located between the roots of the maxillary lateral incisor and canine.",4.73719454713706e-08,0.12742698604294844,0.03840000000000001,0.003626852929563759,0.07696104113612945,0.0,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
262,0.3,3,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Yes, globulomaxillary cysts do exist. They are rare, benign lesions that occur between the roots of the maxillary lateral incisor and canine","Question: Is the existence of globulomaxillary cysts confirmed? Answer: Yes, globulomaxillary cysts are confirmed to exist. They are rare, benign cysts appearing between the roots of the maxillary lateral incisor and canine.",7.10579182070559e-08,0.05706352137059145,0.0322222222222222,0.005440279394345639,0.10536051565782545,0.0,0.005432404622858621,0.10919929196499067,0.0,7.105791820705622e-08,0.11332868530700413,0.0
262,0.3,4,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Yes, globulomaxillary cysts do exist. They are rare, benign lesions that occur between the roots of the maxillary lateral incisor and canine","Question: Are globulomaxillary cysts a real condition? Answer: Yes, globulomaxillary cysts are a real condition. They are infrequent, benign lesions found between the roots of the maxillary lateral incisor and canine.",4.73719454713706e-08,0.02342675258770832,0.06632653061224487,0.003626852929563759,0.07145896398214369,0.0,0.003621603081905747,0.07410797215372167,0.0,4.737194547137081e-08,0.07696104113612945,0.0
262,0.3,5,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Yes, globulomaxillary cysts do exist. They are rare, benign lesions that occur between the roots of the maxillary lateral incisor and canine","Question: Do globulomaxillary cysts truly exist? Answer: Yes, globulomaxillary cysts truly exist. They are rare, benign lesions that develop between the roots of the maxillary lateral incisor and canine.",0.0,0.09902102579427874,0.07100591715976333,0.0,0.05134423559703327,0.03698224852071005,0.0,0.0,0.0,0.0,0.0,0.0
262,0.3,6,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Yes, globulomaxillary cysts do exist. They are rare, benign lesions that occur between the roots of the maxillary lateral incisor and canine","Question: Can globulomaxillary cysts be found in patients? Answer: Yes, globulomaxillary cysts can be found. They are rare, benign lesions occurring between the roots of the maxillary lateral incisor and canine.",4.73719454713706e-08,0.022783059449621224,0.033293697978596916,0.003626852929563759,0.07145896398214369,0.0,0.003621603081905747,0.07410797215372167,0.0,4.737194547137081e-08,0.07696104113612945,0.0
262,0.3,7,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Yes, globulomaxillary cysts do exist. They are rare, benign lesions that occur between the roots of the maxillary lateral incisor and canine","Question: Are globulomaxillary cysts recognized as existing? Answer: Yes, globulomaxillary cysts are recognized as existing. They are rare, benign lesions located between the roots of the maxillary lateral incisor and canine.",4.73719454713706e-08,0.02342675258770832,0.06632653061224487,0.003626852929563759,0.07145896398214369,0.0,0.003621603081905747,0.07410797215372167,0.0,4.737194547137081e-08,0.07696104113612945,0.0
262,0.3,8,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Yes, globulomaxillary cysts do exist. They are rare, benign lesions that occur between the roots of the maxillary lateral incisor and canine","Question: Is there evidence that globulomaxillary cysts exist? Answer: Yes, there is evidence that globulomaxillary cysts exist. They are rare, benign lesions found between the roots of the maxillary lateral incisor and canine.",9.47438909427412e-08,0.0035662962695313105,0.09274673008323425,0.007253705859127518,0.04871199260211467,0.06420927467300831,0.007243206163811494,0.09689103160334289,0.033293697978596916,9.474389094274162e-08,0.14842000511827314,0.0
262,0.3,9,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Yes, globulomaxillary cysts do exist. They are rare, benign lesions that occur between the roots of the maxillary lateral incisor and canine","Question: Do globulomaxillary cysts exist in reality? Answer: Yes, globulomaxillary cysts do exist in reality. They are rare, benign lesions occurring between the roots of the maxillary lateral incisor and canine.",4.73719454713706e-08,0.02342675258770832,0.06632653061224487,0.003626852929563759,0.07145896398214369,0.0,0.003621603081905747,0.07410797215372167,0.0,4.737194547137081e-08,0.07696104113612945,0.0
262,0.3,10,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Yes, globulomaxillary cysts do exist. They are rare, benign lesions that occur between the roots of the maxillary lateral incisor and canine","Question: Are globulomaxillary cysts an actual medical entity? Answer: Yes, globulomaxillary cysts are an actual medical entity. They are rare, benign lesions situated between the roots of the maxillary lateral incisor and canine.",9.47438909427412e-08,0.0035662962695313105,0.09274673008323425,0.007253705859127518,0.09343116554146613,0.0322222222222222,0.007243206163811494,0.14310084364067244,0.0,9.474389094274162e-08,0.14842000511827314,0.0
263,0.3,1,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a","Are opioid dependence and methadone maintenance treatment (MMT) recorded in the medical records? For most patients undergoing MMT and receiving care at various locations, opioid dependence and MMT are documented in their medical records, though some records lack this information.",9.474389094274152e-08,0.03977287309498978,0.040912494134947394,0.0072537058591274906,0.07055087191658371,0.021203433162892627,0.007243206163811466,0.10265415406008227,0.0,9.474389094274162e-08,0.10536051565782589,0.0
263,0.3,2,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a","Is opioid dependence and methadone maintenance treatment (MMT) noted in the medical records? The majority of patients on MMT and treated at different sites have documentation of opioid dependence and MMT in their medical files, but some do not.",1.1842986367842682e-07,0.06761920209085259,0.039575571626853705,0.009067132323909363,0.09820510360836066,0.020493827160493836,0.009054007704764333,0.1300531282481976,0.0,1.1842986367842703e-07,0.13353139262452274,0.0
263,0.3,3,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a","Do medical records include documentation of opioid dependence and methadone maintenance treatment (MMT)? Among patients receiving MMT and care at multiple sites, most have opioid dependence and MMT recorded, although some records are incomplete.",2.3685972735685332e-07,0.21975277930705817,0.03169090930237176,0.018134264647818747,0.24924139707245496,0.016282518210197695,0.018108015409528694,0.27958486221916123,0.0,2.3685972735685406e-07,0.28768207245178123,0.0
263,0.3,4,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a","Is there documentation of opioid dependence and methadone maintenance treatment (MMT) in the medical records? For most patients treated with MMT at various locations, opioid dependence and MMT are noted, but some records are missing this data.",1.6580180914979742e-07,0.12573991564510534,0.03668138563001487,0.012693985253473108,0.15591594991548163,0.01895328719723184,0.012675610786670073,0.18721154208814594,0.0,1.6580180914979784e-07,0.19237189264745602,0.0
263,0.3,5,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a","Are opioid dependence and methadone maintenance treatment (MMT) documented within medical records? The majority of patients receiving MMT and medical care at different sites have these details recorded, but some records lack such documentation.",2.3685972735685332e-07,0.13573493923918578,0.09204470742932284,0.018134264647818747,0.20591969828745738,0.0475,0.018108015409528694,0.27958486221916123,0.0,2.3685972735685406e-07,0.28768207245178123,0.0
263,0.3,6,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a","Is opioid dependence and methadone maintenance treatment (MMT) documented in patients' medical records? Most patients undergoing MMT and treated at different sites have this information recorded, though it is absent in some cases.",2.605457000925386e-07,0.16650659790593947,0.09204470742932284,0.019947691112600627,0.2376683966020372,0.0475,0.019918816950481567,0.31237468504215293,0.0,2.6054570009253947e-07,0.321583624127463,0.0
263,0.3,7,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a","Do medical records reflect opioid dependence and methadone maintenance treatment (MMT)? For most patients receiving MMT at various care sites, opioid dependence and MMT are documented, but some records do not include this information.",2.3685972735685332e-07,0.21975277930705817,0.03169090930237176,0.018134264647818747,0.24924139707245496,0.016282518210197695,0.018108015409528694,0.27958486221916123,0.0,2.3685972735685406e-07,0.28768207245178123,0.0
263,0.3,8,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a","Are opioid dependence and methadone maintenance treatment (MMT) included in the medical records? Among patients on MMT and receiving care at multiple sites, the majority have documentation of these conditions, though some records are missing it.",1.8948778188548272e-07,0.0768944392162525,0.09204470742932284,0.014507411718254988,0.1452950764710219,0.0475,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
263,0.3,9,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a","Is the documentation of opioid dependence and methadone maintenance treatment (MMT) present in medical records? Most patients receiving MMT and care at different sites have these details recorded, but some records lack them.",2.605457000925386e-07,0.16650659790593947,0.09204470742932284,0.019947691112600627,0.2376683966020372,0.0475,0.019918816950481567,0.31237468504215293,0.0,2.6054570009253947e-07,0.321583624127463,0.0
263,0.3,10,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a","Are opioid dependence and methadone maintenance treatment (MMT) recorded in the medical records? Among patients treated with MMT at various sites, documentation is present for most, but absent in some cases.",3.079176455639092e-07,0.231045119043511,0.09204470742932284,0.023574544042164386,0.30435977110071066,0.0475,0.023540420032387314,0.3813675565291037,0.0,3.079176455639103e-07,0.3930425881096067,0.0
264,0.3,1,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Question: Does the quantity of needles influence acupuncture treatment for neck pain? Answer: For this condition, whether using 5 or 11 needles does not appear to significantly affect the therapeutic outcome, provided the stimulation duration is equal in both groups.",1.6580180914979774e-07,0.10480608248467238,0.043388429752066124,0.012693985253473108,0.13826978868571338,0.02221074380165289,0.012675610786670066,0.17327172127403623,0.0,1.6580180914979784e-07,0.17768117723745203,0.0
264,0.3,2,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Question: In acupuncture for neck pain, is the number of needles used significant? Answer: For this ailment, the therapeutic effect seems unaffected by using either 5 or 11 needles when the stimulation time is consistent across groups.",2.3685972735685364e-07,0.18484879015820654,0.043388429752066124,0.018134264647818726,0.2205078869226864,0.02221074380165289,0.018108015409528673,0.2578291093020999,0.0,2.3685972735685406e-07,0.26469255422708216,0.0
264,0.3,3,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Question: Does the number of needles impact acupuncture efficacy in neck pain treatment? Answer: For this disorder, using 5 versus 11 needles does not seem to change the therapeutic results if the stimulation time remains the same in both groups.",1.6580180914979774e-07,0.10480608248467238,0.043388429752066124,0.012693985253473108,0.13826978868571338,0.02221074380165289,0.012675610786670066,0.17327172127403623,0.0,1.6580180914979784e-07,0.17768117723745203,0.0
264,0.3,4,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Question: When treating neck pain with acupuncture, does needle count matter? Answer: For this condition, the therapeutic effect appears similar whether 5 or 11 needles are used, as long as stimulation time is equal in both groups.",2.3685972735685364e-07,0.18484879015820654,0.043388429752066124,0.018134264647818726,0.2205078869226864,0.02221074380165289,0.018108015409528673,0.2578291093020999,0.0,2.3685972735685406e-07,0.26469255422708216,0.0
264,0.3,5,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Question: Is the number of needles a key factor in acupuncture treatment for neck pain? Answer: For this pathology, the number of needles—5 or 11—does not seem to influence the therapeutic effect when stimulation time is identical in both groups.",1.6580180914979774e-07,0.17589810100364067,0.0077437835423093265,0.012693985253473108,0.17475121924149972,0.004085823035454482,0.012675610786670066,0.17327172127403623,0.0,1.6580180914979784e-07,0.17768117723745203,0.0
264,0.3,6,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Question: Does acupuncture needle quantity affect neck pain treatment outcomes? Answer: For this condition, using 5 or 11 needles does not significantly alter the therapeutic effect if the stimulation duration is the same in both groups.",2.6054570009253894e-07,0.2130196671249034,0.043388429752066124,0.019947691112600606,0.24949542379593792,0.02221074380165289,0.019918816950481547,0.2876820724517817,0.0,2.6054570009253947e-07,0.29546421289383584,0.0
264,0.3,7,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Question: In neck pain acupuncture therapy, is the number of needles important? Answer: For this pathology, the therapeutic effect does not seem to depend on whether 5 or 11 needles are used, provided the stimulation time is equal in both groups.",1.4211583641411244e-07,0.07948827450038065,0.043388429752066124,0.010880558788691236,0.1122943022824554,0.02221074380165289,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
264,0.3,8,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Question: Does the number of needles used in acupuncture affect neck pain relief? Answer: For this condition, the therapeutic outcome appears unaffected by using either 5 or 11 needles when the stimulation time is consistent between groups.",2.3685972735685364e-07,0.18484879015820654,0.043388429752066124,0.018134264647818726,0.2205078869226864,0.02221074380165289,0.018108015409528673,0.2578291093020999,0.0,2.3685972735685406e-07,0.26469255422708216,0.0
264,0.3,9,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Question: Is the therapeutic effect of acupuncture for neck pain influenced by needle count? Answer: For this pathology, whether 5 or 11 needles are used does not seem to impact the therapeutic effect if stimulation time is the same in both groups.",1.1842986367842703e-07,0.15623183467487856,0.029326251688377103,0.009067132323909363,0.12163385332616006,0.0027728196434490295,0.009054007704764333,0.12062798778861739,0.0,1.1842986367842703e-07,0.12361395596717584,0.0
264,0.3,10,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Question: Does the number of needles matter in acupuncture treatment for neck pain? Answer: For this condition, the therapeutic effect seems independent of using 5 or 11 needles, as long as the stimulation time is equal in both groups.",1.8948778188548304e-07,0.13078156888793036,0.043388429752066124,0.014507411718254981,0.16493803576787425,0.02221074380165289,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
265,0.3,1,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation has been found to be associated with increased expression of vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-beta1). These growth factors play a role in angiogenesis and tissue remodeling, which may contribute to the development and growth of endometrial","Is the formation of endometrial polyps linked to elevated levels of vascular endothelial growth factor and transforming growth factor-beta1? Yes, studies have shown that endometrial polyp formation correlates with increased expression of VEGF and TGF-beta1, which are involved in angiogenesis and tissue remodeling, potentially aiding polyp development and growth.",3.552895910352811e-07,0.007877646698902119,0.17993079584775093,0.02720139697172809,0.07575050510795123,0.14097543609825555,0.027162023114293,0.14587564527898023,0.09719008264462808,3.552895910352811e-07,0.1721575423584567,0.08264462809917351
265,0.3,2,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation has been found to be associated with increased expression of vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-beta1). These growth factors play a role in angiogenesis and tissue remodeling, which may contribute to the development and growth of endometrial","Does the development of endometrial polyps involve higher expression of vascular endothelial growth factor and transforming growth factor-beta1? Indeed, endometrial polyps are associated with increased VEGF and TGF-beta1 expression, factors that contribute to blood vessel formation and tissue changes facilitating polyp growth.",5.210914001850789e-07,0.19931864849077519,0.15555579584775092,0.0398953822252012,0.23701865270407296,0.14097543609825555,0.039837633900963065,0.31095539563843033,0.09719008264462808,5.210914001850789e-07,0.3412338724023898,0.08264462809917351
265,0.3,3,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation has been found to be associated with increased expression of vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-beta1). These growth factors play a role in angiogenesis and tissue remodeling, which may contribute to the development and growth of endometrial","Is there an association between endometrial polyp formation and increased vascular endothelial growth factor and transforming growth factor-beta1 expression? Yes, the formation of endometrial polyps is linked to elevated VEGF and TGF-beta1, which promote angiogenesis and tissue remodeling, supporting polyp development.",5.447773729207643e-07,0.19019920349285702,0.17993079584775093,0.04170880868998307,0.2623364606883647,0.14097543609825555,0.04164843544191593,0.3369308820416883,0.09719008264462808,5.447773729207643e-07,0.36790211948455065,0.08264462809917351
265,0.3,4,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation has been found to be associated with increased expression of vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-beta1). These growth factors play a role in angiogenesis and tissue remodeling, which may contribute to the development and growth of endometrial","Are elevated levels of vascular endothelial growth factor and transforming growth factor-beta1 connected to the formation of endometrial polyps? Yes, endometrial polyps show increased expression of VEGF and TGF-beta1, growth factors that play key roles in angiogenesis and tissue remodeling, contributing to polyp growth.",4.737194547137081e-07,0.11787854191323088,0.17993079584775093,0.03626852929563745,0.18822848853464125,0.14097543609825555,0.03621603081905733,0.2609449750637669,0.09719008264462808,4.737194547137081e-07,0.2899405780148401,0.08264462809917351
265,0.3,5,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation has been found to be associated with increased expression of vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-beta1). These growth factors play a role in angiogenesis and tissue remodeling, which may contribute to the development and growth of endometrial","Is increased expression of vascular endothelial growth factor and transforming growth factor-beta1 associated with endometrial polyp formation? Yes, endometrial polyp formation is accompanied by heightened VEGF and TGF-beta1 levels, which facilitate angiogenesis and tissue remodeling involved in polyp development.",5.921493183921349e-07,0.27797392843619306,0.15363422901064355,0.045335661619546816,0.31498019417378353,0.14097543609825555,0.045270038523821665,0.3909981033119645,0.09719008264462808,5.921493183921352e-07,0.4234719706393628,0.08264462809917351
265,0.3,6,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation has been found to be associated with increased expression of vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-beta1). These growth factors play a role in angiogenesis and tissue remodeling, which may contribute to the development and growth of endometrial","Does endometrial polyp formation correspond with higher expression of vascular endothelial growth factor and transforming growth factor-beta1? Yes, the presence of endometrial polyps is associated with increased VEGF and TGF-beta1, factors important for angiogenesis and tissue remodeling that may promote polyp growth.",5.210914001850789e-07,0.16550659090248532,0.17993079584775093,0.0398953822252012,0.23701865270407296,0.14097543609825555,0.039837633900963065,0.31095539563843033,0.09719008264462808,5.210914001850789e-07,0.3412338724023898,0.08264462809917351
265,0.3,7,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation has been found to be associated with increased expression of vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-beta1). These growth factors play a role in angiogenesis and tissue remodeling, which may contribute to the development and growth of endometrial","Is the occurrence of endometrial polyps related to increased vascular endothelial growth factor and transforming growth factor-beta1 expression? Yes, endometrial polyps are linked to elevated VEGF and TGF-beta1, which contribute to angiogenesis and tissue remodeling processes aiding polyp formation.",5.921493183921349e-07,0.27797392843619306,0.15363422901064355,0.045335661619546816,0.31498019417378353,0.14097543609825555,0.045270038523821665,0.3909981033119645,0.09719008264462808,5.921493183921352e-07,0.4234719706393628,0.08264462809917351
265,0.3,8,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation has been found to be associated with increased expression of vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-beta1). These growth factors play a role in angiogenesis and tissue remodeling, which may contribute to the development and growth of endometrial","Are vascular endothelial growth factor and transforming growth factor-beta1 overexpressed in endometrial polyp formation? Yes, increased VEGF and TGF-beta1 expression is observed in endometrial polyps, playing roles in angiogenesis and tissue remodeling that support polyp development.",6.632072365991908e-07,0.363339006435091,0.15138408304498277,0.05077594101389244,0.3995375822018472,0.14097543609825555,0.05070244314668028,0.4780094803015946,0.09719008264462808,6.632072365991914e-07,0.5130841293290498,0.08264462809917351
265,0.3,9,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation has been found to be associated with increased expression of vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-beta1). These growth factors play a role in angiogenesis and tissue remodeling, which may contribute to the development and growth of endometrial","Is the increased expression of vascular endothelial growth factor and transforming growth factor-beta1 a feature of endometrial polyp formation? Yes, endometrial polyps exhibit higher levels of VEGF and TGF-beta1, growth factors involved in angiogenesis and tissue remodeling that may facilitate polyp growth.",5.210914001850789e-07,0.16550659090248532,0.17993079584775093,0.0398953822252012,0.23701865270407296,0.14097543609825555,0.039837633900963065,0.31095539563843033,0.09719008264462808,5.210914001850789e-07,0.3412338724023898,0.08264462809917351
265,0.3,10,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation has been found to be associated with increased expression of vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-beta1). These growth factors play a role in angiogenesis and tissue remodeling, which may contribute to the development and growth of endometrial","Does the formation of endometrial polyps involve upregulation of vascular endothelial growth factor and transforming growth factor-beta1? Yes, endometrial polyps are associated with increased VEGF and TGF-beta1 expression, which are crucial for angiogenesis and tissue remodeling contributing to polyp development.",5.684633456564496e-07,0.25106302073663267,0.15430752714968998,0.04352223515476494,0.28831194709162267,0.14097543609825555,0.0434592369828688,0.3635991291238492,0.09719008264462808,5.684633456564497e-07,0.39530109367266597,0.08264462809917351
266,0.3,1,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification may contribute to the difference in birthweights between Australian aborigines and whites, but it is not the sole factor. Other factors such as socioeconomic disparities and","Does incorrect gestational age account for the birthweight differences between Australian aborigines and whites? Gestational age misclassification might partly explain the birthweight differences between Australian aborigines and whites, but it is not the only reason. Other elements like socioeconomic inequalities also play a role.",2.3685972735685406e-08,0.028118514275353945,0.0032391625860094253,0.0018134264647818726,0.05960792541276172,0.024828922957821048,0.0018108015409528666,0.1263387733341279,0.07262538516457519,2.3685972735685406e-08,0.12866468967436262,0.07450693937180423
266,0.3,2,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification may contribute to the difference in birthweights between Australian aborigines and whites, but it is not the sole factor. Other factors such as socioeconomic disparities and","Is gestational age misclassification responsible for the birthweight gap between Australian aborigines and whites? While gestational age misclassification could contribute to the birthweight differences between Australian aborigines and whites, it is not the sole cause. Additional factors such as socioeconomic disparities are involved.",4.737194547137081e-08,0.02401523704528552,0.014507750994237456,0.0036268529295637453,0.020106606766227664,0.019330025988879604,0.003621603081905733,0.05044051459933652,0.0011882035402833654,4.737194547137081e-08,0.05001042057466343,0.0
266,0.3,3,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification may contribute to the difference in birthweights between Australian aborigines and whites, but it is not the sole factor. Other factors such as socioeconomic disparities and","Can the difference in birthweights between Australian aborigines and whites be explained by gestational age misclassification? Gestational age misclassification may partly explain the birthweight differences between Australian aborigines and whites, but other factors like socioeconomic status also influence this disparity.",1.1842986367842692e-07,0.04226519464838896,0.052172150087207964,0.009067132323909363,0.06761920209085259,0.03957557162685369,0.009054007704764333,0.13121211220645312,0.003210812934687609,1.1842986367842703e-07,0.1300531282481976,0.0
266,0.3,4,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification may contribute to the difference in birthweights between Australian aborigines and whites, but it is not the sole factor. Other factors such as socioeconomic disparities and","Does the misclassification of gestational age explain why Australian aborigines and whites have different birthweights? Gestational age misclassification might be a factor in the birthweight differences between Australian aborigines and whites, but it is not the only one. Socioeconomic differences also contribute.",7.105791820705622e-08,0.04849309019934056,0.08068195844268312,0.005440279394345618,0.02197959438027386,0.06706114398422092,0.0054324046228586,0.041100963555631864,0.023795359904818555,7.105791820705622e-08,0.0759859069779214,0.0
266,0.3,5,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification may contribute to the difference in birthweights between Australian aborigines and whites, but it is not the sole factor. Other factors such as socioeconomic disparities and","Is the variation in birthweights between Australian aborigines and whites due to gestational age misclassification? Gestational age misclassification could partially account for the birthweight differences between Australian aborigines and whites, but other factors such as socioeconomic disparities also matter.",1.4211583641411222e-07,0.07198236623685794,0.04959041150942392,0.010880558788691236,0.09625941839224605,0.03816715640891465,0.0108648092457172,0.15965184792694087,0.003959742135997774,1.4211583641411244e-07,0.15822400521489444,0.0
266,0.3,6,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification may contribute to the difference in birthweights between Australian aborigines and whites, but it is not the sole factor. Other factors such as socioeconomic disparities and","Could gestational age misclassification explain the birthweight differences observed between Australian aborigines and whites? While gestational age misclassification may contribute to the birthweight differences between Australian aborigines and whites, it is not the only factor. Socioeconomic disparities also play a significant role.",7.105791820705622e-08,0.08675514015381935,0.01009816980545497,0.005440279394345618,0.08199248270371795,0.006720724669442624,0.0054324046228586,0.07664697281511579,0.0018279087932423985,7.105791820705622e-08,0.0759859069779214,0.0
266,0.3,7,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification may contribute to the difference in birthweights between Australian aborigines and whites, but it is not the sole factor. Other factors such as socioeconomic disparities and","Does misclassifying gestational age clarify the birthweight differences between Australian aborigines and whites? Gestational age misclassification might explain some of the birthweight differences between Australian aborigines and whites, but it is not the sole explanation. Other factors like socioeconomic status are also important.",4.737194547137081e-08,0.05702224564337799,0.00660336011687368,0.0036268529295637453,0.0877307219428074,0.02755405800277598,0.003621603081905733,0.15441259168332833,0.07497007219394691,4.737194547137081e-08,0.15664844835311564,0.0763888888888889
266,0.3,8,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification may contribute to the difference in birthweights between Australian aborigines and whites, but it is not the sole factor. Other factors such as socioeconomic disparities and","Is the difference in birthweights between Australian aborigines and whites explained by gestational age misclassification? Gestational age misclassification may be one reason for the birthweight differences between Australian aborigines and whites, but it is not the only one. Socioeconomic disparities also contribute.",7.105791820705622e-08,0.014681032611051137,0.05697589481373261,0.005440279394345618,0.012677764647723855,0.042183211584447496,0.0054324046228586,0.07664697281511579,0.0018279087932423985,7.105791820705622e-08,0.0759859069779214,0.0
266,0.3,9,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification may contribute to the difference in birthweights between Australian aborigines and whites, but it is not the sole factor. Other factors such as socioeconomic disparities and","Does gestational age misclassification account for the birthweight disparity between Australian aborigines and whites? Gestational age misclassification might partly explain the birthweight disparity between Australian aborigines and whites, but other factors such as socioeconomic inequalities also play a role.",1.4211583641411222e-07,0.21790808846000376,0.04215891567242916,0.010880558788691236,0.24612907905385484,0.06404270151968869,0.0108648092457172,0.2751763780202654,0.08557964009518144,1.4211583641411244e-07,0.2770492361680277,0.0849609375
266,0.3,10,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification may contribute to the difference in birthweights between Australian aborigines and whites, but it is not the sole factor. Other factors such as socioeconomic disparities and","Is the birthweight difference between Australian aborigines and whites due to gestational age misclassification? Gestational age misclassification may contribute to the birthweight difference between Australian aborigines and whites, but it is not the sole cause. Socioeconomic disparities also influence this difference.",9.474389094274162e-08,0.11736486282214198,0.013729163606313516,0.0072537058591274906,0.146410900873442,0.033387818522234214,0.007243206163811466,0.213002172182037,0.08001086846888386,9.474389094274162e-08,0.21505639955629086,0.08044982698961935
267,0.3,1,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system,"Question: Does the distribution of health care benefits in Kenya align with the principles of universal coverage? Answer: Universal coverage principles dictate that health care benefits should be allocated based on need. However, Kenya's health sector is evidently inequitable, with benefits not distributed according to need. Intentional reforms are necessary to restructure the Kenyan health system.",1.1842986367842703e-07,0.0012073550816364964,0.062453577346184466,0.009067132323909363,0.04373597135420315,0.03218960465994872,0.009054007704764333,0.06624947007843796,0.017236072637734686,1.1842986367842703e-07,0.09180754925312229,0.0
267,0.3,2,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system,"Question: Is the distribution of health care benefits in Kenya consistent with universal coverage principles? Answer: Universal coverage demands that health care benefits be provided according to need. The Kenyan health sector, however, is clearly inequitable, and benefits are not allocated based on need. Focused efforts are required to reform the Kenyan health system.",1.6580180914979784e-07,0.11620569945609294,0.0054494598765432445,0.012693985253473108,0.1091231954277605,0.012301530612244892,0.012675610786670066,0.10471575090623375,0.017236072637734686,1.6580180914979784e-07,0.13102826240640475,0.0
267,0.3,3,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system,"Question: Does Kenya's health care benefits distribution follow the universal coverage principles? Answer: The principles of universal coverage require health care benefits to be distributed based on need. Kenya's health sector is evidently inequitable, with benefits not aligned to need. Purposeful restructuring of the Kenyan health system is necessary.",2.8423167282822487e-07,0.20003864529554427,0.0161208039995919,0.02176111757738247,0.1863959231145822,0.0294349899695228,0.0217296184914344,0.2078999871414644,0.017236072637734686,2.8423167282822487e-07,0.23638877806423064,0.0
267,0.3,4,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system,"Question: Are health care benefits in Kenya distributed in line with universal coverage principles? Answer: Universal coverage principles state that all individuals should receive health care benefits according to their needs. The Kenyan health sector is clearly inequitable, with benefits not distributed by need. Concerted efforts should aim to restructure the Kenyan health system.",1.6580180914979784e-07,0.11620569945609294,0.0054494598765432445,0.012693985253473108,0.1091231954277605,0.012301530612244892,0.012675610786670066,0.10471575090623375,0.017236072637734686,1.6580180914979784e-07,0.13102826240640475,0.0
267,0.3,5,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system,"Question: Does the Kenyan health care benefits distribution meet universal coverage standards? Answer: Universal coverage principles require benefits to be allocated based on need. The Kenyan health sector is evidently inequitable, and benefits are not distributed according to need. Deliberate restructuring of the Kenyan health system is needed.",3.079176455639103e-07,0.275311526381512,0.10134794658604176,0.023574544042164344,0.2500551311527004,0.038141444594366664,0.023540420032387266,0.2298788938602394,0.017236072637734686,3.079176455639103e-07,0.25886163391628836,0.0
267,0.3,6,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system,"Question: Is the distribution of health care benefits in Kenya equitable under universal coverage principles? Answer: Universal coverage principles mandate that health care benefits be given according to need. The Kenyan health sector is clearly inequitable, with benefits not distributed on this basis. Intentional efforts should focus on restructuring the health system in Kenya.",1.6580180914979784e-07,0.06389270469685204,0.04236543209876543,0.012693985253473108,0.08246368848314711,0.03147815498748519,0.012675610786670066,0.10471575090623375,0.017236072637734686,1.6580180914979784e-07,0.13102826240640475,0.0
267,0.3,7,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system,"Question: Does Kenya's health care benefits allocation conform to universal coverage principles? Answer: According to universal coverage, health care benefits should be distributed based on need. The Kenyan health sector is evidently inequitable, with benefits not allocated accordingly. There is a need for deliberate restructuring of the Kenyan health system.",2.6054570009253947e-07,0.2053534362770244,0.00195770839710227,0.0199476911126006,0.19360915425873237,0.00911362891092165,0.019918816950481533,0.18639378192050104,0.017236072637734686,2.6054570009253947e-07,0.21440987134545564,0.0
267,0.3,8,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system,"Question: Are health care benefits in Kenya distributed according to the principles of universal coverage? Answer: Universal coverage requires that health care benefits be provided based on need. The Kenyan health sector is clearly inequitable, with benefits not distributed on this basis. Focused efforts must be made to restructure the Kenyan health system.",1.8948778188548325e-07,0.1111094353071369,0.022376543209876573,0.014507411718254981,0.1295867521454359,0.011551176593086208,0.014486412327622933,0.12451837820241352,0.017236072637734686,1.8948778188548325e-07,0.15123096972392336,0.0
267,0.3,9,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system,"Question: Does the Kenyan health care system distribute benefits in accordance with universal coverage principles? Answer: The principles of universal coverage require benefits to be allocated according to need. Kenya's health sector is evidently inequitable, with benefits not distributed based on need. Deliberate efforts should be made to restructure the health system in Kenya.",1.6580180914979784e-07,0.011579709937611149,0.07990448535320333,0.012693985253473108,0.055804181538533726,0.0507015306122449,0.012675610786670066,0.10471575090623375,0.017236072637734686,1.6580180914979784e-07,0.13102826240640475,0.0
267,0.3,10,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system,"Question: Is the distribution of health care benefits in Kenya aligned with universal coverage principles? Answer: Universal coverage principles demand that health care benefits be distributed according to need. The Kenyan health sector is clearly inequitable, and benefits are not allocated on this basis. Intentional restructuring of the Kenyan health system is necessary.",1.8948778188548325e-07,0.1377689422517494,0.003699791537425459,0.014507411718254981,0.1295867521454359,0.011551176593086208,0.014486412327622933,0.12451837820241352,0.017236072637734686,1.8948778188548325e-07,0.15123096972392336,0.0
268,0.3,1,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes (PPEs) are not necessarily predictive of interictal psychotic episodes (IPEs). While PPEs may occur immediately following seizures, the long-term significance of these episodes in predicting IPEs is","Postictal psychotic episodes (PPEs) do not always predict the occurrence of interictal psychotic episodes (IPEs). Although PPEs happen right after seizures, their long-term role in forecasting IPEs is uncertain.",4.0266153650665063e-07,0.26588842509839505,0.18785552319085858,0.03082824990129189,0.3623260078121233,0.09,0.030783626196198795,0.4708641739251056,0.023242630385487524,4.026615365066519e-07,0.5187937934151678,0.0
268,0.3,2,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes (PPEs) are not necessarily predictive of interictal psychotic episodes (IPEs). While PPEs may occur immediately following seizures, the long-term significance of these episodes in predicting IPEs is","The presence of postictal psychotic episodes (PPEs) does not guarantee that interictal psychotic episodes (IPEs) will follow. PPEs typically occur immediately after seizures, but their predictive value for IPEs over time is unclear.",3.0791764556390943e-07,0.1261682183617312,0.19230333632561045,0.023574544042164372,0.22417566933130617,0.09,0.0235404200323873,0.32776333028443316,0.023242630385487524,3.079176455639103e-07,0.3703737882968947,0.0
268,0.3,3,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes (PPEs) are not necessarily predictive of interictal psychotic episodes (IPEs). While PPEs may occur immediately following seizures, the long-term significance of these episodes in predicting IPEs is","Postictal psychotic episodes (PPEs) are not definitive indicators of future interictal psychotic episodes (IPEs). While PPEs arise soon after seizures, their long-term importance in anticipating IPEs remains ambiguous.",4.2634750924233593e-07,0.30408979196916386,0.1865385695947027,0.03264167636607377,0.4000663357949703,0.09,0.03259442773715167,0.5100848870783881,0.023242630385487524,4.263475092423373e-07,0.5596157879354227,0.0
268,0.3,4,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes (PPEs) are not necessarily predictive of interictal psychotic episodes (IPEs). While PPEs may occur immediately following seizures, the long-term significance of these episodes in predicting IPEs is","Experiencing postictal psychotic episodes (PPEs) does not necessarily mean that interictal psychotic episodes (IPEs) will develop later. PPEs occur right after seizures, but their long-term predictive significance for IPEs is not established.",3.3160361829959473e-07,0.15931439083066445,0.19129859589319054,0.02538797050694625,0.25696549215429787,0.09,0.025351221573340174,0.3616648819601149,0.023242630385487524,3.316036182995957e-07,0.4054651081081637,0.0
268,0.3,5,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes (PPEs) are not necessarily predictive of interictal psychotic episodes (IPEs). While PPEs may occur immediately following seizures, the long-term significance of these episodes in predicting IPEs is","There is no certain predictive relationship between postictal psychotic episodes (PPEs) and interictal psychotic episodes (IPEs). PPEs may follow seizures immediately, yet their long-term relevance to IPE prediction is uncertain.",3.7897556377096533e-07,0.22908984622170703,0.18908204260520867,0.02901482343651001,0.32595836364124864,0.09,0.02897282465524592,0.4331238459422586,0.023242630385487524,3.789755637709665e-07,0.4795730802618854,0.0
268,0.3,6,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes (PPEs) are not necessarily predictive of interictal psychotic episodes (IPEs). While PPEs may occur immediately following seizures, the long-term significance of these episodes in predicting IPEs is","Postictal psychotic episodes (PPEs) are not reliable predictors of interictal psychotic episodes (IPEs). Although PPEs happen immediately post-seizure, their long-term significance in forecasting IPEs is not well-defined.",4.5003348197802123e-07,0.34380489824420435,0.18512081811541273,0.03445510283085565,0.43928704894825277,0.09,0.03440522927810454,0.5509068815986429,0.023242630385487524,4.500334819780227e-07,0.6021754023542183,0.0
268,0.3,7,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes (PPEs) are not necessarily predictive of interictal psychotic episodes (IPEs). While PPEs may occur immediately following seizures, the long-term significance of these episodes in predicting IPEs is","The occurrence of postictal psychotic episodes (PPEs) does not necessarily forecast interictal psychotic episodes (IPEs). PPEs appear soon after seizures, but their long-term predictive value for IPEs is unclear.",4.0266153650665063e-07,0.26588842509839505,0.18785552319085858,0.03082824990129189,0.3623260078121233,0.09,0.030783626196198795,0.4708641739251056,0.023242630385487524,4.026615365066519e-07,0.5187937934151678,0.0
268,0.3,8,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes (PPEs) are not necessarily predictive of interictal psychotic episodes (IPEs). While PPEs may occur immediately following seizures, the long-term significance of these episodes in predicting IPEs is","Postictal psychotic episodes (PPEs) do not inherently predict the development of interictal psychotic episodes (IPEs). While PPEs occur immediately after seizures, their long-term significance in predicting IPEs remains uncertain.",4.0266153650665063e-07,0.26588842509839505,0.18785552319085858,0.03082824990129189,0.3623260078121233,0.09,0.030783626196198795,0.4708641739251056,0.023242630385487524,4.026615365066519e-07,0.5187937934151678,0.0
268,0.3,9,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes (PPEs) are not necessarily predictive of interictal psychotic episodes (IPEs). While PPEs may occur immediately following seizures, the long-term significance of these episodes in predicting IPEs is","Having postictal psychotic episodes (PPEs) does not imply that interictal psychotic episodes (IPEs) will follow. PPEs typically manifest right after seizures, but their long-term predictive importance for IPEs is not confirmed.",3.5528959103528003e-07,0.19359485275163468,0.19022712013681584,0.02720139697172813,0.29086704382997963,0.09,0.027162023114293048,0.39675620177138393,0.023242630385487524,3.552895910352811e-07,0.4418327522790384,0.0
268,0.3,10,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes (PPEs) are not necessarily predictive of interictal psychotic episodes (IPEs). While PPEs may occur immediately following seizures, the long-term significance of these episodes in predicting IPEs is","Postictal psychotic episodes (PPEs) are not necessarily indicative of future interictal psychotic episodes (IPEs). Although PPEs occur immediately post-seizure, their long-term role in predicting IPEs is ambiguous.",4.5003348197802123e-07,0.34380489824420435,0.18512081811541273,0.03445510283085565,0.43928704894825277,0.09,0.03440522927810454,0.5509068815986429,0.023242630385487524,4.500334819780227e-07,0.6021754023542183,0.0
269,0.3,1,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness has been shown to have a positive influence on microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise can improve blood flow and increase the density of small blood","Does aerobic fitness affect microvascular function in healthy adults who are at risk for Type 2 diabetes? Yes, aerobic fitness positively impacts microvascular function in these individuals. Regular aerobic exercise enhances blood flow and boosts the density of small blood vessels.",3.552895910352811e-07,0.14516693597854768,0.11299306062819577,0.02720139697172809,0.12991934950746575,0.13437673130193908,0.027162023114293,0.12345377478877007,0.14617283950617282,3.552895910352811e-07,0.15370925732490948,0.131358024691358
269,0.3,2,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness has been shown to have a positive influence on microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise can improve blood flow and increase the density of small blood","Is there an effect of aerobic fitness on microvascular function in healthy adults at risk of Type 2 diabetes? Indeed, aerobic fitness improves microvascular function in such adults. Consistent aerobic exercise promotes better blood circulation and increases small vessel density.",3.789755637709664e-07,0.1731506946573007,0.1111111111111111,0.029014823436509962,0.15683025720702615,0.13370343316289265,0.028972824655245866,0.15012202187093093,0.14617283950617282,3.789755637709665e-07,0.1811082315130248,0.131358024691358
269,0.3,3,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness has been shown to have a positive influence on microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise can improve blood flow and increase the density of small blood","Can aerobic fitness influence microvascular function in healthy adults susceptible to Type 2 diabetes? Yes, it does. Aerobic fitness has a beneficial effect on microvascular function by improving blood flow and increasing the number of small blood vessels.",4.26347509242337e-07,0.19409123069507306,0.13362244897959183,0.03264167636607371,0.174416047921516,0.16000000000000003,0.0325944277371516,0.2056918730257431,0.14617283950617282,4.263475092423373e-07,0.23826664535297315,0.131358024691358
269,0.3,4,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness has been shown to have a positive influence on microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise can improve blood flow and increase the density of small blood","Does aerobic fitness play a role in microvascular function among healthy adults at risk for Type 2 diabetes? Yes, aerobic fitness positively affects microvascular function. Engaging in regular aerobic exercise improves blood flow and elevates the density of small blood vessels.",3.552895910352811e-07,0.07585221792255314,0.16251643655489809,0.02720139697172809,0.09437334024798183,0.16000000000000003,0.027162023114293,0.12345377478877007,0.14617283950617282,3.552895910352811e-07,0.15370925732490948,0.131358024691358
269,0.3,5,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness has been shown to have a positive influence on microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise can improve blood flow and increase the density of small blood","Is microvascular function in healthy adults at risk of Type 2 diabetes influenced by aerobic fitness? Yes, aerobic fitness enhances microvascular function. Regular aerobic workouts improve circulation and increase small vessel density.",5.684633456564488e-07,0.2960871085233463,0.1875,0.04352223515476498,0.35673760471547133,0.16000000000000003,0.04345923698286884,0.39374410452868336,0.14617283950617282,5.684633456564497e-07,0.4324226597939309,0.131358024691358
269,0.3,6,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness has been shown to have a positive influence on microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise can improve blood flow and increase the density of small blood",How does aerobic fitness impact microvascular function in healthy adults at risk of developing Type 2 diabetes? Aerobic fitness positively influences microvascular function by improving blood flow and raising the density of small blood vessels through regular exercise.,4.26347509242337e-07,0.19409123069507306,0.13362244897959183,0.03264167636607371,0.174416047921516,0.16000000000000003,0.0325944277371516,0.2056918730257431,0.14617283950617282,4.263475092423373e-07,0.23826664535297315,0.131358024691358
269,0.3,7,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness has been shown to have a positive influence on microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise can improve blood flow and increase the density of small blood","Does aerobic fitness have an effect on microvascular function in healthy adults with a risk of Type 2 diabetes? Yes, aerobic fitness benefits microvascular function by enhancing blood flow and increasing small vessel density via regular aerobic activity.",4.26347509242337e-07,0.19409123069507306,0.13362244897959183,0.03264167636607371,0.174416047921516,0.16000000000000003,0.0325944277371516,0.2056918730257431,0.14617283950617282,4.263475092423373e-07,0.23826664535297315,0.131358024691358
269,0.3,8,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness has been shown to have a positive influence on microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise can improve blood flow and increase the density of small blood","Is there a relationship between aerobic fitness and microvascular function in healthy adults at risk for Type 2 diabetes? Yes, aerobic fitness improves microvascular function by promoting better blood flow and greater small blood vessel density.",4.737194547137076e-07,0.2539430721545015,0.1305670339761249,0.03626852929563746,0.23157446176146435,0.16000000000000003,0.036216030819057346,0.2645323730486764,0.14617283950617282,4.737194547137081e-07,0.2988912671694086,0.131358024691358
269,0.3,9,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness has been shown to have a positive influence on microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise can improve blood flow and increase the density of small blood","Can aerobic fitness improve microvascular function in healthy adults at risk of Type 2 diabetes? Yes, it positively influences microvascular function by increasing blood flow and the density of small blood vessels through consistent aerobic exercise.",4.737194547137076e-07,0.21433466183679073,0.15895328719723184,0.03626852929563746,0.23157446176146435,0.16000000000000003,0.036216030819057346,0.2645323730486764,0.14617283950617282,4.737194547137081e-07,0.2988912671694086,0.131358024691358
269,0.3,10,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness has been shown to have a positive influence on microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise can improve blood flow and increase the density of small blood","Does aerobic fitness contribute to microvascular function in healthy adults at risk for Type 2 diabetes? Yes, aerobic fitness enhances microvascular function by improving circulation and increasing the density of small blood vessels with regular aerobic exercise.",4.500334819780223e-07,0.22357172794793234,0.13213667820069203,0.03445510283085558,0.20258692488821284,0.16000000000000003,0.03440522927810447,0.2346794098989946,0.14617283950617282,4.500334819780227e-07,0.2681196085026549,0.131358024691358
270,0.3,1,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache,Does initiating migraine treatment early reduce the time to headache peak and lessen its severity? Early intervention and triptan use might shorten the interval from migraine onset to peak but do not reduce headache intensity.,7.10579182070559e-08,0.08455738802806367,0.0,0.005440279394345632,0.08701137698963013,0.0,0.005432404622858621,0.08961215868968697,0.0,7.105791820705622e-08,0.09237332013101529,0.0
270,0.3,2,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache,Can early migraine treatment decrease the time until headache peak and mitigate its severity? Starting treatment early with triptans may shorten the duration from migraine start to peak but does not ease the headache itself.,7.10579182070559e-08,0.08455738802806367,0.0,0.005440279394345632,0.08701137698963013,0.0,0.005432404622858621,0.08961215868968697,0.0,7.105791820705622e-08,0.09237332013101529,0.0
270,0.3,3,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache,Is early treatment of migraines effective in shortening the time to headache peak and lowering its severity? Early use of triptans can reduce the time from headache onset to peak but does not relieve the headache.,4.73719454713706e-08,0.0951782614725234,0.02854671280276816,0.003626852929563752,0.05715841383994835,0.0,0.003621603081905747,0.058840500022933284,0.0,4.737194547137081e-08,0.060624621816435464,0.0
270,0.3,4,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache,Does treating migraines early shorten the time to peak headache and diminish its severity? Early treatment and triptan administration may lead to a quicker peak after migraine onset but do not reduce headache severity.,9.47438909427412e-08,0.11441035117774545,0.0,0.007253705859127511,0.11778303565638382,0.0,0.007243206163811494,0.1213608570042668,0.0,9.474389094274162e-08,0.125163142954007,0.0
270,0.3,5,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache,Will early migraine treatment shorten the time to headache peak and reduce headache severity? Early intervention with triptans might shorten the time from migraine onset to peak but does not alleviate the headache.,1.184298636784265e-07,0.23182540741449342,0.06222222222222223,0.009067132323909391,0.19425090691031466,0.0322222222222222,0.009054007704764368,0.1541506798272585,0.0,1.1842986367842703e-07,0.15906469462968875,0.0
270,0.3,6,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache,Does early intervention in migraine reduce the time to headache peak and its severity? Using triptans early may shorten the duration from migraine onset to peak but does not lessen headache pain.,1.421158364141118e-07,0.17693070815907896,0.0,0.01088055878869127,0.18232155679395534,0.0,0.010864809245717241,0.18805223150294026,0.0,1.4211583641411244e-07,0.19415601444095776,0.0
270,0.3,7,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache,Is early migraine treatment associated with a shorter time to headache peak and reduced severity? Early use of triptans can lead to a shorter interval from migraine onset to peak but does not improve headache severity.,4.73719454713706e-08,0.0951782614725234,0.02854671280276816,0.003626852929563752,0.05715841383994835,0.0,0.003621603081905747,0.058840500022933284,0.0,4.737194547137081e-08,0.060624621816435464,0.0
270,0.3,8,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache,Does starting migraine treatment early shorten the time to headache peak and decrease its severity? Early treatment with triptans may reduce the time from migraine onset to peak but does not relieve headache symptoms.,9.47438909427412e-08,0.1564192712116812,0.0302734375,0.007253705859127511,0.11778303565638382,0.0,0.007243206163811494,0.1213608570042668,0.0,9.474389094274162e-08,0.125163142954007,0.0
270,0.3,9,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache,Can early treatment of migraines shorten the time to headache peak and reduce its severity? Early use of triptans may lead to a shorter duration from migraine onset to peak but does not alleviate headache pain.,4.73719454713706e-08,0.055569851154812167,0.0,0.003626852929563752,0.05715841383994835,0.0,0.003621603081905747,0.058840500022933284,0.0,4.737194547137081e-08,0.060624621816435464,0.0
270,0.3,10,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache,Does early migraine therapy shorten the time to headache peak and reduce severity? Early treatment and triptan use may shorten the time from migraine onset to peak but do not reduce headache intensity.,1.184298636784265e-07,0.23182540741449342,0.06222222222222223,0.009067132323909391,0.19425090691031466,0.0322222222222222,0.009054007704764368,0.1541506798272585,0.0,1.1842986367842703e-07,0.15906469462968875,0.0
271,0.3,1,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Does a geriatric oncology consultation change the cancer treatment strategy for elderly patients? The consultation resulted in changes to the treatment plan in over one third of cases. Additional research is required to assess if these changes enhance outcomes for older patients.,2.1317375462116866e-07,0.05982150261184849,0.09876543209876545,0.016320838183036854,0.11806567903016685,0.060964083175803374,0.0162972138685758,0.17875823225491594,0.020823902218198284,2.1317375462116866e-07,0.21256144198367144,0.0
271,0.3,2,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Can a geriatric oncology consultation alter the cancer treatment plan in elderly patients? More than one third of cases saw a modification in the treatment plan following the consultation. Further studies are necessary to evaluate whether these adjustments improve patient outcomes.,2.3685972735685406e-07,0.11917147423021657,0.07378186865366354,0.018134264647818726,0.14338348701445858,0.060964083175803374,0.018108015409528666,0.2047337186581739,0.020823902218198284,2.3685972735685406e-07,0.2392296890658323,0.0
271,0.3,3,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Is the cancer treatment plan for elderly patients modified after a geriatric oncology consultation? The consultation led to treatment plan changes in over one third of cases. More research is needed to determine if these changes benefit older patients.,2.8423167282822466e-07,0.17228884014555623,0.07246886526165808,0.02176111757738247,0.19602722049987742,0.060964083175803374,0.0217296184914344,0.2588009399284501,0.020823902218198284,2.8423167282822487e-07,0.2947995402206445,0.0
271,0.3,4,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,"Does consulting a geriatric oncologist lead to changes in cancer treatment plans for elderly patients? In more than one third of cases, the treatment plan was modified after consultation. Further investigation is needed to see if these modifications improve outcomes.",2.6054570009253936e-07,0.10983192318651191,0.09876543209876545,0.0199476911126006,0.16935897341771655,0.060964083175803374,0.019918816950481533,0.23140196574033478,0.020823902218198284,2.6054570009253947e-07,0.26662866325394763,0.0
271,0.3,5,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Does a geriatric oncology consultation impact the cancer treatment plan for elderly patients? The treatment plan was altered in over one third of cases following the consultation. Additional studies are needed to confirm if these changes improve outcomes.,3.0791764556390996e-07,0.19994307183733318,0.07175925925925929,0.023574544042164344,0.22342619468799274,0.060964083175803374,0.023540420032387266,0.28697181689514695,0.020823902218198284,3.079176455639103e-07,0.323787077093896,0.0
271,0.3,6,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Can a geriatric oncology consultation influence the cancer treatment plan for older patients? More than one third of cases experienced treatment plan modifications after the consultation. Further research is required to determine if these modifications lead to better outcomes.,2.8423167282822466e-07,0.17228884014555623,0.07246886526165808,0.02176111757738247,0.19602722049987742,0.060964083175803374,0.0217296184914344,0.2588009399284501,0.020823902218198284,2.8423167282822487e-07,0.2947995402206445,0.0
271,0.3,7,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Does a consultation in geriatric oncology modify cancer treatment plans for elderly patients? Treatment plans were changed in more than one third of cases after the consultation. More studies are needed to assess whether these changes improve patient outcomes.,2.8423167282822466e-07,0.17228884014555623,0.07246886526165808,0.02176111757738247,0.19602722049987742,0.060964083175803374,0.0217296184914344,0.2588009399284501,0.020823902218198284,2.8423167282822487e-07,0.2947995402206445,0.0
271,0.3,8,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Is the cancer treatment plan for elderly patients changed by a geriatric oncology consultation? Over one third of cases had treatment plan modifications following the consultation. Further research is necessary to evaluate the impact on patient outcomes.,3.3160361829959526e-07,0.22838280755782092,0.07101033005794913,0.025387970506946217,0.2515970716546896,0.060964083175803374,0.02535122157334014,0.31595935376839845,0.020823902218198284,3.316036182995957e-07,0.35364004024357776,0.0
271,0.3,9,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Does a geriatric oncology consultation result in changes to cancer treatment plans for elderly patients? The consultation led to modifications in the treatment plan in more than one third of cases. Additional studies are needed to determine if these changes improve outcomes.,2.1317375462116866e-07,0.05982150261184849,0.09876543209876545,0.016320838183036854,0.11806567903016685,0.060964083175803374,0.0162972138685758,0.17875823225491594,0.020823902218198284,2.1317375462116866e-07,0.21256144198367144,0.0
271,0.3,10,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,"Can the cancer treatment plan for elderly patients be modified by a geriatric oncology consultation? In over one third of cases, the treatment plan was altered after the consultation. Further research is needed to understand if these modifications enhance patient outcomes.",2.3685972735685406e-07,0.11917147423021657,0.07378186865366354,0.018134264647818726,0.14338348701445858,0.060964083175803374,0.018108015409528666,0.2047337186581739,0.020823902218198284,2.3685972735685406e-07,0.2392296890658323,0.0
272,0.3,1,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) and bone scintigraphy are both imaging techniques used to detect bone metastases from breast cancer. While CT can,Question: Is it possible for computerized tomography to substitute bone scintigraphy in identifying bone metastases from breast cancer? Answer: Both computerized tomography (CT) and bone scintigraphy serve as imaging methods to detect bone metastases originating from breast cancer. While CT can,1.184298636784265e-07,0.1929440081010898,0.04012345679012341,0.00906713232390937,0.21874784863818242,0.05859375,0.009054007704764347,0.18308751829384207,0.0302734375,1.1842986367842703e-07,0.14518200984449914,0.0
272,0.3,2,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) and bone scintigraphy are both imaging techniques used to detect bone metastases from breast cancer. While CT can,Question: Can computerized tomography take the place of bone scintigraphy in the detection of bone metastases from breast cancer? Answer: Computerized tomography (CT) and bone scintigraphy are imaging techniques utilized to identify bone metastases in breast cancer patients. While CT can,1.184298636784265e-07,0.1929440081010898,0.04012345679012341,0.00906713232390937,0.21874784863818242,0.05859375,0.009054007704764347,0.18308751829384207,0.0302734375,1.1842986367842703e-07,0.14518200984449914,0.0
272,0.3,3,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) and bone scintigraphy are both imaging techniques used to detect bone metastases from breast cancer. While CT can,Question: Could computerized tomography replace bone scintigraphy when detecting bone metastases caused by breast cancer? Answer: Both computerized tomography (CT) and bone scintigraphy are imaging modalities used for detecting bone metastases from breast cancer. While CT can,2.36859727356853e-08,0.07218022176415273,0.029513888888888867,0.0018134264647818796,0.07092585368024018,0.03004703719723184,0.0018108015409528735,0.07186188318361753,0.0302734375,2.3685972735685406e-08,0.030771658666753687,0.0
272,0.3,4,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) and bone scintigraphy are both imaging techniques used to detect bone metastases from breast cancer. While CT can,Question: Is computerized tomography a viable alternative to bone scintigraphy for detecting bone metastases in breast cancer? Answer: Computerized tomography (CT) and bone scintigraphy are both imaging techniques employed to find bone metastases linked to breast cancer. While CT can,9.47438909427412e-08,0.19961760845033405,0.06249999999999997,0.0072537058591274975,0.19277236223492444,0.05859375,0.00724320616381148,0.1564192712116812,0.0302734375,9.474389094274162e-08,0.11778303565638382,0.0
272,0.3,5,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) and bone scintigraphy are both imaging techniques used to detect bone metastases from breast cancer. While CT can,Question: Can CT imaging replace bone scintigraphy in the diagnosis of bone metastases from breast cancer? Answer: CT and bone scintigraphy are imaging methods used to detect bone metastases resulting from breast cancer. While CT can,0.0,0.07921682063542201,0.05392795138888887,0.0,0.0815467271246999,0.05859375,0.0,0.04200892003393575,0.0302734375,0.0,0.0,0.0
272,0.3,6,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) and bone scintigraphy are both imaging techniques used to detect bone metastases from breast cancer. While CT can,Question: Does computerized tomography have the potential to replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Both CT and bone scintigraphy are imaging techniques applied to identify bone metastases in breast cancer cases. While CT can,7.10579182070559e-08,0.20731728871395516,0.08641975308641972,0.005440279394345625,0.16610411515276358,0.05859375,0.005432404622858614,0.12902029702356588,0.0302734375,7.105791820705622e-08,0.08961215868968697,0.0
272,0.3,7,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) and bone scintigraphy are both imaging techniques used to detect bone metastases from breast cancer. While CT can,Question: Is it feasible for computerized tomography to substitute bone scintigraphy in the detection of bone metastases from breast cancer? Answer: Computerized tomography (CT) and bone scintigraphy are imaging tools used to detect bone metastases caused by breast cancer. While CT can,1.421158364141119e-07,0.25482988403857965,0.06617420744844564,0.010880558788691243,0.24406565662247415,0.05859375,0.010864809245717214,0.20906300469710004,0.0302734375,1.4211583641411244e-07,0.17185025692666,0.0
272,0.3,8,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) and bone scintigraphy are both imaging techniques used to detect bone metastases from breast cancer. While CT can,Question: Can computerized tomography serve as a replacement for bone scintigraphy in detecting bone metastases from breast cancer? Answer: Both computerized tomography (CT) and bone scintigraphy are imaging techniques used to find bone metastases from breast cancer. While CT can,9.47438909427412e-08,0.12852558993136576,0.013456362937331823,0.0072537058591274975,0.11980950112335131,0.00612461419753086,0.00724320616381148,0.11895185604627878,0.0032672646604938356,9.474389094274162e-08,0.11778303565638382,0.0
272,0.3,9,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) and bone scintigraphy are both imaging techniques used to detect bone metastases from breast cancer. While CT can,Question: Might computerized tomography replace bone scintigraphy in the identification of bone metastases from breast cancer? Answer: Computerized tomography (CT) and bone scintigraphy are imaging methods utilized to detect bone metastases associated with breast cancer. While CT can,4.73719454713706e-08,0.14120965724715884,0.05843906189926952,0.003626852929563752,0.13870514096464825,0.05859375,0.003621603081905747,0.10084942005686903,0.0302734375,4.737194547137081e-08,0.060624621816435464,0.0
272,0.3,10,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) and bone scintigraphy are both imaging techniques used to detect bone metastases from breast cancer. While CT can,Question: Is computerized tomography capable of replacing bone scintigraphy for detecting bone metastases from breast cancer? Answer: Both computerized tomography (CT) and bone scintigraphy are imaging techniques used to identify bone metastases from breast cancer. While CT can,4.73719454713706e-08,0.066274826916354,0.007052951388888867,0.003626852929563752,0.06168878756909857,0.003230428200692026,0.003621603081905747,0.0612410097391578,0.0017267246972318406,4.737194547137081e-08,0.060624621816435464,0.0
273,0.3,1,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: There is currently no consensus on whether HIV-infected patients should be routinely screened for silent myocardial ischemia using gated myocardial perfusion SPECT. Further research is needed to evaluate the benefits, risks, and cost-effectiveness of such screening in this population. Clinicians should consider individual patient factors and guidelines when making screening decisions.","Is it advisable to screen HIV-infected patients for silent myocardial ischemia with gated myocardial perfusion SPECT? Currently, there is no agreement on routine screening for silent myocardial ischemia in HIV-infected patients using gated myocardial perfusion SPECT. More studies are necessary to assess the advantages, risks, and cost-effectiveness of this screening approach. Healthcare providers should take into account individual patient circumstances and existing guidelines when deciding on screening.",0.0,0.021004460016968096,0.014567652973283551,0.0,0.021327605555690354,0.015228065475333244,0.0,0.02166084939249835,0.015596418549691437,0.0,0.0,0.0
273,0.3,2,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: There is currently no consensus on whether HIV-infected patients should be routinely screened for silent myocardial ischemia using gated myocardial perfusion SPECT. Further research is needed to evaluate the benefits, risks, and cost-effectiveness of such screening in this population. Clinicians should consider individual patient factors and guidelines when making screening decisions.","Should patients with HIV undergo screening for silent myocardial ischemia via gated myocardial perfusion SPECT? At present, no consensus exists regarding routine screening of HIV-infected individuals for silent myocardial ischemia using gated myocardial perfusion SPECT. Additional research is required to determine the benefits, potential harms, and economic viability of such screening. Clinicians must consider patient-specific factors and relevant guidelines when making screening choices.",9.474389094274162e-08,0.027287069210935933,0.02454303001237247,0.0072537058591274906,0.04638139470218228,0.012225099628965834,0.007243206163811466,0.0443217283712416,0.014555603019334038,9.474389094274162e-08,0.06559728248581642,0.0
273,0.3,3,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: There is currently no consensus on whether HIV-infected patients should be routinely screened for silent myocardial ischemia using gated myocardial perfusion SPECT. Further research is needed to evaluate the benefits, risks, and cost-effectiveness of such screening in this population. Clinicians should consider individual patient factors and guidelines when making screening decisions.","Is screening for silent myocardial ischemia with gated myocardial perfusion SPECT recommended for HIV-infected patients? There is no current consensus on routine screening for silent myocardial ischemia in HIV-positive patients using gated myocardial perfusion SPECT. Further investigation is needed to evaluate the clinical benefits, risks, and cost-effectiveness. Medical professionals should weigh individual patient factors and guideline recommendations when deciding on screening.",1.4211583641411244e-07,0.08690839579753717,0.005802220874518052,0.010880558788691236,0.10552546214816472,0.006164165413634001,0.0108648092457172,0.1029216278599776,0.0032212937204017973,1.4211583641411244e-07,0.12440441226084253,0.017538265306122455
273,0.3,4,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: There is currently no consensus on whether HIV-infected patients should be routinely screened for silent myocardial ischemia using gated myocardial perfusion SPECT. Further research is needed to evaluate the benefits, risks, and cost-effectiveness of such screening in this population. Clinicians should consider individual patient factors and guidelines when making screening decisions.","Should silent myocardial ischemia be screened in HIV-infected patients using gated myocardial perfusion SPECT? Presently, no consensus supports routine screening for silent myocardial ischemia in HIV-infected individuals with gated myocardial perfusion SPECT. More research is necessary to clarify the benefits, risks, and cost-effectiveness of this practice. Clinicians should consider patient-specific details and guidelines when making screening decisions.",2.3685972735685406e-07,0.1410481134153465,0.016140125099388863,0.018134264647818726,0.13215436648112755,0.02496199636271064,0.018108015409528666,0.12657733801040116,0.031217481789802295,2.3685972735685406e-07,0.17284281283941416,0.0
273,0.3,5,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: There is currently no consensus on whether HIV-infected patients should be routinely screened for silent myocardial ischemia using gated myocardial perfusion SPECT. Further research is needed to evaluate the benefits, risks, and cost-effectiveness of such screening in this population. Clinicians should consider individual patient factors and guidelines when making screening decisions.","Is it appropriate to screen HIV-infected patients for silent myocardial ischemia using gated myocardial perfusion SPECT? Currently, there is no agreement on routine screening for silent myocardial ischemia in HIV-positive patients with gated myocardial perfusion SPECT. Further studies are needed to assess the benefits, risks, and cost-effectiveness of such screening. Healthcare providers should evaluate individual patient factors and adhere to guidelines when deciding on screening.",4.737194547137081e-08,0.007955314489532128,0.027003734559034764,0.0036268529295637453,0.011956138477525968,0.013773851115291613,0.003621603081905733,0.010786585999261078,0.015092784127883448,4.737194547137081e-08,0.03226086221822477,0.0
273,0.3,6,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: There is currently no consensus on whether HIV-infected patients should be routinely screened for silent myocardial ischemia using gated myocardial perfusion SPECT. Further research is needed to evaluate the benefits, risks, and cost-effectiveness of such screening in this population. Clinicians should consider individual patient factors and guidelines when making screening decisions.","Should HIV patients be screened for silent myocardial ischemia by gated myocardial perfusion SPECT? There is no consensus at present on routine screening of HIV-infected patients for silent myocardial ischemia using gated myocardial perfusion SPECT. Additional research is required to determine the benefits, risks, and cost-effectiveness. Clinicians should consider individual patient factors and guidelines when making decisions about screening.",1.8948778188548325e-07,0.10168864594053062,0.019127994731916495,0.014507411718254981,0.11898844094989869,0.008804715312822516,0.014486412327622933,0.11496495028809672,0.013366242120380803,1.8948778188548325e-07,0.13580154115906407,0.0
273,0.3,7,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: There is currently no consensus on whether HIV-infected patients should be routinely screened for silent myocardial ischemia using gated myocardial perfusion SPECT. Further research is needed to evaluate the benefits, risks, and cost-effectiveness of such screening in this population. Clinicians should consider individual patient factors and guidelines when making screening decisions.","Is routine screening for silent myocardial ischemia with gated myocardial perfusion SPECT recommended in HIV-infected patients? Currently, no consensus exists on this practice. More research is needed to evaluate the potential benefits, risks, and cost-effectiveness. Medical professionals should consider patient-specific factors and guidelines when determining screening protocols.",4.737194547137081e-07,0.21398212541855388,0.10456765297328353,0.03626852929563745,0.28241435790255576,0.06127385111529163,0.03621603081905733,0.33137175065641467,0.031217481789802295,4.737194547137081e-07,0.38193461069797285,0.0
273,0.3,8,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: There is currently no consensus on whether HIV-infected patients should be routinely screened for silent myocardial ischemia using gated myocardial perfusion SPECT. Further research is needed to evaluate the benefits, risks, and cost-effectiveness of such screening in this population. Clinicians should consider individual patient factors and guidelines when making screening decisions.","Should gated myocardial perfusion SPECT be used to screen HIV-infected patients for silent myocardial ischemia? There is currently no consensus on routine screening for silent myocardial ischemia in this population. Further research is needed to assess the benefits, risks, and cost-effectiveness. Clinicians should take into account individual patient factors and guidelines when making screening decisions.",2.8423167282822487e-07,0.10498371094040682,0.06758540445257348,0.02176111757738247,0.1449414315003752,0.0424129043697295,0.0217296184914344,0.1643176659932486,0.031217481789802295,2.8423167282822487e-07,0.21130909366720996,0.0
273,0.3,9,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: There is currently no consensus on whether HIV-infected patients should be routinely screened for silent myocardial ischemia using gated myocardial perfusion SPECT. Further research is needed to evaluate the benefits, risks, and cost-effectiveness of such screening in this population. Clinicians should consider individual patient factors and guidelines when making screening decisions.","Is screening for silent myocardial ischemia via gated myocardial perfusion SPECT advised for patients with HIV? At this time, no consensus supports routine screening in HIV-infected patients. Additional studies are necessary to evaluate benefits, risks, and cost-effectiveness. Healthcare providers should consider individual patient factors and guidelines when deciding on screening.",4.026615365066519e-07,0.1508032237970216,0.10456765297328353,0.030828249901291835,0.21787583676498423,0.06127385111529163,0.030783626196198732,0.2654137828646186,0.031217481789802295,4.026615365066519e-07,0.3144933299024406,0.0
273,0.3,10,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: There is currently no consensus on whether HIV-infected patients should be routinely screened for silent myocardial ischemia using gated myocardial perfusion SPECT. Further research is needed to evaluate the benefits, risks, and cost-effectiveness of such screening in this population. Clinicians should consider individual patient factors and guidelines when making screening decisions.","Should silent myocardial ischemia screening using gated myocardial perfusion SPECT be performed routinely in HIV-infected patients? There is no current consensus on this issue. Further research is required to assess benefits, risks, and cost-effectiveness. Clinicians should base screening decisions on individual patient factors and guideline recommendations.",4.974054274493935e-07,0.23596103213732889,0.10456765297328353,0.038081955760419325,0.3048872137546135,0.06127385111529163,0.0380268323600102,0.3543612688811142,0.031217481789802295,4.974054274493935e-07,0.40546510810816727,0.0
274,0.3,1,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: There is no direct association between crime and over-the-counter pharmacy syringe sales. However, improper disposal or misuse of syringes can contribute to public health","Is there a link between crime and over-the-counter pharmacy syringe sales? No direct connection exists, but improper syringe disposal or misuse may impact public health.",2.131737546211677e-07,0.23443589105066254,0.06035379812695108,0.016320838183036916,0.2869199880855793,0.031217481789802305,0.016297213868575862,0.3429447511268311,0.0,2.1317375462116866e-07,0.35667494393873334,0.0
274,0.3,2,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: There is no direct association between crime and over-the-counter pharmacy syringe sales. However, improper disposal or misuse of syringes can contribute to public health","Does crime relate to over-the-counter pharmacy syringe sales? There is no direct association, though improper use or disposal of syringes can affect public health.",2.36859727356853e-07,0.27699550546945817,0.06035379812695108,0.018134264647818796,0.33137175065641333,0.031217481789802305,0.018108015409528735,0.38946476676172503,0.0,2.36859727356854e-07,0.4054651081081646,0.0
274,0.3,3,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: There is no direct association between crime and over-the-counter pharmacy syringe sales. However, improper disposal or misuse of syringes can contribute to public health","Are over-the-counter pharmacy syringe sales connected to crime? No direct link is found, but misuse or improper disposal of syringes can harm public health.",2.36859727356853e-07,0.27699550546945817,0.06035379812695108,0.018134264647818796,0.33137175065641333,0.031217481789802305,0.018108015409528735,0.38946476676172503,0.0,2.36859727356854e-07,0.4054651081081646,0.0
274,0.3,4,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: There is no direct association between crime and over-the-counter pharmacy syringe sales. However, improper disposal or misuse of syringes can contribute to public health","Is crime connected to the sale of syringes over the counter at pharmacies? No direct association exists, yet improper syringe disposal or misuse can pose public health risks.",1.421158364141118e-07,0.11665285539427828,0.06035379812695108,0.010880558788691277,0.16431766599324638,0.031217481789802305,0.010864809245717241,0.2151113796169466,0.0,1.4211583641411244e-07,0.2231435513142097,0.0
274,0.3,5,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: There is no direct association between crime and over-the-counter pharmacy syringe sales. However, improper disposal or misuse of syringes can contribute to public health","Does the sale of syringes at pharmacies over the counter correlate with crime? No direct correlation, but improper disposal or misuse of syringes may contribute to public health issues.",1.184298636784265e-07,0.12979572412054274,0.024688503202396905,0.009067132323909398,0.1265773380103994,0.031217481789802305,0.009054007704764368,0.17589066646366414,0.0,1.1842986367842703e-07,0.1823215567939549,0.0
274,0.3,6,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: There is no direct association between crime and over-the-counter pharmacy syringe sales. However, improper disposal or misuse of syringes can contribute to public health","Is there a crime association with over-the-counter pharmacy syringe sales? No direct association, but improper syringe use or disposal can impact public health.",2.605457000925383e-07,0.3214472680402922,0.06035379812695108,0.019947691112600675,0.3778917662913073,0.031217481789802305,0.01991881695048161,0.4382549309311563,0.0,2.6054570009253936e-07,0.45675840249571475,0.0
274,0.3,7,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: There is no direct association between crime and over-the-counter pharmacy syringe sales. However, improper disposal or misuse of syringes can contribute to public health","Are crimes linked to over-the-counter sales of syringes at pharmacies? No direct link, though improper disposal or misuse of syringes can affect public health.",2.36859727356853e-07,0.33726917334423634,0.01696536837488495,0.018134264647818796,0.33137175065641333,0.031217481789802305,0.018108015409528735,0.38946476676172503,0.0,2.36859727356854e-07,0.4054651081081646,0.0
274,0.3,8,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: There is no direct association between crime and over-the-counter pharmacy syringe sales. However, improper disposal or misuse of syringes can contribute to public health","Is crime related to the over-the-counter sale of syringes in pharmacies? There is no direct association, but misuse or improper disposal of syringes can contribute to public health concerns.",1.184298636784265e-07,0.12979572412054274,0.024688503202396905,0.009067132323909398,0.1265773380103994,0.031217481789802305,0.009054007704764368,0.17589066646366414,0.0,1.1842986367842703e-07,0.1823215567939549,0.0
274,0.3,9,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: There is no direct association between crime and over-the-counter pharmacy syringe sales. However, improper disposal or misuse of syringes can contribute to public health","Does crime have a connection with over-the-counter pharmacy syringe sales? No direct connection, but improper syringe misuse or disposal can pose public health challenges.",2.36859727356853e-07,0.27699550546945817,0.06035379812695108,0.018134264647818796,0.33137175065641333,0.031217481789802305,0.018108015409528735,0.38946476676172503,0.0,2.36859727356854e-07,0.4054651081081646,0.0
274,0.3,10,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: There is no direct association between crime and over-the-counter pharmacy syringe sales. However, improper disposal or misuse of syringes can contribute to public health","Is there a relationship between crime and over-the-counter pharmacy syringe sales? No direct relationship exists, but improper disposal or misuse of syringes can affect public health.",1.894877818854824e-07,0.19361389653040773,0.06035379812695108,0.014507411718255037,0.24436037366678365,0.031217481789802305,0.014486412327622988,0.29849298855599704,0.0,1.8948778188548325e-07,0.3101549283038394,0.0
275,0.3,1,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Recent studies have shown that D-dimer, a blood test used to detect the presence of blood","Question: Could D-dimer serve as a novel diagnostic marker for acute appendicitis? Answer: Recent research indicates that D-dimer, a blood test detecting blood presence,",9.47438909427412e-08,0.1603426500751799,0.0,0.007253705859127518,0.16705408466316696,0.0,0.007243206163811494,0.17435338714477844,0.0,9.474389094274157e-08,0.1823215567939549,0.0
275,0.3,2,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Recent studies have shown that D-dimer, a blood test used to detect the presence of blood","Question: Is D-dimer a potential new diagnostic tool for acute appendicitis? Answer: Recent studies reveal that D-dimer, a blood test identifying blood presence,",1.184298636784265e-07,0.20479441264601395,0.0,0.009067132323909398,0.2135741002980609,0.0,0.009054007704764368,0.2231435513142097,0.0,1.1842986367842692e-07,0.23361485118150505,0.0
275,0.3,3,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Recent studies have shown that D-dimer, a blood test used to detect the presence of blood","Question: Can D-dimer be considered a new diagnostic parameter for acute appendicitis? Answer: Recent findings suggest that D-dimer, a blood test used to detect blood presence,",4.73719454713706e-08,0.07696104113612945,0.0,0.003626852929563759,0.08004270767353727,0.0,0.003621603081905747,0.08338160893905044,0.0,4.737194547137081e-08,0.08701137698962969,0.0
275,0.3,4,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Recent studies have shown that D-dimer, a blood test used to detect the presence of blood","Question: Might D-dimer become an innovative diagnostic marker for acute appendicitis? Answer: Recent research shows that D-dimer, a blood test for detecting blood presence,",9.47438909427412e-08,0.1603426500751799,0.0,0.007253705859127518,0.16705408466316696,0.0,0.007243206163811494,0.17435338714477844,0.0,9.474389094274157e-08,0.1823215567939549,0.0
275,0.3,5,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Recent studies have shown that D-dimer, a blood test used to detect the presence of blood","Question: Is it possible for D-dimer to be a new diagnostic parameter in acute appendicitis? Answer: Recent studies have demonstrated that D-dimer, a blood test detecting blood presence,",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
275,0.3,6,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Recent studies have shown that D-dimer, a blood test used to detect the presence of blood","Question: Could D-dimer act as a novel diagnostic indicator for acute appendicitis? Answer: Recent investigations have found that D-dimer, a blood test used to identify blood presence,",2.36859727356853e-08,0.03774032798284699,0.0,0.0018134264647818796,0.03922071315328246,0.0,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
275,0.3,7,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Recent studies have shown that D-dimer, a blood test used to detect the presence of blood","Question: Can D-dimer function as a new diagnostic parameter for acute appendicitis? Answer: Recent research has shown that D-dimer, a blood test detecting blood presence,",7.10579182070559e-08,0.11778303565638426,0.0,0.005440279394345639,0.1226023220923329,0.0,0.005432404622858621,0.1278333715098845,0.0,7.105791820705622e-08,0.13353139262452363,0.0
275,0.3,8,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Recent studies have shown that D-dimer, a blood test used to detect the presence of blood","Question: Is D-dimer likely to become a new diagnostic marker for acute appendicitis? Answer: Recent studies suggest that D-dimer, a blood test used to detect blood presence,",2.36859727356853e-08,0.03774032798284699,0.0,0.0018134264647818796,0.03922071315328246,0.0,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
275,0.3,9,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Recent studies have shown that D-dimer, a blood test used to detect the presence of blood","Question: Could D-dimer be introduced as a new diagnostic parameter for acute appendicitis? Answer: Recent findings have revealed that D-dimer, a blood test detecting blood presence,",4.73719454713706e-08,0.07696104113612945,0.0,0.003626852929563759,0.08004270767353727,0.0,0.003621603081905747,0.08338160893905044,0.0,4.737194547137081e-08,0.08701137698962969,0.0
275,0.3,10,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Recent studies have shown that D-dimer, a blood test used to detect the presence of blood","Question: Can D-dimer be utilized as a new diagnostic tool for acute appendicitis? Answer: Recent research indicates that D-dimer, a blood test used to detect blood presence,",2.36859727356853e-08,0.03774032798284699,0.0,0.0018134264647818796,0.03922071315328246,0.0,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
276,0.3,1,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: There is limited evidence suggesting that bezafibrate, a lipid-lowering drug that activates peroxisome proliferator-activated receptors, may have a preventive effect on colon cancer in patients","Question: Can the lipid-lowering agent bezafibrate, which activates peroxisome proliferator-activated receptors, prevent colon cancer in patients with coronary artery disease? Answer: Limited evidence indicates that bezafibrate might help prevent colon cancer in these patients.",2.3685972735685332e-07,0.2617616993409939,0.0020447074293228062,0.018134264647818747,0.29256309585745166,0.014722222222222213,0.018108015409528694,0.2904919775702224,0.0078472222222222,2.3685972735685406e-07,0.28768207245178123,0.0
276,0.3,2,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: There is limited evidence suggesting that bezafibrate, a lipid-lowering drug that activates peroxisome proliferator-activated receptors, may have a preventive effect on colon cancer in patients","Question: Does bezafibrate, a peroxisome proliferator-activated receptor ligand used to lower lipids, reduce colon cancer risk in coronary artery disease patients? Answer: There is some limited evidence suggesting a preventive effect of bezafibrate on colon cancer in such patients.",1.1842986367842682e-07,0.031137771535065806,0.06574814059221547,0.009067132323909363,0.06073768844295824,0.047500000000000014,0.009054007704764333,0.09624107065990772,0.024375,1.1842986367842703e-07,0.13353139262452274,0.0
276,0.3,3,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: There is limited evidence suggesting that bezafibrate, a lipid-lowering drug that activates peroxisome proliferator-activated receptors, may have a preventive effect on colon cancer in patients","Question: Is bezafibrate, a lipid-lowering drug activating peroxisome proliferator-activated receptors, effective in preventing colon cancer in patients with coronary artery disease? Answer: Evidence is limited but suggests a possible preventive role of bezafibrate against colon cancer in these patients.",1.1842986367842682e-07,0.06761920209085259,0.039575571626853705,0.009067132323909363,0.09820510360836066,0.02049382716049385,0.009054007704764333,0.09624107065990772,0.024375,1.1842986367842703e-07,0.13353139262452274,0.0
276,0.3,4,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: There is limited evidence suggesting that bezafibrate, a lipid-lowering drug that activates peroxisome proliferator-activated receptors, may have a preventive effect on colon cancer in patients","Question: Does the peroxisome proliferator-activated receptor ligand bezafibrate, used for lipid lowering, prevent colon cancer in coronary artery disease patients? Answer: Limited data suggest bezafibrate may have a protective effect against colon cancer in these patients.",1.8948778188548272e-07,0.1561112598516745,0.03511174140544774,0.014507411718254988,0.18606844003337164,0.018115243342516078,0.014486412327622947,0.18325244764953785,0.024375,1.8948778188548325e-07,0.2231435513142097,0.0
276,0.3,5,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: There is limited evidence suggesting that bezafibrate, a lipid-lowering drug that activates peroxisome proliferator-activated receptors, may have a preventive effect on colon cancer in patients","Question: Can bezafibrate, a lipid-lowering peroxisome proliferator-activated receptor ligand, prevent colon cancer in patients with coronary artery disease? Answer: There is limited evidence that bezafibrate might prevent colon cancer in this patient group.",2.605457000925386e-07,0.29647169426093,0.0007020226539114077,0.019947691112600627,0.3271067424807397,0.016709274673008298,0.019918816950481567,0.3247724394911926,0.008918697978596915,2.6054570009253947e-07,0.321583624127463,0.0
276,0.3,6,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: There is limited evidence suggesting that bezafibrate, a lipid-lowering drug that activates peroxisome proliferator-activated receptors, may have a preventive effect on colon cancer in patients","Question: Is there evidence that bezafibrate, which lowers lipids by activating peroxisome proliferator-activated receptors, prevents colon cancer in coronary artery disease patients? Answer: Some limited evidence suggests it may have a preventive effect.",2.605457000925386e-07,0.16650659790593947,0.09204470742932284,0.019947691112600627,0.2376683966020372,0.047500000000000014,0.019918816950481567,0.27856262745386307,0.024375,2.6054570009253947e-07,0.321583624127463,0.0
276,0.3,7,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: There is limited evidence suggesting that bezafibrate, a lipid-lowering drug that activates peroxisome proliferator-activated receptors, may have a preventive effect on colon cancer in patients","Question: Does treatment with bezafibrate, a peroxisome proliferator-activated receptor ligand used to lower lipids, reduce the incidence of colon cancer in patients with coronary artery disease? Answer: Limited evidence supports a potential preventive effect.",2.3685972735685332e-07,0.13573493923918578,0.09204470742932284,0.018134264647818747,0.20591969828745738,0.047500000000000014,0.018108015409528694,0.24577280463087137,0.024375,2.3685972735685406e-07,0.28768207245178123,0.0
276,0.3,8,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: There is limited evidence suggesting that bezafibrate, a lipid-lowering drug that activates peroxisome proliferator-activated receptors, may have a preventive effect on colon cancer in patients","Question: Could bezafibrate, a lipid-lowering drug targeting peroxisome proliferator-activated receptors, help prevent colon cancer in patients with coronary artery disease? Answer: There is limited but suggestive evidence of such a preventive effect.",2.842316728282239e-07,0.1982552962205193,0.09204470742932284,0.021761117577382506,0.2704582194250289,0.047500000000000014,0.02172961849143444,0.31246417912954483,0.024375,2.8423167282822487e-07,0.356674943938732,0.0
276,0.3,9,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: There is limited evidence suggesting that bezafibrate, a lipid-lowering drug that activates peroxisome proliferator-activated receptors, may have a preventive effect on colon cancer in patients","Question: Is bezafibrate, a drug that activates peroxisome proliferator-activated receptors and lowers lipids, effective in colon cancer prevention among coronary artery disease patients? Answer: Evidence is limited but indicates a possible benefit.",2.842316728282239e-07,0.1982552962205193,0.09204470742932284,0.021761117577382506,0.2704582194250289,0.047500000000000014,0.02172961849143444,0.31246417912954483,0.024375,2.8423167282822487e-07,0.356674943938732,0.0
276,0.3,10,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: There is limited evidence suggesting that bezafibrate, a lipid-lowering drug that activates peroxisome proliferator-activated receptors, may have a preventive effect on colon cancer in patients","Question: Does the lipid-lowering drug bezafibrate, which acts as a peroxisome proliferator-activated receptor ligand, prevent colon cancer in patients with coronary artery disease? Answer: Limited evidence suggests it may have a preventive effect.",2.605457000925386e-07,0.16650659790593947,0.09204470742932284,0.019947691112600627,0.2376683966020372,0.047500000000000014,0.019918816950481567,0.27856262745386307,0.024375,2.6054570009253947e-07,0.321583624127463,0.0
277,0.3,1,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby","The R14C KCNQ1 mutation by itself does not appear to cause atrial fibrillation (AF); instead, a 'second hit' such as an environmental factor like hypertension that leads to atrial stretch may be necessary.",5.210914001850781e-07,0.497576025966032,0.01851192595229618,0.039895382225201226,0.5363047090669744,0.0,0.0398376339009631,0.550046336919273,0.0,5.210914001850789e-07,0.564529802737852,0.0
277,0.3,2,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby","These findings imply that the R14C mutation in KCNQ1 alone is not enough to induce AF, and that an additional factor, for example hypertension causing atrial stretch, is likely required.",5.92149318392134e-07,0.5960160987792853,0.01851192595229618,0.045335661619546865,0.6380874033769168,0.0,0.04527003852382172,0.6554068525770984,0.0,5.921493183921352e-07,0.6737290947028427,0.0
277,0.3,3,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby","Data indicate that the R14C KCNQ1 mutation alone cannot cause atrial fibrillation; rather, a combined effect with an environmental trigger like hypertension-induced atrial stretch is suggested.",6.868932093348752e-07,0.7444361038975584,0.01851192595229618,0.05258936747867438,0.7922380832041758,0.0,0.052513244687633215,0.8157495026522783,0.0,6.868932093348768e-07,0.8407831793660097,0.0
277,0.3,4,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby","The evidence suggests that the R14C mutation in KCNQ1 is insufficient by itself to cause AF, and that a secondary factor such as hypertension, which causes atrial stretch, plays a role.",5.684633456564487e-07,0.5621145471036035,0.01851192595229618,0.043522235154764985,0.6029960835656478,0.0,0.04345923698286885,0.6190392084062237,0.0,5.684633456564497e-07,0.6359887667199957,0.0
277,0.3,5,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby",These results propose that the R14C KCNQ1 mutation needs a 'second hit'—like hypertension leading to atrial stretch—to contribute to atrial fibrillation.,8.053230730133017e-07,1.0368943732677627,0.03134956989257916,0.06165649980258378,1.0258529343856808,0.0,0.06156725239239758,1.060871960685263,0.0,8.053230730133036e-07,1.0986122886681091,0.0
277,0.3,6,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby","It appears that the R14C mutation in KCNQ1 alone does not cause AF; instead, an environmental factor such as hypertension causing atrial stretch is necessary.",7.105791820705605e-07,0.7852580984178132,0.01851192595229618,0.05440279394345626,0.8347976976229714,0.0,0.05432404622858609,0.8602012652231124,0.0,7.105791820705622e-07,0.8873031950009036,0.0
277,0.3,7,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby","The data support a model where the R14C KCNQ1 mutation alone is not enough to cause AF, but when combined with an environmental factor like hypertension-induced atrial stretch, it may lead to disease.",5.210914001850781e-07,0.497576025966032,0.01851192595229618,0.039895382225201226,0.5363047090669744,0.0,0.0398376339009631,0.550046336919273,0.0,5.210914001850789e-07,0.564529802737852,0.0
277,0.3,8,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby","Findings suggest that the R14C KCNQ1 mutation by itself is insufficient for AF development, requiring a second factor such as hypertension that promotes atrial stretch.",7.105791820705605e-07,0.7852580984178132,0.01851192595229618,0.05440279394345626,0.8347976976229714,0.0,0.05432404622858609,0.8602012652231124,0.0,7.105791820705622e-07,0.8873031950009036,0.0
277,0.3,9,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby","These data propose that the R14C mutation in KCNQ1 needs an additional trigger, such as hypertension causing atrial stretch, to result in atrial fibrillation.",7.342651548062458e-07,0.8278177128366089,0.01851192595229618,0.05621622040823814,0.8792494601938055,0.0,0.05613484776953896,0.9067212808580063,0.0,7.342651548062476e-07,0.9360933591703349,0.0
277,0.3,10,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby","The R14C KCNQ1 mutation alone does not cause AF; instead, a 'second hit' like hypertension-induced atrial stretch is likely necessary for pathogenesis.",7.816371002776164e-07,0.9187894910423369,0.01851192595229618,0.0598430733378019,0.9745596399981307,0.0,0.05975645085144471,1.0068047394149877,0.0,7.816371002776182e-07,1.0414538748281603,0.0
278,0.3,1,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Are clinical predictors sufficient for assessing cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors seem insufficient for evaluating the cervical spine in elderly trauma patients with low-energy mechanisms.,0.0,0.0,2.7755575615628914e-17,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
278,0.3,2,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Can clinical predictors reliably identify cervical spine fractures in geriatric blunt trauma patients with low-energy injuries? Answer: Clinical predictors do not appear reliable for assessing cervical spine injuries in elderly patients with low-energy trauma.,0.0,0.08154672712469946,0.05281179138321998,0.0,0.042008920033936636,0.030080360626951082,0.0,0.043321698784997587,0.031217481789802305,0.0,0.0,0.0
278,0.3,3,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Are clinical predictors effective in detecting cervical spine fractures in older adults after low-energy blunt trauma? Answer: Clinical predictors are inadequate for evaluating cervical spine injuries in geriatric patients with low-energy trauma.,4.73719454713706e-08,0.09737216198766818,0.10614512471655332,0.003626852929563759,0.02149748308653887,0.06035379812695108,0.003621603081905747,0.02121682235257394,0.031217481789802305,4.737194547137081e-08,0.06669137449867346,0.0
278,0.3,4,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Do clinical predictors adequately assess cervical spine fractures in elderly patients experiencing low-energy blunt trauma? Answer: Clinical predictors seem inadequate for cervical spine evaluation in geriatric trauma cases involving low-energy mechanisms.,7.10579182070559e-08,0.06282851536438017,0.10415807226576725,0.005440279394345639,0.011292339736452828,0.06035379812695108,0.005432404622858621,0.0551183740282557,0.031217481789802305,7.105791820705622e-08,0.10178269430994247,0.0
278,0.3,5,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Is the use of clinical predictors sufficient for cervical spine fracture evaluation in geriatric blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors appear insufficient for assessing cervical spine injuries in elderly trauma patients with low-energy mechanisms.,7.10579182070559e-08,0.14186049357514818,0.03653140943877556,0.005440279394345632,0.09401286366195283,0.004990476327643115,0.005432404622858621,0.09332544715697333,0.0026707689870341424,7.105791820705622e-08,0.09237332013101529,0.0
278,0.3,6,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Are clinical predictors reliable for evaluating cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors are inadequate for cervical spine assessment in geriatric patients with low-energy trauma.,4.73719454713706e-08,0.01072876441767523,0.04591836734693884,0.003626852929563759,0.023221689852812144,0.02813157590472888,0.003621603081905747,0.02121682235257394,0.031217481789802305,4.737194547137081e-08,0.06669137449867346,0.0
278,0.3,7,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Can clinical predictors adequately evaluate cervical spine fractures in geriatric patients following low-energy blunt trauma? Answer: Clinical predictors seem inadequate for cervical spine evaluation in elderly trauma patients with low-energy mechanisms.,7.10579182070559e-08,0.06282851536438017,0.10415807226576725,0.005440279394345639,0.011292339736452828,0.06035379812695108,0.005432404622858621,0.0551183740282557,0.031217481789802305,7.105791820705622e-08,0.10178269430994247,0.0
278,0.3,8,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Are clinical predictors enough to assess cervical spine fractures in older blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors appear insufficient for evaluating cervical spine injuries in geriatric trauma patients with low-energy mechanisms.,0.0,0.04077336356234973,0.025680069887645984,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
278,0.3,9,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Do clinical predictors provide adequate evaluation of cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors are inadequate for assessing cervical spine injuries in geriatric patients with low-energy trauma.,0.0,0.08154672712469946,0.05281179138321998,0.0,0.042008920033936636,0.030080360626951082,0.0,0.043321698784997587,0.031217481789802305,0.0,0.0,0.0
278,0.3,10,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Is the assessment of cervical spine fractures in geriatric blunt trauma patients with low-energy mechanisms adequately supported by clinical predictors? Answer: Clinical predictors appear inadequate for cervical spine evaluation in elderly trauma patients with low-energy mechanisms.,4.73719454713706e-08,0.14776588842294647,0.05899234693877556,0.003626852929563759,0.06364151945538365,0.003420832103075977,0.003621603081905747,0.06317295703908332,0.0018327251323183684,4.737194547137081e-08,0.06252035698133351,0.0
279,0.3,1,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: The study found that there is no significant difference in target motion between the superior and inferior portions of the clinical target volume in prostate bed target,Does target motion vary between the superior and inferior parts of the clinical target volume in the prostate bed using RTOG consensus definitions and daily CT on rails? The study concluded no significant difference exists.,5.447773729207637e-07,0.2734812061798113,0.16749660479855144,0.041708808689983085,0.35555733412868307,0.12244897959183676,0.04164843544191595,0.41557052233093605,0.08999999999999998,5.447773729207643e-07,0.45230837088506215,0.0736
279,0.3,2,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: The study found that there is no significant difference in target motion between the superior and inferior portions of the clinical target volume in prostate bed target,"Using RTOG consensus definitions and daily CT on rails, is there a difference in target motion between the superior and inferior sections of the prostate bed clinical target volume? The study found none.",5.921493183921343e-07,0.3341058279962468,0.16749660479855144,0.045335661619546844,0.4180776911100166,0.12244897959183676,0.0452700385238217,0.4801090434685076,0.08999999999999998,5.921493183921352e-07,0.5189997453837356,0.0736
279,0.3,3,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: The study found that there is no significant difference in target motion between the superior and inferior portions of the clinical target volume in prostate bed target,Is there a variation in interfractional motion between the superior and inferior portions of the prostate bed clinical target volume according to RTOG consensus and daily CT on rails? The study showed no significant difference.,5.447773729207637e-07,0.2734812061798113,0.16749660479855144,0.041708808689983085,0.35555733412868307,0.12244897959183676,0.04164843544191595,0.41557052233093605,0.08999999999999998,5.447773729207643e-07,0.45230837088506215,0.0736
279,0.3,4,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: The study found that there is no significant difference in target motion between the superior and inferior portions of the clinical target volume in prostate bed target,"According to RTOG consensus definitions and daily CT on rails, does target motion differ between the upper and lower parts of the prostate bed clinical target volume? The study indicated no significant difference.",5.921493183921343e-07,0.3341058279962468,0.16749660479855144,0.045335661619546844,0.4180776911100166,0.12244897959183676,0.0452700385238217,0.4801090434685076,0.08999999999999998,5.921493183921352e-07,0.5189997453837356,0.0736
279,0.3,5,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: The study found that there is no significant difference in target motion between the superior and inferior portions of the clinical target volume in prostate bed target,Does the prostate bed clinical target volume exhibit different interfractional motion in its superior versus inferior parts based on RTOG consensus and daily CT on rails? The study found no notable difference.,6.158352911278196e-07,0.3658545263108266,0.16749660479855144,0.04714908808432872,0.4508675139330083,0.12244897959183676,0.04708084006477457,0.5140105951441893,0.08999999999999998,6.158352911278206e-07,0.5540910651950046,0.0736
279,0.3,6,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: The study found that there is no significant difference in target motion between the superior and inferior portions of the clinical target volume in prostate bed target,"Using daily CT on rails and RTOG consensus definitions, is there a difference in motion between superior and inferior regions of the prostate bed clinical target volume? The study reported no significant difference.",5.921493183921343e-07,0.3341058279962468,0.16749660479855144,0.045335661619546844,0.4180776911100166,0.12244897959183676,0.0452700385238217,0.4801090434685076,0.08999999999999998,5.921493183921352e-07,0.5189997453837356,0.0736
279,0.3,7,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: The study found that there is no significant difference in target motion between the superior and inferior portions of the clinical target volume in prostate bed target,Is there a significant difference in target motion between the superior and inferior portions of the prostate bed clinical target volume as defined by RTOG consensus and assessed with daily CT on rails? The study found none.,4.974054274493931e-07,0.21632279233986296,0.16749660479855144,0.038081955760419325,0.2967168341057498,0.12244897959183676,0.038026832360010206,0.3549459005145006,0.08999999999999998,4.974054274493935e-07,0.38978801390372864,0.0736
279,0.3,8,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: The study found that there is no significant difference in target motion between the superior and inferior portions of the clinical target volume in prostate bed target,Does interfractional motion differ between the superior and inferior parts of the prostate bed clinical target volume using RTOG consensus definitions and daily CT on rails? The study concluded no difference.,6.395212638635049e-07,0.3986443491338183,0.16749660479855144,0.0489625145491106,0.48476906560869004,0.12244897959183676,0.04889164160572745,0.5491019149554583,0.08999999999999998,6.39521263863506e-07,0.5904587093658793,0.0736
279,0.3,9,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: The study found that there is no significant difference in target motion between the superior and inferior portions of the clinical target volume in prostate bed target,"Using RTOG consensus and daily CT on rails, is there a difference in motion between the superior and inferior areas of the prostate bed clinical target volume? The study found no significant difference.",5.921493183921343e-07,0.3341058279962468,0.16749660479855144,0.045335661619546844,0.4180776911100166,0.12244897959183676,0.0452700385238217,0.4801090434685076,0.08999999999999998,5.921493183921352e-07,0.5189997453837356,0.0736
279,0.3,10,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: The study found that there is no significant difference in target motion between the superior and inferior portions of the clinical target volume in prostate bed target,Is there a difference in target motion between the superior and inferior sections of the prostate bed clinical target volume according to RTOG consensus and daily CT on rails? The study found no significant difference.,5.447773729207637e-07,0.2734812061798113,0.16749660479855144,0.041708808689983085,0.35555733412868307,0.12244897959183676,0.04164843544191595,0.41557052233093605,0.08999999999999998,5.447773729207643e-07,0.45230837088506215,0.0736
280,0.3,1,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, studies have shown that mental imagery functional magnetic resonance imaging (fMRI) can potentially predict recovery in patients with disorders of consciousness. By assessing neural activity during mental imagery tasks, fMRI can provide insights into the cognitive capabilities and potential for recovery in these patients.","Can mental imagery functional magnetic resonance imaging forecast recovery in patients with consciousness disorders? Yes, research indicates that mental imagery fMRI can potentially predict recovery in such patients by evaluating neural activity during mental imagery tasks, offering insights into their cognitive functions and recovery potential.",4.026615365066519e-07,0.12050084487603296,0.16421870868861127,0.030828249901291835,0.1252002923605544,0.14532871972318342,0.030783626196198732,0.17539222345558425,0.11649408284023667,4.026615365066519e-07,0.2273628092628095,0.08543965824136704
280,0.3,2,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, studies have shown that mental imagery functional magnetic resonance imaging (fMRI) can potentially predict recovery in patients with disorders of consciousness. By assessing neural activity during mental imagery tasks, fMRI can provide insights into the cognitive capabilities and potential for recovery in these patients.","Is it possible for mental imagery functional magnetic resonance imaging to predict recovery in patients suffering from disorders of consciousness? Indeed, studies have demonstrated that mental imagery fMRI can assess neural activity during mental imagery tasks to provide valuable information about cognitive abilities and recovery prospects in these patients.",3.079176455639103e-07,0.004259337415572606,0.1957498096513338,0.023574544042164344,0.03625280634405881,0.14532871972318342,0.023540420032387266,0.08442044524985759,0.11649408284023667,3.079176455639103e-07,0.13427238619679782,0.08543965824136704
280,0.3,3,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, studies have shown that mental imagery functional magnetic resonance imaging (fMRI) can potentially predict recovery in patients with disorders of consciousness. By assessing neural activity during mental imagery tasks, fMRI can provide insights into the cognitive capabilities and potential for recovery in these patients.","Can mental imagery fMRI be used to predict recovery outcomes in patients with disorders of consciousness? Yes, evidence suggests that mental imagery functional magnetic resonance imaging can evaluate brain activity during mental imagery tasks, thereby indicating the likelihood of recovery in these patients.",4.500334819780227e-07,0.13908109350062903,0.1833159722222222,0.03445510283085558,0.17282834134980884,0.14532871972318342,0.034405229278104466,0.22418238762501597,0.11649408284023667,4.500334819780227e-07,0.2773732298374729,0.08543965824136704
280,0.3,4,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, studies have shown that mental imagery functional magnetic resonance imaging (fMRI) can potentially predict recovery in patients with disorders of consciousness. By assessing neural activity during mental imagery tasks, fMRI can provide insights into the cognitive capabilities and potential for recovery in these patients.","Does mental imagery functional magnetic resonance imaging have the capability to predict recovery in patients with consciousness disorders? Yes, research has shown that by monitoring neural activity during mental imagery tasks, fMRI can offer insights into the cognitive status and recovery potential of these patients.",4.026615365066519e-07,0.045595461557752515,0.2581009911513731,0.030828249901291835,0.1252002923605544,0.14532871972318342,0.030783626196198732,0.17539222345558425,0.11649408284023667,4.026615365066519e-07,0.2273628092628095,0.08543965824136704
280,0.3,5,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, studies have shown that mental imagery functional magnetic resonance imaging (fMRI) can potentially predict recovery in patients with disorders of consciousness. By assessing neural activity during mental imagery tasks, fMRI can provide insights into the cognitive capabilities and potential for recovery in these patients.","Can recovery in patients with disorders of consciousness be predicted using mental imagery functional magnetic resonance imaging? Yes, studies have found that mental imagery fMRI can assess neural responses during mental imagery tasks to help predict recovery chances in these patients.",4.974054274493935e-07,0.19179487298673337,0.1783228974299784,0.038081955760419325,0.22283876192447227,0.14532871972318342,0.0380268323600102,0.27547568201256567,0.11649408284023667,4.974054274493935e-07,0.33001696332289177,0.08543965824136704
280,0.3,6,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, studies have shown that mental imagery functional magnetic resonance imaging (fMRI) can potentially predict recovery in patients with disorders of consciousness. By assessing neural activity during mental imagery tasks, fMRI can provide insights into the cognitive capabilities and potential for recovery in these patients.","Is mental imagery functional magnetic resonance imaging effective in predicting recovery in patients with disorders of consciousness? Yes, it has been shown that fMRI during mental imagery tasks can reveal neural activity patterns that correlate with cognitive function and recovery potential.",4.974054274493935e-07,0.14405631036462196,0.25583240877712027,0.038081955760419325,0.22283876192447227,0.14532871972318342,0.0380268323600102,0.27547568201256567,0.11649408284023667,4.974054274493935e-07,0.33001696332289177,0.08543965824136704
280,0.3,7,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, studies have shown that mental imagery functional magnetic resonance imaging (fMRI) can potentially predict recovery in patients with disorders of consciousness. By assessing neural activity during mental imagery tasks, fMRI can provide insights into the cognitive capabilities and potential for recovery in these patients.","Can mental imagery fMRI predict recovery in patients with disorders of consciousness? Yes, research supports that mental imagery functional magnetic resonance imaging can analyze brain activity during mental imagery tasks to provide insights into patients' cognitive capabilities and recovery prospects.",5.210914001850788e-07,0.21922539691077114,0.1756297048737927,0.0398953822252012,0.24881424832773025,0.14532871972318342,0.039837633900963065,0.30214392909472654,0.11649408284023667,5.210914001850789e-07,0.3574159375110071,0.08543965824136704
280,0.3,8,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, studies have shown that mental imagery functional magnetic resonance imaging (fMRI) can potentially predict recovery in patients with disorders of consciousness. By assessing neural activity during mental imagery tasks, fMRI can provide insights into the cognitive capabilities and potential for recovery in these patients.","Does mental imagery functional magnetic resonance imaging predict recovery in patients with consciousness disorders? Yes, studies indicate that fMRI assessing neural activity during mental imagery tasks can help forecast recovery potential in these patients.",6.632072365991906e-07,0.34377976401801735,0.2505425347222222,0.050775941013892455,0.42066450525439025,0.14532871972318342,0.05070244314668029,0.4790746372538055,0.11649408284023667,6.632072365991914e-07,0.5397374943049624,0.08543965824136704
280,0.3,9,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, studies have shown that mental imagery functional magnetic resonance imaging (fMRI) can potentially predict recovery in patients with disorders of consciousness. By assessing neural activity during mental imagery tasks, fMRI can provide insights into the cognitive capabilities and potential for recovery in these patients.","Is it feasible to use mental imagery functional magnetic resonance imaging to predict recovery in patients with disorders of consciousness? Yes, evidence shows that mental imagery fMRI can evaluate neural activity during such tasks, offering valuable information about cognitive function and recovery likelihood.",4.500334819780227e-07,0.09361579576528545,0.25702061231740364,0.03445510283085558,0.17282834134980884,0.14532871972318342,0.034405229278104466,0.22418238762501597,0.11649408284023667,4.500334819780227e-07,0.2773732298374729,0.08543965824136704
280,0.3,10,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, studies have shown that mental imagery functional magnetic resonance imaging (fMRI) can potentially predict recovery in patients with disorders of consciousness. By assessing neural activity during mental imagery tasks, fMRI can provide insights into the cognitive capabilities and potential for recovery in these patients.","Can mental imagery functional magnetic resonance imaging serve as a predictor of recovery in patients with disorders of consciousness? Yes, research has demonstrated that by examining neural activity during mental imagery tasks, fMRI can provide insights into cognitive abilities and potential recovery in these patients.",4.026615365066519e-07,0.07710215158320466,0.2354644982993197,0.030828249901291835,0.1252002923605544,0.14532871972318342,0.030783626196198732,0.17539222345558425,0.11649408284023667,4.026615365066519e-07,0.2273628092628095,0.08543965824136704
281,0.3,1,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more,Does case-mix based reimbursement encourage the advancement of process-oriented care delivery? This study shows that hospital management can promote the creation of care programs by integrating case-mix reimbursement into hospital budgeting. Further research is suggested to validate this result and to assess if the implementation of care programs will eventually result in more,1.8948778188548325e-07,0.08089532743657513,0.044244628099173504,0.014507411718254981,0.10240450977053595,0.031101530612244906,0.014486412327622933,0.12451837820241352,0.017236072637734686,1.8948778188548325e-07,0.15123096972392336,0.0
281,0.3,2,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more,Is process-oriented care delivery fostered by case-mix based reimbursement? The study indicates that hospital management can drive the development of care programs by adopting case-mix reimbursement in budgeting. Additional studies are needed to confirm this and to explore whether care programs will ultimately lead to more,3.552895910352811e-07,0.2029640837166764,0.060433884297520626,0.02720139697172809,0.2228582662016998,0.0507015306122449,0.027162023114293,0.27534126793699665,0.017236072637734686,3.552895910352811e-07,0.3053816495511823,0.0
281,0.3,3,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more,Does reimbursement based on case-mix promote the evolution of process-oriented care delivery? Findings reveal that hospital management can encourage care program development by using case-mix reimbursement within budgeting. Future investigations should confirm these findings and examine if care programs will eventually produce more,4.263475092423373e-07,0.24115041384540836,0.08264462809917351,0.03264167636607371,0.29347583341565375,0.0507015306122449,0.0325944277371516,0.3476619295166228,0.017236072637734686,4.263475092423373e-07,0.37948962170490574,0.0
281,0.3,4,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more,Can case-mix based reimbursement stimulate process-oriented care delivery development? The research demonstrates that hospital management can encourage care program growth by incorporating case-mix reimbursement into hospital budgets. Further research is recommended to verify this and to determine if care programs will lead to more,4.026615365066519e-07,0.21761991643521394,0.08264462809917351,0.030828249901291835,0.26937828183659374,0.0507015306122449,0.030783626196198732,0.3229693169262511,0.017236072637734686,4.026615365066519e-07,0.354171813720614,0.0
281,0.3,5,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more,Does the use of case-mix based reimbursement drive the development of process-oriented care delivery? This study finds that hospital management can foster care program development by adopting case-mix reimbursement in budgeting processes. Future studies are needed to confirm this and to see if care programs will eventually result in more,2.6054570009253947e-07,0.08699973401814942,0.08264462809917351,0.0199476911126006,0.13584688921207055,0.0507015306122449,0.019918816950481533,0.18639378192050104,0.017236072637734686,2.6054570009253947e-07,0.21440987134545564,0.0
281,0.3,6,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more,Is the development of process-oriented care delivery encouraged by case-mix based reimbursement? The study shows hospital management can promote care programs by integrating case-mix reimbursement into budgeting. Further research is advised to validate this and to investigate whether care programs will eventually lead to more,3.789755637709665e-07,0.226137088235967,0.0599296470283244,0.029014823436509962,0.24584778442639932,0.0507015306122449,0.028972824655245866,0.29887176534719107,0.017236072637734686,3.789755637709665e-07,0.3294792011302423,0.0
281,0.3,7,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more,Does case-mix based reimbursement promote the growth of process-oriented care delivery? This research demonstrates hospital management can stimulate care program development by applying case-mix reimbursement in budgeting. Additional research is suggested to confirm this and to find out if care programs will ultimately produce more,3.789755637709665e-07,0.19463039821051442,0.08264462809917351,0.029014823436509962,0.24584778442639932,0.0507015306122449,0.028972824655245866,0.29887176534719107,0.017236072637734686,3.789755637709665e-07,0.3294792011302423,0.0
281,0.3,8,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more,Can the adoption of case-mix based reimbursement encourage process-oriented care delivery development? The study reveals hospital management can boost care programs by incorporating case-mix reimbursement into budgeting. Future research is needed to confirm this and to determine if care programs will eventually result in more,3.789755637709665e-07,0.226137088235967,0.0599296470283244,0.029014823436509962,0.24584778442639932,0.0507015306122449,0.028972824655245866,0.29887176534719107,0.017236072637734686,3.789755637709665e-07,0.3294792011302423,0.0
281,0.3,9,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more,Does case-mix based reimbursement facilitate the advancement of process-oriented care delivery? Findings indicate hospital management can promote care program development by adopting case-mix reimbursement within budgeting processes. Further studies are recommended to verify this and to assess whether care programs will lead to more,4.026615365066519e-07,0.21761991643521394,0.08264462809917351,0.030828249901291835,0.26937828183659374,0.0507015306122449,0.030783626196198732,0.3229693169262511,0.017236072637734686,4.026615365066519e-07,0.354171813720614,0.0
281,0.3,10,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more,Is process-oriented care delivery development stimulated by case-mix based reimbursement? This study shows hospital management can encourage care programs by integrating case-mix reimbursement into budgeting. Additional research is necessary to confirm this and to explore if care programs will eventually lead to more,4.263475092423373e-07,0.27415742244349994,0.05884926819435496,0.03264167636607371,0.29347583341565375,0.0507015306122449,0.0325944277371516,0.3476619295166228,0.017236072637734686,4.263475092423373e-07,0.37948962170490574,0.0
282,0.3,1,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Research suggests that glomerular hyperfiltration during pregnancy does not necessarily lead to kidney damage in women with more parities. However, further studies are needed to fully understand the long-term effects and potential risks associated with glomerular hyperfiltration","Does glomerular hyperfiltration during pregnancy harm the kidneys of women with multiple pregnancies? Research indicates that this condition does not inherently cause kidney damage in women with higher parity, but more research is required to clarify the long-term impacts and risks.",2.6054570009253947e-07,0.13143255823909072,0.11537560479686407,0.0199476911126006,0.19300958485370545,0.039930555555555566,0.019918816950481533,0.22594241672873228,0.020399305555555556,2.6054570009253947e-07,0.26028309826366547,0.0
282,0.3,2,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Research suggests that glomerular hyperfiltration during pregnancy does not necessarily lead to kidney damage in women with more parities. However, further studies are needed to fully understand the long-term effects and potential risks associated with glomerular hyperfiltration","Is kidney damage caused by glomerular hyperfiltration in pregnant women who have had several births? Studies suggest that glomerular hyperfiltration in pregnancy does not automatically result in kidney injury for women with more parities, though additional research is necessary to understand the potential long-term consequences.",1.6580180914979784e-07,0.06447839945767342,0.09500769431906349,0.012693985253473108,0.1276105190367618,0.016687925170068042,0.012675610786670066,0.12585895817175086,0.020399305555555556,1.6580180914979784e-07,0.1576289442035832,0.0
282,0.3,3,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Research suggests that glomerular hyperfiltration during pregnancy does not necessarily lead to kidney damage in women with more parities. However, further studies are needed to fully understand the long-term effects and potential risks associated with glomerular hyperfiltration","Does glomerular hyperfiltration in pregnancy lead to kidney damage in women with many pregnancies? Evidence shows that it does not necessarily damage the kidneys in women with higher parity, but further investigation is needed to assess the long-term effects and risks.",2.6054570009253947e-07,0.16608991726708844,0.09049767239709064,0.0199476911126006,0.22855559411318938,0.014307286857494612,0.019918816950481533,0.22594241672873228,0.020399305555555556,2.6054570009253947e-07,0.26028309826366547,0.0
282,0.3,4,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Research suggests that glomerular hyperfiltration during pregnancy does not necessarily lead to kidney damage in women with more parities. However, further studies are needed to fully understand the long-term effects and potential risks associated with glomerular hyperfiltration","Can glomerular hyperfiltration during pregnancy cause kidney damage in women with multiple childbirths? Research suggests no direct kidney damage occurs in women with more parities due to this, but more studies are essential to fully understand the long-term implications.",3.0791764556391007e-07,0.2575127852660044,0.061991821303190475,0.023574544042164344,0.2831207335045267,0.012924382716049402,0.023540420032387266,0.28000963799900846,0.020399305555555556,3.079176455639103e-07,0.31585294941847764,0.0
282,0.3,5,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Research suggests that glomerular hyperfiltration during pregnancy does not necessarily lead to kidney damage in women with more parities. However, further studies are needed to fully understand the long-term effects and potential risks associated with glomerular hyperfiltration","Is there kidney damage from glomerular hyperfiltration in pregnant women with increased parity? Current research indicates that glomerular hyperfiltration does not necessarily harm the kidneys in these women, although further studies are needed to explore long-term risks.",3.5528959103528067e-07,0.24064389156669508,0.11260406620114966,0.02720139697172809,0.30122316949393646,0.039930555555555566,0.027162023114293006,0.3371680518389568,0.020399305555555556,3.552895910352811e-07,0.3746934494414109,0.0
282,0.3,6,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Research suggests that glomerular hyperfiltration during pregnancy does not necessarily lead to kidney damage in women with more parities. However, further studies are needed to fully understand the long-term effects and potential risks associated with glomerular hyperfiltration","Does pregnancy-related glomerular hyperfiltration damage kidneys in women with several pregnancies? Research points to no definite kidney damage in women with higher parity, but additional research is required to understand long-term effects and risks.",4.2634750924233657e-07,0.37316493192642275,0.0800053701150149,0.03264167636607373,0.434157026968621,0.008713073765753261,0.03259442773715163,0.4295413719699721,0.020399305555555556,4.263475092423373e-07,0.47000362924573613,0.0
282,0.3,7,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Research suggests that glomerular hyperfiltration during pregnancy does not necessarily lead to kidney damage in women with more parities. However, further studies are needed to fully understand the long-term effects and potential risks associated with glomerular hyperfiltration","Does glomerular hyperfiltration during pregnancy cause kidney injury in women with multiple pregnancies? Studies imply that this condition does not inherently damage kidneys in women with more parities, yet further research is needed to determine long-term outcomes.",3.5528959103528067e-07,0.2791520682644699,0.08499584644265801,0.02720139697172809,0.3408315798116477,0.011383842752787407,0.027162023114293006,0.3371680518389568,0.020399305555555556,3.552895910352811e-07,0.3746934494414109,0.0
282,0.3,8,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Research suggests that glomerular hyperfiltration during pregnancy does not necessarily lead to kidney damage in women with more parities. However, further studies are needed to fully understand the long-term effects and potential risks associated with glomerular hyperfiltration","Is kidney damage a result of glomerular hyperfiltration in women with many pregnancies? Research suggests that glomerular hyperfiltration in pregnancy does not necessarily cause kidney damage in women with increased parity, but more studies are necessary to fully understand the risks.",2.6054570009253947e-07,0.2700619943510798,0.01791018865012925,0.0199476911126006,0.26410160337267374,0.011201657738819884,0.019918816950481533,0.22594241672873228,0.020399305555555556,2.6054570009253947e-07,0.26028309826366547,0.0
282,0.3,9,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Research suggests that glomerular hyperfiltration during pregnancy does not necessarily lead to kidney damage in women with more parities. However, further studies are needed to fully understand the long-term effects and potential risks associated with glomerular hyperfiltration","Does glomerular hyperfiltration in pregnancy harm the kidneys of women with higher parity? Evidence suggests it does not necessarily lead to kidney damage, but further research is needed to clarify long-term effects and potential risks.",4.0266153650665127e-07,0.2592941287088686,0.14035916824196598,0.03082824990129185,0.36006366951686974,0.039930555555555566,0.030783626196198753,0.3977926736553923,0.020399305555555556,4.026615365066519e-07,0.43721380642274443,0.0
282,0.3,10,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Research suggests that glomerular hyperfiltration during pregnancy does not necessarily lead to kidney damage in women with more parities. However, further studies are needed to fully understand the long-term effects and potential risks associated with glomerular hyperfiltration","Does glomerular hyperfiltration during pregnancy cause kidney damage in women with multiple births? Research indicates no direct damage to kidneys in women with more parities, though further studies are essential to understand long-term risks and effects.",3.7897556377096597e-07,0.3095234124710391,0.08342620221809088,0.02901482343650997,0.3709840699295377,0.01054579889807163,0.02897282465524588,0.3670210149886386,0.020399305555555556,3.789755637709665e-07,0.4054651081081646,0.0
283,0.3,1,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty is a surgical procedure aimed at correcting a deviated septum, while compensatory hypertrophy refers to the enlargement of the middle","Does septoplasty alter the size of compensatory hypertrophy in the middle turbinate? Septoplasty is a surgery to fix a deviated septum, whereas compensatory hypertrophy means the middle turbinate has enlarged.",1.184298636784265e-07,0.1323511116060807,0.01882184338730375,0.009067132323909398,0.12229413125734023,0.0302734375,0.009054007704764368,0.16989903679539697,0.0,1.1842986367842703e-07,0.17589066646366414,0.0
283,0.3,2,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty is a surgical procedure aimed at correcting a deviated septum, while compensatory hypertrophy refers to the enlargement of the middle","Can septoplasty modify the dimensions of compensatory hypertrophy of the middle turbinate? Septoplasty corrects a deviated septum, and compensatory hypertrophy is the middle turbinate's enlargement.",2.36859727356853e-07,0.34151113367449115,0.004764320912272871,0.018134264647818796,0.3190044255033948,0.0302734375,0.018108015409528735,0.3746934494414109,0.0,2.3685972735685406e-07,0.38946476676172503,0.0
283,0.3,3,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty is a surgical procedure aimed at correcting a deviated septum, while compensatory hypertrophy refers to the enlargement of the middle","Is there a change in the size of compensatory hypertrophy of the middle turbinate after septoplasty? Septoplasty is performed to correct a deviated septum, while compensatory hypertrophy involves the middle turbinate becoming enlarged.",4.73719454713706e-08,0.06826962748437815,0.005337781071787839,0.003626852929563759,0.06523060988674878,0.0019487847222222007,0.003621603081905747,0.06453852113757153,0.0,4.737194547137081e-08,0.06669137449867346,0.0
283,0.3,4,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty is a surgical procedure aimed at correcting a deviated septum, while compensatory hypertrophy refers to the enlargement of the middle",Does undergoing septoplasty affect the compensatory hypertrophy size of the middle turbinate? Septoplasty aims to correct a deviated septum; compensatory hypertrophy is the enlargement of the middle turbinate.,1.658018091497971e-07,0.26223627471588395,0.021966050988553587,0.012693985253473157,0.24972111730028868,0.00812656250000001,0.012675610786670115,0.24686007793152642,0.0,1.6580180914979784e-07,0.2559333741372014,0.0
283,0.3,5,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty is a surgical procedure aimed at correcting a deviated septum, while compensatory hypertrophy refers to the enlargement of the middle","Will septoplasty impact the dimensions of compensatory hypertrophy in the middle turbinate? Septoplasty corrects a deviated septum, and compensatory hypertrophy refers to the middle turbinate's enlargement.",2.131737546211677e-07,0.29606815795050556,0.00801386394528382,0.016320838183036916,0.2764448110845992,0.0302734375,0.016297213868575862,0.33024168687057687,0.0,2.1317375462116866e-07,0.3429447511268311,0.0
283,0.3,6,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty is a surgical procedure aimed at correcting a deviated septum, while compensatory hypertrophy refers to the enlargement of the middle","Does the procedure of septoplasty change the compensatory hypertrophy dimensions of the middle turbinate? Septoplasty fixes a deviated septum, whereas compensatory hypertrophy is the enlargement of the middle turbinate.",1.421158364141118e-07,0.2203674624453269,0.018191050988553614,0.010880558788691277,0.21000601102524818,0.006708811020710047,0.010864809245717241,0.20763936477824396,0.0,1.4211583641411244e-07,0.2151113796169466,0.0
283,0.3,7,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty is a surgical procedure aimed at correcting a deviated septum, while compensatory hypertrophy refers to the enlargement of the middle","Can the size of compensatory hypertrophy of the middle turbinate be altered by septoplasty? Septoplasty is a surgical correction of a deviated septum, while compensatory hypertrophy means the middle turbinate has enlarged.",7.10579182070559e-08,0.10421074826202092,0.008254316294676059,0.005440279394345639,0.09951107180771901,0.003020260478596916,0.005432404622858621,0.09844007281325329,0.0,7.105791820705622e-08,0.10178269430994247,0.0
283,0.3,8,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty is a surgical procedure aimed at correcting a deviated septum, while compensatory hypertrophy refers to the enlargement of the middle",Is compensatory hypertrophy of the middle turbinate dimensionally affected by septoplasty? Septoplasty corrects a deviated septum; compensatory hypertrophy is the enlargement of the middle turbinate.,2.36859727356853e-07,0.3992733987211534,0.03504003058039029,0.018134264647818796,0.379278093378173,0.01311499225206613,0.018108015409528735,0.3746934494414109,0.0,2.3685972735685406e-07,0.38946476676172503,0.0
283,0.3,9,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty is a surgical procedure aimed at correcting a deviated septum, while compensatory hypertrophy refers to the enlargement of the middle","Does septoplasty influence the size of compensatory hypertrophy in the middle turbinate? Septoplasty is done to correct a deviated septum, and compensatory hypertrophy refers to the enlargement of the middle turbinate.",9.47438909427412e-08,0.09526267634161778,0.02108241839920154,0.007253705859127518,0.08720281144607123,0.0302734375,0.007243206163811494,0.1335313926245223,0.0,9.474389094274162e-08,0.13815033848081715,0.0
283,0.3,10,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty is a surgical procedure aimed at correcting a deviated septum, while compensatory hypertrophy refers to the enlargement of the middle","Is the dimension of compensatory hypertrophy of the middle turbinate changed by septoplasty? Septoplasty is a surgical procedure to correct a deviated septum, while compensatory hypertrophy is the enlargement of the middle turbinate.",4.73719454713706e-08,0.1115913262693744,0.03504003058039032,0.003626852929563759,0.06523060988674878,0.0019487847222222007,0.003621603081905747,0.06453852113757153,0.0,4.737194547137081e-08,0.06669137449867346,0.0
284,0.3,1,ai,"Question: Do Indigenous Australians age prematurely? Answer: There is no scientific evidence to suggest that Indigenous Australians age prematurely. However, factors such as socioeconomic disadvantage, access to healthcare, and lifestyle choices may contribute to health issues that can affect the overall aging process.","Question: Do Indigenous Australians experience premature aging? Answer: Scientific research does not support the idea that Indigenous Australians age prematurely. Nevertheless, elements like socioeconomic challenges, healthcare accessibility, and lifestyle habits might influence health conditions impacting the aging process.",1.1842986367842671e-07,0.09820510360836066,0.02049382716049385,0.009067132323909363,0.09624107065990772,0.024375,0.009054007704764333,0.13353139262452274,0.0,1.1842986367842703e-07,0.13720112151348252,0.0
284,0.3,2,ai,"Question: Do Indigenous Australians age prematurely? Answer: There is no scientific evidence to suggest that Indigenous Australians age prematurely. However, factors such as socioeconomic disadvantage, access to healthcare, and lifestyle choices may contribute to health issues that can affect the overall aging process.","Question: Is premature aging observed among Indigenous Australians? Answer: There is no scientific proof indicating that Indigenous Australians undergo premature aging. However, factors including socioeconomic status, healthcare availability, and lifestyle choices may affect health outcomes related to aging.",1.1842986367842671e-07,0.06073768844295824,0.047500000000000014,0.009067132323909363,0.09624107065990772,0.024375,0.009054007704764333,0.13353139262452274,0.0,1.1842986367842703e-07,0.13720112151348252,0.0
284,0.3,3,ai,"Question: Do Indigenous Australians age prematurely? Answer: There is no scientific evidence to suggest that Indigenous Australians age prematurely. However, factors such as socioeconomic disadvantage, access to healthcare, and lifestyle choices may contribute to health issues that can affect the overall aging process.","Question: Are Indigenous Australians prone to aging earlier than others? Answer: No scientific evidence confirms that Indigenous Australians age earlier. Still, socioeconomic disadvantages, healthcare access, and lifestyle factors can contribute to health problems influencing aging.",1.8948778188548261e-07,0.18606844003337164,0.018115243342516078,0.014507411718254995,0.18325244764953785,0.024375,0.014486412327622954,0.2231435513142097,0.0,1.8948778188548325e-07,0.2295744416444978,0.0
284,0.3,4,ai,"Question: Do Indigenous Australians age prematurely? Answer: There is no scientific evidence to suggest that Indigenous Australians age prematurely. However, factors such as socioeconomic disadvantage, access to healthcare, and lifestyle choices may contribute to health issues that can affect the overall aging process.","Question: Do Indigenous Australians show signs of premature aging? Answer: Current scientific studies do not indicate premature aging in Indigenous Australians. Yet, socioeconomic disadvantages, healthcare access, and lifestyle decisions may impact health issues that relate to aging.",1.42115836414112e-07,0.08813666263107356,0.047500000000000014,0.010880558788691236,0.12441194762660457,0.024375,0.010864809245717207,0.16251892949777424,0.0,1.4211583641411244e-07,0.1670540846631643,0.0
284,0.3,5,ai,"Question: Do Indigenous Australians age prematurely? Answer: There is no scientific evidence to suggest that Indigenous Australians age prematurely. However, factors such as socioeconomic disadvantage, access to healthcare, and lifestyle choices may contribute to health issues that can affect the overall aging process.","Question: Is there premature aging among Indigenous Australians? Answer: Scientific data does not suggest that Indigenous Australians age prematurely. However, health issues influenced by socioeconomic factors, healthcare access, and lifestyle choices might affect their aging process.",1.6580180914979731e-07,0.1163075395977704,0.047500000000000014,0.012693985253473115,0.15339948449985608,0.024375,0.01267561078667008,0.19237189264745602,0.0,1.6580180914979784e-07,0.19782574332991798,0.0
284,0.3,6,ai,"Question: Do Indigenous Australians age prematurely? Answer: There is no scientific evidence to suggest that Indigenous Australians age prematurely. However, factors such as socioeconomic disadvantage, access to healthcare, and lifestyle choices may contribute to health issues that can affect the overall aging process.","Question: Do Indigenous Australians age faster than other populations? Answer: There is no scientific evidence to claim that Indigenous Australians age faster. Nonetheless, socioeconomic disadvantages, healthcare accessibility, and lifestyle choices may contribute to health concerns affecting aging.",1.42115836414112e-07,0.16515301602662324,0.00786332179930796,0.010880558788691236,0.1640203579443158,0.0041717128027681585,0.010864809245717207,0.16251892949777424,0.0,1.4211583641411244e-07,0.1670540846631643,0.0
284,0.3,7,ai,"Question: Do Indigenous Australians age prematurely? Answer: There is no scientific evidence to suggest that Indigenous Australians age prematurely. However, factors such as socioeconomic disadvantage, access to healthcare, and lifestyle choices may contribute to health issues that can affect the overall aging process.","Question: Are Indigenous Australians subject to premature aging? Answer: No scientific evidence supports the notion that Indigenous Australians experience premature aging. However, factors such as socioeconomic challenges, healthcare availability, and lifestyle can influence health issues related to aging.",1.1842986367842671e-07,0.09820510360836066,0.02049382716049385,0.009067132323909363,0.09624107065990772,0.024375,0.009054007704764333,0.13353139262452274,0.0,1.1842986367842703e-07,0.13720112151348252,0.0
284,0.3,8,ai,"Question: Do Indigenous Australians age prematurely? Answer: There is no scientific evidence to suggest that Indigenous Australians age prematurely. However, factors such as socioeconomic disadvantage, access to healthcare, and lifestyle choices may contribute to health issues that can affect the overall aging process.","Question: Does premature aging occur in Indigenous Australians? Answer: Scientific research does not show that Indigenous Australians age prematurely. Still, socioeconomic status, access to healthcare, and lifestyle habits may play a role in health problems that affect aging.",1.1842986367842671e-07,0.06073768844295824,0.047500000000000014,0.009067132323909363,0.09624107065990772,0.024375,0.009054007704764333,0.13353139262452274,0.0,1.1842986367842703e-07,0.13720112151348252,0.0
284,0.3,9,ai,"Question: Do Indigenous Australians age prematurely? Answer: There is no scientific evidence to suggest that Indigenous Australians age prematurely. However, factors such as socioeconomic disadvantage, access to healthcare, and lifestyle choices may contribute to health issues that can affect the overall aging process.","Question: Is premature aging a characteristic of Indigenous Australians? Answer: There is no scientific basis to suggest Indigenous Australians age prematurely. However, socioeconomic disadvantages, healthcare access, and lifestyle choices might impact health conditions influencing the aging process.",1.42115836414112e-07,0.08813666263107356,0.047500000000000014,0.010880558788691236,0.12441194762660457,0.024375,0.010864809245717207,0.16251892949777424,0.0,1.4211583641411244e-07,0.1670540846631643,0.0
284,0.3,10,ai,"Question: Do Indigenous Australians age prematurely? Answer: There is no scientific evidence to suggest that Indigenous Australians age prematurely. However, factors such as socioeconomic disadvantage, access to healthcare, and lifestyle choices may contribute to health issues that can affect the overall aging process.","Question: Do Indigenous Australians undergo premature aging? Answer: Evidence from scientific studies does not indicate premature aging among Indigenous Australians. However, factors like socioeconomic disadvantage, healthcare access, and lifestyle choices may contribute to health issues affecting aging.",1.42115836414112e-07,0.08813666263107356,0.047500000000000014,0.010880558788691236,0.12441194762660457,0.024375,0.010864809245717207,0.16251892949777424,0.0,1.4211583641411244e-07,0.1670540846631643,0.0
285,0.3,1,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: There may be discordance between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology. This could be due to differences in training, experience, or subjective interpretation. Communication and collaboration between the two groups are essential to ensure accurate diagnoses and appropriate patient management.","Is there a discrepancy between clinical pathologists and clinicians when reporting and interpreting red blood cell morphology? There might be differences due to varying training, experience, or subjective views. Effective communication and teamwork are crucial for accurate diagnosis and patient care.",5.210914001850789e-07,0.23701865270407385,0.14097543609825555,0.0398953822252012,0.2882292585708912,0.11282578875171473,0.039837633900963065,0.3412338724023898,0.08264462809917351,5.210914001850789e-07,0.396129987475736,0.0507015306122449
285,0.3,2,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: There may be discordance between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology. This could be due to differences in training, experience, or subjective interpretation. Communication and collaboration between the two groups are essential to ensure accurate diagnoses and appropriate patient management.",Are clinical pathologists and clinicians aligned in their reporting and interpretation of red blood cell morphology? Potential discordance can arise from differences in expertise and subjective judgment. Collaboration is key to ensuring precise diagnoses and proper management.,6.158352911278201e-07,0.34237916836189974,0.14097543609825555,0.04714908808432869,0.3964428432111222,0.11282578875171473,0.04708084006477454,0.4524595075126143,0.08264462809917351,6.158352911278206e-07,0.5105403386534815,0.0507015306122449
285,0.3,3,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: There may be discordance between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology. This could be due to differences in training, experience, or subjective interpretation. Communication and collaboration between the two groups are essential to ensure accurate diagnoses and appropriate patient management.",Does discordance exist between clinical pathologists and clinicians in red blood cell morphology interpretation? Differences in training and experience may lead to varied interpretations. Strong communication and cooperation help achieve accurate patient outcomes.,7.105791820705613e-07,0.46016220401828356,0.14097543609825555,0.05440279394345621,0.517803700215389,0.11282578875171473,0.05432404622858603,0.5776226504666213,0.08264462809917351,7.105791820705622e-07,0.6397520701334884,0.0507015306122449
285,0.3,4,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: There may be discordance between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology. This could be due to differences in training, experience, or subjective interpretation. Communication and collaboration between the two groups are essential to ensure accurate diagnoses and appropriate patient management.",Is there a mismatch between clinical pathologists and clinicians regarding red blood cell morphology reporting? Variations in background and subjective interpretation can cause discrepancies. Joint efforts are necessary for accurate diagnosis and treatment.,7.105791820705613e-07,0.46016220401828356,0.14097543609825555,0.05440279394345621,0.517803700215389,0.11282578875171473,0.05432404622858603,0.5776226504666213,0.08264462809917351,7.105791820705622e-07,0.6397520701334884,0.0507015306122449
285,0.3,5,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: There may be discordance between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology. This could be due to differences in training, experience, or subjective interpretation. Communication and collaboration between the two groups are essential to ensure accurate diagnoses and appropriate patient management.",Are clinical pathologists and clinicians consistent in interpreting red blood cell morphology? Discrepancies may occur due to differing training and subjective perspectives. Collaboration ensures correct diagnosis and effective patient management.,7.816371002776172e-07,0.5586022768315368,0.14097543609825555,0.059843073337801846,0.6195863945253315,0.11282578875171473,0.059756450851444654,0.6829831661244468,0.08264462809917351,7.816371002776184e-07,0.7489513620984791,0.0507015306122449
285,0.3,6,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: There may be discordance between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology. This could be due to differences in training, experience, or subjective interpretation. Communication and collaboration between the two groups are essential to ensure accurate diagnoses and appropriate patient management.",Might clinical pathologists and clinicians differ in their reporting of red blood cell morphology? Differences in experience and interpretation could cause discordance. Communication and teamwork are vital for accurate clinical decisions.,7.579511275419319e-07,0.5247007251558551,0.14097543609825555,0.058029646873019966,0.5844950747140625,0.11282578875171473,0.05794564931049178,0.6466155219535721,0.08264462809917351,7.57951127541933e-07,0.7112110341156321,0.0507015306122449
285,0.3,7,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: There may be discordance between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology. This could be due to differences in training, experience, or subjective interpretation. Communication and collaboration between the two groups are essential to ensure accurate diagnoses and appropriate patient management.",Is there a difference between clinical pathologists and clinicians in red blood cell morphology interpretation? Variations in training and subjective views may lead to discordance. Ensuring collaboration promotes accurate diagnosis and care.,7.342651548062466e-07,0.4919109023328634,0.14097543609825555,0.056216220408238086,0.5505935230383807,0.11282578875171473,0.056134847769538906,0.6115242021423031,0.08264462809917351,7.342651548062476e-07,0.6748433899447575,0.0507015306122449
285,0.3,8,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: There may be discordance between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology. This could be due to differences in training, experience, or subjective interpretation. Communication and collaboration between the two groups are essential to ensure accurate diagnoses and appropriate patient management.",Could reporting and interpreting red blood cell morphology differ between clinical pathologists and clinicians? Divergent training and subjective judgment might cause inconsistencies. Effective collaboration is essential for proper diagnosis and patient management.,7.342651548062466e-07,0.4919109023328634,0.14097543609825555,0.056216220408238086,0.5505935230383807,0.11282578875171473,0.056134847769538906,0.6115242021423031,0.08264462809917351,7.342651548062476e-07,0.6748433899447575,0.0507015306122449
285,0.3,9,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: There may be discordance between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology. This could be due to differences in training, experience, or subjective interpretation. Communication and collaboration between the two groups are essential to ensure accurate diagnoses and appropriate patient management.",Do clinical pathologists and clinicians disagree in their interpretation of red blood cell morphology? Differences in expertise and subjective interpretation may result in discordance. Communication and cooperation are important for accurate diagnosis and treatment.,6.86893209334876e-07,0.4293905453515299,0.14097543609825555,0.05258936747867433,0.4860550019008092,0.11282578875171473,0.05251324468763316,0.5448328276436296,0.08264462809917351,6.868932093348768e-07,0.6058505184578067,0.0507015306122449
285,0.3,10,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: There may be discordance between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology. This could be due to differences in training, experience, or subjective interpretation. Communication and collaboration between the two groups are essential to ensure accurate diagnoses and appropriate patient management.",Is there an inconsistency between clinical pathologists and clinicians in reporting red blood cell morphology? Variations in experience and subjective interpretation might lead to differences. Collaboration and communication are crucial for accurate diagnosis and patient care.,6.395212638635054e-07,0.3705500453285966,0.14097543609825555,0.04896251454911057,0.4254303800843737,0.11282578875171473,0.04889164160572741,0.4823124706622961,0.08264462809917351,6.39521263863506e-07,0.5413119973202352,0.0507015306122449
286,0.3,1,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.","Are reduced fasting plasma glucose levels at the time of type 2 diabetes diagnosis linked to better health outcomes? Individuals diagnosed with type 2 diabetes who have lower initial blood sugar levels, possibly indicating an earlier disease stage, experience fewer negative clinical events despite similar progression in blood sugar levels. Because most of these individuals show no symptoms at diagnosis, proactive screening programs are necessary to detect them.",7.105791820705622e-08,0.027058352975100064,0.013460252585197705,0.005440279394345618,0.04752022801664957,0.0007209575823999993,0.0054324046228586,0.04725288485054513,0.0,7.105791820705622e-08,0.04800921918636103,0.0
286,0.3,2,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.","Is there a connection between lower fasting plasma glucose at type 2 diabetes diagnosis and improved patient outcomes? Patients with type 2 diabetes presenting with lower initial glucose levels, suggesting an earlier phase of the disease, tend to have fewer adverse clinical outcomes even though their glycemic progression is comparable. Since most are asymptomatic when diagnosed, active case-finding initiatives are essential to identify these individuals.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
286,0.3,3,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.","Do lower fasting plasma glucose levels at the diagnosis of type 2 diabetes correlate with better clinical outcomes? People with type 2 diabetes who have lower blood sugar at diagnosis, possibly indicating earlier disease onset, show fewer harmful clinical outcomes despite similar glycemic progression. Because most are symptom-free at diagnosis, active case detection programs are needed to find them.",1.4211583641411244e-07,0.126823254775839,0.020352766144082,0.010880558788691236,0.10239973986211481,0.0016693787296396152,0.0108648092457172,0.10178269430994202,0.0,1.4211583641411244e-07,0.10354067894083929,0.0
286,0.3,4,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.","Are lower fasting plasma glucose levels at type 2 diabetes diagnosis associated with better outcomes? Those diagnosed with type 2 diabetes who have lower initial glycemia, potentially earlier in their disease course, experience fewer adverse clinical outcomes despite similar progression of blood sugar levels. Since most are asymptomatic at diagnosis, active screening programs are required to identify them.",1.6580180914979784e-07,0.12115202414784232,0.0038238405242473107,0.012693985253473108,0.12053361970622767,0.0019823530929386525,0.012675610786670066,0.1198011998126205,0.0,1.6580180914979784e-07,0.12188981760903506,0.0
286,0.3,5,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.","Is there an association between lower fasting plasma glucose at type 2 diabetes diagnosis and improved outcomes? Individuals presenting with type 2 diabetes with lower initial glycemia, possibly indicating earlier disease stage, have fewer negative clinical outcomes despite similar glycemic progression. Because most are asymptomatic at diagnosis, active case detection is necessary to identify them.",2.3685972735685406e-07,0.17792157360743488,0.005764766730907759,0.018134264647818726,0.17699463782030733,0.0029920601690792935,0.018108015409528666,0.1758906664636637,0.0,2.3685972735685406e-07,0.17904823144898518,0.0
286,0.3,6,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.","Do people with lower fasting plasma glucose at type 2 diabetes diagnosis have better outcomes? Patients with type 2 diabetes who show lower initial blood sugar levels, which may suggest earlier disease, experience fewer adverse clinical events despite similar glycemic progression. Since most are asymptomatic at diagnosis, active detection programs are needed to find these cases.",2.1317375462116866e-07,0.15863890338292874,0.005094372962778693,0.016320838183036854,0.15781812522704897,0.002643039375813342,0.0162972138685758,0.1568424714929706,0.0,2.1317375462116866e-07,0.1596301455918825,0.0
286,0.3,7,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.","Are lower fasting plasma glucose levels at the time of type 2 diabetes diagnosis linked to improved clinical outcomes? Those with type 2 diabetes who present with lower initial glycemia, possibly earlier in disease progression, have fewer adverse clinical outcomes despite similar glycemic progression. As most are asymptomatic at diagnosis, active case-finding programs are required to identify them.",1.6580180914979784e-07,0.12115202414784232,0.0038238405242473107,0.012693985253473108,0.12053361970622767,0.0019823530929386525,0.012675610786670066,0.1198011998126205,0.0,1.6580180914979784e-07,0.12188981760903506,0.0
286,0.3,8,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.","Is there a relationship between lower fasting plasma glucose at type 2 diabetes diagnosis and better outcomes? People diagnosed with type 2 diabetes with lower initial blood sugar, potentially earlier in their disease, have fewer negative clinical outcomes despite similar glycemic progression. Because most are asymptomatic at diagnosis, active screening programs are necessary to detect them.",2.1317375462116866e-07,0.15863890338292874,0.005094372962778693,0.016320838183036854,0.15781812522704897,0.002643039375813342,0.0162972138685758,0.1568424714929706,0.0,2.1317375462116866e-07,0.1596301455918825,0.0
286,0.3,9,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.","Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes connected to improved outcomes? Individuals presenting with type 2 diabetes with lower initial glycemia, possibly indicating an earlier stage of disease, experience fewer adverse clinical outcomes despite similar glycemic progression. Since most are asymptomatic at diagnosis, active case detection programs are essential to identify them.",1.8948778188548325e-07,0.13972020673666652,0.004447813134751875,0.014507411718254981,0.13900222078069824,0.0023066964139149618,0.014486412327622933,0.13815033848081626,0.0,1.8948778188548325e-07,0.1405819506211894,0.0
286,0.3,10,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.","Do lower fasting plasma glucose levels at type 2 diabetes diagnosis correspond to better outcomes? Patients with type 2 diabetes who have lower initial glycemia, which may reflect earlier disease, show fewer adverse clinical outcomes despite similar glycemic progression. As most are asymptomatic at diagnosis, active detection programs are needed to identify them.",2.8423167282822487e-07,0.21763667988247537,0.007182518210197716,0.02176111757738247,0.21648666364338176,0.003731113423517153,0.0217296184914344,0.21511137961694615,0.0,2.8423167282822487e-07,0.21905356606268356,0.0
287,0.3,1,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
287,0.3,2,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Numerous children failed to accurately assess how overweight they were. This misjudgment was also common among their parents and doctors. The findings highlight the importance of improving physician education to better identify obesity and overweight, enabling them to advise children and their families effectively.",9.474389094274162e-08,0.07191309609835717,0.0012314688405761602,0.0072537058591274906,0.07145896398214369,0.0,0.007243206163811466,0.07275935428242919,0.0,9.474389094274162e-08,0.07410797215372167,0.0
287,0.3,3,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: A significant number of children did not realize the extent of their overweight condition. Their parents and even their doctors often shared this incorrect perception. This research underscores the necessity of enhancing physician training to detect obesity and overweight, so they can provide appropriate guidance to children and their families.",2.3685972735685406e-07,0.17093183112783628,0.002794723615397801,0.018134264647818726,0.16989903679539609,0.0,0.018108015409528666,0.17284281283941416,0.0,2.3685972735685406e-07,0.1758906664636637,0.0
287,0.3,4,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated how overweight they were, a misconception also held by their parents and attending physicians. This study highlights the need for better physician education to identify obesity and overweight, allowing them to counsel children and their families properly.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
287,0.3,5,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Children often underestimated their overweight status, and this misperception was shared by their parents and doctors. The study emphasizes the importance of educating physicians to recognize obesity and overweight to effectively advise children and their families.",9.474389094274162e-08,0.07748444286268352,0.0014244170096021913,0.0072537058591274906,0.07696104113612989,0.0,0.007243206163811466,0.07847161544149417,0.0,9.474389094274162e-08,0.08004270767353683,0.0
287,0.3,6,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children did not accurately perceive their overweight condition, a misunderstanding also common among their parents and physicians. The research points to the need for improved physician education to identify and manage obesity and overweight in children and their families.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
287,0.3,7,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: A large number of children underestimated their overweight level, with parents and doctors sharing this misperception. This study stresses the importance of educating physicians to better recognize obesity and overweight to counsel children and families effectively.",9.474389094274162e-08,0.050302200487784,0.0181755829903978,0.0072537058591274906,0.07696104113612989,0.0,0.007243206163811466,0.07847161544149417,0.0,9.474389094274162e-08,0.08004270767353683,0.0
287,0.3,8,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Children frequently underestimated their overweight status, and this was a shared misperception among their parents and physicians. The findings highlight the need for enhanced physician education to identify obesity and overweight and provide counseling to children and their families.",2.3685972735685406e-08,0.01881590444635073,0.0003363429618983803,0.0018134264647818726,0.018692133012154333,0.0,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
287,0.3,9,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their overweight condition, a misperception also held by their parents and attending doctors. This study reveals the necessity of further educating physicians to recognize obesity and overweight to better counsel children and families.",9.474389094274162e-08,0.050302200487784,0.0181755829903978,0.0072537058591274906,0.07696104113612989,0.0,0.007243206163811466,0.07847161544149417,0.0,9.474389094274162e-08,0.08004270767353683,0.0
287,0.3,10,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Numerous children underestimated their overweight status, with parents and physicians sharing this incorrect perception. The study demonstrates the need to improve physician education to identify obesity and overweight and to counsel children and their families accordingly.",9.474389094274162e-08,0.07748444286268352,0.0014244170096021913,0.0072537058591274906,0.07696104113612989,0.0,0.007243206163811466,0.07847161544149417,0.0,9.474389094274162e-08,0.08004270767353683,0.0
288,0.3,1,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. Risk groups include individuals with a family history of the disease, those with autoimmune disorders, and individuals with symptoms like chronic diarrhea or weight loss. Early detection and diagnosis can lead","Is it justified to screen risk groups for coeliac disease? Yes, screening for coeliac disease in risk groups is warranted. These groups include people with a family history, autoimmune conditions, or symptoms such as chronic diarrhea or weight loss. Early diagnosis is beneficial.",1.6580180914979784e-07,0.01144411188867167,0.13900793650793647,0.012693985253473108,0.042104414110259114,0.08264462809917357,0.012675610786670066,0.0727812734820863,0.06353305785123965,1.6580180914979784e-07,0.10480608248467238,0.043388429752066124
288,0.3,2,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. Risk groups include individuals with a family history of the disease, those with autoimmune disorders, and individuals with symptoms like chronic diarrhea or weight loss. Early detection and diagnosis can lead","Should coeliac disease screening be conducted in risk groups? Indeed, screening is justified for those at risk, including individuals with a family history, autoimmune diseases, or symptoms like chronic diarrhea and weight loss. Early detection aids in management.",2.8423167282822456e-07,0.07218180033162991,0.18650793650793648,0.02176111757738247,0.1721575423584567,0.08264462809917357,0.0217296184914344,0.20631266610660903,0.06353305785123965,2.8423167282822487e-07,0.2420072039981549,0.043388429752066124
288,0.3,3,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. Risk groups include individuals with a family history of the disease, those with autoimmune disorders, and individuals with symptoms like chronic diarrhea or weight loss. Early detection and diagnosis can lead","Is screening for coeliac disease justified in high-risk groups? Yes, it is appropriate to screen individuals at risk, such as those with a family history, autoimmune disorders, or symptoms like chronic diarrhea and weight loss. Early diagnosis improves outcomes.",2.6054570009253926e-07,0.04551355324946904,0.18650793650793648,0.0199476911126006,0.14475856817034138,0.08264462809917357,0.019918816950481533,0.1781417891399122,0.06353305785123965,2.6054570009253947e-07,0.2130196671249034,0.043388429752066124
288,0.3,4,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. Risk groups include individuals with a family history of the disease, those with autoimmune disorders, and individuals with symptoms like chronic diarrhea or weight loss. Early detection and diagnosis can lead","Does screening for coeliac disease make sense in risk groups? Yes, it is justified to screen people with risk factors including family history, autoimmune diseases, and symptoms like chronic diarrhea or weight loss. Early identification can lead to better care.",2.3685972735685396e-07,0.019538066846211066,0.18650793650793648,0.018134264647818726,0.11809032108818052,0.08264462809917357,0.018108015409528666,0.15074281495179687,0.06353305785123965,2.3685972735685406e-07,0.18484879015820654,0.043388429752066124
288,0.3,5,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. Risk groups include individuals with a family history of the disease, those with autoimmune disorders, and individuals with symptoms like chronic diarrhea or weight loss. Early detection and diagnosis can lead","Is coeliac disease screening warranted in risk groups? Yes, screening is justified for individuals with risk factors such as family history, autoimmune disorders, or symptoms like chronic diarrhea and weight loss. Early detection is crucial.",3.5528959103528046e-07,0.15673918835969358,0.18650793650793648,0.027201396971728103,0.25916891934808683,0.08264462809917357,0.02716202311429302,0.295924824796296,0.06353305785123965,3.552895910352811e-07,0.3343805241291702,0.043388429752066124
288,0.3,6,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. Risk groups include individuals with a family history of the disease, those with autoimmune disorders, and individuals with symptoms like chronic diarrhea or weight loss. Early detection and diagnosis can lead","Is it appropriate to screen risk groups for coeliac disease? Yes, screening is justified for those with a family history, autoimmune conditions, or symptoms like chronic diarrhea or weight loss. Early diagnosis facilitates better treatment.",3.5528959103528046e-07,0.15673918835969358,0.18650793650793648,0.027201396971728103,0.25916891934808683,0.08264462809917357,0.02716202311429302,0.295924824796296,0.06353305785123965,3.552895910352811e-07,0.3343805241291702,0.043388429752066124
288,0.3,7,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. Risk groups include individuals with a family history of the disease, those with autoimmune disorders, and individuals with symptoms like chronic diarrhea or weight loss. Early detection and diagnosis can lead","Should individuals in risk groups be screened for coeliac disease? Yes, screening is justified for people with risk factors including family history, autoimmune diseases, and symptoms such as chronic diarrhea or weight loss. Early detection helps management.",3.0791764556390986e-07,0.09958077451974523,0.18650793650793648,0.023574544042164344,0.20032841932515355,0.08264462809917357,0.023540420032387273,0.23530020297986054,0.06353305785123965,3.079176455639103e-07,0.2718601671478367,0.043388429752066124
288,0.3,8,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. Risk groups include individuals with a family history of the disease, those with autoimmune disorders, and individuals with symptoms like chronic diarrhea or weight loss. Early detection and diagnosis can lead","Is coeliac disease screening justified for at-risk populations? Yes, it is justified to screen individuals with a family history, autoimmune disorders, or symptoms like chronic diarrhea and weight loss. Early diagnosis can improve patient outcomes.",3.5528959103528046e-07,0.15673918835969358,0.18650793650793648,0.027201396971728103,0.25916891934808683,0.08264462809917357,0.02716202311429302,0.295924824796296,0.06353305785123965,3.552895910352811e-07,0.3343805241291702,0.043388429752066124
288,0.3,9,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. Risk groups include individuals with a family history of the disease, those with autoimmune disorders, and individuals with symptoms like chronic diarrhea or weight loss. Early detection and diagnosis can lead","Is screening for coeliac disease in risk groups justified? Yes, it is appropriate to screen those at risk, including individuals with family history, autoimmune diseases, or symptoms like chronic diarrhea or weight loss. Early detection is beneficial.",3.0791764556390986e-07,0.09958077451974523,0.18650793650793648,0.023574544042164344,0.20032841932515355,0.08264462809917357,0.023540420032387273,0.23530020297986054,0.06353305785123965,3.079176455639103e-07,0.2718601671478367,0.043388429752066124
288,0.3,10,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. Risk groups include individuals with a family history of the disease, those with autoimmune disorders, and individuals with symptoms like chronic diarrhea or weight loss. Early detection and diagnosis can lead","Is it reasonable to screen risk groups for coeliac disease? Yes, screening is justified for individuals with risk factors such as family history, autoimmune disorders, or symptoms like chronic diarrhea and weight loss. Early diagnosis supports better health management.",2.6054570009253926e-07,0.04551355324946904,0.18650793650793648,0.0199476911126006,0.14475856817034138,0.08264462809917357,0.019918816950481533,0.1781417891399122,0.06353305785123965,2.6054570009253947e-07,0.2130196671249034,0.043388429752066124
289,0.3,1,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Does family practice at residency teaching sites mirror community practice? The residency training locations of the Northeastern Ohio Universities College of Medicine offer patient care experiences comparable to those reported in a national survey of family and general practitioners.,4.73719454713706e-08,0.051293294387549704,0.0,0.0036268529295637453,0.05264373348541884,0.0,0.003621603081905733,0.05406722127027619,0.0,4.737194547137081e-08,0.055569851154812167,0.0
289,0.3,2,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Is family practice at residency teaching sites representative of community practice? Patient care opportunities at the Northeastern Ohio Universities College of Medicine residency sites align closely with those identified in a national survey of family and general practitioners.,7.10579182070559e-08,0.07796154146971057,0.0,0.005440279394345618,0.08004270767353416,0.0,0.0054324046228586,0.08223809823697303,0.0,7.105791820705622e-08,0.08455738802806367,0.0
289,0.3,3,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Do residency teaching sites for family practice reflect the nature of community practice? The Northeastern Ohio Universities College of Medicine residency training sites provide patient care opportunities similar to those found in a national survey of family and general practitioners.,2.36859727356853e-08,0.02531780798429173,0.0,0.0018134264647818726,0.025975486403257975,0.0,0.0018108015409528666,0.026668247082160867,0.0,2.3685972735685406e-08,0.02739897418811532,0.0
289,0.3,4,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Is the family practice at residency teaching sites consistent with community practice? Residency training sites at Northeastern Ohio Universities College of Medicine offer patient care experiences that resemble those in a national survey of family and general practitioners.,7.10579182070559e-08,0.07796154146971057,0.0,0.005440279394345618,0.08004270767353416,0.0,0.0054324046228586,0.08223809823697303,0.0,7.105791820705622e-08,0.08455738802806367,0.0
289,0.3,5,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Does family practice at residency teaching locations correspond to community practice? The residency training sites affiliated with Northeastern Ohio Universities College of Medicine deliver patient care opportunities akin to those in a national survey of family and general practitioners.,4.73719454713706e-08,0.051293294387549704,0.0,0.0036268529295637453,0.05264373348541884,0.0,0.003621603081905733,0.05406722127027619,0.0,4.737194547137081e-08,0.055569851154812167,0.0
289,0.3,6,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Are family practice residency teaching sites reflective of community practice? The patient care opportunities at Northeastern Ohio Universities College of Medicine residency sites are similar to those documented in a national survey of family and general practitioners.,9.47438909427412e-08,0.10536051565782589,0.0,0.0072537058591274906,0.10821358464023101,0.0,0.007243206163811473,0.11122563511022454,0.0,9.474389094274162e-08,0.11441035117774545,0.0
289,0.3,7,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Does family practice at residency training sites represent community practice? The residency sites of Northeastern Ohio Universities College of Medicine provide patient care opportunities comparable to those reported in a national survey of family and general practitioners.,9.47438909427412e-08,0.10536051565782589,0.0,0.0072537058591274906,0.10821358464023101,0.0,0.007243206163811473,0.11122563511022454,0.0,9.474389094274162e-08,0.11441035117774545,0.0
289,0.3,8,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Is family practice at residency teaching sites analogous to community practice? The residency training sites at Northeastern Ohio Universities College of Medicine offer patient care experiences that match those found in a national survey of family and general practitioners.,4.73719454713706e-08,0.051293294387549704,0.0,0.0036268529295637453,0.05264373348541884,0.0,0.003621603081905733,0.05406722127027619,0.0,4.737194547137081e-08,0.055569851154812167,0.0
289,0.3,9,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Do family practice residency teaching sites emulate community practice? Patient care opportunities at the Northeastern Ohio Universities College of Medicine residency training sites are similar to those identified in a national survey of family and general practitioners.,9.47438909427412e-08,0.10536051565782589,0.0,0.0072537058591274906,0.10821358464023101,0.0,0.007243206163811473,0.11122563511022454,0.0,9.474389094274162e-08,0.11441035117774545,0.0
289,0.3,10,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Does the family practice at residency teaching sites reflect the characteristics of community practice? The residency training sites of Northeastern Ohio Universities College of Medicine provide patient care opportunities that are consistent with those in a national survey of family and general practitioners.,4.737194547137081e-08,0.048790164169431716,0.0,0.0036268529295637453,0.05001042057466343,0.0,0.003621603081905733,0.051293294387549704,0.0,4.737194547137081e-08,0.05264373348541884,0.0
290,0.3,1,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending,Does end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants during their first week? There is a strong correlation and agreement between end-tidal CO2 and arterial CO2 in ELBW infants within the EtCO2 range of 30-50 mmHg. Monitoring end-tidal CO2 is useful for trending.,7.105791820705622e-08,0.009368836003363246,0.035646471505457446,0.005440279394345618,0.03344237944153461,0.019599999999999996,0.0054324046228586,0.06187540371808753,0.0,7.105791820705622e-08,0.06317890162153228,0.0
290,0.3,2,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending,"Is there a correlation between end-tidal carbon dioxide and arterial carbon dioxide in extremely low birth weight infants in their first week of life? Yes, end-tidal CO2 and arterial CO2 show good correlation and agreement in ELBW infants when EtCO2 is between 30-50 mmHg. End-tidal CO2 monitoring aids in trending.",7.105791820705622e-08,0.03766055765887133,0.0154248057130855,0.005440279394345618,0.03344237944153461,0.019599999999999996,0.0054324046228586,0.06187540371808753,0.0,7.105791820705622e-08,0.06317890162153228,0.0
290,0.3,3,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending,Does measuring end-tidal carbon dioxide correspond with arterial carbon dioxide levels in extremely low birth weight infants during the first week? There is a good correlation and agreement between end-tidal CO2 and arterial CO2 in ELBW infants within the 30-50 mmHg EtCO2 range. End-tidal CO2 monitoring helps in trending.,9.474389094274162e-08,0.0311669449417451,0.03480098718756563,0.0072537058591274906,0.05449578863936777,0.019599999999999996,0.007243206163811466,0.08338160893905089,0.0,9.474389094274162e-08,0.08515780834030728,0.0
290,0.3,4,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending,Is there a relationship between end-tidal carbon dioxide and arterial carbon dioxide in extremely low birth weight infants in their first week? End-tidal CO2 and arterial CO2 correlate well and agree in ELBW infants when EtCO2 ranges from 30 to 50 mmHg. Monitoring end-tidal CO2 can assist in trending.,9.474389094274162e-08,0.06004807746507623,0.014166666666666675,0.0072537058591274906,0.05449578863936777,0.019599999999999996,0.007243206163811466,0.08338160893905089,0.0,9.474389094274162e-08,0.08515780834030728,0.0
290,0.3,5,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending,Does end-tidal CO2 measurement align with arterial CO2 in extremely low birth weight infants during the first week of life? There is good correlation and agreement between end-tidal and arterial CO2 in ELBW infants in the 30-50 mmHg EtCO2 range. End-tidal CO2 monitoring is helpful for trending.,1.4211583641411244e-07,0.10637479612604661,0.011488942972177132,0.010880558788691236,0.12878744193732583,0.0026107438016528955,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
290,0.3,6,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending,Is end-tidal carbon dioxide measurement consistent with arterial carbon dioxide in extremely low birth weight infants in the first week? End-tidal CO2 correlates well with arterial CO2 in ELBW infants within the EtCO2 range of 30-50 mmHg. End-tidal CO2 monitoring is useful for trending.,2.1317375462116866e-07,0.1801237863503351,0.007013888888888889,0.016320838183036854,0.1669737720660578,0.019599999999999996,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
290,0.3,7,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending,Does end-tidal CO2 correlate with arterial CO2 in extremely low birth weight infants during their first week? There is strong agreement and correlation between end-tidal and arterial CO2 in ELBW infants when EtCO2 is between 30 and 50 mmHg. Monitoring end-tidal CO2 can help with trending.,1.6580180914979784e-07,0.1303628251073139,0.010062358276643993,0.012693985253473108,0.15196044645661644,0.003114981070849114,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
290,0.3,8,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending,"Is there a correlation between end-tidal and arterial carbon dioxide in extremely low birth weight infants in the first week of life? Yes, end-tidal CO2 and arterial CO2 show good agreement and correlation in ELBW infants within the 30-50 mmHg EtCO2 range. End-tidal CO2 monitoring assists in trending.",1.1842986367842703e-07,0.0534493385022734,0.03391975308641975,0.009067132323909363,0.07600199386033113,0.019599999999999996,0.009054007704764333,0.10536051565782589,0.0,1.1842986367842703e-07,0.107630664192365,0.0
290,0.3,9,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending,Does end-tidal carbon dioxide measurement correspond to arterial carbon dioxide in extremely low birth weight infants during the first week? There is a good correlation and agreement between end-tidal and arterial CO2 in ELBW infants in the EtCO2 range of 30-50 mmHg. End-tidal CO2 monitoring is beneficial for trending.,9.474389094274162e-08,0.0022858124184139683,0.0555649866706906,0.0072537058591274906,0.05449578863936777,0.019599999999999996,0.007243206163811466,0.08338160893905089,0.0,9.474389094274162e-08,0.08515780834030728,0.0
290,0.3,10,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending,Is end-tidal CO2 measurement correlated with arterial CO2 in extremely low birth weight infants in their first week? End-tidal CO2 and arterial CO2 have good correlation and agreement in ELBW infants when EtCO2 ranges from 30 to 50 mmHg. Monitoring end-tidal CO2 can be helpful for trending.,1.4211583641411244e-07,0.11774975577310176,0.035022684934799625,0.010880558788691236,0.09798090057910613,0.019599999999999996,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
291,0.3,1,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment can provide valuable information for predicting IVF outcome. Although age and FSH levels are important factors, antral follicle count can offer additional insight into a woman's ovarian reserve and potential response to treatment, making it a potentially better predictor.","Is antral follicle assessment a superior predictor of IVF outcomes compared to age and FSH? Antral follicle count offers valuable insights into ovarian reserve and treatment response, potentially outperforming age and FSH as predictors.",6.86893209334876e-07,0.5720476586386782,0.07102375289345711,0.05258936747867433,0.6224118243060448,0.016388888888888897,0.05251324468763316,0.6603573577369528,0.0,6.868932093348768e-07,0.6763400622435638,0.0
291,0.3,2,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment can provide valuable information for predicting IVF outcome. Although age and FSH levels are important factors, antral follicle count can offer additional insight into a woman's ovarian reserve and potential response to treatment, making it a potentially better predictor.","Can antral follicle assessment better predict IVF success than age and FSH levels? While age and FSH are important, antral follicle count provides additional information on ovarian reserve, making it a potentially stronger predictor.",6.86893209334876e-07,0.614056578672614,0.041377551020408146,0.05258936747867433,0.6657335230910424,0.014828592900913408,0.05251324468763316,0.6603573577369528,0.0,6.868932093348768e-07,0.6763400622435638,0.0
291,0.3,3,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment can provide valuable information for predicting IVF outcome. Although age and FSH levels are important factors, antral follicle count can offer additional insight into a woman's ovarian reserve and potential response to treatment, making it a potentially better predictor.","Does assessing antral follicles predict IVF results more effectively than age and FSH? Antral follicle count gives extra insight into ovarian reserve and treatment response, possibly making it a better predictor.",7.579511275419319e-07,0.5833399983751311,0.13137755102040818,0.058029646873019966,0.7208518971192981,0.016388888888888897,0.05794564931049178,0.7621400520468953,0.0,7.57951127541933e-07,0.7817005779013892,0.0
291,0.3,4,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment can provide valuable information for predicting IVF outcome. Although age and FSH levels are important factors, antral follicle count can offer additional insight into a woman's ovarian reserve and potential response to treatment, making it a potentially better predictor.","Is antral follicle count a more reliable predictor of IVF outcomes than age and FSH? It offers valuable data on ovarian reserve and potential treatment response, which may surpass age and FSH in predictive value.",6.632072365991907e-07,0.4989502189834738,0.10199279436292424,0.05077594101389245,0.5916401656392911,0.016388888888888897,0.050702443146680286,0.628608659422373,0.0,6.632072365991914e-07,0.6435502394205721,0.0
291,0.3,5,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment can provide valuable information for predicting IVF outcome. Although age and FSH levels are important factors, antral follicle count can offer additional insight into a woman's ovarian reserve and potential response to treatment, making it a potentially better predictor.","Can antral follicle assessment outperform age and FSH in predicting IVF outcomes? It provides crucial information about ovarian reserve and response to treatment, potentially making it a better predictor.",8.053230730133025e-07,0.6523328698620818,0.13137755102040818,0.061656499802583725,0.7923108611014418,0.016388888888888897,0.06156725239239753,0.836248024200617,0.0,8.053230730133038e-07,0.8586616190375187,0.0
291,0.3,6,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment can provide valuable information for predicting IVF outcome. Although age and FSH levels are important factors, antral follicle count can offer additional insight into a woman's ovarian reserve and potential response to treatment, making it a potentially better predictor.","Is antral follicle evaluation a better tool for forecasting IVF success than age and FSH? It adds important insight into ovarian reserve and treatment responsiveness, possibly making it a superior predictor.",7.579511275419319e-07,0.5833399983751311,0.13137755102040818,0.058029646873019966,0.7208518971192981,0.016388888888888897,0.05794564931049178,0.7621400520468953,0.0,7.57951127541933e-07,0.7817005779013892,0.0
291,0.3,7,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment can provide valuable information for predicting IVF outcome. Although age and FSH levels are important factors, antral follicle count can offer additional insight into a woman's ovarian reserve and potential response to treatment, making it a potentially better predictor.","Does antral follicle count serve as a more effective predictor of IVF outcomes compared to age and FSH? It offers additional understanding of ovarian reserve and treatment response, potentially enhancing prediction accuracy.",7.342651548062466e-07,0.5505501755521394,0.13137755102040818,0.056216220408238086,0.6869503454436163,0.016388888888888897,0.056134847769538906,0.7270487322356263,0.0,7.342651548062476e-07,0.7453329337305146,0.0
291,0.3,8,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment can provide valuable information for predicting IVF outcome. Although age and FSH levels are important factors, antral follicle count can offer additional insight into a woman's ovarian reserve and potential response to treatment, making it a potentially better predictor.","Is antral follicle assessment more predictive of IVF outcomes than age and FSH? It provides valuable information on ovarian reserve and treatment response, which might make it a better predictor.",7.816371002776172e-07,0.6172415500508128,0.13137755102040818,0.059843073337801846,0.7559432169305671,0.016388888888888897,0.059756450851444654,0.79850769621777,0.0,7.816371002776184e-07,0.8194409058842362,0.0
291,0.3,9,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment can provide valuable information for predicting IVF outcome. Although age and FSH levels are important factors, antral follicle count can offer additional insight into a woman's ovarian reserve and potential response to treatment, making it a potentially better predictor.","Can antral follicle count provide better prediction of IVF success than age and FSH? It supplies extra insight into ovarian reserve and potential treatment response, possibly making it a superior predictor.",7.579511275419319e-07,0.5833399983751311,0.13137755102040818,0.058029646873019966,0.7208518971192981,0.016388888888888897,0.05794564931049178,0.7621400520468953,0.0,7.57951127541933e-07,0.7817005779013892,0.0
291,0.3,10,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment can provide valuable information for predicting IVF outcome. Although age and FSH levels are important factors, antral follicle count can offer additional insight into a woman's ovarian reserve and potential response to treatment, making it a potentially better predictor.","Is antral follicle assessment a more accurate predictor of IVF outcomes than age and FSH? It offers additional valuable information about ovarian reserve and treatment response, potentially making it a better predictor.",7.342651548062466e-07,0.5505501755521394,0.13137755102040818,0.056216220408238086,0.6869503454436163,0.016388888888888897,0.056134847769538906,0.7270487322356263,0.0,7.342651548062476e-07,0.7453329337305146,0.0
292,0.3,1,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Is primary angioplasty a suitable alternative to thrombolysis? Patients and their carers found the reorganization of care to provide a primary angioplasty service acceptable. Satisfaction was generally high across all care types, except for discharge and aftercare.",1.6580180914979742e-07,0.15171054644127846,0.018645849773579876,0.012693985253473108,0.18232155679395445,0.0,0.012675610786670073,0.18721154208814594,0.0,1.6580180914979784e-07,0.19237189264745602,0.0
292,0.3,2,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Can primary angioplasty replace thrombolysis effectively? The restructuring of care to include primary angioplasty was well accepted by patients and carers. Satisfaction remained high regardless of care type, except in areas of discharge and aftercare.",2.1317375462116802e-07,0.25190751070815187,0.012192798185603794,0.016320838183036868,0.24116205681688774,0.0,0.01629721386857582,0.2478361639045814,0.0,2.1317375462116866e-07,0.25489224962878954,0.0
292,0.3,3,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.",Is it acceptable to use primary angioplasty instead of thrombolysis? Patients and carers accepted the care reorganization to offer primary angioplasty. Satisfaction levels were high for all care types except for discharge and aftercare.,2.3685972735685332e-07,0.20021374673313375,0.046400951814396206,0.018134264647818747,0.2719337154836414,0.0,0.018108015409528694,0.27958486221916123,0.0,2.3685972735685406e-07,0.28768207245178123,0.0
292,0.3,4,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Does primary angioplasty serve as an acceptable alternative to thrombolysis? Care reorganization to provide primary angioplasty was welcomed by patients and carers. High satisfaction was noted across care types, except for discharge and aftercare.",2.3685972735685332e-07,0.2422226667670695,0.016127514314396206,0.018134264647818747,0.2719337154836414,0.0,0.018108015409528694,0.27958486221916123,0.0,2.3685972735685406e-07,0.28768207245178123,0.0
292,0.3,5,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Is primary angioplasty an acceptable substitute for thrombolysis? Patients and carers accepted the restructured care offering primary angioplasty. Satisfaction was high regardless of care type, with the exception of discharge and aftercare.",2.842316728282239e-07,0.26273410371446726,0.046400951814396206,0.021761117577382506,0.33647223662121295,0.0,0.02172961849143444,0.3462762367178347,0.0,2.8423167282822487e-07,0.356674943938732,0.0
292,0.3,6,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Can primary angioplasty be considered an acceptable alternative to thrombolysis? The reorganization of care to provide primary angioplasty was accepted by patients and carers. Satisfaction levels were high across different care types, except for discharge and aftercare.",1.6580180914979742e-07,0.15171054644127846,0.018645849773579876,0.012693985253473108,0.18232155679395445,0.0,0.012675610786670073,0.18721154208814594,0.0,1.6580180914979784e-07,0.19237189264745602,0.0
292,0.3,7,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Is the use of primary angioplasty an acceptable alternative to thrombolysis? Patients and carers found the reorganization of care to include primary angioplasty acceptable. Satisfaction was generally high, except in discharge and aftercare.",2.605457000925386e-07,0.274307104184885,0.0151834700245939,0.019947691112600627,0.30368241379822125,0.0,0.019918816950481567,0.31237468504215293,0.0,2.6054570009253947e-07,0.321583624127463,0.0
292,0.3,8,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Is primary angioplasty a viable alternative to thrombolysis? Patients and carers accepted the care reorganization to offer primary angioplasty services. Satisfaction levels were high regardless of care type, except for discharge and aftercare.",2.605457000925386e-07,0.274307104184885,0.0151834700245939,0.019947691112600627,0.30368241379822125,0.0,0.019918816950481567,0.31237468504215293,0.0,2.6054570009253947e-07,0.321583624127463,0.0
292,0.3,9,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Is primary angioplasty an appropriate alternative to thrombolysis? The reorganization of care to provide primary angioplasty was well accepted by patients and carers. Satisfaction remained high across care types, except for discharge and aftercare.",2.3685972735685332e-07,0.2422226667670695,0.016127514314396206,0.018134264647818747,0.2719337154836414,0.0,0.018108015409528694,0.27958486221916123,0.0,2.3685972735685406e-07,0.28768207245178123,0.0
292,0.3,10,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Is primary angioplasty an acceptable option instead of thrombolysis? Patients and their carers accepted the reorganization of care to offer primary angioplasty. Satisfaction was high across care types, except for discharge and aftercare.",2.605457000925386e-07,0.23098540539988743,0.046400951814396206,0.019947691112600627,0.30368241379822125,0.0,0.019918816950481567,0.31237468504215293,0.0,2.6054570009253947e-07,0.321583624127463,0.0
293,0.3,1,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Lower fasting plasma glucose levels at diagnosis of type 2 diabetes are associated with improved outcomes, as they indicate better glycemic control and reduced risk of complications. Maintaining lower glucose levels through appropriate management strategies can lead to better long-term health outcomes for patients with type 2","Are reduced fasting plasma glucose levels at the time of type 2 diabetes diagnosis linked to better health outcomes? Lower fasting plasma glucose levels when type 2 diabetes is diagnosed correlate with improved outcomes, reflecting superior glycemic control and a decreased risk of complications. Effective management to maintain these lower glucose levels can enhance long-term health for type 2 diabetes patients.",9.474389094274162e-08,0.04406321951250014,0.03603786982248516,0.0072537058591274906,0.05159477051428141,0.049277734789887284,0.007243206163811466,0.08828369034287364,0.1089642017106878,9.474389094274162e-08,0.09126036313401453,0.11282578875171474
293,0.3,2,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Lower fasting plasma glucose levels at diagnosis of type 2 diabetes are associated with improved outcomes, as they indicate better glycemic control and reduced risk of complications. Maintaining lower glucose levels through appropriate management strategies can lead to better long-term health outcomes for patients with type 2","Do lower fasting plasma glucose levels at type 2 diabetes diagnosis predict better outcomes? Patients diagnosed with type 2 diabetes who have lower fasting plasma glucose levels tend to experience improved outcomes, as this suggests better glycemic control and fewer complications. Proper management to keep glucose levels low can improve long-term health results.",2.8423167282822487e-07,0.08471498170608305,0.10579753086419752,0.02176111757738247,0.09999133917952463,0.07521610112744702,0.0217296184914344,0.09168646230433541,0.08626971879286692,2.8423167282822487e-07,0.08826232824541691,0.09242648319615919
293,0.3,3,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Lower fasting plasma glucose levels at diagnosis of type 2 diabetes are associated with improved outcomes, as they indicate better glycemic control and reduced risk of complications. Maintaining lower glucose levels through appropriate management strategies can lead to better long-term health outcomes for patients with type 2","Is there an association between lower fasting plasma glucose levels at type 2 diabetes diagnosis and improved patient outcomes? Lower fasting plasma glucose at diagnosis is linked to better outcomes, indicating more effective glycemic control and a reduced chance of complications. Maintaining these levels through appropriate treatment can lead to better long-term health.",2.8423167282822487e-07,0.005326003430920601,0.20521111111111107,0.02176111757738247,0.04562685442972425,0.1139290336632906,0.0217296184914344,0.06396057508193786,0.10620860421097975,2.8423167282822487e-07,0.059970606589908826,0.11282578875171474
293,0.3,4,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Lower fasting plasma glucose levels at diagnosis of type 2 diabetes are associated with improved outcomes, as they indicate better glycemic control and reduced risk of complications. Maintaining lower glucose levels through appropriate management strategies can lead to better long-term health outcomes for patients with type 2","Are improved outcomes connected to lower fasting plasma glucose levels at the diagnosis of type 2 diabetes? Yes, lower fasting plasma glucose levels at diagnosis are associated with better outcomes, as they reflect improved glycemic control and a lower risk of complications. Managing glucose levels effectively can promote better long-term health in type 2 diabetes patients.",2.1317375462116866e-07,0.01789756889601568,0.11536736111111107,0.016320838183036854,0.03679242703404162,0.07947938768244932,0.0162972138685758,0.056435271874426096,0.06980027434842245,2.1317375462116866e-07,0.05386620000833453,0.07442578875171474
293,0.3,5,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Lower fasting plasma glucose levels at diagnosis of type 2 diabetes are associated with improved outcomes, as they indicate better glycemic control and reduced risk of complications. Maintaining lower glucose levels through appropriate management strategies can lead to better long-term health outcomes for patients with type 2","Does having lower fasting plasma glucose at the time of type 2 diabetes diagnosis relate to improved outcomes? Lower fasting plasma glucose levels at diagnosis are related to improved outcomes, signifying better glycemic control and decreased complication risks. Maintaining these levels with suitable management strategies supports better long-term health.",3.789755637709665e-07,0.08360320655748676,0.1989553719008264,0.029014823436509962,0.13193165010354901,0.11061025187998016,0.028972824655245866,0.1497531307359794,0.10447187928669409,3.789755637709665e-07,0.1451284149302161,0.11282578875171474
293,0.3,6,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Lower fasting plasma glucose levels at diagnosis of type 2 diabetes are associated with improved outcomes, as they indicate better glycemic control and reduced risk of complications. Maintaining lower glucose levels through appropriate management strategies can lead to better long-term health outcomes for patients with type 2","Are better outcomes observed in type 2 diabetes patients with lower fasting plasma glucose at diagnosis? Yes, lower fasting plasma glucose levels at diagnosis are linked to improved outcomes, indicating enhanced glycemic control and reduced complication risks. Appropriate management to sustain these levels can lead to improved long-term health.",3.789755637709665e-07,0.08360320655748676,0.1989553719008264,0.029014823436509962,0.13193165010354901,0.11061025187998016,0.028972824655245866,0.1497531307359794,0.10447187928669409,3.789755637709665e-07,0.1451284149302161,0.11282578875171474
293,0.3,7,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Lower fasting plasma glucose levels at diagnosis of type 2 diabetes are associated with improved outcomes, as they indicate better glycemic control and reduced risk of complications. Maintaining lower glucose levels through appropriate management strategies can lead to better long-term health outcomes for patients with type 2","Is there a link between lower fasting plasma glucose levels at type 2 diabetes diagnosis and better health outcomes? Lower fasting plasma glucose at diagnosis correlates with improved outcomes, reflecting superior glycemic control and a lower likelihood of complications. Maintaining these levels through effective management can improve long-term health.",3.789755637709665e-07,0.05472207403415563,0.21937777777777773,0.029014823436509962,0.13193165010354901,0.11061025187998016,0.028972824655245866,0.1497531307359794,0.10447187928669409,3.789755637709665e-07,0.1451284149302161,0.11282578875171474
293,0.3,8,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Lower fasting plasma glucose levels at diagnosis of type 2 diabetes are associated with improved outcomes, as they indicate better glycemic control and reduced risk of complications. Maintaining lower glucose levels through appropriate management strategies can lead to better long-term health outcomes for patients with type 2","Do lower fasting plasma glucose levels at the diagnosis of type 2 diabetes indicate better outcomes? Lower fasting plasma glucose levels at diagnosis are associated with better outcomes, as they suggest improved glycemic control and reduced risk of complications. Proper management to keep glucose levels low can enhance long-term health.",3.552895910352811e-07,0.12788825274069016,0.11502347214710654,0.02720139697172809,0.16741152158968298,0.07043475958327575,0.027162023114293,0.18659696569166284,0.06266721649718283,3.552895910352811e-07,0.18342317608621883,0.06943735899964862
293,0.3,9,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Lower fasting plasma glucose levels at diagnosis of type 2 diabetes are associated with improved outcomes, as they indicate better glycemic control and reduced risk of complications. Maintaining lower glucose levels through appropriate management strategies can lead to better long-term health outcomes for patients with type 2","Are improved health outcomes associated with lower fasting plasma glucose levels at type 2 diabetes diagnosis? Yes, lower fasting plasma glucose levels at diagnosis are linked to better outcomes, indicating better glycemic control and fewer complications. Maintaining these levels through appropriate treatment can result in better long-term health.",4.026615365066519e-07,0.13661020918538824,0.17672471655328792,0.030828249901291835,0.21499394166471086,0.06691158722893455,0.030783626196198732,0.23401482759202485,0.0598737437361776,4.026615365066519e-07,0.23061465083317856,0.06747431482881225
293,0.3,10,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Lower fasting plasma glucose levels at diagnosis of type 2 diabetes are associated with improved outcomes, as they indicate better glycemic control and reduced risk of complications. Maintaining lower glucose levels through appropriate management strategies can lead to better long-term health outcomes for patients with type 2","Is there an association between improved outcomes and lower fasting plasma glucose levels at type 2 diabetes diagnosis? Lower fasting plasma glucose levels at diagnosis are connected to improved outcomes, reflecting better glycemic control and a decreased risk of complications. Effective management to maintain these levels can lead to better long-term health outcomes.",2.8423167282822487e-07,0.021333503513691898,0.18653435943865998,0.02176111757738247,0.09999133917952463,0.07521610112744702,0.0217296184914344,0.11941234952673296,0.06644472885272305,2.8423167282822487e-07,0.11655404990092455,0.0720833713682833
294,0.3,1,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position.","Does the position of the head affect anterior chamber depth in pseudoexfoliation syndrome? In patients with clinically evident unilateral pseudoexfoliation, the lens appears more mobile in the affected eye, causing a shallower anterior chamber when the head is prone.",1.6580180914979763e-07,0.1804261084390668,0.008120839426049457,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
294,0.3,2,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position.","Is anterior chamber depth influenced by head positioning in pseudoexfoliation syndrome? In cases of clinically obvious unilateral pseudoexfoliation, the lens is more mobile in the affected eye, leading to a shallower anterior chamber in the prone position.",2.1317375462116823e-07,0.23854682199331956,0.011015025422888292,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
294,0.3,3,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position.","Does head posture impact anterior chamber depth in pseudoexfoliation syndrome? Patients with clinically apparent unilateral pseudoexfoliation show increased lens mobility in the affected eye, resulting in a shallower anterior chamber when lying prone.",3.0791764556390943e-07,0.3226352030391513,0.013130814586617377,0.023574544042164372,0.3502024294331152,0.0,0.0235404200323873,0.36000273403140737,0.0,3.079176455639103e-07,0.3703737882968947,0.0
294,0.3,4,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position.","Can head positioning change anterior chamber depth in pseudoexfoliation syndrome? In patients with unilateral pseudoexfoliation, the lens tends to be more mobile in the affected eye, causing the anterior chamber to become shallower when the head is prone.",1.8948778188548293e-07,0.17159890957505697,0.017342123536913518,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
294,0.3,5,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position.","Is anterior chamber depth altered by head position in pseudoexfoliation syndrome? The lens in the affected eye of patients with unilateral pseudoexfoliation is more mobile, which leads to a shallower anterior chamber when the head is placed prone.",1.8948778188548293e-07,0.17159890957505697,0.017342123536913518,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
294,0.3,6,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position.","Does the anterior chamber depth vary with head positioning in pseudoexfoliation syndrome? In unilateral pseudoexfoliation patients, the affected eye's lens shows increased mobility, resulting in a shallower anterior chamber in the prone position.",3.0791764556390943e-07,0.3226352030391513,0.013130814586617377,0.023574544042164372,0.3502024294331152,0.0,0.0235404200323873,0.36000273403140737,0.0,3.079176455639103e-07,0.3703737882968947,0.0
294,0.3,7,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position.","How does head positioning affect anterior chamber depth in pseudoexfoliation syndrome? The lens in the affected eye of patients with unilateral pseudoexfoliation is more mobile, causing a shallower anterior chamber when the head is prone.",2.6054570009253883e-07,0.25946224600006795,0.014963539718935746,0.019947691112600613,0.2876820724517817,0.0,0.019918816950481553,0.29546421289383584,0.0,2.6054570009253947e-07,0.30368241379822125,0.0
294,0.3,8,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position.","Does head placement influence anterior chamber depth in pseudoexfoliation syndrome? In clinically apparent unilateral pseudoexfoliation, the lens is more mobile in the affected eye, leading to a shallower anterior chamber with the head prone.",2.8423167282822413e-07,0.29055076562133575,0.014074858876419682,0.021761117577382492,0.31845373111853537,0.0,0.021729618491434427,0.32721291120841567,0.0,2.8423167282822487e-07,0.33647223662121295,0.0
294,0.3,9,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position.","Is the anterior chamber depth influenced by head position in pseudoexfoliation syndrome? Patients with unilateral pseudoexfoliation have a more mobile lens in the affected eye, resulting in a shallower anterior chamber when the head is prone.",2.3685972735685353e-07,0.22930975588217795,0.015801583573651523,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
294,0.3,10,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position.","Does head orientation affect anterior chamber depth in pseudoexfoliation syndrome? The lens in the affected eye of patients with unilateral pseudoexfoliation is more mobile, causing a shallower anterior chamber when the head is in a prone position.",2.1317375462116823e-07,0.20003864529554471,0.016593194335603353,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
295,0.3,1,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: There is limited research on the specific impact of automatic transmission on driving behavior in older drivers. However, it is generally believed that automatic transmission","Question: Does automatic transmission enhance driving behavior in elderly drivers? Answer: Research on the effect of automatic transmission on older drivers' behavior is limited, but it is commonly thought that automatic transmission",9.47438909427412e-08,0.014686176709213683,0.07238076364116786,0.007253705859127518,0.04361641582930709,0.05859375,0.007243206163811494,0.08720281144607123,0.0302734375,9.474389094274162e-08,0.1335313926245223,0.0
295,0.3,2,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: There is limited research on the specific impact of automatic transmission on driving behavior in older drivers. However, it is generally believed that automatic transmission","Question: Can automatic transmission improve the driving habits of senior drivers? Answer: There is scarce research regarding the influence of automatic transmission on the driving behavior of older adults, though it is widely assumed that automatic transmission",2.36859727356853e-08,0.11110367476650351,0.06230486685032138,0.0018134264647818796,0.11053426399795141,0.05859375,0.0018108015409528735,0.07186188318361753,0.0302734375,2.3685972735685406e-08,0.030771658666753687,0.0
295,0.3,3,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: There is limited research on the specific impact of automatic transmission on driving behavior in older drivers. However, it is generally believed that automatic transmission","Question: Does using automatic transmission positively affect driving behavior in older individuals? Answer: Limited studies exist on how automatic transmission impacts older drivers' behavior, yet it is generally accepted that automatic transmission",9.47438909427412e-08,0.014686176709213683,0.07238076364116786,0.007253705859127518,0.04361641582930709,0.05859375,0.007243206163811494,0.08720281144607123,0.0302734375,9.474389094274162e-08,0.1335313926245223,0.0
295,0.3,4,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: There is limited research on the specific impact of automatic transmission on driving behavior in older drivers. However, it is generally believed that automatic transmission","Question: Is driving behavior in elderly drivers better with automatic transmission? Answer: While research is limited on the specific effects of automatic transmission on older drivers, it is generally believed that automatic transmission",7.10579182070559e-08,0.08005814107857256,0.17433807376575325,0.005440279394345639,0.010826593006315388,0.05859375,0.005432404622858621,0.053301259770389464,0.0302734375,7.105791820705622e-08,0.09844007281325329,0.0
295,0.3,5,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: There is limited research on the specific impact of automatic transmission on driving behavior in older drivers. However, it is generally believed that automatic transmission","Question: Does automatic transmission contribute to improved driving behavior among older drivers? Answer: There is a lack of extensive research on this topic, but automatic transmission is generally considered beneficial for older drivers' behavior",4.73719454713706e-08,0.11214257849638809,0.17528211805555555,0.003626852929563759,0.020922105308264438,0.05859375,0.003621603081905747,0.020511436947397765,0.0302734375,4.737194547137081e-08,0.06453852113757153,0.0
295,0.3,6,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: There is limited research on the specific impact of automatic transmission on driving behavior in older drivers. However, it is generally believed that automatic transmission","Question: Can automatic transmission lead to better driving behavior in senior drivers? Answer: Although research is limited on the precise impact, automatic transmission is commonly thought to improve driving behavior in older drivers",7.10579182070559e-08,0.006585256491420832,0.1128088254723213,0.005440279394345639,0.0555457659456664,0.0263715277777778,0.005432404622858621,0.053301259770389464,0.0302734375,7.105791820705622e-08,0.09844007281325329,0.0
295,0.3,7,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: There is limited research on the specific impact of automatic transmission on driving behavior in older drivers. However, it is generally believed that automatic transmission","Question: Does the use of automatic transmission affect driving behavior in older adults? Answer: Limited research exists on this subject, but it is generally believed that automatic transmission has a positive effect",9.47438909427412e-08,0.04691196860963931,0.17333333333333334,0.007253705859127518,0.04361641582930709,0.05859375,0.007243206163811494,0.08720281144607123,0.0302734375,9.474389094274162e-08,0.1335313926245223,0.0
295,0.3,8,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: There is limited research on the specific impact of automatic transmission on driving behavior in older drivers. However, it is generally believed that automatic transmission","Question: Is there an improvement in older drivers' behavior with automatic transmission? Answer: Research on this is limited, but it is widely believed that automatic transmission aids driving behavior in older adults",9.47438909427412e-08,0.04691196860963931,0.17333333333333334,0.007253705859127518,0.04361641582930709,0.05859375,0.007243206163811494,0.08720281144607123,0.0302734375,9.474389094274162e-08,0.1335313926245223,0.0
295,0.3,9,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: There is limited research on the specific impact of automatic transmission on driving behavior in older drivers. However, it is generally believed that automatic transmission","Question: Does automatic transmission influence driving behavior in elderly drivers? Answer: There is little research on its specific impact, but automatic transmission is generally thought to improve driving behavior",1.658018091497971e-07,0.10917257855523088,0.1345496383957922,0.012693985253473157,0.14897693148713254,0.05859375,0.012675610786670115,0.1964021034110619,0.0302734375,1.6580180914979784e-07,0.24686007793152642,0.0
295,0.3,10,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: There is limited research on the specific impact of automatic transmission on driving behavior in older drivers. However, it is generally believed that automatic transmission","Question: Does automatic transmission help improve driving behavior in older drivers? Answer: Although research is scarce, it is generally believed that automatic transmission benefits driving behavior in older adults",1.658018091497971e-07,0.20819360434950873,0.06666666666666668,0.012693985253473157,0.2516654026811991,0.015006249999999985,0.012675610786670115,0.24972111730028868,0.00812656250000001,1.6580180914979784e-07,0.24686007793152642,0.0
296,0.3,1,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Does the use of provider service networks lead to reduced costs compared to HMOs or primary care case management within Florida's Medicaid program? The Medicaid Demonstration in Florida seems to lower PMPM costs. Demonstration PSNs achieved marginally higher expenditure reductions than Demonstration HMOs. PSNs seem to be an effective model for providing care to Medicaid beneficiaries.,7.105791820705622e-08,0.018595055433633156,0.05157024793388431,0.005440279394345618,0.029746267566417295,0.017538265306122455,0.0054324046228586,0.05505977718302857,0.0,7.105791820705622e-08,0.056089466651043196,0.0
296,0.3,2,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Are provider service networks associated with lower spending than HMOs or primary care case management in Florida's Medicaid program? Florida's Medicaid Demonstration shows a decrease in PMPM expenditures. Demonstration PSNs produced slightly greater cost savings than Demonstration HMOs. PSNs appear to offer a promising approach for Medicaid care delivery.,2.3685972735685406e-07,0.14641825141427756,0.030746345715686026,0.018134264647818726,0.16858271242063472,0.017538265306122455,0.018108015409528666,0.19671029424605502,0.0,2.3685972735685406e-07,0.20067069546215155,0.0
296,0.3,3,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Do provider service networks reduce expenditures more than HMOs or primary care case management in Florida's Medicaid program? The Medicaid Demonstration in Florida results in lower PMPM costs. Demonstration PSNs yielded somewhat larger expenditure reductions compared to Demonstration HMOs. PSNs seem to be a viable model for Medicaid care provision.,2.1317375462116866e-07,0.09691783168821111,0.05157024793388431,0.016320838183036854,0.14752930322280156,0.017538265306122455,0.0162972138685758,0.17520408902509166,0.0,2.1317375462116866e-07,0.17869178874337655,0.0
296,0.3,4,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Is there a reduction in expenditures with provider service networks compared to HMOs or primary care case management in Florida's Medicaid program? The Medicaid Demonstration in Florida shows lower PMPM expenditures. Demonstration PSNs led to slightly greater spending reductions than Demonstration HMOs. PSNs appear to be a promising care delivery model for Medicaid enrollees.,1.1842986367842703e-07,0.01844621624671694,0.05157024793388431,0.009067132323909363,0.06748659554926473,0.017538265306122455,0.009054007704764333,0.09352605801082436,0.0,1.1842986367842703e-07,0.09531017980432566,0.0
296,0.3,5,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Do provider service networks lead to lower costs than HMOs or primary care case management in Florida's Medicaid program? Florida's Medicaid Demonstration appears to reduce PMPM expenditures. Demonstration PSNs achieved marginally better expenditure reductions than Demonstration HMOs. PSNs seem to be an effective model for delivering care to Medicaid recipients.,2.1317375462116866e-07,0.1252095533437192,0.031170942378328754,0.016320838183036854,0.14752930322280156,0.017538265306122455,0.0162972138685758,0.17520408902509166,0.0,2.1317375462116866e-07,0.17869178874337655,0.0
296,0.3,6,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Are expenditures lower with provider service networks compared to HMOs or primary care case management in Florida's Medicaid program? The Medicaid Demonstration in Florida results in decreased PMPM costs. Demonstration PSNs generated slightly greater reductions in spending than Demonstration HMOs. PSNs appear to be a promising model for Medicaid care delivery.,1.8948778188548325e-07,0.0767151243706925,0.05157024793388431,0.014507411718254981,0.1269100160200658,0.017538265306122455,0.014486412327622933,0.1541506798272585,0.0,1.8948778188548325e-07,0.15718558352241319,0.0
296,0.3,7,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Do provider service networks result in cost savings compared to HMOs or primary care case management in Florida's Medicaid program? The Medicaid Demonstration in Florida shows lower PMPM expenditures. Demonstration PSNs produced somewhat greater expenditure reductions than Demonstration HMOs. PSNs seem to be a promising approach for Medicaid care provision.,2.1317375462116866e-07,0.09691783168821111,0.05157024793388431,0.016320838183036854,0.14752930322280156,0.017538265306122455,0.0162972138685758,0.17520408902509166,0.0,2.1317375462116866e-07,0.17869178874337655,0.0
296,0.3,8,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Is expenditure lower with provider service networks relative to HMOs or primary care case management in Florida's Medicaid program? The Medicaid Demonstration in Florida appears to reduce PMPM costs. Demonstration PSNs led to slightly larger reductions in expenditures than Demonstration HMOs. PSNs appear to be an effective model for delivering care to Medicaid enrollees.,1.1842986367842703e-07,0.01844621624671694,0.05157024793388431,0.009067132323909363,0.06748659554926473,0.017538265306122455,0.009054007704764333,0.09352605801082436,0.0,1.1842986367842703e-07,0.09531017980432566,0.0
296,0.3,9,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Do provider service networks achieve lower expenditures compared to HMOs or primary care case management in Florida's Medicaid program? The Medicaid Demonstration in Florida results in reduced PMPM expenditures. Demonstration PSNs generated marginally greater cost reductions than Demonstration HMOs. PSNs seem to be a promising model for Medicaid care delivery.,2.1317375462116866e-07,0.09691783168821111,0.05157024793388431,0.016320838183036854,0.14752930322280156,0.017538265306122455,0.0162972138685758,0.17520408902509166,0.0,2.1317375462116866e-07,0.17869178874337655,0.0
296,0.3,10,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Are provider service networks associated with decreased expenditures compared to HMOs or primary care case management in Florida's Medicaid program? The Medicaid Demonstration in Florida appears to lower PMPM costs. Demonstration PSNs achieved slightly greater expenditure reductions than Demonstration HMOs. PSNs seem to be a promising model for providing care to Medicaid enrollees.,1.4211583641411244e-07,0.03749441121741004,0.05157024793388431,0.010880558788691236,0.08690468140636742,0.017538265306122455,0.0108648092457172,0.11332868530700413,0.0,1.4211583641411244e-07,0.11551288712184427,0.0
297,0.3,1,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this","Question: Do mossy fibers release GABA? Answer: We have presented strong evidence indicating the presence of a GABAergic signal from mossy fibers. The physiological function of this mossy fiber GABAergic signal remains unclear, though it might play a role in development. Additional data also suggests that this",9.474389094274162e-08,0.12684896146452207,0.02577160493827161,0.0072537058591274906,0.12690248065430154,0.024375,0.007243206163811466,0.09531017980432566,0.0,9.474389094274162e-08,0.09763846956391786,0.0
297,0.3,2,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this",Question: Are mossy fibers capable of releasing GABA? Answer: Our findings provide convincing proof of a GABAergic signal originating from mossy fibers. The exact physiological purpose of this mossy fiber GABAergic signal is not yet known but could be important during development. Further evidence indicates that this,9.474389094274162e-08,0.12684896146452207,0.02577160493827161,0.0072537058591274906,0.12690248065430154,0.024375,0.007243206163811466,0.09531017980432566,0.0,9.474389094274162e-08,0.09763846956391786,0.0
297,0.3,3,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this","Question: Do mossy fibers emit GABA? Answer: We have demonstrated compelling evidence supporting a GABAergic signal from mossy fibers. The physiological significance of this mossy fiber GABAergic signal is uncertain, but it may have developmental relevance. Other findings suggest that this",4.737194547137081e-08,0.017433506001244048,0.022516436554898087,0.0036268529295637453,0.01619836298637356,0.024375,0.003621603081905733,0.051293294387549704,0.0,4.737194547137081e-08,0.05264373348541884,0.0
297,0.3,4,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this","Question: Is GABA released by mossy fibers? Answer: We have supplied strong evidence for the existence of a mossy fiber GABAergic signal. The physiological role of this mossy fiber GABAergic signal is still unclear, though it might be crucial for development. Additional research suggests that this",7.105791820705622e-08,0.07339380596669631,0.003151703623580318,0.005440279394345618,0.07292293477679124,0.0016600189291508909,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
297,0.3,5,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this",Question: Do mossy fibers secrete GABA? Answer: Evidence we provided strongly supports a GABAergic signal from mossy fibers. The physiological role of this mossy fiber GABAergic signal remains uncertain but could be important in developmental processes. Other data also imply that this,2.3685972735685406e-08,0.008104408028834165,0.023125000000000007,0.0018134264647818726,0.009119444997918169,0.024375,0.0018108015409528666,0.02531780798429173,0.0,2.3685972735685406e-08,0.025975486403257975,0.0
297,0.3,6,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this",Question: Are mossy fibers GABAergic? Answer: We have provided compelling evidence that mossy fibers exhibit a GABAergic signal. The physiological function of this mossy fiber GABAergic signal is not fully understood but may be significant during development. Additional evidence points to this,2.3685972735685406e-08,0.008104408028834165,0.023125000000000007,0.0018134264647818726,0.009119444997918169,0.024375,0.0018108015409528666,0.02531780798429173,0.0,2.3685972735685406e-08,0.025975486403257975,0.0
297,0.3,7,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this","Question: Do mossy fibers produce GABA? Answer: Our evidence strongly indicates the presence of a GABAergic signal from mossy fibers. The physiological role of this mossy fiber GABAergic signal is uncertain, though it may have developmental importance. Other studies suggest that this",2.3685972735685406e-08,0.008104408028834165,0.023125000000000007,0.0018134264647818726,0.009119444997918169,0.024375,0.0018108015409528666,0.02531780798429173,0.0,2.3685972735685406e-08,0.025975486403257975,0.0
297,0.3,8,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this",Question: Is there GABA release from mossy fibers? Answer: We have presented convincing evidence of a GABAergic signal from mossy fibers. The physiological role of this mossy fiber GABAergic signal is unclear but might be important for development. Additional evidence suggests that this,0.0,0.0,0.0,0.0,0.03381205758828987,0.024375,0.0,0.0,0.0,0.0,0.0,0.0
297,0.3,9,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this",Question: Do mossy fibers have a GABAergic signal? Answer: We have shown strong evidence supporting a GABAergic signal in mossy fibers. The physiological significance of this mossy fiber GABAergic signal is uncertain but may be relevant to development. Other evidence indicates that this,0.0,0.0,6.938893903907228e-18,0.0,0.03381205758828987,0.024375,0.0,0.0,0.0,0.0,0.0,0.0
297,0.3,10,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this",Question: Are mossy fibers involved in GABA release? Answer: We have provided compelling proof of a GABAergic signal from mossy fibers. The physiological role of this mossy fiber GABAergic signal is not yet known but could be important during developmental stages. Further evidence suggests that this,7.105791820705622e-08,0.10420034732491601,0.025289256198347116,0.005440279394345618,0.10442962480224383,0.024375,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
298,0.3,1,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: There is no guarantee that low-tone sudden deafness will progress to Meniere's disease. While there may be some cases where this occurs, it is not a universal outcome. The prognosis for each","What is the prognosis for low-tone sudden deafness—does it always lead to Meniere's disease? There is no certainty that low-tone sudden deafness will develop into Meniere's disease. Although it can happen in some instances, it is not an inevitable result. Each case has its own prognosis.",2.3685972735685406e-08,0.06776188767256075,0.06395705665186187,0.0018134264647818726,0.03914022686438168,0.04434829637641968,0.0018108015409528666,0.022989518224699523,0.0,2.3685972735685406e-08,0.023530497410194418,0.0
298,0.3,2,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: There is no guarantee that low-tone sudden deafness will progress to Meniere's disease. While there may be some cases where this occurs, it is not a universal outcome. The prognosis for each","Does low-tone sudden deafness inevitably progress to Meniere's disease? The progression from low-tone sudden deafness to Meniere's disease is not guaranteed. While some patients may experience this, it is not a definite outcome. Prognosis varies per individual.",2.3685972735685364e-07,0.2786078290745282,0.023207199546485244,0.018134264647818726,0.22930975588217795,0.015801583573651523,0.018108015409528673,0.2578291093020999,0.0,2.3685972735685406e-07,0.26469255422708216,0.0
298,0.3,3,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: There is no guarantee that low-tone sudden deafness will progress to Meniere's disease. While there may be some cases where this occurs, it is not a universal outcome. The prognosis for each","Is the prognosis of low-tone sudden deafness such that it always advances to Meniere's disease? Low-tone sudden deafness does not necessarily progress to Meniere's disease. Some cases may evolve this way, but it is not a universal progression. Each prognosis is unique.",1.1842986367842703e-07,0.09595816680010083,0.01345311901307153,0.009067132323909363,0.09082731196794036,0.01936473293131776,0.009054007704764333,0.12062798778861739,0.0,1.1842986367842703e-07,0.12361395596717584,0.0
298,0.3,4,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: There is no guarantee that low-tone sudden deafness will progress to Meniere's disease. While there may be some cases where this occurs, it is not a universal outcome. The prognosis for each","Does low-tone sudden deafness inevitably lead to Meniere's disease? There is no assurance that low-tone sudden deafness will turn into Meniere's disease. Although it can occur in certain cases, it is not a consistent outcome. Prognosis depends on the individual.",1.6580180914979774e-07,0.11562443312886295,0.035035587159139306,0.012693985253473108,0.14394467788328003,0.01805172953931231,0.012675610786670066,0.17327172127403623,0.0,1.6580180914979784e-07,0.17768117723745203,0.0
298,0.3,5,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: There is no guarantee that low-tone sudden deafness will progress to Meniere's disease. While there may be some cases where this occurs, it is not a universal outcome. The prognosis for each","Will low-tone sudden deafness always develop into Meniere's disease? Low-tone sudden deafness does not inevitably result in Meniere's disease. Some patients might experience this progression, but it is not guaranteed. Prognosis is case-dependent.",3.3160361829959484e-07,0.3290015555098069,0.02394557823129253,0.025387970506946245,0.35578137550808453,0.012126074154197482,0.025351221573340167,0.3829922522561069,0.0,3.316036182995957e-07,0.39390428570708913,0.0
298,0.3,6,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: There is no guarantee that low-tone sudden deafness will progress to Meniere's disease. While there may be some cases where this occurs, it is not a universal outcome. The prognosis for each","Is it certain that low-tone sudden deafness progresses to Meniere's disease? There is no certainty that low-tone sudden deafness will progress to Meniere's disease. While it may happen in some cases, it is not an inevitable outcome. Each prognosis differs.",1.6580180914979774e-07,0.1867164516478308,0.015056689342403645,0.012693985253473108,0.1804261084390668,0.008120839426049457,0.012675610786670066,0.21073913643943865,0.027006172839506164,1.6580180914979784e-07,0.17768117723745203,0.0
298,0.3,7,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: There is no guarantee that low-tone sudden deafness will progress to Meniere's disease. While there may be some cases where this occurs, it is not a universal outcome. The prognosis for each","Does low-tone sudden deafness always lead to Meniere's disease? Low-tone sudden deafness does not inevitably lead to Meniere's disease. Although some cases may progress this way, it is not a universal outcome. Prognosis varies with each patient.",2.3685972735685364e-07,0.2786078290745282,0.023207199546485244,0.018134264647818726,0.26891816619988873,0.012584669647455422,0.018108015409528673,0.2578291093020999,0.0,2.3685972735685406e-07,0.26469255422708216,0.0
298,0.3,8,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: There is no guarantee that low-tone sudden deafness will progress to Meniere's disease. While there may be some cases where this occurs, it is not a universal outcome. The prognosis for each",Is progression from low-tone sudden deafness to Meniere's disease inevitable? There is no guarantee that low-tone sudden deafness will progress to Meniere's disease. It can occur in some cases but is not a guaranteed progression. Prognosis is individualized.,2.1317375462116834e-07,0.20957839359152208,0.005717973463895409,0.016320838183036854,0.20003864529554471,0.016593194335603353,0.0162972138685758,0.2288415724288484,0.0,2.1317375462116866e-07,0.23483959107740038,0.0
298,0.3,9,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: There is no guarantee that low-tone sudden deafness will progress to Meniere's disease. While there may be some cases where this occurs, it is not a universal outcome. The prognosis for each","Does low-tone sudden deafness inevitably result in Meniere's disease? Low-tone sudden deafness does not necessarily result in Meniere's disease. While it may happen occasionally, it is not a certain outcome. Prognosis depends on the individual case.",2.6054570009253894e-07,0.31117964052097014,0.02621513398977346,0.019947691112600606,0.3002356095624181,0.014245453623580318,0.019918816950481547,0.2876820724517817,0.0,2.6054570009253947e-07,0.29546421289383584,0.0
298,0.3,10,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: There is no guarantee that low-tone sudden deafness will progress to Meniere's disease. While there may be some cases where this occurs, it is not a universal outcome. The prognosis for each","Is the development of Meniere's disease inevitable after low-tone sudden deafness? There is no certainty that low-tone sudden deafness will develop into Meniere's disease. Although it may occur in some instances, it is not a universal progression. Prognosis is specific to each case.",9.474389094274162e-08,0.0034314510542627907,0.0623724405486962,0.0072537058591274906,0.03147734034957228,0.04434829637641968,0.007243206163811466,0.09531017980432566,0.0,9.474389094274162e-08,0.09763846956391786,0.0
299,0.3,1,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the observation period. We therefore,"Can functional magnetic resonance imaging of mental imagery forecast recovery in patients with consciousness disorders? The fMRI mental imagery paradigm shows strong agreement with the subsequent clinical progression in patients in a vegetative state (VS). All five VS patients exhibiting significant activation in regions of interest (ROIs) experienced a positive clinical course through the observation period. Hence, we...",9.474389094274162e-08,0.04828609254385885,0.014007429172276195,0.0072537058591274906,0.04588796546828533,0.016661878770468257,0.007243206163811466,0.07020425867324764,0.0,9.474389094274162e-08,0.07145896398214369,0.0
299,0.3,2,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the observation period. We therefore,"Is it possible for mental imagery fMRI to predict recovery in patients suffering from disorders of consciousness? The mental imagery fMRI paradigm demonstrates high concordance with the later clinical outcomes of patients in a vegetative state. Each of the five VS patients who showed notable ROI activation had a favorable clinical progression until the end of the study. Therefore, we...",4.737194547137081e-08,0.0356475528507314,0.0016527791259191016,0.0036268529295637453,0.03469827257287594,0.0005741938672664294,0.003621603081905733,0.03448617607116855,0.0,4.737194547137081e-08,0.03509131981126945,0.0
299,0.3,3,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the observation period. We therefore,"Can mental imagery functional MRI serve as a predictor for recovery in patients with consciousness disorders? The fMRI paradigm involving mental imagery correlates strongly with the future clinical trajectory of patients in a vegetative state. All five VS patients with significant ROI activation had a positive clinical course throughout the observation period. Thus, we...",1.8948778188548325e-07,0.12471653417781337,0.011370935261796784,0.014507411718254981,0.119995937622007,0.016661878770468257,0.014486412327622933,0.14571181118139354,0.0,1.8948778188548325e-07,0.14842000511827358,0.0
299,0.3,4,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the observation period. We therefore,"Does mental imagery fMRI predict recovery outcomes in patients with disorders of consciousness? The mental imagery fMRI paradigm aligns closely with the subsequent clinical course of patients in a vegetative state. All five VS patients who demonstrated significant activation in ROIs experienced favorable outcomes by the end of the observation period. Consequently, we...",2.1317375462116866e-07,0.1447707482784919,0.01064875148632579,0.016320838183036854,0.16659626585400922,0.0029381212295317358,0.0162972138685758,0.1655144384775733,0.0,2.1317375462116866e-07,0.1686227124357922,0.0
299,0.3,5,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the observation period. We therefore,"Can functional MRI using mental imagery predict recovery in patients with consciousness disorders? The mental imagery fMRI paradigm shows a high level of agreement with the later clinical progression of patients in a vegetative state. All five VS patients with significant ROI activation had a positive clinical course until the observation period concluded. Hence, we...",1.6580180914979784e-07,0.10505564200345141,0.012066502965615747,0.012693985253473108,0.1009477426513139,0.016661878770468257,0.012675610786670066,0.12629372532429084,0.0,1.6580180914979784e-07,0.12861737782209381,0.0
299,0.3,6,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the observation period. We therefore,"Is mental imagery functional MRI effective in predicting recovery in patients with disorders of consciousness? The fMRI mental imagery paradigm exhibits strong concordance with the subsequent clinical course of patients in a vegetative state. All five VS patients who showed significant ROI activation had favorable outcomes through the observation period. Therefore, we...",2.3685972735685406e-07,0.13805206262126735,0.029448751486325808,0.018134264647818726,0.15921665077528946,0.016661878770468257,0.018108015409528666,0.1857171457950919,0.0,2.3685972735685406e-07,0.18924199963852795,0.0
299,0.3,7,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the observation period. We therefore,"Can mental imagery fMRI be used to predict recovery in patients with disorders of consciousness? The mental imagery fMRI paradigm demonstrates a high concordance with the future clinical course of patients in a vegetative state. All five VS patients with significant activation in ROIs had a favorable clinical progression until the end of the observation period. Thus, we...",9.474389094274162e-08,0.07260704624771641,0.0034203843161433115,0.0072537058591274906,0.07064322191685513,0.0011893608989532352,0.007243206163811466,0.07020425867324764,0.0,9.474389094274162e-08,0.07145896398214369,0.0
299,0.3,8,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the observation period. We therefore,"Is it feasible for mental imagery functional MRI to predict recovery in patients with consciousness disorders? The fMRI paradigm of mental imagery shows strong agreement with the further clinical course of patients in a vegetative state. All five VS patients exhibiting significant ROI activation had a positive clinical course by the end of the observation period. Therefore, we...",9.474389094274162e-08,0.04828609254385885,0.014007429172276195,0.0072537058591274906,0.04588796546828533,0.016661878770468257,0.007243206163811466,0.07020425867324764,0.0,9.474389094274162e-08,0.07145896398214369,0.0
299,0.3,9,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the observation period. We therefore,"Can mental imagery fMRI predict recovery in patients suffering from disorders of consciousness? The mental imagery fMRI paradigm displays high concordance with the subsequent clinical progression of patients in a vegetative state. All five VS patients with significant ROI activation experienced a favorable clinical course until the observation period ended. Hence, we...",2.3685972735685406e-07,0.1652343049961673,0.009898397467167107,0.018134264647818726,0.18694253799768745,0.003329791366974477,0.018108015409528666,0.1857171457950919,0.0,2.3685972735685406e-07,0.18924199963852795,0.0
299,0.3,10,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the observation period. We therefore,"Does functional MRI of mental imagery predict recovery in patients with disorders of consciousness? The fMRI mental imagery paradigm correlates highly with the future clinical course of patients in a vegetative state. All five VS patients who showed significant activation of ROIs had a positive clinical outcome throughout the observation period. Therefore, we...",2.1317375462116866e-07,0.11811124133387851,0.02982537586156609,0.016320838183036854,0.1394140234791097,0.016661878770468257,0.0162972138685758,0.1655144384775733,0.0,2.1317375462116866e-07,0.1686227124357922,0.0
